country,term,count
AF,BLOOD PRESSURE INCREASED,1
AF,DRUG EFFECT DECREASED,1
AF,PRODUCT SUBSTITUTION ISSUE,1
AL,ACUTE MYOCARDIAL INFARCTION,1
AL,LARGE INTESTINE PERFORATION,1
AL,MULTI-ORGAN FAILURE,1
DZ,HAEMATURIA,2
DZ,CARDIAC VENTRICULAR DISORDER,1
DZ,CONVULSION,1
DZ,DEATH,1
DZ,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
DZ,GINGIVAL BLEEDING,1
DZ,MENINGORRHAGIA,1
DZ,MYOCARDIAL ISCHAEMIA,1
AS,FAECES DISCOLOURED,1
AS,GASTRIC HAEMORRHAGE,1
AS,GASTROINTESTINAL ARTERIOVENOUS MALFORMATION,1
AS,GASTROINTESTINAL HAEMORRHAGE,1
AS,OCCULT BLOOD POSITIVE,1
AS,THERAPY CHANGE,1
AR,ANAEMIA,8
AR,BLOOD PRESSURE INCREASED,8
AR,FALL,8
AR,DIABETES MELLITUS,6
AR,PNEUMONIA,6
AR,RENAL FAILURE,6
AR,ANGINA UNSTABLE,5
AR,ARRHYTHMIA,5
AR,ASTHENIA,5
AR,CARDIAC FAILURE,5
AR,COUGH,5
AR,DIARRHOEA,5
AR,FATIGUE,5
AR,HEADACHE,5
AR,HYPERTENSION,5
AR,MALAISE,5
AR,PERIPHERAL SWELLING,5
AR,ACUTE KIDNEY INJURY,4
AR,BLOOD CHOLESTEROL INCREASED,4
AR,CARDIO-RESPIRATORY ARREST,4
AR,CEREBROVASCULAR ACCIDENT,4
AR,DIABETIC FOOT,4
AR,DYSPNOEA,4
AR,MATERNAL EXPOSURE DURING PREGNANCY,4
AR,MYOCARDIAL INFARCTION,4
AR,PAIN IN EXTREMITY,4
AR,SYNCOPE,4
AR,VOMITING,4
AR,WEIGHT DECREASED,4
AR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,4
AR,ABDOMINAL DISTENSION,3
AR,ABDOMINAL PAIN UPPER,3
AR,ABORTION SPONTANEOUS,3
AR,ANGIOEDEMA,3
AR,BLOOD PRESSURE ABNORMAL,3
AR,BLOOD PRESSURE SYSTOLIC INCREASED,3
AR,BRONCHOSPASM,3
AR,CELLULITIS,3
AR,CORONARY ARTERY OCCLUSION,3
AR,DRUG INEFFECTIVE,3
AR,EPISTAXIS,3
AR,GASTRITIS,3
AR,GASTROENTERITIS,3
AR,HAEMORRHAGE,3
AR,HIP FRACTURE,3
AR,HYPOTENSION,3
AR,INFARCTION,3
AR,INFECTION,3
AR,LOSS OF CONSCIOUSNESS,3
AR,OSTEOARTHRITIS,3
AR,PAIN,3
AR,PANCREATITIS ACUTE,3
AR,PULMONARY OEDEMA,3
AR,TACHYCARDIA,3
AR,URTICARIA,3
AR,WHITE BLOOD CELL COUNT INCREASED,3
AR,ABASIA,2
AR,ACUTE MYOCARDIAL INFARCTION,2
AR,AGGRESSION,2
AR,AORTIC ANEURYSM,2
AR,ARTERIAL OCCLUSIVE DISEASE,2
AR,ASPIRATION,2
AR,BACK PAIN,2
AR,BENIGN PROSTATIC HYPERPLASIA,2
AR,BLOOD GLUCOSE INCREASED,2
AR,BLOOD PRESSURE DECREASED,2
AR,CARDIAC FAILURE CONGESTIVE,2
AR,CAROTID ARTERY OCCLUSION,2
AR,CHEST DISCOMFORT,2
AR,CHOLELITHIASIS,2
AR,CHRONIC KIDNEY DISEASE,2
AR,CONCOMITANT DISEASE AGGRAVATED,2
AR,CORONARY ARTERY DISEASE,2
AR,DECREASED APPETITE,2
AR,DEPRESSED MOOD,2
AR,FEELING ABNORMAL,2
AR,FLUID RETENTION,2
AR,GAIT DISTURBANCE,2
AR,GASTROINTESTINAL HAEMORRHAGE,2
AR,GENERAL PHYSICAL HEALTH DETERIORATION,2
AR,GLOMERULAR FILTRATION RATE DECREASED,2
AR,HAEMATOCRIT DECREASED,2
AR,HAEMATOMA,2
AR,HAEMATURIA,2
AR,HEPATIC ENZYME INCREASED,2
AR,HYPERHIDROSIS,2
AR,HYPERSENSITIVITY,2
AR,HYPERTENSIVE CRISIS,2
AR,INSOMNIA,2
AR,MEMORY IMPAIRMENT,2
AR,NAUSEA,2
AR,NERVOUSNESS,2
AR,ORAL PAIN,2
AR,OSTEONECROSIS,2
AR,OVERWEIGHT,2
AR,PANCREATIC CARCINOMA,2
AR,PANCREATITIS,2
AR,PRODUCT USE ISSUE,2
AR,PRURITUS,2
AR,PRURITUS GENERALISED,2
AR,RENAL FAILURE ACUTE,2
AR,SEPSIS,2
AR,SKIN ULCER,2
AR,SUDDEN DEATH,2
AR,THROMBOSIS,2
AR,URINARY INCONTINENCE,2
AR,URINARY TRACT INFECTION,2
AR,ABDOMINAL DISCOMFORT,1
AR,ABDOMINAL PAIN,1
AR,ABNORMAL FAECES,1
AR,ACCIDENT,1
AR,ACCIDENTAL OVERDOSE,1
AR,ACNE,1
AR,ACUTE ABDOMEN,1
AR,ADENOCARCINOMA GASTRIC,1
AR,ADENOCARCINOMA PANCREAS,1
AR,AGITATION,1
AR,ALANINE AMINOTRANSFERASE INCREASED,1
AR,ALOPECIA,1
AR,AMNESIA,1
AR,AMYLASE INCREASED,1
AR,ANAL INCONTINENCE,1
AR,ANXIETY,1
AR,AORTIC BRUIT,1
AR,APHASIA,1
AR,APPARENT DEATH,1
AR,ARTERIAL THROMBOSIS,1
AR,ARTHRALGIA,1
AR,ASCITES,1
AR,ASPARTATE AMINOTRANSFERASE INCREASED,1
AR,ASTHMA,1
AR,BACK INJURY,1
AR,BENIGN OVARIAN TUMOUR,1
AR,BILE DUCT STENOSIS,1
AR,BILE DUCT STONE,1
AR,BLINDNESS UNILATERAL,1
AR,BLISTER,1
AR,BLOOD GLUCOSE DECREASED,1
AR,BLOOD PRESSURE DIASTOLIC DECREASED,1
AR,BLOOD PRESSURE FLUCTUATION,1
AR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
AR,BLOOD TRIGLYCERIDES INCREASED,1
AR,BLOOD UREA INCREASED,1
AR,BLOODY DISCHARGE,1
AR,BRADYARRHYTHMIA,1
AR,BRADYCARDIA,1
AR,BREAST CANCER,1
AR,BREAST HAEMATOMA,1
AR,BREAST INJURY,1
AR,BREAST SWELLING,1
AR,BURNING SENSATION,1
AR,CARDIAC ARREST,1
AR,CARDIAC PACEMAKER REPLACEMENT,1
AR,CARDIAC SIDEROSIS,1
AR,CARDIAC VENTRICULAR DISORDER,1
AR,CARDIOGENIC SHOCK,1
AR,CARDIOPULMONARY FAILURE,1
AR,CARDIOVASCULAR DISORDER,1
AR,CATARACT,1
AR,CATARRH,1
AR,CATATONIA,1
AR,CEREBRAL HAEMORRHAGE,1
AR,CEREBRAL ISCHAEMIA,1
AR,CHEST PAIN,1
AR,CHOLECYSTITIS ACUTE,1
AR,CHRONIC GASTRITIS,1
AR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AR,COLON CANCER,1
AR,COMA,1
AR,COMPLETED SUICIDE,1
AR,COMPLICATION ASSOCIATED WITH DEVICE,1
AR,CONTUSION,1
AR,DEATH,1
AR,DEEP VEIN THROMBOSIS,1
AR,DENGUE FEVER,1
AR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
AR,DEPRESSION,1
AR,DIABETES MELLITUS INADEQUATE CONTROL,1
AR,DIALYSIS,1
AR,DISEASE PROGRESSION,1
AR,DIZZINESS,1
AR,DRUG DEPENDENCE,1
AR,DRUG-INDUCED LIVER INJURY,1
AR,DRY EYE,1
AR,DRY GANGRENE,1
AR,DUODENAL ULCER,1
AR,DYSPEPSIA,1
AR,EATING DISORDER,1
AR,FACIAL PARALYSIS,1
AR,FEAR,1
AR,FEAR OF INJECTION,1
AR,FEMORAL NECK FRACTURE,1
AR,FOETAL DEATH,1
AR,FRACTURE PAIN,1
AR,FRACTURED SACRUM,1
AR,FUNGAL INFECTION,1
AR,GALLBLADDER DISORDER,1
AR,GANGRENE,1
AR,GASTRIC DISORDER,1
AR,GASTRIC DYSPLASIA,1
AR,GASTRIC ULCER,1
AR,GENERAL SYMPTOM,1
AR,GINGIVAL BLEEDING,1
AR,GLAUCOMA,1
AR,GROIN PAIN,1
AR,HAEMOGLOBIN DECREASED,1
AR,HAEMORRHAGE INTRACRANIAL,1
AR,HEAD DISCOMFORT,1
AR,HEAD INJURY,1
AR,HEART VALVE INCOMPETENCE,1
AR,HEPATIC CIRRHOSIS,1
AR,HEPATIC CYST,1
AR,HEPATIC FAILURE,1
AR,HEPATIC PAIN,1
AR,HEPATITIS,1
AR,HEPATITIS A,1
AR,HEPATITIS B,1
AR,HEPATITIS C,1
AR,HERPES VIRUS INFECTION,1
AR,HYPERGLYCAEMIA,1
AR,HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME,1
AR,HYPERTENSIVE EMERGENCY,1
AR,HYPOAESTHESIA,1
AR,HYPOGLYCAEMIA,1
AR,HYPOGLYCAEMIC SEIZURE,1
AR,HYPOTHYROIDISM,1
AR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
AR,INCORRECT DOSE ADMINISTERED,1
AR,INFLUENZA,1
AR,INFREQUENT BOWEL MOVEMENTS,1
AR,INGUINAL HERNIA,1
AR,INSULIN RESISTANT DIABETES,1
AR,INTERNATIONAL NORMALISED RATIO INCREASED,1
AR,INTERVERTEBRAL DISC DISORDER,1
AR,INTESTINAL OBSTRUCTION,1
AR,INTRACRANIAL ANEURYSM,1
AR,ISCHAEMIA,1
AR,ISCHAEMIC STROKE,1
AR,JOINT SWELLING,1
AR,LIMB AMPUTATION,1
AR,LIMB DEFORMITY,1
AR,LIPASE INCREASED,1
AR,LOWER GASTROINTESTINAL HAEMORRHAGE,1
AR,LOWER LIMB FRACTURE,1
AR,LUNG DISORDER,1
AR,LUNG NEOPLASM MALIGNANT,1
AR,LYMPHOCYTE PERCENTAGE DECREASED,1
AR,MEDICATION ERROR,1
AR,MICTURITION URGENCY,1
AR,MOBILITY DECREASED,1
AR,MOVEMENT DISORDER,1
AR,MULTIPLE SCLEROSIS,1
AR,MULTIPLE SCLEROSIS RELAPSE,1
AR,MUSCLE NECROSIS,1
AR,MUSCLE SPASMS,1
AR,MUSCULAR WEAKNESS,1
AR,MUSCULOSKELETAL DISCOMFORT,1
AR,MYALGIA,1
AR,MYOPATHY,1
AR,NASAL DRYNESS,1
AR,NECK PAIN,1
AR,NEPHROLITHIASIS,1
AR,NERVOUS SYSTEM DISORDER,1
AR,NEUROLOGICAL SYMPTOM,1
AR,NEUTROPHIL PERCENTAGE INCREASED,1
AR,NYSTAGMUS,1
AR,OBESITY,1
AR,OPTIC NERVE DISORDER,1
AR,ORAL MUCOSAL BLISTERING,1
AR,PAINFUL RESPIRATION,1
AR,PANCREATIC DISORDER,1
AR,PANCREATIC NEOPLASM,1
AR,PANCYTOPENIA,1
AR,PELVIC FRACTURE,1
AR,PERICARDIAL EFFUSION,1
AR,PERICARDIAL HAEMORRHAGE,1
AR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AR,PERIPHERAL VASCULAR DISORDER,1
AR,PERIPHERAL VENOUS DISEASE,1
AR,PERITONITIS,1
AR,PHIMOSIS,1
AR,PLASMA CELL MYELOMA,1
AR,PLATELET COUNT DECREASED,1
AR,POLYMYOSITIS,1
AR,PRESCRIBED UNDERDOSE,1
AR,PRODUCTIVE COUGH,1
AR,PROSTATE CANCER,1
AR,PROSTATIC OPERATION,1
AR,PSYCHOMOTOR HYPERACTIVITY,1
AR,PSYCHOTIC DISORDER,1
AR,PULMONARY EMBOLISM,1
AR,PULMONARY FIBROSIS,1
AR,PULMONARY MASS,1
AR,PURULENT DISCHARGE,1
AR,PYREXIA,1
AR,RADIUS FRACTURE,1
AR,RED BLOOD CELL COUNT INCREASED,1
AR,RENAL CANCER,1
AR,RENAL DISORDER,1
AR,RENAL IMPAIRMENT,1
AR,RESPIRATORY FAILURE,1
AR,SARCOMA,1
AR,SCAR,1
AR,SEPTIC SHOCK,1
AR,SINUS NODE DYSFUNCTION,1
AR,SKIN DISCOLOURATION,1
AR,SKIN INFECTION,1
AR,SKIN ULCER HAEMORRHAGE,1
AR,SOFT TISSUE INFECTION,1
AR,SPEECH DISORDER,1
AR,SPINAL CORD DISORDER,1
AR,SPINAL FRACTURE,1
AR,SPLENIC INFARCTION,1
AR,STRESS,1
AR,STRESS ECHOCARDIOGRAM ABNORMAL,1
AR,SUFFOCATION FEELING,1
AR,THYROID MASS,1
AR,TOOTH FRACTURE,1
AR,TOOTH INFECTION,1
AR,TRANSIENT GLOBAL AMNESIA,1
AR,TRANSITIONAL CELL CARCINOMA,1
AR,TUBULOINTERSTITIAL NEPHRITIS,1
AR,UNDERDOSE,1
AR,UPPER GASTROINTESTINAL HAEMORRHAGE,1
AR,URETHRAL STENOSIS,1
AR,URINARY BLADDER POLYP,1
AR,UTERINE DISORDER,1
AR,UTERINE LEIOMYOMA,1
AR,VENOUS THROMBOSIS LIMB,1
AR,VERTIGO,1
AR,VIRAL MYOCARDITIS,1
AR,WRIST FRACTURE,1
AR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
AU,FALL,59
AU,PYREXIA,54
AU,FATIGUE,52
AU,DYSPNOEA,51
AU,DIARRHOEA,48
AU,DIZZINESS,46
AU,HYPOTENSION,44
AU,NAUSEA,41
AU,CHEST PAIN,40
AU,MYOCARDIAL INFARCTION,39
AU,MALAISE,37
AU,VOMITING,37
AU,ATRIAL FIBRILLATION,34
AU,CONFUSIONAL STATE,33
AU,ACUTE KIDNEY INJURY,31
AU,ANAEMIA,30
AU,RENAL FAILURE ACUTE,29
AU,ACUTE MYOCARDIAL INFARCTION,28
AU,BRADYCARDIA,27
AU,HEADACHE,27
AU,RHABDOMYOLYSIS,27
AU,WEIGHT DECREASED,26
AU,HAEMOGLOBIN DECREASED,24
AU,PAIN,24
AU,PAIN IN EXTREMITY,23
AU,ASTHENIA,22
AU,LOWER RESPIRATORY TRACT INFECTION,22
AU,OEDEMA PERIPHERAL,22
AU,RENAL IMPAIRMENT,22
AU,CONSTIPATION,21
AU,DECREASED APPETITE,21
AU,HYPOCALCAEMIA,21
AU,URINARY TRACT INFECTION,21
AU,ARTHRALGIA,20
AU,CEREBROVASCULAR ACCIDENT,20
AU,COUGH,20
AU,HYPERTENSION,20
AU,HYPONATRAEMIA,20
AU,PNEUMONIA,20
AU,BLOOD CREATININE INCREASED,19
AU,EJECTION FRACTION DECREASED,19
AU,ALANINE AMINOTRANSFERASE INCREASED,18
AU,CARDIAC FAILURE,18
AU,CORONARY ARTERY DISEASE,18
AU,DEHYDRATION,18
AU,FEBRILE NEUTROPENIA,18
AU,HYPOMAGNESAEMIA,18
AU,SEPSIS,18
AU,SYNCOPE,18
AU,WHITE BLOOD CELL COUNT INCREASED,18
AU,ABDOMINAL PAIN,17
AU,CARDIAC ARREST,17
AU,LETHARGY,17
AU,OVERDOSE,17
AU,BACK PAIN,16
AU,C-REACTIVE PROTEIN INCREASED,16
AU,DEEP VEIN THROMBOSIS,16
AU,HYPOGLYCAEMIA,16
AU,LOSS OF CONSCIOUSNESS,16
AU,MITRAL VALVE INCOMPETENCE,16
AU,NEUTROPENIA,16
AU,BLOOD GLUCOSE INCREASED,15
AU,GLOMERULAR FILTRATION RATE DECREASED,15
AU,TACHYCARDIA,15
AU,TOXICITY TO VARIOUS AGENTS,15
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,14
AU,GASTROINTESTINAL HAEMORRHAGE,14
AU,INSOMNIA,14
AU,MUSCULAR WEAKNESS,14
AU,RESPIRATORY FAILURE,14
AU,THROMBOCYTOPENIA,14
AU,ANGINA PECTORIS,13
AU,CARDIAC FAILURE CONGESTIVE,13
AU,CELLULITIS,13
AU,CHILLS,13
AU,CONDITION AGGRAVATED,13
AU,DEATH,13
AU,DELIRIUM,13
AU,FEELING ABNORMAL,13
AU,LEFT VENTRICULAR DYSFUNCTION,13
AU,MOBILITY DECREASED,13
AU,RASH,13
AU,RECTAL HAEMORRHAGE,13
AU,SOMNOLENCE,13
AU,TROPONIN INCREASED,13
AU,VENTRICULAR HYPOKINESIA,13
AU,BLOOD PRESSURE INCREASED,12
AU,CHEST DISCOMFORT,12
AU,CONVULSION,12
AU,DIASTOLIC DYSFUNCTION,12
AU,HAEMORRHAGE INTRACRANIAL,12
AU,INTENTIONAL OVERDOSE,12
AU,LIVER FUNCTION TEST ABNORMAL,12
AU,MUSCLE SPASMS,12
AU,MYOCARDITIS,12
AU,NEUTROPHIL COUNT INCREASED,12
AU,PLEURAL EFFUSION,12
AU,PULMONARY OEDEMA,12
AU,SUBDURAL HAEMATOMA,12
AU,SUICIDAL IDEATION,12
AU,DRUG INEFFECTIVE,11
AU,DYSPNOEA EXERTIONAL,11
AU,GAIT DISTURBANCE,11
AU,HYPERKALAEMIA,11
AU,MYOCARDIAL ISCHAEMIA,11
AU,SCHIZOPHRENIA,11
AU,TRANSIENT ISCHAEMIC ATTACK,11
AU,AGITATION,10
AU,APHASIA,10
AU,ASPARTATE AMINOTRANSFERASE INCREASED,10
AU,BALANCE DISORDER,10
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,10
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,10
AU,EPISTAXIS,10
AU,EXERCISE TOLERANCE DECREASED,10
AU,MYALGIA,10
AU,PULMONARY EMBOLISM,10
AU,SINUS TACHYCARDIA,10
AU,VISION BLURRED,10
AU,ABDOMINAL DISTENSION,9
AU,ACIDOSIS,9
AU,ANTIPSYCHOTIC DRUG LEVEL INCREASED,9
AU,BASAL CELL CARCINOMA,9
AU,COLITIS,9
AU,CONTUSION,9
AU,ELECTROCARDIOGRAM QT PROLONGED,9
AU,INFECTION,9
AU,MUSCULOSKELETAL CHEST PAIN,9
AU,OXYGEN SATURATION DECREASED,9
AU,PARAESTHESIA,9
AU,PRURITUS,9
AU,SPEECH DISORDER,9
AU,TRICUSPID VALVE INCOMPETENCE,9
AU,UROSEPSIS,9
AU,WHITE BLOOD CELL COUNT DECREASED,9
AU,ANGIOEDEMA,8
AU,BLOOD UREA DECREASED,8
AU,CONGESTIVE CARDIOMYOPATHY,8
AU,DRUG HYPERSENSITIVITY,8
AU,HAEMATOCRIT DECREASED,8
AU,HYPERHIDROSIS,8
AU,HYPERLACTACIDAEMIA,8
AU,HYPOPHAGIA,8
AU,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,8
AU,INFLUENZA LIKE ILLNESS,8
AU,LACTIC ACIDOSIS,8
AU,MALIGNANT NEOPLASM PROGRESSION,8
AU,NECK PAIN,8
AU,ORTHOSTATIC HYPOTENSION,8
AU,OSTEOARTHRITIS,8
AU,PANCREATITIS,8
AU,SKIN ULCER,8
AU,SQUAMOUS CELL CARCINOMA,8
AU,TREMOR,8
AU,URINARY RETENTION,8
AU,WEIGHT INCREASED,8
AU,ASTHMA,7
AU,ATAXIA,7
AU,BLOOD CHOLESTEROL INCREASED,7
AU,BLOOD PRESSURE SYSTOLIC INCREASED,7
AU,BLOOD UREA INCREASED,7
AU,CARDIAC DISORDER,7
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,7
AU,CIRCULATORY COLLAPSE,7
AU,DEPRESSION,7
AU,ERYTHEMA,7
AU,GASTRIC ULCER,7
AU,GLOBULINS DECREASED,7
AU,HEART RATE IRREGULAR,7
AU,HYPOAESTHESIA,7
AU,INTESTINAL OBSTRUCTION,7
AU,JOINT SWELLING,7
AU,LYMPHOCYTE COUNT DECREASED,7
AU,MANIA,7
AU,MULTI-ORGAN FAILURE,7
AU,MYOPATHY,7
AU,PERICARDIAL EFFUSION,7
AU,PERIPHERAL SWELLING,7
AU,PLATELET COUNT DECREASED,7
AU,PSYCHOTIC DISORDER,7
AU,RENAL FAILURE,7
AU,SUBDURAL HAEMORRHAGE,7
AU,UNRESPONSIVE TO STIMULI,7
AU,URINE OUTPUT DECREASED,7
AU,VIRAL INFECTION,7
AU,ABDOMINAL DISCOMFORT,6
AU,ABDOMINAL PAIN UPPER,6
AU,ANGINA UNSTABLE,6
AU,ANXIETY,6
AU,BLOOD ALBUMIN DECREASED,6
AU,BLOOD PRESSURE DECREASED,6
AU,BLOOD SODIUM INCREASED,6
AU,BLOOD TRIGLYCERIDES INCREASED,6
AU,BLOOD URIC ACID INCREASED,6
AU,BRONCHITIS,6
AU,CEREBRAL HAEMORRHAGE,6
AU,CYANOSIS,6
AU,DEMENTIA,6
AU,DRUG-INDUCED LIVER INJURY,6
AU,DYSARTHRIA,6
AU,DYSPEPSIA,6
AU,DYSPHAGIA,6
AU,ELECTROCARDIOGRAM PR PROLONGATION,6
AU,FLANK PAIN,6
AU,GASTRIC ULCER HAEMORRHAGE,6
AU,HAEMATURIA,6
AU,HAEMORRHAGE,6
AU,HAEMORRHAGIC STROKE,6
AU,HEPATITIS,6
AU,HYPERCHOLESTEROLAEMIA,6
AU,HYPOKALAEMIA,6
AU,HYPOPITUITARISM,6
AU,INTERNATIONAL NORMALISED RATIO INCREASED,6
AU,IRON DEFICIENCY ANAEMIA,6
AU,LIMB DISCOMFORT,6
AU,MENTAL DISORDER,6
AU,MONOCYTE COUNT INCREASED,6
AU,MUSCLE TWITCHING,6
AU,MUSCULOSKELETAL STIFFNESS,6
AU,MYOCLONUS,6
AU,MYOSITIS,6
AU,NEURALGIA,6
AU,NEUTROPHIL COUNT DECREASED,6
AU,PALPITATIONS,6
AU,PERICARDITIS,6
AU,POST PROCEDURAL HAEMORRHAGE,6
AU,RASH PRURITIC,6
AU,RED BLOOD CELL COUNT DECREASED,6
AU,RESPIRATORY TRACT INFECTION,6
AU,SEIZURE,6
AU,SEPTIC SHOCK,6
AU,SMALL INTESTINAL OBSTRUCTION,6
AU,SUICIDE ATTEMPT,6
AU,SUPRAVENTRICULAR EXTRASYSTOLES,6
AU,TETANY,6
AU,THROMBOTIC MICROANGIOPATHY,6
AU,TREATMENT NONCOMPLIANCE,6
AU,TROPONIN T INCREASED,6
AU,UPPER GASTROINTESTINAL HAEMORRHAGE,6
AU,ACUTE PULMONARY OEDEMA,5
AU,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,5
AU,BLOOD PHOSPHORUS DECREASED,5
AU,BLOOD PRESSURE ABNORMAL,5
AU,BLOOD SODIUM DECREASED,5
AU,BONE PAIN,5
AU,BUNDLE BRANCH BLOCK LEFT,5
AU,CARDIAC SEPTAL HYPERTROPHY,5
AU,CARDIOMYOPATHY,5
AU,CHOLELITHIASIS,5
AU,CORONARY ARTERY OCCLUSION,5
AU,CORONARY ARTERY STENOSIS,5
AU,DEAFNESS NEUROSENSORY,5
AU,DEPRESSED MOOD,5
AU,DIABETIC KETOACIDOSIS,5
AU,DISTURBANCE IN ATTENTION,5
AU,DIVERTICULITIS,5
AU,DRUG ADMINISTRATION ERROR,5
AU,DRY MOUTH,5
AU,EOSINOPHILIA,5
AU,ESCHERICHIA URINARY TRACT INFECTION,5
AU,EXPOSURE DURING PREGNANCY,5
AU,EYE PAIN,5
AU,FAECALOMA,5
AU,FLUID OVERLOAD,5
AU,FOETAL EXPOSURE DURING PREGNANCY,5
AU,GASTROENTERITIS,5
AU,GASTROOESOPHAGEAL REFLUX DISEASE,5
AU,HEART RATE INCREASED,5
AU,HEMIPARESIS,5
AU,HEPATIC FUNCTION ABNORMAL,5
AU,HEPATIC STEATOSIS,5
AU,HIGH DENSITY LIPOPROTEIN DECREASED,5
AU,HIP FRACTURE,5
AU,HOT FLUSH,5
AU,HYPERSENSITIVITY,5
AU,INTERSTITIAL LUNG DISEASE,5
AU,IRON DEFICIENCY,5
AU,ISCHAEMIC CARDIOMYOPATHY,5
AU,ISCHAEMIC STROKE,5
AU,LEFT ATRIAL DILATATION,5
AU,LEUKOCYTOSIS,5
AU,MEMORY IMPAIRMENT,5
AU,METABOLIC ACIDOSIS,5
AU,NEUROPATHY PERIPHERAL,5
AU,NEUTROPHILIA,5
AU,OEDEMA,5
AU,OROPHARYNGEAL PAIN,5
AU,PALLOR,5
AU,PANCYTOPENIA,5
AU,PARANOIA,5
AU,POLLAKIURIA,5
AU,PULMONARY HYPERTENSION,5
AU,RASH ERYTHEMATOUS,5
AU,RENAL CYST,5
AU,SLEEP APNOEA SYNDROME,5
AU,STRESS,5
AU,TEMPERATURE INTOLERANCE,5
AU,THINKING ABNORMAL,5
AU,TOTAL CHOLESTEROL/HDL RATIO INCREASED,5
AU,TYPE 2 DIABETES MELLITUS,5
AU,VITAMIN D DECREASED,5
AU,ABASIA,4
AU,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,4
AU,ACUTE CORONARY SYNDROME,4
AU,AGRANULOCYTOSIS,4
AU,AMNESIA,4
AU,ANAPHYLACTIC REACTION,4
AU,ANTICONVULSANT DRUG LEVEL DECREASED,4
AU,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,4
AU,AORTIC STENOSIS,4
AU,AORTIC VALVE INCOMPETENCE,4
AU,ARTHRITIS,4
AU,ASCITES,4
AU,BLOOD BICARBONATE DECREASED,4
AU,BLOOD CALCIUM DECREASED,4
AU,BLOOD LACTATE DEHYDROGENASE INCREASED,4
AU,CALCIPHYLAXIS,4
AU,CARDIOMEGALY,4
AU,COLD SWEAT,4
AU,COMA SCALE ABNORMAL,4
AU,DEAFNESS,4
AU,DELUSION,4
AU,DIABETES MELLITUS,4
AU,DIABETES MELLITUS INADEQUATE CONTROL,4
AU,DIABETIC ULCER,4
AU,DISSEMINATED INTRAVASCULAR COAGULATION,4
AU,DIVERTICULUM,4
AU,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
AU,DUODENAL ULCER,4
AU,ELECTROCARDIOGRAM ABNORMAL,4
AU,EMOTIONAL DISTRESS,4
AU,EMPHYSEMA,4
AU,ENCEPHALOPATHY,4
AU,EYE HAEMORRHAGE,4
AU,FLUSHING,4
AU,FOETAL DEATH,4
AU,FOETAL GROWTH RESTRICTION,4
AU,HAEMATOMA,4
AU,HEAD INJURY,4
AU,HEPATIC ENZYME INCREASED,4
AU,HERNIA,4
AU,HERPES ZOSTER,4
AU,HYPERAMMONAEMIC ENCEPHALOPATHY,4
AU,HYPOALBUMINAEMIA,4
AU,HYPOXIA,4
AU,INFLAMMATION,4
AU,ISCHAEMIA,4
AU,LEFT VENTRICULAR HYPERTROPHY,4
AU,LIP SWELLING,4
AU,LYMPHOCYTE COUNT INCREASED,4
AU,MEAN CELL VOLUME ABNORMAL,4
AU,MEDICATION ERROR,4
AU,MELAENA,4
AU,MIGRAINE,4
AU,MOUTH ULCERATION,4
AU,PNEUMONIA ASPIRATION,4
AU,PNEUMONIA HAEMOPHILUS,4
AU,PRESYNCOPE,4
AU,PRODUCT USE ISSUE,4
AU,PROSTATE CANCER,4
AU,PROTEIN TOTAL DECREASED,4
AU,PSEUDOMONAL SEPSIS,4
AU,RED CELL DISTRIBUTION WIDTH INCREASED,4
AU,SEDATION,4
AU,SEROTONIN SYNDROME,4
AU,SHOCK,4
AU,SINUS NODE DYSFUNCTION,4
AU,SKIN LESION,4
AU,SQUAMOUS CELL CARCINOMA OF SKIN,4
AU,SWELLING FACE,4
AU,SWOLLEN TONGUE,4
AU,SYSTOLIC DYSFUNCTION,4
AU,TACHYPNOEA,4
AU,THROMBOSIS,4
AU,TREATMENT FAILURE,4
AU,URINARY TRACT INFECTION PSEUDOMONAL,4
AU,URTICARIA,4
AU,VASCULITIS,4
AU,VERTIGO,4
AU,VISUAL ACUITY REDUCED,4
AU,VITREOUS HAEMORRHAGE,4
AU,WRONG DRUG ADMINISTERED,4
AU,ABNORMAL BEHAVIOUR,3
AU,ACCIDENTAL EXPOSURE TO PRODUCT,3
AU,ACTIVITIES OF DAILY LIVING IMPAIRED,3
AU,ACUTE MYELOID LEUKAEMIA,3
AU,ALOPECIA,3
AU,AORTIC DILATATION,3
AU,ATRIAL FLUTTER,3
AU,AUTOIMMUNE HEPATITIS,3
AU,BLOOD BILIRUBIN INCREASED,3
AU,BLOOD CALCIUM INCREASED,3
AU,BLOOD CHLORIDE INCREASED,3
AU,BLOOD CHOLESTEROL DECREASED,3
AU,BLOOD GLUCOSE DECREASED,3
AU,BLOOD IRON DECREASED,3
AU,BLOOD MAGNESIUM DECREASED,3
AU,BLOOD POTASSIUM INCREASED,3
AU,BONE DENSITY DECREASED,3
AU,BREAST CANCER,3
AU,BURNING SENSATION,3
AU,CARDIAC MURMUR,3
AU,CHOLANGITIS,3
AU,CHOLECYSTITIS,3
AU,CHRONIC KIDNEY DISEASE,3
AU,CHRONIC MYELOID LEUKAEMIA,3
AU,COGNITIVE DISORDER,3
AU,CORONARY ARTERY BYPASS,3
AU,CRYING,3
AU,CYSTOID MACULAR OEDEMA,3
AU,CYTOPENIA,3
AU,DERMATITIS CONTACT,3
AU,DEVICE RELATED INFECTION,3
AU,DILATATION ATRIAL,3
AU,DILATATION VENTRICULAR,3
AU,DRUG DOSE OMISSION,3
AU,DRUG EFFECT INCOMPLETE,3
AU,DUODENITIS,3
AU,DYSGEUSIA,3
AU,DYSPHONIA,3
AU,DYSSTASIA,3
AU,EMBOLIC STROKE,3
AU,EMBOLISM,3
AU,EOSINOPHIL COUNT INCREASED,3
AU,ESCHERICHIA SEPSIS,3
AU,EXTRAOCULAR MUSCLE DISORDER,3
AU,EXTRAPYRAMIDAL DISORDER,3
AU,FEELING COLD,3
AU,FEMUR FRACTURE,3
AU,GASTRITIS EROSIVE,3
AU,GASTROINTESTINAL DISORDER,3
AU,GENERAL PHYSICAL HEALTH DETERIORATION,3
AU,HAEMORRHOIDAL HAEMORRHAGE,3
AU,HAEMORRHOIDS,3
AU,HALLUCINATION,3
AU,HEPATIC ENCEPHALOPATHY,3
AU,HEPATIC FAILURE,3
AU,HYDRONEPHROSIS,3
AU,HYPERCALCAEMIA,3
AU,HYPERTHYROIDISM,3
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
AU,INCORRECT DOSE ADMINISTERED,3
AU,INTERVERTEBRAL DISC PROTRUSION,3
AU,INTESTINAL HAEMORRHAGE,3
AU,INTESTINAL ISCHAEMIA,3
AU,KIDNEY FIBROSIS,3
AU,KIDNEY INFECTION,3
AU,LOW BIRTH WEIGHT BABY,3
AU,LOW DENSITY LIPOPROTEIN INCREASED,3
AU,LUNG CONSOLIDATION,3
AU,MENTAL IMPAIRMENT,3
AU,MOTOR DYSFUNCTION,3
AU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
AU,MUSCULOSKELETAL PAIN,3
AU,NEUTROPENIC COLITIS,3
AU,NEUTROPENIC SEPSIS,3
AU,OCULAR HYPERAEMIA,3
AU,OLIGURIA,3
AU,ORTHOPNOEA,3
AU,OSTEOPOROSIS,3
AU,PANCREATIC CYST,3
AU,PELVIC VENOUS THROMBOSIS,3
AU,PERIPHERAL COLDNESS,3
AU,PLASMA CELL MYELOMA,3
AU,PLATELET COUNT INCREASED,3
AU,PNEUMONITIS,3
AU,PNEUMOTHORAX,3
AU,POLYCHROMASIA,3
AU,POOR QUALITY SLEEP,3
AU,PREMATURE BABY,3
AU,PROTHROMBIN TIME PROLONGED,3
AU,PULMONARY ARTERY OCCLUSION,3
AU,PULMONARY HYPOPERFUSION,3
AU,PULSELESS ELECTRICAL ACTIVITY,3
AU,RASH GENERALISED,3
AU,RASH MACULO-PAPULAR,3
AU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
AU,RENAL FAILURE CHRONIC,3
AU,RENAL PAIN,3
AU,RENAL TUBULAR ATROPHY,3
AU,RESPIRATORY DISTRESS,3
AU,RESTLESSNESS,3
AU,RETINAL HAEMORRHAGE,3
AU,RHINORRHOEA,3
AU,SENSORY LOSS,3
AU,SERUM FERRITIN DECREASED,3
AU,STEVENS-JOHNSON SYNDROME,3
AU,TOXIC ENCEPHALOPATHY,3
AU,TRANSFERRIN SATURATION DECREASED,3
AU,TUBULOINTERSTITIAL NEPHRITIS,3
AU,UPPER RESPIRATORY TRACT INFECTION,3
AU,VASCULAR PSEUDOANEURYSM,3
AU,VESTIBULAR NEURONITIS,3
AU,VISUAL IMPAIRMENT,3
AU,VITAMIN B12 DEFICIENCY,3
AU,VITAMIN D DEFICIENCY,3
AU,WHEEZING,3
AU,WRIST FRACTURE,3
AU,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
AU,ABDOMINAL PAIN LOWER,2
AU,ABNORMAL PRECORDIAL MOVEMENT,2
AU,ACCIDENTAL OVERDOSE,2
AU,ACUTE HEPATIC FAILURE,2
AU,ACUTE PHOSPHATE NEPHROPATHY,2
AU,ADDISON^S DISEASE,2
AU,ADENOVIRUS INFECTION,2
AU,ADVERSE DRUG REACTION,2
AU,ANAL INCONTINENCE,2
AU,ANASTOMOTIC LEAK,2
AU,ANGIOCENTRIC LYMPHOMA,2
AU,ANION GAP INCREASED,2
AU,ANTICOAGULATION DRUG LEVEL INCREASED,2
AU,ANTIPSYCHOTIC DRUG LEVEL DECREASED,2
AU,AORTIC VALVE SCLEROSIS,2
AU,APLASIA PURE RED CELL,2
AU,ARRHYTHMIA,2
AU,ARRHYTHMIA SUPRAVENTRICULAR,2
AU,ARTHROPATHY,2
AU,ASPIRATION,2
AU,ATELECTASIS,2
AU,ATYPICAL FEMUR FRACTURE,2
AU,AUTOIMMUNE COLITIS,2
AU,AUTONOMIC NEUROPATHY,2
AU,BACTERIAL SEPSIS,2
AU,BILE DUCT OBSTRUCTION,2
AU,BLADDER CANCER,2
AU,BLADDER INJURY,2
AU,BLINDNESS,2
AU,BLOOD CHLORIDE DECREASED,2
AU,BLOOD CREATININE DECREASED,2
AU,BLOOD LACTATE DEHYDROGENASE DECREASED,2
AU,BLOOD OSMOLARITY INCREASED,2
AU,BLOOD PHOSPHORUS INCREASED,2
AU,BLOOD POTASSIUM DECREASED,2
AU,BODY TEMPERATURE INCREASED,2
AU,BOWEN^S DISEASE,2
AU,BRADYCARDIA FOETAL,2
AU,BURSITIS,2
AU,CARDIAC TAMPONADE,2
AU,CAROTID ARTERIOSCLEROSIS,2
AU,CAROTID ARTERY STENOSIS,2
AU,CATARACT,2
AU,CEREBRAL INFARCTION,2
AU,CHOLESTASIS,2
AU,CHROMATURIA,2
AU,CLOSTRIDIUM DIFFICILE INFECTION,2
AU,COAGULOPATHY,2
AU,COGWHEEL RIGIDITY,2
AU,COLITIS ISCHAEMIC,2
AU,COLORECTAL CANCER METASTATIC,2
AU,CONCOMITANT DISEASE AGGRAVATED,2
AU,CONCOMITANT DISEASE PROGRESSION,2
AU,CONJUNCTIVAL HAEMORRHAGE,2
AU,CONTRAINDICATED DRUG PRESCRIBED,2
AU,CULTURE URINE POSITIVE,2
AU,CUTANEOUS LUPUS ERYTHEMATOSUS,2
AU,DEPRESSED LEVEL OF CONSCIOUSNESS,2
AU,DEVICE DISLOCATION,2
AU,DIABETIC FOOT,2
AU,DIFFUSE LARGE B-CELL LYMPHOMA,2
AU,DISEASE PROGRESSION,2
AU,DIZZINESS POSTURAL,2
AU,DRUG DISPENSING ERROR,2
AU,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
AU,DRUG LEVEL ABOVE THERAPEUTIC,2
AU,DRUG LEVEL INCREASED,2
AU,DRY SKIN,2
AU,DRY THROAT,2
AU,DUODENAL ULCER HAEMORRHAGE,2
AU,EAR INFECTION,2
AU,EATING DISORDER,2
AU,ECZEMA,2
AU,EMBOLISM VENOUS,2
AU,ENTEROCOCCAL BACTERAEMIA,2
AU,ENTEROCOLITIS INFECTIOUS,2
AU,EXTRASYSTOLES,2
AU,EYE PRURITUS,2
AU,EYE SWELLING,2
AU,FACIAL BONES FRACTURE,2
AU,FAT TISSUE INCREASED,2
AU,FEMALE GENITAL TRACT FISTULA,2
AU,FIBROSIS,2
AU,FOOD INTOLERANCE,2
AU,FUNCTIONAL GASTROINTESTINAL DISORDER,2
AU,GALLBLADDER DISORDER,2
AU,GASTROENTERITIS SALMONELLA,2
AU,GLAUCOMA,2
AU,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
AU,GOUTY TOPHUS,2
AU,GRAND MAL CONVULSION,2
AU,HAEMATEMESIS,2
AU,HAEMATOCHEZIA,2
AU,HAEMODYNAMIC INSTABILITY,2
AU,HAEMOLYSIS,2
AU,HAEMOPTYSIS,2
AU,HALLUCINATION_ AUDITORY,2
AU,HALLUCINATIONS_ MIXED,2
AU,HEPATITIS C,2
AU,HISTIOCYTOSIS HAEMATOPHAGIC,2
AU,HYDROCEPHALUS,2
AU,HYPERGLYCAEMIA,2
AU,HYPERSENSITIVITY VASCULITIS,2
AU,HYPERSPLENISM,2
AU,HYPOPHOSPHATAEMIA,2
AU,IMPAIRED SELF-CARE,2
AU,INFECTIVE EXACERBATION OF BRONCHIECTASIS,2
AU,INFLUENZA,2
AU,INFUSION RELATED REACTION,2
AU,INGUINAL HERNIA,2
AU,INJURY,2
AU,INTENTIONAL PRODUCT MISUSE,2
AU,INTENTIONAL PRODUCT USE ISSUE,2
AU,INTENTIONAL SELF-INJURY,2
AU,INTESTINAL VILLI ATROPHY,2
AU,INTRAOCULAR PRESSURE INCREASED,2
AU,ISCHAEMIC HEPATITIS,2
AU,JAUNDICE,2
AU,JAUNDICE CHOLESTATIC,2
AU,JOINT LOCK,2
AU,JOINT STIFFNESS,2
AU,KERATOACANTHOMA,2
AU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
AU,LARGE INTESTINAL STENOSIS,2
AU,LEUKOPENIA,2
AU,LIMBIC ENCEPHALITIS,2
AU,LIPASE INCREASED,2
AU,LIVER DISORDER,2
AU,LIVER INJURY,2
AU,LOCAL SWELLING,2
AU,LOCALISED INFECTION,2
AU,LUMBAR VERTEBRAL FRACTURE,2
AU,LYMPHOPENIA,2
AU,MALABSORPTION,2
AU,MALIGNANT MELANOMA IN SITU,2
AU,MASS,2
AU,MATERNAL EXPOSURE DURING PREGNANCY,2
AU,MEAN CELL VOLUME DECREASED,2
AU,MENINGITIS ASEPTIC,2
AU,METASTASES TO CENTRAL NERVOUS SYSTEM,2
AU,METASTATIC SQUAMOUS CELL CARCINOMA,2
AU,MONOCYTE COUNT DECREASED,2
AU,MOVEMENT DISORDER,2
AU,MUCOSAL INFLAMMATION,2
AU,MULTIPLE SCLEROSIS RELAPSE,2
AU,MUSCLE TIGHTNESS,2
AU,MYELOCYTE COUNT INCREASED,2
AU,MYELODYSPLASTIC SYNDROME,2
AU,NASOPHARYNGITIS,2
AU,NEOPLASM MALIGNANT,2
AU,NEOPLASM PROGRESSION,2
AU,NEPHRITIS,2
AU,NEPHROLITHIASIS,2
AU,NEPHROPATHY,2
AU,NERVE INJURY,2
AU,NEUROLEPTIC MALIGNANT SYNDROME,2
AU,NIGHT SWEATS,2
AU,ORAL CANDIDIASIS,2
AU,ORAL INFECTION,2
AU,ORAL PAIN,2
AU,ORBITAL INFECTION,2
AU,OSTEITIS DEFORMANS,2
AU,OSTEOMYELITIS,2
AU,OSTEONECROSIS OF JAW,2
AU,OVERWEIGHT,2
AU,PARAPLEGIA,2
AU,PARKINSON^S DISEASE,2
AU,PATHOLOGICAL FRACTURE,2
AU,PERIORBITAL OEDEMA,2
AU,PERIPHERAL VASCULAR DISORDER,2
AU,PETIT MAL EPILEPSY,2
AU,PLACENTAL INSUFFICIENCY,2
AU,PLEURAL FIBROSIS,2
AU,POLYDIPSIA,2
AU,POLYURIA,2
AU,PRODUCT USE IN UNAPPROVED INDICATION,2
AU,PRODUCTIVE COUGH,2
AU,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
AU,PROSTATE CANCER METASTATIC,2
AU,PROTEIN TOTAL INCREASED,2
AU,PROTEINURIA,2
AU,PSYCHIATRIC SYMPTOM,2
AU,PULMONARY ARTERIAL HYPERTENSION,2
AU,PULMONARY MASS,2
AU,PULSE ABSENT,2
AU,PURPURA,2
AU,QUALITY OF LIFE DECREASED,2
AU,RASH MACULAR,2
AU,RED BLOOD CELL COUNT INCREASED,2
AU,REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA,2
AU,REGURGITATION,2
AU,RENAL CANCER,2
AU,RENAL HAEMORRHAGE,2
AU,RENAL INJURY,2
AU,RESPIRATORY ARREST,2
AU,RETINAL ARTERY OCCLUSION,2
AU,RETINAL DETACHMENT,2
AU,RETINAL DISORDER,2
AU,RETINAL EXUDATES,2
AU,RIB FRACTURE,2
AU,SEBACEOUS CARCINOMA,2
AU,SENSORY DISTURBANCE,2
AU,SINUS BRADYCARDIA,2
AU,SINUS DISORDER,2
AU,SKIN BURNING SENSATION,2
AU,SKIN MASS,2
AU,SPINAL COLUMN STENOSIS,2
AU,SPINAL CORD COMPRESSION,2
AU,SPINAL OSTEOARTHRITIS,2
AU,SPINAL PAIN,2
AU,STAPHYLOCOCCAL INFECTION,2
AU,STENT PLACEMENT,2
AU,STILLBIRTH,2
AU,SUBARACHNOID HAEMORRHAGE,2
AU,SUDDEN DEATH,2
AU,TEARFULNESS,2
AU,THERAPEUTIC RESPONSE DECREASED,2
AU,THROMBOCYTOSIS,2
AU,THROMBOSIS IN DEVICE,2
AU,TINNITUS,2
AU,TONGUE ULCERATION,2
AU,TOOTH DISORDER,2
AU,TRANSFUSION,2
AU,TROPONIN NORMAL,2
AU,TROUSSEAU^S SIGN,2
AU,URETERIC OBSTRUCTION,2
AU,URINARY TRACT OBSTRUCTION,2
AU,URINE FLOW DECREASED,2
AU,VASODILATATION,2
AU,VENTRICULAR EXTRASYSTOLES,2
AU,VENTRICULAR HYPERTROPHY,2
AU,VENTRICULAR TACHYCARDIA,2
AU,VIITH NERVE PARALYSIS,2
AU,VITREOUS FLOATERS,2
AU,WALKING DISABILITY,2
AU,WEIGHT FLUCTUATION,2
AU,WOUND,2
AU,WOUND DEHISCENCE,2
AU,WOUND INFECTION,2
AU,ABNORMAL DREAMS,1
AU,ABNORMAL LOSS OF WEIGHT,1
AU,ABORTION INCOMPLETE,1
AU,ABSCESS,1
AU,ABSCESS INTESTINAL,1
AU,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,1
AU,ACNE,1
AU,ACQUIRED MITOCHONDRIAL DNA DELETION,1
AU,ACTINIC KERATOSIS,1
AU,ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL,1
AU,ACUTE ABDOMEN,1
AU,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
AU,ACUTE LUNG INJURY,1
AU,ACUTE LYMPHOCYTIC LEUKAEMIA,1
AU,ACUTE PRERENAL FAILURE,1
AU,ACUTE RESPIRATORY DISTRESS SYNDROME,1
AU,ACUTE SINUSITIS,1
AU,ADENOCARCINOMA OF COLON,1
AU,AFFECTIVE DISORDER,1
AU,AGGRESSION,1
AU,AIRWAY COMPLICATION OF ANAESTHESIA,1
AU,AKATHISIA,1
AU,ALBUMIN URINE PRESENT,1
AU,ALCOHOL ABUSE,1
AU,ALLERGY TO CHEMICALS,1
AU,ALVEOLITIS,1
AU,AMMONIA INCREASED,1
AU,AMYLOIDOSIS,1
AU,ANAEMIA OF CHRONIC DISEASE,1
AU,ANAESTHETIC COMPLICATION PULMONARY,1
AU,ANAPHYLACTIC SHOCK,1
AU,ANASTOMOTIC FISTULA,1
AU,ANEURYSM,1
AU,ANGER,1
AU,ANGIOPATHY,1
AU,ANIMAL BITE,1
AU,ANISOCYTOSIS,1
AU,ANKLE FRACTURE,1
AU,ANTICOAGULATION DRUG LEVEL ABNORMAL,1
AU,ANTICONVULSANT DRUG LEVEL INCREASED,1
AU,ANTIPHOSPHOLIPID ANTIBODIES POSITIVE,1
AU,ANTISOCIAL PERSONALITY DISORDER,1
AU,AORTIC VALVE DISEASE,1
AU,APHAGIA,1
AU,APPENDICEAL ABSCESS,1
AU,APPENDICITIS PERFORATED,1
AU,APPENDIX DISORDER,1
AU,APPLICATION SITE VESICLES,1
AU,APRAXIA,1
AU,ARACHNOID CYST,1
AU,ARTERIAL DISORDER,1
AU,ARTERIOSCLEROSIS,1
AU,ARTERIOSPASM CORONARY,1
AU,ARTERIOVENOUS FISTULA ANEURYSM,1
AU,ARTHRITIS BACTERIAL,1
AU,ATRIAL THROMBOSIS,1
AU,ATRIOVENTRICULAR BLOCK,1
AU,ATRIOVENTRICULAR BLOCK COMPLETE,1
AU,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
AU,ATYPICAL PNEUMONIA,1
AU,AURA,1
AU,AUTOIMMUNE PANCREATITIS,1
AU,AZOTAEMIA,1
AU,BACK DISORDER,1
AU,BACTERIAL INFECTION,1
AU,BACTERIURIA,1
AU,BALANOPOSTHITIS,1
AU,BALINT^S SYNDROME,1
AU,BAND SENSATION,1
AU,BARRETT^S OESOPHAGUS,1
AU,BASE EXCESS DECREASED,1
AU,BASOPHIL COUNT INCREASED,1
AU,BASOPHILIA,1
AU,BEDRIDDEN,1
AU,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
AU,BILE DUCT STONE,1
AU,BILIARY SEPSIS,1
AU,BITE,1
AU,BLADDER ADENOCARCINOMA STAGE III,1
AU,BLADDER DYSFUNCTION,1
AU,BLADDER NEOPLASM,1
AU,BLINDNESS CORTICAL,1
AU,BLINDNESS UNILATERAL,1
AU,BLISTER,1
AU,BLOOD ALKALINE PHOSPHATASE DECREASED,1
AU,BLOOD BICARBONATE ABNORMAL,1
AU,BLOOD BILIRUBIN ABNORMAL,1
AU,BLOOD CREATINE DECREASED,1
AU,BLOOD CREATINE PHOSPHOKINASE ABNORMAL,1
AU,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
AU,BLOOD FIBRINOGEN INCREASED,1
AU,BLOOD FOLATE DECREASED,1
AU,BLOOD GLUCOSE FLUCTUATION,1
AU,BLOOD IMMUNOGLOBULIN M DECREASED,1
AU,BLOOD IRON INCREASED,1
AU,BLOOD LACTIC ACID INCREASED,1
AU,BLOOD MAGNESIUM INCREASED,1
AU,BLOOD METHAEMOGLOBIN PRESENT,1
AU,BLOOD PRESSURE DIASTOLIC DECREASED,1
AU,BLOOD PRESSURE FLUCTUATION,1
AU,BLOOD PRESSURE SYSTOLIC DECREASED,1
AU,BLOOD PROLACTIN INCREASED,1
AU,BLOOD TEST ABNORMAL,1
AU,BLOOD THYROID STIMULATING HORMONE INCREASED,1
AU,BLOOD URIC ACID DECREASED,1
AU,BLOOD URINE PRESENT,1
AU,BODY MASS INDEX INCREASED,1
AU,BODY TEMPERATURE DECREASED,1
AU,BONE DISORDER,1
AU,BONE LOSS,1
AU,BONE MARROW DISORDER,1
AU,BONE MARROW FAILURE,1
AU,BONE METABOLISM DISORDER,1
AU,BOWEL MOVEMENT IRREGULARITY,1
AU,BRAIN ABSCESS,1
AU,BRAIN DEATH,1
AU,BRAIN HERNIATION,1
AU,BRAIN MIDLINE SHIFT,1
AU,BRAIN NATRIURETIC PEPTIDE INCREASED,1
AU,BRAIN NEOPLASM,1
AU,BRAIN OEDEMA,1
AU,BRAIN SCAN ABNORMAL,1
AU,BRAIN STEM INFARCTION,1
AU,BRAIN STEM STROKE,1
AU,BRONCHIAL CARCINOMA,1
AU,BRONCHIAL SECRETION RETENTION,1
AU,BRONCHIECTASIS,1
AU,BRONCHOMALACIA,1
AU,BRONCHOPNEUMONIA,1
AU,BRONCHOSPASM,1
AU,C-REACTIVE PROTEIN ABNORMAL,1
AU,CAESAREAN SECTION,1
AU,CALCIUM IONISED DECREASED,1
AU,CALCIUM IONISED INCREASED,1
AU,CAMPYLOBACTER INFECTION,1
AU,CANDIDA INFECTION,1
AU,CANDIDA SEPSIS,1
AU,CARCINOID CRISIS,1
AU,CARDIAC AMYLOIDOSIS,1
AU,CARDIAC ANEURYSM,1
AU,CARDIAC FAILURE ACUTE,1
AU,CARDIAC HYPERTROPHY,1
AU,CARDIAC VALVE DISEASE,1
AU,CARDIAC VALVE REPLACEMENT COMPLICATION,1
AU,CARDIO-RESPIRATORY ARREST,1
AU,CARDIOGENIC SHOCK,1
AU,CARDIOVASCULAR DISORDER,1
AU,CAROTID ARTERY OCCLUSION,1
AU,CAROTID BRUIT,1
AU,CARPAL TUNNEL SYNDROME,1
AU,CATARACT OPERATION,1
AU,CATARACT SUBCAPSULAR,1
AU,CATHETER SITE EROSION,1
AU,CATHETER SITE HAEMORRHAGE,1
AU,CATHETER SITE INFECTION,1
AU,CEREBRAL ARTERY THROMBOSIS,1
AU,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY,1
AU,CEREBRAL ISCHAEMIA,1
AU,CHEST INJURY,1
AU,CHOLANGITIS INFECTIVE,1
AU,CHOLECYSTITIS INFECTIVE,1
AU,CHRONIC MYELOID LEUKAEMIA (IN REMISSION),1
AU,CHVOSTEK^S SIGN,1
AU,CITROBACTER INFECTION,1
AU,CLAUSTROPHOBIA,1
AU,CLEFT PALATE,1
AU,CLOSTRIDIUM DIFFICILE COLITIS,1
AU,CLUSTER HEADACHE,1
AU,COLITIS ULCERATIVE,1
AU,COLON ADENOMA,1
AU,COLON CANCER,1
AU,COLONIC ABSCESS,1
AU,COLONOSCOPY,1
AU,COMPARTMENT SYNDROME,1
AU,COMPLICATION ASSOCIATED WITH DEVICE,1
AU,CONJUNCTIVITIS,1
AU,CONSCIOUSNESS FLUCTUATING,1
AU,CONTRAINDICATED PRODUCT ADMINISTERED,1
AU,CONTRAST MEDIA REACTION,1
AU,COSTOVERTEBRAL ANGLE TENDERNESS,1
AU,CREATININE RENAL CLEARANCE DECREASED,1
AU,CREPITATIONS,1
AU,CRYPTOCOCCOSIS,1
AU,CYST,1
AU,CYTOMEGALOVIRUS COLITIS,1
AU,CYTOMEGALOVIRUS INFECTION,1
AU,DECREASED IMMUNE RESPONSIVENESS,1
AU,DECUBITUS ULCER,1
AU,DEFECT CONDUCTION INTRAVENTRICULAR,1
AU,DELIRIUM FEBRILE,1
AU,DEMENTIA ALZHEIMER^S TYPE,1
AU,DEPENDENCE,1
AU,DERMAL CYST,1
AU,DERMATITIS ACNEIFORM,1
AU,DERMATITIS ATOPIC,1
AU,DEVICE DIFFICULT TO USE,1
AU,DIABETIC COMPLICATION,1
AU,DIABETIC FOOT INFECTION,1
AU,DIABETIC RETINAL OEDEMA,1
AU,DIABETIC RETINOPATHY,1
AU,DIET REFUSAL,1
AU,DIPLOPIA,1
AU,DISCOMFORT,1
AU,DISEASE RECURRENCE,1
AU,DISORIENTATION,1
AU,DIVERTICULUM INTESTINAL,1
AU,DRUG ABUSE,1
AU,DRUG DEPENDENCE,1
AU,DRUG EFFECT DECREASED,1
AU,DRUG LEVEL FLUCTUATING,1
AU,DRUG RESISTANCE,1
AU,DRUG WITHDRAWAL MAINTENANCE THERAPY,1
AU,DRUG WITHDRAWAL SYNDROME NEONATAL,1
AU,DYSKINESIA,1
AU,DYSLIPIDAEMIA,1
AU,DYSPNOEA AT REST,1
AU,EAR DISCOMFORT,1
AU,ECCHYMOSIS,1
AU,ECZEMA NUMMULAR,1
AU,ELECTROCARDIOGRAM Q WAVE ABNORMAL,1
AU,ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL,1
AU,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
AU,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
AU,ELECTROCARDIOGRAM ST-T CHANGE,1
AU,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
AU,ENCOPRESIS,1
AU,ENDOSCOPY UPPER GASTROINTESTINAL TRACT,1
AU,ENDOTRACHEAL INTUBATION COMPLICATION,1
AU,ENTERITIS INFECTIOUS,1
AU,EOSINOPHIL COUNT DECREASED,1
AU,EPIGLOTTITIS,1
AU,EPISCLERITIS,1
AU,EROSIVE DUODENITIS,1
AU,ERUCTATION,1
AU,ERYTHEMA MULTIFORME,1
AU,ERYTHROPOIESIS ABNORMAL,1
AU,ESCHERICHIA BACTERAEMIA,1
AU,EXCORIATION,1
AU,EXERCISE TEST ABNORMAL,1
AU,EXFOLIATIVE RASH,1
AU,EXOSTOSIS,1
AU,EXTREMITY NECROSIS,1
AU,EYELID OEDEMA,1
AU,EYELID PTOSIS,1
AU,FACE INJURY,1
AU,FACIAL PARALYSIS,1
AU,FACIAL PARESIS,1
AU,FAECAL INCONTINENCE,1
AU,FAECES DISCOLOURED,1
AU,FASCIAL OPERATION,1
AU,FEEDING DISORDER,1
AU,FEELING HOT,1
AU,FEELING JITTERY,1
AU,FEMORAL NECK FRACTURE,1
AU,FIBRIN D DIMER INCREASED,1
AU,FIBULA FRACTURE,1
AU,FISTULA,1
AU,FLUID INTAKE REDUCED,1
AU,FLUID RETENTION,1
AU,FOLATE DEFICIENCY,1
AT,FALL,7
AT,ACUTE MYOCARDIAL INFARCTION,6
AT,HAEMORRHAGE,6
AT,ANAEMIA,5
AT,CARDIOGENIC SHOCK,5
AT,GASTROINTESTINAL HAEMORRHAGE,5
AT,HAEMOGLOBIN DECREASED,5
AT,BLOOD GLUCOSE INCREASED,4
AT,CORONARY ARTERY DISEASE,4
AT,DELIRIUM,4
AT,DIARRHOEA,4
AT,DRUG INEFFECTIVE,4
AT,INCORRECT ROUTE OF DRUG ADMINISTRATION,4
AT,NAUSEA,4
AT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,4
AT,ANGINA PECTORIS,3
AT,ATRIAL FIBRILLATION,3
AT,DEATH,3
AT,GENERAL PHYSICAL HEALTH DETERIORATION,3
AT,HAEMATOMA,3
AT,HEMIPARESIS,3
AT,HYPERTENSION,3
AT,HYPONATRAEMIA,3
AT,OSTEONECROSIS OF JAW,3
AT,OVERDOSE,3
AT,SEPSIS,3
AT,SLEEP DISORDER,3
AT,SYNCOPE,3
AT,URINARY TRACT INFECTION,3
AT,VOMITING,3
AT,APHASIA,2
AT,ARTHRALGIA,2
AT,BLOOD GLUCOSE DECREASED,2
AT,CHEST PAIN,2
AT,COAGULATION TIME SHORTENED,2
AT,COUGH,2
AT,DEPRESSION,2
AT,DIZZINESS,2
AT,DYSPNOEA,2
AT,EPISTAXIS,2
AT,HAEMORRHAGE INTRACRANIAL,2
AT,HEADACHE,2
AT,HYPERCHOLESTEROLAEMIA,2
AT,HYPERGLYCAEMIA,2
AT,HYPOCHLORAEMIA,2
AT,HYPOKALAEMIA,2
AT,LOSS OF CONSCIOUSNESS,2
AT,MULTIPLE INJURIES,2
AT,MUSCLE HAEMORRHAGE,2
AT,MYOCARDIAL INFARCTION,2
AT,NEPHROPATHY,2
AT,OEDEMA PERIPHERAL,2
AT,PANCREATITIS,2
AT,PNEUMONIA,2
AT,PYREXIA,2
AT,RESPIRATORY DEPRESSION,2
AT,RESTLESSNESS,2
AT,RHABDOMYOLYSIS,2
AT,SHOCK,2
AT,STATUS EPILEPTICUS,2
AT,THROMBOCYTOPENIA,2
AT,THROMBOSIS IN DEVICE,2
AT,VASCULAR STENT THROMBOSIS,2
AT,WEIGHT INCREASED,2
AT,WHITE BLOOD CELL COUNT INCREASED,2
AT,ABDOMINAL DISTENSION,1
AT,ABSCESS,1
AT,ABSCESS NECK,1
AT,ACCIDENT,1
AT,ACCOMMODATION DISORDER,1
AT,ACUTE ABDOMEN,1
AT,ACUTE CORONARY SYNDROME,1
AT,ACUTE KIDNEY INJURY,1
AT,ACUTE MYELOID LEUKAEMIA,1
AT,AGITATION,1
AT,AKATHISIA,1
AT,AMAUROSIS FUGAX,1
AT,ANGINA UNSTABLE,1
AT,ANGIOPATHY,1
AT,ANXIETY,1
AT,AORTIC ARTERIOSCLEROSIS,1
AT,AORTIC STENOSIS,1
AT,ARACHNOID CYST,1
AT,ARTERIAL HAEMORRHAGE,1
AT,ARTERIOSCLEROSIS MOENCKEBERG-TYPE,1
AT,ASCITES,1
AT,ASTHENIA,1
AT,ASTHMA,1
AT,ATELECTASIS,1
AT,AUTOIMMUNE THYROIDITIS,1
AT,BASAL GANGLIA HAEMORRHAGE,1
AT,BENIGN PROSTATIC HYPERPLASIA,1
AT,BLOOD ALBUMIN DECREASED,1
AT,BLOOD CHLORIDE DECREASED,1
AT,BLOOD CHOLESTEROL INCREASED,1
AT,BLOOD CREATININE DECREASED,1
AT,BLOOD CREATININE INCREASED,1
AT,BLOOD PHOSPHORUS INCREASED,1
AT,BLOOD PRESSURE INCREASED,1
AT,BLOOD SODIUM DECREASED,1
AT,BLOOD TRIGLYCERIDES INCREASED,1
AT,BLOOD URIC ACID INCREASED,1
AT,BONE GIANT CELL TUMOUR,1
AT,BONE PAIN,1
AT,BRADYCARDIA,1
AT,BRAIN INJURY,1
AT,BREATH SOUNDS ABNORMAL,1
AT,BRONCHIAL OBSTRUCTION,1
AT,BRONCHITIS,1
AT,CANDIDURIA,1
AT,CARDIAC ARREST,1
AT,CARDIOVASCULAR DISORDER,1
AT,CAROTID ARTERY STENOSIS,1
AT,CAVERNOUS SINUS THROMBOSIS,1
AT,CEREBRAL HAEMORRHAGE,1
AT,CEREBRAL INFARCTION,1
AT,CERVICAL MYELOPATHY,1
AT,CHEST DISCOMFORT,1
AT,CHEYNE-STOKES RESPIRATION,1
AT,CHRONIC GASTRITIS,1
AT,CIRCULATORY COLLAPSE,1
AT,COAGULOPATHY,1
AT,COGNITIVE DISORDER,1
AT,COLD SWEAT,1
AT,COLITIS MICROSCOPIC,1
AT,COMA,1
AT,CONTUSION,1
AT,CORONARY ARTERY OCCLUSION,1
AT,CORONARY ARTERY RESTENOSIS,1
AT,CORONARY ARTERY STENOSIS,1
AT,CORONARY OSTIAL STENOSIS,1
AT,DECREASED APPETITE,1
AT,DECUBITUS ULCER,1
AT,DEHYDRATION,1
AT,DERMATITIS ALLERGIC,1
AT,DIABETES MELLITUS,1
AT,DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA,1
AT,DIASTOLIC DYSFUNCTION,1
AT,DILATATION VENTRICULAR,1
AT,DIPLOPIA,1
AT,DRUG WITHDRAWAL SYNDROME,1
AT,DRY MOUTH,1
AT,ELECTROCARDIOGRAM QT PROLONGED,1
AT,EPILEPSY,1
AT,ERECTILE DYSFUNCTION,1
AT,EROSIVE DUODENITIS,1
AT,ERYSIPELAS,1
AT,ESSENTIAL HYPERTENSION,1
AT,EXCORIATION,1
AT,EYE MOVEMENT DISORDER,1
AT,FACIAL BONES FRACTURE,1
AT,FACIAL NERVE DISORDER,1
AT,FAECES DISCOLOURED,1
AT,FATIGUE,1
AT,FEAR OF FALLING,1
AT,FEMORAL ARTERY ANEURYSM,1
AT,FEMUR FRACTURE,1
AT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
AT,GASTRIC ULCER HAEMORRHAGE,1
AT,GASTRITIS,1
AT,GASTRITIS EROSIVE,1
AT,GASTRITIS HAEMORRHAGIC,1
AT,GASTROINTESTINAL MUCOSAL DISORDER,1
AT,H1N1 INFLUENZA,1
AT,HAEMATOCRIT DECREASED,1
AT,HAEMODYNAMIC INSTABILITY,1
AT,HAEMORRHAGE SUBCUTANEOUS,1
AT,HEPATOCELLULAR CARCINOMA,1
AT,HEPATOMEGALY,1
AT,HERPES SIMPLEX,1
AT,HERPES ZOSTER,1
AT,HYDRONEPHROSIS,1
AT,HYPERLIPIDAEMIA,1
AT,HYPERTENSIVE CRISIS,1
AT,HYPERTONIA,1
AT,HYPOCALCAEMIA,1
AT,HYPOGLOSSAL NERVE PARESIS,1
AT,HYPOMAGNESAEMIA,1
AT,HYPOTENSION,1
AT,IMMOBILE,1
AT,IMMUNE THROMBOCYTOPENIC PURPURA,1
AT,INFECTION,1
AT,INFLAMMATION,1
AT,INFLUENZA,1
AT,INHIBITORY DRUG INTERACTION,1
AT,INTENTIONAL DOSE OMISSION,1
AT,INTERMITTENT CLAUDICATION,1
AT,INTRAVENTRICULAR HAEMORRHAGE,1
AT,ISCHAEMIA,1
AT,ISCHAEMIC STROKE,1
AT,KETOACIDOSIS,1
AT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
AT,LEUKOPENIA,1
AT,LUMBAR VERTEBRAL FRACTURE,1
AT,LYMPHADENITIS,1
AT,MACULAR DEGENERATION,1
AT,MASTITIS,1
AT,MENTAL DISORDER,1
AT,MICTURITION DISORDER,1
AT,MULTI-ORGAN FAILURE,1
AT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
AT,MUSCULAR WEAKNESS,1
AT,MUSCULOSKELETAL PAIN,1
AT,MYALGIA,1
AT,MYCOBACTERIAL INFECTION,1
AT,NEUTROPHIL COUNT DECREASED,1
AT,NOCTURNAL DYSPNOEA,1
AT,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
AT,OEDEMATOUS PANCREATITIS,1
AT,OESOPHAGEAL ULCER,1
AT,ORAL CANDIDIASIS,1
AT,OXYGEN SATURATION DECREASED,1
AT,PANCREATIC STEATOSIS,1
AT,PARKINSONISM,1
AT,PERICARDIAL HAEMORRHAGE,1
AT,PERIPHERAL ARTERY ANEURYSM,1
AT,PERIPHERAL ARTERY STENOSIS,1
AT,PERIPHERAL VENOUS DISEASE,1
AT,PERITONITIS,1
AT,PLATELET COUNT DECREASED,1
AT,PLATELET FUNCTION TEST ABNORMAL,1
AT,PNEUMONIA KLEBSIELLA,1
AT,POISONING,1
AT,POLYDIPSIA,1
AT,POST PROCEDURAL COMPLICATION,1
AT,PRERENAL FAILURE,1
AT,PRIAPISM,1
AT,PRODUCT USE IN UNAPPROVED INDICATION,1
AT,PRODUCT USE ISSUE,1
AT,PSYCHOTIC DISORDER,1
AT,PULMONARY ARTERIAL HYPERTENSION,1
AT,PULMONARY EMBOLISM,1
AT,PULMONARY FIBROSIS,1
AT,RED BLOOD CELL COUNT DECREASED,1
AT,RED CELL DISTRIBUTION WIDTH INCREASED,1
AT,RENAL CANCER RECURRENT,1
AT,RENAL CELL CARCINOMA,1
AT,RENAL CYST,1
AT,RENAL FAILURE,1
AT,RENAL TRANSPLANT FAILURE,1
AT,RESPIRATORY FAILURE,1
AT,RETINAL ISCHAEMIA,1
AT,RETROPERITONEAL HAEMATOMA,1
AT,SEDATION,1
AT,SINUS POLYP,1
AT,SKIN EROSION,1
AT,SKIN ULCER,1
AT,SLEEP APNOEA SYNDROME,1
AT,SPINAL CORD ABSCESS,1
AT,SPINAL CORD HAEMORRHAGE,1
AT,SPLENOMEGALY,1
AT,SPONTANEOUS HAEMATOMA,1
AT,STAPHYLOCOCCUS TEST POSITIVE,1
AT,STARING,1
AT,SUBCUTANEOUS ABSCESS,1
AT,SUBDURAL HAEMORRHAGE,1
AT,SUBDURAL HYGROMA,1
AT,SUBILEUS,1
AT,SUDDEN CARDIAC DEATH,1
AT,SYSTOLIC DYSFUNCTION,1
AT,TACHYCARDIA,1
AT,TENDON PAIN,1
AT,THERAPEUTIC RESPONSE DECREASED,1
AT,THIRST,1
AT,THORACIC HAEMORRHAGE,1
AT,THROMBOCYTOSIS,1
AT,TONGUE PARALYSIS,1
AT,TOTAL LUNG CAPACITY DECREASED,1
AT,TRAUMATIC HAEMATOMA,1
AT,TREMOR,1
AT,TYPE 2 DIABETES MELLITUS,1
AT,UPPER GASTROINTESTINAL HAEMORRHAGE,1
AT,URINARY HESITATION,1
AT,URINARY RETENTION,1
AT,VARICES OESOPHAGEAL,1
AT,VASCULAR OCCLUSION,1
AT,VASCULAR PROCEDURE COMPLICATION,1
AT,VENTRICLE RUPTURE,1
AT,VENTRICULAR FIBRILLATION,1
AT,VENTRICULAR HYPOKINESIA,1
AT,VENTRICULAR TACHYCARDIA,1
AT,VERTIGO,1
AT,VIRAL INFECTION,1
AT,VISUAL ACUITY REDUCED,1
AT,VITAMIN B12 DEFICIENCY,1
AT,WHITE BLOOD CELL COUNT DECREASED,1
AT,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
BS,DIABETES MELLITUS,1
BS,GINGIVAL BLEEDING,1
BS,MITRAL VALVE INCOMPETENCE,1
BS,NEPHROLITHIASIS,1
BH,DRUG INEFFECTIVE,3
BH,PRODUCT QUALITY ISSUE,3
BH,THROMBOSIS IN DEVICE,3
BD,CARDIAC TAMPONADE,2
BD,PERICARDIAL EFFUSION,2
BD,PLEURAL EFFUSION,2
BD,ACUTE PULMONARY OEDEMA,1
BD,BLOOD PRESSURE INCREASED,1
BD,BONE DISORDER,1
BD,CONDITION AGGRAVATED,1
BD,DRUG RESISTANCE,1
BD,FRACTURE,1
BD,HYPOTENSION,1
BD,JUGULAR VEIN DISTENSION,1
BD,OEDEMA,1
BD,OSTEOPOROSIS,1
BD,PAIN,1
BD,PERICARDIAL RUB,1
BD,TACHYCARDIA,1
BB,PARAPSORIASIS,3
BB,DRY SKIN,2
BB,RASH PAPULAR,2
BB,ASTHMA,1
BB,CHEST DISCOMFORT,1
BB,RASH ERYTHEMATOUS,1
BB,RASH MACULO-PAPULAR,1
BB,SKIN HYPERPIGMENTATION,1
BB,TINEA VERSICOLOUR,1
BB,WHEEZING,1
BY,CARDIAC TAMPONADE,1
BY,DYSPNOEA,1
BY,FEELING ABNORMAL,1
BY,HYPOTENSION,1
BY,INFECTION,1
BY,RASH GENERALISED,1
BY,THERAPY NON-RESPONDER,1
BY,TONSILLITIS,1
BE,ANAEMIA,11
BE,CEREBROVASCULAR ACCIDENT,7
BE,DECREASED APPETITE,7
BE,ACUTE MYOCARDIAL INFARCTION,6
BE,ANGINA PECTORIS,6
BE,SHOCK,6
BE,DIARRHOEA,5
BE,DYSKINESIA,5
BE,RENAL IMPAIRMENT,5
BE,ATRIAL FIBRILLATION,4
BE,CARDIAC ARREST,4
BE,CONFUSIONAL STATE,4
BE,CONTRAINDICATED PRODUCT ADMINISTERED,4
BE,DEATH,4
BE,DRUG INEFFECTIVE,4
BE,FOETAL EXPOSURE DURING PREGNANCY,4
BE,GENERAL PHYSICAL HEALTH DETERIORATION,4
BE,GRAFT LOSS,4
BE,HAEMOGLOBIN DECREASED,4
BE,HAEMORRHAGE,4
BE,HYPOTENSION,4
BE,MATERNAL EXPOSURE DURING PREGNANCY,4
BE,MYOCARDIAL INFARCTION,4
BE,NAUSEA,4
BE,ABDOMINAL PAIN,3
BE,ACUTE KIDNEY INJURY,3
BE,ANGINA UNSTABLE,3
BE,ATRIOVENTRICULAR BLOCK COMPLETE,3
BE,CARDIAC FAILURE,3
BE,CARDIOGENIC SHOCK,3
BE,GASTROINTESTINAL HAEMORRHAGE,3
BE,HEADACHE,3
BE,ISCHAEMIC STROKE,3
BE,METABOLIC ACIDOSIS,3
BE,PERICARDITIS,3
BE,PREMATURE BABY,3
BE,PREMATURE DELIVERY,3
BE,PYREXIA,3
BE,RESPIRATORY DISTRESS,3
BE,SINUS BRADYCARDIA,3
BE,THROMBOCYTOPENIA,3
BE,WEIGHT DECREASED,3
BE,ABDOMINAL DISCOMFORT,2
BE,ABDOMINAL DISTENSION,2
BE,ASTHENIA,2
BE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
BE,C-REACTIVE PROTEIN INCREASED,2
BE,CHEST PAIN,2
BE,COGNITIVE DISORDER,2
BE,CONTUSION,2
BE,DELIRIUM,2
BE,DIVERTICULUM,2
BE,DRUG ADMINISTRATION ERROR,2
BE,DYSPNOEA,2
BE,DYSPNOEA EXERTIONAL,2
BE,ECCHYMOSIS,2
BE,EJECTION FRACTION DECREASED,2
BE,EPISTAXIS,2
BE,FATIGUE,2
BE,GASTROINTESTINAL DISORDER,2
BE,HAEMATOMA,2
BE,HAEMORRHAGIC STROKE,2
BE,HYPERHIDROSIS,2
BE,HYPERTENSION,2
BE,HYPERVENTILATION,2
BE,INSOMNIA,2
BE,KLUVER-BUCY SYNDROME,2
BE,MYALGIA,2
BE,NEUTROPENIA,2
BE,PAIN,2
BE,PERITONEAL HAEMORRHAGE,2
BE,PNEUMONIA,2
BE,PRINZMETAL ANGINA,2
BE,SEPSIS,2
BE,SPLENIC RUPTURE,2
BE,TACHYCARDIA,2
BE,TUBULOINTERSTITIAL NEPHRITIS,2
BE,VENTRICULAR TACHYCARDIA,2
BE,VOMITING,2
BE,ABASIA,1
BE,ABDOMINAL PAIN UPPER,1
BE,ABDOMINAL TENDERNESS,1
BE,ABNORMAL BEHAVIOUR,1
BE,ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL,1
BE,ACUTE CORONARY SYNDROME,1
BE,ACUTE PULMONARY OEDEMA,1
BE,AKATHISIA,1
BE,AMNESIA,1
BE,ANAL HAEMORRHAGE,1
BE,ANAPHYLACTIC REACTION,1
BE,ANGIOPLASTY,1
BE,ANXIETY,1
BE,ARRHYTHMIA,1
BE,ARTERIAL STENT INSERTION,1
BE,ARTERIAL THROMBOSIS,1
BE,ARTERIOSCLEROSIS,1
BE,ARTERIOSPASM CORONARY,1
BE,ARTHRALGIA,1
BE,ATAXIA,1
BE,ATRIAL THROMBOSIS,1
BE,ATRIOVENTRICULAR BLOCK,1
BE,ATROPHY,1
BE,BACK PAIN,1
BE,BLADDER CATHETERISATION,1
BE,BLADDER TRANSITIONAL CELL CARCINOMA,1
BE,BLINDNESS,1
BE,BLOOD BILIRUBIN INCREASED,1
BE,BLOOD CREATININE INCREASED,1
BE,BRADYCARDIA,1
BE,BRAIN NEOPLASM,1
BE,BRAIN OEDEMA,1
BE,BRAIN STEM ISCHAEMIA,1
BE,BRONCHITIS,1
BE,BRONCHOPULMONARY ASPERGILLOSIS,1
BE,CAESAREAN SECTION,1
BE,CANDIDA INFECTION,1
BE,CARCINOEMBRYONIC ANTIGEN INCREASED,1
BE,CARDIOVASCULAR DISORDER,1
BE,CATHETER SITE NECROSIS,1
BE,CENTRAL NERVOUS SYSTEM LESION,1
BE,CHOLECYSTITIS ACUTE,1
BE,CHROMATURIA,1
BE,CHRONIC KIDNEY DISEASE,1
BE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
BE,CLOSTRIDIUM DIFFICILE COLITIS,1
BE,COLITIS,1
BE,COMPLICATIONS OF INTESTINAL TRANSPLANT,1
BE,CORONARY ARTERY DISEASE,1
BE,CREATININE URINE INCREASED,1
BE,CROHN^S DISEASE,1
BE,DECUBITUS ULCER,1
BE,DEEP VEIN THROMBOSIS,1
BE,DEVICE DAMAGE,1
BE,DEVICE DISLOCATION,1
BE,DEVICE ISSUE,1
BE,DIABETES MELLITUS,1
BE,DISEASE PROGRESSION,1
BE,DISEASE RECURRENCE,1
BE,DISINHIBITION,1
BE,DISTURBANCE IN ATTENTION,1
BE,DRUG INTOLERANCE,1
BE,DRUG RESISTANCE,1
BE,DRUG WITHDRAWAL SYNDROME,1
BE,DRY MOUTH,1
BE,DUODENAL OBSTRUCTION,1
BE,DYSARTHRIA,1
BE,DYSLIPIDAEMIA,1
BE,DYSPHAGIA,1
BE,DYSPHONIA,1
BE,DYSPRAXIA,1
BE,DYSSTASIA,1
BE,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
BE,EMBOLIC STROKE,1
BE,ENCEPHALOPATHY,1
BE,ENTEROCOCCAL SEPSIS,1
BE,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,1
BE,EPSTEIN-BARR VIRUS INFECTION,1
BE,ERYTHEMA,1
BE,EXTRADURAL HAEMATOMA,1
BE,FALL,1
BE,FEBRILE NEUTROPENIA,1
BE,FLUID RETENTION,1
BE,FOETAL GROWTH RESTRICTION,1
BE,FREEZING PHENOMENON,1
BE,GAIT DISTURBANCE,1
BE,GASTRIC ULCER,1
BE,GASTRIC ULCER HAEMORRHAGE,1
BE,GASTROINTESTINAL TRACT ADENOMA,1
BE,GENITOURINARY TRACT INFECTION,1
BE,GOUT,1
BE,HAEMATOMA INFECTION,1
BE,HAEMATURIA,1
BE,HAEMODYNAMIC INSTABILITY,1
BE,HAEMOPTYSIS,1
BE,HAEMORRHAGE INTRACRANIAL,1
BE,HAEMORRHAGIC TRANSFORMATION STROKE,1
BE,HAEMORRHOIDAL HAEMORRHAGE,1
BE,HALLUCINATION_ VISUAL,1
BE,HEMIPLEGIA,1
BE,HEPATIC CIRRHOSIS,1
BE,HEPATIC FUNCTION ABNORMAL,1
BE,HEPATITIS CHOLESTATIC,1
BE,HERPES SIMPLEX OESOPHAGITIS,1
BE,HIP FRACTURE,1
BE,HYPEROXALURIA,1
BE,HYPERPHAGIA,1
BE,HYPERSEXUALITY,1
BE,HYPOMANIA,1
BE,HYPONATRAEMIA,1
BE,HYPOVOLAEMIC SHOCK,1
BE,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
BE,IMPLANTABLE DEFIBRILLATOR INSERTION,1
BE,INAPPROPRIATE AFFECT,1
BE,INFARCTION,1
BE,INFECTION,1
BE,INGUINAL HERNIA,1
BE,INJURY,1
BE,INTESTINAL PERFORATION,1
BE,INTESTINAL ULCER,1
BE,INTESTINE TRANSPLANT REJECTION,1
BE,INTRA-ABDOMINAL HAEMORRHAGE,1
BE,IRON DEFICIENCY ANAEMIA,1
BE,ISCHAEMIA,1
BE,JAUNDICE,1
BE,LACRIMAL GLAND ENLARGEMENT,1
BE,LIVE BIRTH,1
BE,LOWER GASTROINTESTINAL HAEMORRHAGE,1
BE,LUNG INFECTION,1
BE,LUNG INFILTRATION,1
BE,LYMPHOMA,1
BE,MEMORY IMPAIRMENT,1
BE,METASTASES TO BONE,1
BE,MINOR COGNITIVE MOTOR DISORDER,1
BE,MITRAL VALVE INCOMPETENCE,1
BE,MOBILITY DECREASED,1
BE,MONOCYTOPENIA,1
BE,MOVEMENT DISORDER,1
BE,MULTI-ORGAN FAILURE,1
BE,MUSCLE SPASMS,1
BE,MUSCULAR WEAKNESS,1
BE,MYASTHENIA GRAVIS,1
BE,NEPHRITIS,1
BE,NEPHROPATHY,1
BE,NO THERAPEUTIC RESPONSE,1
BE,NON-CARDIAC CHEST PAIN,1
BE,NORMAL NEWBORN,1
BE,OBESITY,1
BE,OEDEMA PERIPHERAL,1
BE,OVERDOSE,1
BE,OXYGEN SATURATION DECREASED,1
BE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
BE,PANCYTOPENIA,1
BE,PERICARDIAL EFFUSION,1
BE,PERICARDIAL HAEMORRHAGE,1
BE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
BE,PERIPHERAL ISCHAEMIA,1
BE,PHLEBITIS,1
BE,PHOTOSENSITIVITY REACTION,1
BE,PLASMA CELL MYELOMA,1
BE,PLATELET AGGREGATION INCREASED,1
BE,PLEUROPERICARDITIS,1
BE,PNEUMONIA KLEBSIELLA,1
BE,PNEUMONITIS,1
BE,POLYNEUROPATHY,1
BE,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
BE,POSTOPERATIVE WOUND COMPLICATION,1
BE,POSTOPERATIVE WOUND INFECTION,1
BE,PRESCRIBED UNDERDOSE,1
BE,PROTEINURIA,1
BE,PSEUDOMONAL SEPSIS,1
BE,PSYCHOMOTOR HYPERACTIVITY,1
BE,PULMONARY EMBOLISM,1
BE,PULMONARY HAEMORRHAGE,1
BE,PYROGLUTAMATE INCREASED,1
BE,RECTAL CANCER METASTATIC,1
BE,REGURGITATION,1
BE,RENAL CELL CARCINOMA,1
BE,RENAL FAILURE,1
BE,RENAL FAILURE ACUTE,1
BE,RENAL TUBULAR NECROSIS,1
BE,RESPIRATORY FAILURE,1
BE,RETINAL INFILTRATES,1
BE,RETROPERITONEAL HAEMORRHAGE,1
BE,RHABDOMYOLYSIS,1
BE,RHYTHM IDIOVENTRICULAR,1
BE,ROAD TRAFFIC ACCIDENT,1
BE,SALIVA ALTERED,1
BE,SALIVARY HYPERSECRETION,1
BE,SEPTIC SHOCK,1
BE,SEXUALLY INAPPROPRIATE BEHAVIOUR,1
BE,SHOCK HAEMORRHAGIC,1
BE,SINUS ARREST,1
BE,SINUSITIS,1
BE,SMALL INTESTINE POLYP,1
BE,SOMNOLENCE,1
BE,SPLENIC HAEMATOMA,1
BE,STOMA SITE DISCHARGE,1
BE,STOMA SITE INFECTION,1
BE,STOMA SITE ULCER,1
BE,STRESS,1
BE,SUBDURAL HAEMORRHAGE,1
BE,SUSAC^S SYNDROME,1
BE,SYSTEMIC CANDIDA,1
BE,TENDON RUPTURE,1
BE,THROMBOANGIITIS OBLITERANS,1
BE,THROMBOSIS IN DEVICE,1
BE,TOXICITY TO VARIOUS AGENTS,1
BE,TRAUMATIC INTRACRANIAL HAEMORRHAGE,1
BE,TREMOR,1
BE,TROPONIN INCREASED,1
BE,ULCER HAEMORRHAGE,1
BE,UNRESPONSIVE TO STIMULI,1
BE,UPPER RESPIRATORY TRACT INFECTION,1
BE,URINARY BLADDER HAEMORRHAGE,1
BE,UROGENITAL HAEMORRHAGE,1
BE,VASCULAR MALFORMATION,1
BE,VASCULAR OPERATION,1
BE,VASCULAR PSEUDOANEURYSM,1
BE,VASCULAR STENT THROMBOSIS,1
BE,VASODILATATION,1
BE,VASOSPASM,1
BE,VENTRICLE RUPTURE,1
BE,VENTRICULAR FIBRILLATION,1
BE,VENTRICULAR SEPTAL DEFECT ACQUIRED,1
BE,VISUAL IMPAIRMENT,1
BE,WHITE BLOOD CELL DISORDER,1
BE,WITHDRAWAL SYNDROME,1
BE,WOUND,1
BO,BRAIN NEOPLASM BENIGN,1
BO,HEADACHE,1
BO,SYNCOPE,1
BA,ABDOMINAL PAIN UPPER,1
BA,ASTHENIA,1
BA,BLOOD GLUCOSE INCREASED,1
BA,BLOOD PRESSURE DECREASED,1
BA,HYPOAESTHESIA ORAL,1
BA,INCORRECT DOSE ADMINISTERED,1
BA,MALAISE,1
BA,NAUSEA,1
BA,THROMBOCYTOPENIA,1
BW,FALL,1
BW,SUBDURAL HAEMATOMA,1
BR,CORONARY ARTERY OCCLUSION,32
BR,MYOCARDIAL INFARCTION,31
BR,MALAISE,30
BR,DRUG INEFFECTIVE,29
BR,HYPERTENSION,29
BR,BLOOD GLUCOSE INCREASED,23
BR,PAIN IN EXTREMITY,23
BR,PNEUMONIA,23
BR,DIZZINESS,22
BR,FALL,22
BR,WEIGHT DECREASED,22
BR,URINARY TRACT INFECTION,21
BR,CEREBROVASCULAR ACCIDENT,19
BR,DYSPNOEA,19
BR,ARTERIAL OCCLUSIVE DISEASE,18
BR,PAIN,18
BR,BLOOD CHOLESTEROL INCREASED,17
BR,BLOOD PRESSURE INCREASED,17
BR,COUGH,16
BR,FATIGUE,16
BR,INFLUENZA,16
BR,ASTHENIA,15
BR,DIARRHOEA,15
BR,HYPERGLYCAEMIA,15
BR,CARDIAC DISORDER,13
BR,CATARACT,13
BR,HEADACHE,13
BR,INFARCTION,13
BR,VOMITING,13
BR,HYPOTENSION,12
BR,VENOUS OCCLUSION,12
BR,DEATH,11
BR,GAIT DISTURBANCE,11
BR,NAUSEA,11
BR,VISUAL IMPAIRMENT,11
BR,ANAEMIA,10
BR,ARRHYTHMIA,10
BR,ARTHRALGIA,10
BR,PYREXIA,10
BR,CHEST PAIN,9
BR,DIABETES MELLITUS,9
BR,INSOMNIA,9
BR,MEMORY IMPAIRMENT,9
BR,APHASIA,8
BR,DECREASED APPETITE,8
BR,HYPOGLYCAEMIA,8
BR,ABDOMINAL PAIN UPPER,7
BR,BLOOD PRESSURE DECREASED,7
BR,DEPRESSION,7
BR,DRUG ADMINISTRATION ERROR,7
BR,FEELING ABNORMAL,7
BR,HYPERSENSITIVITY,7
BR,HYPOAESTHESIA,7
BR,MUSCLE SPASMS,7
BR,NERVOUSNESS,7
BR,SOMNOLENCE,7
BR,SPEECH DISORDER,7
BR,WEIGHT INCREASED,7
BR,BLOOD TRIGLYCERIDES INCREASED,6
BR,CHILLS,6
BR,DRUG DOSE OMISSION,6
BR,ERYTHEMA,6
BR,FLUID RETENTION,6
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,6
BR,LEUKOPENIA,6
BR,LIVER DISORDER,6
BR,OEDEMA PERIPHERAL,6
BR,PALPITATIONS,6
BR,SEPSIS,6
BR,SEPTIC SHOCK,6
BR,SYNCOPE,6
BR,VISION BLURRED,6
BR,ACUTE MYOCARDIAL INFARCTION,5
BR,ANGINA PECTORIS,5
BR,ATRIAL FIBRILLATION,5
BR,BONE MARROW TOXICITY,5
BR,CARDIAC FAILURE CONGESTIVE,5
BR,DYSURIA,5
BR,EXPOSURE DURING PREGNANCY,5
BR,FEMUR FRACTURE,5
BR,IMMUNODEFICIENCY,5
BR,INJECTION SITE PAIN,5
BR,PARAESTHESIA,5
BR,PERIPHERAL SWELLING,5
BR,PRODUCT USE ISSUE,5
BR,PRURITUS,5
BR,RENAL IMPAIRMENT,5
BR,RHEUMATIC DISORDER,5
BR,SKIN DISCOLOURATION,5
BR,SWELLING FACE,5
BR,TREMOR,5
BR,ANXIETY,4
BR,ARTHROPATHY,4
BR,ATYPICAL PNEUMONIA,4
BR,BLOOD IRON DECREASED,4
BR,CHOLELITHIASIS,4
BR,CONDITION AGGRAVATED,4
BR,FEBRILE NEUTROPENIA,4
BR,HAEMORRHAGE,4
BR,HAEMORRHAGIC STROKE,4
BR,HEART RATE INCREASED,4
BR,HERPES ZOSTER,4
BR,INCORRECT DOSE ADMINISTERED,4
BR,INFECTION,4
BR,INJECTION SITE DISCOLOURATION,4
BR,INTENTIONAL PRODUCT MISUSE,4
BR,ISCHAEMIC STROKE,4
BR,MYALGIA,4
BR,MYOCARDIAL ISCHAEMIA,4
BR,OSTEOPOROSIS,4
BR,POLLAKIURIA,4
BR,RASH,4
BR,RENAL FAILURE,4
BR,RHEUMATOID ARTHRITIS,4
BR,SWELLING,4
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,4
BR,THIRST,4
BR,THROMBOSIS,4
BR,WOUND,4
BR,ABDOMINAL HERNIA,3
BR,AGITATION,3
BR,ANGIOPATHY,3
BR,APPLICATION SITE ERYTHEMA,3
BR,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,3
BR,BACK PAIN,3
BR,BLINDNESS,3
BR,BLOOD PRESSURE FLUCTUATION,3
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,3
BR,CARDIO-RESPIRATORY ARREST,3
BR,CARDIOMYOPATHY,3
BR,CATARACT OPERATION,3
BR,CEREBRAL ISCHAEMIA,3
BR,COGNITIVE DISORDER,3
BR,COLD SWEAT,3
BR,CONCOMITANT DISEASE AGGRAVATED,3
BR,CORONARY ARTERY DISEASE,3
BR,DEHYDRATION,3
BR,DEMENTIA ALZHEIMER^S TYPE,3
BR,DRUG HYPERSENSITIVITY,3
BR,EMOTIONAL DISORDER,3
BR,EYE HAEMORRHAGE,3
BR,FEEDING DISORDER,3
BR,FEELING HOT,3
BR,FIBROMYALGIA,3
BR,FOETAL EXPOSURE DURING PREGNANCY,3
BR,GASTRIC DISORDER,3
BR,GASTRITIS,3
BR,GASTROOESOPHAGEAL REFLUX DISEASE,3
BR,HAEMATOCHEZIA,3
BR,HAEMATOMA,3
BR,HEARING IMPAIRED,3
BR,HEART RATE DECREASED,3
BR,HEPATIC NEOPLASM,3
BR,HIGH DENSITY LIPOPROTEIN DECREASED,3
BR,HIP FRACTURE,3
BR,ILL-DEFINED DISORDER,3
BR,IMPAIRED HEALING,3
BR,INJECTION SITE HAEMORRHAGE,3
BR,JOINT SWELLING,3
BR,LIMB OPERATION,3
BR,LUNG DISORDER,3
BR,MOVEMENT DISORDER,3
BR,NASOPHARYNGITIS,3
BR,NEUTROPENIA,3
BR,OVERDOSE,3
BR,PERIPHERAL VASCULAR DISORDER,3
BR,PLEURAL EFFUSION,3
BR,PRODUCT QUALITY ISSUE,3
BR,PROSTATIC DISORDER,3
BR,PSORIASIS,3
BR,PULMONARY EMBOLISM,3
BR,RENAL DISORDER,3
BR,RETINAL DETACHMENT,3
BR,RIB FRACTURE,3
BR,SENSORY LOSS,3
BR,SINUSITIS,3
BR,SKIN HAEMORRHAGE,3
BR,STAPHYLOCOCCAL INFECTION,3
BR,STRESS,3
BR,THROMBOCYTOPENIA,3
BR,UPPER LIMB FRACTURE,3
BR,WEIGHT FLUCTUATION,3
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
BR,ABASIA,2
BR,ABDOMINAL DISCOMFORT,2
BR,ABDOMINAL PAIN,2
BR,ACCIDENT,2
BR,ACNE,2
BR,ACUTE KIDNEY INJURY,2
BR,ACUTE PULMONARY OEDEMA,2
BR,ADVERSE EVENT,2
BR,AMNESIA,2
BR,ANAPHYLACTIC REACTION,2
BR,ANGINA UNSTABLE,2
BR,ANGIOEDEMA,2
BR,AORTIC ANEURYSM,2
BR,APPLICATION SITE PRURITUS,2
BR,ARTERIAL DISORDER,2
BR,ARTERIOGRAM CORONARY ABNORMAL,2
BR,ARTHRITIS,2
BR,ASTHMA,2
BR,ASTHMATIC CRISIS,2
BR,BACTERIAL INFECTION,2
BR,BENIGN OVARIAN TUMOUR,2
BR,BILE DUCT STONE,2
BR,BLISTER,2
BR,BLOOD CALCIUM DECREASED,2
BR,BLOOD CHOLESTEROL ABNORMAL,2
BR,BLOOD GLUCOSE ABNORMAL,2
BR,BLOOD MAGNESIUM DECREASED,2
BR,BLOOD URIC ACID INCREASED,2
BR,BRADYCARDIA,2
BR,BREAST CANCER,2
BR,BREAST CANCER FEMALE,2
BR,BREATH SOUNDS ABNORMAL,2
BR,BURNING SENSATION,2
BR,BURSITIS,2
BR,CARDIAC FAILURE,2
BR,CARDIAC MURMUR,2
BR,CARDIAC OPERATION,2
BR,CARDIAC STRESS TEST ABNORMAL,2
BR,CAROTID ARTERY OCCLUSION,2
BR,CATHETERISATION CARDIAC,2
BR,CATHETERISATION VENOUS,2
BR,CHOKING,2
BR,CHROMATURIA,2
BR,COMA,2
BR,CONFUSIONAL STATE,2
BR,CONGENITAL NAEVUS,2
BR,CONSTIPATION,2
BR,CONTUSION,2
BR,CRYING,2
BR,DEAFNESS UNILATERAL,2
BR,DENGUE FEVER,2
BR,DEPRESSED MOOD,2
BR,DEVICE OCCLUSION,2
BR,DRY MOUTH,2
BR,DRY SKIN,2
BR,DYSGEUSIA,2
BR,DYSPEPSIA,2
BR,DYSPHAGIA,2
BR,DYSPHONIA,2
BR,DYSPNOEA EXERTIONAL,2
BR,DYSSTASIA,2
BR,EATING DISORDER,2
BR,ENDOCARDITIS,2
BR,EYE IRRITATION,2
BR,EYE PRURITUS,2
BR,EYE SWELLING,2
BR,FLATULENCE,2
BR,FOOT FRACTURE,2
BR,FORMICATION,2
BR,FUNGAL INFECTION,2
BR,GAIT INABILITY,2
BR,GASTRIC HAEMORRHAGE,2
BR,GASTRIC INFECTION,2
BR,GASTRIC ULCER,2
BR,GASTROINTESTINAL BACTERIAL OVERGROWTH,2
BR,GASTROINTESTINAL CARCINOMA,2
BR,GASTROINTESTINAL DISORDER,2
BR,GLAUCOMA,2
BR,HAEMANGIOMA OF LIVER,2
BR,HAEMODYNAMIC INSTABILITY,2
BR,HALLUCINATION,2
BR,HEAD DISCOMFORT,2
BR,HEMIPLEGIA,2
BR,HEPATIC CANCER,2
BR,HEPATIC CYST,2
BR,HEPATIC STEATOSIS,2
BR,HEPATITIS,2
BR,HYPERAESTHESIA,2
BR,HYPERHIDROSIS,2
BR,HYPERKALAEMIA,2
BR,HYPOACUSIS,2
BR,INJECTION SITE MASS,2
BR,INJURY,2
BR,INTENTIONAL DRUG MISUSE,2
BR,INTESTINAL ISCHAEMIA,2
BR,LACRIMATION INCREASED,2
BR,LIMB INJURY,2
BR,LINEAR IGA DISEASE,2
BR,LIVE BIRTH,2
BR,LOCAL SWELLING,2
BR,LOCALISED INFECTION,2
BR,LOSS OF CONSCIOUSNESS,2
BR,MALIGNANT NEOPLASM PROGRESSION,2
BR,MASS,2
BR,METASTASES TO LUNG,2
BR,MICTURITION DISORDER,2
BR,MIGRAINE,2
BR,MOBILITY DECREASED,2
BR,MOOD ALTERED,2
BR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
BR,MUSCLE RIGIDITY,2
BR,MUSCULAR WEAKNESS,2
BR,MUSCULOSKELETAL STIFFNESS,2
BR,NECK PAIN,2
BR,NEUROPATHY PERIPHERAL,2
BR,OCULAR HYPERAEMIA,2
BR,OSTEOARTHRITIS,2
BR,PARKINSON^S DISEASE,2
BR,POLYURIA,2
BR,PRODUCT USE IN UNAPPROVED INDICATION,2
BR,PROSTATE CANCER,2
BR,RESPIRATORY FAILURE,2
BR,RESPIRATORY RATE INCREASED,2
BR,RETINAL HAEMORRHAGE,2
BR,SEIZURE,2
BR,SERUM FERRITIN INCREASED,2
BR,SKIN BURNING SENSATION,2
BR,SKIN DISORDER,2
BR,SKIN EXFOLIATION,2
BR,SKIN GRAFT,2
BR,SKIN INFECTION,2
BR,SKIN IRRITATION,2
BR,SLUGGISHNESS,2
BR,SPINAL PAIN,2
BR,TACHYARRHYTHMIA,2
BR,TINNITUS,2
BR,TRANSFUSION,2
BR,TYMPANIC MEMBRANE PERFORATION,2
BR,URINARY INCONTINENCE,2
BR,URTICARIA,2
BR,VASCULITIS,2
BR,VENOUS THROMBOSIS LIMB,2
BR,VISUAL ACUITY REDUCED,2
BR,VITAMIN B12 DECREASED,2
BR,VITAMIN D DECREASED,2
BR,WHEEZING,2
BR,ABDOMINAL DISTENSION,1
BR,ABDOMINAL RIGIDITY,1
BR,ABDOMINAL SEPSIS,1
BR,ABNORMAL BEHAVIOUR,1
BR,ABNORMAL FAECES,1
BR,ABNORMAL SENSATION IN EYE,1
BR,ACUTE CORONARY SYNDROME,1
BR,ACUTE RESPIRATORY DISTRESS SYNDROME,1
BR,ALANINE AMINOTRANSFERASE INCREASED,1
BR,ALLERGIC SINUSITIS,1
BR,ALOPECIA,1
BR,ALTERED STATE OF CONSCIOUSNESS,1
BR,AMENORRHOEA,1
BR,AMPUTATION,1
BR,ANAL FISTULA,1
BR,ANAL ULCER,1
BR,ANGIOPLASTY,1
BR,AORTIC DISORDER,1
BR,AORTIC DISSECTION,1
BR,AORTIC VALVE REPAIR,1
BR,APATHY,1
BR,APPARENT DEATH,1
BR,APPENDICITIS,1
BR,APPLICATION SITE HYPERSENSITIVITY,1
BR,APPLICATION SITE IRRITATION,1
BR,APPLICATION SITE MASS,1
BR,APPLICATION SITE ULCER,1
BR,ARTERIOSCLEROSIS,1
BR,ARTERIOSCLEROSIS CORONARY ARTERY,1
BR,ARTERITIS,1
BR,ASPARTATE AMINOTRANSFERASE INCREASED,1
BR,ASPIRATION BRONCHIAL,1
BR,ATELECTASIS,1
BR,ATRIOVENTRICULAR BLOCK,1
BR,ATROPHY,1
BR,BALANCE DISORDER,1
BR,BEDRIDDEN,1
BR,BILIARY COLIC,1
BR,BLADDER DILATATION,1
BR,BLEEDING TIME PROLONGED,1
BR,BLINDNESS TRANSIENT,1
BR,BLINDNESS UNILATERAL,1
BR,BLOOD CHOLESTEROL DECREASED,1
BR,BLOOD CREATININE INCREASED,1
BR,BLOOD GASTRIN INCREASED,1
BR,BLOOD GLUCOSE FLUCTUATION,1
BR,BLOOD HOMOCYSTEINE INCREASED,1
BR,BLOOD INSULIN DECREASED,1
BR,BLOOD PRESSURE ABNORMAL,1
BR,BLOOD PRESSURE SYSTOLIC INCREASED,1
BR,BLOOD SODIUM ABNORMAL,1
BR,BLOOD TRIGLYCERIDES ABNORMAL,1
BR,BLOOD UREA INCREASED,1
BR,BONE DISORDER,1
BR,BONE FORMATION DECREASED,1
BR,BONE LESION,1
BR,BONE LOSS,1
BR,BONE PAIN,1
BR,BRAIN HYPOXIA,1
BR,BREAST CYST,1
BR,BREAST MASS,1
BR,BREAST NEOPLASM,1
BR,BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS,1
BR,BRONCHITIS,1
BR,BRONCHOPNEUMONIA,1
BR,BROWN-SEQUARD SYNDROME,1
BR,BUNDLE BRANCH BLOCK LEFT,1
BR,CAESAREAN SECTION,1
BR,CALCULUS URETHRAL,1
BR,CARCINOID TUMOUR OF THE PROSTATE,1
BR,CARDIAC ARREST,1
BR,CARDIAC HYPERTROPHY,1
BR,CARDIAC PACEMAKER INSERTION,1
BR,CARDIAC VENTRICULAR THROMBOSIS,1
BR,CARDIOPULMONARY FAILURE,1
BR,CAROTID ARTERY STENOSIS,1
BR,CARTILAGE INJURY,1
BR,CATARRH,1
BR,CATHETER PLACEMENT,1
BR,CEREBRAL CALCIFICATION,1
BR,CERUMEN IMPACTION,1
BR,CHEST DISCOMFORT,1
BR,CHOLANGIOCARCINOMA,1
BR,CHOLESTASIS,1
BR,CHRONIC GASTRITIS,1
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
BR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
BR,COLITIS,1
BR,COLLATERAL CIRCULATION,1
BR,COMPLICATION OF DELIVERY,1
BR,COMPLICATION OF PREGNANCY,1
BR,CONGENITAL HEART VALVE DISORDER,1
BR,CONJUNCTIVITIS,1
BR,CONVULSION,1
BR,CORONARY ARTERY RESTENOSIS,1
BR,CORONARY ARTERY STENOSIS,1
BR,CUSHING^S SYNDROME,1
BR,CYSTITIS,1
BR,DANDRUFF,1
BR,DECREASED IMMUNE RESPONSIVENESS,1
BR,DEFAECATION URGENCY,1
BR,DELIRIUM,1
BR,DELUSION,1
BR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
BR,DERMATITIS,1
BR,DEVICE BREAKAGE,1
BR,DEVICE MALFUNCTION,1
BR,DEVICE RELATED INFECTION,1
BR,DIABETIC NEUROPATHY,1
BR,DILATATION VENTRICULAR,1
BR,DISABILITY,1
BR,DISCOMFORT,1
BR,DISEASE RECURRENCE,1
BR,DISLOCATION OF VERTEBRA,1
BR,DISORIENTATION,1
BR,DISTURBANCE IN ATTENTION,1
BR,DISTURBANCE IN SOCIAL BEHAVIOUR,1
BR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
BR,DRUG DISPENSING ERROR,1
BR,DRUG INTOLERANCE,1
BR,DRUG LEVEL ABOVE THERAPEUTIC,1
BR,DRUG PRESCRIBING ERROR,1
BR,DRUG-INDUCED LIVER INJURY,1
BR,DRY EYE,1
BR,DUCTUS ARTERIOSUS PREMATURE CLOSURE,1
BR,DUCTUS ARTERIOSUS STENOSIS FOETAL,1
BR,DYSARTHRIA,1
BR,DYSBACTERIOSIS,1
BR,DYSCHEZIA,1
BR,EAR HAEMORRHAGE,1
BR,EAR INFECTION,1
BR,EAR PAIN,1
BR,ECCHYMOSIS,1
BR,ELECTROCARDIOGRAM PR PROLONGATION,1
BR,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
BR,EMBOLIC STROKE,1
BR,EMBOLISM VENOUS,1
BR,EMOTIONAL DISTRESS,1
BR,EMPHYSEMA,1
BR,EPISTAXIS,1
BR,ERYSIPELAS,1
BR,EXPIRED DRUG ADMINISTERED,1
BR,EXPIRED PRODUCT ADMINISTERED,1
BR,EXTRAVASATION BLOOD,1
BR,EXTREMITY NECROSIS,1
BR,FACE INJURY,1
BR,FACIAL BONES FRACTURE,1
BR,FEAR,1
BR,FEAR OF DISEASE,1
BR,FEAR OF FALLING,1
BR,FEELING COLD,1
BR,FIBROSIS,1
BR,FINGER DEFORMITY,1
BR,FLAVIVIRUS INFECTION,1
BR,FLUID INTAKE REDUCED,1
BR,FOETAL DISTRESS SYNDROME,1
BR,FOOT DEFORMITY,1
BR,GANGRENE,1
BR,GASTROINTESTINAL HAEMORRHAGE,1
BR,GASTROINTESTINAL INJURY,1
BR,GASTROINTESTINAL NEOPLASM,1
BR,GENERAL PHYSICAL HEALTH DETERIORATION,1
BR,GENERALISED ERYTHEMA,1
BR,GENERALISED OEDEMA,1
BR,GENITAL CYST,1
BR,GENITAL HAEMORRHAGE,1
BR,GINGIVITIS,1
BR,GLUCOSE TOLERANCE IMPAIRED,1
BR,GOITRE,1
BR,GOUT,1
BR,GROIN PAIN,1
BR,GROWING PAINS,1
BR,H1N1 INFLUENZA,1
BR,HAEMATEMESIS,1
BR,HAEMATOCRIT DECREASED,1
BR,HAEMODIALYSIS,1
BR,HAIR COLOUR CHANGES,1
BR,HAND DEFORMITY,1
BR,HEAD INJURY,1
BR,HEART RATE ABNORMAL,1
BR,HEART RATE IRREGULAR,1
BR,HEART SOUNDS ABNORMAL,1
BR,HELICOBACTER GASTRITIS,1
BR,HEPATOMEGALY,1
BR,HEPATOTOXICITY,1
BR,HEREDITARY ANGIOEDEMA,1
BR,HERPES VIRUS INFECTION,1
BR,HORMONE LEVEL ABNORMAL,1
BR,HOSPITALISATION,1
BR,HUNGER,1
BR,HYPERKERATOSIS,1
BR,HYPERMETROPIA,1
BR,HYPERSOMNIA,1
BR,HYPERTENSIVE CRISIS,1
BR,HYPOPERFUSION,1
BR,HYPOTHERMIA,1
BR,HYPOTHYROIDISM,1
BR,HYPOXIA,1
BR,HYSTERECTOMY,1
BR,ILEUS PARALYTIC,1
BR,ILLUSION,1
BR,IMMOBILE,1
BR,IMMUNE SYSTEM DISORDER,1
BR,INCARCERATED INGUINAL HERNIA,1
BR,INCOHERENT,1
BR,INCORRECT PRODUCT STORAGE,1
BR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
BR,INCREASED APPETITE,1
BR,INCREASED UPPER AIRWAY SECRETION,1
BR,INFLAMMATION,1
BR,INJECTION SITE BRUISING,1
BR,INJECTION SITE ERYTHEMA,1
BR,INJECTION SITE HAEMATOMA,1
BR,INJECTION SITE HYPERSENSITIVITY,1
BR,INJECTION SITE INDURATION,1
BR,INJECTION SITE NODULE,1
BR,INJECTION SITE PRURITUS,1
BR,INJECTION SITE REACTION,1
BR,INJECTION SITE SWELLING,1
BR,INJECTION SITE VESICLES,1
BR,INNER EAR DISORDER,1
BR,INTERVERTEBRAL DISC PROTRUSION,1
BR,INTESTINAL HAEMORRHAGE,1
BR,INTESTINAL RESECTION,1
BR,INTRACARDIAC THROMBUS,1
BR,INTRAOCULAR PRESSURE TEST ABNORMAL,1
BR,IRRITABLE BOWEL SYNDROME,1
BR,ISCHAEMIA,1
BR,ISCHAEMIC CARDIOMYOPATHY,1
BR,JAW DISORDER,1
BR,LABORATORY TEST ABNORMAL,1
BR,LABYRINTHITIS,1
BR,LARYNGEAL OEDEMA,1
BR,LEFT VENTRICULAR DYSFUNCTION,1
BR,LEUKAEMIA,1
BR,LOW DENSITY LIPOPROTEIN,1
BR,LOW DENSITY LIPOPROTEIN ABNORMAL,1
BR,LOW DENSITY LIPOPROTEIN INCREASED,1
BR,LUNG INFECTION,1
BR,MALIGNANT MELANOMA,1
BR,MASTICATION DISORDER,1
BR,MATERNAL EXPOSURE BEFORE PREGNANCY,1
BR,MATERNAL EXPOSURE DURING PREGNANCY,1
BR,MEDIASTINITIS,1
BR,MEDICAL DEVICE IMPLANTATION,1
BR,MENINGITIS,1
BR,MENORRHAGIA,1
BR,METASTASES TO LIVER,1
BR,METASTASES TO OESOPHAGUS,1
BR,MINERAL DEFICIENCY,1
BR,MITRAL VALVE DISEASE,1
BR,MONOPLEGIA,1
BR,MOUTH INJURY,1
BR,MOUTH ULCERATION,1
BR,MULTI-ORGAN FAILURE,1
BR,MUSCLE DISORDER,1
BR,MUSCLE TIGHTNESS,1
BR,MUSCULOSKELETAL PAIN,1
BR,MYELITIS,1
BR,MYOPIA,1
BR,NAIL DISCOLOURATION,1
BR,NAIL DISORDER,1
BR,NASAL CONGESTION,1
BR,NASAL CYST,1
BR,NASAL DISCHARGE DISCOLOURATION,1
BR,NASAL INJURY,1
BR,NASAL PRURITUS,1
BR,NASAL SEPTAL OPERATION,1
BR,NEOPLASM MALIGNANT,1
BR,NEOPLASM PROSTATE,1
BR,NEPHRITIS,1
BR,NEPHROCALCINOSIS,1
BR,NEPHROLITHIASIS,1
BR,NIKOLSKY^S SIGN,1
BR,NODULE,1
BR,OESOPHAGEAL CANDIDIASIS,1
BR,OESOPHAGEAL CARCINOMA,1
BR,OESOPHAGEAL DISORDER,1
BR,ORAL DISCOMFORT,1
BR,ORAL DISORDER,1
BR,OROPHARYNGEAL PAIN,1
BR,ORTHOPNOEA,1
BR,OSTEOPENIA,1
BR,OVARIAN NEOPLASM,1
BR,PAIN OF SKIN,1
BR,PALLOR,1
BR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
BR,PANIC REACTION,1
BR,PARALYSIS,1
BR,PARKINSONISM,1
BR,PEAK EXPIRATORY FLOW RATE DECREASED,1
BR,PELVIC DEFORMITY,1
BR,PELVIC INFLAMMATORY DISEASE,1
BR,PERIPHERAL ARTERY OCCLUSION,1
BR,PERIPHERAL COLDNESS,1
BR,PERIPHERAL EMBOLISM,1
BR,PERITONITIS,1
BR,PHARYNGEAL CYST,1
BR,PIGMENTATION DISORDER,1
BR,PLASMA CELL MYELOMA,1
BR,PLATELET COUNT ABNORMAL,1
BR,PNEUMONIA ASPIRATION,1
BR,PNEUMONIA KLEBSIELLA,1
BR,PNEUMONITIS,1
BR,POLYDIPSIA,1
BR,POOR PERIPHERAL CIRCULATION,1
BR,POST PROCEDURAL HAEMORRHAGE,1
BR,POST PROCEDURAL INFECTION,1
BR,PRESCRIBED UNDERDOSE,1
BR,PRESYNCOPE,1
BR,PRODUCT PACKAGING ISSUE,1
BR,PRODUCTIVE COUGH,1
BR,PROSTATIC MASS,1
BR,PSEUDOMEMBRANOUS COLITIS,1
BR,PSYCHIATRIC SYMPTOM,1
BR,PSYCHOMOTOR HYPERACTIVITY,1
BR,PTERYGIUM,1
BR,PULMONARY FUNCTION TEST DECREASED,1
BR,PULMONARY HAEMORRHAGE,1
BR,PULMONARY HILAR ENLARGEMENT,1
BR,PULMONARY NECROSIS,1
BR,PULMONARY OEDEMA,1
BR,PUNCTURE SITE HAEMORRHAGE,1
BR,PYELONEPHRITIS,1
BR,RASH MACULAR,1
BR,RAYNAUD^S PHENOMENON,1
BR,RECTAL ADENOCARCINOMA,1
BR,RECTAL CANCER,1
BR,RECTAL HAEMORRHAGE,1
BR,RENAL ARTERY OCCLUSION,1
BR,RENAL FAILURE ACUTE,1
BR,RENAL PAIN,1
BR,RESPIRATORY DISORDER,1
BR,RESTLESSNESS,1
BR,RETINAL DEGENERATION,1
BR,RETINAL DISORDER,1
BR,RETINOPATHY,1
BR,RETROPERITONEAL MASS,1
BR,RHINORRHOEA,1
BR,RHONCHI,1
BR,RIGHT VENTRICULAR DYSFUNCTION,1
BR,ROAD TRAFFIC ACCIDENT,1
BR,SALIVARY HYPERSECRETION,1
BR,SALMONELLOSIS,1
BR,SCAR,1
BR,SCRATCH,1
BR,SEBORRHOEA,1
BR,SENSORY DISTURBANCE,1
BR,SHOCK,1
BR,SKIN EROSION,1
BR,SKIN HYPERPIGMENTATION,1
BR,SKIN INDURATION,1
BR,SKIN PAPILLOMA,1
BR,SKIN PLAQUE,1
BR,SKIN ULCER,1
BR,SLEEP DISORDER,1
BR,SNEEZING,1
BR,SPINAL FLATTENING,1
BR,SPINAL MANIPULATION,1
BR,SPLEEN DISORDER,1
BR,SPLENIC ARTERY ANEURYSM,1
BR,STENT PLACEMENT,1
BR,STRESS FRACTURE,1
BR,SUFFOCATION FEELING,1
BR,SUICIDE ATTEMPT,1
BR,SWOLLEN TONGUE,1
BR,SYNOVITIS,1
BR,TENDON RUPTURE,1
BR,THERAPEUTIC RESPONSE DECREASED,1
BR,THROMBOCYTOSIS,1
BR,THYROID NEOPLASM,1
BR,TONGUE DISORDER,1
BR,TONSILLECTOMY,1
BR,TOOTH DISORDER,1
BR,TOOTH FRACTURE,1
BR,TOOTH INFECTION,1
BR,TOXIC ENCEPHALOPATHY,1
BR,TOXICITY TO VARIOUS AGENTS,1
BR,TREATMENT NONCOMPLIANCE,1
BR,TRICUSPID VALVE INCOMPETENCE,1
BR,ULCER,1
BR,UNDERDOSE,1
BR,UPPER RESPIRATORY TRACT INFECTION,1
BR,URINARY RETENTION,1
BR,URINARY TRACT DISORDER,1
BR,URINE OUTPUT DECREASED,1
BR,URINE POTASSIUM ABNORMAL,1
BR,UTERINE CANCER,1
BR,UTERINE HAEMORRHAGE,1
BR,VASCULAR CATHETERISATION,1
BR,VASCULAR OCCLUSION,1
BR,VASCULAR RUPTURE,1
BR,VENOOCCLUSIVE DISEASE,1
BR,VENOUS THROMBOSIS,1
BR,VENTRICULAR EXTRASYSTOLES,1
BR,VENTRICULAR FIBRILLATION,1
BR,VENTRICULAR TACHYCARDIA,1
BR,VERTIGO,1
BR,WALKING AID USER,1
BR,YELLOW SKIN,1
BN,VASCULAR PSEUDOANEURYSM,1
BG,ANGINA PECTORIS,4
BG,COMA,4
BG,ANGINA UNSTABLE,3
BG,DUODENAL ULCER HAEMORRHAGE,3
BG,DYSPNOEA,3
BG,ALANINE AMINOTRANSFERASE INCREASED,2
BG,ANAEMIA,2
BG,APHASIA,2
BG,ASPARTATE AMINOTRANSFERASE INCREASED,2
BG,ASTHMA,2
BG,DEATH,2
BG,DYSLIPIDAEMIA,2
BG,EPISTAXIS,2
BG,FAECES DISCOLOURED,2
BG,FATIGUE,2
BG,GASTRIC ULCER HAEMORRHAGE,2
BG,GASTROOESOPHAGEAL REFLUX DISEASE,2
BG,HAEMOGLOBIN DECREASED,2
BG,HAEMORRHAGIC STROKE,2
BG,HAEMORRHOIDS,2
BG,HEMIPLEGIA,2
BG,RHABDOMYOLYSIS,2
BG,THROMBOSIS IN DEVICE,2
BG,URINARY TRACT INFECTION,2
BG,VASCULAR STENT THROMBOSIS,2
BG,ABNORMAL BEHAVIOUR,1
BG,ACUTE HAEMORRHAGIC ULCERATIVE COLITIS,1
BG,ACUTE KIDNEY INJURY,1
BG,ACUTE MYELOID LEUKAEMIA,1
BG,ACUTE MYOCARDIAL INFARCTION,1
BG,AMMONIA INCREASED,1
BG,AMYLASE INCREASED,1
BG,ANXIETY,1
BG,ARRHYTHMIA,1
BG,ATRIAL FIBRILLATION,1
BG,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
BG,BLOOD ALBUMIN DECREASED,1
BG,BLOOD ALKALINE PHOSPHATASE INCREASED,1
BG,BLOOD CALCIUM DECREASED,1
BG,BLOOD CHOLINESTERASE INCREASED,1
BG,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
BG,BLOOD CREATINE PHOSPHOKINASE MB,1
BG,BLOOD FIBRINOGEN DECREASED,1
BG,BLOOD GLUCOSE ABNORMAL,1
BG,BLOOD IRON DECREASED,1
BG,BLOOD POTASSIUM DECREASED,1
BG,BLOOD PRESSURE INCREASED,1
BG,BLOOD SODIUM DECREASED,1
BG,BLOOD TRIGLYCERIDES INCREASED,1
BG,BLOOD UREA INCREASED,1
BG,BLOOD URIC ACID INCREASED,1
BG,BRAIN OEDEMA,1
BG,CARDIAC ANEURYSM,1
BG,CARDIAC FAILURE,1
BG,CARDIAC FAILURE CHRONIC,1
BG,CARDIAC TAMPONADE,1
BG,CEREBRAL HAEMATOMA,1
BG,CEREBROVASCULAR ACCIDENT,1
BG,CERVICAL RADICULOPATHY,1
BG,CHEST DISCOMFORT,1
BG,CHOKING,1
BG,CHOLELITHIASIS,1
BG,CHROMATURIA,1
BG,CHRONIC ALLOGRAFT NEPHROPATHY,1
BG,CHRONIC GASTRITIS,1
BG,COAGULOPATHY,1
BG,COLITIS ULCERATIVE,1
BG,CONTUSION,1
BG,CORONARY ARTERY RESTENOSIS,1
BG,CORONARY ARTERY STENOSIS,1
BG,COUGH,1
BG,CYTOMEGALOVIRUS INFECTION,1
BG,DECUBITUS ULCER,1
BG,DEEP VEIN THROMBOSIS,1
BG,DEMENTIA,1
BG,DEPRESSION,1
BG,DIABETES MELLITUS,1
BG,DIABETES MELLITUS INADEQUATE CONTROL,1
BG,DRUG DOSE OMISSION,1
BG,DRUG INEFFECTIVE,1
BG,DRY MOUTH,1
BG,DUODENITIS HAEMORRHAGIC,1
BG,DYSARTHRIA,1
BG,ELECTROCARDIOGRAM PR PROLONGATION,1
BG,ENCEPHALOPATHY,1
BG,EPIDERMOLYSIS,1
BG,EXPOSURE DURING PREGNANCY,1
BG,FALL,1
BG,FIBRIN D DIMER INCREASED,1
BG,FLUID RETENTION,1
BG,GAMMA-GLUTAMYLTRANSFERASE,1
BG,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
BG,GASTRODUODENITIS,1
BG,GASTRODUODENITIS HAEMORRHAGIC,1
BG,GASTROINTESTINAL HAEMORRHAGE,1
BG,GENERAL PHYSICAL HEALTH DETERIORATION,1
BG,GOUT,1
BG,HAEMATEMESIS,1
BG,HAEMATOCRIT DECREASED,1
BG,HAEMORRHAGE SUBCUTANEOUS,1
BG,HAEMORRHAGIC ANAEMIA,1
BG,HEAD INJURY,1
BG,HEMIPARESIS,1
BG,HEPATIC ENZYME INCREASED,1
BG,HIATUS HERNIA,1
BG,HIGH DENSITY LIPOPROTEIN DECREASED,1
BG,HYDRONEPHROSIS,1
BG,HYPERSENSITIVITY,1
BG,HYPERTENSION,1
BG,HYPOAESTHESIA,1
BG,IGA NEPHROPATHY,1
BG,INFARCTION,1
BG,INFECTIOUS PLEURAL EFFUSION,1
BG,INSOMNIA,1
BG,INTENTIONAL PRODUCT MISUSE,1
BG,INTERMITTENT CLAUDICATION,1
BG,INTERNATIONAL NORMALISED RATIO INCREASED,1
BG,IRON DEFICIENCY ANAEMIA,1
BG,ISCHAEMIC STROKE,1
BG,LACTATE DEHYDROGENASE URINE INCREASED,1
BG,LARGE INTESTINE POLYP,1
BG,LEUKOPENIA,1
BG,LUNG ABSCESS,1
BG,LYMPHOCYTE COUNT,1
BG,MONOPARESIS,1
BG,MOUTH HAEMORRHAGE,1
BG,MUSCLE INJURY,1
BG,MUSCLE SPASMS,1
BG,MUSCULAR WEAKNESS,1
BG,MYOCARDIAL ISCHAEMIA,1
BG,MYOGLOBIN BLOOD INCREASED,1
BG,NAUSEA,1
BG,NEUTROPENIA,1
BG,NIGHT BLINDNESS,1
BG,NYSTAGMUS,1
BG,OEDEMA PERIPHERAL,1
BG,OESOPHAGEAL DISORDER,1
BG,OSTEOCHONDROSIS,1
BG,OSTEOPOROSIS,1
BG,PAIN,1
BG,PALLOR,1
BG,PARAESTHESIA,1
BG,PARESIS,1
BG,PERICARDIAL HAEMORRHAGE,1
BG,PERICARDITIS,1
BG,PETECHIAE,1
BG,PLATELET COUNT INCREASED,1
BG,PNEUMONIA,1
BG,POLYURIA,1
BG,PROTEIN TOTAL DECREASED,1
BG,PSYCHOMOTOR HYPERACTIVITY,1
BG,PULMONARY FIBROSIS,1
BG,PYELONEPHRITIS,1
BG,RASH,1
BG,RECTAL ADENOCARCINOMA,1
BG,RECTAL HAEMORRHAGE,1
BG,RED BLOOD CELL COUNT DECREASED,1
BG,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
BG,SHOCK HAEMORRHAGIC,1
BG,SINUS BRADYCARDIA,1
BG,SOMNOLENCE,1
BG,SPINAL OSTEOARTHRITIS,1
BG,SUBARACHNOID HAEMORRHAGE,1
BG,SUBDURAL HAEMATOMA,1
BG,SUDDEN CARDIAC DEATH,1
BG,SYNCOPE,1
BG,TACHYCARDIA,1
BG,THERAPY CESSATION,1
BG,THIRST,1
BG,THROMBOCYTOPENIA,1
BG,TONGUE BITING,1
BG,ULCER,1
BG,UPPER RESPIRATORY TRACT INFECTION,1
BG,URINARY BLADDER HAEMORRHAGE,1
BG,URINARY INCONTINENCE,1
BG,UTERINE LEIOMYOMA,1
BG,VASCULAR STENT STENOSIS,1
BG,VENTRICULAR EXTRASYSTOLES,1
BG,VOMITING,1
BG,WHITE BLOOD CELL DISORDER,1
BG,WOUND HAEMORRHAGE,1
CA,NAUSEA,216
CA,DRUG INEFFECTIVE,190
CA,HEADACHE,186
CA,DIZZINESS,183
CA,FATIGUE,183
CA,VOMITING,182
CA,WEIGHT DECREASED,177
CA,DYSPNOEA,148
CA,ASTHENIA,135
CA,RHEUMATOID ARTHRITIS,133
CA,DIARRHOEA,126
CA,CORONARY ARTERY DISEASE,125
CA,DECREASED APPETITE,124
CA,MALAISE,117
CA,ARTHRALGIA,114
CA,PNEUMONIA,113
CA,PAIN,111
CA,PAIN IN EXTREMITY,111
CA,FALL,105
CA,NASOPHARYNGITIS,99
CA,EAR INFECTION,93
CA,COUGH,92
CA,PHARYNGITIS,85
CA,ABDOMINAL PAIN UPPER,81
CA,HYPOTENSION,81
CA,BLOOD PRESSURE INCREASED,79
CA,MYOCARDIAL INFARCTION,78
CA,DRUG HYPERSENSITIVITY,74
CA,DEATH,72
CA,NO THERAPEUTIC RESPONSE,70
CA,BACK PAIN,69
CA,PYREXIA,66
CA,ABDOMINAL DISCOMFORT,64
CA,CHEST PAIN,63
CA,WEIGHT INCREASED,62
CA,PERIPHERAL SWELLING,60
CA,CEREBROVASCULAR ACCIDENT,58
CA,GAIT DISTURBANCE,58
CA,GASTROINTESTINAL PAIN,57
CA,URINARY TRACT INFECTION,56
CA,ABDOMINAL PAIN,51
CA,JOINT SWELLING,51
CA,ARTHROPATHY,49
CA,HAEMOGLOBIN DECREASED,49
CA,DEAFNESS,48
CA,INFECTION,48
CA,INFUSION RELATED REACTION,48
CA,CARDIAC FAILURE CONGESTIVE,47
CA,CONFUSIONAL STATE,46
CA,ANAEMIA,45
CA,ATRIAL FIBRILLATION,44
CA,CONSTIPATION,44
CA,RASH,43
CA,CONDITION AGGRAVATED,42
CA,INFLUENZA,42
CA,OROPHARYNGEAL PAIN,42
CA,PRURITUS,42
CA,DRUG INTOLERANCE,41
CA,GASTROINTESTINAL DISORDER,41
CA,INSOMNIA,41
CA,SHOULDER ARTHROPLASTY,41
CA,DRUG EFFECT DECREASED,40
CA,MUSCULOSKELETAL DISORDER,40
CA,GASTROINTESTINAL HAEMORRHAGE,38
CA,HEART RATE DECREASED,38
CA,HYPERSENSITIVITY,38
CA,HYPOAESTHESIA,38
CA,HYPOPHAGIA,38
CA,DEHYDRATION,37
CA,CHEST DISCOMFORT,35
CA,OEDEMA PERIPHERAL,35
CA,ARTHRITIS,34
CA,BALANCE DISORDER,34
CA,CHILLS,34
CA,DEAFNESS TRANSITORY,34
CA,ERYTHEMA,34
CA,FEEDING DISORDER,34
CA,MYALGIA,34
CA,DRY MOUTH,33
CA,HAEMORRHAGE,33
CA,HEPATIC ENZYME INCREASED,33
CA,HYPERHIDROSIS,33
CA,MUSCLE SPASMS,33
CA,MUSCULAR WEAKNESS,33
CA,ANXIETY,31
CA,BLOOD CREATININE INCREASED,31
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,31
CA,CONTUSION,31
CA,PSORIASIS,31
CA,DYSPEPSIA,30
CA,SWOLLEN TONGUE,30
CA,SYNCOPE,30
CA,BURNING SENSATION,29
CA,LOWER RESPIRATORY TRACT INFECTION,29
CA,OSTEOARTHRITIS,29
CA,TREMOR,29
CA,BLOOD PRESSURE SYSTOLIC INCREASED,28
CA,BRONCHITIS,28
CA,SINUSITIS,28
CA,DRUG EFFECT INCOMPLETE,27
CA,MUSCULOSKELETAL PAIN,27
CA,PLEURAL EFFUSION,27
CA,SWELLING FACE,27
CA,HEART RATE INCREASED,26
CA,HYPERTENSION,26
CA,INFLAMMATION,26
CA,RENAL FAILURE,26
CA,SOMNOLENCE,26
CA,URTICARIA,26
CA,CARDIAC DISORDER,25
CA,DEPRESSION,25
CA,EPISTAXIS,25
CA,FEELING ABNORMAL,25
CA,GENERAL PHYSICAL HEALTH DETERIORATION,25
CA,HYPOGLYCAEMIA,25
CA,PRODUCTIVE COUGH,25
CA,SKIN ULCER,25
CA,SWELLING,25
CA,HERPES ZOSTER,24
CA,MOBILITY DECREASED,24
CA,PARAESTHESIA,24
CA,STRESS,24
CA,WHEEZING,24
CA,ABDOMINAL DISTENSION,23
CA,ASTHMA,23
CA,BREAST CANCER,23
CA,DYSPHAGIA,23
CA,LOCAL SWELLING,23
CA,PHARYNGEAL OEDEMA,23
CA,SEPSIS,23
CA,PLATELET COUNT DECREASED,22
CA,ACUTE CORONARY SYNDROME,21
CA,ACUTE KIDNEY INJURY,21
CA,ACUTE MYOCARDIAL INFARCTION,21
CA,ANGINA PECTORIS,21
CA,BODY TEMPERATURE DECREASED,21
CA,LIVER DISORDER,21
CA,NEUROPATHY PERIPHERAL,21
CA,THROAT IRRITATION,21
CA,TRANSIENT ISCHAEMIC ATTACK,21
CA,BLOOD GLUCOSE INCREASED,20
CA,BLOOD PRESSURE DECREASED,20
CA,CELLULITIS,20
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,20
CA,PALPITATIONS,20
CA,CARDIAC ARREST,19
CA,COGNITIVE DISORDER,19
CA,CYSTITIS,19
CA,DYSSTASIA,19
CA,PULMONARY OEDEMA,19
CA,RHINORRHOEA,19
CA,TOXICITY TO VARIOUS AGENTS,19
CA,ADVERSE DRUG REACTION,18
CA,BONE EROSION,18
CA,DIABETES MELLITUS,18
CA,DYSPHONIA,18
CA,DYSURIA,18
CA,LOCALISED INFECTION,18
CA,OXYGEN SATURATION DECREASED,18
CA,SCAR,18
CA,SKIN DISORDER,18
CA,THROMBOSIS,18
CA,VISION BLURRED,18
CA,ABASIA,17
CA,ARTERIOSCLEROSIS CORONARY ARTERY,17
CA,BLOOD PRESSURE DIASTOLIC DECREASED,17
CA,BLOOD PRESSURE FLUCTUATION,17
CA,EATING DISORDER,17
CA,FOOT OPERATION,17
CA,LOSS OF CONSCIOUSNESS,17
CA,NECK PAIN,17
CA,RENAL IMPAIRMENT,17
CA,ADVERSE EVENT,16
CA,AMNESIA,16
CA,CATARACT,16
CA,CEREBRAL HAEMORRHAGE,16
CA,EYE DISORDER,16
CA,GAIT INABILITY,16
CA,INJECTION SITE PAIN,16
CA,LUNG INFECTION,16
CA,MALIGNANT NEOPLASM PROGRESSION,16
CA,METABOLIC ACIDOSIS,16
CA,PANCREATITIS,16
CA,RESPIRATORY TRACT INFECTION,16
CA,TINNITUS,16
CA,ASPHYXIA,15
CA,DELIRIUM,15
CA,DISCOMFORT,15
CA,DYSGEUSIA,15
CA,INTERNATIONAL NORMALISED RATIO INCREASED,15
CA,MUSCULOSKELETAL STIFFNESS,15
CA,PULMONARY EMBOLISM,15
CA,ULCER,15
CA,BONE PAIN,14
CA,C-REACTIVE PROTEIN ABNORMAL,14
CA,DEPRESSED MOOD,14
CA,DISEASE PROGRESSION,14
CA,DYSPNOEA EXERTIONAL,14
CA,GASTROOESOPHAGEAL REFLUX DISEASE,14
CA,HOT FLUSH,14
CA,NASAL CONGESTION,14
CA,RED BLOOD CELL COUNT DECREASED,14
CA,SLEEP APNOEA SYNDROME,14
CA,VERTIGO,14
CA,VISUAL IMPAIRMENT,14
CA,ADRENAL INSUFFICIENCY,13
CA,ANGIOEDEMA,13
CA,APHASIA,13
CA,DRUG DOSE OMISSION,13
CA,DRY SKIN,13
CA,EAR PAIN,13
CA,FEELING HOT,13
CA,FLUID RETENTION,13
CA,HAEMOPTYSIS,13
CA,HAEMORRHAGE INTRACRANIAL,13
CA,HALLUCINATION,13
CA,ILL-DEFINED DISORDER,13
CA,IMPAIRED HEALING,13
CA,IMPAIRED WORK ABILITY,13
CA,MALIGNANT MELANOMA,13
CA,MEMORY IMPAIRMENT,13
CA,PRODUCT USE ISSUE,13
CA,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,13
CA,THROMBOCYTOPENIA,13
CA,UPPER GASTROINTESTINAL HAEMORRHAGE,13
CA,ALOPECIA,12
CA,DIABETIC KETOACIDOSIS,12
CA,EXTREMITY CONTRACTURE,12
CA,FLATULENCE,12
CA,HAEMATURIA,12
CA,HAEMORRHAGIC STROKE,12
CA,HEMIPARESIS,12
CA,INJECTION SITE BRUISING,12
CA,LUNG NEOPLASM MALIGNANT,12
CA,MULTIPLE SCLEROSIS,12
CA,PUSTULAR PSORIASIS,12
CA,RASH PRURITIC,12
CA,RENAL FAILURE ACUTE,12
CA,ASCITES,11
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,11
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,11
CA,HAEMATOCHEZIA,11
CA,HYPOMAGNESAEMIA,11
CA,INJECTION SITE ERYTHEMA,11
CA,MELAENA,11
CA,OSTEOPOROSIS,11
CA,PERIPHERAL COLDNESS,11
CA,POST PROCEDURAL INFECTION,11
CA,PROSTATE CANCER,11
CA,PULMONARY CONGESTION,11
CA,RECTAL HAEMORRHAGE,11
CA,RENAL DISORDER,11
CA,SKIN EXFOLIATION,11
CA,SPUTUM DISCOLOURED,11
CA,STAPHYLOCOCCAL INFECTION,11
CA,SYNOVITIS,11
CA,TACHYCARDIA,11
CA,TEMPERATURE INTOLERANCE,11
CA,THERAPEUTIC RESPONSE DECREASED,11
CA,UPPER RESPIRATORY TRACT INFECTION,11
CA,URINE ODOUR ABNORMAL,11
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,11
CA,WHITE BLOOD CELL COUNT DECREASED,11
CA,WHITE BLOOD CELL COUNT INCREASED,11
CA,AGITATION,10
CA,BASAL CELL CARCINOMA,10
CA,C-REACTIVE PROTEIN INCREASED,10
CA,ECZEMA,10
CA,FOOT DEFORMITY,10
CA,FUNCTIONAL GASTROINTESTINAL DISORDER,10
CA,HYPERGLYCAEMIA,10
CA,MYOCARDIAL ISCHAEMIA,10
CA,PNEUMONIA ASPIRATION,10
CA,POLYP,10
CA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,10
CA,RIB FRACTURE,10
CA,SEIZURE,10
CA,TOOTH DISORDER,10
CA,URINARY INCONTINENCE,10
CA,URINE ABNORMALITY,10
CA,WOUND,10
CA,APHONIA,9
CA,ARRHYTHMIA,9
CA,ASPARTATE AMINOTRANSFERASE INCREASED,9
CA,BLOOD GLUCOSE DECREASED,9
CA,CARDIAC FAILURE,9
CA,CHOLELITHIASIS,9
CA,CORONARY ARTERY OCCLUSION,9
CA,CYST,9
CA,DEAFNESS BILATERAL,9
CA,DENTAL CARIES,9
CA,DIARRHOEA HAEMORRHAGIC,9
CA,DISORIENTATION,9
CA,FEBRILE NEUTROPENIA,9
CA,FLUSHING,9
CA,FREQUENT BOWEL MOVEMENTS,9
CA,JOINT STIFFNESS,9
CA,LIMB DISCOMFORT,9
CA,LYMPHADENOPATHY,9
CA,LYMPHOMA,9
CA,MIDDLE INSOMNIA,9
CA,NEOPLASM,9
CA,NEOPLASM MALIGNANT,9
CA,NEUTROPENIA,9
CA,NIGHT SWEATS,9
CA,ORAL PAIN,9
CA,OVERDOSE,9
CA,PRODUCT QUALITY ISSUE,9
CA,PULMONARY FIBROSIS,9
CA,RASH ERYTHEMATOUS,9
CA,RENAL PAIN,9
CA,RESPIRATORY FAILURE,9
CA,RESPIRATORY RATE INCREASED,9
CA,SLEEP DISORDER,9
CA,SPEECH DISORDER,9
CA,SUICIDAL IDEATION,9
CA,WHEELCHAIR USER,9
CA,BLISTER,8
CA,BLOOD SODIUM DECREASED,8
CA,BLOOD URINE PRESENT,8
CA,BRADYCARDIA,8
CA,COORDINATION ABNORMAL,8
CA,DECREASED ACTIVITY,8
CA,DEMYELINATION,8
CA,DYSARTHRIA,8
CA,ELECTRIC SHOCK,8
CA,FAECES DISCOLOURED,8
CA,GASTRIC ULCER,8
CA,GOUT,8
CA,HEPATIC ENZYME ABNORMAL,8
CA,HEPATITIS,8
CA,HIP FRACTURE,8
CA,HYPERCHOLESTEROLAEMIA,8
CA,HYPONATRAEMIA,8
CA,INCORRECT DOSE ADMINISTERED,8
CA,INFLUENZA LIKE ILLNESS,8
CA,INTERVERTEBRAL DISCITIS,8
CA,IRRITABILITY,8
CA,LETHARGY,8
CA,LUNG DISORDER,8
CA,MOUTH ULCERATION,8
CA,MOVEMENT DISORDER,8
CA,MUSCULOSKELETAL DISCOMFORT,8
CA,OEDEMA,8
CA,PAIN IN JAW,8
CA,PALLOR,8
CA,PERIPHERAL VASCULAR DISORDER,8
CA,POLLAKIURIA,8
CA,POLYMYALGIA RHEUMATICA,8
CA,POST-TRAUMATIC STRESS DISORDER,8
CA,PRURITUS GENERALISED,8
CA,PULMONARY MASS,8
CA,RESPIRATORY TRACT CONGESTION,8
CA,RHEUMATOID FACTOR POSITIVE,8
CA,ROAD TRAFFIC ACCIDENT,8
CA,SEPTIC SHOCK,8
CA,SKIN LESION,8
CA,SPINAL FRACTURE,8
CA,STOMATITIS,8
CA,URINE OUTPUT DECREASED,8
CA,VIRAL INFECTION,8
CA,VOMITING PROJECTILE,8
CA,ADENOCARCINOMA OF COLON,7
CA,ADVERSE REACTION,7
CA,ALANINE AMINOTRANSFERASE INCREASED,7
CA,ATRIOVENTRICULAR BLOCK,7
CA,BLOOD GLUCOSE ABNORMAL,7
CA,BLOOD IRON DECREASED,7
CA,BLOOD POTASSIUM DECREASED,7
CA,BLOOD POTASSIUM INCREASED,7
CA,BONE DISORDER,7
CA,CARDIOMEGALY,7
CA,CHOKING,7
CA,DEEP VEIN THROMBOSIS,7
CA,DERMATITIS ALLERGIC,7
CA,DIVERTICULITIS,7
CA,DRUG LEVEL INCREASED,7
CA,DYSKINESIA,7
CA,ELECTROLYTE IMBALANCE,7
CA,EYE IRRITATION,7
CA,FOOT FRACTURE,7
CA,GASTRIC DISORDER,7
CA,HEAD INJURY,7
CA,HEPATIC FAILURE,7
CA,HEPATIC NEOPLASM,7
CA,HEPATIC STEATOSIS,7
CA,HEPATOTOXICITY,7
CA,HUNGER,7
CA,HYPOKALAEMIA,7
CA,INTESTINAL OBSTRUCTION,7
CA,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,7
CA,LIP SWELLING,7
CA,MASS,7
CA,METASTASES TO LIVER,7
CA,MUSCULOSKELETAL CHEST PAIN,7
CA,NERVOUS SYSTEM DISORDER,7
CA,OCULAR HYPERAEMIA,7
CA,ORAL CANDIDIASIS,7
CA,PARALYSIS,7
CA,PULMONARY HYPERTENSION,7
CA,RASH MACULAR,7
CA,RASH PAPULAR,7
CA,RHABDOMYOLYSIS,7
CA,SCIATICA,7
CA,SKIN CANCER,7
CA,SKIN DISCOLOURATION,7
CA,SQUAMOUS CELL CARCINOMA,7
CA,TEMPORAL ARTERITIS,7
CA,ABDOMINAL PAIN LOWER,6
CA,ACCIDENTAL OVERDOSE,6
CA,ATYPICAL FEMUR FRACTURE,6
CA,BLOOD CHOLESTEROL INCREASED,6
CA,BREAST PAIN,6
CA,CARDIOVASCULAR DISORDER,6
CA,COAGULOPATHY,6
CA,CORONARY ARTERY BYPASS,6
CA,CRYING,6
CA,DERMATITIS PSORIASIFORM,6
CA,DIABETES MELLITUS INADEQUATE CONTROL,6
CA,DISTURBANCE IN ATTENTION,6
CA,DRUG ADMINISTRATION ERROR,6
CA,DRY EYE,6
CA,DYSLIPIDAEMIA,6
CA,ECCHYMOSIS,6
CA,EYE INFECTION,6
CA,EYE SWELLING,6
CA,FEMUR FRACTURE,6
CA,FIBROMYALGIA,6
CA,FORCED EXPIRATORY VOLUME DECREASED,6
CA,FUNGAL INFECTION,6
CA,GASTROENTERITIS,6
CA,GLOMERULAR FILTRATION RATE DECREASED,6
CA,HAEMATOCRIT DECREASED,6
CA,HAEMATOMA,6
CA,HAND DEFORMITY,6
CA,HOSPITALISATION,6
CA,HYPERLIPIDAEMIA,6
CA,HYPOCALCAEMIA,6
CA,HYPOTHYROIDISM,6
CA,HYPOVENTILATION,6
CA,HYPOVOLAEMIA,6
CA,INJECTION SITE MASS,6
CA,ISCHAEMIC STROKE,6
CA,JAUNDICE,6
CA,LARGE INTESTINE POLYP,6
CA,LIMB INJURY,6
CA,LYMPHOCYTE COUNT DECREASED,6
CA,MALLORY-WEISS SYNDROME,6
CA,MIGRAINE,6
CA,MONOCYTE COUNT INCREASED,6
CA,MYOCARDITIS,6
CA,NASAL DRYNESS,6
CA,NEPHROLITHIASIS,6
CA,NEUTROPHIL COUNT INCREASED,6
CA,PERIPHERAL ISCHAEMIA,6
CA,POST PROCEDURAL COMPLICATION,6
CA,RALES,6
CA,RESTLESSNESS,6
CA,SKIN BURNING SENSATION,6
CA,SKIN DEPIGMENTATION,6
CA,SUICIDE ATTEMPT,6
CA,UNDERDOSE,6
CA,UPPER-AIRWAY COUGH SYNDROME,6
CA,VASODILATATION,6
CA,VISUAL ACUITY REDUCED,6
CA,WOUND INFECTION,6
CA,ABNORMAL BEHAVIOUR,5
CA,ACNE,5
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,5
CA,AFFECT LABILITY,5
CA,ANGER,5
CA,ANGINA UNSTABLE,5
CA,AORTIC STENOSIS,5
CA,BACK DISORDER,5
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,5
CA,BODY TEMPERATURE INCREASED,5
CA,BRONCHIECTASIS,5
CA,BURSITIS INFECTIVE,5
CA,CARDIOGENIC SHOCK,5
CA,CHROMATURIA,5
CA,COLITIS,5
CA,COLON ADENOMA,5
CA,COMPLETED SUICIDE,5
CA,CONCUSSION,5
CA,CROHN^S DISEASE,5
CA,DEMENTIA,5
CA,EMOTIONAL DISORDER,5
CA,ENCEPHALOPATHY,5
CA,EXOSTOSIS,5
CA,EYE DISCHARGE,5
CA,EYE HAEMORRHAGE,5
CA,EYE PAIN,5
CA,FAECES SOFT,5
CA,GASTROENTERITIS VIRAL,5
CA,GLAUCOMA,5
CA,HAEMATEMESIS,5
CA,HEAD DISCOMFORT,5
CA,HEART RATE IRREGULAR,5
CA,HEPATIC CIRRHOSIS,5
CA,HIP ARTHROPLASTY,5
CA,HYPERKALAEMIA,5
CA,HYPOXIA,5
CA,INFARCTION,5
CA,INFECTION SUSCEPTIBILITY INCREASED,5
CA,INJECTION SITE SWELLING,5
CA,INTENTIONAL OVERDOSE,5
CA,JOINT EFFUSION,5
CA,JOINT INJURY,5
CA,LIGAMENT SPRAIN,5
CA,LIVER FUNCTION TEST ABNORMAL,5
CA,LIVER INJURY,5
CA,LOWER GASTROINTESTINAL HAEMORRHAGE,5
CA,MACULAR DEGENERATION,5
CA,MICTURITION URGENCY,5
CA,MONOPLEGIA,5
CA,MUSCLE SPASTICITY,5
CA,NEOPLASM PROGRESSION,5
CA,NERVE INJURY,5
CA,NODULE,5
CA,PANCREATIC CARCINOMA,5
CA,PANCREATITIS CHRONIC,5
CA,PERITONEAL DIALYSIS COMPLICATION,5
CA,PNEUMOTHORAX,5
CA,POOR VENOUS ACCESS,5
CA,RASH GENERALISED,5
CA,RASH MACULO-PAPULAR,5
CA,SERUM FERRITIN INCREASED,5
CA,SHOCK,5
CA,SINUS CONGESTION,5
CA,SJOGREN^S SYNDROME,5
CA,SPINAL PAIN,5
CA,TONGUE DISORDER,5
CA,TOOTH ABSCESS,5
CA,TRANSFUSION,5
CA,TROPONIN INCREASED,5
CA,URINARY BLADDER HAEMORRHAGE,5
CA,URINARY TRACT INFECTION BACTERIAL,5
CA,VENTRICULAR TACHYCARDIA,5
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,5
CA,ABSCESS,4
CA,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,4
CA,ACUTE PULMONARY OEDEMA,4
CA,ANAPHYLACTIC REACTION,4
CA,ANEURYSM,4
CA,ANKLE FRACTURE,4
CA,AORTIC ANEURYSM,4
CA,ARTERIAL OCCLUSIVE DISEASE,4
CA,ATELECTASIS,4
CA,BACTERIAL INFECTION,4
CA,BLADDER DISORDER,4
CA,BLOOD BILIRUBIN INCREASED,4
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,4
CA,BLOOD MAGNESIUM DECREASED,4
CA,BLOOD PRESSURE ABNORMAL,4
CA,BLOOD TEST ABNORMAL,4
CA,BLOOD UREA INCREASED,4
CA,CARDIAC PACEMAKER INSERTION,4
CA,CAROTID ARTERY OCCLUSION,4
CA,CAROTID ARTERY STENOSIS,4
CA,CATHETERISATION CARDIAC,4
CA,CHOLECYSTITIS,4
CA,COLON CANCER,4
CA,COMPLICATION ASSOCIATED WITH DEVICE,4
CA,CONCOMITANT DISEASE AGGRAVATED,4
CA,CONJUNCTIVITIS,4
CA,CUSHINGOID,4
CA,DEVICE DEPLOYMENT ISSUE,4
CA,DEVICE OCCLUSION,4
CA,DIVERTICULUM INTESTINAL,4
CA,DRUG DEPENDENCE,4
CA,DRUG WITHDRAWAL SYNDROME,4
CA,DUODENITIS,4
CA,EAR DISORDER,4
CA,EMPHYSEMA,4
CA,EXPOSURE DURING PREGNANCY,4
CA,EYE INFLAMMATION,4
CA,FOETAL EXPOSURE DURING PREGNANCY,4
CA,FOETAL GROWTH RESTRICTION,4
CA,FOOT PROSTHESIS USER,4
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
CA,GROIN PAIN,4
CA,HAEMOGLOBIN INCREASED,4
CA,HAEMORRHAGE URINARY TRACT,4
CA,HELICOBACTER INFECTION,4
CA,HEMIPLEGIA,4
CA,HEPARIN-INDUCED THROMBOCYTOPENIA,4
CA,HEPATIC LESION,4
CA,HEPATITIS ACUTE,4
CA,HERNIA,4
CA,HIATUS HERNIA,4
CA,HYPERKERATOSIS,4
CA,HYPOKINESIA,4
CA,INCREASED TENDENCY TO BRUISE,4
CA,INCREASED UPPER AIRWAY SECRETION,4
CA,INJECTION SITE EXTRAVASATION,4
CA,INJECTION SITE PRURITUS,4
CA,INJECTION SITE REACTION,4
CA,INJECTION SITE WARMTH,4
CA,INTENTIONAL PRODUCT MISUSE,4
CA,INTENTIONAL PRODUCT USE ISSUE,4
CA,INTERVERTEBRAL DISC PROTRUSION,4
CA,IRON DEFICIENCY ANAEMIA,4
CA,JOINT RANGE OF MOTION DECREASED,4
CA,KERATITIS,4
CA,KIDNEY INFECTION,4
CA,KNEE ARTHROPLASTY,4
CA,KNEE OPERATION,4
CA,LABORATORY TEST ABNORMAL,4
CA,LACRIMATION INCREASED,4
CA,LACTIC ACIDOSIS,4
CA,LEG AMPUTATION,4
CA,LIPASE INCREASED,4
CA,LOWER LIMB FRACTURE,4
CA,LUMBAR VERTEBRAL FRACTURE,4
CA,MUSCLE STRAIN,4
CA,MYOCLONUS,4
CA,NEUTROPHIL COUNT DECREASED,4
CA,NOCTURIA,4
CA,OBESITY,4
CA,OBSTRUCTIVE AIRWAYS DISORDER,4
CA,ONYCHOMADESIS,4
CA,ORAL HERPES,4
CA,OTOTOXICITY,4
CA,PANCREATIC CYST,4
CA,PANCREATIC MASS,4
CA,PANCREATITIS ACUTE,4
CA,PANIC ATTACK,4
CA,PERITONITIS BACTERIAL,4
CA,PHOTOSENSITIVITY REACTION,4
CA,PLASMA CELL MYELOMA,4
CA,PROCEDURAL PAIN,4
CA,PROCTALGIA,4
CA,PROSTATE CANCER METASTATIC,4
CA,PROSTATIC SPECIFIC ANTIGEN INCREASED,4
CA,PROTEINURIA,4
CA,PSORIATIC ARTHROPATHY,4
CA,PSYCHOTIC DISORDER,4
CA,QUALITY OF LIFE DECREASED,4
CA,RECTAL ADENOCARCINOMA,4
CA,RED CELL DISTRIBUTION WIDTH INCREASED,4
CA,RESPIRATORY DEPRESSION,4
CA,RHEUMATOID NODULE,4
CA,RHINITIS,4
CA,SCAB,4
CA,SECRETION DISCHARGE,4
CA,SINUS BRADYCARDIA,4
CA,SKIN PLAQUE,4
CA,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,4
CA,SNEEZING,4
CA,STENT PLACEMENT,4
CA,SUBARACHNOID HAEMORRHAGE,4
CA,SUBDURAL HAEMATOMA,4
CA,SUNBURN,4
CA,SURGERY,4
CA,TENDONITIS,4
CA,THERAPY NON-RESPONDER,4
CA,THROAT TIGHTNESS,4
CA,THYROID DISORDER,4
CA,TOOTH FRACTURE,4
CA,TOOTH INFECTION,4
CA,TYPE 2 DIABETES MELLITUS,4
CA,UPPER LIMB FRACTURE,4
CA,UROSEPSIS,4
CA,VARICOSE VEIN,4
CA,VEIN DISORDER,4
CA,VENTRICULAR FIBRILLATION,4
CA,WRIST FRACTURE,4
CA,WRONG TECHNIQUE IN DRUG USAGE PROCESS,4
CA,ABDOMINAL RIGIDITY,3
CA,ABSCESS LIMB,3
CA,ACTINIC KERATOSIS,3
CA,ACUTE RESPIRATORY DISTRESS SYNDROME,3
CA,AGNOSIA,3
CA,ANAL HAEMORRHAGE,3
CA,ANGIOPATHY,3
CA,ANORECTAL DISCOMFORT,3
CA,ARTERIOSCLEROSIS,3
CA,AZOTAEMIA,3
CA,BLINDNESS UNILATERAL,3
CA,BLOOD GLUCOSE FLUCTUATION,3
CA,BLOOD IRON INCREASED,3
CA,BLOOD PRESSURE SYSTOLIC DECREASED,3
CA,BRONCHOSPASM,3
CA,BURSITIS,3
CA,CARDIAC VALVE DISEASE,3
CA,CARPAL TUNNEL SYNDROME,3
CA,CENTRAL NERVOUS SYSTEM LESION,3
CA,CHAPPED LIPS,3
CA,CHOKING SENSATION,3
CA,CHRONIC KIDNEY DISEASE,3
CA,CLOSTRIDIUM DIFFICILE COLITIS,3
CA,COLD SWEAT,3
CA,COMA,3
CA,CONJUNCTIVAL HAEMORRHAGE,3
CA,CORONARY ARTERIAL STENT INSERTION,3
CA,CORONARY ARTERY STENOSIS,3
CA,CREATININE RENAL CLEARANCE DECREASED,3
CA,CREPITATIONS,3
CA,CYSTITIS KLEBSIELLA,3
CA,DECUBITUS ULCER,3
CA,DERMATITIS ATOPIC,3
CA,DERMATITIS EXFOLIATIVE,3
CA,DEVICE INTERACTION,3
CA,DEVICE RELATED INFECTION,3
CA,DIVERTICULUM,3
CA,DIZZINESS POSTURAL,3
CA,DRUG TOLERANCE INCREASED,3
CA,DRUG-INDUCED LIVER INJURY,3
CA,DUODENAL ULCER,3
CA,EAR DISCOMFORT,3
CA,EJECTION FRACTION DECREASED,3
CA,EMOTIONAL DISTRESS,3
CA,EOSINOPHIL COUNT INCREASED,3
CA,EROSIVE DUODENITIS,3
CA,ESCHERICHIA INFECTION,3
CA,ESCHERICHIA URINARY TRACT INFECTION,3
CA,EXERCISE TOLERANCE DECREASED,3
CA,EXPIRED PRODUCT ADMINISTERED,3
CA,EYE DEGENERATIVE DISORDER,3
CA,EYE PRURITUS,3
CA,EYELID MARGIN CRUSTING,3
CA,FEAR,3
CA,FEELING OF BODY TEMPERATURE CHANGE,3
CA,FLANK PAIN,3
CA,FULL BLOOD COUNT DECREASED,3
CA,GALLBLADDER DISORDER,3
CA,GASTRIC ULCER HAEMORRHAGE,3
CA,GASTRITIS EROSIVE,3
CA,GENERALISED OEDEMA,3
CA,GINGIVAL BLEEDING,3
CA,GINGIVAL PAIN,3
CA,HAEMARTHROSIS,3
CA,HAEMORRHOIDAL HAEMORRHAGE,3
CA,HAEMOTHORAX,3
CA,HEARING IMPAIRED,3
CA,HEART RATE ABNORMAL,3
CA,HEMIANOPIA HETERONYMOUS,3
CA,HEPATIC CANCER,3
CA,HEPATIC CYST,3
CA,HEPATIC FUNCTION ABNORMAL,3
CA,HICCUPS,3
CA,HYPERBILIRUBINAEMIA,3
CA,HYPERREFLEXIA,3
CA,HYPERVENTILATION,3
CA,HYPOACUSIS,3
CA,ILEUS,3
CA,IMMUNOSUPPRESSION,3
CA,INCORRECT DRUG ADMINISTRATION DURATION,3
CA,INCREASED APPETITE,3
CA,INFLAMMATORY MARKER INCREASED,3
CA,INTERSTITIAL LUNG DISEASE,3
CA,INTESTINAL ISCHAEMIA,3
CA,IRITIS,3
CA,IRRITABLE BOWEL SYNDROME,3
CA,JOINT LOCK,3
CA,JUGULAR VEIN THROMBOSIS,3
CA,LACERATION,3
CA,LARYNGITIS,3
CA,LATENT TUBERCULOSIS,3
CA,LIP OEDEMA,3
CA,LONG QT SYNDROME,3
CA,LYMPHOEDEMA,3
CA,MALABSORPTION,3
CA,MATERNAL EXPOSURE DURING PREGNANCY,3
CA,MEAN CELL VOLUME INCREASED,3
CA,MEDICATION ERROR,3
CA,MENISCUS INJURY,3
CA,MENTAL IMPAIRMENT,3
CA,METABOLIC ENCEPHALOPATHY,3
CA,METASTASES TO BONE,3
CA,MIGRAINE WITH AURA,3
CA,MOTOR DYSFUNCTION,3
CA,MUSCLE RUPTURE,3
CA,MUSCLE TIGHTNESS,3
CA,MYOSITIS,3
CA,NASAL DISCHARGE DISCOLOURATION,3
CA,NASAL DISORDER,3
CA,NEPHROTIC SYNDROME,3
CA,NERVOUSNESS,3
CA,NEURALGIA,3
CA,NON-CARDIAC CHEST PAIN,3
CA,OESOPHAGEAL DISORDER,3
CA,OESOPHAGEAL ULCER,3
CA,ORAL MUCOSAL BLISTERING,3
CA,ORTHOPNOEA,3
CA,OSTEOMYELITIS,3
CA,OVARIAN CYST,3
CA,PANCREATIC CARCINOMA METASTATIC,3
CA,PELVIC FRACTURE,3
CA,PELVIC PAIN,3
CA,PEMPHIGOID,3
CA,PERICARDIAL EFFUSION,3
CA,PERICARDITIS,3
CA,PERONEAL NERVE PALSY,3
CA,PERSONALITY DISORDER,3
CA,PETECHIAE,3
CA,PHOTOPHOBIA,3
CA,PILOERECTION,3
CA,PLATELET COUNT INCREASED,3
CA,POLYURIA,3
CA,POOR PERIPHERAL CIRCULATION,3
CA,POOR QUALITY SLEEP,3
CA,PRECANCEROUS SKIN LESION,3
CA,PRERENAL FAILURE,3
CA,PRODUCT SUBSTITUTION ISSUE,3
CA,PRODUCT USE IN UNAPPROVED INDICATION,3
CA,PROSTATIC DISORDER,3
CA,PULMONARY FUNCTION TEST DECREASED,3
CA,RAYNAUD^S PHENOMENON,3
CA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
CA,RESPIRATORY DISORDER,3
CA,RESPIRATORY DISTRESS,3
CA,RESTLESS LEGS SYNDROME,3
CA,RETROPERITONEAL HAEMATOMA,3
CA,RETROPERITONEAL HAEMORRHAGE,3
CA,ROTATOR CUFF SYNDROME,3
CA,SCLERODERMA,3
CA,SECOND PRIMARY MALIGNANCY,3
CA,SENSATION OF HEAVINESS,3
CA,SENSITIVITY TO WEATHER CHANGE,3
CA,SHOULDER OPERATION,3
CA,SINUS DISORDER,3
CA,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,3
CA,SPINAL COLUMN STENOSIS,3
CA,SPINAL DISORDER,3
CA,SPLENOMEGALY,3
CA,SQUAMOUS CELL CARCINOMA OF SKIN,3
CA,STASIS DERMATITIS,3
CA,SUBSTANCE ABUSE,3
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,3
CA,TENOSYNOVITIS,3
CA,THERAPEUTIC RESPONSE UNEXPECTED,3
CA,THERAPY CESSATION,3
CA,THERMAL BURN,3
CA,THROMBOSIS IN DEVICE,3
CA,TOBACCO ABUSE,3
CA,TONGUE OEDEMA,3
CA,TOOTH LOSS,3
CA,TOOTHACHE,3
CA,TORSADE DE POINTES,3
CA,TRAUMATIC LUNG INJURY,3
CA,TUMOUR LYSIS SYNDROME,3
CA,URINARY TRACT OBSTRUCTION,3
CA,UTERINE LEIOMYOMA,3
CA,VAGINAL HAEMORRHAGE,3
CA,VASCULAR GRAFT,3
CA,VASCULITIS,3
CA,VITAMIN B12 DECREASED,3
CA,WHITE BLOOD CELLS URINE POSITIVE,3
CA,WOUND COMPLICATION,3
CA,WOUND NECROSIS,3
CA,ABDOMINAL HERNIA,2
CA,ABDOMINAL INFECTION,2
CA,ABDOMINAL MASS,2
CA,ABDOMINAL WALL ABSCESS,2
CA,ABNORMAL DREAMS,2
CA,ABNORMAL LOSS OF WEIGHT,2
CA,ABORTION SPONTANEOUS,2
CA,ABSCESS NECK,2
CA,ACUTE HEPATIC FAILURE,2
CA,AGEUSIA,2
CA,ALTERED STATE OF CONSCIOUSNESS,2
CA,ALVEOLITIS,2
CA,ANAL FISTULA,2
CA,ANGIOGRAM,2
CA,ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC,2
CA,ANTIPHOSPHOLIPID ANTIBODIES POSITIVE,2
CA,AORTIC VALVE REPLACEMENT,2
CA,APATHY,2
CA,APHAGIA,2
CA,APHTHOUS STOMATITIS,2
CA,ARTHRITIS BACTERIAL,2
CA,ARTHRITIS INFECTIVE,2
CA,ATRIOVENTRICULAR BLOCK COMPLETE,2
CA,AUTOIMMUNE HEPATITIS,2
CA,AXILLARY MASS,2
CA,BACK INJURY,2
CA,BLEEDING TIME PROLONGED,2
CA,BLOOD ALBUMIN DECREASED,2
CA,BLOOD CALCIUM DECREASED,2
CA,BLOOD CHOLESTEROL DECREASED,2
CA,BLOOD COPPER INCREASED,2
CA,BLOOD CREATINE ABNORMAL,2
CA,BLOOD CREATININE ABNORMAL,2
CA,BLOOD CREATININE DECREASED,2
CA,BLOOD IMMUNOGLOBULIN G INCREASED,2
CA,BLOOD PRESSURE DIASTOLIC INCREASED,2
CA,BLOOD TRIGLYCERIDES INCREASED,2
CA,BONE LOSS,2
CA,BONE NEOPLASM,2
CA,BRAIN NEOPLASM,2
CA,BRAIN OEDEMA,2
CA,BREAST MASS,2
CA,BREAST OPERATION,2
CA,BUNDLE BRANCH BLOCK LEFT,2
CA,CANDIDA INFECTION,2
CA,CARDIAC DEATH,2
CA,CARDIAC DISCOMFORT,2
CA,CARDIAC FLUTTER,2
CA,CARDIAC MURMUR,2
CA,CARDIAC OPERATION,2
CA,CARDIAC PROCEDURE COMPLICATION,2
CA,CARDIO-RESPIRATORY ARREST,2
CA,CARTILAGE INJURY,2
CA,CATHETER SITE DISCHARGE,2
CA,CATHETER SITE PAIN,2
CA,CENTRAL VENOUS CATHETERISATION,2
CA,CEREBELLAR HAEMORRHAGE,2
CA,CERVICAL VERTEBRAL FRACTURE,2
CA,CHANGE OF BOWEL HABIT,2
CA,CHOLECYSTECTOMY,2
CA,CHOLECYSTITIS INFECTIVE,2
CA,CHONDROCALCINOSIS,2
CA,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,2
CA,CLAVICLE FRACTURE,2
CA,CLOSTRIDIUM DIFFICILE INFECTION,2
CA,COLITIS ISCHAEMIC,2
CA,COLITIS MICROSCOPIC,2
CA,COLON DYSPLASIA,2
CA,COMPLEX PARTIAL SEIZURES,2
CA,CONTRAINDICATED PRODUCT ADMINISTERED,2
CA,CORONARY ARTERY EMBOLISM,2
CA,CORONARY ARTERY THROMBOSIS,2
CA,CYTOMEGALOVIRUS INFECTION,2
CA,DEAFNESS UNILATERAL,2
CA,DELUSION,2
CA,DEMENTIA ALZHEIMER^S TYPE,2
CA,DIASTOLIC DYSFUNCTION,2
CA,DIPLOPIA,2
CA,DISEASE COMPLICATION,2
CA,DRAIN PLACEMENT,2
CA,DRUG TOLERANCE,2
CA,DRY THROAT,2
CA,DUODENAL ULCER PERFORATION,2
CA,DUPUYTREN^S CONTRACTURE,2
CA,DUST ALLERGY,2
CA,DYSPHEMIA,2
CA,DYSPNOEA AT REST,2
CA,EAR HAEMORRHAGE,2
CA,EARLY SATIETY,2
CA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,2
CA,EMBOLIC STROKE,2
CA,ENCEPHALITIS VIRAL,2
CA,ENDOCARDITIS,2
CA,ENDOMETRIAL ADENOCARCINOMA,2
CA,ENTERITIS,2
CA,EOSINOPHILIA,2
CA,EPIGASTRIC DISCOMFORT,2
CA,ERUCTATION,2
CA,ESCHERICHIA SEPSIS,2
CA,EYE CONTUSION,2
CA,EYE OPERATION,2
CA,FACE OEDEMA,2
CA,FAECES PALE,2
CA,FISTULA,2
CA,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,2
CA,FOLLICULITIS,2
CA,FORCED VITAL CAPACITY DECREASED,2
CA,FRACTURE NONUNION,2
CA,FRUSTRATION TOLERANCE DECREASED,2
CA,FULL BLOOD COUNT ABNORMAL,2
CA,FURUNCLE,2
CA,GALLBLADDER PAIN,2
CA,GASTRIC BYPASS,2
CA,GASTRIC CANCER,2
CA,GASTRIC INFECTION,2
CA,GASTROINTESTINAL INFLAMMATION,2
CA,GASTROINTESTINAL ULCER,2
CA,GENERALISED TONIC-CLONIC SEIZURE,2
CA,GINGIVAL DISORDER,2
CA,GLUCOSE TOLERANCE IMPAIRED,2
CA,GRANULOCYTOPENIA,2
CA,GRANULOMATOSIS WITH POLYANGIITIS,2
CA,HAEMODYNAMIC INSTABILITY,2
CA,HAEMOGLOBIN ABNORMAL,2
CA,HAEMOLYTIC ANAEMIA,2
CA,HAEMORRHOIDS,2
CA,HEPATIC ENCEPHALOPATHY,2
CA,HEPATIC INFECTION,2
CA,HEPATOCELLULAR INJURY,2
CA,HERPES ZOSTER DISSEMINATED,2
CA,HIP DEFORMITY,2
CA,HYPERPLASIA,2
CA,HYPERSENSITIVITY VASCULITIS,2
CA,HYPERSOMNIA,2
CA,HYPERTRIGLYCERIDAEMIA,2
CA,HYPOAESTHESIA ORAL,2
CA,HYPOVOLAEMIC SHOCK,2
CA,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,2
CA,HYSTERECTOMY,2
CA,IMMUNODEFICIENCY,2
CA,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,2
CA,IMPLANTABLE DEFIBRILLATOR INSERTION,2
CA,INCONTINENCE,2
CA,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
CA,INFECTED SKIN ULCER,2
CA,INFUSION SITE ERYTHEMA,2
CA,INGROWING NAIL,2
KY,DIZZINESS,1
KY,HYPERSENSITIVITY,1
KY,PALPITATIONS,1
KY,PANCREATIC CARCINOMA STAGE IV,1
CL,ACUTE MYOCARDIAL INFARCTION,8
CL,HYPERKALAEMIA,8
CL,LACTIC ACIDOSIS,7
CL,CEREBROVASCULAR ACCIDENT,5
CL,DIZZINESS,5
CL,HEADACHE,5
CL,HYPOGLYCAEMIA,5
CL,NAUSEA,5
CL,OVERDOSE,5
CL,CARDIO-RESPIRATORY ARREST,4
CL,DECREASED APPETITE,4
CL,POSTOPERATIVE WOUND INFECTION,4
CL,SEPSIS,4
CL,VOMITING,4
CL,WEIGHT DECREASED,4
CL,ASTHENIA,3
CL,ATRIOVENTRICULAR BLOCK,3
CL,CATARACT,3
CL,CHEST PAIN,3
CL,DEATH,3
CL,DIARRHOEA,3
CL,DRUG INEFFECTIVE,3
CL,METABOLIC ACIDOSIS,3
CL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
CL,PAIN,3
CL,PNEUMONIA,3
CL,SYNCOPE,3
CL,VISUAL IMPAIRMENT,3
CL,ABDOMINAL PAIN,2
CL,ACUTE KIDNEY INJURY,2
CL,AGITATION,2
CL,ARTERIAL OCCLUSIVE DISEASE,2
CL,ARTHROPATHY,2
CL,AZOTAEMIA,2
CL,BACK PAIN,2
CL,CARDIAC DISORDER,2
CL,CHOLELITHIASIS,2
CL,CONDITION AGGRAVATED,2
CL,CORONARY ARTERY DISEASE,2
CL,COUGH,2
CL,DEPRESSION,2
CL,GENERAL PHYSICAL HEALTH DETERIORATION,2
CL,HEMIPLEGIA,2
CL,HYPERGLYCAEMIA,2
CL,HYPOGEUSIA,2
CL,LOSS OF CONSCIOUSNESS,2
CL,METASTASIS,2
CL,MYOCARDIAL INFARCTION,2
CL,OSTEOARTHRITIS,2
CL,PARAESTHESIA,2
CL,PERITONITIS BACTERIAL,2
CL,RENAL FAILURE ACUTE,2
CL,RESPIRATORY FAILURE,2
CL,SINUS BRADYCARDIA,2
CL,SPEECH DISORDER,2
CL,SPINAL DISORDER,2
CL,URINARY TRACT INFECTION,2
CL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
CL,ABASIA,1
CL,ABDOMINAL INJURY,1
CL,ABNORMAL BEHAVIOUR,1
CL,ADENOCARCINOMA,1
CL,ANAEMIA,1
CL,AORTIC RUPTURE,1
CL,APLASTIC ANAEMIA,1
CL,ARRHYTHMIA,1
CL,ARTERIAL INSUFFICIENCY,1
CL,ARTHRALGIA,1
CL,ATROPHY,1
CL,BACTERIAL TRANSLOCATION,1
CL,BENIGN PROSTATIC HYPERPLASIA,1
CL,BILE DUCT STONE,1
CL,BLEPHAROCHALASIS,1
CL,BLOOD CHOLESTEROL INCREASED,1
CL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
CL,BLOOD CREATININE INCREASED,1
CL,BLOOD GLUCOSE ABNORMAL,1
CL,BLOOD PRESSURE DECREASED,1
CL,BLOOD PRESSURE INCREASED,1
CL,BLOOD ZINC DECREASED,1
CL,BONE PAIN,1
CL,BRAIN NATRIURETIC PEPTIDE ABNORMAL,1
CL,BRAIN NATRIURETIC PEPTIDE INCREASED,1
CL,BREATH ODOUR,1
CL,CARDIAC FAILURE,1
CL,CARDIAC FAILURE CONGESTIVE,1
CL,CATHETER SITE INFECTION,1
CL,CATHETER SITE INFLAMMATION,1
CL,CEREBRAL ARTERY EMBOLISM,1
CL,CEREBRAL THROMBOSIS,1
CL,CLOSTRIDIUM DIFFICILE INFECTION,1
CL,COLITIS,1
CL,COLON ADENOMA,1
CL,CONCOMITANT DISEASE AGGRAVATED,1
CL,CONJUNCTIVAL HAEMORRHAGE,1
CL,CONJUNCTIVITIS,1
CL,CRANIOCEREBRAL INJURY,1
CL,DEAFNESS,1
CL,DEEP VEIN THROMBOSIS,1
CL,DEMENTIA ALZHEIMER^S TYPE,1
CL,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CL,DEVICE RELATED INFECTION,1
CL,DIABETIC FOOT,1
CL,DIABETIC METABOLIC DECOMPENSATION,1
CL,DIABETIC NEUROPATHY,1
CL,DIARRHOEA INFECTIOUS,1
CL,DISCOMFORT,1
CL,DISEASE COMPLICATION,1
CL,DISORIENTATION,1
CL,DIVERTICULITIS,1
CL,DRUG ADMINISTRATION ERROR,1
CL,DYSARTHRIA,1
CL,DYSPNOEA,1
CL,ECHOCARDIOGRAM ABNORMAL,1
CL,EMOTIONAL DISORDER,1
CL,ERYTHEMA MULTIFORME,1
CL,EYE DISORDER,1
CL,EYE IRRITATION,1
CL,EYE PRURITUS,1
CL,EYELID PTOSIS,1
CL,FALL,1
CL,FOLLICULITIS,1
CL,FOOT OPERATION,1
CL,FUNGAL PERITONITIS,1
CL,GAIT DISTURBANCE,1
CL,GANGRENE,1
CL,GASTROENTERITIS,1
CL,GASTROINTESTINAL HAEMORRHAGE,1
CL,GINGIVAL INFECTION,1
CL,GLAUCOMA,1
CL,GLOMERULAR FILTRATION RATE DECREASED,1
CL,GROIN PAIN,1
CL,HAEMATEMESIS,1
CL,HAEMODYNAMIC INSTABILITY,1
CL,HEMIPARESIS,1
CL,HEPATITIS B,1
CL,HICCUPS,1
CL,HIP FRACTURE,1
CL,HYPERSPLENISM,1
CL,HYPERTENSION,1
CL,HYPERTENSIVE CRISIS,1
CL,HYPOAESTHESIA,1
CL,HYPOTENSION,1
CL,IMMUNE SYSTEM DISORDER,1
CL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CL,INCREASED APPETITE,1
CL,INFLAMMATION,1
CL,INTERNAL HAEMORRHAGE,1
CL,INTRA-ABDOMINAL HAEMORRHAGE,1
CL,ISCHAEMIC STROKE,1
CL,JAUNDICE,1
CL,LACUNAR INFARCTION,1
CL,LIGAMENT SPRAIN,1
CL,LIMB INJURY,1
CL,LOCALISED INFECTION,1
CL,LUMBAR RADICULOPATHY,1
CL,MELAENA,1
CL,MEMORY IMPAIRMENT,1
CL,MICROANGIOPATHY,1
CL,MUSCLE ABSCESS,1
CL,MUSCLE SPASMS,1
CL,MUSCULOSKELETAL PAIN,1
CL,MYALGIA,1
CL,NASOPHARYNGITIS,1
CL,NECK MASS,1
CL,NECROTISING FASCIITIS,1
CL,NEOPLASM,1
CL,NEOPLASM MALIGNANT,1
CL,NEUTROPENIA,1
CL,NODULE,1
CL,NON-HODGKIN^S LYMPHOMA,1
CL,OSTEOMYELITIS,1
CL,PALLOR,1
CL,PANCREATIC CARCINOMA,1
CL,PANCREATITIS,1
CL,PARALYSIS,1
CL,PARANEOPLASTIC PLEURAL EFFUSION,1
CL,PEMPHIGUS,1
CL,PERICARDIAL EFFUSION,1
CL,PERIPHERAL EMBOLISM,1
CL,PERIPHERAL ISCHAEMIA,1
CL,PERITONITIS,1
CL,PLASMA CELL MYELOMA,1
CL,PLATELET COUNT DECREASED,1
CL,POLYDIPSIA,1
CL,POLYMERASE CHAIN REACTION POSITIVE,1
CL,PRESCRIBED OVERDOSE,1
CL,PRURITUS,1
CL,PSYCHOTIC DISORDER,1
CL,PULMONARY FIBROSIS,1
CL,RADICULOPATHY,1
CL,RECTAL NEOPLASM,1
CL,RECURRENT CANCER,1
CL,RENAL FAILURE,1
CL,SEIZURE,1
CL,SEPTIC SHOCK,1
CL,SKIN ULCER,1
CL,SOMNOLENCE,1
CL,STAPHYLOCOCCAL INFECTION,1
CL,SUBACUTE ENDOCARDITIS,1
CL,SUPERINFECTION,1
CL,TENDON RUPTURE,1
CL,TRANSIENT GLOBAL AMNESIA,1
CL,TRANSPLANT FAILURE,1
CL,TROPONIN INCREASED,1
CL,UMBILICAL HERNIA,1
CL,VARICOSE VEIN,1
CL,VASCULAR PSEUDOANEURYSM,1
CL,VASOCONSTRICTION,1
CL,VISION BLURRED,1
CL,VISUAL FIELD DEFECT,1
CN,VASCULAR STENT THROMBOSIS,35
CN,GASTROINTESTINAL HAEMORRHAGE,32
CN,DIZZINESS,27
CN,PLATELET AGGREGATION INCREASED,27
CN,CHEST DISCOMFORT,25
CN,DYSPNOEA,25
CN,NAUSEA,24
CN,HAEMOGLOBIN DECREASED,22
CN,UPPER GASTROINTESTINAL HAEMORRHAGE,21
CN,CEREBRAL INFARCTION,20
CN,VOMITING,20
CN,BLOOD GLUCOSE INCREASED,19
CN,CEREBRAL HAEMORRHAGE,19
CN,DRUG INEFFECTIVE,19
CN,CHEST PAIN,18
CN,DRUG RESISTANCE,18
CN,ASTHENIA,16
CN,CORONARY ARTERY DISEASE,16
CN,ANGINA UNSTABLE,15
CN,CARDIAC FAILURE,15
CN,MYOCARDIAL INFARCTION,15
CN,PYREXIA,15
CN,ASPARTATE AMINOTRANSFERASE INCREASED,14
CN,HAEMORRHAGE,14
CN,ALANINE AMINOTRANSFERASE INCREASED,13
CN,DIARRHOEA,13
CN,LIVER INJURY,13
CN,PALPITATIONS,13
CN,DEATH,12
CN,LUNG INFECTION,12
CN,LYMPHOCYTE COUNT DECREASED,12
CN,PRODUCT COUNTERFEIT,12
CN,RASH,12
CN,ABDOMINAL DISTENSION,11
CN,ANGINA PECTORIS,11
CN,HAEMORRHAGE INTRACRANIAL,11
CN,HEPATIC FUNCTION ABNORMAL,11
CN,HYPERHIDROSIS,11
CN,WHITE BLOOD CELL COUNT INCREASED,11
CN,ACUTE MYOCARDIAL INFARCTION,10
CN,ANAEMIA,10
CN,BLOOD PRESSURE DECREASED,10
CN,BLOOD PRESSURE INCREASED,10
CN,BLOOD UREA INCREASED,10
CN,COMA,10
CN,HAEMATEMESIS,10
CN,PLATELET COUNT DECREASED,10
CN,SYNCOPE,10
CN,GINGIVAL BLEEDING,9
CN,HAEMATOCHEZIA,9
CN,HEADACHE,9
CN,LACTIC ACIDOSIS,9
CN,NERVOUS SYSTEM DISORDER,9
CN,THROMBOCYTOPENIA,9
CN,TRANSIENT ISCHAEMIC ATTACK,9
CN,ABDOMINAL DISCOMFORT,8
CN,ATRIAL FIBRILLATION,8
CN,CHILLS,8
CN,DECREASED APPETITE,8
CN,DISEASE PROGRESSION,8
CN,FATIGUE,8
CN,GASTRIC HAEMORRHAGE,8
CN,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,8
CN,MELAENA,8
CN,NEUTROPHIL COUNT INCREASED,8
CN,PNEUMONIA,8
CN,PRURITUS,8
CN,RENAL IMPAIRMENT,8
CN,THROMBOSIS,8
CN,BRAIN HERNIATION,7
CN,COAGULOPATHY,7
CN,DRUG-INDUCED LIVER INJURY,7
CN,HAEMOPTYSIS,7
CN,HYPOTENSION,7
CN,MUSCULAR WEAKNESS,7
CN,OEDEMA PERIPHERAL,7
CN,RESPIRATORY FAILURE,7
CN,VENTRICULAR FIBRILLATION,7
CN,CORONARY ARTERY STENOSIS,6
CN,EPISTAXIS,6
CN,GASTRIC ULCER,6
CN,INJECTION SITE HAEMATOMA,6
CN,LACUNAR INFARCTION,6
CN,PALLOR,6
CN,SHOCK,6
CN,ALTERED STATE OF CONSCIOUSNESS,5
CN,ANAPHYLACTIC SHOCK,5
CN,ARTERIOSCLEROSIS,5
CN,ARTERIOSCLEROSIS CORONARY ARTERY,5
CN,BLOOD CREATININE INCREASED,5
CN,BONE MARROW FAILURE,5
CN,C-REACTIVE PROTEIN INCREASED,5
CN,CARDIAC ARREST,5
CN,CARDIAC DISORDER,5
CN,CONFUSIONAL STATE,5
CN,CONSTIPATION,5
CN,DRUG HYPERSENSITIVITY,5
CN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
CN,DUODENAL ULCER,5
CN,FAECES DISCOLOURED,5
CN,HAEMATURIA,5
CN,HEPATOCELLULAR INJURY,5
CN,HERPES ZOSTER,5
CN,MYALGIA,5
CN,NASOPHARYNGITIS,5
CN,RHABDOMYOLYSIS,5
CN,SUSPECTED COUNTERFEIT PRODUCT,5
CN,URINARY TRACT INFECTION,5
CN,WHITE BLOOD CELL COUNT DECREASED,5
CN,ABDOMINAL PAIN,4
CN,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,4
CN,APLASIA PURE RED CELL,4
CN,ARTERIAL THROMBOSIS,4
CN,ASTHMA,4
CN,ATRIOVENTRICULAR BLOCK COMPLETE,4
CN,CARDIAC FAILURE ACUTE,4
CN,CORONARY ARTERY RESTENOSIS,4
CN,DEEP VEIN THROMBOSIS,4
CN,DELIRIUM,4
CN,DIABETES MELLITUS,4
CN,GAIT DISTURBANCE,4
CN,HYPERKALAEMIA,4
CN,HYPERTENSION,4
CN,HYPOAESTHESIA,4
CN,HYPOGLYCAEMIA,4
CN,INCISION SITE PAIN,4
CN,INTENTIONAL PRODUCT MISUSE,4
CN,KIDNEY TRANSPLANT REJECTION,4
CN,LOSS OF CONSCIOUSNESS,4
CN,MYOPATHY,4
CN,NEPHROTIC SYNDROME,4
CN,NEUROPATHY PERIPHERAL,4
CN,NEUTROPENIA,4
CN,OCCULT BLOOD POSITIVE,4
CN,PAIN IN EXTREMITY,4
CN,PEPTIC ULCER,4
CN,PROTEIN URINE PRESENT,4
CN,SHOCK HAEMORRHAGIC,4
CN,SUDDEN CARDIAC DEATH,4
CN,TENDERNESS,4
CN,THROMBOSIS IN DEVICE,4
CN,TRANSAMINASES INCREASED,4
CN,URINARY RETENTION,4
CN,VASCULAR PSEUDOANEURYSM,4
CN,ABDOMINAL PAIN UPPER,3
CN,ACUTE KIDNEY INJURY,3
CN,ANEURYSM RUPTURED,3
CN,ARRHYTHMIA,3
CN,ATRIOVENTRICULAR BLOCK FIRST DEGREE,3
CN,BACK PAIN,3
CN,BILIRUBIN CONJUGATED INCREASED,3
CN,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
CN,BODY TEMPERATURE INCREASED,3
CN,CEREBRAL HAEMATOMA,3
CN,CHROMATURIA,3
CN,CHRONIC GASTRITIS,3
CN,CONDITION AGGRAVATED,3
CN,CORONARY ARTERY OCCLUSION,3
CN,COUGH,3
CN,DERMATITIS EXFOLIATIVE,3
CN,DIABETIC NEPHROPATHY,3
CN,DISCOMFORT,3
CN,DRUG ADMINISTRATION ERROR,3
CN,DYSKINESIA,3
CN,DYSPHORIA,3
CN,DYSURIA,3
CN,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,3
CN,EMBOLISM,3
CN,ERUCTATION,3
CN,FACE OEDEMA,3
CN,FALL,3
CN,GLOMERULAR FILTRATION RATE DECREASED,3
CN,HAEMATOMA,3
CN,HEART RATE DECREASED,3
CN,HEMIPLEGIA,3
CN,HEPATIC ENZYME INCREASED,3
CN,HYPERGLYCAEMIA,3
CN,HYPERSENSITIVITY,3
CN,INSOMNIA,3
CN,INTERNATIONAL NORMALISED RATIO INCREASED,3
CN,INTRAVENTRICULAR HAEMORRHAGE,3
CN,JAUNDICE CHOLESTATIC,3
CN,LEFT VENTRICULAR FAILURE,3
CN,LETHARGY,3
CN,MYOCARDIAL ISCHAEMIA,3
CN,MYOCARDIAL NECROSIS MARKER INCREASED,3
CN,OVERDOSE,3
CN,PAIN,3
CN,PERIPHERAL ARTERY OCCLUSION,3
CN,PERIPHERAL COLDNESS,3
CN,PERIPHERAL SWELLING,3
CN,PLEURAL EFFUSION,3
CN,PRODUCT USE ISSUE,3
CN,PRODUCTIVE COUGH,3
CN,PROTHROMBIN TIME PROLONGED,3
CN,PSORIASIS,3
CN,REGURGITATION,3
CN,SINUS ARRHYTHMIA,3
CN,SINUS BRADYCARDIA,3
CN,SOMNAMBULISM,3
CN,SUBARACHNOID HAEMORRHAGE,3
CN,UPPER RESPIRATORY TRACT INFECTION,3
CN,VASCULAR OPERATION,3
CN,VENTRICULAR TACHYCARDIA,3
CN,VERTIGO,3
CN,WEIGHT DECREASED,3
CN,ACUTE CORONARY SYNDROME,2
CN,AMAUROSIS FUGAX,2
CN,ANAL ABSCESS,2
CN,ANGIOPATHY,2
CN,ANXIETY,2
CN,AORTIC ANEURYSM,2
CN,ARTHRALGIA,2
CN,ASPHYXIA,2
CN,ATRIOVENTRICULAR BLOCK,2
CN,BASAL GANGLIA HAEMORRHAGE,2
CN,BLOOD ALBUMIN DECREASED,2
CN,BLOOD BILIRUBIN INCREASED,2
CN,BLOOD CHOLESTEROL DECREASED,2
CN,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,2
CN,BLOOD LACTIC ACID INCREASED,2
CN,BLOOD POTASSIUM DECREASED,2
CN,BLOOD PRESSURE SYSTOLIC INCREASED,2
CN,BRADYCARDIA,2
CN,BRAIN STEM HAEMORRHAGE,2
CN,BUNDLE BRANCH BLOCK RIGHT,2
CN,CARDIAC FAILURE CHRONIC,2
CN,CARDIOGENIC SHOCK,2
CN,CEREBELLAR INFARCTION,2
CN,CEREBRAL DISORDER,2
CN,CEREBRAL ISCHAEMIA,2
CN,CEREBROVASCULAR ACCIDENT,2
CN,CEREBROVASCULAR DISORDER,2
CN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
CN,CIRCULATORY COLLAPSE,2
CN,CORONARY ARTERY THROMBOSIS,2
CN,DEPRESSED LEVEL OF CONSCIOUSNESS,2
CN,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
CN,DRUG LEVEL INCREASED,2
CN,DYSARTHRIA,2
CN,ECCHYMOSIS,2
CN,ECZEMA,2
CN,ELECTROCARDIOGRAM QT INTERVAL ABNORMAL,2
CN,ELECTROCARDIOGRAM QT PROLONGED,2
CN,EPILEPSY,2
CN,FEELING ABNORMAL,2
CN,FEELING HOT,2
CN,FLUSHING,2
CN,GASTRIC ULCER HAEMORRHAGE,2
CN,GASTRITIS,2
CN,GASTROENTERITIS,2
CN,GASTROENTERITIS EOSINOPHILIC,2
CN,GLASSY EYES,2
CN,GLOMERULONEPHRITIS MEMBRANOUS,2
CN,GRANULOCYTOPENIA,2
CN,HAEMOLYTIC ANAEMIA,2
CN,HALLUCINATION,2
CN,HEART RATE INCREASED,2
CN,HEMIPARESIS,2
CN,HEPATIC CIRRHOSIS,2
CN,HEPATIC FAILURE,2
CN,HEPATIC LESION,2
CN,HICCUPS,2
CN,HYPERLIPIDAEMIA,2
CN,HYPERTONIA,2
CN,HYPERURICAEMIA,2
CN,HYPOALBUMINAEMIA,2
CN,HYPOCHROMIC ANAEMIA,2
CN,HYPOGLYCAEMIC COMA,2
CN,HYPOPROTEINAEMIA,2
CN,IGA NEPHROPATHY,2
CN,IMPAIRED HEALING,2
CN,INFARCTION,2
CN,INFECTION,2
CN,INTENTIONAL DRUG MISUSE,2
CN,INTERSTITIAL LUNG DISEASE,2
CN,INTRACRANIAL PRESSURE INCREASED,2
CN,ISCHAEMIC CARDIOMYOPATHY,2
CN,ISCHAEMIC STROKE,2
CN,KOUNIS SYNDROME,2
CN,LATENT SYPHILIS,2
CN,LEFT ATRIAL ENLARGEMENT,2
CN,LOW DENSITY LIPOPROTEIN DECREASED,2
CN,LUNG NEOPLASM MALIGNANT,2
CN,MATERNAL EXPOSURE DURING PREGNANCY,2
CN,MEMORY IMPAIRMENT,2
CN,MENORRHAGIA,2
CN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
CN,MYOSITIS,2
CN,NEPHROPATHY TOXIC,2
CN,NOCTURIA,2
CN,OEDEMA,2
CN,PANCREATITIS ACUTE,2
CN,PARALYSIS,2
CN,PARAPLEGIA,2
CN,PEPTIC ULCER HAEMORRHAGE,2
CN,POEMS SYNDROME,2
CN,PRESCRIBED OVERDOSE,2
CN,PULMONARY OEDEMA,2
CN,PURPURA,2
CN,RASH ERYTHEMATOUS,2
CN,RED BLOOD CELL COUNT DECREASED,2
CN,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
CN,RENAL FAILURE,2
CN,RENAL INJURY,2
CN,RESPIRATORY ARREST,2
CN,SELF-MEDICATION,2
CN,SENSE OF OPPRESSION,2
CN,SEPSIS,2
CN,SINUS TACHYCARDIA,2
CN,SPEECH DISORDER,2
CN,SPINAL EPIDURAL HAEMATOMA,2
CN,SUBDURAL HAEMATOMA,2
CN,SUDDEN DEATH,2
CN,SUPRAVENTRICULAR EXTRASYSTOLES,2
CN,TACHYPNOEA,2
CN,THERAPEUTIC RESPONSE DECREASED,2
CN,THROMBIN TIME PROLONGED,2
CN,TINNITUS,2
CN,TORSADE DE POINTES,2
CN,TOXIC EPIDERMAL NECROLYSIS,2
CN,TOXICITY TO VARIOUS AGENTS,2
CN,TREATMENT NONCOMPLIANCE,2
CN,ULCER,2
CN,URTICARIA,2
CN,VASCULAR OCCLUSION,2
CN,VASCULAR STENT OCCLUSION,2
CN,WOUND COMPLICATION,2
CN,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
CN,ABDOMINAL INFECTION,1
CN,ABDOMINAL TENDERNESS,1
CN,ABNORMAL BEHAVIOUR,1
CN,ABNORMAL FAECES,1
CN,ACCIDENTAL OVERDOSE,1
CN,ACUTE ABDOMEN,1
CN,ACUTE HEPATIC FAILURE,1
CN,ACUTE LEFT VENTRICULAR FAILURE,1
CN,ACUTE PULMONARY OEDEMA,1
CN,ACUTE RESPIRATORY DISTRESS SYNDROME,1
CN,AGITATION,1
CN,AGRANULOCYTOSIS,1
CN,ALLERGY TEST POSITIVE,1
CN,ANION GAP INCREASED,1
CN,ANKYLOGLOSSIA CONGENITAL,1
CN,ANURIA,1
CN,AORTIC ARTERIOSCLEROSIS,1
CN,AORTIC CALCIFICATION,1
CN,AORTIC DILATATION,1
CN,AORTIC VALVE CALCIFICATION,1
CN,AORTIC VALVE INCOMPETENCE,1
CN,APHASIA,1
CN,APHTHOUS ULCER,1
CN,APPENDICITIS,1
CN,ARTERIAL OCCLUSIVE DISEASE,1
CN,ARTERIOSPASM CORONARY,1
CN,ASCITES,1
CN,ATRIAL FLUTTER,1
CN,BACTERAEMIA,1
CN,BASE EXCESS NEGATIVE,1
CN,BILE DUCT CANCER,1
CN,BK VIRUS INFECTION,1
CN,BLISTER,1
CN,BLOOD ALBUMIN INCREASED,1
CN,BLOOD BICARBONATE DECREASED,1
CN,BLOOD COUNT ABNORMAL,1
CN,BLOOD CREATININE ABNORMAL,1
CN,BLOOD FIBRINOGEN INCREASED,1
CN,BLOOD GLUCOSE FLUCTUATION,1
CN,BLOOD IMMUNOGLOBULIN E INCREASED,1
CN,BLOOD PH DECREASED,1
CN,BLOOD PRESSURE ABNORMAL,1
CN,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
CN,BLOOD PRESSURE SYSTOLIC DECREASED,1
CN,BLOOD SODIUM INCREASED,1
CN,BLOOD TRIGLYCERIDES INCREASED,1
CN,BLOOD URIC ACID INCREASED,1
CN,BLOOD URINE,1
CN,BLOOD URINE PRESENT,1
CN,BONE PAIN,1
CN,BRAIN DEATH,1
CN,BRAIN OEDEMA,1
CN,BREAST MASS,1
CN,BREATH SOUNDS ABNORMAL,1
CN,BRONCHITIS,1
CN,BRONCHITIS CHRONIC,1
CN,BUNDLE BRANCH BLOCK LEFT,1
CN,CAESAREAN SECTION,1
CN,CANDIDA INFECTION,1
CN,CARDIAC ANEURYSM,1
CN,CARDIAC DISCOMFORT,1
CN,CARDIAC FAILURE CONGESTIVE,1
CN,CARDIAC MYXOMA,1
CN,CARDIAC VALVE DISEASE,1
CN,CARDIO-RESPIRATORY ARREST,1
CN,CARDIOPULMONARY FAILURE,1
CN,CAROTID ARTERY STENT INSERTION,1
CN,CATARACT,1
CN,CEREBRAL ARTERIOSCLEROSIS,1
CN,CEREBRAL ARTERY OCCLUSION,1
CN,CEREBRAL ATROPHY,1
CN,CEREBRAL VASOCONSTRICTION,1
CN,CERVICAL INCOMPETENCE,1
CN,CHOLANGITIS,1
CN,CHOLECYSTITIS,1
CN,CHOLECYSTITIS ACUTE,1
CN,CHOLELITHIASIS,1
CN,COAGULATION TEST ABNORMAL,1
CN,COAGULATION TIME PROLONGED,1
CN,COGNITIVE DISORDER,1
CN,COLD SWEAT,1
CN,COLON CANCER STAGE 0,1
CN,COLON NEOPLASM,1
CN,COMA HEPATIC,1
CN,COMPUTERISED TOMOGRAM ABNORMAL,1
CN,CONCOMITANT DISEASE PROGRESSION,1
CN,CONGESTIVE CARDIOMYOPATHY,1
CN,CONJUNCTIVAL HYPERAEMIA,1
CN,CONJUNCTIVITIS,1
CN,CONTRAINDICATED PRODUCT ADMINISTERED,1
CN,CONTUSION,1
CN,CONVULSION,1
CN,CORONARY ARTERY INSUFFICIENCY,1
CN,CORONARY REVASCULARISATION,1
CN,CUPULOLITHIASIS,1
CN,CYANOSIS,1
CN,DEAFNESS,1
CN,DEGENERATIVE AORTIC VALVE DISEASE,1
CN,DEHYDRATION,1
CN,DELAYED ISCHAEMIC NEUROLOGICAL DEFICIT,1
CN,DEMYELINATION,1
CN,DEPRESSED MOOD,1
CN,DERMATITIS ALLERGIC,1
CN,DEVICE OCCLUSION,1
CN,DIABETIC KETOACIDOSIS,1
CN,DIABETIC NEUROPATHY,1
CN,DIABETIC VASCULAR DISORDER,1
CN,DILATATION VENTRICULAR,1
CN,DISORIENTATION,1
CN,DIVERTICULUM,1
CN,DRUG DOSE OMISSION,1
CN,DRUG ERUPTION,1
CN,DRY MOUTH,1
CN,DYSBACTERIOSIS,1
CN,DYSGEUSIA,1
CN,DYSPHONIA,1
CN,EAR SWELLING,1
CN,EJECTION FRACTION DECREASED,1
CN,ELECTROCARDIOGRAM ABNORMAL,1
CN,ELECTROCARDIOGRAM RR INTERVAL PROLONGED,1
CN,ELECTROLYTE IMBALANCE,1
CN,EMBOLISM ARTERIAL,1
CN,EMPHYSEMA,1
CN,ENCEPHALOPATHY,1
CN,ENTERITIS,1
CN,EOSINOPHILIA,1
CN,EPIGASTRIC DISCOMFORT,1
CN,ERYTHEMA,1
CN,ERYTHEMA OF EYELID,1
CN,ERYTHROPENIA,1
CN,ESSENTIAL HYPERTENSION,1
CN,EYE DISORDER,1
CN,EYE MOVEMENT DISORDER,1
CN,EYE PAIN,1
CN,EYE SWELLING,1
CN,EYELID OEDEMA,1
CN,FACIAL BONES FRACTURE,1
CN,FACIAL PARALYSIS,1
CN,FALSE LABOUR,1
CN,FIBRIN D DIMER INCREASED,1
CN,FLATULENCE,1
CN,FOETAL EXPOSURE DURING PREGNANCY,1
CN,FOETAL MALPOSITION,1
CN,FRACTURE,1
CN,FREQUENT BOWEL MOVEMENTS,1
CN,FUNGAL INFECTION,1
CN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CN,GASTRIC CANCER,1
CN,GASTRIC LAVAGE ABNORMAL,1
CN,GASTRIC MUCOSAL LESION,1
CN,GASTRIC PERFORATION,1
CN,GASTRITIS EROSIVE,1
CN,GASTRITIS HAEMORRHAGIC,1
CN,GASTROINTESTINAL OBSTRUCTION,1
CN,GASTROINTESTINAL PERFORATION,1
CN,GASTROINTESTINAL VASCULAR MALFORMATION,1
CN,GASTROOESOPHAGEAL REFLUX DISEASE,1
CN,GINGIVITIS,1
CN,GLUTATHIONE S-TRANSFERASE INCREASED,1
CN,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
CN,GRANULOCYTE COUNT DECREASED,1
CN,HAEMOGLOBIN ABNORMAL,1
CN,HAEMOGLOBIN INCREASED,1
CN,HAEMORRHAGE SUBCUTANEOUS,1
CN,HAEMORRHAGIC ANAEMIA,1
CN,HAEMORRHAGIC DIATHESIS,1
CN,HAEMORRHAGIC TRANSFORMATION STROKE,1
CN,HAIR COLOUR CHANGES,1
CN,HALO VISION,1
CN,HEAD DISCOMFORT,1
CN,HEAD INJURY,1
CN,HELICOBACTER TEST POSITIVE,1
CN,HEPATIC CYST,1
CN,HEPATIC HAEMATOMA,1
CN,HEPATIC NEOPLASM,1
CN,HEPATITIS B CORE ANTIBODY POSITIVE,1
CN,HERPES VIRUS INFECTION,1
CN,HIGH DENSITY LIPOPROTEIN DECREASED,1
CN,HIGH DENSITY LIPOPROTEIN INCREASED,1
CN,HOSPITALISATION,1
CN,HYDROCEPHALUS,1
CN,HYPERCAPNIA,1
CN,HYPERCOAGULATION,1
CN,HYPERPYREXIA,1
CN,HYPERTENSIVE CRISIS,1
CN,HYPOAESTHESIA ORAL,1
CN,HYPOCHLORAEMIA,1
CN,HYPOKALAEMIA,1
CN,HYPONATRAEMIA,1
CN,HYPOURICAEMIA,1
CN,HYPOVOLAEMIC SHOCK,1
CN,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
CN,ILIAC ARTERY OCCLUSION,1
CN,ILLOGICAL THINKING,1
CN,ILLUSION,1
CN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CN,INCISION SITE EROSION,1
CN,INCISION SITE HAEMORRHAGE,1
CN,INCREASED TENDENCY TO BRUISE,1
CN,INFUSION RELATED REACTION,1
CN,INFUSION SITE EXTRAVASATION,1
CN,INGUINAL HERNIA,1
CN,INJECTION SITE HAEMORRHAGE,1
CN,INTENTION TREMOR,1
CN,INTENTIONAL PRODUCT USE ISSUE,1
CN,INTESTINAL DIAPHRAGM DISEASE,1
CN,INTESTINAL OBSTRUCTION,1
CN,INTRA-ABDOMINAL HAEMATOMA,1
CN,INTRA-ABDOMINAL HAEMORRHAGE,1
CN,INTRACRANIAL ANEURYSM,1
CN,IRON DEFICIENCY ANAEMIA,1
CN,IRRITABILITY,1
CN,ISCHAEMIC HEPATITIS,1
CN,JOINT CREPITATION,1
CN,JOINT MICROHAEMORRHAGE,1
CN,KLEBSIELLA INFECTION,1
CN,LACRIMATION INCREASED,1
CN,LACTOSE INTOLERANCE,1
CN,LACUNAR STROKE,1
CN,LARGE INTESTINAL STENOSIS,1
CN,LARYNGOSPASM,1
CN,LEFT ATRIAL DILATATION,1
CN,LEUKAEMIA,1
CN,LIBIDO DECREASED,1
CN,LIMB DISCOMFORT,1
CN,LIP DISCOLOURATION,1
CN,LIVE BIRTH,1
CN,LIVER DISORDER,1
CN,LIVER FUNCTION TEST ABNORMAL,1
CN,LOCAL SWELLING,1
CN,LOWER GASTROINTESTINAL HAEMORRHAGE,1
CN,MACULE,1
CN,MALAISE,1
CN,MALIGNANT NEOPLASM PROGRESSION,1
CN,MEDIASTINAL HAEMORRHAGE,1
CN,MEDICATION RESIDUE PRESENT,1
CN,METABOLIC ENCEPHALOPATHY,1
CN,METASTASES TO LUNG,1
CN,MICTURITION FREQUENCY DECREASED,1
CN,MILIARIA,1
CN,MOUTH ULCERATION,1
CN,MUSCLE RIGIDITY,1
CN,MUSCULOSKELETAL PAIN,1
CN,MUSCULOSKELETAL STIFFNESS,1
CN,MYOCARDIAL RUPTURE,1
CN,MYOGLOBIN BLOOD INCREASED,1
CN,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
CN,NECK PAIN,1
CN,NEOPLASM PROGRESSION,1
CN,NEPHROGENIC DIABETES INSIPIDUS,1
CN,NEPHROLITHIASIS,1
CN,NEPHROPATHY,1
CN,NERVE INJURY,1
CN,NEUROLOGICAL SYMPTOM,1
CN,NEUTROPHIL COUNT DECREASED,1
CN,NIGHT SWEATS,1
CN,NODAL RHYTHM,1
CN,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
CN,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
CN,OCCULT BLOOD,1
CN,OCULAR DISCOMFORT,1
CN,OCULAR HYPERAEMIA,1
CN,OESOPHAGEAL MASS,1
CN,OLIGOHYDRAMNIOS,1
CN,OLIGURIA,1
CN,ONYCHOMADESIS,1
CN,OPEN ANGLE GLAUCOMA,1
CN,ORAL MUCOSAL ERUPTION,1
CN,ORBITAL OEDEMA,1
CN,ORTHOPNOEA,1
CN,OSTEOMYELITIS,1
CN,OSTEOPOROSIS,1
CN,OVERWEIGHT,1
CN,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
CN,PANCYTOPENIA,1
CN,PARKINSON^S DISEASE,1
CN,PARURESIS,1
CN,PCO2 INCREASED,1
CN,PERCUTANEOUS CORONARY INTERVENTION,1
CN,PERFORATION,1
CN,PERICARDIAL CALCIFICATION,1
CN,PERINATAL DEPRESSION,1
CN,PERIODONTITIS,1
CN,PERIPHERAL ARTERY THROMBOSIS,1
CN,PERIPHERAL ISCHAEMIA,1
CN,PETECHIAE,1
CN,PHARYNGEAL DISORDER,1
CN,PHARYNGITIS,1
CN,PIGMENTATION DISORDER,1
CN,PLASMA CELL MYELOMA,1
CN,PNEUMONIA KLEBSIELLA,1
CN,PO2 DECREASED,1
CN,POLYCYTHAEMIA VERA,1
CN,POOR PERIPHERAL CIRCULATION,1
CN,POOR QUALITY SLEEP,1
CN,POST PROCEDURAL URINE LEAK,1
CN,PRESYNCOPE,1
CN,PROCEDURAL PAIN,1
CN,PRODUCT PHYSICAL ISSUE,1
CN,PRODUCT TASTE ABNORMAL,1
CN,PROSTATECTOMY,1
CN,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
CN,PROTEIN TOTAL ABNORMAL,1
CN,PRURITUS GENERALISED,1
CN,PULMONARY ARTERY THROMBOSIS,1
CN,PULMONARY EMBOLISM,1
CN,PULMONARY HILAR ENLARGEMENT,1
CN,PULMONARY MASS,1
CN,PULMONARY TOXICITY,1
CN,PULSE ABNORMAL,1
CN,PURULENT DISCHARGE,1
CN,PYELONEPHRITIS ACUTE,1
CN,QUADRIPLEGIA,1
CN,RALES,1
CN,RASH GENERALISED,1
CN,RED BLOOD CELLS URINE,1
CN,RED BLOOD CELLS URINE POSITIVE,1
CN,REFLEXES ABNORMAL,1
CN,RENAL ANEURYSM,1
CN,RENAL CYST,1
CN,RENAL FAILURE ACUTE,1
CN,RENAL FAILURE CHRONIC,1
CN,RESPIRATORY DISTRESS,1
CN,RETICULOCYTE COUNT DECREASED,1
CN,RETINAL DETACHMENT,1
CN,RETROPERITONEAL HAEMATOMA,1
CN,RHYTHM IDIOVENTRICULAR,1
CN,RIGHT VENTRICULAR FAILURE,1
CN,SARCOMA,1
CN,SCAB,1
CN,SEIZURE,1
CN,SENSORY DISTURBANCE,1
CN,SENSORY LOSS,1
CN,SEPTIC SHOCK,1
CN,SINUS ARREST,1
CN,SINUS RHYTHM,1
CN,SINUSITIS,1
CN,SKIN EXFOLIATION,1
CN,SKIN PLAQUE,1
CN,SLEEP DISORDER,1
CN,SNORING,1
CN,SOMNOLENCE,1
CN,SPINAL CORD COMPRESSION,1
CN,SPINAL OSTEOARTHRITIS,1
CN,SPONTANEOUS HAEMATOMA,1
CN,SQUAMOUS CELL CARCINOMA OF LUNG,1
CN,STENT PLACEMENT,1
CN,STEVENS-JOHNSON SYNDROME,1
CN,STOMATITIS,1
CN,SUICIDAL IDEATION,1
CN,SUPRAVENTRICULAR TACHYCARDIA,1
CN,SWELLING FACE,1
CN,TACHYCARDIA,1
CN,TACITURNITY,1
CN,THERAPEUTIC RESPONSE UNEXPECTED,1
CN,THROMBOTIC CEREBRAL INFARCTION,1
CN,THYROID NEOPLASM,1
CN,TONSILLITIS,1
CN,TRANSITIONAL CELL CANCER OF THE RENAL PELVIS AND URETER,1
CN,TREMOR,1
CN,TROPONIN T INCREASED,1
CN,TRYPTASE INCREASED,1
CN,TUBERCULOUS PLEURISY,1
CN,TUBULOINTERSTITIAL NEPHRITIS,1
CN,TUMOUR HAEMORRHAGE,1
CN,TYPE 2 DIABETES MELLITUS,1
CN,ULCER HAEMORRHAGE,1
CN,UNRESPONSIVE TO STIMULI,1
CN,URETHRAL PAIN,1
CN,URINARY BLADDER HAEMORRHAGE,1
CN,URINARY INCONTINENCE,1
CN,URINE ABNORMALITY,1
CN,URINE OUTPUT DECREASED,1
CN,VASCULAR STENT STENOSIS,1
CN,VENTRICULAR ARRHYTHMIA,1
CN,VENTRICULAR EXTRASYSTOLES,1
CN,VERBIGERATION,1
CN,VERTEBRAL ARTERY STENOSIS,1
CN,VISION BLURRED,1
CN,VISUAL ACUITY REDUCED,1
CN,VITREOUS HAEMORRHAGE,1
CN,VOLUME BLOOD DECREASED,1
CN,WEIGHT INCREASED,1
CN,WERNICKE^S ENCEPHALOPATHY,1
CN,WHEEZING,1
CN,WHITE MATTER LESION,1
CN,WOUND SECRETION,1
CN,WRIST FRACTURE,1
CN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
CN,XANTHOCHROMIA,1
CN,YELLOW SKIN,1
CO,ACUTE MYOCARDIAL INFARCTION,46
CO,CARDIO-RESPIRATORY ARREST,40
CO,DEATH,35
CO,MALAISE,32
CO,GENERAL PHYSICAL HEALTH DETERIORATION,28
CO,PNEUMONIA,24
CO,DYSPNOEA,23
CO,PYREXIA,22
CO,HYPOTENSION,21
CO,FATIGUE,20
CO,PAIN IN EXTREMITY,20
CO,DIZZINESS,19
CO,URINARY TRACT INFECTION,16
CO,HEADACHE,15
CO,PAIN,15
CO,ABDOMINAL PAIN,14
CO,ASTHENIA,14
CO,DIABETIC FOOT,14
CO,FALL,14
CO,MYOCARDIAL INFARCTION,14
CO,CHEST PAIN,13
CO,DIARRHOEA,13
CO,SEPSIS,13
CO,VOMITING,13
CO,ARTHRALGIA,12
CO,CARDIAC FAILURE,11
CO,COUGH,11
CO,DECREASED APPETITE,11
CO,CEREBROVASCULAR ACCIDENT,10
CO,HAEMOGLOBIN DECREASED,10
CO,ANAEMIA,9
CO,BACK PAIN,9
CO,CARDIAC DISORDER,9
CO,PERITONITIS BACTERIAL,9
CO,SEIZURE,9
CO,SYNCOPE,9
CO,ABDOMINAL PAIN UPPER,8
CO,ASPHYXIA,8
CO,DEPRESSION,8
CO,HIP FRACTURE,8
CO,HYPERTENSION,8
CO,HYPERTENSIVE CRISIS,8
CO,INFLAMMATION,8
CO,PULMONARY OEDEMA,8
CO,CORONARY ARTERY DISEASE,7
CO,GAIT DISTURBANCE,7
CO,GASTRITIS,7
CO,HYPOGLYCAEMIA,7
CO,INFLUENZA,7
CO,TACHYCARDIA,7
CO,UROSEPSIS,7
CO,ARRHYTHMIA,6
CO,CARDIOVASCULAR DISORDER,6
CO,DEPRESSED MOOD,6
CO,DISEASE COMPLICATION,6
CO,HYPERHIDROSIS,6
CO,INFARCTION,6
CO,MOBILITY DECREASED,6
CO,NERVOUS SYSTEM DISORDER,6
CO,PLATELET COUNT INCREASED,6
CO,RESPIRATORY FAILURE,6
CO,WEIGHT DECREASED,6
CO,ANXIETY,5
CO,BLOOD CHOLESTEROL INCREASED,5
CO,BLOOD GLUCOSE INCREASED,5
CO,BLOOD TRIGLYCERIDES INCREASED,5
CO,CONDITION AGGRAVATED,5
CO,DRUG INEFFECTIVE,5
CO,FEELING ABNORMAL,5
CO,LUNG DISORDER,5
CO,MALIGNANT NEOPLASM PROGRESSION,5
CO,NAUSEA,5
CO,NEPHROLITHIASIS,5
CO,PERITONEAL DIALYSIS COMPLICATION,5
CO,PERITONITIS,5
CO,PLATELET COUNT DECREASED,5
CO,PRURITUS,5
CO,RENAL DISORDER,5
CO,VISION BLURRED,5
CO,ABDOMINAL DISTENSION,4
CO,ASCITES,4
CO,BLOOD CREATININE INCREASED,4
CO,BONE PAIN,4
CO,BRADYCARDIA,4
CO,CARDIOGENIC SHOCK,4
CO,CATARACT,4
CO,COMA,4
CO,CONTUSION,4
CO,CORONARY ARTERY OCCLUSION,4
CO,DIABETES MELLITUS,4
CO,DISORIENTATION,4
CO,DYSURIA,4
CO,FLUID RETENTION,4
CO,GASTROINTESTINAL HAEMORRHAGE,4
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
CO,INFECTION,4
CO,INTESTINAL PERFORATION,4
CO,MUSCLE SPASMS,4
CO,OEDEMA PERIPHERAL,4
CO,OXYGEN SATURATION DECREASED,4
CO,PSYCHIATRIC SYMPTOM,4
CO,SEPTIC SHOCK,4
CO,SKIN ULCER,4
CO,SOFT TISSUE INFECTION,4
CO,SWELLING,4
CO,WEIGHT INCREASED,4
CO,WOUND,4
CO,ABDOMINAL DISCOMFORT,3
CO,ABDOMINAL SEPSIS,3
CO,ARTHROPATHY,3
CO,BLOOD PRESSURE DECREASED,3
CO,BLOOD PRESSURE INCREASED,3
CO,BRONCHITIS,3
CO,CARDIAC FAILURE CONGESTIVE,3
CO,CHILLS,3
CO,CHOKING,3
CO,CHOLECYSTITIS,3
CO,CHOLELITHIASIS,3
CO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
CO,DEHYDRATION,3
CO,DEVICE RELATED INFECTION,3
CO,DISCOMFORT,3
CO,EPISTAXIS,3
CO,ERYTHEMA,3
CO,HYPERGLYCAEMIA,3
CO,IMMUNOSUPPRESSION,3
CO,INGUINAL HERNIA,3
CO,INTESTINAL OBSTRUCTION,3
CO,ISCHAEMIC STROKE,3
CO,LIMB INJURY,3
CO,LOSS OF CONSCIOUSNESS,3
CO,METASTASES TO LUNG,3
CO,MOUTH HAEMORRHAGE,3
CO,MYOCARDIAL ISCHAEMIA,3
CO,POST PROCEDURAL COMPLICATION,3
CO,PRODUCT USE IN UNAPPROVED INDICATION,3
CO,RASH,3
CO,RENAL FAILURE,3
CO,SINUS ARRHYTHMIA,3
CO,TUBERCULOSIS,3
CO,TYMPANIC MEMBRANE PERFORATION,3
CO,UPPER GASTROINTESTINAL HAEMORRHAGE,3
CO,VENOUS OCCLUSION,3
CO,VISUAL IMPAIRMENT,3
CO,ABASIA,2
CO,AFFECTIVE DISORDER,2
CO,AMNESIA,2
CO,ANGINA UNSTABLE,2
CO,APNOEA,2
CO,ARTERIAL OCCLUSIVE DISEASE,2
CO,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,2
CO,ATRIAL FIBRILLATION,2
CO,ATRIAL TACHYCARDIA,2
CO,BACTERAEMIA,2
CO,BACTERIAL SEPSIS,2
CO,BLOOD GLUCOSE DECREASED,2
CO,BLOOD GLUCOSE FLUCTUATION,2
CO,CARDIAC ARREST,2
CO,CARDIOMEGALY,2
CO,CELLULITIS,2
CO,CEREBRAL INFARCTION,2
CO,CEREBRAL ISCHAEMIA,2
CO,CEREBROVASCULAR DISORDER,2
CO,CERVICAL SPINAL STENOSIS,2
CO,CHOKING SENSATION,2
CO,CONTRAINDICATED PRODUCT ADMINISTERED,2
CO,CRANIOCEREBRAL INJURY,2
CO,DEEP VEIN THROMBOSIS,2
CO,DIABETIC COMPLICATION,2
CO,DISEASE PROGRESSION,2
CO,DISEASE RECURRENCE,2
CO,DRUG INTOLERANCE,2
CO,DYSPHONIA,2
CO,EAR HAEMORRHAGE,2
CO,EAR PAIN,2
CO,EXTREMITY NECROSIS,2
CO,EYE HAEMORRHAGE,2
CO,FEELING OF DESPAIR,2
CO,FUNGAL PERITONITIS,2
CO,GASTRIC DISORDER,2
CO,GASTRIC ULCER,2
CO,GASTROINTESTINAL INFECTION,2
CO,HAEMATOCHEZIA,2
CO,HAEMATURIA,2
CO,HAEMOPTYSIS,2
CO,HAEMORRHAGE,2
CO,HEPATIC CANCER,2
CO,HIATUS HERNIA,2
CO,HYPERSENSITIVITY,2
CO,HYPOAESTHESIA,2
CO,HYPOPHAGIA,2
CO,INCOHERENT,2
CO,INCORRECT DOSE ADMINISTERED,2
CO,INFECTED SKIN ULCER,2
CO,INFLUENZA LIKE ILLNESS,2
CO,INJECTION SITE PAIN,2
CO,INSOMNIA,2
CO,INSULIN-LIKE GROWTH FACTOR INCREASED,2
CO,LIMB DISCOMFORT,2
CO,MALNUTRITION,2
CO,MATERNAL EXPOSURE DURING PREGNANCY,2
CO,METABOLIC ACIDOSIS,2
CO,METASTASES TO BONE,2
CO,METASTASES TO LIVER,2
CO,NONINFECTIOUS PERITONITIS,2
CO,NOSOCOMIAL INFECTION,2
CO,OSTEOMYELITIS,2
CO,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
CO,PERIPHERAL COLDNESS,2
CO,PERIPHERAL SWELLING,2
CO,PLEURAL EFFUSION,2
CO,PROCEDURAL COMPLICATION,2
CO,PRODUCTIVE COUGH,2
CO,PSORIASIS,2
CO,RECTAL HAEMORRHAGE,2
CO,RESPIRATORY ARREST,2
CO,RESPIRATORY DISORDER,2
CO,RESPIRATORY DISTRESS,2
CO,RETINAL DETACHMENT,2
CO,RETINAL HAEMORRHAGE,2
CO,RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION,2
CO,SENSORY DISTURBANCE,2
CO,SERUM FERRITIN INCREASED,2
CO,SHOCK HAEMORRHAGIC,2
CO,SKIN DISCOLOURATION,2
CO,SLEEP DISORDER,2
CO,SPINAL PAIN,2
CO,SPLENITIS,2
CO,SPLENOMEGALY,2
CO,SUPRAVENTRICULAR EXTRASYSTOLES,2
CO,SYNOVIAL CYST,2
CO,THROMBOSIS,2
CO,TREMOR,2
CO,TYPE 2 DIABETES MELLITUS,2
CO,UMBILICAL HERNIA,2
CO,UNRESPONSIVE TO STIMULI,2
CO,URTICARIA,2
CO,WOUND INFECTION,2
CO,ABDOMINAL COMPARTMENT SYNDROME,1
CO,ABDOMINAL HERNIA,1
CO,ABDOMINAL INFECTION,1
CO,ABDOMINAL MASS,1
CO,ABDOMINAL PAIN LOWER,1
CO,ABDOMINAL RIGIDITY,1
CO,ABSCESS LIMB,1
CO,ACCIDENT,1
CO,ACUTE CORONARY SYNDROME,1
CO,ACUTE PULMONARY OEDEMA,1
CO,ACUTE RESPIRATORY FAILURE,1
CO,ADRENAL INSUFFICIENCY,1
CO,AGEUSIA,1
CO,AGITATION,1
CO,AGNOSIA,1
CO,ALCOHOL POISONING,1
CO,ALOPECIA,1
CO,ANAL CANCER,1
CO,ANAL FISTULA,1
CO,ANAL HAEMORRHAGE,1
CO,ANGER,1
CO,ANGINA PECTORIS,1
CO,ANGIOPATHY,1
CO,ANGIOPLASTY,1
CO,ANOPHTHALMOS,1
CO,AORTIC ANEURYSM,1
CO,ARTERIAL DISORDER,1
CO,ARTERIAL RUPTURE,1
CO,ARTERIAL THROMBOSIS,1
CO,ARTERIOSCLEROSIS CORONARY ARTERY,1
CO,ARTHRITIS,1
CO,ARTHRITIS BACTERIAL,1
CO,ASPIRATION BRONCHIAL,1
CO,ASTHMATIC CRISIS,1
CO,ATRIAL SEPTAL DEFECT,1
CO,ATRIOVENTRICULAR BLOCK COMPLETE,1
CO,AZOTAEMIA,1
CO,BACTERIAL INFECTION,1
CO,BACTERIAL TRANSLOCATION,1
CO,BEDRIDDEN,1
CO,BILE DUCT STONE,1
CO,BIPOLAR I DISORDER,1
CO,BLINDNESS,1
CO,BLISTER,1
CO,BLOOD CALCIUM ABNORMAL,1
CO,BLOOD CHROMOGRANIN A INCREASED,1
CO,BLOOD ELECTROLYTES DECREASED,1
CO,BLOOD GLUCOSE ABNORMAL,1
CO,BLOOD IRON INCREASED,1
CO,BLOOD POTASSIUM ABNORMAL,1
CO,BLOOD POTASSIUM INCREASED,1
CO,BLOOD PRESSURE FLUCTUATION,1
CO,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
CO,BLOOD SODIUM DECREASED,1
CO,BLOOD URIC ACID INCREASED,1
CO,BLOOD URINE PRESENT,1
CO,BONE DISORDER,1
CO,BONE EROSION,1
CO,BONE LESION,1
CO,BOREDOM,1
CO,BRAIN DEATH,1
CO,BRAIN HYPOXIA,1
CO,BRAIN INJURY,1
CO,BREAST RECONSTRUCTION,1
CO,BRONCHOPNEUMONIA,1
CO,BURNING SENSATION,1
CO,CARDIO-RESPIRATORY DISTRESS,1
CO,CARDIOMYOPATHY,1
CO,CARDIOPULMONARY FAILURE,1
CO,CARPAL TUNNEL SYNDROME,1
CO,CATHETER SITE INFECTION,1
CO,CELLULITIS ORBITAL,1
CO,CEREBRAL HAEMATOMA,1
CO,CEREBRAL HAEMORRHAGE,1
CO,CEREBRAL THROMBOSIS,1
CO,CEREBRAL VENTRICLE DILATATION,1
CO,CERVICAL DYSPLASIA,1
CO,CLOSTRIDIUM DIFFICILE INFECTION,1
CO,COAGULOPATHY,1
CO,COLITIS,1
CO,COMPLICATIONS OF TRANSPLANT SURGERY,1
CO,CONCOMITANT DISEASE AGGRAVATED,1
CO,CONFUSIONAL STATE,1
CO,CONSTIPATION,1
CO,CONVULSION,1
CO,CORNEAL DISORDER,1
CO,CRITICAL ILLNESS,1
CO,CUSHING^S SYNDROME,1
CO,CYSTITIS,1
CO,DECUBITUS ULCER,1
CO,DELIRIUM,1
CO,DEMENTIA ALZHEIMER^S TYPE,1
CO,DENGUE FEVER,1
CO,DERMATITIS,1
CO,DIABETIC COMA,1
CO,DIABETIC VASCULAR DISORDER,1
CO,DIALYSIS,1
CO,DIALYSIS RELATED COMPLICATION,1
CO,DIARRHOEA HAEMORRHAGIC,1
CO,DISSEMINATED TUBERCULOSIS,1
CO,DISTURBANCE IN ATTENTION,1
CO,DIVERTICULITIS,1
CO,DIVERTICULUM,1
CO,DRUG DOSE OMISSION,1
CO,DRUG EFFECT INCOMPLETE,1
CO,DRUG PRESCRIBING ERROR,1
CO,DRUG TOLERANCE DECREASED,1
CO,DYSARTHRIA,1
CO,DYSPNOEA PAROXYSMAL NOCTURNAL,1
CO,DYSSTASIA,1
CO,EAR INFECTION,1
CO,EAR NEOPLASM MALIGNANT,1
CO,EATING DISORDER,1
CO,ECZEMA,1
CO,EJECTION FRACTION DECREASED,1
CO,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
CO,EMBOLISM VENOUS,1
CO,ENCEPHALOPATHY,1
CO,ENDOCARDITIS,1
CO,ESCHERICHIA URINARY TRACT INFECTION,1
CO,EXCESSIVE CERUMEN PRODUCTION,1
CO,EXPOSURE DURING BREAST FEEDING,1
CO,EYE COLOUR CHANGE,1
CO,EYE MOVEMENT DISORDER,1
CO,EYE PAIN,1
CO,FACE INJURY,1
CO,FEELING COLD,1
CO,FEELING HOT,1
CO,FEMUR FRACTURE,1
CO,FINGER DEFORMITY,1
CO,FLATULENCE,1
CO,FOOT DEFORMITY,1
CO,FOOT FRACTURE,1
CO,FOREIGN BODY IN RESPIRATORY TRACT,1
CO,GAIT INABILITY,1
CO,GASTRIC CANCER,1
CO,GASTRIC HAEMORRHAGE,1
CO,GASTRIC ULCER HAEMORRHAGE,1
CO,GASTROENTERITIS,1
CO,GASTROENTERITIS VIRAL,1
CO,GASTROINTESTINAL DISORDER,1
CO,GASTROINTESTINAL INFLAMMATION,1
CO,GENERAL PHYSICAL CONDITION ABNORMAL,1
CO,GESTATIONAL HYPERTENSION,1
CO,GLAUCOMA,1
CO,GLYCOSYLATED HAEMOGLOBIN DECREASED,1
CO,GROIN PAIN,1
CO,HAEMATOCRIT DECREASED,1
CO,HAEMATOMA,1
CO,HAEMORRHAGE URINARY TRACT,1
CO,HAEMORRHAGIC DISORDER,1
CO,HAEMORRHAGIC STROKE,1
CO,HALLUCINATION_ VISUAL,1
CO,HEAD DISCOMFORT,1
CO,HEAD INJURY,1
CO,HEART RATE DECREASED,1
CO,HEART RATE INCREASED,1
CO,HEMIPLEGIA,1
CO,HEPATIC CIRRHOSIS,1
CO,HEPATIC FAILURE,1
CO,HEPATIC INFECTION,1
CO,HEPATIC LESION,1
CO,HEPATIC SIDEROSIS,1
CO,HEPATITIS,1
CO,HERNIA,1
CO,HERNIAL EVENTRATION,1
CO,HERPES VIRUS INFECTION,1
CO,HERPES ZOSTER,1
CO,HIGH DENSITY LIPOPROTEIN DECREASED,1
CO,HYDRONEPHROSIS,1
CO,HYPERTROPHIC SCAR,1
CO,HYPOALBUMINAEMIA,1
CO,HYPOKALAEMIA,1
CO,HYPONATRAEMIA,1
CO,HYPOPERFUSION,1
CO,IMMUNE SYSTEM DISORDER,1
CO,IMMUNODEFICIENCY,1
CO,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CO,INJECTION SITE DISCOMFORT,1
CO,INJURY,1
CO,INTESTINAL DILATATION,1
CO,INTESTINAL FISTULA,1
CO,INTESTINAL ISCHAEMIA,1
CO,INTRACRANIAL HAEMATOMA,1
CO,INTRAPARTUM HAEMORRHAGE,1
CO,INVASIVE LOBULAR BREAST CARCINOMA,1
CO,IRON OVERLOAD,1
CO,IRRITABILITY,1
CO,ISCHAEMIA,1
CO,JOINT DISLOCATION,1
CO,JOINT EFFUSION,1
CO,JOINT INJURY,1
CO,JOINT STIFFNESS,1
CO,JOINT SWELLING,1
CO,KIDNEY TRANSPLANT REJECTION,1
CO,LACRIMAL HAEMORRHAGE,1
CO,LACUNAR INFARCTION,1
CO,LARGE INTESTINAL ULCER,1
CO,LEFT VENTRICULAR HYPERTROPHY,1
CO,LEIOMYOMA,1
CO,LIMB ASYMMETRY,1
CO,LIPOSUCTION,1
CO,LIVER ABSCESS,1
CO,LOCALISED INFECTION,1
CO,LOWER GASTROINTESTINAL HAEMORRHAGE,1
CO,LUMBAR VERTEBRAL FRACTURE,1
CO,LUNG INFECTION,1
CO,LYMPHADENOPATHY,1
CO,MASS,1
CO,MELAENA,1
CO,MENINGITIS BACTERIAL,1
CO,MENINGOENCEPHALITIS HERPETIC,1
CO,MENTAL DISORDER,1
CO,METASTASES TO CENTRAL NERVOUS SYSTEM,1
CO,METASTATIC RENAL CELL CARCINOMA,1
CO,MITRAL VALVE REPLACEMENT,1
CO,MOUTH ULCERATION,1
CO,MOVEMENT DISORDER,1
CO,MULTI-ORGAN FAILURE,1
CO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CO,MUSCLE HAEMORRHAGE,1
CO,MUSCLE RIGIDITY,1
CO,MUSCLE RUPTURE,1
CO,MUSCULAR WEAKNESS,1
CO,MUSCULOSKELETAL PAIN,1
CO,MUSCULOSKELETAL STIFFNESS,1
CO,MYALGIA,1
CO,MYOCARDIAL NECROSIS MARKER INCREASED,1
CO,NASAL CONGESTION,1
CO,NASAL INFLAMMATION,1
CO,NASOPHARYNGITIS,1
CO,NEPHROPATHY,1
CO,NEUROPATHY PERIPHERAL,1
CO,NEUTROPENIA,1
CO,NIGHT SWEATS,1
CO,NO THERAPEUTIC RESPONSE,1
CO,NODULE,1
CO,NORMAL NEWBORN,1
CO,OCULAR HYPERAEMIA,1
CO,OCULAR VASCULAR DISORDER,1
CO,OEDEMA,1
CO,OESOPHAGEAL MASS,1
CO,OESOPHAGITIS,1
CO,OLIGOHYDRAMNIOS,1
CO,ONCOLOGIC COMPLICATION,1
CO,OPEN FRACTURE,1
CO,OPTIC NERVE DISORDER,1
CO,OROPHARYNGEAL PAIN,1
CO,OSTEONECROSIS,1
CO,OSTEONECROSIS OF EXTERNAL AUDITORY CANAL,1
CO,OSTEOPOROSIS,1
CO,OXYGEN CONSUMPTION DECREASED,1
CO,PAIN IN JAW,1
CO,PAINFUL RESPIRATION,1
CO,PALPITATIONS,1
CO,PANCREATIC MASS,1
CO,PANCREATITIS,1
CO,PARACENTESIS,1
CO,PARATHYROID DISORDER,1
CO,PATHOGEN RESISTANCE,1
CO,PEAU D^ORANGE,1
CO,PERICARDIAL EFFUSION,1
CO,PERIPHERAL ARTERY THROMBOSIS,1
CO,PERIPHERAL ISCHAEMIA,1
CO,PERIPHERAL VASCULAR DISORDER,1
CO,PERIPHERAL VENOUS DISEASE,1
CO,PETIT MAL EPILEPSY,1
CO,PHANTOM PAIN,1
CO,PHLEBITIS,1
CO,PLACENTA PRAEVIA,1
CO,PLEURAL DISORDER,1
CO,PNEUMONIA BACTERIAL,1
CO,POLYCYTHAEMIA VERA,1
CO,POST PROCEDURAL INFECTION,1
CO,POSTOPERATIVE WOUND COMPLICATION,1
CO,POSTOPERATIVE WOUND INFECTION,1
CO,PRE-ECLAMPSIA,1
CO,PREMATURE RUPTURE OF MEMBRANES,1
CO,PRESCRIBED UNDERDOSE,1
CO,PRODUCT CONTAINER ISSUE,1
CO,PRODUCT QUALITY ISSUE,1
CO,PROSTATE CANCER,1
CO,PROSTATE CANCER METASTATIC,1
CO,PROSTATIC DISORDER,1
CO,PROSTATITIS,1
CO,PROSTATOMEGALY,1
CO,PROTEIN TOTAL DECREASED,1
CO,PROTEINURIA,1
CO,PRURITUS GENERALISED,1
CO,PULMONARY ARTERIAL HYPERTENSION,1
CO,PULMONARY CONGESTION,1
CO,PULMONARY HYPERTENSION,1
CO,PULMONARY SEPSIS,1
CO,PURULENT DISCHARGE,1
CO,RASH ERYTHEMATOUS,1
CO,RASH PRURITIC,1
CO,RENAL CELL CARCINOMA,1
CO,RENAL COLIC,1
CO,RENAL CYST,1
CO,RENAL FAILURE CHRONIC,1
CO,RENAL IMPAIRMENT,1
CO,RENAL TRANSPLANT,1
CO,RESPIRATORY TRACT INFECTION VIRAL,1
CO,RHEUMATOID ARTHRITIS,1
CO,RIGHT ATRIAL DILATATION,1
CO,SECRETION DISCHARGE,1
CO,SEPTIC ENCEPHALOPATHY,1
CO,SICKLE CELL ANAEMIA,1
CO,SINUS BRADYCARDIA,1
CO,SINUSITIS,1
CO,SKIN ATROPHY,1
CO,SKIN BURNING SENSATION,1
CO,SKIN EXFOLIATION,1
CO,SKIN HAEMORRHAGE,1
CO,SKIN TOXICITY,1
CO,SPEECH DISORDER,1
CO,SPLEEN DISORDER,1
CO,STAPHYLOCOCCAL SEPSIS,1
CO,STARING,1
CO,SUBARACHNOID HAEMORRHAGE,1
CO,SUBCUTANEOUS ABSCESS,1
CO,SUBDURAL HAEMATOMA,1
CO,SUDDEN DEATH,1
CO,SUPERINFECTION,1
CO,SYNOVITIS,1
CO,TESTICULAR PAIN,1
CO,THORACIC VERTEBRAL FRACTURE,1
CO,THROMBOCYTOPENIA,1
CO,THROMBOPHLEBITIS,1
CO,THYROID DISORDER,1
CO,TONGUE SPASM,1
CO,TOOTH DISORDER,1
CO,TOOTH FRACTURE,1
CO,TOOTH LOSS,1
CO,TRANSFUSION,1
CO,TRANSITIONAL CELL CARCINOMA,1
CO,TREATMENT NONCOMPLIANCE,1
CO,TRISMUS,1
CO,TUBERCULIN TEST POSITIVE,1
CO,TUMOUR MARKER INCREASED,1
CO,UNDERDOSE,1
CO,UNEVALUABLE EVENT,1
CO,URAEMIC ENCEPHALOPATHY,1
CO,URINARY BLADDER POLYP,1
CO,URINARY TRACT DISORDER,1
CO,URINE ANALYSIS ABNORMAL,1
CO,URTICARIAL VASCULITIS,1
CO,UTERINE LEIOMYOMA,1
CO,VAGINAL HAEMORRHAGE,1
CO,VARICES OESOPHAGEAL,1
CO,VENTRICULAR ARRHYTHMIA,1
CO,VENTRICULAR EXTRASYSTOLES,1
CO,VIRAL INFECTION,1
CO,VISUAL ACUITY REDUCED,1
CO,VULVOVAGINAL INFLAMMATION,1
CO,VULVOVAGINAL PRURITUS,1
CO,WHEEZING,1
CO,WOUND SECRETION,1
CO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
CO,YELLOW SKIN,1
CR,DIZZINESS,2
CR,DRUG INEFFECTIVE,2
CR,HEADACHE,2
CR,INFARCTION,2
CR,UPPER LIMB FRACTURE,2
CR,ACUTE PULMONARY OEDEMA,1
CR,ARTHRALGIA,1
CR,BACK PAIN,1
CR,BLINDNESS,1
CR,BLOOD TEST ABNORMAL,1
CR,BRAIN STEM HAEMORRHAGE,1
CR,CARDIAC DISORDER,1
CR,CARDIAC FAILURE,1
CR,CARDIOMEGALY,1
CR,CARDIOMYOPATHY,1
CR,CEREBRAL HAEMORRHAGE,1
CR,CEREBRAL INFARCTION,1
CR,CHEST PAIN,1
CR,CHOKING SENSATION,1
CR,CHROMATURIA,1
CR,DEHYDRATION,1
CR,DIABETES MELLITUS,1
CR,DRUG HYPERSENSITIVITY,1
CR,DRUG PRESCRIBING ERROR,1
CR,DYSPNOEA,1
CR,DYSURIA,1
CR,EMBOLISM,1
CR,FATIGUE,1
CR,FUSARIUM INFECTION,1
CR,HYPERHIDROSIS,1
CR,HYPERTENSION,1
CR,HYPOTENSION,1
CR,INFECTION,1
CR,INSOMNIA,1
CR,INTERMITTENT CLAUDICATION,1
CR,LEUKAEMIA,1
CR,LOSS OF CONSCIOUSNESS,1
CR,MEMORY IMPAIRMENT,1
CR,MYELOFIBROSIS,1
CR,PALPITATIONS,1
CR,PERIPHERAL SWELLING,1
CR,PULMONARY THROMBOSIS,1
CR,PYREXIA,1
CR,SEIZURE,1
CR,SYNCOPE,1
CR,URINARY RETENTION,1
CR,URTICARIA,1
CR,VAGINAL HAEMORRHAGE,1
CR,VERTIGO,1
CR,VISUAL ACUITY REDUCED,1
CR,VISUAL IMPAIRMENT,1
CR,VITH NERVE PARALYSIS,1
CR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
HR,CARDIAC FAILURE,4
HR,EXTRAPYRAMIDAL DISORDER,3
HR,PANCREATITIS ACUTE,3
HR,SOMNOLENCE,3
HR,ANAEMIA,2
HR,HYPOTENSION,2
HR,RECTAL HAEMORRHAGE,2
HR,RENAL FAILURE ACUTE,2
HR,RHABDOMYOLYSIS,2
HR,SUICIDE ATTEMPT,2
HR,THROMBOCYTOPENIA,2
HR,ACUTE MYOCARDIAL INFARCTION,1
HR,AGGRESSION,1
HR,ANGINA PECTORIS,1
HR,AORTIC ANEURYSM RUPTURE,1
HR,ARTERIOSCLEROSIS CORONARY ARTERY,1
HR,ASTHENIA,1
HR,BLOOD IRON DECREASED,1
HR,CHRONIC KIDNEY DISEASE,1
HR,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
HR,COGNITIVE DISORDER,1
HR,CORONARY ARTERY DISEASE,1
HR,DIARRHOEA,1
HR,DISEASE PROGRESSION,1
HR,DIZZINESS,1
HR,DRUG INEFFECTIVE,1
HR,DRY SKIN,1
HR,GASTRIC ULCER,1
HR,GASTRITIS EROSIVE,1
HR,HAEMARTHROSIS,1
HR,HAEMATEMESIS,1
HR,HAEMATOCHEZIA,1
HR,HAEMOGLOBIN DECREASED,1
HR,HYPERGLYCAEMIA,1
HR,HYPERTENSION,1
HR,HYPERTROPHIC CARDIOMYOPATHY,1
HR,INTESTINAL HAEMORRHAGE,1
HR,IRRITABILITY,1
HR,LOSS OF CONSCIOUSNESS,1
HR,MALAISE,1
HR,MEAN CELL VOLUME DECREASED,1
HR,MELAENA,1
HR,METEOROPATHY,1
HR,MITRAL VALVE INCOMPETENCE,1
HR,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
HR,OVERDOSE,1
HR,PARAESTHESIA,1
HR,PARKINSON^S DISEASE,1
HR,PLEURAL EFFUSION,1
HR,POISONING,1
HR,PYELONEPHRITIS,1
HR,RENAL CANCER METASTATIC,1
HR,RIGHT VENTRICULAR FAILURE,1
HR,SKIN BURNING SENSATION,1
HR,SKIN INFECTION,1
HR,SPLENIC RUPTURE,1
HR,SUPRAVENTRICULAR EXTRASYSTOLES,1
HR,TRANSPLANT DYSFUNCTION,1
HR,TRICUSPID VALVE INCOMPETENCE,1
HR,TYPE I HYPERSENSITIVITY,1
HR,WEIGHT INCREASED,1
CY,BLOOD CREATININE INCREASED,2
CY,CARDIAC VENTRICULAR THROMBOSIS,2
CY,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
CY,ARTERIOSCLEROSIS,1
CY,BLOOD UREA INCREASED,1
CY,CEREBRAL HAEMORRHAGE,1
CY,CORNEAL SCAR,1
CY,DIARRHOEA,1
CY,DYSLIPIDAEMIA,1
CY,DYSPNOEA,1
CY,GASTROINTESTINAL HAEMORRHAGE,1
CY,GENERAL PHYSICAL HEALTH DETERIORATION,1
CY,HAEMOGLOBIN DECREASED,1
CY,HYPOPYON,1
CY,MYOCARDIAL INFARCTION,1
CY,NAUSEA,1
CY,NEUTROPHIL COUNT DECREASED,1
CY,OEDEMA PERIPHERAL,1
CY,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
CY,PANCREATIC CARCINOMA,1
CY,PENILE ULCERATION,1
CY,PLATELET COUNT DECREASED,1
CY,PNEUMONITIS,1
CY,PYREXIA,1
CY,RENAL IMPAIRMENT,1
CY,RESPIRATORY FAILURE,1
CY,STREPTOCOCCUS TEST POSITIVE,1
CY,SYNCOPE,1
CY,TRANSIENT ISCHAEMIC ATTACK,1
CY,ULCERATIVE KERATITIS,1
CZ,CARDIAC ARREST,3
CZ,ASTHENIA,2
CZ,CIRCULATORY COLLAPSE,2
CZ,DYSPNOEA,2
CZ,LEUKOPENIA,2
CZ,PANCREATIC MASS,2
CZ,PNEUMONIA,2
CZ,POLYMYOSITIS,2
CZ,RENAL CYST HAEMORRHAGE,2
CZ,RENAL FAILURE,2
CZ,SPINAL FRACTURE,2
CZ,THROMBOCYTOPENIA,2
CZ,ACUTE MYOCARDIAL INFARCTION,1
CZ,ANAEMIA,1
CZ,ANAPHYLACTIC SHOCK,1
CZ,ATYPICAL PNEUMONIA,1
CZ,BODY TEMPERATURE INCREASED,1
CZ,BONE PAIN,1
CZ,BRONCHOPULMONARY DYSPLASIA,1
CZ,C-REACTIVE PROTEIN INCREASED,1
CZ,CARDIAC FAILURE,1
CZ,CHILLS,1
CZ,CLOSTRIDIUM DIFFICILE COLITIS,1
CZ,COGNITIVE DISORDER,1
CZ,DEATH,1
CZ,DEPRESSION,1
CZ,DIABETES MELLITUS,1
CZ,DIARRHOEA,1
CZ,DIZZINESS,1
CZ,DRUG-INDUCED LIVER INJURY,1
CZ,DYSPEPSIA,1
CZ,ELECTROCARDIOGRAM CHANGE,1
CZ,EPISTAXIS,1
CZ,ERYTHROPENIA,1
CZ,EYE HAEMORRHAGE,1
CZ,FATIGUE,1
CZ,FOETAL EXPOSURE DURING PREGNANCY,1
CZ,FOETAL GROWTH RESTRICTION,1
CZ,GOUTY ARTHRITIS,1
CZ,HEPATIC FUNCTION ABNORMAL,1
CZ,HERPES VIRUS INFECTION,1
CZ,HUMERUS FRACTURE,1
CZ,HYPERKALAEMIA,1
CZ,HYPERTONIA,1
CZ,HYPOGLYCAEMIA,1
CZ,HYPOKALAEMIA,1
CZ,HYPOKINESIA,1
CZ,HYPONATRAEMIA,1
CZ,HYPOTENSION,1
CZ,HYPOTHYROIDISM,1
CZ,HYPOXIA,1
CZ,IMMUNOSUPPRESSION,1
CZ,INGUINAL HERNIA,1
CZ,INTENTIONAL OVERDOSE,1
CZ,LOW BIRTH WEIGHT BABY,1
CZ,LUPUS NEPHRITIS,1
CZ,MATERNAL EXPOSURE DURING PREGNANCY,1
CZ,MECONIUM ABNORMAL,1
CZ,MENINGITIS,1
CZ,MENTAL DISABILITY,1
CZ,MOTOR DYSFUNCTION,1
CZ,MUSCULAR WEAKNESS,1
CZ,MUSCULOSKELETAL STIFFNESS,1
CZ,MYELODYSPLASTIC SYNDROME,1
CZ,NAUSEA,1
CZ,NECROTISING COLITIS,1
CZ,NEONATAL CHOLESTASIS,1
CZ,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
CZ,NEUROMYOPATHY,1
CZ,OSTEOPOROSIS,1
CZ,OTITIS MEDIA ACUTE,1
CZ,OXYGEN SATURATION DECREASED,1
CZ,PAIN IN EXTREMITY,1
CZ,PARAESTHESIA,1
CZ,PATHOLOGICAL FRACTURE,1
CZ,PELVIC FRACTURE,1
CZ,PLASMA CELL MYELOMA,1
CZ,PREMATURE BABY,1
CZ,PREMATURE LABOUR,1
CZ,PROTEINURIA,1
CZ,PSYCHOMOTOR HYPERACTIVITY,1
CZ,PULMONARY CONGESTION,1
CZ,PULMONARY OEDEMA,1
CZ,PYREXIA,1
CZ,RESPIRATORY ALKALOSIS,1
CZ,RESPIRATORY ARREST,1
CZ,RETINAL DETACHMENT,1
CZ,SINUS BRADYCARDIA,1
CZ,SPEECH DISORDER,1
CZ,SUDDEN DEATH,1
CZ,SUICIDE ATTEMPT,1
CZ,VOMITING,1
CZ,WRIST FRACTURE,1
DK,HYPOTENSION,7
DK,SYNCOPE,7
DK,ANAEMIA,6
DK,ACUTE MYOCARDIAL INFARCTION,5
DK,ANGINA PECTORIS,5
DK,PNEUMONIA,5
DK,RENAL FAILURE,5
DK,SEPSIS,5
DK,AORTIC VALVE STENOSIS,4
DK,CARDIAC FAILURE,4
DK,COAGULATION FACTOR INCREASED,4
DK,HAEMATEMESIS,4
DK,HYPERKALAEMIA,4
DK,INTERNATIONAL NORMALISED RATIO INCREASED,4
DK,ABDOMINAL PAIN UPPER,3
DK,ACUTE KIDNEY INJURY,3
DK,ADENOCARCINOMA OF COLON,3
DK,ANGINA UNSTABLE,3
DK,ARTERIOSCLEROSIS,3
DK,ASTHENIA,3
DK,ATRIAL FIBRILLATION,3
DK,BEZOAR,3
DK,BLOOD CREATININE INCREASED,3
DK,DIARRHOEA,3
DK,DIZZINESS,3
DK,DRUG INEFFECTIVE,3
DK,DYSPNOEA,3
DK,HAEMOGLOBIN DECREASED,3
DK,MALAISE,3
DK,OESOPHAGEAL OBSTRUCTION,3
DK,PALPITATIONS,3
DK,PANCREATITIS,3
DK,PNEUMONIA ASPIRATION,3
DK,PULMONARY OEDEMA,3
DK,RENAL IMPAIRMENT,3
DK,VOMITING,3
DK,BODY TEMPERATURE INCREASED,2
DK,CARDIAC ARREST,2
DK,CARDIOVASCULAR DISORDER,2
DK,CEREBROVASCULAR ACCIDENT,2
DK,CORONARY ARTERY RESTENOSIS,2
DK,DEPRESSION,2
DK,DISTURBANCE IN ATTENTION,2
DK,DUODENAL ULCER HAEMORRHAGE,2
DK,DYSBACTERIOSIS,2
DK,FATIGUE,2
DK,FUNGAL SKIN INFECTION,2
DK,GASTRIC ULCER,2
DK,GASTROOESOPHAGEAL REFLUX DISEASE,2
DK,HEADACHE,2
DK,INFECTED SKIN ULCER,2
DK,INFECTION,2
DK,INTENTIONAL OVERDOSE,2
DK,LOSS OF CONSCIOUSNESS,2
DK,MENTAL STATUS CHANGES,2
DK,MYALGIA,2
DK,MYOCARDIAL INFARCTION,2
DK,NAUSEA,2
DK,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
DK,PLASMA CELL MYELOMA,2
DK,PULMONARY CONGESTION,2
DK,RESPIRATORY DISORDER,2
DK,TOXICITY TO VARIOUS AGENTS,2
DK,VISUAL IMPAIRMENT,2
DK,ABDOMINAL DISCOMFORT,1
DK,ABDOMINAL INJURY,1
DK,ABDOMINAL PAIN,1
DK,ACUTE RESPIRATORY FAILURE,1
DK,AGEUSIA,1
DK,ANOSMIA,1
DK,ASPIRATION,1
DK,ASPIRATION PLEURAL CAVITY,1
DK,BACK PAIN,1
DK,BLOOD PRESSURE DECREASED,1
DK,BLOOD SODIUM DECREASED,1
DK,CARDIOMYOPATHY,1
DK,CEREBRAL INFARCTION,1
DK,CHEST DISCOMFORT,1
DK,CHEST PAIN,1
DK,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
DK,COAGULOPATHY,1
DK,COLD SWEAT,1
DK,COLITIS,1
DK,COMPLETED SUICIDE,1
DK,CORONARY ARTERY OCCLUSION,1
DK,COUGH,1
DK,CREPITATIONS,1
DK,DEATH,1
DK,DEHYDRATION,1
DK,DELIRIUM,1
DK,DEMENTIA,1
DK,DEVICE DISLOCATION,1
DK,DIABETES MELLITUS,1
DK,DISCOMFORT,1
DK,DRUG EFFECT DECREASED,1
DK,DUODENAL ULCER,1
DK,DUODENITIS,1
DK,DYSPHAGIA,1
DK,DYSPNOEA EXERTIONAL,1
DK,EPISTAXIS,1
DK,ERECTILE DYSFUNCTION,1
DK,FALL,1
DK,FEELING ABNORMAL,1
DK,FEELING DRUNK,1
DK,FINE MOTOR DELAY,1
DK,FOETAL EXPOSURE DURING PREGNANCY,1
DK,FOOD AVERSION,1
DK,GASTRIC HAEMORRHAGE,1
DK,GASTRIC ULCER HAEMORRHAGE,1
DK,GASTROINTESTINAL HAEMORRHAGE,1
DK,GASTROINTESTINAL OEDEMA,1
DK,HAEMATOMA,1
DK,HAEMATURIA,1
DK,HAEMODIALYSIS,1
DK,HAEMOPTYSIS,1
DK,HEART RATE DECREASED,1
DK,HEART RATE INCREASED,1
DK,HELICOBACTER INFECTION,1
DK,HYPERHIDROSIS,1
DK,HYPERSENSITIVITY,1
DK,HYPERTENSION,1
DK,HYPONATRAEMIA,1
DK,IMPAIRED HEALING,1
DK,INJECTION SITE HAEMATOMA,1
DK,INTERMITTENT CLAUDICATION,1
DK,ISCHAEMIC CARDIOMYOPATHY,1
DK,JAW OPERATION,1
DK,LIP SWELLING,1
DK,LIVER FUNCTION TEST ABNORMAL,1
DK,LOWER RESPIRATORY TRACT INFECTION FUNGAL,1
DK,LUNG INFILTRATION,1
DK,LUNG NEOPLASM MALIGNANT,1
DK,MELAENA,1
DK,MENTAL IMPAIRMENT,1
DK,MUCOSAL HAEMORRHAGE,1
DK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
DK,NASOPHARYNGITIS,1
DK,NEUTROPENIC COLITIS,1
DK,OEDEMA,1
DK,OEDEMA PERIPHERAL,1
DK,OESOPHAGEAL HAEMORRHAGE,1
DK,OSTEONECROSIS OF JAW,1
DK,OSTEOPOROSIS,1
DK,OVERDOSE,1
DK,PAIN,1
DK,PAIN IN EXTREMITY,1
DK,PALLOR,1
DK,PERICARDIAL EFFUSION,1
DK,PERIPHERAL COLDNESS,1
DK,PERIRENAL HAEMATOMA,1
DK,PNEUMONIA PNEUMOCOCCAL,1
DK,PRESYNCOPE,1
DK,PROCEDURAL PAIN,1
DK,PYELONEPHRITIS ACUTE,1
DK,RASH PRURITIC,1
DK,RECTAL HAEMORRHAGE,1
DK,RESPIRATORY TRACT INFECTION,1
DK,RESTLESSNESS,1
DK,RETINAL VASCULAR OCCLUSION,1
DK,RETINAL VEIN THROMBOSIS,1
DK,SKIN HAEMORRHAGE,1
DK,SKIN ULCER,1
DK,SPINAL DEFORMITY,1
DK,SUBDURAL HAEMATOMA,1
DK,SWELLING FACE,1
DK,TACHYCARDIA,1
DK,THROAT IRRITATION,1
DK,TOOTH DISORDER,1
DK,URINARY TRACT INFECTION ENTEROCOCCAL,1
DK,URTICARIA,1
DK,VENTRICULAR TACHYCARDIA,1
DK,WEIGHT DECREASED,1
DK,WEIGHT INCREASED,1
DK,WHITE BLOOD CELL COUNT INCREASED,1
DO,THROMBOSIS,2
DO,ANAEMIA,1
DO,ASTHENIA,1
DO,BLOOD GLUCOSE INCREASED,1
DO,CARDIAC ARREST,1
DO,CORONARY ARTERY OCCLUSION,1
DO,DIAPHRAGM NEOPLASM,1
DO,DIZZINESS,1
DO,FALL,1
DO,FATIGUE,1
DO,HYDROCHOLECYSTIS,1
DO,HYPERTENSION,1
DO,INJECTION SITE ABSCESS,1
DO,INJECTION SITE ERYTHEMA,1
DO,INJECTION SITE PAIN,1
DO,INJECTION SITE PUSTULE,1
DO,INJECTION SITE SWELLING,1
DO,MYOCARDIAL INFARCTION,1
DO,NAUSEA,1
DO,PERIPHERAL SWELLING,1
DO,PHARYNGITIS STREPTOCOCCAL,1
DO,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
DO,PULMONARY HYPERTENSION,1
DO,PYREXIA,1
DO,UPPER LIMB FRACTURE,1
DO,VISUAL IMPAIRMENT,1
EC,ACUTE MYOCARDIAL INFARCTION,5
EC,ABDOMINAL PAIN,3
EC,CARDIO-RESPIRATORY ARREST,3
EC,DIABETIC COMPLICATION,2
EC,DYSPNOEA,2
EC,HYPOTENSION,2
EC,VASCULAR STENT THROMBOSIS,2
EC,ACINETOBACTER TEST POSITIVE,1
EC,ANGIOEDEMA,1
EC,APHONIA,1
EC,ASTHMATIC CRISIS,1
EC,BACTERIAL INFECTION,1
EC,BLOOD GLUCOSE INCREASED,1
EC,BRADYCARDIA,1
EC,CARDIAC ARREST,1
EC,CARDIAC FAILURE,1
EC,CHEST PAIN,1
EC,CHOLELITHIASIS,1
EC,COMA,1
EC,CONTRAINDICATED PRODUCT ADMINISTERED,1
EC,CORONARY ARTERY STENOSIS,1
EC,DEATH,1
EC,DEMENTIA,1
EC,DISORIENTATION,1
EC,DIZZINESS,1
EC,DRUG DOSE OMISSION,1
EC,DRUG INEFFECTIVE,1
EC,DYSPHONIA,1
EC,FATIGUE,1
EC,GENERAL PHYSICAL HEALTH DETERIORATION,1
EC,GROIN ABSCESS,1
EC,HAEMORRHAGE INTRACRANIAL,1
EC,HYPONATRAEMIA,1
EC,INFECTION,1
EC,INSOMNIA,1
EC,ISCHAEMIA,1
EC,LARYNGEAL CANCER,1
EC,MALAISE,1
EC,MEMORY IMPAIRMENT,1
EC,MITRAL VALVE CALCIFICATION,1
EC,MUSCULAR WEAKNESS,1
EC,NERVOUS SYSTEM DISORDER,1
EC,PARAESTHESIA,1
EC,PNEUMONIA,1
EC,PNEUMONIA STAPHYLOCOCCAL,1
EC,PNEUMOTHORAX,1
EC,RESPIRATORY FAILURE,1
EC,SENSORY DISTURBANCE,1
EC,SEPTIC SHOCK,1
EC,SYSTEMIC LUPUS ERYTHEMATOSUS,1
EC,TRICUSPID VALVE INCOMPETENCE,1
EC,URINE SODIUM ABNORMAL,1
EC,VASCULAR STENT RESTENOSIS,1
EC,VIRAL PHARYNGITIS,1
EC,VISION BLURRED,1
EC,VOMITING,1
EG,HYPERGLYCAEMIA,3
EG,ABASIA,2
EG,CEREBROVASCULAR ACCIDENT,2
EG,CONFUSIONAL STATE,2
EG,FATIGUE,2
EG,ABNORMAL FAECES,1
EG,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
EG,AMNESIA,1
EG,ASTHENIA,1
EG,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
EG,BALLOON ATRIAL SEPTOSTOMY,1
EG,BIOPSY BONE MARROW,1
EG,BLISTER,1
EG,BLOOD URINE PRESENT,1
EG,CARDIAC ARREST,1
EG,CHROMATURIA,1
EG,COUGH,1
EG,DEEP VEIN THROMBOSIS,1
EG,DEHYDRATION,1
EG,DIZZINESS,1
EG,DYSPHAGIA,1
EG,DYSPNOEA,1
EG,EPILEPSY,1
EG,FAECES DISCOLOURED,1
EG,HAEMATEMESIS,1
EG,HAEMOGLOBIN DECREASED,1
EG,HEADACHE,1
EG,HEART RATE IRREGULAR,1
EG,HEPATIC ENZYME INCREASED,1
EG,JAUNDICE,1
EG,LIP SWELLING,1
EG,LIVER TRANSPLANT REJECTION,1
EG,LOWER RESPIRATORY TRACT INFECTION,1
EG,MEDICATION ERROR,1
EG,MEGAKARYOCYTE DESTRUCTION INCREASED,1
EG,MELAENA,1
EG,MUCOSAL PAIN,1
EG,MYOCARDIAL INFARCTION,1
EG,MYOCARDIAL ISCHAEMIA,1
EG,OEDEMA,1
EG,OVERDOSE,1
EG,PALLOR,1
EG,PERCUTANEOUS CORONARY INTERVENTION,1
EG,PLATELET COUNT DECREASED,1
EG,PLATELET MORPHOLOGY ABNORMAL,1
EG,POLYCYTHAEMIA,1
EG,PYREXIA,1
EG,RENAL IMPAIRMENT,1
EG,SPEECH DISORDER,1
EG,SPLENECTOMY,1
EG,STEVENS-JOHNSON SYNDROME,1
EG,SUPRAVENTRICULAR TACHYCARDIA,1
EG,THERMAL BURN,1
EG,THROAT TIGHTNESS,1
EG,THROMBOCYTOPENIA,1
EG,TONGUE DRY,1
EG,TREATMENT FAILURE,1
EG,UPPER RESPIRATORY TRACT INFECTION,1
EG,URINARY SEDIMENT PRESENT,1
EG,URINE OUTPUT DECREASED,1
EG,VENTRICULAR SEPTAL DEFECT REPAIR,1
EG,WHITE BLOOD CELL COUNT DECREASED,1
SV,BRAIN DEATH,1
SV,CAROTID ARTERY OCCLUSION,1
SV,CEREBELLAR HAEMORRHAGE,1
EE,CEREBRAL HAEMORRHAGE,1
EE,CNS VENTRICULITIS,1
EE,COMA,1
EE,DRUG INEFFECTIVE,1
EE,HAEMORRHAGE INTRACRANIAL,1
EE,HYDROCEPHALUS,1
EE,ISCHAEMIC STROKE,1
EE,VISUAL ACUITY REDUCED TRANSIENTLY,1
FJ,CELLULITIS,1
FI,CEREBROVASCULAR ACCIDENT,10
FI,ATRIAL FIBRILLATION,3
FI,FALL,3
FI,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
FI,RETINAL DETACHMENT,3
FI,ARRHYTHMIA,2
FI,CEREBRAL HAEMORRHAGE,2
FI,DEATH,2
FI,DRUG ADMINISTRATION ERROR,2
FI,HEAD INJURY,2
FI,LOSS OF CONSCIOUSNESS,2
FI,SUBARACHNOID HAEMORRHAGE,2
FI,SYNCOPE,2
FI,ABSCESS,1
FI,ALBUMINURIA,1
FI,AMNESIA,1
FI,ARTERIOSPASM CORONARY,1
FI,BACK PAIN,1
FI,BRADYCARDIA,1
FI,CLOSTRIDIUM DIFFICILE COLITIS,1
FI,CONFUSIONAL STATE,1
FI,CUSHINGOID,1
FI,DIABETES MELLITUS,1
FI,DRUG EFFECT INCOMPLETE,1
FI,DRUG INEFFECTIVE,1
FI,GAIT DISTURBANCE,1
FI,GASTRIC ULCER PERFORATION,1
FI,GLOMERULAR FILTRATION RATE DECREASED,1
FI,GOUT,1
FI,HYPOGLYCAEMIA,1
FI,HYPOKINESIA,1
FI,HYPOTENSION,1
FI,HYPOTHERMIA,1
FI,MEMORY IMPAIRMENT,1
FI,MUSCULAR WEAKNESS,1
FI,MUSCULOSKELETAL STIFFNESS,1
FI,MYALGIA,1
FI,MYOCARDIAL INFARCTION,1
FI,MYOPATHY,1
FI,OVERDOSE,1
FI,PAIN IN EXTREMITY,1
FI,PALPITATIONS,1
FI,PANCREATIC NEOPLASM,1
FI,PANCREATITIS,1
FI,PNEUMONIA,1
FI,POLYMYALGIA RHEUMATICA,1
FI,PYREXIA,1
FI,RADIUS FRACTURE,1
FI,SEIZURE,1
FI,SEPSIS,1
FI,SOMNOLENCE,1
FI,SWELLING,1
FI,UNRESPONSIVE TO STIMULI,1
FI,URINARY TRACT INFECTION,1
FI,URINE KETONE BODY,1
FI,WOUND COMPLICATION,1
FR,DIARRHOEA,20
FR,ANAEMIA,19
FR,THROMBOCYTOPENIA,18
FR,ACUTE KIDNEY INJURY,17
FR,DRUG INEFFECTIVE,17
FR,DEATH,16
FR,NEUTROPENIA,14
FR,ASTHENIA,13
FR,RENAL FAILURE,13
FR,PLASMA CELL MYELOMA,12
FR,PYREXIA,12
FR,CARDIAC FAILURE,11
FR,CEREBROVASCULAR ACCIDENT,11
FR,EXPOSURE DURING PREGNANCY,11
FR,HAEMORRHAGE,11
FR,AGRANULOCYTOSIS,10
FR,DYSPNOEA,10
FR,TOXICITY TO VARIOUS AGENTS,10
FR,ABDOMINAL PAIN,9
FR,HYPOTENSION,9
FR,RHABDOMYOLYSIS,9
FR,COMA,8
FR,CONDITION AGGRAVATED,8
FR,CONFUSIONAL STATE,8
FR,FATIGUE,8
FR,GASTROINTESTINAL DISORDER,8
FR,HEADACHE,8
FR,HYPERTENSION,8
FR,SEPTIC SHOCK,8
FR,DECREASED APPETITE,7
FR,FOETAL DEATH,7
FR,HAEMATOMA,7
FR,HEPATOCELLULAR INJURY,7
FR,LYMPHOPENIA,7
FR,NAUSEA,7
FR,NEUROPATHY PERIPHERAL,7
FR,SHOCK,7
FR,STATUS EPILEPTICUS,7
FR,THROMBOSIS IN DEVICE,7
FR,VOMITING,7
FR,ALOPECIA,6
FR,ARTHRALGIA,6
FR,ATRIAL FIBRILLATION,6
FR,CARDIAC ARREST,6
FR,CARDIOGENIC SHOCK,6
FR,ELECTROCARDIOGRAM QT PROLONGED,6
FR,EOSINOPHILIA,6
FR,FALL,6
FR,FEBRILE NEUTROPENIA,6
FR,GASTROINTESTINAL HAEMORRHAGE,6
FR,GENERAL PHYSICAL HEALTH DETERIORATION,6
FR,HAEMATOTOXICITY,6
FR,HYPOGAMMAGLOBULINAEMIA,6
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,6
FR,INSOMNIA,6
FR,INTENTIONAL OVERDOSE,6
FR,ISCHAEMIC STROKE,6
FR,PLATELET AGGREGATION INHIBITION,6
FR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,6
FR,QUADRIPARESIS,6
FR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,6
FR,WEIGHT DECREASED,6
FR,ABDOMINAL PAIN UPPER,5
FR,ANGIOEDEMA,5
FR,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,5
FR,CEREBRAL HAEMORRHAGE,5
FR,DERMATITIS EXFOLIATIVE,5
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
FR,DRUG RESISTANCE,5
FR,EPISTAXIS,5
FR,FOETAL EXPOSURE DURING PREGNANCY,5
FR,HEPATITIS,5
FR,HEPATITIS ACUTE,5
FR,HYPERTHERMIA,5
FR,HYPOKALAEMIA,5
FR,INFECTION,5
FR,MULTI-ORGAN FAILURE,5
FR,MUSCLE SPASMS,5
FR,MYALGIA,5
FR,NERVOUS SYSTEM DISORDER,5
FR,PAIN IN EXTREMITY,5
FR,PULMONARY EMBOLISM,5
FR,RASH,5
FR,SEPSIS,5
FR,TACHYCARDIA,5
FR,ACUTE RESPIRATORY FAILURE,4
FR,ADENOCARCINOMA OF COLON,4
FR,AGITATION,4
FR,ALANINE AMINOTRANSFERASE INCREASED,4
FR,ASPHYXIA,4
FR,BRONCHITIS,4
FR,CARDIO-RESPIRATORY ARREST,4
FR,COLITIS,4
FR,CONSTIPATION,4
FR,DEPRESSION,4
FR,DRUG LEVEL INCREASED,4
FR,ENCEPHALOPATHY,4
FR,EPSTEIN-BARR VIRUS INFECTION,4
FR,HAEMOGLOBIN DECREASED,4
FR,HYPONATRAEMIA,4
FR,LUNG DISORDER,4
FR,MATERNAL EXPOSURE DURING PREGNANCY,4
FR,MYOCARDIAL ISCHAEMIA,4
FR,OEDEMA PERIPHERAL,4
FR,OVERDOSE,4
FR,PAIN,4
FR,PANCYTOPENIA,4
FR,PERIPHERAL SENSORY NEUROPATHY,4
FR,PNEUMONIA,4
FR,RASH MACULO-PAPULAR,4
FR,RENAL FAILURE ACUTE,4
FR,RENAL IMPAIRMENT,4
FR,RENAL TUBULAR DISORDER,4
FR,RESPIRATORY DISTRESS,4
FR,RESPIRATORY FAILURE,4
FR,SEIZURE,4
FR,SINUS NODE DYSFUNCTION,4
FR,SYNCOPE,4
FR,THROMBOSIS,4
FR,ABORTION INDUCED,3
FR,ACCIDENTAL OVERDOSE,3
FR,ACUTE CORONARY SYNDROME,3
FR,ADVERSE EVENT,3
FR,BASAL CELL CARCINOMA,3
FR,BLOOD PRESSURE DECREASED,3
FR,BLOOD TRIGLYCERIDES INCREASED,3
FR,BREAST CANCER,3
FR,CANDIDA INFECTION,3
FR,CARDIAC DEATH,3
FR,CHEST PAIN,3
FR,COLITIS ISCHAEMIC,3
FR,COUGH,3
FR,ERYSIPELAS,3
FR,ERYTHEMA,3
FR,ESCHERICHIA INFECTION,3
FR,ESSENTIAL THROMBOCYTHAEMIA,3
FR,FACE OEDEMA,3
FR,FEELING ABNORMAL,3
FR,GAIT DISTURBANCE,3
FR,GASTROOESOPHAGEAL REFLUX DISEASE,3
FR,GENERALISED TONIC-CLONIC SEIZURE,3
FR,GINGIVAL BLEEDING,3
FR,HAEMATURIA,3
FR,HEPATIC ENZYME INCREASED,3
FR,HIGH DENSITY LIPOPROTEIN DECREASED,3
FR,HYDROCEPHALUS,3
FR,HYPERGLYCAEMIA,3
FR,HYPERURICAEMIA,3
FR,INCORRECT DOSE ADMINISTERED,3
FR,INFLAMMATION,3
FR,INFUSION RELATED REACTION,3
FR,INTERNATIONAL NORMALISED RATIO INCREASED,3
FR,INTRA-ABDOMINAL HAEMORRHAGE,3
FR,IRRITABILITY,3
FR,LOSS OF CONSCIOUSNESS,3
FR,LUNG ADENOCARCINOMA,3
FR,METABOLIC ACIDOSIS,3
FR,MUCOSAL INFLAMMATION,3
FR,MYOCARDIAL INFARCTION,3
FR,OEDEMA,3
FR,PALPITATIONS,3
FR,PERICARDIAL EFFUSION,3
FR,PERICARDITIS,3
FR,PHLEBITIS,3
FR,PLEURAL EFFUSION,3
FR,SOMNOLENCE,3
FR,SUBDURAL HAEMATOMA,3
FR,TUMOUR FLARE,3
FR,VASCULAR STENT THROMBOSIS,3
FR,VENTRICULAR FIBRILLATION,3
FR,ABDOMINAL DISTENSION,2
FR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,2
FR,ACUTE PULMONARY OEDEMA,2
FR,ALCOHOL WITHDRAWAL SYNDROME,2
FR,ANALGESIC DRUG LEVEL INCREASED,2
FR,ANAPHYLACTIC REACTION,2
FR,ANGINA PECTORIS,2
FR,ANTIPHOSPHOLIPID SYNDROME,2
FR,APHASIA,2
FR,ARRHYTHMIA,2
FR,ASPARTATE AMINOTRANSFERASE INCREASED,2
FR,BACK PAIN,2
FR,BONE MARROW FAILURE,2
FR,BOWEN^S DISEASE,2
FR,BRADYCARDIA,2
FR,CARDIAC MURMUR,2
FR,CARDIOMYOPATHY,2
FR,CATARACT,2
FR,CEREBRAL INFARCTION,2
FR,CHILLS,2
FR,COLON CANCER METASTATIC,2
FR,CONGENITAL TOXOPLASMOSIS,2
FR,CORONARY ARTERY THROMBOSIS,2
FR,DEHYDRATION,2
FR,DEVICE RELATED INFECTION,2
FR,DIABETES MELLITUS INADEQUATE CONTROL,2
FR,DIABETIC RETINOPATHY,2
FR,DIARRHOEA HAEMORRHAGIC,2
FR,DISORIENTATION,2
FR,DISTURBANCE IN ATTENTION,2
FR,DRUG INTOLERANCE,2
FR,DYSARTHRIA,2
FR,DYSPEPSIA,2
FR,DYSPHONIA,2
FR,ECCHYMOSIS,2
FR,EJECTION FRACTION DECREASED,2
FR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
FR,EMBOLISM,2
FR,FACIAL PARALYSIS,2
FR,FANCONI SYNDROME,2
FR,GASTRIC ULCER HAEMORRHAGE,2
FR,GASTRITIS,2
FR,GASTROINTESTINAL PAIN,2
FR,HAEMORRHAGE INTRACRANIAL,2
FR,HEMIPARESIS,2
FR,HEPATITIS FULMINANT,2
FR,HEPATOTOXICITY,2
FR,HYPERCALCAEMIA,2
FR,HYPERKALAEMIA,2
FR,HYPERTHYROIDISM,2
FR,HYPOCALCAEMIA,2
FR,HYPOMAGNESAEMIA,2
FR,INFARCTION,2
FR,INTERSTITIAL LUNG DISEASE,2
FR,INTRACRANIAL HAEMATOMA,2
FR,INTRACRANIAL PRESSURE INCREASED,2
FR,IRON DEFICIENCY ANAEMIA,2
FR,ISCHAEMIA,2
FR,KLEBSIELLA INFECTION,2
FR,LARYNGEAL HAEMATOMA,2
FR,LINEAR IGA DISEASE,2
FR,LIVER FUNCTION TEST ABNORMAL,2
FR,LOCALISED INFECTION,2
FR,LUNG INFECTION,2
FR,LYMPHOMA,2
FR,MALAISE,2
FR,MALIGNANT MELANOMA IN SITU,2
FR,MELAENA,2
FR,METRORRHAGIA,2
FR,MORGANELLA INFECTION,2
FR,MOUTH ULCERATION,2
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
FR,MYDRIASIS,2
FR,MYOPATHY,2
FR,NON-CARDIAC CHEST PAIN,2
FR,NON-HODGKIN^S LYMPHOMA,2
FR,PALLOR,2
FR,PARAESTHESIA,2
FR,PELVIC FRACTURE,2
FR,PERICARDIAL HAEMORRHAGE,2
FR,PERIPHERAL SWELLING,2
FR,PLASMACYTOMA,2
FR,PNEUMONIA ASPIRATION,2
FR,PNEUMONITIS,2
FR,POISONING DELIBERATE,2
FR,PROTHROMBIN TIME SHORTENED,2
FR,PSEUDOMONAL SEPSIS,2
FR,PURPURA,2
FR,PYELONEPHRITIS,2
FR,RENAL TUBULAR NECROSIS,2
FR,SECOND PRIMARY MALIGNANCY,2
FR,SHOCK HAEMORRHAGIC,2
FR,SINUS BRADYCARDIA,2
FR,SKIN TOXICITY,2
FR,SPEECH DISORDER,2
FR,SPINAL PAIN,2
FR,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,2
FR,STAPHYLOCOCCUS TEST POSITIVE,2
FR,SWELLING,2
FR,T-CELL LYMPHOMA,2
FR,THERAPEUTIC RESPONSE DECREASED,2
FR,THROMBOPHLEBITIS,2
FR,TOXIC ENCEPHALOPATHY,2
FR,TOXOPLASMOSIS,2
FR,TRANSIENT ISCHAEMIC ATTACK,2
FR,TREATMENT FAILURE,2
FR,URINARY RETENTION,2
FR,URTICARIA,2
FR,VENOUS THROMBOSIS,2
FR,VERTIGO,2
FR,5Q MINUS SYNDROME,1
FR,ABDOMINAL DISCOMFORT,1
FR,ABNORMAL BEHAVIOUR,1
FR,ABORTION SPONTANEOUS,1
FR,ABSCESS,1
FR,ABSCESS LIMB,1
FR,ABSCESS NECK,1
FR,ACCELERATED IDIOVENTRICULAR RHYTHM,1
FR,ACUTE LEUKAEMIA,1
FR,ACUTE MYELOID LEUKAEMIA,1
FR,ACUTE MYOCARDIAL INFARCTION,1
FR,ACUTE PRERENAL FAILURE,1
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,1
FR,ADVERSE DRUG REACTION,1
FR,AMNESIA,1
FR,ANAL ABSCESS,1
FR,ANAL ULCER,1
FR,ANEMBRYONIC GESTATION,1
FR,ANGINA UNSTABLE,1
FR,ANXIETY,1
FR,AORTIC STENOSIS,1
FR,APHTHOUS ULCER,1
FR,ARRHYTHMIA SUPRAVENTRICULAR,1
FR,ARTERIAL HAEMORRHAGE,1
FR,ARTERIAL STENOSIS,1
FR,ARTERIOSCLEROSIS,1
FR,ARTERIOSCLEROSIS CORONARY ARTERY,1
FR,ARTERIOSPASM CORONARY,1
FR,ASCITES,1
FR,ASTERIXIS,1
FR,ASTHMA,1
FR,ATRIAL FLUTTER,1
FR,ATRIAL THROMBOSIS,1
FR,ATRIOVENTRICULAR BLOCK,1
FR,ATRIOVENTRICULAR BLOCK COMPLETE,1
FR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
FR,AXONAL NEUROPATHY,1
FR,B-CELL LYMPHOMA,1
FR,BACTERAEMIA,1
FR,BLADDER CANCER,1
FR,BLISTER,1
FR,BLOOD BLISTER,1
FR,BLOOD CHOLESTEROL ABNORMAL,1
FR,BLOOD CREATININE INCREASED,1
FR,BLOOD PRESSURE INCREASED,1
FR,BLOOD PRESSURE SYSTOLIC INCREASED,1
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,1
FR,BLOOD THYROID STIMULATING HORMONE INCREASED,1
FR,BLOOD URINE PRESENT,1
FR,BONE LESION,1
FR,BONE MARROW DISORDER,1
FR,BRADYARRHYTHMIA,1
FR,BRAIN HERNIATION,1
FR,BUNDLE BRANCH BLOCK LEFT,1
FR,C-REACTIVE PROTEIN INCREASED,1
FR,CACHEXIA,1
FR,CANDIDIASIS,1
FR,CARDIAC FAILURE CONGESTIVE,1
FR,CARDIAC TAMPONADE,1
FR,CARDIAC VENTRICULAR THROMBOSIS,1
FR,CARDIOVASCULAR DISORDER,1
FR,CATHETER SITE HAEMATOMA,1
FR,CATHETER SITE HAEMORRHAGE,1
FR,CEREBELLAR ATAXIA,1
FR,CEREBELLAR SYNDROME,1
FR,CEREBRAL HAEMATOMA,1
FR,CEREBRAL ISCHAEMIA,1
FR,CEREBRAL THROMBOSIS,1
FR,CEREBRAL VENTRICLE DILATATION,1
FR,CHEST DISCOMFORT,1
FR,CHOLANGITIS,1
FR,CHOLESTASIS,1
FR,CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS,1
FR,CHRONIC KIDNEY DISEASE,1
FR,CHRONIC RESPIRATORY FAILURE,1
FR,CLAVICLE FRACTURE,1
FR,CLOSTRIDIUM DIFFICILE INFECTION,1
FR,COAGULATION TIME SHORTENED,1
FR,COELIAC ARTERY STENOSIS,1
FR,COGNITIVE DISORDER,1
FR,COLITIS MICROSCOPIC,1
FR,COLONOSCOPY,1
FR,COLORECTAL CANCER,1
FR,CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY,1
FR,CONGENITAL HYDROCEPHALUS,1
FR,CONJUNCTIVITIS,1
FR,CONTUSION,1
FR,CORONARY ARTERY OCCLUSION,1
FR,CORONARY ARTERY STENOSIS,1
FR,CREATININE RENAL CLEARANCE DECREASED,1
FR,CUSHING^S SYNDROME,1
FR,CUTANEOUS SARCOIDOSIS,1
FR,CYANOSIS,1
FR,CYTOPENIA,1
FR,DEEP VEIN THROMBOSIS,1
FR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
FR,DERMATITIS BULLOUS,1
FR,DERMATITIS CONTACT,1
FR,DERMATOMYOSITIS,1
FR,DEVICE OCCLUSION,1
FR,DIABETIC KETOACIDOSIS,1
FR,DIPLOPIA,1
FR,DISEASE RECURRENCE,1
FR,DISSEMINATED INTRAVASCULAR COAGULATION,1
FR,DIVERTICULAR PERFORATION,1
FR,DIVERTICULUM INTESTINAL,1
FR,DIZZINESS,1
FR,DRUG EFFECT DECREASED,1
FR,DRUG EFFECT INCOMPLETE,1
FR,DRUG ERUPTION,1
FR,DRUG HYPERSENSITIVITY,1
FR,DRUG PRESCRIBING ERROR,1
FR,DRUG WITHDRAWAL CONVULSIONS,1
FR,DRUG WITHDRAWAL SYNDROME NEONATAL,1
FR,DRUG-INDUCED LIVER INJURY,1
FR,DUCTUS ARTERIOSUS PREMATURE CLOSURE,1
FR,DUCTUS ARTERIOSUS STENOSIS FOETAL,1
FR,DYSAESTHESIA,1
FR,DYSMORPHISM,1
FR,DYSPHAGIA,1
FR,EFFUSION,1
FR,EMBOLIC STROKE,1
FR,EMOTIONAL DISORDER,1
FR,ENCEPHALITIS,1
FR,ENDOMETRIAL ADENOCARCINOMA,1
FR,ENTEROCOCCAL INFECTION,1
FR,EPIDERMAL NECROSIS,1
FR,EPIDURAL HAEMORRHAGE,1
FR,EPILEPSY,1
FR,EPSTEIN-BARR VIRUS TEST POSITIVE,1
FR,EXTRAPYRAMIDAL DISORDER,1
FR,EXTRASYSTOLES,1
FR,EXTREMITY NECROSIS,1
FR,FACIAL BONES FRACTURE,1
FR,FAILED INDUCTION OF LABOUR,1
FR,FEBRILE BONE MARROW APLASIA,1
FR,FEEDING DISORDER,1
FR,FEELING HOT,1
FR,FEELING OF BODY TEMPERATURE CHANGE,1
FR,FLUID OVERLOAD,1
FR,FLUSHING,1
FR,FOETAL HEART RATE ABNORMAL,1
FR,FOETAL MACROSOMIA,1
FR,GASTRIC POLYPS,1
FR,GASTRIC ULCER,1
FR,GASTROINTESTINAL OBSTRUCTION,1
FR,GASTROINTESTINAL PERFORATION,1
FR,GASTROINTESTINAL ULCER PERFORATION,1
FR,GENERAL PHYSICAL CONDITION ABNORMAL,1
FR,GENOTYPE DRUG RESISTANCE TEST POSITIVE,1
FR,GOUT,1
FR,GRANULOMA SKIN,1
FR,GUILLAIN-BARRE SYNDROME,1
FR,HAEMODYNAMIC INSTABILITY,1
FR,HAEMORRHAGIC STROKE,1
FR,HAEMORRHAGIC TRANSFORMATION STROKE,1
FR,HAEMOTHORAX,1
FR,HAIR TEXTURE ABNORMAL,1
FR,HALLUCINATION,1
FR,HEAD DISCOMFORT,1
FR,HEAD INJURY,1
FR,HEART RATE INCREASED,1
FR,HELICOBACTER GASTRITIS,1
FR,HEMIANOPIA,1
FR,HEMIPLEGIA,1
FR,HEPARIN-INDUCED THROMBOCYTOPENIA,1
FR,HEPATIC ARTERY THROMBOSIS,1
FR,HEPATIC ENCEPHALOPATHY,1
FR,HEPATIC NECROSIS,1
FR,HERNIA,1
FR,HERPES ZOSTER,1
FR,HISTIOCYTOSIS HAEMATOPHAGIC,1
FR,HIV INFECTION,1
FR,HODGKIN^S DISEASE,1
FR,HYPERAESTHESIA,1
FR,HYPERHIDROSIS,1
FR,HYPERTENSIVE CRISIS,1
FR,HYPOAESTHESIA,1
FR,HYPOGLYCAEMIA,1
FR,HYPOTHYROIDISM,1
FR,HYPOXIA,1
FR,IMMOBILE,1
FR,IMMUNOGLOBULINS DECREASED,1
FR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
FR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
FR,INFLUENZA,1
FR,INGROWING NAIL,1
FR,INJECTION SITE HAEMATOMA,1
FR,INJURY,1
FR,INTENTIONAL PRODUCT USE ISSUE,1
FR,INTERMITTENT CLAUDICATION,1
FR,INTERNATIONAL NORMALISED RATIO DECREASED,1
FR,INTERVERTEBRAL DISC PROTRUSION,1
FR,INTESTINAL INFARCTION,1
FR,INTESTINAL ISCHAEMIA,1
FR,INTESTINAL OBSTRUCTION,1
FR,INTESTINAL PROLAPSE,1
FR,INTESTINAL VILLI ATROPHY,1
FR,INTRACARDIAC THROMBUS,1
FR,INTRAVENTRICULAR HAEMORRHAGE,1
FR,INVASIVE DUCTAL BREAST CARCINOMA,1
FR,JAUNDICE,1
FR,JAUNDICE CHOLESTATIC,1
FR,JAW FRACTURE,1
FR,JOINT INJURY,1
FR,KAPOSI^S SARCOMA,1
FR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
FR,LACTIC ACIDOSIS,1
FR,LEFT ATRIAL DILATATION,1
FR,LEUKOCYTOSIS,1
FR,LEUKOENCEPHALOPATHY,1
FR,LEUKOPENIA,1
FR,LIPASE INCREASED,1
FR,LIVER INJURY,1
FR,LIVIDITY,1
FR,LOCAL SWELLING,1
FR,LUMBAR VERTEBRAL FRACTURE,1
FR,MACROGLOSSIA,1
FR,MADAROSIS,1
FR,MALIGNANT MELANOMA,1
FR,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,1
FR,MATERNAL EXPOSURE DURING BREAST FEEDING,1
FR,MENINGITIS ASEPTIC,1
FR,MESENTERIC ARTERIAL OCCLUSION,1
FR,METASTASES TO LIVER,1
FR,MONOCYTOPENIA,1
FR,MONOPLEGIA,1
FR,MUSCLE DISORDER,1
FR,MUSCLE HAEMORRHAGE,1
FR,MUSCULAR WEAKNESS,1
FR,MUSCULOSKELETAL PAIN,1
FR,MYCOBACTERIUM AVIUM COMPLEX INFECTION,1
FR,MYELITIS TRANSVERSE,1
FR,MYELOCYTOSIS,1
FR,MYELODYSPLASTIC SYNDROME,1
FR,MYOCLONUS,1
FR,NASAL CONGESTION,1
FR,NECK PAIN,1
FR,NECROTISING FASCIITIS,1
FR,NEPHRITIS,1
FR,NEPHROPATHY TOXIC,1
FR,NEURILEMMOMA BENIGN,1
FR,NEUROLOGICAL SYMPTOM,1
FR,NIGHT SWEATS,1
FR,NOCTURIA,1
FR,OEDEMA MOUTH,1
FR,OLIGURIA,1
FR,OPTIC NEUROPATHY,1
FR,ORAL CANDIDIASIS,1
FR,ORAL FUNGAL INFECTION,1
FR,ORAL HERPES,1
FR,ORAL PUSTULE,1
FR,ORTHOPNOEA,1
FR,ORTHOSTATIC HYPOTENSION,1
FR,OSTEITIS,1
FR,OSTEONECROSIS OF JAW,1
FR,PAIN IN JAW,1
FR,PALATAL OEDEMA,1
FR,PANCREATITIS ACUTE,1
FR,PARAESTHESIA ORAL,1
FR,PARECHOVIRUS INFECTION,1
FR,PARONYCHIA,1
FR,PEMPHIGOID,1
FR,PERIPHERAL COLDNESS,1
FR,PERIPHERAL NERVE INJURY,1
FR,PERITONITIS,1
FR,PERNICIOUS ANAEMIA,1
FR,PETECHIAE,1
FR,PHARYNGITIS,1
FR,PHOTOSENSITIVITY REACTION,1
FR,PLEURISY,1
FR,PNEUMOCOCCAL INFECTION,1
FR,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
FR,PNEUMONIA CRYPTOCOCCAL,1
FR,PNEUMONIA CYTOMEGALOVIRAL,1
FR,POST PROCEDURAL HAEMATOMA,1
FR,POSTOPERATIVE RESPIRATORY DISTRESS,1
FR,PRECURSOR B-LYMPHOBLASTIC LYMPHOMA,1
FR,PREMATURE DELIVERY,1
FR,PRESCRIBED OVERDOSE,1
FR,PRESCRIBED UNDERDOSE,1
FR,PRIMARY EFFUSION LYMPHOMA,1
FR,PRINZMETAL ANGINA,1
FR,PROCEDURAL HAEMORRHAGE,1
FR,PRODUCT USE IN UNAPPROVED INDICATION,1
FR,PRODUCT USE ISSUE,1
FR,PROPIONIBACTERIUM INFECTION,1
FR,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
FR,PROSTATITIS,1
FR,PROTHROMBIN TIME PROLONGED,1
FR,PROTHROMBIN TIME RATIO DECREASED,1
FR,PRURITUS,1
FR,PULMONARY MASS,1
FR,PULMONARY TOXICITY,1
FR,PULSELESS ELECTRICAL ACTIVITY,1
FR,PYELONEPHRITIS ACUTE,1
FR,PYRAMIDAL TRACT SYNDROME,1
FR,PYROGLUTAMATE INCREASED,1
FR,QUADRANTANOPIA,1
FR,RECTAL ADENOCARCINOMA,1
FR,RECTAL TENESMUS,1
FR,REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS,1
FR,RENAL CYST,1
FR,RENAL HAEMORRHAGE,1
FR,RESPIRATORY TRACT INFECTION,1
FR,RESTLESSNESS,1
FR,RETROPERITONEAL HAEMATOMA,1
FR,REYE^S SYNDROME,1
FR,RHEUMATIC DISORDER,1
FR,RIB FRACTURE,1
FR,ROAD TRAFFIC ACCIDENT,1
FR,SCIATICA,1
FR,SCROTAL OEDEMA,1
FR,SENSORY LOSS,1
FR,SERUM FERRITIN DECREASED,1
FR,SINOATRIAL BLOCK,1
FR,SKIN BURNING SENSATION,1
FR,SKIN DISCOLOURATION,1
FR,SKIN LESION,1
FR,SKIN NECROSIS,1
FR,SKIN ULCER,1
FR,SOFT TISSUE INFECTION,1
FR,SOFT TISSUE NECROSIS,1
FR,SPINAL COMPRESSION FRACTURE,1
FR,SPINAL EPIDURAL HAEMORRHAGE,1
FR,SPLENOMEGALY,1
FR,SQUAMOUS CELL CARCINOMA OF SKIN,1
FR,STAPHYLOCOCCAL SEPSIS,1
FR,STENOSIS,1
FR,STREPTOCOCCAL SEPSIS,1
FR,STRESS,1
FR,STRESS CARDIOMYOPATHY,1
FR,SUBARACHNOID HAEMORRHAGE,1
FR,SUBCUTANEOUS ABSCESS,1
FR,SUDDEN DEATH,1
FR,SUICIDAL IDEATION,1
FR,SURGERY,1
FR,SWOLLEN TONGUE,1
FR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
FR,SYSTOLIC DYSFUNCTION,1
FR,T-CELL PROLYMPHOCYTIC LEUKAEMIA,1
FR,TELANGIECTASIA,1
FR,TENDERNESS,1
FR,TENDON DISCOMFORT,1
FR,TENDON RUPTURE,1
FR,THINKING ABNORMAL,1
FR,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
FR,TOOTH LOSS,1
FR,TOXIC EPIDERMAL NECROLYSIS,1
FR,TRANSPOSITION OF THE GREAT VESSELS,1
FR,TROPONIN I INCREASED,1
FR,TROPONIN INCREASED,1
FR,TUMOUR HAEMORRHAGE,1
FR,ULCER HAEMORRHAGE,1
FR,UPPER AIRWAY OBSTRUCTION,1
FR,UPPER GASTROINTESTINAL HAEMORRHAGE,1
FR,URINARY TRACT INFECTION,1
FR,URINE OUTPUT DECREASED,1
FR,URINE OUTPUT INCREASED,1
FR,UROGENITAL FISTULA,1
FR,VAGINAL HAEMORRHAGE,1
FR,VASCULAR PSEUDOANEURYSM,1
FR,VASCULITIS,1
FR,VENTRICULAR TACHYCARDIA,1
FR,VIITH NERVE PARALYSIS,1
FR,VISION BLURRED,1
FR,VITAMIN B12 DEFICIENCY,1
FR,WEIGHT INCREASED,1
FR,WITHDRAWAL SYNDROME,1
FR,YELLOW NAIL SYNDROME,1
GE,DEATH,10
GE,AGITATION,1
GE,ANAEMIA,1
GE,BONE PAIN,1
GE,CONSTIPATION,1
GE,COUGH,1
GE,DECREASED APPETITE,1
GE,DEEP VEIN THROMBOSIS,1
GE,DYSPNOEA,1
GE,FATIGUE,1
GE,GASTRITIS,1
GE,HEADACHE,1
GE,HERPES ZOSTER,1
GE,INSOMNIA,1
GE,MUSCLE SPASMS,1
GE,NAUSEA,1
GE,NEUROPATHY PERIPHERAL,1
GE,NEUTROPENIA,1
GE,OEDEMA PERIPHERAL,1
GE,PAIN IN EXTREMITY,1
GE,PARAESTHESIA,1
GE,PULMONARY EMBOLISM,1
GE,PYREXIA,1
GE,RASH,1
GE,THROMBOCYTOPENIA,1
GE,TRANSAMINASES INCREASED,1
GE,TREMOR,1
GE,UPPER RESPIRATORY TRACT INFECTION,1
GE,VOMITING,1
DE,PNEUMONIA,186
DE,GENERAL PHYSICAL HEALTH DETERIORATION,175
DE,FALL,162
DE,DYSPNOEA,156
DE,FATIGUE,154
DE,NAUSEA,136
DE,DIARRHOEA,127
DE,ANAEMIA,112
DE,DEATH,107
DE,VOMITING,98
DE,DIZZINESS,97
DE,ACUTE KIDNEY INJURY,94
DE,CARDIAC FAILURE,94
DE,RENAL FAILURE,91
DE,ARTHRALGIA,88
DE,MYOCARDIAL INFARCTION,88
DE,PYREXIA,86
DE,SYNCOPE,83
DE,THROMBOCYTOPENIA,80
DE,ASTHENIA,77
DE,HAEMOGLOBIN DECREASED,73
DE,BLOOD CREATININE INCREASED,71
DE,CEREBROVASCULAR ACCIDENT,71
DE,WEIGHT DECREASED,71
DE,ATRIAL FIBRILLATION,70
DE,FOETAL EXPOSURE DURING PREGNANCY,69
DE,GASTROINTESTINAL HAEMORRHAGE,68
DE,PAIN IN EXTREMITY,68
DE,HYPERTENSION,67
DE,SEPSIS,66
DE,HEADACHE,64
DE,LEUKOPENIA,62
DE,ATRIAL SEPTAL DEFECT,61
DE,GAIT DISTURBANCE,60
DE,MYALGIA,60
DE,PAIN,60
DE,DRUG INEFFECTIVE,57
DE,OEDEMA PERIPHERAL,57
DE,URINARY TRACT INFECTION,56
DE,ACUTE MYOCARDIAL INFARCTION,55
DE,DEPRESSION,54
DE,DECREASED APPETITE,53
DE,HYPOTENSION,53
DE,HAEMORRHAGE,51
DE,PLEURAL EFFUSION,50
DE,ABDOMINAL PAIN,49
DE,CEREBRAL INFARCTION,49
DE,HAEMATOMA,49
DE,PULMONARY EMBOLISM,48
DE,CHEST PAIN,46
DE,COUGH,46
DE,PRURITUS,46
DE,ABDOMINAL PAIN UPPER,45
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,45
DE,BACK PAIN,44
DE,CORONARY ARTERY DISEASE,44
DE,DEHYDRATION,44
DE,SLEEP DISORDER,44
DE,ALANINE AMINOTRANSFERASE INCREASED,43
DE,CEREBRAL HAEMORRHAGE,43
DE,HEPATIC ENZYME INCREASED,43
DE,MUSCLE SPASMS,43
DE,RESPIRATORY FAILURE,43
DE,C-REACTIVE PROTEIN INCREASED,42
DE,MUSCULAR WEAKNESS,42
DE,RESTLESSNESS,41
DE,TRANSAMINASES INCREASED,41
DE,MALIGNANT NEOPLASM PROGRESSION,40
DE,CHILLS,39
DE,EPISTAXIS,39
DE,CONFUSIONAL STATE,38
DE,HYPERKINESIA,38
DE,RASH,38
DE,BLOOD PRESSURE INCREASED,37
DE,HYPONATRAEMIA,37
DE,SEIZURE,37
DE,ASPARTATE AMINOTRANSFERASE INCREASED,36
DE,ERYTHEMA,36
DE,HYPERKALAEMIA,36
DE,INFECTION,36
DE,LOSS OF CONSCIOUSNESS,36
DE,ANGINA PECTORIS,35
DE,CIRCULATORY COLLAPSE,35
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,34
DE,SUBDURAL HAEMATOMA,34
DE,CONSTIPATION,33
DE,DYSPHAGIA,33
DE,HYPOAESTHESIA,33
DE,HYPOGLYCAEMIA,33
DE,TRANSIENT ISCHAEMIC ATTACK,33
DE,VERTIGO,33
DE,BLOOD GLUCOSE INCREASED,32
DE,HEMIPARESIS,32
DE,HYPERTENSIVE CRISIS,32
DE,HYPOKALAEMIA,32
DE,PARAESTHESIA,32
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,31
DE,BLOOD PRESSURE DECREASED,31
DE,MALAISE,31
DE,CARDIAC ARREST,30
DE,HALLUCINATION,30
DE,POLYNEUROPATHY,30
DE,RHABDOMYOLYSIS,30
DE,SOMNOLENCE,30
DE,VISUAL IMPAIRMENT,30
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,29
DE,OVERDOSE,29
DE,SMALL FOR DATES BABY,29
DE,ANGIOEDEMA,28
DE,BASAL CELL CARCINOMA,28
DE,BRONCHITIS,28
DE,DRUG-INDUCED LIVER INJURY,28
DE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,28
DE,NASOPHARYNGITIS,28
DE,OSTEOARTHRITIS,28
DE,PANCYTOPENIA,28
DE,TOXICITY TO VARIOUS AGENTS,28
DE,TREMOR,28
DE,WHITE BLOOD CELL COUNT INCREASED,28
DE,ANXIETY,27
DE,DELIRIUM,27
DE,EPILEPSY,27
DE,MELAENA,27
DE,AKINESIA,26
DE,ARRHYTHMIA,26
DE,HYPERHIDROSIS,26
DE,INSOMNIA,26
DE,METABOLIC ACIDOSIS,26
DE,NEUTROPENIA,26
DE,SUICIDE ATTEMPT,26
DE,TACHYCARDIA,26
DE,TENDON RUPTURE,26
DE,WEIGHT INCREASED,26
DE,CARDIAC DISORDER,25
DE,DRUG INTOLERANCE,25
DE,VENTRICULAR FIBRILLATION,25
DE,APHASIA,24
DE,DISTURBANCE IN ATTENTION,24
DE,ERYSIPELAS,24
DE,HERPES ZOSTER,24
DE,OEDEMA,24
DE,PRODUCT USE IN UNAPPROVED INDICATION,24
DE,CONDITION AGGRAVATED,23
DE,DYSARTHRIA,23
DE,DYSPNOEA EXERTIONAL,23
DE,HEPATIC FAILURE,23
DE,MOBILITY DECREASED,23
DE,MUSCULOSKELETAL PAIN,23
DE,PERIPHERAL SWELLING,23
DE,CHOLESTASIS,22
DE,HOSPITALISATION,22
DE,LACERATION,22
DE,SKIN ULCER,22
DE,UPPER GASTROINTESTINAL HAEMORRHAGE,22
DE,VISION BLURRED,22
DE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,21
DE,LACTIC ACIDOSIS,21
DE,MEMORY IMPAIRMENT,21
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,21
DE,PULMONARY OEDEMA,21
DE,WOUND,21
DE,BLOOD ALKALINE PHOSPHATASE INCREASED,20
DE,EXPOSURE DURING PREGNANCY,20
DE,GASTRITIS,20
DE,IMPAIRED HEALING,20
DE,INFLAMMATION,20
DE,INTERVERTEBRAL DISC PROTRUSION,20
DE,KETOACIDOSIS,20
DE,MOVEMENT DISORDER,20
DE,RHEUMATOID ARTHRITIS,20
DE,ACUTE CORONARY SYNDROME,19
DE,ALOPECIA,19
DE,ASCITES,19
DE,DEPRESSED MOOD,19
DE,DISORIENTATION,19
DE,DRY MOUTH,19
DE,GLOMERULAR FILTRATION RATE DECREASED,19
DE,ISCHAEMIC STROKE,19
DE,NEONATAL RESPIRATORY DISTRESS SYNDROME,19
DE,PREMATURE BABY,19
DE,RED BLOOD CELL COUNT DECREASED,19
DE,SEPTIC SHOCK,19
DE,ACUTE HEPATIC FAILURE,18
DE,DEEP VEIN THROMBOSIS,18
DE,DEMENTIA,18
DE,GASTRIC ULCER,18
DE,ILEUS,18
DE,INFLAMMATORY MARKER INCREASED,18
DE,PANCREATITIS,18
DE,STAPHYLOCOCCAL INFECTION,18
DE,CHOLELITHIASIS,17
DE,CORONARY ARTERY STENOSIS,17
DE,HAEMATURIA,17
DE,HYPERGLYCAEMIA,17
DE,HYPOGLYCAEMIA NEONATAL,17
DE,PATENT DUCTUS ARTERIOSUS,17
DE,PRODUCT USE ISSUE,17
DE,SPEECH DISORDER,17
DE,AGGRESSION,16
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,16
DE,BRADYCARDIA,16
DE,CHEST DISCOMFORT,16
DE,CHRONIC KIDNEY DISEASE,16
DE,COLITIS,16
DE,DRUG ADMINISTRATION ERROR,16
DE,FEBRILE NEUTROPENIA,16
DE,GASTROOESOPHAGEAL REFLUX DISEASE,16
DE,INCORRECT DOSE ADMINISTERED,16
DE,PARKINSONISM,16
DE,PARKINSON^S DISEASE,16
DE,PRESCRIBED UNDERDOSE,16
DE,RENAL IMPAIRMENT,16
DE,SPLENOMEGALY,16
DE,URINARY RETENTION,16
DE,UROSEPSIS,16
DE,APATHY,15
DE,BALANCE DISORDER,15
DE,CARDIOVASCULAR DISORDER,15
DE,CEREBRAL ISCHAEMIA,15
DE,CONTRAINDICATED PRODUCT ADMINISTERED,15
DE,CYSTITIS,15
DE,DEVICE DISLOCATION,15
DE,DIVERTICULITIS,15
DE,HAEMOGLOBIN INCREASED,15
DE,JAUNDICE,15
DE,MATERNAL EXPOSURE DURING PREGNANCY,15
DE,MUCOSAL INFLAMMATION,15
DE,PERITONITIS,15
DE,SHOCK HAEMORRHAGIC,15
DE,VASODILATATION,15
DE,BLOOD SODIUM DECREASED,14
DE,CAROTID ARTERY STENOSIS,14
DE,DERMATITIS ALLERGIC,14
DE,DYSPEPSIA,14
DE,FACIAL BONES FRACTURE,14
DE,FOOT DEFORMITY,14
DE,HAEMATOCHEZIA,14
DE,HAEMORRHAGIC DIATHESIS,14
DE,HEPATIC CYST,14
DE,IRON DEFICIENCY ANAEMIA,14
DE,JOINT SWELLING,14
DE,LIVER DISORDER,14
DE,LYMPHADENOPATHY,14
DE,NERVOUSNESS,14
DE,OLIGOHYDRAMNIOS,14
DE,OXYGEN SATURATION DECREASED,14
DE,PERICARDIAL EFFUSION,14
DE,PLATELET COUNT INCREASED,14
DE,PNEUMONIA ASPIRATION,14
DE,PULMONARY HYPERTENSION,14
DE,RENAL FAILURE ACUTE,14
DE,RESPIRATORY DISORDER NEONATAL,14
DE,RESTLESS LEGS SYNDROME,14
DE,STOMATITIS,14
DE,TACHYARRHYTHMIA,14
DE,THROMBOCYTOPENIA NEONATAL,14
DE,ABDOMINAL DISTENSION,13
DE,COGNITIVE DISORDER,13
DE,COMA,13
DE,CONCOMITANT DISEASE AGGRAVATED,13
DE,CONTUSION,13
DE,FEEDING DISORDER NEONATAL,13
DE,HAEMATOCRIT DECREASED,13
DE,HAEMORRHAGE INTRACRANIAL,13
DE,HYPOSPADIAS,13
DE,JOINT STIFFNESS,13
DE,PANCREATITIS ACUTE,13
DE,RESPIRATORY DISTRESS,13
DE,SPINAL PAIN,13
DE,BLOOD BILIRUBIN INCREASED,12
DE,BOWEN^S DISEASE,12
DE,CATARACT,12
DE,CHOLANGITIS,12
DE,COAGULOPATHY,12
DE,CONJUNCTIVITIS,12
DE,DRY SKIN,12
DE,ELECTROCARDIOGRAM QT PROLONGED,12
DE,HEPATOTOXICITY,12
DE,INTRAVENTRICULAR HAEMORRHAGE,12
DE,IRRITABILITY,12
DE,LOWER GASTROINTESTINAL HAEMORRHAGE,12
DE,LUNG INFECTION,12
DE,NEUTROPHIL COUNT INCREASED,12
DE,OSTEOPOROSIS,12
DE,PALPITATIONS,12
DE,PNEUMOTHORAX,12
DE,PROSTATE CANCER,12
DE,PSORIASIS,12
DE,PULMONARY CONGESTION,12
DE,STOMA SITE DISCHARGE,12
DE,ANAEMIA OF MALIGNANT DISEASE,11
DE,ARTHRITIS,11
DE,BLOOD UREA INCREASED,11
DE,CORONARY ARTERY OCCLUSION,11
DE,DIABETES MELLITUS,11
DE,DISCOMFORT,11
DE,DYSMORPHISM,11
DE,EYE CONTUSION,11
DE,GINGIVAL BLEEDING,11
DE,HAEMATEMESIS,11
DE,HIATUS HERNIA,11
DE,HYPOKINESIA,11
DE,HYPOTHYROIDISM,11
DE,IRON DEFICIENCY,11
DE,LEUKOCYTOSIS,11
DE,LIPASE INCREASED,11
DE,NEUROPATHY PERIPHERAL,11
DE,NIGHT SWEATS,11
DE,PANCREATITIS NECROTISING,11
DE,PARTIAL SEIZURES,11
DE,PRODUCTIVE COUGH,11
DE,RAYNAUD^S PHENOMENON,11
DE,RECTAL HAEMORRHAGE,11
DE,RENAL CYST,11
DE,RESPIRATORY TRACT INFECTION,11
DE,SECOND PRIMARY MALIGNANCY,11
DE,SPINAL OSTEOARTHRITIS,11
DE,STENT PLACEMENT,11
DE,SUDDEN DEATH,11
DE,THROMBOSIS IN DEVICE,11
DE,URTICARIA,11
DE,ACTINIC KERATOSIS,10
DE,ANGINA UNSTABLE,10
DE,BONE PAIN,10
DE,BRAIN INJURY,10
DE,CARDIAC FAILURE CHRONIC,10
DE,CHOLECYSTITIS,10
DE,COLITIS ULCERATIVE,10
DE,DIASTOLIC DYSFUNCTION,10
DE,DIPLOPIA,10
DE,DISEASE PROGRESSION,10
DE,DRUG EFFECT DECREASED,10
DE,DRUG WITHDRAWAL CONVULSIONS,10
DE,ERECTILE DYSFUNCTION,10
DE,FEBRILE INFECTION,10
DE,FEELING ABNORMAL,10
DE,HEPATIC ENCEPHALOPATHY,10
DE,HYPERNATRAEMIA,10
DE,HYPERSENSITIVITY,10
DE,HYPOXIA,10
DE,INGUINAL HERNIA,10
DE,INTESTINAL HAEMORRHAGE,10
DE,LUNG DISORDER,10
DE,MITRAL VALVE INCOMPETENCE,10
DE,MULTI-ORGAN FAILURE,10
DE,ON AND OFF PHENOMENON,10
DE,OSTEONECROSIS OF JAW,10
DE,PERONEAL NERVE PALSY,10
DE,POST PROCEDURAL HAEMORRHAGE,10
DE,PULMONARY FIBROSIS,10
DE,SKIN EXFOLIATION,10
DE,SUBARACHNOID HAEMORRHAGE,10
DE,SUICIDAL IDEATION,10
DE,SWELLING FACE,10
DE,THROMBOSIS,10
DE,TINNITUS,10
DE,TYPE 2 DIABETES MELLITUS,10
DE,URINARY INCONTINENCE,10
DE,VENTRICULAR EXTRASYSTOLES,10
DE,VISUAL ACUITY REDUCED,10
DE,AGITATION,9
DE,AGRANULOCYTOSIS,9
DE,ARTERIOSCLEROSIS,9
DE,BENIGN PROSTATIC HYPERPLASIA,9
DE,BLOOD URIC ACID INCREASED,9
DE,BRONCHIAL CARCINOMA,9
DE,BUNDLE BRANCH BLOCK RIGHT,9
DE,BURSITIS,9
DE,CACHEXIA,9
DE,CELLULITIS,9
DE,COAGULATION DISORDER NEONATAL,9
DE,COMPARTMENT SYNDROME,9
DE,DERMATITIS EXFOLIATIVE,9
DE,DUODENAL ULCER,9
DE,DYSPHONIA,9
DE,EXTRAPYRAMIDAL DISORDER,9
DE,FEELING COLD,9
DE,GASTROENTERITIS,9
DE,GASTROINTESTINAL DISORDER,9
DE,HICCUPS,9
DE,HYPERLIPIDAEMIA,9
DE,HYPOCALCAEMIA,9
DE,METASTASES TO LIVER,9
DE,NASAL DRYNESS,9
DE,NEONATAL HYPOTENSION,9
DE,PLATELET COUNT DECREASED,9
DE,PLEUROTHOTONUS,9
DE,PNEUMONITIS,9
DE,PRECANCEROUS SKIN LESION,9
DE,PRESYNCOPE,9
DE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,9
DE,RASH GENERALISED,9
DE,RIB FRACTURE,9
DE,SALIVARY HYPERSECRETION,9
DE,SYSTEMIC LUPUS ERYTHEMATOSUS,9
DE,VASCULITIS,9
DE,ABDOMINAL DISCOMFORT,8
DE,ABDOMINAL PAIN LOWER,8
DE,AMNESIA,8
DE,AORTIC ARTERIOSCLEROSIS,8
DE,AORTIC VALVE STENOSIS,8
DE,ATYPICAL PNEUMONIA,8
DE,BLADDER CANCER,8
DE,BLEEDING TIME PROLONGED,8
DE,BLOOD CHOLESTEROL INCREASED,8
DE,BLOOD POTASSIUM INCREASED,8
DE,BLOOD PRESSURE SYSTOLIC INCREASED,8
DE,BONE MARROW FAILURE,8
DE,BRADYCARDIA NEONATAL,8
DE,BRAIN OEDEMA,8
DE,BUNDLE BRANCH BLOCK LEFT,8
DE,CARDIOGENIC SHOCK,8
DE,CHROMATURIA,8
DE,DEVELOPMENTAL HIP DYSPLASIA,8
DE,DISSEMINATED INTRAVASCULAR COAGULATION,8
DE,DRUG DOSE OMISSION,8
DE,EMBOLISM,8
DE,ENCEPHALOPATHY,8
DE,ESCHERICHIA URINARY TRACT INFECTION,8
DE,FACIAL PARESIS,8
DE,FAECALOMA,8
DE,FEELING HOT,8
DE,GASTRITIS EROSIVE,8
DE,GENERALISED TONIC-CLONIC SEIZURE,8
DE,GESTATIONAL DIABETES,8
DE,GLAUCOMA,8
DE,HAEMORRHAGIC ANAEMIA,8
DE,HAEMORRHOIDS,8
DE,HEPATIC CIRRHOSIS,8
DE,HEPATIC FUNCTION ABNORMAL,8
DE,HYDROCEPHALUS,8
DE,HYPERTHYROIDISM,8
DE,HYPOVOLAEMIC SHOCK,8
DE,INFLUENZA,8
DE,INTENTIONAL OVERDOSE,8
DE,INTERSTITIAL LUNG DISEASE,8
DE,LARGE FOR DATES BABY,8
DE,LEFT VENTRICULAR HYPERTROPHY,8
DE,LUNG INFILTRATION,8
DE,MALIGNANT MELANOMA,8
DE,MENTAL DISORDER,8
DE,MUSCLE ATROPHY,8
DE,MUSCLE RUPTURE,8
DE,NASAL CONGESTION,8
DE,NIGHTMARE,8
DE,ORTHOSTATIC INTOLERANCE,8
DE,OSTEOCHONDROSIS,8
DE,OSTEOMYELITIS,8
DE,OSTEONECROSIS,8
DE,PLASMA CELL MYELOMA,8
DE,PROTEINURIA,8
DE,PRURITUS GENERALISED,8
DE,PSYCHOTIC DISORDER,8
DE,RETINAL DETACHMENT,8
DE,ROTATOR CUFF SYNDROME,8
DE,SELECTIVE EATING DISORDER,8
DE,TACHYPNOEA,8
DE,TORSADE DE POINTES,8
DE,TRANSFUSION,8
DE,VIRAL INFECTION,8
DE,WHEEZING,8
DE,ALVEOLITIS,7
DE,ANAL INCONTINENCE,7
DE,ANAPHYLACTIC REACTION,7
DE,AORTIC VALVE INCOMPETENCE,7
DE,ARTERIAL OCCLUSIVE DISEASE,7
DE,ATELECTASIS,7
DE,ATRIAL FLUTTER,7
DE,BLISTER,7
DE,BLOOD CALCIUM DECREASED,7
DE,BLOOD PRESSURE FLUCTUATION,7
DE,BLOOD TEST ABNORMAL,7
DE,BRONCHOPULMONARY DYSPLASIA,7
DE,CANDIDA INFECTION,7
DE,CARDIAC FAILURE CONGESTIVE,7
DE,CARDIOMYOPATHY,7
DE,CEREBRAL ARTERY OCCLUSION,7
DE,CHRONIC GASTRITIS,7
DE,CREATININE RENAL CLEARANCE DECREASED,7
DE,DEVICE ISSUE,7
DE,DIVERTICULUM,7
DE,DRY EYE,7
DE,DYSPNOEA AT REST,7
DE,DYSURIA,7
DE,ECZEMA,7
DE,ENDOCARDITIS,7
DE,GASTRIC HAEMORRHAGE,7
DE,GASTROINTESTINAL INFECTION,7
DE,GLYCOSYLATED HAEMOGLOBIN INCREASED,7
DE,HAEMOPTYSIS,7
DE,HEART RATE INCREASED,7
DE,HEPATIC STEATOSIS,7
DE,HEPATITIS,7
DE,HYPOCHROMIC ANAEMIA,7
DE,HYPOTHERMIA,7
DE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,7
DE,INFLUENZA LIKE ILLNESS,7
DE,INTRACARDIAC THROMBUS,7
DE,MENISCUS INJURY,7
DE,METASTASES TO CENTRAL NERVOUS SYSTEM,7
DE,MYOPATHY,7
DE,NECK PAIN,7
DE,NEPHROGENIC ANAEMIA,7
DE,NON-ALCOHOLIC STEATOHEPATITIS,7
DE,ORAL CANDIDIASIS,7
DE,PERFORMANCE STATUS DECREASED,7
DE,PERIORBITAL HAEMATOMA,7
DE,POST PROCEDURAL COMPLICATION,7
DE,PRETERM PREMATURE RUPTURE OF MEMBRANES,7
DE,RENAL APLASIA,7
DE,RENAL CELL CARCINOMA,7
DE,RENAL DISORDER,7
DE,RENAL FUNCTION TEST ABNORMAL,7
DE,RESPIRATORY DISORDER,7
DE,RHINITIS,7
DE,SCIATICA,7
DE,SEDATION,7
DE,SINUS BRADYCARDIA,7
DE,SKIN DISORDER,7
DE,SKIN HAEMORRHAGE,7
DE,SPINAL DISORDER,7
DE,SQUAMOUS CELL CARCINOMA,7
DE,STOMA SITE INFLAMMATION,7
DE,SUBILEUS,7
DE,TENDONITIS,7
DE,THROMBOTIC THROMBOCYTOPENIC PURPURA,7
DE,TOXIC EPIDERMAL NECROLYSIS,7
DE,TRICUSPID VALVE INCOMPETENCE,7
DE,TRUNCUS ARTERIOSUS PERSISTENT,7
DE,UNRESPONSIVE TO STIMULI,7
DE,UPPER RESPIRATORY TRACT INFECTION,7
DE,VASCULAR STENT THROMBOSIS,7
DE,VENTRICULAR SEPTAL DEFECT,7
DE,WHITE BLOOD CELL COUNT DECREASED,7
DE,ACCESSORY SPLEEN,6
DE,ACCIDENT,6
DE,ACIDOSIS,6
DE,AGEUSIA,6
DE,ALLERGIC OEDEMA,6
DE,ANAL HAEMORRHAGE,6
DE,ANAL STENOSIS,6
DE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR FOETOPATHY,6
DE,AORTIC VALVE SCLEROSIS,6
DE,APPENDICITIS,6
DE,ARTHROPATHY,6
DE,ASTHMA,6
DE,ATAXIA,6
DE,ATRIOVENTRICULAR BLOCK,6
DE,BLOOD URINE PRESENT,6
DE,BODY TEMPERATURE INCREASED,6
DE,CARDIAC FAILURE ACUTE,6
DE,CAROTID ARTERY OCCLUSION,6
DE,CONGESTIVE CARDIOMYOPATHY,6
DE,CRYPTORCHISM,6
DE,DEAFNESS,6
DE,DEPRESSED LEVEL OF CONSCIOUSNESS,6
DE,DEVICE RELATED INFECTION,6
DE,DIABETES MELLITUS INADEQUATE CONTROL,6
DE,DRUG PRESCRIBING ERROR,6
DE,DYSGEUSIA,6
DE,DYSKINESIA,6
DE,EAR NEOPLASM MALIGNANT,6
DE,EMPHYSEMA,6
DE,EXTREMITY NECROSIS,6
DE,EYELID OEDEMA,6
DE,FLANK PAIN,6
DE,FLATULENCE,6
DE,FLUSHING,6
DE,FOOD INTERACTION,6
DE,GASTROINTESTINAL OEDEMA,6
DE,GOUT,6
DE,HAEMORRHOIDAL HAEMORRHAGE,6
DE,HALLUCINATION_ VISUAL,6
DE,HEART RATE DECREASED,6
DE,HEMIPLEGIA,6
DE,HEPATITIS CHOLESTATIC,6
DE,HEPATOMEGALY,6
DE,HYPERCALCAEMIA,6
DE,HYPERURICAEMIA,6
DE,HYPOTONIA,6
DE,INJECTION SITE PAIN,6
DE,INTENTIONAL PRODUCT MISUSE,6
DE,INTENTIONAL PRODUCT USE ISSUE,6
DE,INTRACRANIAL PRESSURE INCREASED,6
DE,JOINT CONTRACTURE,6
DE,JOINT DISLOCATION,6
DE,LACRIMATION INCREASED,6
DE,LARGE INTESTINE POLYP,6
DE,LIP SWELLING,6
DE,LIVER FUNCTION TEST ABNORMAL,6
DE,LYMPHOCYTE COUNT DECREASED,6
DE,LYMPHOPENIA,6
DE,METASTASES TO BONE,6
DE,METASTASES TO LUNG,6
DE,MOUTH HAEMORRHAGE,6
DE,MUSCLE ABSCESS,6
DE,MYELODYSPLASTIC SYNDROME,6
DE,NOCTURIA,6
DE,ORAL HERPES,6
DE,OROPHARYNGEAL PAIN,6
DE,ORTHOPNOEA,6
DE,PERIPHERAL VASCULAR DISORDER,6
DE,PERSISTENT FOETAL CIRCULATION,6
DE,PHOTOPHOBIA,6
DE,PNEUMONIA BACTERIAL,6
DE,POISONING,6
DE,PULMONARY ARTERY STENOSIS,6
DE,PULMONARY HYPOPLASIA,6
DE,PULMONARY TOXICITY,6
DE,RASH MACULO-PAPULAR,6
DE,RETINAL HAEMORRHAGE,6
DE,RHEUMATIC DISORDER,6
DE,SINOATRIAL BLOCK,6
DE,SINUS NODE DYSFUNCTION,6
DE,SKIN BURNING SENSATION,6
DE,SMALL CELL LUNG CANCER,6
DE,STRESS,6
DE,SUDDEN HEARING LOSS,6
DE,SURGERY,6
DE,SWOLLEN TONGUE,6
DE,TROPONIN INCREASED,6
DE,UNDERDOSE,6
DE,VASCULAR PSEUDOANEURYSM,6
DE,VITAMIN B12 DEFICIENCY,6
DE,ABORTION MISSED,5
DE,ABSCESS,5
DE,ALTERED STATE OF CONSCIOUSNESS,5
DE,ARTERIAL HAEMORRHAGE,5
DE,ARTERIOSCLEROSIS CORONARY ARTERY,5
DE,ASPIRATION,5
DE,ATRIOVENTRICULAR BLOCK COMPLETE,5
DE,AUTOIMMUNE HEPATITIS,5
DE,BLOOD POTASSIUM DECREASED,5
DE,BODY TEMPERATURE DECREASED,5
DE,BORDERLINE PERSONALITY DISORDER,5
DE,BREAST CANCER,5
DE,CAESAREAN SECTION,5
DE,CENTRAL NERVOUS SYSTEM INFLAMMATION,5
DE,CEREBRAL MICROANGIOPATHY,5
DE,COARCTATION OF THE AORTA,5
DE,COLD SWEAT,5
DE,CYANOSIS,5
DE,DERMATITIS,5
DE,DIVERTICULUM INTESTINAL,5
DE,DRUG RESISTANCE,5
DE,DYSSTASIA,5
DE,EJECTION FRACTION DECREASED,5
DE,EOSINOPHILIA,5
DE,FAECES DISCOLOURED,5
DE,FAECES PALE,5
DE,FLUID RETENTION,5
DE,FOETAL GROWTH RESTRICTION,5
DE,FOLATE DEFICIENCY,5
DE,FUNGAL INFECTION,5
DE,GASTROINTESTINAL INFLAMMATION,5
DE,GROIN PAIN,5
DE,HAEMANGIOMA CONGENITAL,5
DE,HELICOBACTER GASTRITIS,5
DE,HEMIANOPIA,5
DE,HEPATIC NECROSIS,5
DE,HEPATITIS FULMINANT,5
DE,HEPATOCELLULAR INJURY,5
DE,HIGH ARCHED PALATE,5
DE,HYPERFERRITINAEMIA,5
DE,HYPOCALVARIA,5
DE,HYPOPHAGIA,5
DE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,5
DE,INFUSION RELATED REACTION,5
DE,INTERMITTENT CLAUDICATION,5
DE,INTRACRANIAL ANEURYSM,5
DE,LACRIMAL DISORDER,5
DE,LUMBAR SPINAL STENOSIS,5
DE,LUMBAR VERTEBRAL FRACTURE,5
DE,MACULAR OEDEMA,5
DE,MAGNESIUM DEFICIENCY,5
DE,MALLORY-WEISS SYNDROME,5
DE,MICTURITION URGENCY,5
DE,MULTIPLE SCLEROSIS RELAPSE,5
DE,MUSCULOSKELETAL DISCOMFORT,5
DE,MUSCULOSKELETAL STIFFNESS,5
DE,MYELOFIBROSIS,5
DE,NECROSIS,5
DE,NEUTROPENIC SEPSIS,5
DE,NO THERAPEUTIC RESPONSE,5
DE,OCULAR ICTERUS,5
DE,PACKED RED BLOOD CELL TRANSFUSION,5
DE,PALLOR,5
DE,PANCREATIC CARCINOMA,5
DE,PANIC ATTACK,5
DE,PAPILLOEDEMA,5
DE,PERIPHERAL SENSORY NEUROPATHY,5
DE,PERSONALITY CHANGE,5
DE,PLACENTAL INSUFFICIENCY,5
DE,PLEURISY,5
DE,PORTAL FIBROSIS,5
DE,PROSTATITIS,5
DE,PULMONARY MASS,5
DE,RASH PUSTULAR,5
DE,RED CELL DISTRIBUTION WIDTH INCREASED,5
DE,RESUSCITATION,5
DE,SENSORY DISTURBANCE,5
DE,SERUM FERRITIN INCREASED,5
DE,SEXUAL DYSFUNCTION,5
DE,SKIN DISCOLOURATION,5
DE,SKIN REACTION,5
DE,SUBCUTANEOUS ABSCESS,5
DE,SUBCUTANEOUS HAEMATOMA,5
DE,SUPRAVENTRICULAR EXTRASYSTOLES,5
DE,SWELLING,5
DE,THALAMIC INFARCTION,5
DE,THERAPEUTIC RESPONSE SHORTENED,5
DE,UPPER LIMB FRACTURE,5
DE,URINARY BLADDER HAEMORRHAGE,5
DE,VENTRICULAR TACHYCARDIA,5
DE,WOUND HAEMORRHAGE,5
DE,ABASIA,4
DE,ABSCESS LIMB,4
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,4
DE,ACUTE MYELOID LEUKAEMIA,4
DE,ADENOCARCINOMA OF COLON,4
DE,ALVEOLITIS ALLERGIC,4
DE,ANAPHYLACTIC SHOCK,4
DE,ARTERIAL STENOSIS,4
DE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,4
DE,BACTERIAL INFECTION,4
DE,BEDRIDDEN,4
DE,BICYTOPENIA,4
DE,BLOOD CHLORIDE DECREASED,4
DE,BLOOD GLUCOSE DECREASED,4
DE,BLOOD IRON DECREASED,4
DE,BLOOD TRIGLYCERIDES INCREASED,4
DE,BONE MARROW OEDEMA,4
DE,BRAIN STEM INFARCTION,4
DE,BRONCHITIS BACTERIAL,4
DE,CARDIAC DISCOMFORT,4
DE,CARDIOMEGALY,4
DE,CARDIOVASCULAR INSUFFICIENCY,4
DE,CARDIOVERSION,4
DE,CARPAL TUNNEL SYNDROME,4
DE,CHEST X-RAY ABNORMAL,4
DE,CLOSTRIDIUM DIFFICILE COLITIS,4
DE,CLOSTRIDIUM DIFFICILE INFECTION,4
DE,COORDINATION ABNORMAL,4
DE,DECUBITUS ULCER,4
DE,DEVICE OCCLUSION,4
DE,DIABETIC FOOT,4
DE,DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA,4
DE,DIABETIC NEUROPATHY,4
DE,DIARRHOEA HAEMORRHAGIC,4
DE,DIVERTICULUM INTESTINAL HAEMORRHAGIC,4
DE,DRUG ERUPTION,4
DE,DRUG WITHDRAWAL SYNDROME NEONATAL,4
DE,EMBOLIC CEREBRAL INFARCTION,4
DE,EMBOLIC STROKE,4
DE,ENTERITIS,4
DE,ENURESIS,4
DE,EOSINOPHIL COUNT INCREASED,4
DE,EPIGASTRIC DISCOMFORT,4
DE,ESCHERICHIA INFECTION,4
DE,EXTRASYSTOLES,4
DE,EYE HAEMORRHAGE,4
DE,FEMORAL NECK FRACTURE,4
DE,FEMUR FRACTURE,4
DE,FOETAL HEART RATE DECELERATION ABNORMALITY,4
DE,FORCED EXPIRATORY VOLUME DECREASED,4
DE,GASTROENTERITIS NOROVIRUS,4
DE,GENERAL PHYSICAL CONDITION ABNORMAL,4
DE,GOITRE,4
DE,GYNAECOMASTIA,4
DE,HAEMOTHORAX,4
DE,HEAD INJURY,4
DE,HELICOBACTER INFECTION,4
DE,HEPATIC LESION,4
DE,HEPATITIS ACUTE,4
DE,HOT FLUSH,4
DE,HYPERCHOLESTEROLAEMIA,4
DE,HYPERKERATOSIS,4
DE,HYPERTONIA,4
DE,HYPOACUSIS,4
DE,HYPOTONIA NEONATAL,4
DE,IDIOPATHIC PULMONARY FIBROSIS,4
DE,ILEUS PARALYTIC,4
DE,INCISIONAL HERNIA,4
DE,INFANTILE APNOEA,4
DE,INFANTILE HAEMANGIOMA,4
DE,INFECTION SUSCEPTIBILITY INCREASED,4
DE,INJECTION SITE SWELLING,4
DE,INSULIN C-PEPTIDE DECREASED,4
DE,INTERNATIONAL NORMALISED RATIO INCREASED,4
DE,IRON OVERLOAD,4
DE,ISCHAEMIC CEREBRAL INFARCTION,4
DE,JOINT INJURY,4
DE,LARGE INTESTINE PERFORATION,4
DE,LEFT ATRIAL DILATATION,4
DE,LEFT VENTRICULAR DYSFUNCTION,4
DE,LEUKOCYTURIA,4
DE,LEUKOENCEPHALOPATHY,4
DE,LIMB DISCOMFORT,4
DE,LOW BIRTH WEIGHT BABY,4
DE,LOW DENSITY LIPOPROTEIN INCREASED,4
DE,LUNG ADENOCARCINOMA,4
DE,LYMPHOEDEMA,4
DE,MAJOR DEPRESSION,4
DE,MEAN CELL HAEMOGLOBIN DECREASED,4
DE,MEDICATION ERROR,4
DE,METASTASES TO LYMPH NODES,4
DE,METASTATIC MALIGNANT MELANOMA,4
DE,MICROANGIOPATHY,4
DE,MICTURITION DISORDER,4
DE,MONOPARESIS,4
DE,MOTOR DYSFUNCTION,4
DE,MUSCLE DISORDER,4
DE,MUSCLE RIGIDITY,4
DE,MUSCLE SPASTICITY,4
DE,NAIL DISORDER,4
DE,NERVOUS SYSTEM DISORDER,4
DE,NON-SMALL CELL LUNG CANCER,4
DE,NORMOCHROMIC NORMOCYTIC ANAEMIA,4
DE,OEDEMA NEONATAL,4
DE,ONYCHOMYCOSIS,4
DE,ORAL DISORDER,4
DE,PARAPLEGIA,4
DE,PELVIC FRACTURE,4
DE,PERIPHERAL ARTERY STENOSIS,4
DE,PETECHIAE,4
DE,PHARYNGEAL HAEMORRHAGE,4
DE,PHOTOSENSITIVITY REACTION,4
DE,POLYMYALGIA RHEUMATICA,4
DE,PRE-ECLAMPSIA,4
DE,PREMATURE LABOUR,4
DE,PROCALCITONIN INCREASED,4
DE,PROCEDURAL COMPLICATION,4
DE,PROSTATOMEGALY,4
DE,PSEUDOMONAS INFECTION,4
DE,PULMONARY HAEMORRHAGE,4
DE,PULMONARY SEPSIS,4
DE,PULSE ABSENT,4
DE,QUADRIPARESIS,4
DE,REBOUND EFFECT,4
DE,RECTAL CANCER,4
DE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,4
DE,RIGHT VENTRICULAR FAILURE,4
DE,ROAD TRAFFIC ACCIDENT,4
DE,SCHIZOAFFECTIVE DISORDER,4
DE,SCOLIOSIS,4
DE,SHOCK,4
DE,SINUS TACHYCARDIA,4
DE,SKIN INFECTION,4
DE,SLEEP APNOEA SYNDROME,4
DE,STEVENS-JOHNSON SYNDROME,4
DE,STOMA SITE ERYTHEMA,4
DE,STOMA SITE HAEMORRHAGE,4
DE,STOMA SITE INFECTION,4
DE,SUPRAVENTRICULAR TACHYCARDIA,4
DE,SYNOVITIS,4
DE,TEMPERATURE REGULATION DISORDER,4
DE,TENDON PAIN,4
DE,TENSION HEADACHE,4
DE,THIRST,4
DE,THORACIC VERTEBRAL FRACTURE,4
DE,THROMBOCYTOSIS,4
DE,TOOTH ABSCESS,4
DE,TOOTH DISORDER,4
DE,TRAUMATIC HAEMORRHAGE,4
DE,TROPONIN T INCREASED,4
DE,UNINTENTIONAL MEDICAL DEVICE REMOVAL,4
DE,URETHRAL HAEMORRHAGE,4
DE,VAGINAL HAEMORRHAGE,4
DE,VASCULAR OCCLUSION,4
DE,VISUAL FIELD DEFECT,4
DE,WOUND INFECTION,4
DE,ABDOMINAL HERNIA,3
DE,ABDOMINAL WALL HAEMATOMA,3
DE,ABNORMAL BEHAVIOUR,3
DE,ABNORMAL FAECES,3
DE,ABORTION SPONTANEOUS,3
DE,ACNE,3
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED,3
DE,ACUTE RESPIRATORY DISTRESS SYNDROME,3
DE,ADVERSE DRUG REACTION,3
DE,ADVERSE EVENT,3
DE,ANGIOPATHY,3
DE,ANGIOPLASTY,3
DE,AORTIC ANEURYSM,3
DE,AORTIC DISSECTION,3
DE,AORTIC VALVE DISEASE,3
DE,APNOEA,3
DE,BACTERIAL TEST POSITIVE,3
DE,BALANITIS CANDIDA,3
DE,BLADDER DISORDER,3
DE,BLINDNESS UNILATERAL,3
DE,BLOOD ALBUMIN DECREASED,3
DE,BLOOD CREATINE INCREASED,3
DE,BLOOD DISORDER,3
DE,BLOOD FIBRINOGEN INCREASED,3
DE,BLOOD PRESSURE ABNORMAL,3
DE,BONE MARROW TOXICITY,3
DE,BRADYKINESIA,3
DE,BRAIN NATRIURETIC PEPTIDE INCREASED,3
DE,CANCER PAIN,3
DE,CARDIAC TAMPONADE,3
DE,CARDIAC VENTRICULAR THROMBOSIS,3
DE,CARDIO-RESPIRATORY ARREST,3
DE,CAROTID ARTERIOSCLEROSIS,3
DE,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY,3
DE,COAGULATION TEST ABNORMAL,3
DE,COLITIS ISCHAEMIC,3
DE,COLON ADENOMA,3
DE,COMPLETED SUICIDE,3
DE,CONVULSION,3
DE,COR PULMONALE,3
DE,CORONARY ARTERIAL STENT INSERTION,3
DE,CORONARY ARTERY THROMBOSIS,3
DE,CREATININE RENAL CLEARANCE INCREASED,3
DE,CRYING,3
DE,CSF PROTEIN INCREASED,3
DE,CUBITAL TUNNEL SYNDROME,3
DE,DERMAL CYST,3
DE,DIABETIC NEPHROPATHY,3
DE,DISEASE RECURRENCE,3
DE,DIVERTICULAR PERFORATION,3
DE,DIZZINESS POSTURAL,3
DE,DOUBLE STRANDED DNA ANTIBODY POSITIVE,3
DE,DRUG HYPERSENSITIVITY,3
DE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
DE,DRUG LEVEL INCREASED,3
DE,DUODENAL ULCER HAEMORRHAGE,3
DE,DUODENITIS,3
DE,DYSAESTHESIA,3
DE,DYSPNOEA PAROXYSMAL NOCTURNAL,3
DE,ENTEROCOLITIS,3
DE,ERYTHEMA NODOSUM,3
DE,ESCHERICHIA SEPSIS,3
DE,EYE INFLAMMATION,3
DE,FACIAL PARALYSIS,3
DE,FEAR,3
DE,FLUID INTAKE REDUCED,3
DE,FRACTURE DELAYED UNION,3
DE,FREEZING PHENOMENON,3
DE,GANGRENE,3
DE,GASTRIC CYST,3
DE,GASTROENTERITIS CLOSTRIDIAL,3
DE,GASTROINTESTINAL NECROSIS,3
DE,GRAFT VERSUS HOST DISEASE,3
DE,HAEMATOTOXICITY,3
DE,HAEMORRHAGE SUBCUTANEOUS,3
DE,HAEMORRHAGIC INFARCTION,3
DE,HALLUCINATION_ AUDITORY,3
DE,HAND FRACTURE,3
DE,HEAD DISCOMFORT,3
DE,HEPATORENAL SYNDROME,3
DE,HERPES VIRUS INFECTION,3
DE,HYPERCOAGULATION,3
DE,HYPOAESTHESIA ORAL,3
DE,HYPOALBUMINAEMIA,3
DE,IMMUNE THROMBOCYTOPENIC PURPURA,3
DE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
DE,INCONTINENCE,3
DE,INFARCTION,3
DE,INTENSIVE CARE UNIT ACQUIRED WEAKNESS,3
DE,INTERVERTEBRAL DISCITIS,3
DE,INTRAOCULAR PRESSURE INCREASED,3
DE,ISCHAEMIA,3
DE,JAW DISORDER,3
DE,JOINT EFFUSION,3
DE,KNEE ARTHROPLASTY,3
DE,LANGUAGE DISORDER,3
DE,LEFT VENTRICULAR ENLARGEMENT,3
DE,LERICHE SYNDROME,3
DE,LIPID METABOLISM DISORDER,3
DE,LONG QT SYNDROME,3
DE,MALIGNANT PERITONEAL NEOPLASM,3
DE,MALNUTRITION,3
DE,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,3
DE,MEAN CELL VOLUME INCREASED,3
DE,MIGRAINE,3
DE,MONOCYTE COUNT INCREASED,3
DE,MULTIPLE SCLEROSIS,3
DE,MUSCLE ENZYME INCREASED,3
DE,MUSCLE TIGHTNESS,3
DE,MUSCULOSKELETAL CHEST PAIN,3
DE,MYOCARDIAL ISCHAEMIA,3
DE,MYOCARDITIS,3
DE,MYOGLOBIN BLOOD INCREASED,3
DE,NEOPLASM SKIN,3
DE,NEPHROTIC SYNDROME,3
DE,NERVE INJURY,3
DE,NEUTROPHILIA,3
DE,NODULE,3
DE,NUCLEAR MAGNETIC RESONANCE IMAGING SPINAL ABNORMAL,3
DE,OBESITY,3
DE,OCULAR HYPERAEMIA,3
DE,OESOPHAGEAL CANDIDIASIS,3
DE,OESOPHAGEAL ULCER,3
DE,ORGAN FAILURE,3
DE,ORTHOSTATIC HYPOTENSION,3
DE,OSTEOLYSIS,3
DE,OSTEOPENIA,3
GR,EXPOSURE DURING PREGNANCY,7
GR,PREMATURE DELIVERY,7
GR,DEATH,5
GR,HYPOTENSION,5
GR,SEROTONIN SYNDROME,5
GR,DERMATITIS EXFOLIATIVE,4
GR,DYSPNOEA,4
GR,FATIGUE,4
GR,OEDEMA PERIPHERAL,4
GR,CONSTIPATION,3
GR,DIZZINESS,3
GR,HAEMATOCRIT DECREASED,3
GR,MYOCARDIAL ISCHAEMIA,3
GR,RENAL FAILURE ACUTE,3
GR,ABDOMINAL PAIN,2
GR,ANGIOEDEMA,2
GR,AORTIC VALVE INCOMPETENCE,2
GR,ASTHENIA,2
GR,BLOOD CREATININE INCREASED,2
GR,CARDIAC FAILURE CONGESTIVE,2
GR,CEREBROVASCULAR ACCIDENT,2
GR,CORONARY ARTERY ANEURYSM,2
GR,DRUG HYPERSENSITIVITY,2
GR,GASTRIC HAEMORRHAGE,2
GR,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
GR,HAEMODYNAMIC INSTABILITY,2
GR,HYPERKALAEMIA,2
GR,HYPONATRAEMIA,2
GR,JUVENILE IDIOPATHIC ARTHRITIS,2
GR,MITRAL VALVE INCOMPETENCE,2
GR,NEUROPATHY PERIPHERAL,2
GR,PALLOR,2
GR,PYREXIA,2
GR,RASH PRURITIC,2
GR,RENAL IMPAIRMENT,2
GR,RESPIRATORY TRACT INFECTION,2
GR,THROMBOCYTOPENIA,2
GR,THROMBOSIS,2
GR,ABDOMINAL PAIN UPPER,1
GR,ACUTE CORONARY SYNDROME,1
GR,ACUTE MYOCARDIAL INFARCTION,1
GR,ALVEOLAR OXYGEN PARTIAL PRESSURE DECREASED,1
GR,AMYLOIDOSIS,1
GR,ANAEMIA,1
GR,ANGINA PECTORIS,1
GR,APLASTIC ANAEMIA,1
GR,ARRHYTHMIA,1
GR,ASCITES,1
GR,ASPIRATION,1
GR,ATRIAL FIBRILLATION,1
GR,ATRIAL FLUTTER,1
GR,ATRIAL TACHYCARDIA,1
GR,ATRIOVENTRICULAR BLOCK,1
GR,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
GR,BLINDNESS,1
GR,BLOOD GLUCOSE INCREASED,1
GR,BLOOD LACTIC ACID INCREASED,1
GR,BLOOD PRESSURE DECREASED,1
GR,BONE MARROW FAILURE,1
GR,BRADYCARDIA,1
GR,BRAIN NATRIURETIC PEPTIDE INCREASED,1
GR,CARDIAC ARREST,1
GR,CARDIAC TAMPONADE,1
GR,CARDIO-RESPIRATORY ARREST,1
GR,CEREBRAL VENTRICLE DILATATION,1
GR,CHILLS,1
GR,CONDITION AGGRAVATED,1
GR,CONGENITAL CEREBELLAR AGENESIS,1
GR,CORONARY ARTERY DILATATION,1
GR,CORONARY ARTERY DISEASE,1
GR,COUGH,1
GR,CROSS SENSITIVITY REACTION,1
GR,DEEP VEIN THROMBOSIS,1
GR,DENTAL NECROSIS,1
GR,DIABETES MELLITUS,1
GR,DIARRHOEA,1
GR,DISEASE PROGRESSION,1
GR,DIVERTICULAR PERFORATION,1
GR,DRESSLER^S SYNDROME,1
GR,DRUG INEFFECTIVE,1
GR,DRUG RESISTANCE,1
GR,DYSPNOEA EXERTIONAL,1
GR,ENTERITIS,1
GR,ENTEROVESICAL FISTULA,1
GR,ERYTHEMA,1
GR,EXFOLIATIVE RASH,1
GR,FEBRILE NEUTROPENIA,1
GR,GASTROINTESTINAL HAEMORRHAGE,1
GR,GENERAL PHYSICAL HEALTH DETERIORATION,1
GR,HAEMATURIA,1
GR,HAEMODIALYSIS,1
GR,HAEMOPTYSIS,1
GR,HYPERGLYCAEMIA,1
GR,HYPERHIDROSIS,1
GR,HYPERSENSITIVITY,1
GR,HYPOCALCAEMIA,1
GR,HYPOKALAEMIA,1
GR,HYPOVOLAEMIA,1
GR,INFECTION,1
GR,INFLAMMATORY MARKER INCREASED,1
GR,ISCHAEMIC CEREBRAL INFARCTION,1
GR,ISCHAEMIC STROKE,1
GR,LARGE INTESTINAL HAEMORRHAGE,1
GR,LIMB REDUCTION DEFECT,1
GR,LOSS OF CONSCIOUSNESS,1
GR,MALAISE,1
GR,MATERNAL EXPOSURE DURING PREGNANCY,1
GR,MELAENA,1
GR,METABOLIC ACIDOSIS,1
GR,MICROALBUMINURIA,1
GR,MUSCULAR WEAKNESS,1
GR,MYALGIA,1
GR,MYOCARDIAL INFARCTION,1
GR,NEPHROPATHY TOXIC,1
GR,NEUROMYOPATHY,1
GR,NEUTROPENIA,1
GR,NOSOCOMIAL INFECTION,1
GR,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,1
GR,ORTHOSTATIC HYPOTENSION,1
GR,PANCREATITIS ACUTE,1
GR,PELVIC HAEMATOMA,1
GR,PEMPHIGOID,1
GR,PLASMA CELL MYELOMA,1
GR,PLATELET COUNT DECREASED,1
GR,PNEUMONIA,1
GR,POLYDIPSIA,1
GR,POLYURIA,1
GR,PULMONARY ARTERIAL HYPERTENSION,1
GR,PULMONARY CONGESTION,1
GR,PULSE ABSENT,1
GR,PURPURA,1
GR,RASH,1
GR,RENAL FAILURE,1
GR,RENAL INJURY,1
GR,RETINAL VEIN THROMBOSIS,1
GR,RETINOPATHY,1
GR,RHABDOMYOLYSIS,1
GR,RIGHT VENTRICULAR FAILURE,1
GR,SHOCK HAEMORRHAGIC,1
GR,SINUS BRADYCARDIA,1
GR,SKELETAL DYSPLASIA,1
GR,SKIN EXFOLIATION,1
GR,SKIN OEDEMA,1
GR,SUDDEN DEATH,1
GR,SUPRAPUBIC PAIN,1
GR,SYNCOPE,1
GR,THERAPEUTIC RESPONSE DECREASED,1
GR,THERAPY CHANGE,1
GR,THROMBOCYTOSIS,1
GR,TROPONIN INCREASED,1
GR,TYPE I HYPERSENSITIVITY,1
GR,URINARY RETENTION,1
GR,URTICARIA,1
GR,VERTIGO,1
GR,VOMITING,1
GR,WEIGHT DECREASED,1
GR,WHITE BLOOD CELL COUNT DECREASED,1
GR,WITHDRAWAL SYNDROME,1
GT,DYSPNOEA,2
GT,MALAISE,2
GT,ASPHYXIA,1
GT,CARDIAC DISORDER,1
GT,CEREBROVASCULAR ACCIDENT,1
GT,COUGH,1
GT,DISCOMFORT,1
GT,DIZZINESS,1
GT,EPISTAXIS,1
GT,FATIGUE,1
GT,GAIT DISTURBANCE,1
GT,GINGIVAL BLEEDING,1
GT,HEAD DISCOMFORT,1
GT,HYPOTENSION,1
GT,INFARCTION,1
GT,MEMORY IMPAIRMENT,1
GT,MYOCARDIAL INFARCTION,1
GT,NON-HODGKIN^S LYMPHOMA,1
GT,PNEUMONIA,1
GT,PRESCRIBED UNDERDOSE,1
GT,PRODUCT USE IN UNAPPROVED INDICATION,1
GT,PRODUCTIVE COUGH,1
GT,SPEECH DISORDER,1
GT,SUDDEN DEATH,1
GT,WEIGHT DECREASED,1
HN,BRAIN HYPOXIA,1
HN,CAROTID ARTERY CALCIFICATION,1
HN,CHOLELITHIASIS,1
HN,DIZZINESS,1
HN,HYPERTHYROIDISM,1
HN,HYPOACUSIS,1
HN,METABOLIC ACIDOSIS,1
HN,PROSTATIC OBSTRUCTION,1
HN,RENAL FAILURE,1
HN,UTERINE OPERATION,1
HK,DYSPNOEA,5
HK,VOMITING,5
HK,TOXICITY TO VARIOUS AGENTS,4
HK,ABDOMINAL DISTENSION,2
HK,ABDOMINAL WALL HAEMATOMA,2
HK,ACUTE KIDNEY INJURY,2
HK,CARDIAC ARREST,2
HK,DECREASED APPETITE,2
HK,DIARRHOEA,2
HK,GAIT DISTURBANCE,2
HK,HAEMATURIA,2
HK,HAEMODYNAMIC INSTABILITY,2
HK,MULTI-ORGAN FAILURE,2
HK,NAUSEA,2
HK,NEUROPATHY PERIPHERAL,2
HK,OEDEMA PERIPHERAL,2
HK,PERITONEAL HAEMORRHAGE,2
HK,PNEUMONIA,2
HK,POLYMYOSITIS,2
HK,RENAL FAILURE ACUTE,2
HK,SHOCK,2
HK,ABDOMINAL PAIN,1
HK,ABDOMINAL PAIN UPPER,1
HK,ADENOCARCINOMA GASTRIC,1
HK,ANAEMIA,1
HK,ANGINA PECTORIS,1
HK,APLASIA PURE RED CELL,1
HK,BLOOD CREATININE INCREASED,1
HK,BLOOD SODIUM INCREASED,1
HK,BLOOD UREA INCREASED,1
HK,BRAIN CANCER METASTATIC,1
HK,CARDIAC NEOPLASM UNSPECIFIED,1
HK,CARDIOMEGALY,1
HK,CELLULITIS,1
HK,CHEST PAIN,1
HK,COAGULOPATHY,1
HK,COUGH,1
HK,CRANIOCEREBRAL INJURY,1
HK,CYTOMEGALOVIRUS CHORIORETINITIS,1
HK,DEATH,1
HK,DEHYDRATION,1
HK,DEPOSIT EYE,1
HK,DISEASE PROGRESSION,1
HK,DIZZINESS,1
HK,DRUG DISPENSING ERROR,1
HK,DRY MOUTH,1
HK,ECZEMA,1
HK,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
HK,ENCEPHALITIS,1
HK,EROSIVE DUODENITIS,1
HK,ERUCTATION,1
HK,FALL,1
HK,GASTRITIS,1
HK,GASTROINTESTINAL STROMAL TUMOUR,1
HK,GENERALISED OEDEMA,1
HK,HAEMATEMESIS,1
HK,HAEMOGLOBIN DECREASED,1
HK,HAEMOPTYSIS,1
HK,HALLUCINATION,1
HK,HALLUCINATION_ VISUAL,1
HK,HERBAL INTERACTION,1
HK,HICCUPS,1
HK,HYPERBILIRUBINAEMIA,1
HK,HYPERGLYCAEMIA,1
HK,HYPOGLYCAEMIA,1
HK,IMPAIRED HEALING,1
HK,INSOMNIA,1
HK,JAUNDICE,1
HK,JOINT INJURY,1
HK,LUNG NEOPLASM MALIGNANT,1
HK,MALAISE,1
HK,MALIGNANT NEOPLASM PROGRESSION,1
HK,METABOLIC ENCEPHALOPATHY,1
HK,NEPHROGENIC DIABETES INSIPIDUS,1
HK,NEUROTOXICITY,1
HK,OESOPHAGITIS HAEMORRHAGIC,1
HK,ORTHOPNOEA,1
HK,OVERDOSE,1
HK,PALLOR,1
HK,PALPITATIONS,1
HK,PANCREATITIS,1
HK,PERIPHERAL VASCULAR DISORDER,1
HK,PLATELET COUNT DECREASED,1
HK,PLEURAL EFFUSION,1
HK,PULMONARY CONGESTION,1
HK,PULMONARY OEDEMA,1
HK,RECTAL CANCER,1
HK,RENAL DISORDER,1
HK,RENAL IMPAIRMENT,1
HK,RETROPERITONEAL HAEMATOMA,1
HK,ROTATOR CUFF SYNDROME,1
HK,SICK SINUS SYNDROME,1
HK,SOMNOLENCE,1
HK,SUBDURAL EFFUSION,1
HK,SUPERINFECTION,1
HK,SYNCOPE,1
HK,THROMBOCYTOPENIA,1
HK,THROMBOSIS IN DEVICE,1
HK,TUMOUR RUPTURE,1
HK,UPPER GASTROINTESTINAL HAEMORRHAGE,1
HK,VERTIGO,1
HK,VESSEL PUNCTURE SITE HAEMATOMA,1
HK,VISION BLURRED,1
HK,WEIGHT DECREASED,1
HK,WOUND INFECTION FUNGAL,1
HK,ZYGOMYCOSIS,1
HU,PYREXIA,10
HU,PNEUMONIA,9
HU,ANAEMIA,7
HU,ASTHENIA,7
HU,DIARRHOEA,7
HU,HEADACHE,7
HU,BLOOD PRESSURE INCREASED,6
HU,DEHYDRATION,6
HU,MUSCULAR WEAKNESS,6
HU,PARAESTHESIA,6
HU,ATRIAL FIBRILLATION,5
HU,CHEST PAIN,5
HU,CONDITION AGGRAVATED,5
HU,HYPOAESTHESIA,5
HU,LYMPHADENOPATHY,5
HU,MYALGIA,5
HU,PAIN IN EXTREMITY,5
HU,ACUTE LEUKAEMIA,4
HU,ACUTE MYOCARDIAL INFARCTION,4
HU,ARTHRALGIA,4
HU,DYSPNOEA EXERTIONAL,4
HU,EAR INFECTION,4
HU,FATIGUE,4
HU,GINGIVAL SWELLING,4
HU,GRANULOMATOSIS WITH POLYANGIITIS,4
HU,INFECTIOUS MONONUCLEOSIS,4
HU,INSOMNIA,4
HU,MALAISE,4
HU,NASAL CONGESTION,4
HU,NAUSEA,4
HU,PAIN,4
HU,PANCREATITIS,4
HU,PAROTID GLAND ENLARGEMENT,4
HU,PURULENT DISCHARGE,4
HU,PYOGENIC GRANULOMA,4
HU,SINUSITIS,4
HU,ABDOMINAL PAIN,3
HU,BACK PAIN,3
HU,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
HU,CLOSTRIDIUM DIFFICILE COLITIS,3
HU,CONFUSIONAL STATE,3
HU,DEATH,3
HU,DYSPHAGIA,3
HU,DYSPNOEA,3
HU,FALL,3
HU,HYPERHIDROSIS,3
HU,MUSCLE SPASMS,3
HU,MYELODYSPLASTIC SYNDROME,3
HU,NEUTROPENIA,3
HU,PERIPHERAL SWELLING,3
HU,PLATELET COUNT DECREASED,3
HU,PRURITUS,3
HU,PULMONARY EMBOLISM,3
HU,RESPIRATORY TRACT INFECTION,3
HU,STEVENS-JOHNSON SYNDROME,3
HU,VENTRICULAR FIBRILLATION,3
HU,WEIGHT DECREASED,3
HU,ABDOMINAL PAIN UPPER,2
HU,APHTHOUS STOMATITIS,2
HU,BLISTER,2
HU,BLOOD PRESSURE FLUCTUATION,2
HU,BRONCHITIS,2
HU,CARDIAC ARREST,2
HU,CATARACT,2
HU,CEREBROVASCULAR ACCIDENT,2
HU,CHILLS,2
HU,CONTUSION,2
HU,COUGH,2
HU,DYSGEUSIA,2
HU,EYELID OEDEMA,2
HU,FEMUR FRACTURE,2
HU,GASTROINTESTINAL HAEMORRHAGE,2
HU,GRANULOCYTE COUNT DECREASED,2
HU,HAEMATOMA,2
HU,HAEMATURIA,2
HU,HEART RATE INCREASED,2
HU,HIATUS HERNIA,2
HU,HYPERTENSION,2
HU,HYPOTENSION,2
HU,HYPOVOLAEMIC SHOCK,2
HU,ISCHAEMIC STROKE,2
HU,LIP SWELLING,2
HU,MACROCYTOSIS,2
HU,MUCOSAL INFLAMMATION,2
HU,OSTEONECROSIS OF JAW,2
HU,PHARYNGEAL OEDEMA,2
HU,POLYCHROMASIA,2
HU,RED BLOOD CELL ABNORMALITY,2
HU,RED BLOOD CELL COUNT DECREASED,2
HU,RENAL FAILURE,2
HU,RESPIRATORY RATE DECREASED,2
HU,RHINORRHOEA,2
HU,SKIN LESION,2
HU,SNEEZING,2
HU,SWELLING FACE,2
HU,SWOLLEN TONGUE,2
HU,THROMBOCYTOPENIA,2
HU,TONGUE DISORDER,2
HU,URTICARIA,2
HU,VASCULITIS,2
HU,VASODILATATION,2
HU,VOMITING,2
HU,WHITE BLOOD CELL COUNT DECREASED,2
HU,ABDOMINAL DISTENSION,1
HU,ABSCESS,1
HU,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
HU,ACUTE ABDOMEN,1
HU,ACUTE CORONARY SYNDROME,1
HU,ACUTE HEPATIC FAILURE,1
HU,ACUTE MYELOID LEUKAEMIA,1
HU,ADENOCARCINOMA OF COLON,1
HU,ADRENAL INSUFFICIENCY,1
HU,ANGINA PECTORIS,1
HU,ANGIOPATHY,1
HU,APHASIA,1
HU,APHONIA,1
HU,ARRHYTHMIA,1
HU,ARTHRITIS,1
HU,ARTHROPATHY,1
HU,ASPIRATION,1
HU,ASTHMA,1
HU,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
HU,AXILLARY PAIN,1
HU,BLOOD FIBRINOGEN DECREASED,1
HU,BREATH ODOUR,1
HU,BRONCHOPNEUMONIA,1
HU,BURNING SENSATION,1
HU,CANDIDA INFECTION,1
HU,CARDIAC FAILURE,1
HU,CARDIOGENIC SHOCK,1
HU,CARDIOPULMONARY FAILURE,1
HU,CEREBRAL ISCHAEMIA,1
HU,CEREBROVASCULAR INSUFFICIENCY,1
HU,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
HU,CHRONIC MYELOID LEUKAEMIA,1
HU,COLORECTAL CANCER METASTATIC,1
HU,CONSTIPATION,1
HU,CRYPTOCOCCOSIS,1
HU,DECREASED APPETITE,1
HU,DEEP VEIN THROMBOSIS,1
HU,DEPRESSION,1
HU,DIZZINESS,1
HU,DRUG DOSE OMISSION,1
HU,DRUG EFFECT INCOMPLETE,1
HU,DRUG HYPERSENSITIVITY,1
HU,DRUG INEFFECTIVE,1
HU,DRUG RESISTANCE,1
HU,DRY SKIN,1
HU,DUODENAL ULCER HAEMORRHAGE,1
HU,DUODENAL ULCER PERFORATION,1
HU,DYSPHONIA,1
HU,EJECTION FRACTION DECREASED,1
HU,ENCEPHALOMALACIA,1
HU,EPISTAXIS,1
HU,ERYTHEMA,1
HU,ERYTHEMA MULTIFORME,1
HU,EXTRAVASATION BLOOD,1
HU,FAECES DISCOLOURED,1
HU,FIBRIN D DIMER INCREASED,1
HU,GAIT DISTURBANCE,1
HU,GASTROENTERITIS,1
HU,GASTROINTESTINAL STROMAL TUMOUR,1
HU,GENERAL PHYSICAL HEALTH DETERIORATION,1
HU,GENERALISED TONIC-CLONIC SEIZURE,1
HU,HAEMATOCHEZIA,1
HU,HEPATIC CIRRHOSIS,1
HU,HEPATIC ENZYME INCREASED,1
HU,HEPATIC FUNCTION ABNORMAL,1
HU,HEPATIC STEATOSIS,1
HU,HEPATOMEGALY,1
HU,HYPERAESTHESIA,1
HU,HYPERGLYCAEMIA,1
HU,HYPONATRAEMIA,1
HU,INFECTION,1
HU,INTENTIONAL PRODUCT MISUSE,1
HU,JAUNDICE,1
HU,LEFT VENTRICULAR FAILURE,1
HU,LIPASE INCREASED,1
HU,LIVIDITY,1
HU,LUNG NEOPLASM,1
HU,MALIGNANT NEOPLASM PROGRESSION,1
HU,METASTASES TO CENTRAL NERVOUS SYSTEM,1
HU,METASTASES TO LIVER,1
HU,METASTASES TO SPINE,1
HU,MOBILITY DECREASED,1
HU,MULTI-ORGAN FAILURE,1
HU,MUSCLE ABSCESS,1
HU,MUSCLE HAEMORRHAGE,1
HU,MUSCULOSKELETAL DISORDER,1
HU,MUSCULOSKELETAL PAIN,1
HU,MYOCARDIAL ISCHAEMIA,1
HU,NASOPHARYNGITIS,1
HU,NECK PAIN,1
HU,NEOPLASM,1
HU,NEUTROPENIC INFECTION,1
HU,NON-CARDIAC CHEST PAIN,1
HU,OCCULT BLOOD POSITIVE,1
HU,OEDEMA,1
HU,ONYCHOCLASIS,1
HU,OROPHARYNGEAL SQUAMOUS CELL CARCINOMA,1
HU,OSTEOPOROSIS,1
HU,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
HU,PANCREATIC CARCINOMA,1
HU,PANCREATIC CARCINOMA METASTATIC,1
HU,PANCREATITIS CHRONIC,1
HU,PERICARDITIS,1
HU,PERIPHERAL ARTERY OCCLUSION,1
HU,PERIPHERAL ISCHAEMIA,1
HU,PHOTOSENSITIVITY REACTION,1
HU,POLLAKIURIA,1
HU,POLYNEUROPATHY,1
HU,POOR PERIPHERAL CIRCULATION,1
HU,PROSTATE CANCER METASTATIC,1
HU,PROTHROMBIN LEVEL DECREASED,1
HU,PSYCHOTIC DISORDER,1
HU,RASH,1
HU,RAYNAUD^S PHENOMENON,1
HU,RECTAL HAEMORRHAGE,1
HU,RENAL FAILURE ACUTE,1
HU,RENAL PAIN,1
HU,RHEUMATOID ARTHRITIS,1
HU,RICHTER^S SYNDROME,1
HU,SENILE DEMENTIA,1
HU,SEPSIS,1
HU,SEPTIC SHOCK,1
HU,SINUS ARRHYTHMIA,1
HU,SINUS TACHYCARDIA,1
HU,SKIN ABRASION,1
HU,SKIN EXFOLIATION,1
HU,SKIN HAEMORRHAGE,1
HU,SKIN HYPERTROPHY,1
HU,SKIN NECROSIS,1
HU,SKIN ULCER,1
HU,SMALL INTESTINAL PERFORATION,1
HU,SPINAL FRACTURE,1
HU,SPLENOMEGALY,1
HU,STOMA SITE DISCHARGE,1
HU,STOMA SITE ERYTHEMA,1
HU,STOMA SITE INDURATION,1
HU,STOMA SITE INFLAMMATION,1
HU,STOMATITIS,1
HU,SUFFOCATION FEELING,1
HU,SURGERY,1
HU,TACHYCARDIA,1
HU,THERAPEUTIC RESPONSE DECREASED,1
HU,THROAT IRRITATION,1
HU,THROMBIN TIME PROLONGED,1
HU,TOXIC EPIDERMAL NECROLYSIS,1
HU,TOXIC SHOCK SYNDROME STREPTOCOCCAL,1
HU,TOXIC SKIN ERUPTION,1
HU,TRANSFUSION,1
HU,TRANSIENT ISCHAEMIC ATTACK,1
HU,TRAUMATIC HAEMORRHAGE,1
HU,TUMOUR COMPRESSION,1
HU,TUMOUR LYSIS SYNDROME,1
HU,URETERIC OBSTRUCTION,1
HU,URINARY RETENTION,1
HU,URINARY TRACT INFECTION,1
HU,URINARY TRACT INFECTION BACTERIAL,1
HU,VASCULAR ENCEPHALOPATHY,1
HU,VASCULAR STENT STENOSIS,1
HU,VENTRICULAR ARRHYTHMIA,1
HU,VON WILLEBRAND^S DISEASE,1
HU,WALKING AID USER,1
HU,WEIGHT INCREASED,1
HU,WOUND NECROSIS,1
IS,JAUNDICE,4
IS,DRUG-INDUCED LIVER INJURY,2
IS,HEPATOTOXICITY,2
IS,CHILLS,1
IS,HEPATIC ENZYME INCREASED,1
IS,HEPATITIS ACUTE,1
IS,HYPERHIDROSIS,1
IS,MYALGIA,1
IN,CARDIAC ARREST,17
IN,OVERDOSE,12
IN,CARDIOGENIC SHOCK,11
IN,DYSPNOEA,11
IN,METABOLIC ACIDOSIS,11
IN,SHOCK,11
IN,CARDIAC DISORDER,10
IN,RESPIRATORY ALKALOSIS,9
IN,BRADYCARDIA,8
IN,DRUG INEFFECTIVE,7
IN,HAEMOGLOBIN DECREASED,7
IN,HAEMORRHAGE,7
IN,ANURIA,6
IN,BUNDLE BRANCH BLOCK RIGHT,6
IN,CEREBROVASCULAR ACCIDENT,6
IN,DEATH,6
IN,NAUSEA,6
IN,VOMITING,6
IN,ANAEMIA,5
IN,COUGH,5
IN,GASTROINTESTINAL HAEMORRHAGE,5
IN,HYPOTENSION,5
IN,PYREXIA,5
IN,THROMBOCYTOPENIA,5
IN,ACUTE MYOCARDIAL INFARCTION,4
IN,ANAPHYLACTIC REACTION,4
IN,ANXIETY,4
IN,ASTHENIA,4
IN,BLOOD PRESSURE DECREASED,4
IN,CORONARY ARTERY DISEASE,4
IN,FOETAL EXPOSURE DURING PREGNANCY,4
IN,HAEMORRHAGE INTRACRANIAL,4
IN,HYPERKALAEMIA,4
IN,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
IN,INTENTIONAL OVERDOSE,4
IN,MULTI-ORGAN FAILURE,4
IN,PREMATURE BABY,4
IN,SUBDURAL HAEMATOMA,4
IN,TORSADE DE POINTES,4
IN,VASCULAR STENT THROMBOSIS,4
IN,ABDOMINAL DISCOMFORT,3
IN,ACUTE HEPATIC FAILURE,3
IN,ATAXIA,3
IN,BLOOD GLUCOSE INCREASED,3
IN,CEREBRAL HAEMORRHAGE,3
IN,CHEST PAIN,3
IN,CHILLS,3
IN,CONFUSIONAL STATE,3
IN,DECREASED APPETITE,3
IN,DIZZINESS,3
IN,DYSARTHRIA,3
IN,ELECTROCARDIOGRAM QT PROLONGED,3
IN,GASTROENTERITIS,3
IN,GENERAL PHYSICAL HEALTH DETERIORATION,3
IN,HAEMATEMESIS,3
IN,HAEMATOMA,3
IN,HAEMATURIA,3
IN,HAEMOTHORAX,3
IN,HYPERSENSITIVITY,3
IN,HYPERSENSITIVITY VASCULITIS,3
IN,HYPOGLYCAEMIA,3
IN,LOW BIRTH WEIGHT BABY,3
IN,MATERNAL EXPOSURE DURING PREGNANCY,3
IN,MELAENA,3
IN,MYOGLOBINURIA,3
IN,PAIN IN EXTREMITY,3
IN,PANCYTOPENIA,3
IN,PERIPHERAL COLDNESS,3
IN,PNEUMONIA,3
IN,PRURITUS,3
IN,RENAL TUBULAR NECROSIS,3
IN,RHABDOMYOLYSIS,3
IN,SKIN DISCOLOURATION,3
IN,THROMBOSIS IN DEVICE,3
IN,TOXICITY TO VARIOUS AGENTS,3
IN,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
IN,ACUTE CORONARY SYNDROME,2
IN,ACUTE KIDNEY INJURY,2
IN,ALOPECIA,2
IN,ANGIOEDEMA,2
IN,BRAIN STEM STROKE,2
IN,BRONCHITIS,2
IN,CARDIAC FAILURE,2
IN,CARDIAC FAILURE CONGESTIVE,2
IN,CARDIO-RESPIRATORY ARREST,2
IN,CARDIOMEGALY,2
IN,CEREBELLAR SYNDROME,2
IN,COAGULOPATHY,2
IN,DIARRHOEA,2
IN,DIASTOLIC DYSFUNCTION,2
IN,DRUG-INDUCED LIVER INJURY,2
IN,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
IN,EXPOSURE DURING PREGNANCY,2
IN,FALL,2
IN,GASTRITIS EROSIVE,2
IN,HALLUCINATION_ VISUAL,2
IN,HEART RATE INCREASED,2
IN,HEPATITIS C,2
IN,ISCHAEMIC STROKE,2
IN,LEUKOPENIA,2
IN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
IN,MYOCARDIAL INFARCTION,2
IN,NODAL ARRHYTHMIA,2
IN,OXYGEN SATURATION DECREASED,2
IN,PALLOR,2
IN,PERICARDIAL EFFUSION,2
IN,PLATELET COUNT DECREASED,2
IN,PSORIASIS,2
IN,PULMONARY HYPERTENSION,2
IN,PULMONARY OEDEMA,2
IN,RED BLOOD CELL COUNT DECREASED,2
IN,SEIZURE,2
IN,SEPSIS,2
IN,SEPTIC SHOCK,2
IN,SINUS BRADYCARDIA,2
IN,STEVENS-JOHNSON SYNDROME,2
IN,STRONGYLOIDIASIS,2
IN,SYNCOPE,2
IN,TACHYCARDIA,2
IN,TACHYPNOEA,2
IN,TUBERCULOSIS,2
IN,VASCULAR OCCLUSION,2
IN,VASCULAR PSEUDOANEURYSM,2
IN,VENTRICULAR FIBRILLATION,2
IN,VENTRICULAR TACHYCARDIA,2
IN,VESSEL PUNCTURE SITE HAEMATOMA,2
IN,WHEEZING,2
IN,WHITE BLOOD CELL COUNT DECREASED,2
IN,ABDOMINAL DISTENSION,1
IN,ABDOMINAL PAIN UPPER,1
IN,ABDOMINAL TENDERNESS,1
IN,ABDOMINAL WALL HAEMATOMA,1
IN,ACNE,1
IN,ALANINE AMINOTRANSFERASE INCREASED,1
IN,AMNIORRHOEA,1
IN,ANAL INCONTINENCE,1
IN,ANEURYSM RECANALISATION,1
IN,ANGINA UNSTABLE,1
IN,AORTIC CALCIFICATION,1
IN,ARTERIOSCLEROSIS,1
IN,ARTHRALGIA,1
IN,ATRIOVENTRICULAR BLOCK,1
IN,AZOTAEMIA,1
IN,BLADDER CANCER,1
IN,BLISTER,1
IN,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IN,BLOOD CHOLESTEROL INCREASED,1
IN,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
IN,BLOOD CREATININE INCREASED,1
IN,BLOOD GLUCOSE FLUCTUATION,1
IN,BLOOD PRESSURE INCREASED,1
IN,BLOOD THYROID STIMULATING HORMONE INCREASED,1
IN,BLOOD UREA INCREASED,1
IN,BREATH SOUNDS ABSENT,1
IN,BURNING SENSATION,1
IN,CAESAREAN SECTION,1
IN,CARDIAC TAMPONADE,1
IN,CARDIOVASCULAR DISORDER,1
IN,CELLULITIS,1
IN,CHEST DISCOMFORT,1
IN,CHOKING,1
IN,CHOLELITHIASIS,1
IN,CIRCULATORY COLLAPSE,1
IN,COLON CANCER,1
IN,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
IN,CONDITION AGGRAVATED,1
IN,CONJUNCTIVAL HAEMORRHAGE,1
IN,CONSTIPATION,1
IN,CORONARY ARTERY ANEURYSM,1
IN,CREPITATIONS,1
IN,CUSHINGOID,1
IN,DECREASED ACTIVITY,1
IN,DEEP VEIN THROMBOSIS,1
IN,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IN,DETACHMENT OF RETINAL PIGMENT EPITHELIUM,1
IN,DIABETES MELLITUS,1
IN,DIABETIC NEPHROPATHY,1
IN,DISEASE PROGRESSION,1
IN,DRUG EFFECT INCOMPLETE,1
IN,DRUG PRESCRIBING ERROR,1
IN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
IN,DYSMETRIA,1
IN,DYSPHAGIA,1
IN,DYSPHONIA,1
IN,DYSPNOEA EXERTIONAL,1
IN,DYSURIA,1
IN,ECCHYMOSIS,1
IN,EFFUSION,1
IN,EJECTION FRACTION DECREASED,1
IN,ELECTROCARDIOGRAM P WAVE ABNORMAL,1
IN,EMBOLIC STROKE,1
IN,ENCEPHALOPATHY,1
IN,EPISTAXIS,1
IN,ERYTHEMA,1
IN,EXTRADURAL HAEMATOMA,1
IN,EYE HAEMORRHAGE,1
IN,FATIGUE,1
IN,FEBRILE NEUTROPENIA,1
IN,FEELING COLD,1
IN,FEELING HOT,1
IN,FIXED DRUG ERUPTION,1
IN,FLUSHING,1
IN,FUSARIUM INFECTION,1
IN,GAIT DISTURBANCE,1
IN,GALLBLADDER CANCER,1
IN,GANGRENE,1
IN,GASTROINTESTINAL ULCER,1
IN,GINGIVAL BLEEDING,1
IN,GINGIVAL HYPERTROPHY,1
IN,GLOSSITIS,1
IN,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
IN,HAEMATOCRIT DECREASED,1
IN,HAEMOPTYSIS,1
IN,HALLUCINATION,1
IN,HEAD DISCOMFORT,1
IN,HEART RATE DECREASED,1
IN,HEMIPARESIS,1
IN,HEPATIC ENCEPHALOPATHY,1
IN,HEPATIC FUNCTION ABNORMAL,1
IN,HEPATITIS,1
IN,HEPATITIS FULMINANT,1
IN,HEPATOMEGALY,1
IN,HEPATOSPLENOMEGALY,1
IN,HISTIOCYTOSIS HAEMATOPHAGIC,1
IN,HISTOPLASMOSIS,1
IN,HYDROPS FOETALIS,1
IN,HYPERTENSION,1
IN,HYPERTHERMIA,1
IN,HYPOKINESIA,1
IN,HYPONATRAEMIA,1
IN,HYPOVOLAEMIA,1
IN,ILIAC ARTERY OCCLUSION,1
IN,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
IN,INFARCTION,1
IN,INSULIN AUTOIMMUNE SYNDROME,1
IN,INTERCAPILLARY GLOMERULOSCLEROSIS,1
IN,INTERSTITIAL LUNG DISEASE,1
IN,INTERVERTEBRAL DISC SPACE NARROWING,1
IN,IRRITABILITY,1
IN,JAUNDICE,1
IN,JOINT CREPITATION,1
IN,JOINT DISLOCATION,1
IN,JOINT EFFUSION,1
IN,JOINT INSTABILITY,1
IN,JUVENILE IDIOPATHIC ARTHRITIS,1
IN,KETOSIS,1
IN,KIDNEY FIBROSIS,1
IN,LARYNGEAL ULCERATION,1
IN,LEFT VENTRICULAR FAILURE,1
IN,LEFT VENTRICULAR HYPERTROPHY,1
IN,LETHARGY,1
IN,LIP SWELLING,1
IN,LIVE BIRTH,1
IN,LOWER GASTROINTESTINAL HAEMORRHAGE,1
IN,LOWER RESPIRATORY TRACT INFECTION,1
IN,LUMBAR SPINE FLATTENING,1
IN,MAJOR DEPRESSION,1
IN,MALAISE,1
IN,MANIA,1
IN,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
IN,MEAN ARTERIAL PRESSURE DECREASED,1
IN,MEDICATION ERROR,1
IN,MENINGITIS CRYPTOCOCCAL,1
IN,METASTATIC SQUAMOUS CELL CARCINOMA,1
IN,MOUTH ULCERATION,1
IN,MUSCLE HAEMORRHAGE,1
IN,NEPHROLITHIASIS,1
IN,NEPHROPATHY,1
IN,NEUROTOXICITY,1
IN,NEUTROPENIA,1
IN,NODAL RHYTHM,1
IN,OEDEMA PERIPHERAL,1
IN,OESOPHAGEAL COMPRESSION,1
IN,ORAL CANDIDIASIS,1
IN,ORTHOSTATIC HYPOTENSION,1
IN,OSTEOARTHRITIS,1
IN,PAIN,1
IN,PANCREATITIS,1
IN,PANCREATITIS ACUTE,1
IN,PARATHYROID TUMOUR BENIGN,1
IN,PARATYPHOID FEVER,1
IN,PARKINSONISM,1
IN,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
IN,PERIPHERAL ISCHAEMIA,1
IN,PERIPHERAL SWELLING,1
IN,PHOTOSENSITIVITY REACTION,1
IN,PLACENTAL CHORIOANGIOMA,1
IN,PLASMA CELL MYELOMA,1
IN,PLATELET COUNT ABNORMAL,1
IN,PLEURAL EFFUSION,1
IN,PLEUROPERICARDITIS,1
IN,PNEUMONITIS,1
IN,PORTAL VEIN EMBOLISATION,1
IN,POST PROCEDURAL HAEMORRHAGE,1
IN,POTENTIATING DRUG INTERACTION,1
IN,PREMATURE DELIVERY,1
IN,PRESCRIBED UNDERDOSE,1
IN,PRETERM PREMATURE RUPTURE OF MEMBRANES,1
IN,PRODUCT USE ISSUE,1
IN,PROSTATOMEGALY,1
IN,PROTHROMBIN TIME PROLONGED,1
IN,PRURITUS GENERALISED,1
IN,PULMONARY ALVEOLAR HAEMORRHAGE,1
IN,PULMONARY ARTERIAL HYPERTENSION,1
IN,PULMONARY FIBROSIS,1
IN,PULMONARY TOXICITY,1
IN,PULMONARY TUBERCULOSIS,1
IN,PURPURA,1
IN,PUSTULAR PSORIASIS,1
IN,RADIUS FRACTURE,1
IN,RASH,1
IN,RASH GENERALISED,1
IN,RASH MACULO-PAPULAR,1
IN,RASH PUSTULAR,1
IN,RECTAL HAEMORRHAGE,1
IN,RECTAL ULCER,1
IN,RECTAL ULCER HAEMORRHAGE,1
IN,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
IN,RED CELL DISTRIBUTION WIDTH INCREASED,1
IN,RENAL ARTERY ARTERIOSCLEROSIS,1
IN,RENAL FAILURE ACUTE,1
IN,RENAL FAILURE CHRONIC,1
IN,RENAL IMPAIRMENT,1
IN,RENAL TUBULAR ATROPHY,1
IN,RENAL TUBULAR DISORDER,1
IN,RESPIRATORY RATE INCREASED,1
IN,RETROPERITONEAL HAEMORRHAGE,1
IN,RHONCHI,1
IN,SHOCK HAEMORRHAGIC,1
IN,SINOATRIAL BLOCK,1
IN,SKIN EROSION,1
IN,SKIN PLAQUE,1
IN,SPINAL COMPRESSION FRACTURE,1
IN,SPINAL CORD COMPRESSION,1
IN,SPINAL FRACTURE,1
IN,SPINAL PAIN,1
IN,SPONTANEOUS HAEMATOMA,1
IN,STILLBIRTH,1
IN,STRABISMUS,1
IN,SUNBURN,1
IN,THERAPEUTIC RESPONSE DECREASED,1
IN,THERAPY PARTIAL RESPONDER,1
IN,THROMBOCYTOSIS,1
IN,THROMBOSIS,1
IN,TRANSIENT ISCHAEMIC ATTACK,1
IN,TRANSPLANT REJECTION,1
IN,TROPONIN T INCREASED,1
IN,ULCER,1
IN,UMBILICAL CORD VASCULAR DISORDER,1
IN,UPPER RESPIRATORY TRACT INFECTION,1
IN,URINARY INCONTINENCE,1
IN,URINARY RETENTION,1
IN,URINARY TRACT INFECTION,1
IN,URTICARIA,1
IN,VAGINAL HAEMORRHAGE,1
IN,VASCULAR COMPRESSION,1
IN,VASOSPASM,1
IN,VENTRICULAR EXTRASYSTOLES,1
IN,VERTEBRAL OSTEOPHYTE,1
IN,VERTIGO,1
IN,VISION BLURRED,1
IN,VOLVULUS,1
IN,WEIGHT DECREASED,1
IN,WHITE BLOOD CELL COUNT INCREASED,1
IN,WHITE BLOOD CELL DISORDER,1
ID,DYSPNOEA,3
ID,MELAENA,3
ID,ACUTE MYOCARDIAL INFARCTION,2
ID,DRUG RESISTANCE,2
ID,HAEMATEMESIS,2
ID,HAEMOGLOBIN DECREASED,2
ID,LOSS OF CONSCIOUSNESS,2
ID,NAUSEA,2
ID,VENTRICULAR TACHYCARDIA,2
ID,ACUTE CORONARY SYNDROME,1
ID,ANAEMIA,1
ID,BACK PAIN,1
ID,BLOOD PRESSURE DECREASED,1
ID,BRADYCARDIA,1
ID,CARDIAC ARREST,1
ID,CHEST PAIN,1
ID,CORONARY ARTERY RESTENOSIS,1
ID,DRY GANGRENE,1
ID,EJECTION FRACTION DECREASED,1
ID,EMBOLIC STROKE,1
ID,FALL,1
ID,GASTRIC DISORDER,1
ID,HAEMATURIA,1
ID,HAEMORRHAGE INTRACRANIAL,1
ID,HAEMORRHAGIC STROKE,1
ID,HEAD INJURY,1
ID,INTENTIONAL DRUG MISUSE,1
ID,PERIPHERAL ARTERY THROMBOSIS,1
ID,PERIPHERAL COLDNESS,1
ID,PNEUMONIA,1
ID,PROCEDURAL HAEMORRHAGE,1
ID,SEPSIS,1
ID,SNORING,1
ID,SYNCOPE,1
ID,THROMBOCYTOPENIA,1
ID,THROMBOSIS,1
ID,URINARY TRACT INFECTION,1
ID,VOMITING,1
IR,ANXIETY,11
IR,DEPRESSION,7
IR,AKATHISIA,6
IR,DRUG INEFFECTIVE,4
IR,RESTLESSNESS,4
IR,AGITATION,2
IR,CARDIOGENIC SHOCK,2
IR,CRYING,2
IR,HEMIPLEGIA,2
IR,HYPERKALAEMIA,2
IR,INHIBITORY DRUG INTERACTION,2
IR,METABOLIC ACIDOSIS,2
IR,MYOCARDIAL INFARCTION,2
IR,RENAL FAILURE ACUTE,2
IR,RHABDOMYOLYSIS,2
IR,SUICIDAL IDEATION,2
IR,VASCULAR PSEUDOANEURYSM,2
IR,APHTHOUS ULCER,1
IR,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IR,CEREBROVASCULAR ACCIDENT,1
IR,CHROMATURIA,1
IR,CORONARY ARTERY ANEURYSM,1
IR,DIARRHOEA,1
IR,ERYTHEMA,1
IR,EXPOSURE DURING PREGNANCY,1
IR,HYPERTENSION,1
IR,ISCHAEMIA,1
IR,ISCHAEMIC STROKE,1
IR,MASS,1
IR,MUSCULAR WEAKNESS,1
IR,MYALGIA,1
IR,MYOGLOBINURIA,1
IR,PAIN IN EXTREMITY,1
IR,PALPITATIONS,1
IR,PARADOXICAL EMBOLISM,1
IR,PERICARDIAL EFFUSION,1
IR,PULMONARY ARTERIAL HYPERTENSION,1
IR,SUICIDAL BEHAVIOUR,1
IR,THROMBOSIS,1
IQ,HEADACHE,3
IQ,DYSPHAGIA,2
IQ,INFLUENZA,2
IQ,INSOMNIA,2
IQ,LOSS OF CONSCIOUSNESS,2
IQ,PYREXIA,2
IQ,THALAMUS HAEMORRHAGE,2
IQ,ANAEMIA,1
IQ,ANXIETY,1
IQ,APHASIA,1
IQ,ARTHRALGIA,1
IQ,ASPHYXIA,1
IQ,BACK PAIN,1
IQ,CEREBROVASCULAR ACCIDENT,1
IQ,CHEST PAIN,1
IQ,COUGH,1
IQ,CYTOGENETIC ANALYSIS ABNORMAL,1
IQ,DEATH,1
IQ,DECREASED IMMUNE RESPONSIVENESS,1
IQ,DECUBITUS ULCER,1
IQ,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IQ,DEPRESSED MOOD,1
IQ,DIARRHOEA,1
IQ,DRUG INEFFECTIVE,1
IQ,DYSPNOEA,1
IQ,ERYTHEMA,1
IQ,EXTENSOR PLANTAR RESPONSE,1
IQ,FALL,1
IQ,FATIGUE,1
IQ,GENERAL PHYSICAL HEALTH DETERIORATION,1
IQ,HAEMOGLOBIN DECREASED,1
IQ,HEMIPARESIS,1
IQ,HYPERSENSITIVITY,1
IQ,HYPOPHAGIA,1
IQ,LAZINESS,1
IQ,LEFT VENTRICULAR HYPERTROPHY,1
IQ,LEUKOCYTOSIS,1
IQ,LEUKOPENIA,1
IQ,MEMORY IMPAIRMENT,1
IQ,MENTAL DISORDER,1
IQ,MOVEMENT DISORDER,1
IQ,NAUSEA,1
IQ,OEDEMA,1
IQ,OSTEOPOROSIS,1
IQ,PAIN,1
IQ,PARAESTHESIA,1
IQ,PRODUCTIVE COUGH,1
IQ,PRURITUS,1
IQ,QUADRIPARESIS,1
IQ,QUADRIPLEGIA,1
IQ,RASH,1
IQ,RHINORRHOEA,1
IQ,SPINAL PAIN,1
IQ,SUSPECTED COUNTERFEIT PRODUCT,1
IQ,URINARY TRACT INFECTION,1
IQ,VITAMIN D DECREASED,1
IQ,VOMITING,1
IQ,WEIGHT DECREASED,1
IQ,WEIGHT INCREASED,1
IE,DEATH,45
IE,LOWER RESPIRATORY TRACT INFECTION,32
IE,FALL,31
IE,DIARRHOEA,25
IE,NAUSEA,21
IE,FATIGUE,20
IE,MALAISE,18
IE,VOMITING,18
IE,CONFUSIONAL STATE,17
IE,DYSPNOEA,17
IE,COUGH,15
IE,HAEMOGLOBIN DECREASED,15
IE,ASTHENIA,14
IE,PAIN,13
IE,PYREXIA,13
IE,PNEUMONIA,12
IE,ABDOMINAL PAIN,11
IE,CONSTIPATION,11
IE,HEADACHE,11
IE,ACUTE KIDNEY INJURY,10
IE,DECREASED APPETITE,10
IE,RASH,10
IE,CEREBROVASCULAR ACCIDENT,9
IE,INSOMNIA,9
IE,PAIN IN EXTREMITY,9
IE,TRANSIENT ISCHAEMIC ATTACK,9
IE,ANAEMIA,8
IE,BACK PAIN,8
IE,CHEST PAIN,8
IE,DIZZINESS,8
IE,DRUG INEFFECTIVE,8
IE,INFECTION,8
IE,LETHARGY,8
IE,NEUTROPHIL COUNT INCREASED,8
IE,PLATELET COUNT DECREASED,8
IE,PRODUCT USE ISSUE,8
IE,TOXICITY TO VARIOUS AGENTS,8
IE,VISION BLURRED,8
IE,WHITE BLOOD CELL COUNT INCREASED,8
IE,ANXIETY,7
IE,C-REACTIVE PROTEIN INCREASED,7
IE,CHOREOATHETOSIS,7
IE,CONTUSION,7
IE,DEHYDRATION,7
IE,HYPERTENSION,7
IE,HYPOAESTHESIA,7
IE,HYPOTENSION,7
IE,PRODUCT USE IN UNAPPROVED INDICATION,7
IE,SYNCOPE,7
IE,WEIGHT DECREASED,7
IE,ARTHRALGIA,6
IE,ATRIAL FIBRILLATION,6
IE,BLOOD CREATININE INCREASED,6
IE,DRY SKIN,6
IE,DYSKINESIA,6
IE,DYSPHAGIA,6
IE,GAIT DISTURBANCE,6
IE,HAEMATOMA,6
IE,MUSCULOSKELETAL STIFFNESS,6
IE,RESPIRATORY TRACT INFECTION,6
IE,URINARY TRACT INFECTION,6
IE,CARDIAC FAILURE,5
IE,CHEST DISCOMFORT,5
IE,DEEP VEIN THROMBOSIS,5
IE,HYPONATRAEMIA,5
IE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
IE,KIDNEY INFECTION,5
IE,MYALGIA,5
IE,MYOCARDIAL INFARCTION,5
IE,NEUROMYOPATHY,5
IE,NEUROPATHY PERIPHERAL,5
IE,OROPHARYNGEAL PAIN,5
IE,PERIPHERAL SWELLING,5
IE,PRURITUS,5
IE,PULMONARY EMBOLISM,5
IE,SEPSIS,5
IE,SOMNOLENCE,5
IE,TREMOR,5
IE,ABDOMINAL DISCOMFORT,4
IE,ACUTE MYOCARDIAL INFARCTION,4
IE,ALANINE AMINOTRANSFERASE INCREASED,4
IE,ANGINA PECTORIS,4
IE,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
IE,BLOOD GLUCOSE INCREASED,4
IE,BLOOD PRESSURE INCREASED,4
IE,BURNING SENSATION,4
IE,CARDIAC ARREST,4
IE,CARDIAC DISORDER,4
IE,CEREBRAL HAEMORRHAGE,4
IE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
IE,CYANOSIS,4
IE,DIABETIC KETOACIDOSIS,4
IE,ERYTHEMA,4
IE,EYE PAIN,4
IE,HAEMORRHAGE,4
IE,HALLUCINATION,4
IE,HOSPITALISATION,4
IE,INTESTINAL OBSTRUCTION,4
IE,LIVER FUNCTION TEST ABNORMAL,4
IE,MOBILITY DECREASED,4
IE,OEDEMA PERIPHERAL,4
IE,PARAESTHESIA,4
IE,PNEUMONIA ASPIRATION,4
IE,PRESYNCOPE,4
IE,RECTAL HAEMORRHAGE,4
IE,RESTLESSNESS,4
IE,SUBDURAL HAEMATOMA,4
IE,THROMBOCYTOPENIA,4
IE,WHITE BLOOD CELL COUNT DECREASED,4
IE,BLOOD ALKALINE PHOSPHATASE INCREASED,3
IE,BLOOD UREA INCREASED,3
IE,CHOKING,3
IE,COGNITIVE DISORDER,3
IE,CONVULSION,3
IE,DELIRIUM,3
IE,DEPRESSION,3
IE,DRUG DOSE OMISSION,3
IE,DRUG RESISTANCE,3
IE,EYE INFECTION,3
IE,FEELING ABNORMAL,3
IE,FLUSHING,3
IE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
IE,GASTRITIS,3
IE,GASTROINTESTINAL HAEMORRHAGE,3
IE,GLOMERULAR FILTRATION RATE DECREASED,3
IE,HAEMATEMESIS,3
IE,HAEMOGLOBIN ABNORMAL,3
IE,HEAD INJURY,3
IE,HYPERKALAEMIA,3
IE,HYPOKALAEMIA,3
IE,HYPOPHAGIA,3
IE,IMMUNE SYSTEM DISORDER,3
IE,INCORRECT DOSE ADMINISTERED,3
IE,INFLUENZA LIKE ILLNESS,3
IE,INTENTIONAL DRUG MISUSE,3
IE,JOINT SWELLING,3
IE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
IE,LUNG DISORDER,3
IE,LUNG NEOPLASM MALIGNANT,3
IE,MATERNAL EXPOSURE DURING PREGNANCY,3
IE,MELAENA,3
IE,MOVEMENT DISORDER,3
IE,MUSCULAR WEAKNESS,3
IE,MYOCARDIAL ISCHAEMIA,3
IE,NEUTROPENIA,3
IE,NEUTROPHIL COUNT DECREASED,3
IE,ON AND OFF PHENOMENON,3
IE,ORTHOSTATIC HYPOTENSION,3
IE,OSTEONECROSIS OF JAW,3
IE,PALPITATIONS,3
IE,PARKINSON^S DISEASE,3
IE,RENAL FAILURE,3
IE,SKIN DISCOLOURATION,3
IE,STAPHYLOCOCCAL INFECTION,3
IE,UNRESPONSIVE TO STIMULI,3
IE,VIRAL INFECTION,3
IE,WHEEZING,3
IE,ABDOMINAL PAIN LOWER,2
IE,ABDOMINAL PAIN UPPER,2
IE,ABORTION SPONTANEOUS,2
IE,ABSCESS,2
IE,ACIDOSIS,2
IE,ACUTE RESPIRATORY FAILURE,2
IE,AGITATION,2
IE,ALOPECIA,2
IE,ANAPHYLACTOID REACTION,2
IE,ANTIPSYCHOTIC DRUG LEVEL INCREASED,2
IE,ARTERIOSCLEROSIS CORONARY ARTERY,2
IE,ASPARTATE AMINOTRANSFERASE INCREASED,2
IE,ATRIAL FLUTTER,2
IE,BLISTER,2
IE,BLOOD PRESSURE DECREASED,2
IE,BLOOD SODIUM DECREASED,2
IE,BONE LESION,2
IE,BRONCHIOLITIS,2
IE,BRONCHOPNEUMONIA,2
IE,CARDIAC FAILURE CHRONIC,2
IE,CARDIOGENIC SHOCK,2
IE,CARDIOVASCULAR DISORDER,2
IE,CATARACT,2
IE,CELLULITIS,2
IE,CEREBRAL INFARCTION,2
IE,CHRONIC KIDNEY DISEASE,2
IE,CONCOMITANT DISEASE PROGRESSION,2
IE,CORONARY ARTERY DISEASE,2
IE,CRYING,2
IE,DERMATITIS,2
IE,DIARRHOEA INFECTIOUS,2
IE,DIET NONCOMPLIANCE,2
IE,DISEASE PROGRESSION,2
IE,DIVERTICULITIS,2
IE,DRUG ADMINISTRATION ERROR,2
IE,DYSPEPSIA,2
IE,EAR INFECTION,2
IE,EAR PAIN,2
IE,EMOTIONAL DISTRESS,2
IE,ENTEROCOCCAL INFECTION,2
IE,EPISTAXIS,2
IE,EXTRAPYRAMIDAL DISORDER,2
IE,EYE PRURITUS,2
IE,EYE SWELLING,2
IE,EYELID PTOSIS,2
IE,FAECALOMA,2
IE,GANGRENE,2
IE,GASTROENTERITIS,2
IE,GASTROINTESTINAL EROSION,2
IE,GENERAL PHYSICAL HEALTH DETERIORATION,2
IE,GROIN PAIN,2
IE,HALLUCINATION_ AUDITORY,2
IE,HALLUCINATION_ VISUAL,2
IE,HEART RATE INCREASED,2
IE,HEART RATE IRREGULAR,2
IE,HEPATIC ENZYME INCREASED,2
IE,HEPATIC FAILURE,2
IE,HEPATITIS,2
IE,HERPES ZOSTER,2
IE,HIATUS HERNIA,2
IE,HYPERHIDROSIS,2
IE,HYPOGLYCAEMIA,2
IE,HYPOMAGNESAEMIA,2
IE,INTERNATIONAL NORMALISED RATIO INCREASED,2
IE,INTESTINAL RESECTION,2
IE,IRON DEFICIENCY ANAEMIA,2
IE,IRRITABILITY,2
IE,LACERATION,2
IE,LACTIC ACIDOSIS,2
IE,LIMB INJURY,2
IE,LOCAL SWELLING,2
IE,LOCALISED INFECTION,2
IE,LOSS OF CONSCIOUSNESS,2
IE,LYMPHOCYTE COUNT DECREASED,2
IE,MULTIPLE SCLEROSIS RELAPSE,2
IE,MUSCLE ATROPHY,2
IE,MUSCLE SPASMS,2
IE,MYOPATHY,2
IE,OESOPHAGEAL FOOD IMPACTION,2
IE,ONYCHOLYSIS,2
IE,ONYCHOMADESIS,2
IE,PALLOR,2
IE,PANCREATITIS,2
IE,PERIPHERAL SENSORY NEUROPATHY,2
IE,PLATELET COUNT INCREASED,2
IE,PLEURAL EFFUSION,2
IE,POST PROCEDURAL COMPLICATION,2
IE,PSORIASIS,2
IE,PSYCHOTIC DISORDER,2
IE,RENAL DISORDER,2
IE,RENAL FAILURE ACUTE,2
IE,RENAL IMPAIRMENT,2
IE,RESPIRATORY ARREST,2
IE,RESPIRATORY FAILURE,2
IE,RESPIRATORY TRACT CONGESTION,2
IE,SCHIZOPHRENIA,2
IE,SINUS DISORDER,2
IE,SINUS TACHYCARDIA,2
IE,SINUSITIS,2
IE,SPEECH DISORDER,2
IE,SUDDEN DEATH,2
IE,TACHYPNOEA,2
IE,TEMPORAL ARTERITIS,2
IE,TOXIC EPIDERMAL NECROLYSIS,2
IE,TRANSFUSION REACTION,2
IE,TRAUMATIC INTRACRANIAL HAEMORRHAGE,2
IE,UPPER RESPIRATORY TRACT INFECTION,2
IE,URINARY INCONTINENCE,2
IE,VENTRICULAR TACHYCARDIA,2
IE,VERTIGO,2
IE,VISUAL IMPAIRMENT,2
IE,WOUND SECRETION,2
IE,ABASIA,1
IE,ABDOMINAL DISTENSION,1
IE,ABDOMINAL TENDERNESS,1
IE,ABNORMAL CLOTTING FACTOR,1
IE,ABNORMAL FAECES,1
IE,ACCIDENT,1
IE,ACCIDENTAL OVERDOSE,1
IE,ACETONAEMIA,1
IE,ACUTE RESPIRATORY DISTRESS SYNDROME,1
IE,ADRENAL INSUFFICIENCY,1
IE,ADVERSE EVENT,1
IE,ADVERSE REACTION,1
IE,AGORAPHOBIA,1
IE,AMNESIA,1
IE,ANAPHYLACTIC REACTION,1
IE,ANEURYSM,1
IE,ANGIOEDEMA,1
IE,ANGIOPATHY,1
IE,ANURIA,1
IE,AORTIC ANEURYSM,1
IE,AORTIC DISORDER,1
IE,APPENDICITIS,1
IE,ARRHYTHMIA,1
IE,ARTHRITIS,1
IE,ASTHMA,1
IE,AUTOIMMUNE DISORDER,1
IE,AXONAL NEUROPATHY,1
IE,B-CELL LYMPHOMA,1
IE,BACK INJURY,1
IE,BALANCE DISORDER,1
IE,BILIARY SEPSIS,1
IE,BLOOD CALCIUM DECREASED,1
IE,BLOOD CALCIUM INCREASED,1
IE,BLOOD CREATINE INCREASED,1
IE,BLOOD DISORDER,1
IE,BLOOD POTASSIUM INCREASED,1
IE,BLOOD PRESSURE ABNORMAL,1
IE,BLOOD TEST ABNORMAL,1
IE,BLOOD UREA DECREASED,1
IE,BLOOD URIC ACID INCREASED,1
IE,BODY TEMPERATURE,1
IE,BODY TEMPERATURE DECREASED,1
IE,BONE CANCER,1
IE,BONE DISORDER,1
IE,BONE PAIN,1
IE,BRADYKINESIA,1
IE,BRAIN MIDLINE SHIFT,1
IE,BRAIN OEDEMA,1
IE,BREAST DISORDER,1
IE,BRONCHIECTASIS,1
IE,BRONCHOSPASM,1
IE,BUNDLE BRANCH BLOCK RIGHT,1
IE,CAESAREAN SECTION,1
IE,CANDIDA INFECTION,1
IE,CARDIAC FAILURE ACUTE,1
IE,CARDIAC FAILURE CONGESTIVE,1
IE,CARDIAC PROCEDURE COMPLICATION,1
IE,CARDIOPULMONARY FAILURE,1
IE,CAROTID SINUS SYNDROME,1
IE,CATARACT OPERATION,1
IE,CATATONIA,1
IE,CEREBRAL CALCIFICATION,1
IE,CEREBRAL CYST,1
IE,CERVICAL VERTEBRAL FRACTURE,1
IE,CHEST X-RAY ABNORMAL,1
IE,CHOKING SENSATION,1
IE,CHOLANGITIS,1
IE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
IE,CIRCULATORY COLLAPSE,1
IE,CLOSTRIDIUM DIFFICILE INFECTION,1
IE,COAGULOPATHY,1
IE,COLITIS,1
IE,COLON ADENOMA,1
IE,COLORECTAL CANCER METASTATIC,1
IE,COMA SCALE ABNORMAL,1
IE,COMPLETED SUICIDE,1
IE,CONDITION AGGRAVATED,1
IE,CONGENITAL BRAIN DAMAGE,1
IE,CONGENITAL TOXOPLASMOSIS,1
IE,CORONARY ARTERY ANEURYSM,1
IE,CORONARY ARTERY OCCLUSION,1
IE,CREPITATIONS,1
IE,CROHN^S DISEASE,1
IE,CROUP INFECTIOUS,1
IE,CYTOMEGALOVIRUS INFECTION,1
IE,CYTOPENIA,1
IE,DEAFNESS,1
IE,DEAFNESS UNILATERAL,1
IE,DECREASED ACTIVITY,1
IE,DEMENTIA,1
IE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IE,DEPRESSED MOOD,1
IE,DEVICE BREAKAGE,1
IE,DEVICE DISLOCATION,1
IE,DEVICE ISSUE,1
IE,DEVICE KINK,1
IE,DEVICE LEAKAGE,1
IE,DIABETIC NEUROPATHY,1
IE,DIPLOPIA,1
IE,DISORGANISED SPEECH,1
IE,DISORIENTATION,1
IE,DISTURBANCE IN ATTENTION,1
IE,DIVERTICULUM,1
IE,DIZZINESS POSTURAL,1
IE,DROOLING,1
IE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
IE,DRUG DISPENSING ERROR,1
IE,DRUG ERUPTION,1
IE,DRUG WITHDRAWAL SYNDROME,1
IE,DRUG-DISEASE INTERACTION,1
IE,DRUG-INDUCED LIVER INJURY,1
IE,DRY MOUTH,1
IE,DYSARTHRIA,1
IE,DYSPHONIA,1
IE,DYSPNOEA AT REST,1
IE,DYSPNOEA EXERTIONAL,1
IE,DYSURIA,1
IE,ECZEMA,1
IE,ELECTROCARDIOGRAM QT PROLONGED,1
IE,EMBOLIC STROKE,1
IE,EMPHYSEMA,1
IE,ENCEPHALOPATHY,1
IE,ENDOCARDITIS,1
IE,EOSINOPHILIC PNEUMONIA,1
IE,EPIGASTRIC DISCOMFORT,1
IE,ERECTILE DYSFUNCTION,1
IE,ESCHAR,1
IE,ESCHERICHIA INFECTION,1
IE,EUPHORIC MOOD,1
IE,EXPOSURE DURING PREGNANCY,1
IE,EYE DISORDER,1
IE,EYE INJURY,1
IE,EYELID OEDEMA,1
IE,FACIAL BONES FRACTURE,1
IE,FACIAL PARESIS,1
IE,FACTOR VIII DEFICIENCY,1
IE,FAECAL INCONTINENCE,1
IE,FAECES DISCOLOURED,1
IE,FEAR OF INJECTION,1
IE,FEBRILE NEUTROPENIA,1
IE,FEEDING DISORDER,1
IE,FEELING COLD,1
IE,FEELING HOT,1
IE,FEMORAL NECK FRACTURE,1
IE,FLANK PAIN,1
IE,FOETAL EXPOSURE DURING PREGNANCY,1
IE,FOOT FRACTURE,1
IE,FREEZING PHENOMENON,1
IE,FREQUENT BOWEL MOVEMENTS,1
IE,GASTRIC DISORDER,1
IE,GASTRIC HAEMORRHAGE,1
IE,GASTRIC ULCER,1
IE,GASTROENTERITIS VIRAL,1
IE,GASTROINTESTINAL CANCER METASTATIC,1
IE,GASTROINTESTINAL STOMA COMPLICATION,1
IE,GENITAL INFECTION MALE,1
IE,GESTATIONAL HYPERTENSION,1
IE,GINGIVAL ABSCESS,1
IE,GINGIVAL BLEEDING,1
IE,GLASSY EYES,1
IE,GLOBULINS INCREASED,1
IE,GLYCOSYLATED HAEMOGLOBIN,1
IE,GLYCOSYLATED HAEMOGLOBIN DECREASED,1
IE,H1N1 INFLUENZA,1
IE,HAEMATOCRIT DECREASED,1
IE,HAEMATOMA INFECTION,1
IE,HAEMATURIA,1
IE,HAEMOPTYSIS,1
IE,HAEMORRHAGE INTRACRANIAL,1
IE,HAEMORRHAGIC STROKE,1
IE,HAEMORRHAGIC TRANSFORMATION STROKE,1
IE,HEAD DISCOMFORT,1
IE,HELICOBACTER INFECTION,1
IE,HEMIPARESIS,1
IE,HEPATIC CYST,1
IE,HEPATIC ENCEPHALOPATHY,1
IE,HEPATIC FUNCTION ABNORMAL,1
IE,HEPATITIS ALCOHOLIC,1
IE,HEPATOSPLENOMEGALY,1
IE,HICCUPS,1
IE,HIP ARTHROPLASTY,1
IE,HIP FRACTURE,1
IE,HORDEOLUM,1
IE,HUNGER,1
IE,HYPERCALCAEMIA,1
IE,HYPEROSMOLAR HYPERGLYCAEMIC STATE,1
IE,HYPERPARATHYROIDISM,1
IE,HYPERPARATHYROIDISM SECONDARY,1
IE,HYPERPROTEINAEMIA,1
IE,HYPERSENSITIVITY,1
IE,HYPERVENTILATION,1
IE,HYPOACUSIS,1
IE,HYPOCALCAEMIA,1
IE,HYPOKINESIA,1
IE,HYPOPHOSPHATAEMIA,1
IE,IDIOPATHIC PULMONARY FIBROSIS,1
IE,ILEAL ULCER,1
IE,ILEUS,1
IE,ILL-DEFINED DISORDER,1
IE,IMPAIRED GASTRIC EMPTYING,1
IE,INCONTINENCE,1
IE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
IE,INFUSION SITE HAEMORRHAGE,1
IE,INJECTION SITE ERYTHEMA,1
IE,INJECTION SITE HAEMORRHAGE,1
IE,INJECTION SITE INFLAMMATION,1
IE,INJECTION SITE PAIN,1
IE,INJECTION SITE PAPULE,1
IE,INJECTION SITE REACTION,1
IE,INJECTION SITE SWELLING,1
IE,INTENTIONAL OVERDOSE,1
IE,INTERNAL HAEMORRHAGE,1
IE,INTERVERTEBRAL DISC DISPLACEMENT,1
IE,INTRAVENTRICULAR HAEMORRHAGE,1
IE,INVASIVE DUCTAL BREAST CARCINOMA,1
IE,INVESTIGATION,1
IE,JAUNDICE,1
IE,JAUNDICE CHOLESTATIC,1
IE,JOINT DISLOCATION,1
IE,JOINT INJURY,1
IE,KETOACIDOSIS,1
IE,LACRIMATION INCREASED,1
IE,LARGE INTESTINAL ULCER,1
IE,LATENT TUBERCULOSIS,1
IE,LEUKOCYTOSIS,1
IE,LEUKOPENIA,1
IE,LIMB DISCOMFORT,1
IE,LIP EXFOLIATION,1
IE,LIVEDO RETICULARIS,1
IE,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
IE,LOWER RESPIRATORY TRACT INFECTION FUNGAL,1
IE,LUMBAR VERTEBRAL FRACTURE,1
IE,LUNG INFECTION,1
IE,LYMPHADENOPATHY,1
IE,MACULAR DEGENERATION,1
IE,MALABSORPTION,1
IE,MALIGNANT MELANOMA,1
IE,MASS,1
IE,MATERNAL DRUGS AFFECTING FOETUS,1
IE,MEAN CELL HAEMOGLOBIN DECREASED,1
IE,MEAN CELL VOLUME DECREASED,1
IE,MECHANICAL VENTILATION,1
IE,MEDIASTINAL HAEMATOMA,1
IE,MEDICATION ERROR,1
IE,MEDICATION RESIDUE PRESENT,1
IE,MENORRHAGIA,1
IE,MENTAL DISORDER,1
IE,MENTAL IMPAIRMENT,1
IE,METABOLIC ACIDOSIS,1
IE,MITRAL VALVE INCOMPETENCE,1
IE,MONOPARESIS,1
IE,MOUTH ULCERATION,1
IE,MUSCLE TWITCHING,1
IE,MUSCULOSKELETAL DISCOMFORT,1
IE,MYOSITIS,1
IE,NAIL DISCOLOURATION,1
IE,NASAL CONGESTION,1
IE,NASAL DISCOMFORT,1
IE,NASAL DRYNESS,1
IE,NASOPHARYNGITIS,1
IE,NECK MASS,1
IE,NECROTISING FASCIITIS,1
IE,NEPHROTIC SYNDROME,1
IE,NEURALGIA,1
IE,NEUROLEPTIC MALIGNANT SYNDROME,1
IE,NEUROMYOTONIA,1
IE,NIGHT SWEATS,1
IE,NIGHTMARE,1
IE,OBSTRUCTION,1
IE,OCULAR HYPERAEMIA,1
IE,ODYNOPHAGIA,1
IE,ORAL CANDIDIASIS,1
IE,ORAL DISORDER,1
IE,ORAL HERPES,1
IE,OROPHARYNGEAL DISCOMFORT,1
IE,OVERDOSE,1
IE,OVERWEIGHT,1
IE,PAIN OF SKIN,1
IE,PALATAL DISORDER,1
IE,PALLIATIVE CARE,1
IE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
IE,PANCREATIC CARCINOMA,1
IE,PANCREATIC NECROSIS,1
IE,PARALYSIS,1
IE,PARANOIA,1
IE,PARAPLEGIA,1
IE,PARKINSONISM,1
IE,PATIENT-DEVICE INCOMPATIBILITY,1
IE,PENILE SQUAMOUS CELL CARCINOMA,1
IE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
IE,PERIPHERAL ARTERY BYPASS,1
IE,PERIPHERAL COLDNESS,1
IE,PERITONITIS,1
IE,PETECHIAE,1
IE,PHARYNGEAL HAEMATOMA,1
IE,PHARYNGEAL OEDEMA,1
IE,PHARYNGEAL POLYP,1
IE,PHOTOPHOBIA,1
IE,PHOTOSENSITIVITY REACTION,1
IE,PIGMENTATION DISORDER,1
IE,PLASMA CELL LEUKAEMIA,1
IE,PLASMA CELL MYELOMA,1
IE,PLEURITIC PAIN,1
IE,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
IE,PNEUMONIA STREPTOCOCCAL,1
IE,POLYDIPSIA,1
IE,POOR DENTAL CONDITION,1
IE,POOR QUALITY SLEEP,1
IE,PREMATURE BABY,1
IE,PRODUCT QUALITY ISSUE,1
IE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
IE,PROSTATE CANCER,1
IE,PROSTATOMEGALY,1
IE,PRURITUS GENERALISED,1
IE,PSORIATIC ARTHROPATHY,1
IE,PSYCHOMOTOR HYPERACTIVITY,1
IE,PULMONARY CONGESTION,1
IE,PULMONARY FIBROSIS,1
IE,PULMONARY HYPERTENSION,1
IE,PULMONARY OEDEMA,1
IE,PULMONARY THROMBOSIS,1
IE,PULMONARY VALVE INCOMPETENCE,1
IE,PULSE ABNORMAL,1
IE,PUPIL FIXED,1
IE,RADIATION SICKNESS SYNDROME,1
IE,RALES,1
IE,RASH MACULAR,1
IE,RASH VESICULAR,1
IE,RAYNAUD^S PHENOMENON,1
IE,RED BLOOD CELL COUNT DECREASED,1
IE,REHABILITATION THERAPY,1
IE,RENAL FUNCTION TEST ABNORMAL,1
IE,RESPIRATORY DISORDER,1
IE,RESPIRATORY DISTRESS,1
IE,RESPIRATORY RATE INCREASED,1
IE,RESPIRATORY SYNCYTIAL VIRUS INFECTION,1
IE,RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE,1
IE,RETINAL DETACHMENT,1
IE,RHABDOMYOLYSIS,1
IE,RHEUMATOID ARTHRITIS,1
IE,RHEUMATOID NODULE,1
IE,RHINORRHOEA,1
IE,RIB FRACTURE,1
IE,ROAD TRAFFIC ACCIDENT,1
IE,SALIVARY HYPERSECRETION,1
IE,SCAR,1
IE,SCIATICA,1
IE,SECOND PRIMARY MALIGNANCY,1
IE,SEIZURE,1
IE,SENSORY LOSS,1
IE,SEPTIC SHOCK,1
IE,SEROSITIS,1
IE,SKIN BURNING SENSATION,1
IE,SKIN DISORDER,1
IE,SKIN EXFOLIATION,1
IE,SKIN FISSURES,1
IE,SKIN INFECTION,1
IE,SKIN INJURY,1
IE,SKIN LESION,1
IE,SLEEP DISORDER,1
IE,SOMNAMBULISM,1
IE,SPINAL COMPRESSION FRACTURE,1
IE,SPINAL PAIN,1
IE,STENT PLACEMENT,1
IE,STILLBIRTH,1
IE,STOMA SITE HAEMORRHAGE,1
IE,STOMATITIS,1
IE,SUBARACHNOID HAEMORRHAGE,1
IE,SWELLING,1
IE,SWELLING FACE,1
IE,SWOLLEN TONGUE,1
IE,SYNOVIAL CYST,1
IE,TACHYCARDIA,1
IE,TEARFULNESS,1
IE,TENSION HEADACHE,1
IE,TERMINAL STATE,1
IE,THERAPEUTIC RESPONSE UNEXPECTED,1
IE,THERAPY CESSATION,1
IE,THERAPY NON-RESPONDER,1
IE,THIRST,1
IE,THROAT TIGHTNESS,1
IE,THROMBOSIS IN DEVICE,1
IE,THYROID DISORDER,1
IE,TONGUE COATED,1
IE,TONGUE DISCOLOURATION,1
IE,TONGUE ULCERATION,1
IE,TONSILLITIS,1
IE,TOOTH ABSCESS,1
IE,TOOTH DISCOLOURATION,1
IE,TOOTH DISORDER,1
IE,TRANSAMINASES INCREASED,1
IE,TREATMENT NONCOMPLIANCE,1
IE,TRICHORRHEXIS,1
IE,TROPONIN INCREASED,1
IE,TYPE 2 DIABETES MELLITUS,1
IE,ULCERATIVE KERATITIS,1
IE,ULTRASOUND DOPPLER ABNORMAL,1
IE,UNEVALUABLE EVENT,1
IE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
IE,UPPER LIMB FRACTURE,1
IE,URINARY RETENTION,1
IE,URINARY TRACT INFECTION STAPHYLOCOCCAL,1
IE,URINE KETONE BODY,1
IE,URINE ODOUR ABNORMAL,1
IE,UTERINE HAEMORRHAGE,1
IE,VASCULAR STENT THROMBOSIS,1
IE,VASCULITIS,1
IE,VEIN DISORDER,1
IE,VISUAL ACUITY REDUCED,1
IE,WEIGHT INCREASED,1
IE,WOUND,1
IE,YELLOW SKIN,1
IL,PANCYTOPENIA,19
IL,ASTHENIA,18
IL,DYSPNOEA,16
IL,PYREXIA,16
IL,ABDOMINAL PAIN,13
IL,CEREBROVASCULAR ACCIDENT,13
IL,PNEUMONIA,13
IL,NAUSEA,12
IL,FALL,11
IL,HAEMOGLOBIN DECREASED,11
IL,VOMITING,11
IL,DIARRHOEA,10
IL,SEPSIS,10
IL,TOXICITY TO VARIOUS AGENTS,10
IL,ANAEMIA,9
IL,DIZZINESS,9
IL,MUCOSAL INFLAMMATION,9
IL,COUGH,8
IL,DEATH,8
IL,FATIGUE,8
IL,MYOCARDIAL INFARCTION,8
IL,ACUTE KIDNEY INJURY,7
IL,CHEST PAIN,7
IL,DECREASED APPETITE,7
IL,GASTROINTESTINAL HAEMORRHAGE,7
IL,SYNCOPE,7
IL,WEIGHT DECREASED,7
IL,ACUTE MYOCARDIAL INFARCTION,6
IL,CARDIAC FAILURE CONGESTIVE,6
IL,INTERNATIONAL NORMALISED RATIO INCREASED,6
IL,RENAL FAILURE,6
IL,CEREBRAL HAEMORRHAGE,5
IL,DUODENAL ULCER,5
IL,HEPATOTOXICITY,5
IL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,5
IL,PANCREATITIS,5
IL,RENAL FAILURE ACUTE,5
IL,THROMBOCYTOPENIA,5
IL,ATRIAL FIBRILLATION,4
IL,BLOOD CREATININE INCREASED,4
IL,BRADYCARDIA,4
IL,CARDIAC FAILURE,4
IL,CHILLS,4
IL,DIABETIC KETOACIDOSIS,4
IL,DRUG INEFFECTIVE,4
IL,ERYTHEMA,4
IL,GENERAL PHYSICAL HEALTH DETERIORATION,4
IL,HYPERTENSION,4
IL,HYPOGLYCAEMIA,4
IL,MATERNAL EXPOSURE DURING PREGNANCY,4
IL,MIXED LIVER INJURY,4
IL,MYOCARDIAL ISCHAEMIA,4
IL,PAIN IN EXTREMITY,4
IL,PANCREATIC CARCINOMA METASTATIC,4
IL,PLEURAL EFFUSION,4
IL,RASH,4
IL,RENAL IMPAIRMENT,4
IL,VASCULAR STENT THROMBOSIS,4
IL,ABDOMINAL PAIN UPPER,3
IL,ALANINE AMINOTRANSFERASE INCREASED,3
IL,ANGINA UNSTABLE,3
IL,ARRHYTHMIA,3
IL,ASPARTATE AMINOTRANSFERASE INCREASED,3
IL,ATRIOVENTRICULAR BLOCK COMPLETE,3
IL,BACTERAEMIA,3
IL,BLOOD GLUCOSE INCREASED,3
IL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
IL,CONDITION AGGRAVATED,3
IL,CONFUSIONAL STATE,3
IL,DEHYDRATION,3
IL,DRUG HYPERSENSITIVITY,3
IL,DYSPHAGIA,3
IL,EPISTAXIS,3
IL,FEBRILE NEUTROPENIA,3
IL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
IL,GASTROENTERITIS,3
IL,HAEMATOMA,3
IL,HAEMATURIA,3
IL,HEAD INJURY,3
IL,HEADACHE,3
IL,HEPATIC ENZYME INCREASED,3
IL,HYPONATRAEMIA,3
IL,INTRACARDIAC THROMBUS,3
IL,LOSS OF CONSCIOUSNESS,3
IL,MALIGNANT NEOPLASM PROGRESSION,3
IL,MELAENA,3
IL,OEDEMA,3
IL,OEDEMA PERIPHERAL,3
IL,PANCREATITIS ACUTE,3
IL,PARALYSIS,3
IL,PLASMA CELL MYELOMA,3
IL,PNEUMONIA ASPIRATION,3
IL,PRURITUS,3
IL,PULMONARY OEDEMA,3
IL,RESPIRATORY FAILURE,3
IL,SUBCUTANEOUS HAEMATOMA,3
IL,SUBDURAL HAEMATOMA,3
IL,THROMBOSIS IN DEVICE,3
IL,UPPER RESPIRATORY TRACT INFECTION,3
IL,URINARY TRACT INFECTION,3
IL,ABDOMINAL DISTENSION,2
IL,ANAPHYLACTIC SHOCK,2
IL,ANGINA PECTORIS,2
IL,ANGIOEDEMA,2
IL,ARTERIAL THROMBOSIS,2
IL,ARTHRITIS,2
IL,ASPHYXIA,2
IL,BACK PAIN,2
IL,BACTERIAL INFECTION,2
IL,BALANCE DISORDER,2
IL,BLOOD BILIRUBIN INCREASED,2
IL,BLOOD LACTATE DEHYDROGENASE INCREASED,2
IL,BLOOD LACTIC ACID INCREASED,2
IL,CARDIAC FAILURE CHRONIC,2
IL,CARDIAC TAMPONADE,2
IL,CELLULITIS,2
IL,CHEST DISCOMFORT,2
IL,CHOLESTATIC LIVER INJURY,2
IL,CLOSTRIDIAL INFECTION,2
IL,COGNITIVE DISORDER,2
IL,COMA,2
IL,CYTOMEGALOVIRUS COLITIS,2
IL,DEEP VEIN THROMBOSIS,2
IL,DEPRESSION,2
IL,DISEASE PROGRESSION,2
IL,DRY SKIN,2
IL,DYSPEPSIA,2
IL,ELECTROCARDIOGRAM QT PROLONGED,2
IL,EMBOLISM,2
IL,FLUID INTAKE REDUCED,2
IL,GASTROINTESTINAL ULCER HAEMORRHAGE,2
IL,HAEMATEMESIS,2
IL,HEPATIC FUNCTION ABNORMAL,2
IL,HEPATOCELLULAR INJURY,2
IL,HYPERGLYCAEMIA,2
IL,HYPERKALAEMIA,2
IL,HYPERSENSITIVITY VASCULITIS,2
IL,HYPOKALAEMIA,2
IL,HYPOMAGNESAEMIA,2
IL,HYPOPHAGIA,2
IL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
IL,INTESTINAL ISCHAEMIA,2
IL,INTRAVENTRICULAR HAEMORRHAGE,2
IL,ISCHAEMIC STROKE,2
IL,JAUNDICE,2
IL,LARGE INTESTINE POLYP,2
IL,LARYNGEAL OEDEMA,2
IL,LEUKOCYTOSIS,2
IL,LEUKOPENIA,2
IL,LIPASE INCREASED,2
IL,MALAISE,2
IL,MECHANICAL VENTILATION,2
IL,METABOLIC ACIDOSIS,2
IL,MICTURITION URGENCY,2
IL,MOUTH HAEMORRHAGE,2
IL,MUSCULOSKELETAL CHEST PAIN,2
IL,NEUTROPENIA,2
IL,OROPHARYNGEAL PAIN,2
IL,OSTEOPOROSIS,2
IL,OXYGEN SATURATION DECREASED,2
IL,PNEUMONITIS,2
IL,PULMONARY EMBOLISM,2
IL,PULMONARY HYPERTENSION,2
IL,RECTOSIGMOID CANCER,2
IL,RENAL FAILURE CHRONIC,2
IL,RETROPERITONEAL HAEMATOMA,2
IL,STUPOR,2
IL,SUBDURAL HAEMORRHAGE,2
IL,SUDDEN DEATH,2
IL,SUDDEN HEARING LOSS,2
IL,SUICIDE ATTEMPT,2
IL,TRANSIENT ISCHAEMIC ATTACK,2
IL,URINARY RETENTION,2
IL,VENTRICULAR TACHYCARDIA,2
IL,WHEEZING,2
IL,WHITE BLOOD CELL COUNT INCREASED,2
IL,ABDOMINAL TENDERNESS,1
IL,ABSCESS LIMB,1
IL,ACIDOSIS,1
IL,ACUTE CORONARY SYNDROME,1
IL,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
IL,ACUTE RESPIRATORY FAILURE,1
IL,ADENOCARCINOMA GASTRIC,1
IL,ADENOCARCINOMA OF COLON,1
IL,AGEUSIA,1
IL,AMYLASE INCREASED,1
IL,ANEURYSM,1
IL,ANURIA,1
IL,APHASIA,1
IL,APHTHOUS STOMATITIS,1
IL,ARTERIOVENOUS GRAFT SITE INFECTION,1
IL,ARTHRALGIA,1
IL,ASPIRATION,1
IL,ATRIOVENTRICULAR BLOCK,1
IL,AURICULAR HAEMATOMA,1
IL,BENIGN PROSTATIC HYPERPLASIA,1
IL,BILIRUBIN CONJUGATED INCREASED,1
IL,BLADDER CANCER,1
IL,BLINDNESS,1
IL,BLISTER,1
IL,BLOOD ALBUMIN DECREASED,1
IL,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IL,BLOOD CALCIUM DECREASED,1
IL,BLOOD CHLORIDE DECREASED,1
IL,BLOOD COUNT ABNORMAL,1
IL,BLOOD GLUCOSE FLUCTUATION,1
IL,BLOOD OSMOLARITY INCREASED,1
IL,BLOOD PHOSPHORUS DECREASED,1
IL,BLOOD PRESSURE ABNORMAL,1
IL,BLOOD PRESSURE DECREASED,1
IL,BLOOD PRESSURE FLUCTUATION,1
IL,BLOOD PRESSURE SYSTOLIC INCREASED,1
IL,BLOOD TESTOSTERONE DECREASED,1
IL,BLOOD THYROID STIMULATING HORMONE,1
IL,BLOOD THYROID STIMULATING HORMONE INCREASED,1
IL,BLOOD UREA INCREASED,1
IL,BONE MARROW FAILURE,1
IL,BRUCELLOSIS,1
IL,BUNDLE BRANCH BLOCK RIGHT,1
IL,CAESAREAN SECTION,1
IL,CALCIUM IONISED INCREASED,1
IL,CARDIAC DISORDER,1
IL,CARDIAC PACEMAKER INSERTION,1
IL,CARDIAC PERFORATION,1
IL,CARDIOGENIC SHOCK,1
IL,CAROTENE INCREASED,1
IL,CAROTID ARTERIOSCLEROSIS,1
IL,CATARACT,1
IL,CATHETERISATION CARDIAC,1
IL,CEREBRAL INFARCTION,1
IL,CEREBRAL ISCHAEMIA,1
IL,CERVIX CARCINOMA,1
IL,CHOLECYSTITIS,1
IL,CHOLECYSTITIS ACUTE,1
IL,CHOROIDAL NEOVASCULARISATION,1
IL,CHROMATURIA,1
IL,CHRONIC MYELOID LEUKAEMIA,1
IL,COAGULATION TIME PROLONGED,1
IL,COLITIS,1
IL,COMA SCALE ABNORMAL,1
IL,CONJUNCTIVITIS,1
IL,CONSTIPATION,1
IL,CONTRAINDICATED PRODUCT ADMINISTERED,1
IL,CONVULSION,1
IL,CORONARY ARTERY DISEASE,1
IL,CORONARY ARTERY OCCLUSION,1
IL,CORONARY ARTERY RESTENOSIS,1
IL,CREATININE RENAL CLEARANCE DECREASED,1
IL,CUTANEOUS VASCULITIS,1
IL,DEAFNESS,1
IL,DERMATITIS BULLOUS,1
IL,DEVICE OCCLUSION,1
IL,DIASTOLIC DYSFUNCTION,1
IL,DISORIENTATION,1
IL,DRUG ADMINISTRATION ERROR,1
IL,DRUG DOSE OMISSION,1
IL,DRUG ERUPTION,1
IL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
IL,DRY MOUTH,1
IL,DUODENITIS,1
IL,DYSGEUSIA,1
IL,DYSPHONIA,1
IL,DYSPNOEA EXERTIONAL,1
IL,DYSURIA,1
IL,EAR INFECTION,1
IL,ELECTROCARDIOGRAM ABNORMAL,1
IL,ELECTROCARDIOGRAM T WAVE INVERSION,1
IL,ELECTROCARDIOGRAM T WAVE PEAKED,1
IL,ELECTROLYTE IMBALANCE,1
IL,EMBOLIC STROKE,1
IL,EMPHYSEMA,1
IL,ERECTILE DYSFUNCTION,1
IL,ERYSIPELAS,1
IL,ESCHERICHIA PYELONEPHRITIS,1
IL,ESCHERICHIA SEPSIS,1
IL,EXPOSURE DURING PREGNANCY,1
IL,EXTENSOR PLANTAR RESPONSE,1
IL,FEEDING DISORDER,1
IL,FEELING ABNORMAL,1
IL,FEELING COLD,1
IL,FEELING HOT,1
IL,FLATULENCE,1
IL,FLUID RETENTION,1
IL,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
IL,FURUNCLE,1
IL,GASTRINOMA,1
IL,GASTRITIS,1
IL,GASTROINTESTINAL ANGIODYSPLASIA,1
IL,GASTROINTESTINAL STROMAL TUMOUR,1
IL,GINGIVAL BLEEDING,1
IL,GINGIVAL PAIN,1
IL,GLOBULINS DECREASED,1
IL,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
IL,GRANULOMATOSIS WITH POLYANGIITIS,1
IL,GROIN ABSCESS,1
IL,HAEMATOCHEZIA,1
IL,HAEMATOCRIT INCREASED,1
IL,HAEMODIALYSIS,1
IL,HAEMOGLOBIN ABNORMAL,1
IL,HAEMOPTYSIS,1
IL,HAEMORRHAGE,1
IL,HAEMORRHAGE INTRACRANIAL,1
IL,HAEMORRHAGIC EROSIVE GASTRITIS,1
IL,HAEMORRHAGIC STROKE,1
IL,HAEMORRHAGIC TRANSFORMATION STROKE,1
IL,HAND FRACTURE,1
IL,HEART RATE IRREGULAR,1
IL,HELICOBACTER TEST POSITIVE,1
IL,HEMIPARESIS,1
IL,HEPATIC CANCER,1
IL,HEPATIC FAILURE,1
IL,HERPES SIMPLEX,1
IL,HOSPITALISATION,1
IL,HYDROCEPHALUS,1
IL,HYDRONEPHROSIS,1
IL,HYPERAESTHESIA,1
IL,HYPERCALCAEMIA,1
IL,HYPERCHOLESTEROLAEMIA,1
IL,HYPERCOAGULATION,1
IL,HYPERMETABOLISM,1
IL,HYPERTHYROIDISM,1
IL,HYPERTRIGLYCERIDAEMIA,1
IL,HYPOAESTHESIA,1
IL,HYPOALBUMINAEMIA,1
IL,HYPOCALCAEMIA,1
IL,HYPOPHOSPHATAEMIA,1
IL,HYPOTENSION,1
IL,HYPOTHERMIA,1
IL,HYPOTHYROIDISM,1
IL,HYPOTONIA,1
IL,HYSTEROSALPINGO-OOPHORECTOMY,1
IL,ILLUSION,1
IL,IMPATIENCE,1
IL,INFECTIVE EXACERBATION OF BRONCHIECTASIS,1
IL,INFLUENZA,1
IL,INFLUENZA LIKE ILLNESS,1
IL,INJECTION SITE ABSCESS,1
IL,INJECTION SITE BRUISING,1
IL,INJECTION SITE ERYTHEMA,1
IL,INJECTION SITE SWELLING,1
IL,INSOMNIA,1
IL,INTENTIONAL PRODUCT USE ISSUE,1
IL,INTERMITTENT CLAUDICATION,1
IL,INTERSTITIAL LUNG DISEASE,1
IL,INTESTINAL OBSTRUCTION,1
IL,INTRA-ABDOMINAL HAEMATOMA,1
IL,INTRA-UTERINE CONTRACEPTIVE DEVICE REMOVAL,1
IL,INVASIVE DUCTAL BREAST CARCINOMA,1
IL,KAPOSI^S SARCOMA,1
IL,LACTIC ACIDOSIS,1
IL,LEFT VENTRICULAR HYPERTROPHY,1
IL,LETHARGY,1
IL,LIMB INJURY,1
IL,LIP SWELLING,1
IL,LIVER ABSCESS,1
IL,LIVER INJURY,1
IL,LOCAL SWELLING,1
IL,LOWER LIMB FRACTURE,1
IL,LUMBAR VERTEBRAL FRACTURE,1
IL,LUNG ADENOCARCINOMA,1
IL,LYMPHOCYTE COUNT DECREASED,1
IL,LYMPHOCYTE PERCENTAGE DECREASED,1
IL,MACULAR OEDEMA,1
IL,MATERNAL EXPOSURE BEFORE PREGNANCY,1
IL,MEAN PLATELET VOLUME INCREASED,1
IL,MESOTHELIOMA,1
IL,METABOLIC DISORDER,1
IL,MITRAL VALVE CALCIFICATION,1
IL,MITRAL VALVE INCOMPETENCE,1
IL,MONOCYTE COUNT INCREASED,1
IL,MONOPLEGIA,1
IL,MULTI-ORGAN FAILURE,1
IL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
IL,MUSCLE HAEMORRHAGE,1
IL,MUSCULOSKELETAL PAIN,1
IL,MYALGIA,1
IL,MYASTHENIA GRAVIS,1
IL,MYCOPLASMA INFECTION,1
IL,MYELODYSPLASTIC SYNDROME,1
IL,MYOCARDITIS,1
IL,MYOPATHY,1
IL,NASOPHARYNGITIS,1
IL,NECK PAIN,1
IL,NEPHROSTOMY,1
IL,NEUTROPHIL COUNT ABNORMAL,1
IL,NEUTROPHIL COUNT INCREASED,1
IL,NEUTROPHIL PERCENTAGE INCREASED,1
IL,NORMAL NEWBORN,1
IL,ODYNOPHAGIA,1
IL,ORAL PAIN,1
IL,ORGANISING PNEUMONIA,1
IL,OVERDOSE,1
IL,PAIN,1
IL,PAIN OF SKIN,1
IL,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
IL,PANCREATIC CARCINOMA,1
IL,PANCREATIC ENZYMES INCREASED,1
IL,PAPILLARY THYROID CANCER,1
IL,PARANOIA,1
IL,PELVIC FRACTURE,1
IL,PERCUTANEOUS CORONARY INTERVENTION,1
IL,PLATELET COUNT ABNORMAL,1
IL,PNEUMONIA MYCOPLASMAL,1
IL,POLYMERASE CHAIN REACTION,1
IL,POST PROCEDURAL HAEMATOMA,1
IL,POSTPERICARDIOTOMY SYNDROME,1
IL,PRESYNCOPE,1
IL,PROCTITIS,1
IL,PRODUCT USE ISSUE,1
IL,PRODUCTIVE COUGH,1
IL,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
IL,PROSTATITIS,1
IL,PROTEIN TOTAL DECREASED,1
IL,PROTHROMBIN TIME PROLONGED,1
IL,PSEUDOMONAL SEPSIS,1
IL,PSYCHOTIC BEHAVIOUR,1
IL,PUBIS FRACTURE,1
IL,PULMONARY ARTERIAL HYPERTENSION,1
IL,RADIOTHERAPY,1
IL,RASH MACULAR,1
IL,RECTAL HAEMORRHAGE,1
IL,RENAL ABSCESS,1
IL,RENAL CELL CARCINOMA,1
IL,RENAL INJURY,1
IL,RENAL TUBULAR ACIDOSIS,1
IL,RENAL VASCULITIS,1
IL,RESPIRATORY DISORDER,1
IL,RHABDOMYOLYSIS,1
IL,RHINORRHOEA,1
IL,ROAD TRAFFIC ACCIDENT,1
IL,SALMONELLOSIS,1
IL,SCIATICA,1
IL,SEPTIC SHOCK,1
IL,SHOCK,1
IL,SHOCK HAEMORRHAGIC,1
IL,SINUS TACHYCARDIA,1
IL,SKIN DISCOLOURATION,1
IL,SKIN EXFOLIATION,1
IL,SKIN LESION,1
IL,SKIN PAPILLOMA,1
IL,SLEEP DISORDER,1
IL,SMALL CELL LUNG CANCER,1
IL,SOMNOLENCE,1
IL,SPEECH DISORDER,1
IL,SQUAMOUS CELL CARCINOMA OF LUNG,1
IL,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
IL,SUBARACHNOID HAEMORRHAGE,1
IL,SUPRAVENTRICULAR TACHYCARDIA,1
IL,SWELLING,1
IL,SWELLING FACE,1
IL,TACHYCARDIA,1
IL,TENDON RUPTURE,1
IL,THROMBOSIS,1
IL,THYROID NEOPLASM,1
IL,THYROIDECTOMY,1
IL,THYROXINE DECREASED,1
IL,TOOTH INFECTION,1
IL,TRANSFERRIN DECREASED,1
IL,TRANSFUSION,1
IL,TRANSFUSION REACTION,1
IL,TUMOUR LYSIS SYNDROME,1
IL,ULCER,1
IL,UMBILICAL HERNIA,1
IL,UNDERDOSE,1
IL,UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE,1
IL,URINE KETONE BODY PRESENT,1
IL,VAGINAL HAEMORRHAGE,1
IL,VASCULAR CALCIFICATION,1
IL,VASCULAR GRAFT,1
IL,VASCULAR OCCLUSION,1
IL,VASCULAR PSEUDOANEURYSM,1
IL,VASCULAR STENT OCCLUSION,1
IL,VENTRICULAR ASYSTOLE,1
IL,VENTRICULAR DYSFUNCTION,1
IL,VERTIGO,1
IL,VIRAL INFECTION,1
IL,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
IL,VOCAL CORD PARALYSIS,1
IL,WHITE BLOOD CELL COUNT ABNORMAL,1
IL,WHITE BLOOD CELL COUNT DECREASED,1
IL,WOUND INFECTION,1
IL,YELLOW SKIN,1
IT,ANAEMIA,36
IT,ACUTE KIDNEY INJURY,22
IT,LACTIC ACIDOSIS,19
IT,ASTHENIA,17
IT,TOXICITY TO VARIOUS AGENTS,17
IT,HYPOTENSION,16
IT,CARDIAC FAILURE,14
IT,VOMITING,13
IT,DEATH,12
IT,DYSPNOEA,12
IT,HEADACHE,12
IT,PLEURAL EFFUSION,12
IT,PNEUMONIA,12
IT,HAEMORRHAGE,11
IT,ATRIAL FIBRILLATION,10
IT,DRUG INEFFECTIVE,10
IT,HAEMATURIA,10
IT,HAEMOGLOBIN DECREASED,10
IT,NEUTROPENIA,10
IT,ACUTE MYOCARDIAL INFARCTION,9
IT,ELECTROCARDIOGRAM QT PROLONGED,9
IT,FATIGUE,9
IT,HYPOGLYCAEMIA,9
IT,LUPUS-LIKE SYNDROME,9
IT,MELAENA,9
IT,METABOLIC ACIDOSIS,9
IT,RHABDOMYOLYSIS,9
IT,ABDOMINAL PAIN,8
IT,CARDIAC ARREST,8
IT,DRUG ABUSE,8
IT,GASTROINTESTINAL HAEMORRHAGE,8
IT,LOSS OF CONSCIOUSNESS,8
IT,OVERDOSE,8
IT,PYREXIA,8
IT,RENAL FAILURE ACUTE,8
IT,SYNCOPE,8
IT,THROMBOCYTOPENIA,8
IT,ARTHRALGIA,7
IT,BLOOD CREATININE INCREASED,7
IT,BRADYCARDIA,7
IT,DIARRHOEA,7
IT,HAEMORRHAGE INTRACRANIAL,7
IT,HYPOKALAEMIA,7
IT,SHOCK,7
IT,THROMBOSIS IN DEVICE,7
IT,THROMBOTIC THROMBOCYTOPENIC PURPURA,7
IT,AORTIC THROMBOSIS,6
IT,CEREBRAL HAEMORRHAGE,6
IT,CEREBRAL ISCHAEMIA,6
IT,DECREASED APPETITE,6
IT,HYPOCALCAEMIA,6
IT,HYPOMAGNESAEMIA,6
IT,MYOCARDIAL INFARCTION,6
IT,NAUSEA,6
IT,NEPHROPATHY TOXIC,6
IT,PRODUCT USE ISSUE,6
IT,RENAL FAILURE,6
IT,ANGINA PECTORIS,5
IT,ANGIOEDEMA,5
IT,CONFUSIONAL STATE,5
IT,DRUG RESISTANCE,5
IT,EMBOLIC STROKE,5
IT,EXPOSURE DURING PREGNANCY,5
IT,FALL,5
IT,GAIT DISTURBANCE,5
IT,HAEMATOMA,5
IT,HEPATITIS ACUTE,5
IT,HYPERKALAEMIA,5
IT,HYPONATRAEMIA,5
IT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,5
IT,MALAISE,5
IT,MYOPATHY,5
IT,OEDEMA PERIPHERAL,5
IT,OPTIC ISCHAEMIC NEUROPATHY,5
IT,PANCYTOPENIA,5
IT,RECTAL HAEMORRHAGE,5
IT,SINUS ARREST,5
IT,SOMNOLENCE,5
IT,SOPOR,5
IT,VENTRICULAR TACHYCARDIA,5
IT,BASAL CELL CARCINOMA,4
IT,CARDIAC VENTRICULAR THROMBOSIS,4
IT,COLITIS,4
IT,CONTRAINDICATED PRODUCT ADMINISTERED,4
IT,CORONARY ARTERY BYPASS,4
IT,DEEP VEIN THROMBOSIS,4
IT,HALLUCINATION_ VISUAL,4
IT,HYPERHIDROSIS,4
IT,INTENTIONAL OVERDOSE,4
IT,ISCHAEMIC STROKE,4
IT,PALPITATIONS,4
IT,PHOTOPSIA,4
IT,SEPSIS,4
IT,THERAPEUTIC RESPONSE DECREASED,4
IT,TRANSFUSION,4
IT,TRANSIENT ISCHAEMIC ATTACK,4
IT,ABDOMINAL PAIN UPPER,3
IT,ABDOMINAL TENDERNESS,3
IT,ANXIETY,3
IT,BLOOD CREATININE ABNORMAL,3
IT,BRONCHITIS,3
IT,CARDIAC DISORDER,3
IT,CHEST PAIN,3
IT,CONDITION AGGRAVATED,3
IT,CONGESTIVE CARDIOMYOPATHY,3
IT,COUGH,3
IT,DELIRIUM,3
IT,DIVERTICULITIS,3
IT,DRUG HYPERSENSITIVITY,3
IT,ECCHYMOSIS,3
IT,EJECTION FRACTION DECREASED,3
IT,EPISTAXIS,3
IT,ERYTHEMA,3
IT,FEBRILE NEUTROPENIA,3
IT,GASTRIC ULCER,3
IT,GASTRITIS,3
IT,HAEMOLYTIC ANAEMIA,3
IT,HYPERCHOLESTEROLAEMIA,3
IT,HYPERTENSION,3
IT,HYPERTENSIVE CRISIS,3
IT,INFECTION,3
IT,INTESTINAL ISCHAEMIA,3
IT,INTESTINAL OBSTRUCTION,3
IT,MEDICATION ERROR,3
IT,MUCOSAL INFLAMMATION,3
IT,MULTI-ORGAN FAILURE,3
IT,MUSCULOSKELETAL PAIN,3
IT,MYALGIA,3
IT,PAIN,3
IT,PERICARDIAL EFFUSION,3
IT,PERICARDITIS,3
IT,PETECHIAE,3
IT,PLATELET COUNT DECREASED,3
IT,PLATELET COUNT INCREASED,3
IT,PREMATURE DELIVERY,3
IT,PRESCRIBED OVERDOSE,3
IT,RASH,3
IT,RENAL IMPAIRMENT,3
IT,RENAL ISCHAEMIA,3
IT,RESPIRATORY FAILURE,3
IT,SHOCK HAEMORRHAGIC,3
IT,SPLENIC RUPTURE,3
IT,SUDDEN DEATH,3
IT,SUICIDE ATTEMPT,3
IT,VERTIGO,3
IT,VISCERAL ARTERIAL ISCHAEMIA,3
IT,ABDOMINAL DISTENSION,2
IT,ACUTE CORONARY SYNDROME,2
IT,ACUTE PULMONARY OEDEMA,2
IT,ADVERSE EVENT,2
IT,ALANINE AMINOTRANSFERASE INCREASED,2
IT,ALTERED STATE OF CONSCIOUSNESS,2
IT,ANAPHYLACTIC REACTION,2
IT,ANURIA,2
IT,ARTERIAL THROMBOSIS,2
IT,ARTERIOSCLEROSIS CORONARY ARTERY,2
IT,ARTHRITIS BACTERIAL,2
IT,ATAXIA,2
IT,BLINDNESS,2
IT,BLOOD ALKALINE PHOSPHATASE INCREASED,2
IT,BLOOD BILIRUBIN INCREASED,2
IT,BLOOD PRESSURE SYSTOLIC INCREASED,2
IT,BONE CYST,2
IT,BRONCHOPNEUMONIA,2
IT,CARDIAC FAILURE ACUTE,2
IT,CARPAL TUNNEL SYNDROME,2
IT,CEREBRAL SALT-WASTING SYNDROME,2
IT,CEREBROVASCULAR ACCIDENT,2
IT,CHEST DISCOMFORT,2
IT,CHROMATURIA,2
IT,COMA,2
IT,CONSTIPATION,2
IT,CORONARY OSTIAL STENOSIS,2
IT,DEPRESSED LEVEL OF CONSCIOUSNESS,2
IT,DEPRESSION,2
IT,DEVICE MALFUNCTION,2
IT,DIABETIC METABOLIC DECOMPENSATION,2
IT,DISEASE PROGRESSION,2
IT,DIZZINESS,2
IT,DRUG ADMINISTRATION ERROR,2
IT,DRUG-DISEASE INTERACTION,2
IT,DRUG-INDUCED LIVER INJURY,2
IT,DYSARTHRIA,2
IT,DYSPHAGIA,2
IT,DYSSTASIA,2
IT,EROSIVE OESOPHAGITIS,2
IT,EYE SWELLING,2
IT,FOETAL EXPOSURE DURING PREGNANCY,2
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
IT,GASTRIC ULCER HAEMORRHAGE,2
IT,GASTRITIS EROSIVE,2
IT,GASTROINTESTINAL DISORDER,2
IT,GASTROINTESTINAL TOXICITY,2
IT,GASTROOESOPHAGEAL REFLUX DISEASE,2
IT,HAEMATOCHEZIA,2
IT,HAEMATOCRIT DECREASED,2
IT,HAEMATOTOXICITY,2
IT,HAEMODYNAMIC INSTABILITY,2
IT,HAEMOPTYSIS,2
IT,HAEMORRHAGE SUBCUTANEOUS,2
IT,HALLUCINATION,2
IT,HEAD INJURY,2
IT,HEMIPLEGIA,2
IT,HEPATIC ISCHAEMIA,2
IT,HEPATITIS,2
IT,HEPATOCELLULAR INJURY,2
IT,HEPATOTOXICITY,2
IT,HYPERGLYCAEMIA,2
IT,HYPERSENSITIVITY VASCULITIS,2
IT,HYPOTHERMIA,2
IT,HYPOXIA,2
IT,INFLAMMATORY MARKER INCREASED,2
IT,INTENTIONAL SELF-INJURY,2
IT,INTERNATIONAL NORMALISED RATIO ABNORMAL,2
IT,IRON DEFICIENCY,2
IT,ISCHAEMIA,2
IT,JAUNDICE,2
IT,MENTAL STATUS CHANGES,2
IT,MITRAL VALVE INCOMPETENCE,2
IT,MUSCLE HAEMORRHAGE,2
IT,MUSCLE SPASMS,2
IT,NASAL CAVITY CANCER,2
IT,NEONATAL RESPIRATORY DISTRESS SYNDROME,2
IT,NEUROTOXICITY,2
IT,OESOPHAGEAL CANDIDIASIS,2
IT,OSTEONECROSIS,2
IT,OXYGEN SATURATION DECREASED,2
IT,PALLOR,2
IT,PANCREATIC CARCINOMA,2
IT,PARAESTHESIA,2
IT,PLASMA CELL MYELOMA,2
IT,POISONING,2
IT,PRESYNCOPE,2
IT,PRODUCT USE IN UNAPPROVED INDICATION,2
IT,PROTEINURIA,2
IT,PRURITUS,2
IT,PULMONARY EMBOLISM,2
IT,PULMONARY OEDEMA,2
IT,QUADRIPLEGIA,2
IT,RED BLOOD CELL COUNT DECREASED,2
IT,RESPIRATORY DISTRESS,2
IT,RIB FRACTURE,2
IT,SEIZURE,2
IT,SEPTIC SHOCK,2
IT,SPLENOMEGALY,2
IT,SYSTEMIC LUPUS ERYTHEMATOSUS,2
IT,TACHYCARDIA,2
IT,TETANY,2
IT,TRANSAMINASES INCREASED,2
IT,TRAUMATIC HAEMORRHAGE,2
IT,TREMOR,2
IT,ULCER,2
IT,URTICARIA,2
IT,VASCULAR OPERATION,2
IT,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
IT,ABASIA,1
IT,ABDOMINAL WALL HAEMATOMA,1
IT,ABNORMAL WEIGHT GAIN,1
IT,ABORTION SPONTANEOUS,1
IT,ACCIDENTAL OVERDOSE,1
IT,ACUTE LYMPHOCYTIC LEUKAEMIA,1
IT,ADAMS-STOKES SYNDROME,1
IT,ADENOCARCINOMA,1
IT,ADENOCARCINOMA PANCREAS,1
IT,ADRENAL INSUFFICIENCY,1
IT,AEROMONA INFECTION,1
IT,AGITATION,1
IT,AKINESIA,1
IT,ALCOHOL INTERACTION,1
IT,AMNESIA,1
IT,AMNIOTIC FLUID VOLUME DECREASED,1
IT,AMYLASE INCREASED,1
IT,ANAPHYLACTIC SHOCK,1
IT,ANGINA UNSTABLE,1
IT,ANION GAP INCREASED,1
IT,ANTI FACTOR VIII ANTIBODY POSITIVE,1
IT,ANTINUCLEAR ANTIBODY POSITIVE,1
IT,APLASTIC ANAEMIA,1
IT,APPENDICITIS,1
IT,APRAXIA,1
IT,AREFLEXIA,1
IT,ARRHYTHMIA,1
IT,ASCITES,1
IT,ATELECTASIS,1
IT,AUTOIMMUNE HEPATITIS,1
IT,BACK PAIN,1
IT,BACTERAEMIA,1
IT,BALANCE DISORDER,1
IT,BASILAR ARTERY THROMBOSIS,1
IT,BEHCET^S SYNDROME,1
IT,BETA 2 MICROGLOBULIN INCREASED,1
IT,BILE DUCT STONE,1
IT,BLADDER TRANSITIONAL CELL CARCINOMA,1
IT,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
IT,BLOOD PRESSURE INCREASED,1
IT,BLOOD THYROID STIMULATING HORMONE INCREASED,1
IT,BRONCHIAL SECRETION RETENTION,1
IT,BUNDLE BRANCH BLOCK LEFT,1
IT,BUNDLE BRANCH BLOCK RIGHT,1
IT,BUTTERFLY RASH,1
IT,C-REACTIVE PROTEIN INCREASED,1
IT,CAESAREAN SECTION,1
IT,CANDIDA INFECTION,1
IT,CARDIAC FAILURE CONGESTIVE,1
IT,CARDIAC FIBRILLATION,1
IT,CARDIO-RESPIRATORY ARREST,1
IT,CARDIOGENIC SHOCK,1
IT,CARDIOTOXICITY,1
IT,CATARACT,1
IT,CATHETER SITE HAEMORRHAGE,1
IT,CEREBELLAR HAEMORRHAGE,1
IT,CEREBRAL ARTERY STENOSIS,1
IT,CEREBROVASCULAR DISORDER,1
IT,CHEYNE-STOKES RESPIRATION,1
IT,CHOLANGIOCARCINOMA,1
IT,CHOLESTEATOMA,1
IT,CIRCADIAN RHYTHM SLEEP DISORDER,1
IT,CLAVICLE FRACTURE,1
IT,CLOSTRIDIUM DIFFICILE INFECTION,1
IT,COLITIS EROSIVE,1
IT,COLITIS ULCERATIVE,1
IT,COLON CANCER,1
IT,CONDUCTION DISORDER,1
IT,CONGENITAL ANOMALY,1
IT,CONJUNCTIVITIS,1
IT,CONSCIOUSNESS FLUCTUATING,1
IT,CORONARY ARTERY DISEASE,1
IT,CORONARY ARTERY EMBOLISM,1
IT,CORONARY ARTERY OCCLUSION,1
IT,CORONARY ARTERY STENOSIS,1
IT,CORONARY ARTERY THROMBOSIS,1
IT,CRANIOCEREBRAL INJURY,1
IT,CYSTITIS,1
IT,CYTOMEGALOVIRUS INFECTION,1
IT,CYTOPENIA,1
IT,DEHYDRATION,1
IT,DERMATITIS,1
IT,DERMATITIS BULLOUS,1
IT,DERMATITIS CONTACT,1
IT,DIABETES MELLITUS,1
IT,DIALYSIS,1
IT,DIFFUSE LARGE B-CELL LYMPHOMA,1
IT,DISABILITY,1
IT,DIVERTICULUM,1
IT,DROP ATTACKS,1
IT,DRUG ERUPTION,1
IT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
IT,DRUG INTOLERANCE,1
IT,DRUG LEVEL INCREASED,1
IT,DRUG PRESCRIBING ERROR,1
IT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
IT,DRUG USE DISORDER,1
IT,DRY MOUTH,1
IT,DRY SKIN,1
IT,DUODENAL ULCER,1
IT,DUODENITIS,1
IT,DYSPEPSIA,1
IT,ECZEMA,1
IT,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
IT,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
IT,ELECTROCARDIOGRAM T WAVE INVERSION,1
IT,ELECTROLYTE IMBALANCE,1
IT,EMBOLIC CEREBRAL INFARCTION,1
IT,EPIDIDYMITIS,1
IT,ERECTILE DYSFUNCTION,1
IT,EROSIVE DUODENITIS,1
IT,ERYTHEMA MULTIFORME,1
IT,ESCHERICHIA SEPSIS,1
IT,ESCHERICHIA URINARY TRACT INFECTION,1
IT,EYELID OEDEMA,1
IT,FACTOR VIII INHIBITION,1
IT,FAECES DISCOLOURED,1
IT,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
IT,FOETAL EXPOSURE TIMING UNSPECIFIED,1
IT,FRACTURE,1
IT,GASTRIC HAEMORRHAGE,1
IT,GASTROENTERITIS,1
IT,GASTROINTESTINAL MUCOSA HYPERAEMIA,1
IT,GENERAL PHYSICAL CONDITION ABNORMAL,1
IT,GENERAL PHYSICAL HEALTH DETERIORATION,1
IT,GINGIVAL DISORDER,1
IT,GLAUCOMA,1
IT,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
IT,GOUT,1
IT,GRANULOMA ANNULARE,1
IT,GYNAECOMASTIA,1
IT,H1N1 INFLUENZA,1
IT,HAEMATEMESIS,1
IT,HAEMOLYTIC URAEMIC SYNDROME,1
IT,HAEMORRHAGIC ANAEMIA,1
IT,HAEMOTHORAX,1
IT,HALLUCINATION_ AUDITORY,1
IT,HELICOBACTER GASTRITIS,1
IT,HELLP SYNDROME,1
IT,HEPATIC FAILURE,1
IT,HEPATIC FUNCTION ABNORMAL,1
IT,HEPATOMEGALY,1
IT,HER-2 POSITIVE GASTRIC CANCER,1
IT,HERPES ZOSTER,1
IT,HIATUS HERNIA,1
IT,HYDROCELE,1
IT,HYPERALDOSTERONISM,1
IT,HYPERCREATINAEMIA,1
IT,HYPERPYREXIA,1
IT,HYPERTENSIVE CARDIOMYOPATHY,1
IT,HYPERTRANSAMINASAEMIA,1
IT,HYPOGLYCAEMIC COMA,1
IT,HYPOKINESIA,1
IT,HYPOPARATHYROIDISM,1
IT,HYPOTONIA,1
IT,HYPOVOLAEMIC SHOCK,1
IT,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
IT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IT,INCORRECT DRUG ADMINISTRATION DURATION,1
IT,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
IT,INFARCTION,1
IT,INFECTIOUS MONONUCLEOSIS,1
IT,INFLAMMATION,1
IT,INJURY,1
IT,INSOMNIA,1
IT,INTERNATIONAL NORMALISED RATIO INCREASED,1
IT,INTERSTITIAL LUNG DISEASE,1
IT,JOINT SWELLING,1
IT,KAPOSI^S SARCOMA,1
IT,LARGE INTESTINAL ULCER HAEMORRHAGE,1
IT,LARYNGEAL OEDEMA,1
IT,LEFT VENTRICULAR DYSFUNCTION,1
IT,LEFT VENTRICULAR HYPERTROPHY,1
IT,LEUKOCYTOSIS,1
IT,LEUKOPENIA,1
IT,LINEAR IGA DISEASE,1
IT,LIP OEDEMA,1
IT,LIPASE INCREASED,1
IT,LISTERIOSIS,1
IT,LISTLESS,1
IT,LIVER DISORDER,1
IT,LIVER FUNCTION TEST ABNORMAL,1
IT,LIVER INJURY,1
IT,LOCALISED OEDEMA,1
IT,LONG QT SYNDROME,1
IT,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
IT,LOWER GASTROINTESTINAL HAEMORRHAGE,1
IT,LUNG CONSOLIDATION,1
IT,LUNG NEOPLASM,1
IT,LYMPHOPENIA,1
IT,MALIGNANT HYPERTENSION,1
IT,MALIGNANT NEOPLASM PROGRESSION,1
IT,MATERNAL EXPOSURE DURING PREGNANCY,1
IT,MEGACOLON,1
IT,MEMORY IMPAIRMENT,1
IT,MENINGITIS,1
IT,MENINGITIS ASEPTIC,1
IT,METABOLIC ALKALOSIS,1
IT,METABOLIC DISORDER,1
IT,MICROCYTIC ANAEMIA,1
IT,MIGRAINE,1
IT,MIXED LIVER INJURY,1
IT,MOTOR DYSFUNCTION,1
IT,MOUTH ULCERATION,1
IT,MOVEMENT DISORDER,1
IT,MULTIPLE-DRUG RESISTANCE,1
IT,MUSCULAR WEAKNESS,1
IT,MUSCULOSKELETAL CHEST PAIN,1
IT,MUSCULOSKELETAL STIFFNESS,1
IT,MYELOFIBROSIS,1
IT,MYOCARDIAL NECROSIS MARKER INCREASED,1
IT,NASOPHARYNGITIS,1
IT,NEONATAL RESPIRATORY DEPRESSION,1
IT,NEPHRITIS,1
IT,NEPHROLITHIASIS,1
IT,NEURALGIA,1
IT,NEUROPATHY PERIPHERAL,1
IT,NEUTROPHILIA,1
IT,OBESITY,1
IT,OBSTRUCTIVE AIRWAYS DISORDER,1
IT,OCULAR DISCOMFORT,1
IT,OEDEMA MOUTH,1
IT,OESOPHAGITIS,1
IT,OLIGURIA,1
IT,ORAL CANDIDIASIS,1
IT,ORCHITIS,1
IT,ORTHOSTATIC HYPOTENSION,1
IT,OSTEOARTHRITIS,1
IT,OSTEONECROSIS OF JAW,1
IT,OSTEOPOROSIS,1
IT,PACKED RED BLOOD CELL TRANSFUSION,1
IT,PANCREATITIS,1
IT,PANCREATITIS ACUTE,1
IT,PAPILLARY THYROID CANCER,1
IT,PARALYSIS,1
IT,PARESIS,1
IT,PELVIC HAEMATOMA,1
IT,PEMPHIGOID,1
IT,PERCUTANEOUS CORONARY INTERVENTION,1
IT,PERIODONTITIS,1
IT,PERIPHERAL ARTERY STENOSIS,1
IT,PERIPHERAL ARTERY THROMBOSIS,1
IT,PERIPHERAL ISCHAEMIA,1
IT,PERIPHERAL MOTOR NEUROPATHY,1
IT,PERIPHERAL SENSORY NEUROPATHY,1
IT,PERITONEAL HAEMORRHAGE,1
IT,PERITONITIS,1
IT,PHOTOSENSITIVITY REACTION,1
IT,PLATELET DISORDER,1
IT,PLEURAL MESOTHELIOMA,1
IT,PLEUROPERICARDITIS,1
IT,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
IT,PNEUMONIA LEGIONELLA,1
IT,PNEUMONITIS,1
IT,POLYNEUROPATHY,1
IT,PREGNANCY,1
IT,PROSTATE CANCER,1
IT,PROSTATIC ADENOMA,1
IT,PSYCHOMOTOR HYPERACTIVITY,1
IT,PSYCHOTIC DISORDER,1
IT,PULMONARY CONGESTION,1
IT,PULMONARY INFARCTION,1
IT,QUADRIPARESIS,1
IT,RASH GENERALISED,1
IT,RASH MACULAR,1
IT,RASH MACULO-PAPULAR,1
IT,RASH PAPULAR,1
IT,RESPIRATORY TRACT HAEMORRHAGE,1
IT,RETICULOCYTOPENIA,1
IT,SECOND PRIMARY MALIGNANCY,1
IT,SELF INJURIOUS BEHAVIOUR,1
IT,SELF-MEDICATION,1
IT,SENSORY LOSS,1
IT,SINOATRIAL BLOCK,1
IT,SINUS BRADYCARDIA,1
IT,SINUS TACHYCARDIA,1
IT,SKIN DISORDER,1
IT,SKIN HYPOPIGMENTATION,1
IT,SKIN IRRITATION,1
IT,SKIN LESION,1
IT,SKIN ULCER,1
IT,SLUGGISHNESS,1
IT,SMALL INTESTINAL HAEMORRHAGE,1
IT,SMALL INTESTINAL PERFORATION,1
IT,SPINAL COMPRESSION FRACTURE,1
IT,SPINAL FRACTURE,1
IT,SPLENIC INFARCTION,1
IT,SPONTANEOUS HAEMATOMA,1
IT,STAPHYLOCOCCAL SEPSIS,1
IT,STRESS,1
IT,SUBARACHNOID HAEMORRHAGE,1
IT,SUBDURAL HAEMATOMA,1
IT,SUDDEN VISUAL LOSS,1
IT,SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED,1
IT,SUPRAVENTRICULAR TACHYARRHYTHMIA,1
IT,SUPRAVENTRICULAR TACHYCARDIA,1
IT,SWELLING FACE,1
IT,SWOLLEN TONGUE,1
IT,SYSTEMIC MASTOCYTOSIS,1
IT,TACHYARRHYTHMIA,1
IT,TACHYPNOEA,1
IT,THYROID DISORDER,1
IT,TINNITUS,1
IT,TONGUE OEDEMA,1
IT,TORSADE DE POINTES,1
IT,TOXIC EPIDERMAL NECROLYSIS,1
IT,TRANSPLANT REJECTION,1
IT,TREATMENT NONCOMPLIANCE,1
IT,UNDERDOSE,1
IT,UPPER GASTROINTESTINAL HAEMORRHAGE,1
IT,URINARY CASTS,1
IT,URINARY TRACT INFECTION,1
IT,VASCULAR STENT RESTENOSIS,1
IT,VENTRICULAR FIBRILLATION,1
IT,VENTRICULAR TACHYARRHYTHMIA,1
IT,WEIGHT DECREASED,1
IT,WITHDRAWAL SYNDROME,1
IT,WOUND HAEMORRHAGE,1
JM,CEREBROVASCULAR ACCIDENT,1
JM,DEATH,1
JM,ISCHAEMIC STROKE,1
JM,PULMONARY OEDEMA,1
JP,ANAEMIA,53
JP,PYREXIA,49
JP,CARDIAC FAILURE,43
JP,CEREBRAL INFARCTION,35
JP,PNEUMONIA,34
JP,ALTERED STATE OF CONSCIOUSNESS,32
JP,RENAL IMPAIRMENT,31
JP,CORONARY ARTERY DISEASE,30
JP,HEPATIC FUNCTION ABNORMAL,28
JP,BLOOD PRESSURE DECREASED,27
JP,DECREASED APPETITE,27
JP,DRUG INEFFECTIVE,25
JP,NO THERAPEUTIC RESPONSE,24
JP,FALL,23
JP,HAEMATOMA,23
JP,ANAPHYLACTIC REACTION,22
JP,CONDITION AGGRAVATED,22
JP,RASH,22
JP,CEREBRAL HAEMORRHAGE,21
JP,INTERSTITIAL LUNG DISEASE,20
JP,NAUSEA,19
JP,VOMITING,19
JP,DIARRHOEA,18
JP,PLATELET COUNT DECREASED,18
JP,ACUTE KIDNEY INJURY,17
JP,ACUTE MYOCARDIAL INFARCTION,17
JP,CARDIO-RESPIRATORY ARREST,17
JP,DEHYDRATION,17
JP,DYSPNOEA,17
JP,GASTROINTESTINAL HAEMORRHAGE,17
JP,HYPOGLYCAEMIA,17
JP,WHITE BLOOD CELL COUNT INCREASED,17
JP,ASPARTATE AMINOTRANSFERASE INCREASED,16
JP,BRADYCARDIA,16
JP,NEUTROPENIA,16
JP,ALANINE AMINOTRANSFERASE INCREASED,15
JP,C-REACTIVE PROTEIN INCREASED,15
JP,HAEMATURIA,15
JP,LOSS OF CONSCIOUSNESS,15
JP,MALAISE,15
JP,SHOCK HAEMORRHAGIC,15
JP,DISSEMINATED INTRAVASCULAR COAGULATION,14
JP,EPISTAXIS,14
JP,HAEMOGLOBIN DECREASED,14
JP,HYPONATRAEMIA,14
JP,HYPOTENSION,14
JP,LIVER DISORDER,14
JP,OEDEMA PERIPHERAL,14
JP,RENAL FAILURE ACUTE,14
JP,VASCULAR STENT THROMBOSIS,14
JP,VENTRICULAR FIBRILLATION,14
JP,ANGINA PECTORIS,13
JP,COAGULOPATHY,13
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,13
JP,DIZZINESS,13
JP,HAEMORRHAGE,13
JP,MATERNAL EXPOSURE DURING PREGNANCY,13
JP,MYOCARDIAL INFARCTION,13
JP,SUBDURAL HAEMATOMA,13
JP,VENTRICULAR TACHYCARDIA,13
JP,BLOOD CREATININE INCREASED,12
JP,CHEST PAIN,12
JP,CONSTIPATION,12
JP,HEADACHE,12
JP,INTERNATIONAL NORMALISED RATIO INCREASED,12
JP,THROMBOSIS,12
JP,TUBULOINTERSTITIAL NEPHRITIS,12
JP,CARDIAC ARREST,11
JP,COLITIS MICROSCOPIC,11
JP,DEATH,11
JP,HEMIPLEGIA,11
JP,NEUROPATHY PERIPHERAL,11
JP,SEPSIS,11
JP,WHITE BLOOD CELL COUNT DECREASED,11
JP,ELECTROCARDIOGRAM QT PROLONGED,10
JP,ERYTHEMA,10
JP,EXPOSURE DURING PREGNANCY,10
JP,HYPERKALAEMIA,10
JP,MELAENA,10
JP,PRODUCT USE ISSUE,10
JP,SUBARACHNOID HAEMORRHAGE,10
JP,CARDIAC FAILURE CONGESTIVE,9
JP,DRUG-INDUCED LIVER INJURY,9
JP,EOSINOPHIL COUNT INCREASED,9
JP,FOETAL EXPOSURE DURING PREGNANCY,9
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,9
JP,HAEMATEMESIS,9
JP,HYPOXIA,9
JP,JAUNDICE,9
JP,OVERDOSE,9
JP,PALPITATIONS,9
JP,PANCYTOPENIA,9
JP,PNEUMONIA ASPIRATION,9
JP,PRURITUS,9
JP,SEPTIC SHOCK,9
JP,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,8
JP,BLOOD UREA INCREASED,8
JP,CEREBROVASCULAR ACCIDENT,8
JP,DRUG ERUPTION,8
JP,HAEMORRHAGE SUBCUTANEOUS,8
JP,HYPERTENSION,8
JP,LEUKOPENIA,8
JP,POST PROCEDURAL HAEMORRHAGE,8
JP,THROMBOCYTOPENIA,8
JP,URINARY TRACT INFECTION,8
JP,URTICARIA,8
JP,VASCULAR PSEUDOANEURYSM,8
JP,BLOOD BILIRUBIN INCREASED,7
JP,DISEASE PROGRESSION,7
JP,HAEMORRHAGE INTRACRANIAL,7
JP,HYPOVOLAEMIC SHOCK,7
JP,KAWASAKI^S DISEASE,7
JP,METABOLIC ACIDOSIS,7
JP,MUSCLE HAEMORRHAGE,7
JP,NEUTROPHIL COUNT DECREASED,7
JP,PULMONARY HYPERTENSION,7
JP,SEIZURE,7
JP,ANEURYSM,6
JP,ARTHRALGIA,6
JP,BLOOD ALKALINE PHOSPHATASE INCREASED,6
JP,BLOOD CREATINE PHOSPHOKINASE INCREASED,6
JP,BLOOD GLUCOSE INCREASED,6
JP,BONE MARROW FAILURE,6
JP,CATARACT,6
JP,CORONARY ARTERY ANEURYSM,6
JP,DELIRIUM,6
JP,DRUG RESISTANCE,6
JP,EMBOLIC STROKE,6
JP,GAIT DISTURBANCE,6
JP,HAEMOPTYSIS,6
JP,ILEAL ULCER,6
JP,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,6
JP,LYMPHADENOPATHY,6
JP,NASOPHARYNGITIS,6
JP,ORGANISING PNEUMONIA,6
JP,PREMATURE BABY,6
JP,PROTEIN-LOSING GASTROENTEROPATHY,6
JP,PURPURA,6
JP,RED BLOOD CELL COUNT DECREASED,6
JP,RENAL FAILURE,6
JP,RHABDOMYOLYSIS,6
JP,SHOCK,6
JP,SOMNOLENCE,6
JP,STEVENS-JOHNSON SYNDROME,6
JP,SYNCOPE,6
JP,VENTRICULAR EXTRASYSTOLES,6
JP,ABDOMINAL PAIN,5
JP,ANAPHYLACTIC SHOCK,5
JP,ANGIOEDEMA,5
JP,ATRIAL FIBRILLATION,5
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,5
JP,BLOOD PRESSURE INCREASED,5
JP,CHEST DISCOMFORT,5
JP,DYSPHAGIA,5
JP,EOSINOPHILIA,5
JP,FEELING ABNORMAL,5
JP,HEPARIN-INDUCED THROMBOCYTOPENIA,5
JP,HYPERURICAEMIA,5
JP,HYPOALBUMINAEMIA,5
JP,OXYGEN SATURATION DECREASED,5
JP,PAIN IN EXTREMITY,5
JP,PERITONITIS,5
JP,PLEURAL EFFUSION,5
JP,PREMATURE LABOUR,5
JP,PULMONARY ALVEOLAR HAEMORRHAGE,5
JP,STILLBIRTH,5
JP,TACHYCARDIA,5
JP,THALAMUS HAEMORRHAGE,5
JP,TRANSFUSION,5
JP,UPPER GASTROINTESTINAL HAEMORRHAGE,5
JP,VITAMIN K DEFICIENCY,5
JP,ACUTE RESPIRATORY DISTRESS SYNDROME,4
JP,AGRANULOCYTOSIS,4
JP,ANGINA UNSTABLE,4
JP,APHASIA,4
JP,ARTERIOSPASM CORONARY,4
JP,ASTHENIA,4
JP,ASTHMA,4
JP,ATRIAL THROMBOSIS,4
JP,BACK PAIN,4
JP,BLOOD GLUCOSE DECREASED,4
JP,BLOOD URIC ACID INCREASED,4
JP,CAESAREAN SECTION,4
JP,CELLULITIS,4
JP,COLITIS ISCHAEMIC,4
JP,COLON CANCER,4
JP,COMA,4
JP,CONTUSION,4
JP,CORONARY ARTERY THROMBOSIS,4
JP,DECUBITUS ULCER,4
JP,DEEP VEIN THROMBOSIS,4
JP,DEMENTIA,4
JP,DRUG LEVEL INCREASED,4
JP,EMBOLISM VENOUS,4
JP,FATIGUE,4
JP,GASTRIC ULCER,4
JP,GASTRIC ULCER HAEMORRHAGE,4
JP,GASTROINTESTINAL DISORDER,4
JP,GASTROINTESTINAL EROSION,4
JP,GASTROINTESTINAL MUCOSAL DISORDER,4
JP,GASTROINTESTINAL ULCER HAEMORRHAGE,4
JP,GENERALISED ERYTHEMA,4
JP,HAEMATOCHEZIA,4
JP,HAEMATOCRIT DECREASED,4
JP,HAEMORRHOIDAL HAEMORRHAGE,4
JP,HAEMOTHORAX,4
JP,HEAD INJURY,4
JP,HEMIPARESIS,4
JP,HERPES ZOSTER,4
JP,HYDROCEPHALUS,4
JP,HYPERSENSITIVITY VASCULITIS,4
JP,HYPOKALAEMIA,4
JP,INFLUENZA,4
JP,INTESTINAL OBSTRUCTION,4
JP,LIVER INJURY,4
JP,LOW BIRTH WEIGHT BABY,4
JP,LYMPHOCYTE COUNT DECREASED,4
JP,MOUTH HAEMORRHAGE,4
JP,MUSCULAR WEAKNESS,4
JP,MYELOFIBROSIS,4
JP,PERICARDIAL EFFUSION,4
JP,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,4
JP,PLASMA CELL MYELOMA,4
JP,PRESCRIBED UNDERDOSE,4
JP,PROTEINURIA,4
JP,PYELONEPHRITIS,4
JP,RENAL DISORDER,4
JP,RESPIRATORY DEPRESSION,4
JP,RETROPERITONEAL HAEMATOMA,4
JP,ROAD TRAFFIC ACCIDENT,4
JP,SKIN DISCOLOURATION,4
JP,SKIN ULCER,4
JP,SMALL INTESTINAL HAEMORRHAGE,4
JP,SMALL INTESTINE ULCER,4
JP,SUBCUTANEOUS HAEMATOMA,4
JP,SYSTEMIC LUPUS ERYTHEMATOSUS,4
JP,THROMBOSIS IN DEVICE,4
JP,THROMBOTIC MICROANGIOPATHY,4
JP,THROMBOTIC THROMBOCYTOPENIC PURPURA,4
JP,UPPER RESPIRATORY TRACT INFLAMMATION,4
JP,ABDOMINAL DISTENSION,3
JP,ABDOMINAL PAIN UPPER,3
JP,ABORTION,3
JP,ADENOCARCINOMA OF COLON,3
JP,ARTERIAL HAEMORRHAGE,3
JP,ASCITES,3
JP,BACTERAEMIA,3
JP,BENIGN PROSTATIC HYPERPLASIA,3
JP,BRAIN CONTUSION,3
JP,BRAIN HERNIATION,3
JP,BRAIN NATRIURETIC PEPTIDE INCREASED,3
JP,BRAIN STEM HAEMORRHAGE,3
JP,BRONCHITIS,3
JP,BRONCHOPULMONARY ASPERGILLOSIS,3
JP,BUNDLE BRANCH BLOCK RIGHT,3
JP,CARDIAC FAILURE CHRONIC,3
JP,CARDIAC TAMPONADE,3
JP,CHILLS,3
JP,CHOLECYSTITIS,3
JP,CHOLELITHIASIS,3
JP,COMPUTERISED TOMOGRAM ABNORMAL,3
JP,CONCOMITANT DISEASE AGGRAVATED,3
JP,CORONARY ARTERY RESTENOSIS,3
JP,CORONARY ARTERY STENOSIS,3
JP,COUGH,3
JP,CYTOMEGALOVIRUS INFECTION,3
JP,DEPRESSION,3
JP,DEVICE RELATED INFECTION,3
JP,DIABETES MELLITUS,3
JP,DIPLOPIA,3
JP,DIVERTICULUM INTESTINAL HAEMORRHAGIC,3
JP,DRUG EFFECT INCOMPLETE,3
JP,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,3
JP,DYSPNOEA EXERTIONAL,3
JP,EATING DISORDER,3
JP,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,3
JP,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,3
JP,ENCEPHALOPATHY,3
JP,ENTEROCOLITIS,3
JP,EOSINOPHILIC PNEUMONIA,3
JP,EROSIVE OESOPHAGITIS,3
JP,FAECES DISCOLOURED,3
JP,FAT EMBOLISM,3
JP,FEBRILE NEUTROPENIA,3
JP,FLANK PAIN,3
JP,GASTROINTESTINAL NECROSIS,3
JP,GASTROINTESTINAL PERFORATION,3
JP,GENERAL PHYSICAL HEALTH DETERIORATION,3
JP,GENERALISED OEDEMA,3
JP,GENITAL HAEMORRHAGE,3
JP,HAEMATOCOELE,3
JP,HAEMODYNAMIC INSTABILITY,3
JP,HAEMOLYTIC ANAEMIA,3
JP,HAEMORRHAGIC INFARCTION,3
JP,HEART RATE DECREASED,3
JP,HEPATIC ENZYME INCREASED,3
JP,HYPERGLYCAEMIA,3
JP,HYPOPHAGIA,3
JP,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,3
JP,INFECTION,3
JP,INFLAMMATION,3
JP,INSOMNIA,3
JP,INTESTINAL DIAPHRAGM DISEASE,3
JP,INTRACRANIAL ANEURYSM,3
JP,LARGE INTESTINAL ULCER,3
JP,LARGE INTESTINE PERFORATION,3
JP,LEFT VENTRICULAR FAILURE,3
JP,LOWER GASTROINTESTINAL HAEMORRHAGE,3
JP,LUNG NEOPLASM MALIGNANT,3
JP,MECHANICAL VENTILATION,3
JP,METASTASES TO LIVER,3
JP,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
JP,MYELODYSPLASTIC SYNDROME,3
JP,NEUTROPHIL COUNT INCREASED,3
JP,NO ADVERSE EVENT,3
JP,OEDEMA,3
JP,OESOPHAGEAL INTRAMURAL HAEMATOMA,3
JP,OROPHARYNGEAL PAIN,3
JP,OROPHARYNGEAL SWELLING,3
JP,PAIN,3
JP,PALLOR,3
JP,PEMPHIGOID,3
JP,PNEUMONIA INFLUENZAL,3
JP,PNEUMONIA PNEUMOCOCCAL,3
JP,PNEUMOTHORAX,3
JP,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,3
JP,PRE-ECLAMPSIA,3
JP,PRINZMETAL ANGINA,3
JP,PROCEDURAL HAEMORRHAGE,3
JP,PROSTATE CANCER,3
JP,PROTEIN URINE PRESENT,3
JP,PULMONARY EMBOLISM,3
JP,PUTAMEN HAEMORRHAGE,3
JP,RESPIRATION ABNORMAL,3
JP,RESPIRATORY FAILURE,3
JP,RESTLESSNESS,3
JP,SINUS TACHYCARDIA,3
JP,SKIN DISORDER,3
JP,SPEECH DISORDER,3
JP,SPINAL COMPRESSION FRACTURE,3
JP,SUBDURAL HAEMORRHAGE,3
JP,SWELLING,3
JP,TENDERNESS,3
JP,THROMBOTIC CEREBRAL INFARCTION,3
JP,TRANSIENT ISCHAEMIC ATTACK,3
JP,UPPER AIRWAY OBSTRUCTION,3
JP,URINARY RETENTION,3
JP,VISUAL ACUITY REDUCED,3
JP,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
JP,ABASIA,2
JP,ABDOMINAL TENDERNESS,2
JP,ABDOMINAL WALL HAEMATOMA,2
JP,ABORTION SPONTANEOUS,2
JP,ACUTE HEPATIC FAILURE,2
JP,ACUTE MYELOID LEUKAEMIA,2
JP,AMNESIA,2
JP,ANAEMIA MACROCYTIC,2
JP,ANASTOMOTIC HAEMORRHAGE,2
JP,ANOMALOUS PULMONARY VENOUS CONNECTION,2
JP,AORTIC ANEURYSM,2
JP,AORTIC DISSECTION,2
JP,AORTIC VALVE STENOSIS,2
JP,ARRHYTHMIA,2
JP,ARTHRITIS,2
JP,ASPERGILLUS INFECTION,2
JP,BASAL CELL CARCINOMA,2
JP,BILIRUBIN CONJUGATED INCREASED,2
JP,BLOOD ALBUMIN DECREASED,2
JP,BLOOD CALCIUM DECREASED,2
JP,BLOOD CHLORIDE INCREASED,2
JP,BLOOD COUNT ABNORMAL,2
JP,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,2
JP,BLOOD IMMUNOGLOBULIN E INCREASED,2
JP,BLOOD PRESSURE SYSTOLIC DECREASED,2
JP,BLUE TOE SYNDROME,2
JP,CARDIAC DISORDER,2
JP,CARDIAC VENTRICULAR THROMBOSIS,2
JP,CARDIOGENIC SHOCK,2
JP,CARDIOMEGALY,2
JP,CAROTID ARTERY OCCLUSION,2
JP,CEREBELLAR EMBOLISM,2
JP,CEREBELLAR INFARCTION,2
JP,CHOLECYSTITIS ACUTE,2
JP,CIRCULATORY COLLAPSE,2
JP,CLOSTRIDIUM DIFFICILE COLITIS,2
JP,COLITIS,2
JP,COLITIS ULCERATIVE,2
JP,COMPUTERISED TOMOGRAM THORAX ABNORMAL,2
JP,CONTRAST ENCEPHALOPATHY,2
JP,CONVULSION,2
JP,CORONARY ARTERY BYPASS,2
JP,CORONARY ARTERY DILATATION,2
JP,CORONARY ARTERY OCCLUSION,2
JP,DERMATITIS CONTACT,2
JP,DERMATITIS PSORIASIFORM,2
JP,DIABETIC KETOACIDOSIS,2
JP,DISSEMINATED TUBERCULOSIS,2
JP,DRUG ADMINISTRATION ERROR,2
JP,DRUG HYPERSENSITIVITY,2
JP,DRUG LEVEL DECREASED,2
JP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
JP,DUODENAL ULCER,2
JP,DYSKINESIA,2
JP,DYSLALIA,2
JP,DYSSTASIA,2
JP,ECZEMA ASTEATOTIC,2
JP,EMBOLIC CEREBRAL INFARCTION,2
JP,ERYTHEMA MULTIFORME,2
JP,EXTRAVASATION,2
JP,FACE OEDEMA,2
JP,FAECES SOFT,2
JP,FEEDING DISORDER,2
JP,FLUID RETENTION,2
JP,FOETAL DEATH,2
JP,FOETAL GROWTH RESTRICTION,2
JP,GALLBLADDER ADENOCARCINOMA,2
JP,GASTRIC CANCER,2
JP,GASTRIC HAEMORRHAGE,2
JP,GASTROINTESTINAL INJURY,2
JP,GASTROINTESTINAL POLYP HAEMORRHAGE,2
JP,GENERALISED TONIC-CLONIC SEIZURE,2
JP,GINGIVAL BLEEDING,2
JP,GLAUCOMA,2
JP,GLUCOSE TOLERANCE IMPAIRED,2
JP,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
JP,GYNAECOMASTIA,2
JP,HAEMODIALYSIS,2
JP,HAEMORRHAGE URINARY TRACT,2
JP,HAEMORRHAGIC CEREBRAL INFARCTION,2
JP,HAEMORRHAGIC CYST,2
JP,HEART RATE INCREASED,2
JP,HEPATIC FAILURE,2
JP,HEPATIC HAEMORRHAGE,2
JP,HEPATOTOXICITY,2
JP,HICCUPS,2
JP,HYPERBILIRUBINAEMIA,2
JP,HYPERCALCAEMIA,2
JP,HYPERHIDROSIS,2
JP,HYPERNATRAEMIA,2
JP,HYPOAESTHESIA,2
JP,HYPOCALCAEMIA,2
JP,HYPOGLYCAEMIC UNCONSCIOUSNESS,2
JP,HYPOKINESIA,2
JP,HYPOTHERMIA,2
JP,ILEUS,2
JP,ILEUS PARALYTIC,2
JP,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
JP,INCORRECT DOSE ADMINISTERED,2
JP,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
JP,INSULIN AUTOIMMUNE SYNDROME,2
JP,INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT,2
JP,INTERNAL HAEMORRHAGE,2
JP,INTERNATIONAL NORMALISED RATIO DECREASED,2
JP,INTESTINAL HAEMORRHAGE,2
JP,INTRAOCULAR PRESSURE INCREASED,2
JP,INTRAVASCULAR HAEMOLYSIS,2
JP,INTRAVENTRICULAR HAEMORRHAGE,2
JP,IRON DEFICIENCY ANAEMIA,2
JP,ISCHAEMIC CARDIOMYOPATHY,2
JP,ISCHAEMIC STROKE,2
JP,JOINT SWELLING,2
JP,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
JP,LACUNAR INFARCTION,2
JP,LARGE INTESTINE POLYP,2
JP,LATENT TUBERCULOSIS,2
JP,LEUKOCYTOSIS,2
JP,LIP HAEMORRHAGE,2
JP,LIVE BIRTH,2
JP,LIVER FUNCTION TEST ABNORMAL,2
JP,LOCAL SWELLING,2
JP,LOGORRHOEA,2
JP,LONG QT SYNDROME,2
JP,LUNG INFECTION,2
JP,LYMPHOCYTE COUNT INCREASED,2
JP,MALABSORPTION FROM APPLICATION SITE,2
JP,MALIGNANT NEOPLASM PROGRESSION,2
JP,MALNUTRITION,2
JP,METASTASES TO ADRENALS,2
JP,MUCOSAL HAEMORRHAGE,2
JP,MUSCLE CONTRACTURE,2
JP,MYOCARDIAL RUPTURE,2
JP,MYOCARDITIS,2
JP,NERVOUS SYSTEM DISORDER,2
JP,NEUROGENIC BLADDER,2
JP,NEUROLOGICAL DECOMPENSATION,2
JP,OBSTRUCTIVE AIRWAYS DISORDER,2
JP,OCCULT BLOOD POSITIVE,2
JP,OESOPHAGEAL HAEMORRHAGE,2
JP,OESOPHAGEAL VARICES HAEMORRHAGE,2
JP,ORAL MUCOSA HAEMATOMA,2
JP,ORTHOPNOEA,2
JP,PANCREATIC CARCINOMA,2
JP,PANCREATITIS,2
JP,PARALYSIS,2
JP,PARINAUD SYNDROME,2
JP,PARKINSONISM,2
JP,PELVIC FRACTURE,2
JP,PERIPHERAL ARTERY OCCLUSION,2
JP,PERIPHERAL ARTERY THROMBOSIS,2
JP,PERIPHERAL VENOUS DISEASE,2
JP,PHARYNGEAL HAEMATOMA,2
JP,PHARYNGITIS,2
JP,PIGMENTATION DISORDER,2
JP,PLATELET COUNT INCREASED,2
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
JP,PNEUMOMEDIASTINUM,2
JP,PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL,2
JP,POLYP,2
JP,PORTAL VEIN THROMBOSIS,2
JP,POSTOPERATIVE WOUND INFECTION,2
JP,PREMATURE DELIVERY,2
JP,PRERENAL FAILURE,2
JP,PRODUCT USE IN UNAPPROVED INDICATION,2
JP,PRODUCTIVE COUGH,2
JP,PROTHROMBIN TIME PROLONGED,2
JP,PULMONARY ARTERIAL HYPERTENSION,2
JP,PULMONARY ARTERIOVENOUS FISTULA,2
JP,PULMONARY HAEMORRHAGE,2
JP,PUNCTURE SITE HAEMORRHAGE,2
JP,PUPILS UNEQUAL,2
JP,RASH MACULO-PAPULAR,2
JP,RASH PAPULAR,2
JP,RENAL CELL CARCINOMA,2
JP,RENAL FAILURE CHRONIC,2
JP,RENAL HAEMORRHAGE,2
JP,RESPIRATORY ARREST,2
JP,RETROPERITONEAL HAEMORRHAGE,2
JP,RHEUMATOID ARTHRITIS,2
JP,RHINORRHOEA,2
JP,SINUS ARREST,2
JP,SKIN EXFOLIATION,2
JP,SKIN LESION,2
JP,SMALL INTESTINAL ULCER HAEMORRHAGE,2
JP,SMALL INTESTINE CARCINOMA,2
JP,SPLENOMEGALY,2
JP,STATUS MIGRAINOSUS,2
JP,STOMATITIS,2
JP,SUBCHORIONIC HAEMATOMA,2
JP,SUDDEN DEATH,2
JP,SWOLLEN TONGUE,2
JP,THERAPY CESSATION,2
JP,THROMBOTIC STROKE,2
JP,TONGUE HAEMORRHAGE,2
JP,TREMOR,2
JP,TROPONIN T INCREASED,2
JP,TUMOUR HAEMORRHAGE,2
JP,UPPER RESPIRATORY TRACT INFECTION,2
JP,URINE OUTPUT DECREASED,2
JP,VASCULAR STENT OCCLUSION,2
JP,VASCULAR STENT RESTENOSIS,2
JP,VENTRICULAR HYPOKINESIA,2
JP,VERTIGO,2
JP,VIRAL MYOCARDITIS,2
JP,WEIGHT DECREASED,2
JP,WEIGHT INCREASED,2
JP,WHEEZING,2
JP,ABDOMINAL REBOUND TENDERNESS,1
JP,ABDOMINAL RIGIDITY,1
JP,ACCIDENTAL EXPOSURE TO PRODUCT,1
JP,ACIDOSIS HYPERCHLORAEMIC,1
JP,ACQUIRED HAEMOPHILIA,1
JP,ACUTE CORONARY SYNDROME,1
JP,ACUTE RESPIRATORY FAILURE,1
JP,ADRENAL INSUFFICIENCY,1
JP,AGGRESSION,1
JP,ALCOHOL INTERACTION,1
JP,ALCOHOLIC PANCREATITIS,1
JP,ALLERGIC GRANULOMATOUS ANGIITIS,1
JP,ALOPECIA,1
JP,ALVEOLAR LUNG DISEASE,1
JP,AMAUROSIS,1
JP,AMYLASE INCREASED,1
JP,AMYLOIDOSIS,1
JP,ANAL POLYP,1
JP,ANAPHYLACTOID REACTION,1
JP,ANGER,1
JP,ANTI-INSULIN ANTIBODY INCREASED,1
JP,ANTI-INSULIN ANTIBODY POSITIVE,1
JP,ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC,1
JP,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,1
JP,ANURIA,1
JP,APATHY,1
JP,ARTERIAL OCCLUSIVE DISEASE,1
JP,ARTERIOSCLEROSIS,1
JP,ARTERIOSCLEROSIS CORONARY ARTERY,1
JP,ARTERIOVENOUS FISTULA,1
JP,ARTHRITIS BACTERIAL,1
JP,ATHEROEMBOLISM,1
JP,ATRIAL TACHYCARDIA,1
JP,ATRIOVENTRICULAR BLOCK,1
JP,ATYPICAL MYCOBACTERIAL INFECTION,1
JP,ATYPICAL PNEUMONIA,1
JP,AUTOANTIBODY POSITIVE,1
JP,AUTOIMMUNE HEPATITIS,1
JP,AUTOIMMUNE PANCREATITIS,1
JP,B-CELL LYMPHOMA,1
JP,BACTERIAL INFECTION,1
JP,BASAL GANGLIA HAEMORRHAGE,1
JP,BASEDOW^S DISEASE,1
JP,BASILAR ARTERY OCCLUSION,1
JP,BEHCET^S SYNDROME,1
JP,BENIGN NEOPLASM OF BLADDER,1
JP,BILE DUCT CANCER,1
JP,BILE DUCT STONE,1
JP,BILIARY COLIC,1
JP,BILIARY DILATATION,1
JP,BIOPSY HEART ABNORMAL,1
JP,BLADDER CATHETERISATION,1
JP,BLADDER PAPILLOMA,1
JP,BLADDER SPASM,1
JP,BLAST CELL COUNT INCREASED,1
JP,BLISTER RUPTURE,1
JP,BLOOD ANTIDIURETIC HORMONE ABNORMAL,1
JP,BLOOD BETA-D-GLUCAN INCREASED,1
JP,BLOOD CHLORIDE DECREASED,1
JP,BLOOD CHOLESTEROL INCREASED,1
JP,BLOOD CREATININE ABNORMAL,1
JP,BLOOD FIBRINOGEN DECREASED,1
JP,BLOOD OSMOLARITY DECREASED,1
JP,BLOOD POTASSIUM INCREASED,1
JP,BLOOD TRIGLYCERIDES INCREASED,1
JP,BLOOD UREA ABNORMAL,1
JP,BODY TEMPERATURE DECREASED,1
JP,BONE CANCER,1
JP,BONE EROSION,1
JP,BONE PAIN,1
JP,BRACHYDACTYLY,1
JP,BRAIN CANCER METASTATIC,1
JP,BRAIN NEOPLASM,1
JP,BRAIN OEDEMA,1
JP,BRAIN STEM SYNDROME,1
JP,BREAST INFLAMMATION,1
JP,BREATH SOUNDS ABNORMAL,1
JP,BRONCHITIS CHRONIC,1
JP,BUNDLE BRANCH BLOCK,1
JP,BURNING SENSATION,1
JP,CACHEXIA,1
JP,CANDIDA INFECTION,1
JP,CAPILLARY LEAK SYNDROME,1
JP,CARCINOEMBRYONIC ANTIGEN INCREASED,1
JP,CARDIAC IMAGING PROCEDURE ABNORMAL,1
JP,CARDIAC INFECTION,1
JP,CARDIAC MURMUR,1
JP,CARDIAC PACEMAKER INSERTION,1
JP,CARDIAC VALVE DISEASE,1
JP,CAROTID ARTERY DISEASE,1
JP,CAROTID ARTERY DISSECTION,1
JP,CAROTID ARTERY THROMBOSIS,1
JP,CAROTID BRUIT,1
JP,CATHETER PLACEMENT,1
JP,CATHETER REMOVAL,1
JP,CATHETERISATION CARDIAC,1
JP,CELL MARKER INCREASED,1
JP,CELLULITIS ORBITAL,1
JP,CEREBRAL ARTERY EMBOLISM,1
JP,CEREBRAL ARTERY OCCLUSION,1
JP,CEREBRAL MICROHAEMORRHAGE,1
JP,CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE,1
JP,CEREBRAL VASOCONSTRICTION,1
JP,CEREBROVASCULAR DISORDER,1
JP,CHEST X-RAY ABNORMAL,1
JP,CHEYNE-STOKES RESPIRATION,1
JP,CHOLANGITIS,1
JP,CHOLINERGIC SYNDROME,1
JP,CHROMATURIA,1
JP,CHRONIC KIDNEY DISEASE,1
JP,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
JP,CHRONIC MYELOID LEUKAEMIA,1
JP,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
JP,CILIARY BODY HAEMORRHAGE,1
JP,CIRCADIAN RHYTHM SLEEP DISORDER,1
JP,COATING IN MOUTH,1
JP,COGNITIVE DISORDER,1
JP,COLD SWEAT,1
JP,COLLAGEN DISORDER,1
JP,COLON CANCER METASTATIC,1
JP,COLON CANCER STAGE 0,1
JP,COMA SCALE ABNORMAL,1
JP,COMPLEMENT FACTOR C3 DECREASED,1
JP,COMPLEMENT FACTOR DECREASED,1
JP,COMPLICATED FRACTURE,1
JP,COMPUTERISED TOMOGRAM ABDOMEN ABNORMAL,1
JP,CONFUSIONAL STATE,1
JP,CONGENITAL CORONARY ARTERY MALFORMATION,1
JP,CONGENITAL FOOT MALFORMATION,1
JP,CONJUNCTIVAL HAEMORRHAGE,1
JP,CONTRAINDICATED DRUG ADMINISTERED,1
JP,CONTRAINDICATED PRODUCT ADMINISTERED,1
JP,CORNEAL BLEEDING,1
JP,CORNEAL SCAR,1
JP,CORONARY ANGIOPLASTY,1
JP,CORONARY ARTERY EMBOLISM,1
JP,CRANIOCEREBRAL INJURY,1
JP,CRANIOTOMY,1
JP,CSF PROTEIN INCREASED,1
JP,CYANOSIS,1
JP,CYSTITIS,1
JP,CYTOGENETIC ABNORMALITY,1
JP,CYTOMEGALOVIRUS CHORIORETINITIS,1
JP,CYTOMEGALOVIRUS ENTEROCOLITIS,1
JP,CYTOMEGALOVIRUS TEST POSITIVE,1
JP,DEAFNESS NEUROSENSORY,1
JP,DEEP DISSECTING HAEMATOMA,1
JP,DEPRESSIVE SYMPTOM,1
JP,DERMATITIS,1
JP,DERMATITIS EXFOLIATIVE,1
JP,DERMATOMYOSITIS,1
JP,DEVICE EMBOLISATION,1
JP,DEVICE OCCLUSION,1
JP,DIABETES MELLITUS INADEQUATE CONTROL,1
JP,DIABETIC RETINOPATHY,1
JP,DIALYSIS,1
JP,DILATATION VENTRICULAR,1
JP,DISABILITY,1
JP,DISEASE COMPLICATION,1
JP,DISORIENTATION,1
JP,DISTURBANCE IN ATTENTION,1
JP,DISUSE SYNDROME,1
JP,DIVERTICULAR PERFORATION,1
JP,DIVERTICULUM INTESTINAL,1
JP,DNA ANTIBODY POSITIVE,1
JP,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
JP,DRUG INTOLERANCE,1
JP,DRUG PRESCRIBING ERROR,1
JP,DRY GANGRENE,1
JP,DUODENITIS,1
JP,DYSARTHRIA,1
JP,DYSPHONIA,1
JP,DYSPRAXIA,1
JP,DYSTONIA,1
JP,DYSURIA,1
JP,ECCHYMOSIS,1
JP,ELECTROCARDIOGRAM ABNORMAL,1
JP,ELECTROCARDIOGRAM P WAVE ABNORMAL,1
JP,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
JP,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,1
JP,ELECTROLYTE IMBALANCE,1
JP,EMBOLISM,1
JP,EMBOLISM ARTERIAL,1
JP,EMPHYSEMATOUS CYSTITIS,1
JP,ENDOCARDITIS,1
JP,ENDOSCOPY SMALL INTESTINE ABNORMAL,1
JP,ENDOTRACHEAL INTUBATION,1
JP,ENTERITIS,1
JP,ENTEROCOLITIS BACTERIAL,1
JP,ENTEROCOLITIS HAEMORRHAGIC,1
JP,EPIDIDYMITIS,1
JP,EPIGASTRIC DISCOMFORT,1
JP,EPIGLOTTITIS,1
JP,EPILEPSY,1
JP,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,1
JP,ERYTHROBLAST COUNT INCREASED,1
JP,ESCHERICHIA INFECTION,1
JP,EVANS SYNDROME,1
JP,EXFOLIATIVE RASH,1
JP,EXTRAPYRAMIDAL DISORDER,1
JP,EXTRASYSTOLES,1
JP,EXTRAVASATION BLOOD,1
JP,EXTREMITY NECROSIS,1
JP,EYE DISORDER,1
JP,EYE HAEMORRHAGE,1
JP,EYE SYMPTOM,1
JP,FACTOR V INHIBITION,1
JP,FACTOR VIII INHIBITION,1
JP,FAMILIAL MEDITERRANEAN FEVER,1
JP,FEAR,1
JP,FEBRILE CONVULSION,1
JP,FEELING HOT,1
JP,FEMUR FRACTURE,1
JP,FOETAL HYPOKINESIA,1
JP,FOLATE DEFICIENCY,1
JP,FOOD INTERACTION,1
JP,FOOT FRACTURE,1
JP,FORCED EXPIRATORY VOLUME DECREASED,1
JP,FULMINANT TYPE 1 DIABETES MELLITUS,1
JP,FUNGAL INFECTION,1
JP,GALLBLADDER CANCER,1
JP,GASTRIC MUCOSAL LESION,1
JP,GASTRIC PERFORATION,1
JP,GASTRITIS BACTERIAL,1
JP,GASTROENTERITIS ESCHERICHIA COLI,1
JP,GASTROENTERITIS NOROVIRUS,1
JP,GASTROINTESTINAL CARCINOMA,1
JP,GASTROINTESTINAL INFLAMMATION,1
JP,GASTROINTESTINAL MALFORMATION,1
JP,GASTROINTESTINAL STENOSIS,1
JP,GASTROINTESTINAL STROMAL TUMOUR,1
JP,GASTROOESOPHAGEAL REFLUX DISEASE,1
JP,GENITAL EROSION,1
JP,GIANOTTI-CROSTI SYNDROME,1
JP,GLIOSIS,1
JP,GLOMERULONEPHRITIS,1
JP,GLUCOSE TOLERANCE DECREASED,1
JP,GOUTY ARTHRITIS,1
JP,GOUTY TOPHUS,1
JP,GRANULOCYTE COUNT DECREASED,1
JP,HAEMOBILIA,1
JP,HAEMOLYSIS,1
JP,HAEMOLYTIC URAEMIC SYNDROME,1
JP,HAEMORRHAGIC ANAEMIA,1
JP,HAEMORRHAGIC STROKE,1
JP,HAEMOSTASIS,1
JP,HALLUCINATION_ VISUAL,1
JP,HAND FRACTURE,1
JP,HAPTOGLOBIN DECREASED,1
JP,HEART TRANSPLANT REJECTION,1
JP,HEART VALVE INCOMPETENCE,1
JP,HEART VALVE STENOSIS,1
JP,HEAT ILLNESS,1
JP,HEMIANOPIA HOMONYMOUS,1
JP,HENOCH-SCHONLEIN PURPURA,1
JP,HEPATIC CANCER,1
JP,HEPATIC CANCER METASTATIC,1
JP,HEPATIC CIRRHOSIS,1
JP,HEPATIC CYST,1
JP,HEPATIC ENCEPHALOPATHY,1
JP,HEPATIC STEATOSIS,1
JP,HEPATIC VEIN OCCLUSION,1
JP,HEPATITIS B,1
JP,HEPATITIS B ANTIGEN POSITIVE,1
JP,HEPATITIS B CORE ANTIBODY POSITIVE,1
JP,HEPATITIS B SURFACE ANTIBODY POSITIVE,1
JP,HEPATITIS E,1
JP,HEPATOCELLULAR CARCINOMA,1
JP,HEPATOSPLENOMEGALY,1
JP,HERPES VIRUS INFECTION,1
JP,HIGH DENSITY LIPOPROTEIN DECREASED,1
JP,HIGH FREQUENCY ABLATION,1
JP,HISTIOCYTOSIS HAEMATOPHAGIC,1
JP,HUMERUS FRACTURE,1
JP,HUNGER,1
JP,HYALOSIS ASTEROID,1
JP,HYPERAEMIA,1
JP,HYPERAMMONAEMIA,1
JP,HYPERAMYLASAEMIA,1
JP,HYPEREOSINOPHILIC SYNDROME,1
JP,HYPERKERATOSIS,1
JP,HYPERSENSITIVITY,1
JP,HYPERTHERMIA,1
JP,HYPERTHYROIDISM,1
JP,HYPERTRIGLYCERIDAEMIA,1
JP,HYPERVISCOSITY SYNDROME,1
JP,HYPOCHOLESTEROLAEMIA,1
JP,HYPOCOAGULABLE STATE,1
JP,HYPOMAGNESAEMIA,1
JP,HYPOPNOEA,1
JP,HYPOTHYROIDISM,1
JP,IGA NEPHROPATHY,1
JP,ILEAL STENOSIS,1
JP,IMMUNE THROMBOCYTOPENIC PURPURA,1
JP,IMPAIRED HEALING,1
JP,IMPETIGO,1
JP,INCOHERENT,1
JP,INCORRECT DOSE ADMINISTERED BY DEVICE,1
JP,INDURATION,1
JP,INFUSION RELATED REACTION,1
JP,INJECTION SITE ERYTHEMA,1
JP,INJURY,1
JP,INTENSIVE CARE,1
JP,INTENTIONAL PRODUCT MISUSE,1
JP,INTENTIONAL PRODUCT USE ISSUE,1
JP,INTENTIONAL UNDERDOSE,1
JP,INTERLEUKIN LEVEL INCREASED,1
JP,INTERLEUKIN-2 RECEPTOR INCREASED,1
JP,INTERMITTENT CLAUDICATION,1
JP,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
JP,INTERNATIONAL NORMALISED RATIO FLUCTUATION,1
JP,INTERVERTEBRAL DISC PROTRUSION,1
JP,INTESTINAL HAEMATOMA,1
JP,INTESTINAL MASS,1
JP,INTESTINAL SCARRING,1
JP,INTRA-ABDOMINAL HAEMORRHAGE,1
JP,INTRACRANIAL PRESSURE INCREASED,1
JP,IRIS HAEMORRHAGE,1
JP,IRON DEFICIENCY,1
JP,ISCHAEMIA,1
JP,ISCHAEMIC ENTERITIS,1
JP,JAW FRACTURE,1
JP,JEJUNAL ULCER,1
JP,JOINT RANGE OF MOTION DECREASED,1
JP,LACERATION,1
JP,LARGE INTESTINAL STENOSIS,1
JP,LARYNGEAL OEDEMA,1
JP,LEFT VENTRICULAR DYSFUNCTION,1
JP,LEUKAEMOID REACTION,1
JP,LEUKOENCEPHALOPATHY,1
JP,LIMB REDUCTION DEFECT,1
JP,LIP PAIN,1
JP,LIP SWELLING,1
JP,LISTERIA ENCEPHALITIS,1
JP,LIVEDO RETICULARIS,1
JP,LIVER ABSCESS,1
JP,LOSS OF CONTROL OF LEGS,1
JP,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
JP,LOW DENSITY LIPOPROTEIN INCREASED,1
JP,LUNG ABSCESS,1
JP,LUNG ADENOCARCINOMA,1
JP,LUNG ADENOCARCINOMA METASTATIC,1
JP,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,1
JP,LUNG NEOPLASM,1
JP,LUPUS NEPHRITIS,1
JP,LYMPHADENOPATHY MEDIASTINAL,1
JP,LYMPHOCYTE PERCENTAGE INCREASED,1
JP,LYMPHOCYTOSIS,1
JP,LYMPHOMA,1
JP,MACULAR FIBROSIS,1
JP,MACULAR OEDEMA,1
JP,MALIGNANT ASCITES,1
JP,MALIGNANT NEOPLASM OF RENAL PELVIS,1
JP,MALLORY-WEISS SYNDROME,1
JP,MARASMUS,1
JP,MATERNAL DRUGS AFFECTING FOETUS,1
JP,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
JP,MEAN CELL VOLUME INCREASED,1
JP,MECONIUM ABNORMAL,1
JP,MEDIASTINAL HAEMATOMA,1
JP,MEDICATION ERROR,1
JP,MENTAL DISORDER,1
JP,MESENTERIC ARTERIAL OCCLUSION,1
JP,MESENTERIC ARTERY EMBOLISM,1
JP,MESENTERIC VEIN THROMBOSIS,1
JP,METASTASES TO BONE,1
JP,METASTASES TO CENTRAL NERVOUS SYSTEM,1
JP,METASTASES TO LUNG,1
JP,METASTASES TO LYMPH NODES,1
JP,METASTASES TO MENINGES,1
JP,METASTASES TO TRACHEA,1
JP,METASTATIC CARCINOMA OF THE BLADDER,1
JP,METHAEMOGLOBINAEMIA,1
JP,MIOSIS,1
JP,MOANING,1
JP,MONOCYTE COUNT INCREASED,1
JP,MONONEUROPATHY MULTIPLEX,1
JP,MONOPLEGIA,1
JP,MULTI-ORGAN FAILURE,1
JP,MULTIPLE SCLEROSIS RELAPSE,1
JP,MUSCLE RUPTURE,1
JP,MUSCLE SPASMS,1
JP,MUSCULOSKELETAL PAIN,1
JP,MYALGIA,1
JP,MYASTHENIA GRAVIS,1
JP,MYOCARDIAL ISCHAEMIA,1
JP,MYOCLONUS,1
JP,MYOSITIS,1
JP,NECK PAIN,1
JP,NECROSIS,1
JP,NECROTISING OESOPHAGITIS,1
JP,NEOPLASM,1
JP,NEOPLASM MALIGNANT,1
JP,NEPHRITIS,1
JP,NEPHROLITHIASIS,1
JP,NEUROENDOCRINE CARCINOMA METASTATIC,1
JP,NEUROLEPTIC MALIGNANT SYNDROME,1
JP,NEURONE-SPECIFIC ENOLASE INCREASED,1
JP,NEUROSIS,1
JP,NODAL OSTEOARTHRITIS,1
JP,NODULE,1
JP,NONREASSURING FOETAL HEART RATE PATTERN,1
JP,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
JP,OCULAR HYPERAEMIA,1
JP,OCULAR ICTERUS,1
JP,OESOPHAGEAL CANDIDIASIS,1
JP,OESOPHAGEAL ULCER,1
JP,OESOPHAGITIS,1
JP,OLIGURIA,1
JP,ONYCHOMADESIS,1
JP,OPTIC ISCHAEMIC NEUROPATHY,1
JP,OPTIC NEURITIS,1
JP,ORAL MUCOSA EROSION,1
JP,ORAL PAIN,1
JP,ORBITAL INFECTION,1
JP,ORTHOSTATIC HYPOTENSION,1
JP,OSTEONECROSIS,1
JP,OSTEONECROSIS OF JAW,1
JP,PACKED RED BLOOD CELL TRANSFUSION,1
JP,PAINFUL RESPIRATION,1
JP,PANCREATIC CARCINOMA METASTATIC,1
JP,PANCREATIC CARCINOMA RECURRENT,1
JP,PANCREATIC CYST,1
JP,PANCREATIC MASS,1
JP,PANCREATITIS ACUTE,1
JP,PANCREATITIS RELAPSING,1
JP,PANTOEA AGGLOMERANS INFECTION,1
JP,PAPULE,1
JP,PARACENTESIS,1
JP,PARESIS,1
JP,PATHOLOGICAL FRACTURE,1
JP,PEAK EXPIRATORY FLOW RATE DECREASED,1
JP,PERIANAL ERYTHEMA,1
JP,PERICARDIAL HAEMORRHAGE,1
JP,PERICARDITIS,1
JP,PERIODONTAL DISEASE,1
JP,PERIPHERAL COLDNESS,1
JP,PERIPHERAL ISCHAEMIA,1
JP,PERIPHERAL SWELLING,1
JP,PERIPHERAL VASCULAR DISORDER,1
JP,PERITONEAL HAEMORRHAGE,1
JP,PETECHIAE,1
JO,ACUTE KIDNEY INJURY,1
JO,CHEST DISCOMFORT,1
JO,DEATH,1
JO,DISSEMINATED INTRAVASCULAR COAGULATION,1
JO,DISTURBANCE IN ATTENTION,1
JO,DYSPNOEA,1
JO,ERYTHEMA,1
JO,FATIGUE,1
JO,HYPERNATRAEMIA,1
JO,HYPERSENSITIVITY,1
JO,LACTIC ACIDOSIS,1
JO,MULTI-ORGAN FAILURE,1
JO,MYOCARDIAL INFARCTION,1
JO,NON-SMALL CELL LUNG CANCER,1
JO,PAIN,1
JO,PLASMA CELL MYELOMA,1
JO,PLASMACYTOMA,1
JO,PNEUMONITIS,1
JO,PYREXIA,1
JO,RESPIRATORY FAILURE,1
JO,SEPSIS,1
JO,VASCULAR STENT THROMBOSIS,1
JO,VITREOUS HAEMORRHAGE,1
KZ,ASTHENIA,1
KZ,CARDIAC ARREST,1
KZ,CHEST PAIN,1
KZ,COLD SWEAT,1
KZ,CORONARY ARTERY OCCLUSION,1
KZ,DRUG INEFFECTIVE,1
KZ,ELECTROCARDIOGRAM ABNORMAL,1
KZ,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
KZ,HEART RATE INCREASED,1
KZ,VASCULAR STENT THROMBOSIS,1
KZ,VENTRICULAR FIBRILLATION,1
KP,COAGULOPATHY,2
KP,GINGIVAL BLEEDING,2
KP,HAEMATURIA,2
KP,OCCUPATIONAL EXPOSURE TO TOXIC AGENT,2
KP,ACQUIRED HAEMOPHILIA,1
KP,BACK PAIN,1
KP,CHEST DISCOMFORT,1
KP,CYANOSIS,1
KP,CYTOPENIA,1
KP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
KP,DYSURIA,1
KP,EXTRADURAL HAEMATOMA,1
KP,HYPONATRAEMIA,1
KP,HYPOVOLAEMIA,1
KP,NAUSEA,1
KP,PERIPHERAL ARTERY OCCLUSION,1
KP,PROSTATIC OPERATION,1
KP,PYELONEPHRITIS ACUTE,1
KP,SEPTIC SHOCK,1
KR,DYSPNOEA,26
KR,PNEUMONIA,26
KR,DIARRHOEA,21
KR,DISEASE PROGRESSION,21
KR,NAUSEA,16
KR,PYREXIA,16
KR,ASTHENIA,12
KR,CHEST PAIN,12
KR,VOMITING,12
KR,ACUTE KIDNEY INJURY,11
KR,ANAEMIA,11
KR,DEATH,10
KR,DIZZINESS,10
KR,NEUTROPENIA,10
KR,CEREBRAL HAEMORRHAGE,9
KR,DECREASED APPETITE,9
KR,PRODUCTIVE COUGH,9
KR,CEREBRAL INFARCTION,8
KR,COUGH,8
KR,ACUTE MYOCARDIAL INFARCTION,7
KR,ASPARTATE AMINOTRANSFERASE INCREASED,7
KR,HAEMORRHAGE,7
KR,HEADACHE,7
KR,HYPOTENSION,7
KR,PLATELET COUNT DECREASED,7
KR,PULMONARY OEDEMA,7
KR,SEPTIC SHOCK,7
KR,THROMBOCYTOPENIA,7
KR,ABDOMINAL PAIN,6
KR,ALANINE AMINOTRANSFERASE INCREASED,6
KR,ANAPHYLACTIC REACTION,6
KR,CARDIAC ARREST,6
KR,DELIRIUM,6
KR,FATIGUE,6
KR,FEBRILE NEUTROPENIA,6
KR,HAEMATOMA,6
KR,HAEMOPTYSIS,6
KR,PAIN IN EXTREMITY,6
KR,PYELONEPHRITIS ACUTE,6
KR,RASH,6
KR,RHABDOMYOLYSIS,6
KR,SEPSIS,6
KR,ANGIOEDEMA,5
KR,BLOOD BILIRUBIN INCREASED,5
KR,CAESAREAN SECTION,5
KR,CARDIOGENIC SHOCK,5
KR,CHEST DISCOMFORT,5
KR,EXPOSURE VIA BODY FLUID,5
KR,GASTROINTESTINAL HAEMORRHAGE,5
KR,HYPOAESTHESIA,5
KR,HYPOKALAEMIA,5
KR,HYPONATRAEMIA,5
KR,IN VITRO FERTILISATION,5
KR,INTERSTITIAL LUNG DISEASE,5
KR,NORMAL NEWBORN,5
KR,PALPITATIONS,5
KR,PLACENTA PRAEVIA,5
KR,PLASMA CELL MYELOMA,5
KR,PRURITUS,5
KR,PULMONARY ALVEOLAR HAEMORRHAGE,5
KR,CARDIAC FAILURE,4
KR,CONSTIPATION,4
KR,CYANOSIS,4
KR,DRUG RESISTANCE,4
KR,EMBOLISM,4
KR,EXTRADURAL HAEMATOMA,4
KR,FEAR OF DEATH,4
KR,GASTRIC ULCER,4
KR,GASTRITIS,4
KR,HAEMATOCHEZIA,4
KR,HAEMATURIA,4
KR,HAEMOGLOBIN DECREASED,4
KR,HYPERKALAEMIA,4
KR,HYPOPHAGIA,4
KR,MELAENA,4
KR,MUSCULAR WEAKNESS,4
KR,OEDEMA,4
KR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,4
KR,PLEURAL EFFUSION,4
KR,PULMONARY CONGESTION,4
KR,VASCULAR STENT THROMBOSIS,4
KR,VENTRICULAR FIBRILLATION,4
KR,WEIGHT DECREASED,4
KR,ABDOMINAL DISCOMFORT,3
KR,ALLERGIC MYOCARDITIS,3
KR,ANGINA PECTORIS,3
KR,ANGINA UNSTABLE,3
KR,ARRHYTHMIA,3
KR,ARTERIAL RUPTURE,3
KR,BLOOD ALKALINE PHOSPHATASE INCREASED,3
KR,BLOOD LACTATE DEHYDROGENASE INCREASED,3
KR,C-REACTIVE PROTEIN INCREASED,3
KR,CHOLECYSTITIS ACUTE,3
KR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
KR,COAGULOPATHY,3
KR,COLITIS MICROSCOPIC,3
KR,COMA,3
KR,CORONARY REVASCULARISATION,3
KR,DRUG INEFFECTIVE,3
KR,EPISTAXIS,3
KR,HAEMORRHAGE INTRACRANIAL,3
KR,HEPATIC ENZYME INCREASED,3
KR,INFLUENZA,3
KR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
KR,MALIGNANT NEOPLASM PROGRESSION,3
KR,MYALGIA,3
KR,MYOCARDIAL INFARCTION,3
KR,NASOPHARYNGITIS,3
KR,NEUTROPHIL COUNT DECREASED,3
KR,PAIN,3
KR,PANCREATITIS ACUTE,3
KR,PULMONARY HAEMORRHAGE,3
KR,RESPIRATORY FAILURE,3
KR,ROAD TRAFFIC ACCIDENT,3
KR,SHOCK,3
KR,TOXICITY TO VARIOUS AGENTS,3
KR,UPPER RESPIRATORY TRACT INFECTION,3
KR,URINARY RETENTION,3
KR,URINARY TRACT INFECTION,3
KR,URTICARIA,3
KR,ACUTE RESPIRATORY DISTRESS SYNDROME,2
KR,ACUTE RESPIRATORY FAILURE,2
KR,ANALGESIC ASTHMA SYNDROME,2
KR,ANGIODYSPLASIA,2
KR,ASCITES,2
KR,ATRIAL FIBRILLATION,2
KR,BACK PAIN,2
KR,BLOOD CREATININE INCREASED,2
KR,BLOOD PRESSURE DECREASED,2
KR,BLOOD UREA INCREASED,2
KR,BRAIN DEATH,2
KR,BRONCHIOLITIS,2
KR,BRONCHOPULMONARY ASPERGILLOSIS,2
KR,CEREBRAL HYPERPERFUSION SYNDROME,2
KR,CHOLANGIOCARCINOMA,2
KR,COLITIS ISCHAEMIC,2
KR,COLITIS ULCERATIVE,2
KR,CORONARY ARTERY STENOSIS,2
KR,DEEP VEIN THROMBOSIS,2
KR,DEPRESSION,2
KR,DYSPEPSIA,2
KR,DYSPHAGIA,2
KR,DYSPNOEA EXERTIONAL,2
KR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
KR,EOSINOPHILIA,2
KR,ERYTHEMA,2
KR,FALL,2
KR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
KR,GASTRIC HAEMORRHAGE,2
KR,GASTRIC PERFORATION,2
KR,GASTRIC ULCER HAEMORRHAGE,2
KR,GINGIVAL BLEEDING,2
KR,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
KR,HEPATIC FAILURE,2
KR,HYPERGLYCAEMIA,2
KR,HYPERHIDROSIS,2
KR,HYPEROSMOLAR HYPERGLYCAEMIC STATE,2
KR,HYPERTHYROIDISM,2
KR,HYPOXIA,2
KR,ILEUS,2
KR,INFECTIOUS COLITIS,2
KR,INSOMNIA,2
KR,ISCHAEMIC STROKE,2
KR,JAUNDICE,2
KR,LARGE INTESTINE POLYP,2
KR,LUNG NEOPLASM MALIGNANT,2
KR,MENTAL IMPAIRMENT,2
KR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
KR,MYOCARDIAL ISCHAEMIA,2
KR,NEUROPATHY PERIPHERAL,2
KR,OVERDOSE,2
KR,PALLOR,2
KR,PANCYTOPENIA,2
KR,RENAL FAILURE,2
KR,RHINORRHOEA,2
KR,SMALL INTESTINAL OBSTRUCTION,2
KR,STATUS EPILEPTICUS,2
KR,STUPOR,2
KR,SUBARACHNOID HAEMORRHAGE,2
KR,SUBDURAL HAEMORRHAGE,2
KR,SUICIDE ATTEMPT,2
KR,SYNCOPE,2
KR,THALAMUS HAEMORRHAGE,2
KR,TOXIC ENCEPHALOPATHY,2
KR,TREMOR,2
KR,VENTRICULAR TACHYCARDIA,2
KR,VITREOUS HAEMORRHAGE,2
KR,WHITE BLOOD CELL COUNT INCREASED,2
KR,ABDOMINAL DISTENSION,1
KR,ABDOMINAL PAIN LOWER,1
KR,ABDOMINAL PAIN UPPER,1
KR,ABNORMAL BEHAVIOUR,1
KR,ABSCESS,1
KR,ACCIDENTAL OVERDOSE,1
KR,ACIDOSIS,1
KR,ACQUIRED HAEMOPHILIA,1
KR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
KR,ACUTE PULMONARY OEDEMA,1
KR,ADENOCARCINOMA,1
KR,ADVERSE EVENT,1
KR,ALCOHOL USE,1
KR,ALCOHOLIC LIVER DISEASE,1
KR,ALOPECIA,1
KR,AMYLASE INCREASED,1
KR,AMYLOIDOSIS,1
KR,AMYOTROPHIC LATERAL SCLEROSIS,1
KR,ANAL ABSCESS,1
KR,ANXIETY,1
KR,AORTIC STENOSIS,1
KR,APHASIA,1
KR,APNOEA,1
KR,APPENDICITIS,1
KR,APRAXIA,1
KR,ARTERIOGRAM CORONARY,1
KR,ARTERIOSCLEROSIS,1
KR,ARTERIOSCLEROSIS CORONARY ARTERY,1
KR,ARTHRALGIA,1
KR,ASPERGILLUS TEST POSITIVE,1
KR,ASPIRATION,1
KR,ATELECTASIS,1
KR,ATRIOVENTRICULAR BLOCK,1
KR,ATYPICAL PNEUMONIA,1
KR,BACTERIAL INFECTION,1
KR,BENIGN SMALL INTESTINAL NEOPLASM,1
KR,BETA 2 MICROGLOBULIN INCREASED,1
KR,BILE DUCT STONE,1
KR,BILIARY TRACT DISORDER,1
KR,BILIRUBIN CONJUGATED INCREASED,1
KR,BIPOLAR I DISORDER,1
KR,BLOOD BILIRUBIN DECREASED,1
KR,BLOOD CALCIUM DECREASED,1
KR,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
KR,BLOOD FIBRINOGEN DECREASED,1
KR,BLOOD GLUCOSE INCREASED,1
KR,BLOOD PHOSPHORUS INCREASED,1
KR,BLOOD POTASSIUM INCREASED,1
KR,BLOOD PRESSURE INCREASED,1
KR,BLOOD SODIUM INCREASED,1
KR,BLOOD URIC ACID INCREASED,1
KR,BODY TEMPERATURE DECREASED,1
KR,BRADYCARDIA,1
KR,BRAIN INJURY,1
KR,BRONCHIECTASIS,1
KR,BRONCHITIS,1
KR,BURSITIS,1
KR,CALCULUS URETERIC,1
KR,CANDIDA INFECTION,1
KR,CARDIAC DEATH,1
KR,CATARACT,1
KR,CATHETER SITE PAIN,1
KR,CENTRAL NERVOUS SYSTEM LESION,1
KR,CEREBELLAR INFARCTION,1
KR,CEREBROVASCULAR ACCIDENT,1
KR,CHILLS,1
KR,CHOLECYSTECTOMY,1
KR,CHOLECYSTITIS CHRONIC,1
KR,CHOLELITHIASIS,1
KR,CHROMATURIA,1
KR,CHRONIC KIDNEY DISEASE,1
KR,CLOSTRIDIUM DIFFICILE COLITIS,1
KR,COLD SWEAT,1
KR,COLITIS,1
KR,COLON CANCER,1
KR,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
KR,CONDITION AGGRAVATED,1
KR,CONFUSIONAL STATE,1
KR,CONGESTIVE CARDIOMYOPATHY,1
KR,CONTUSION,1
KR,CORONARY ARTERIAL STENT INSERTION,1
KR,CORONARY ARTERY DISEASE,1
KR,CYTOMEGALOVIRUS GASTRITIS,1
KR,CYTOMEGALOVIRUS INFECTION,1
KR,DEAFNESS NEUROSENSORY,1
KR,DEMENTIA,1
KR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
KR,DIABETIC ULCER,1
KR,DIABETIC VASCULAR DISORDER,1
KR,DISSEMINATED INTRAVASCULAR COAGULATION,1
KR,DISTURBANCE IN ATTENTION,1
KR,DRUG ABUSE,1
KR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
KR,DUODENITIS,1
KR,DYSURIA,1
KR,EJECTION FRACTION DECREASED,1
KR,ELECTROCARDIOGRAM QT PROLONGED,1
KR,ENCEPHALITIS,1
KR,ENCEPHALOPATHY,1
KR,ENTEROCOLITIS,1
KR,EOSINOPHIL COUNT DECREASED,1
KR,EOSINOPHILIC MYOCARDITIS,1
KR,EYE MOVEMENT DISORDER,1
KR,EYELID PTOSIS,1
KR,FACIAL PARESIS,1
KR,FEELING COLD,1
KR,FEMORAL NECK FRACTURE,1
KR,FEMUR FRACTURE,1
KR,FRACTURE,1
KR,FRACTURE TREATMENT,1
KR,FRACTURED COCCYX,1
KR,FUNCTIONAL GASTROINTESTINAL DISORDER,1
KR,GALLBLADDER EMPYEMA,1
KR,GASTRIC POLYPS,1
KR,GASTRITIS EROSIVE,1
KR,GASTROINTESTINAL POLYP HAEMORRHAGE,1
KR,GENERAL PHYSICAL HEALTH DETERIORATION,1
KR,GINGIVITIS,1
KR,GLOMERULAR FILTRATION RATE DECREASED,1
KR,HAEMATOCRIT INCREASED,1
KR,HAEMOBILIA,1
KR,HAEMOGLOBIN INCREASED,1
KR,HAEMOGLOBINURIA,1
KR,HAEMORRHAGE SUBCUTANEOUS,1
KR,HAEMORRHAGIC STROKE,1
KR,HAEMORRHAGIC TRANSFORMATION STROKE,1
KR,HEAD INJURY,1
KR,HEMIANOPIA,1
KR,HEMIPLEGIA,1
KR,HEPARIN-INDUCED THROMBOCYTOPENIA,1
KR,HEPATITIS,1
KR,HEPATOCELLULAR CARCINOMA,1
KR,HERPES ZOSTER,1
KR,HICCUPS,1
KR,HOSPITALISATION,1
KR,HUMERUS FRACTURE,1
KR,HYPERCALCAEMIA,1
KR,HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME,1
KR,HYPERPLASTIC CHOLECYSTOPATHY,1
KR,HYPERREFLEXIA,1
KR,HYPOGLYCAEMIA,1
KR,HYPOPITUITARISM,1
KR,HYPOREFLEXIA,1
KR,HYPOSMIA,1
KR,HYPOVOLAEMIA,1
KR,HYPOVOLAEMIC SHOCK,1
KR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
KR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
KR,INFECTION,1
KR,INJURY,1
KR,INTENTIONAL OVERDOSE,1
KR,INTERMITTENT CLAUDICATION,1
KR,INTERNATIONAL NORMALISED RATIO INCREASED,1
KR,INTERVERTEBRAL DISC DISORDER,1
KR,INTERVERTEBRAL DISC PROTRUSION,1
KR,INTESTINAL PERFORATION,1
KR,INTRA-ABDOMINAL HAEMATOMA,1
KR,INTRAVENTRICULAR HAEMORRHAGE,1
KR,IRON DEFICIENCY ANAEMIA,1
KR,IRRITABILITY,1
KR,ISCHAEMIA,1
KR,LACERATION,1
KR,LACUNAR INFARCTION,1
KR,LEFT VENTRICULAR HYPERTROPHY,1
KR,LETHARGY,1
KR,LEUKOCYTOSIS,1
KR,LEUKOPENIA,1
KR,LIGAMENT SPRAIN,1
KR,LIPASE INCREASED,1
KR,LOCALISED OEDEMA,1
KR,LOWER LIMB FRACTURE,1
KR,LUMBAR SPINAL STENOSIS,1
KR,LUMBAR VERTEBRAL FRACTURE,1
KR,LUNG CONSOLIDATION,1
KR,LYMPHOCYTE COUNT DECREASED,1
KR,LYMPHOEDEMA,1
KR,MALAISE,1
KR,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
KR,MEAN CELL HAEMOGLOBIN DECREASED,1
KR,MEAN CELL VOLUME INCREASED,1
KR,MEMORY IMPAIRMENT,1
KR,MENINGITIS CHEMICAL,1
KR,MENTAL STATUS CHANGES,1
KR,METABOLIC ACIDOSIS,1
KR,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,1
KR,MOBILITY DECREASED,1
KR,MONOCYTE COUNT DECREASED,1
KR,MONOPLEGIA,1
KR,MUCOSAL INFLAMMATION,1
KR,MUSCLE HAEMORRHAGE,1
KR,MUSCLE RUPTURE,1
KR,MUSCLE STRAIN,1
KR,MUSCULOSKELETAL STIFFNESS,1
KR,MYCOBACTERIUM AVIUM COMPLEX INFECTION,1
KR,MYCOBACTERIUM CHELONAE INFECTION,1
KR,MYELOPATHY,1
KR,NASAL INJURY,1
KR,NASAL OBSTRUCTION,1
KR,NECK PAIN,1
KR,NEOVASCULARISATION,1
KR,NEPHROLITHIASIS,1
KR,NEURALGIA,1
KR,NEUTROPENIC COLITIS,1
KR,NEUTROPHIL COUNT INCREASED,1
KR,OBSTRUCTIVE AIRWAYS DISORDER,1
KR,OESOPHAGEAL CANDIDIASIS,1
KR,OESOPHAGITIS,1
KR,OPEN FRACTURE,1
KR,ORAL CANDIDIASIS,1
KR,ORBITAL OEDEMA,1
KR,ORGANISING PNEUMONIA,1
KR,OROPHARYNGEAL PAIN,1
KR,OSTEOMYELITIS CHRONIC,1
KR,OSTEONECROSIS,1
KR,OXYGEN SATURATION DECREASED,1
KR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
KR,PARALYSIS,1
KR,PARAPLEGIA,1
KR,PARKINSONISM,1
KR,PAROSMIA,1
KR,PEPTIC ULCER,1
KR,PEPTIC ULCER PERFORATION,1
KR,PERICARDIAL HAEMORRHAGE,1
KR,PERIPHERAL SENSORY NEUROPATHY,1
KR,PERIPHERAL SWELLING,1
KR,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,1
KR,PERIPHERAL VENOUS DISEASE,1
KR,PERITONITIS,1
KR,PIGMENTATION DISORDER,1
KR,PLATELET COUNT INCREASED,1
KR,PNEUMONIA VIRAL,1
KR,PNEUMONITIS,1
KR,PNEUMOTHORAX,1
KR,POLLAKIURIA,1
KR,POST PROCEDURAL HAEMORRHAGE,1
KR,PROCEDURAL SITE REACTION,1
KR,PRODUCT USE IN UNAPPROVED INDICATION,1
KR,PRODUCT USE ISSUE,1
KR,PROTEINURIA,1
KR,PROTHROMBIN LEVEL DECREASED,1
KR,PRURIGO,1
KR,PULMONARY EMBOLISM,1
KR,PULMONARY SEPSIS,1
KR,PULMONARY TOXICITY,1
KR,PULMONARY TUBERCULOSIS,1
KR,PURPURA,1
KR,PYELONEPHRITIS,1
KR,RALES,1
KR,RASH ERYTHEMATOUS,1
KR,RASH MACULO-PAPULAR,1
KR,RED BLOOD CELL COUNT INCREASED,1
KR,RED CELL DISTRIBUTION WIDTH INCREASED,1
KR,RENAL FAILURE ACUTE,1
KR,RENAL TUBULAR ACIDOSIS,1
KR,RESPIRATORY DISTRESS,1
KR,RETINAL HAEMORRHAGE,1
KR,RETINAL NEOVASCULARISATION,1
KR,RETROPERITONEAL HAEMATOMA,1
KR,RUPTURED CEREBRAL ANEURYSM,1
KR,SARCOIDOSIS,1
KR,SCOLIOSIS,1
KR,SINUS BRADYCARDIA,1
KR,SINUS TACHYCARDIA,1
KR,SKIN LESION,1
KR,SKIN SWELLING,1
KR,SMALL INTESTINAL HAEMORRHAGE,1
KR,SOMNOLENCE,1
KR,SPEECH DISORDER,1
KR,SPINAL EPIDURAL HAEMATOMA,1
KR,SPINAL FRACTURE,1
KR,SPONTANEOUS HAEMORRHAGE,1
KR,SPUTUM INCREASED,1
KR,STAPHYLOCOCCAL INFECTION,1
KR,STAPHYLOCOCCUS TEST POSITIVE,1
KR,SUDDEN CARDIAC DEATH,1
KR,SUDDEN DEATH,1
KR,TACHYCARDIA,1
KR,TACHYPNOEA,1
KR,TENDON RUPTURE,1
KR,THALAMIC INFARCTION,1
KR,THERAPEUTIC EMBOLISATION,1
KR,THERAPEUTIC RESPONSE DECREASED,1
KR,THORACIC VERTEBRAL FRACTURE,1
KR,THROMBOSIS,1
KR,THROMBOSIS IN DEVICE,1
KR,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
KR,THYROID CANCER,1
KR,TOXIC ANTERIOR SEGMENT SYNDROME,1
KR,TRANSFUSION,1
KR,TRANSIENT ISCHAEMIC ATTACK,1
KR,TYPE 2 DIABETES MELLITUS,1
KR,ULCER HAEMORRHAGE,1
KR,UPPER GASTROINTESTINAL HAEMORRHAGE,1
KR,UPPER LIMB FRACTURE,1
KR,URETEROLITHIASIS,1
KR,URINE OUTPUT DECREASED,1
KR,URINE PROTEIN/CREATININE RATIO INCREASED,1
KR,VASCULAR DEMENTIA,1
KR,VASCULAR OCCLUSION,1
KR,VASCULAR PARKINSONISM,1
KR,VASCULAR PSEUDOANEURYSM RUPTURED,1
KR,VASCULAR STENT STENOSIS,1
KR,VASOGENIC CEREBRAL OEDEMA,1
KR,VENTRICULAR HYPOKINESIA,1
KR,VERTEBROPLASTY,1
KR,VERTIGO,1
KR,WALKING AID USER,1
KR,WHEEZING,1
KR,WHITE BLOOD CELL COUNT ABNORMAL,1
KW,CEREBRAL HAEMORRHAGE,2
KW,COMA,2
KW,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
KW,DEATH,1
KW,DIABETIC NEPHROPATHY,1
KW,DRUG INEFFECTIVE,1
KW,EXPOSURE DURING PREGNANCY,1
KW,FOETAL EXPOSURE DURING PREGNANCY,1
KW,FOETAL GROWTH RESTRICTION,1
KW,HAEMORRHAGIC STROKE,1
KW,HYPERKALAEMIA,1
KW,HYPOVENTILATION,1
KW,LIVE BIRTH,1
KW,NODAL ARRHYTHMIA,1
KW,RENAL IMPAIRMENT,1
KW,RENAL TUBULAR NECROSIS,1
KW,RESPIRATORY DISTRESS,1
KW,TOXICITY TO VARIOUS AGENTS,1
LV,GASTROINTESTINAL HAEMORRHAGE,2
LV,SUBCUTANEOUS HAEMATOMA,2
LV,ACUTE KIDNEY INJURY,1
LV,ARTHRALGIA,1
LV,BLOOD CHOLESTEROL INCREASED,1
LV,BLOOD TRIGLYCERIDES INCREASED,1
LV,CARDIAC FAILURE,1
LV,CARDIAC FAILURE ACUTE,1
LV,CEREBROVASCULAR ACCIDENT,1
LV,DISSEMINATED INTRAVASCULAR COAGULATION,1
LV,DYSPNOEA,1
LV,ERYTHEMA,1
LV,HYPERHIDROSIS,1
LV,ILEAL ULCER,1
LV,JOINT SWELLING,1
LV,LOWER LIMB FRACTURE,1
LV,METASTASES TO LUNG,1
LV,PALPITATIONS,1
LV,PULMONARY ARTERY THROMBOSIS,1
LV,PULMONARY EMBOLISM,1
LV,PYELONEPHRITIS CHRONIC,1
LV,SKIN HAEMORRHAGE,1
LV,TACHYCARDIA,1
LV,THROMBOCYTOPENIA,1
LV,THROMBOSIS IN DEVICE,1
LV,URINARY TRACT INFECTION,1
LB,HYPERGLYCAEMIA,7
LB,DYSPNOEA,6
LB,FALL,5
LB,PYREXIA,5
LB,ABDOMINAL PAIN UPPER,4
LB,CHEST PAIN,4
LB,CATARACT,3
LB,DEATH,3
LB,EMBOLISM,3
LB,GENERAL PHYSICAL HEALTH DETERIORATION,3
LB,HIP FRACTURE,3
LB,ISCHAEMIC STROKE,3
LB,MYOCARDIAL INFARCTION,3
LB,OEDEMA,3
LB,SUBDURAL HAEMATOMA,3
LB,VOMITING,3
LB,ANAEMIA,2
LB,ASTHENIA,2
LB,BLOOD CREATININE INCREASED,2
LB,BONE PAIN,2
LB,CARDIAC DISORDER,2
LB,CHEST DISCOMFORT,2
LB,CHILLS,2
LB,DIARRHOEA,2
LB,ERYTHEMA,2
LB,GASTROENTERITIS,2
LB,HAEMATOCRIT DECREASED,2
LB,HEADACHE,2
LB,HYPERHIDROSIS,2
LB,HYPOGLYCAEMIA,2
LB,HYPOTENSION,2
LB,INFECTION,2
LB,LINEAR IGA DISEASE,2
LB,LUNG INFECTION,2
LB,PANCREATITIS,2
LB,PULMONARY OEDEMA,2
LB,THROMBOPHLEBITIS,2
LB,VISION BLURRED,2
LB,ABSCESS,1
LB,ACUTE PULMONARY OEDEMA,1
LB,BLISTER,1
LB,BLOOD GLUCOSE INCREASED,1
LB,BREAST CANCER,1
LB,BRONCHITIS,1
LB,CARDIAC ARREST,1
LB,CARDIAC FAILURE,1
LB,CARDIAC OPERATION,1
LB,CAROTID ARTERY STENOSIS,1
LB,CAROTID ARTERY THROMBOSIS,1
LB,CATHETER SITE THROMBOSIS,1
LB,CEREBRAL ISCHAEMIA,1
LB,CIRCULATORY COLLAPSE,1
LB,COLON CANCER STAGE IV,1
LB,CONSTIPATION,1
LB,CORNEAL DISORDER,1
LB,DECREASED APPETITE,1
LB,DECUBITUS ULCER,1
LB,DERMATITIS BULLOUS,1
LB,ENCEPHALITIS,1
LB,EPISTAXIS,1
LB,FATIGUE,1
LB,GASTRECTOMY,1
LB,GASTRIC HAEMORRHAGE,1
LB,GASTROINTESTINAL HAEMORRHAGE,1
LB,HAEMATOCHEZIA,1
LB,HAEMOLYTIC ANAEMIA,1
LB,HAND FRACTURE,1
LB,HEPARIN-INDUCED THROMBOCYTOPENIA,1
LB,HEPARIN-INDUCED THROMBOCYTOPENIA TEST POSITIVE,1
LB,HEPATIC CANCER METASTATIC,1
LB,HERNIA,1
LB,HYPERTENSION,1
LB,HYPOAESTHESIA,1
LB,IMMUNOSUPPRESSION,1
LB,INCORRECT DOSE ADMINISTERED,1
LB,INFLUENZA,1
LB,INSOMNIA,1
LB,INTENTIONAL PRODUCT MISUSE,1
LB,INTERVERTEBRAL DISC DISORDER,1
LB,JOINT SWELLING,1
LB,LEUKOCYTOSIS,1
LB,LOCALISED INFECTION,1
LB,LOSS OF CONSCIOUSNESS,1
LB,LOWER LIMB FRACTURE,1
LB,LUNG NEOPLASM MALIGNANT,1
LB,LYMPHOMA,1
LB,LYMPHOPENIA,1
LB,MENINGITIS,1
LB,METASTATIC GASTRIC CANCER,1
LB,METASTATIC RENAL CELL CARCINOMA,1
LB,MUSCLE SPASMS,1
LB,MYALGIA,1
LB,NAUSEA,1
LB,OCULAR HYPERTENSION,1
LB,ORCHITIS,1
LB,ORGAN FAILURE,1
LB,OVERDOSE,1
LB,PAIN IN EXTREMITY,1
LB,PANCREATIC DISORDER,1
LB,PARAESTHESIA,1
LB,PERIPHERAL COLDNESS,1
LB,PERIPHERAL SWELLING,1
LB,PNEUMONIA,1
LB,PRODUCTIVE COUGH,1
LB,RASH,1
LB,RESPIRATORY TRACT INFECTION,1
LB,RETINAL IMPLANT,1
LB,RETROPERITONEAL HAEMORRHAGE,1
LB,SCAB,1
LB,SKIN EROSION,1
LB,SPINAL EPIDURAL HAEMATOMA,1
LB,STAPHYLOCOCCAL INFECTION,1
LB,STOMATITIS,1
LB,SWELLING,1
LB,TACHYCARDIA,1
LB,TESTICULAR CYST,1
LB,THROMBOSIS IN DEVICE,1
LB,TOE AMPUTATION,1
LB,URINARY TRACT INFECTION,1
LB,URINE OUTPUT DECREASED,1
LB,UTERINE LEIOMYOMA,1
LB,VIRAL INFECTION,1
LB,VISUAL IMPAIRMENT,1
LB,WEIGHT DECREASED,1
LB,WHITE BLOOD CELL COUNT INCREASED,1
LB,WOUND INFECTION,1
LB,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
LT,DIABETES MELLITUS,2
LT,MYOCARDIAL INFARCTION,2
LT,ABDOMINAL DISTENSION,1
LT,ACUTE MYOCARDIAL INFARCTION,1
LT,ANEURYSM,1
LT,ANGINA PECTORIS,1
LT,ARTERIAL INJURY,1
LT,CARDIOMYOPATHY,1
LT,CEREBROVASCULAR ACCIDENT,1
LT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
LT,CORONARY ARTERY ANEURYSM,1
LT,CORONARY ARTERY THROMBOSIS,1
LT,DRUG RESISTANCE,1
LT,EXPIRED PRODUCT ADMINISTERED,1
LT,FEELING ABNORMAL,1
LT,INTENTIONAL OVERDOSE,1
LT,MYOCARDITIS,1
LT,NO THERAPEUTIC RESPONSE,1
LT,PEPTIC ULCER PERFORATION,1
LT,RENAL VEIN THROMBOSIS,1
LT,SUICIDE ATTEMPT,1
LT,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
LT,TINNITUS,1
LT,TRANSIENT ISCHAEMIC ATTACK,1
LT,TREMOR,1
LT,URINARY TRACT INFECTION,1
LU,MUSCULAR WEAKNESS,2
LU,ABASIA,1
LU,ALANINE AMINOTRANSFERASE INCREASED,1
LU,ARTERITIS,1
LU,ASPARTATE AMINOTRANSFERASE INCREASED,1
LU,ASTHENIA,1
LU,BETA 2 MICROGLOBULIN INCREASED,1
LU,BLOOD ALKALINE PHOSPHATASE INCREASED,1
LU,BLOOD GLUCOSE INCREASED,1
LU,BLOOD POTASSIUM DECREASED,1
LU,BORRELIA INFECTION,1
LU,CARCINOEMBRYONIC ANTIGEN INCREASED,1
LU,CYTOMEGALOVIRUS TEST POSITIVE,1
LU,EOSINOPHIL COUNT DECREASED,1
LU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
LU,GASTRITIS VIRAL,1
LU,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
LU,GUILLAIN-BARRE SYNDROME,1
LU,HEPATIC FUNCTION ABNORMAL,1
LU,HERPES SIMPLEX SEROLOGY POSITIVE,1
LU,HYPOAESTHESIA,1
LU,INFLAMMATION,1
LU,LATENT TUBERCULOSIS,1
LU,LYME DISEASE,1
LU,LYMPHOCYTE COUNT DECREASED,1
LU,MEAN CELL VOLUME INCREASED,1
LU,MONOCYTE COUNT DECREASED,1
LU,NEPHROTIC SYNDROME,1
LU,NERVOUS SYSTEM DISORDER,1
LU,NEUROBORRELIOSIS,1
LU,PAIN,1
LU,PARAESTHESIA,1
LU,PLATELET COUNT DECREASED,1
LU,SERUM FERRITIN INCREASED,1
LU,TOXOPLASMA SEROLOGY POSITIVE,1
LU,TUBERCULOSIS,1
LU,VARICELLA VIRUS TEST POSITIVE,1
LU,WHITE BLOOD CELL COUNT DECREASED,1
MO,ATRIOVENTRICULAR BLOCK,1
MO,BRADYCARDIA,1
MK,ASPHYXIA,1
MK,ASTHMA,1
MY,PNEUMONIA,7
MY,ANAEMIA,6
MY,HYPOGLYCAEMIA,5
MY,HAEMATEMESIS,4
MY,MELAENA,4
MY,VOMITING,4
MY,WEIGHT DECREASED,4
MY,DIZZINESS,3
MY,DRUG INEFFECTIVE,3
MY,DYSPNOEA,3
MY,MYOCARDIAL INFARCTION,3
MY,PRURITUS,3
MY,STEVENS-JOHNSON SYNDROME,3
MY,ABDOMINAL PAIN UPPER,2
MY,AGEUSIA,2
MY,ANGIOEDEMA,2
MY,BLOOD ALKALINE PHOSPHATASE INCREASED,2
MY,BLOOD BILIRUBIN INCREASED,2
MY,CHANGE OF BOWEL HABIT,2
MY,DEATH,2
MY,DIABETES MELLITUS INADEQUATE CONTROL,2
MY,END STAGE RENAL DISEASE,2
MY,FOETAL EXPOSURE DURING PREGNANCY,2
MY,HAEMORRHAGE INTRACRANIAL,2
MY,HYPONATRAEMIA,2
MY,INFECTION,2
MY,LIP SWELLING,2
MY,LOW BIRTH WEIGHT BABY,2
MY,NAUSEA,2
MY,ORBITAL OEDEMA,2
MY,PRURITUS GENERALISED,2
MY,PYREXIA,2
MY,QUALITY OF LIFE DECREASED,2
MY,RHABDOMYOLYSIS,2
MY,SEPTIC SHOCK,2
MY,TOXIC EPIDERMAL NECROLYSIS,2
MY,TREMOR,2
MY,VISION BLURRED,2
MY,ABASIA,1
MY,ABDOMINAL DISCOMFORT,1
MY,ABDOMINAL DISTENSION,1
MY,ABDOMINAL PAIN,1
MY,ACUTE CORONARY SYNDROME,1
MY,ACUTE KIDNEY INJURY,1
MY,ACUTE MYOCARDIAL INFARCTION,1
MY,ACUTE PULMONARY OEDEMA,1
MY,AFFECT LABILITY,1
MY,ALANINE AMINOTRANSFERASE INCREASED,1
MY,ANAEMIA MACROCYTIC,1
MY,ANAEMIA VITAMIN B12 DEFICIENCY,1
MY,ATRIAL FIBRILLATION,1
MY,BLINDNESS,1
MY,BLISTER,1
MY,BLOOD GLUCOSE INCREASED,1
MY,BLOOD LACTATE DEHYDROGENASE INCREASED,1
MY,CARDIAC ARREST,1
MY,CARDIAC FAILURE,1
MY,CELLULITIS,1
MY,CEREBRAL INFARCTION,1
MY,CEREBROVASCULAR ACCIDENT,1
MY,CHEST PAIN,1
MY,CHRONIC KIDNEY DISEASE,1
MY,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
MY,CONSTIPATION,1
MY,COUGH,1
MY,DEAFNESS NEUROSENSORY,1
MY,DECREASED APPETITE,1
MY,DEHYDRATION,1
MY,DERMATITIS BULLOUS,1
MY,DEVICE RELATED INFECTION,1
MY,DEVICE RELATED SEPSIS,1
MY,DIARRHOEA,1
MY,DISCOMFORT,1
MY,DISEASE PROGRESSION,1
MY,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
MY,DRY SKIN,1
MY,DUODENAL ULCER HAEMORRHAGE,1
MY,DYSPHAGIA,1
MY,EAR DISCOMFORT,1
MY,ERYTHEMA,1
MY,EXFOLIATIVE RASH,1
MY,FACE OEDEMA,1
MY,FEELING HOT,1
MY,FLUID OVERLOAD,1
MY,GAIT DISTURBANCE,1
MY,GASTRIC ULCER,1
MY,GASTRIC ULCER HAEMORRHAGE,1
MY,GASTROENTERITIS,1
MY,GASTROINTESTINAL HAEMORRHAGE,1
MY,GLOMERULAR FILTRATION RATE,1
MY,GLOMERULAR FILTRATION RATE DECREASED,1
MY,GLOSSITIS,1
MY,HAEMATOMA,1
MY,HAEMODIALYSIS,1
MY,HAEMOGLOBIN DECREASED,1
MY,HAEMORRHAGE URINARY TRACT,1
MY,HAEMORRHAGIC ANAEMIA,1
MY,HAEMORRHOIDAL HAEMORRHAGE,1
MY,HEADACHE,1
MY,HEMIPARESIS,1
MY,HERPES VIRUS INFECTION,1
MY,HERPES ZOSTER,1
MY,HYDRONEPHROSIS,1
MY,HYPERKALAEMIA,1
MY,HYPORESPONSIVE TO STIMULI,1
MY,ILEUS PARALYTIC,1
MY,INTERNATIONAL NORMALISED RATIO INCREASED,1
MY,INTERVERTEBRAL DISCITIS,1
MY,INVASIVE DUCTAL BREAST CARCINOMA,1
MY,JAUNDICE,1
MY,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
MY,LETHARGY,1
MY,LEUKOPENIA,1
MY,LIPASE INCREASED,1
MY,LIVER ABSCESS,1
MY,LOSS OF CONSCIOUSNESS,1
MY,MACULAR OEDEMA,1
MY,MALABSORPTION,1
MY,MOUTH ULCERATION,1
MY,MYALGIA,1
MY,MYOCARDIAL ISCHAEMIA,1
MY,NECROTISING FASCIITIS,1
MY,NEPHROGENIC ANAEMIA,1
MY,NEUTROPENIA,1
MY,PAIN,1
MY,PALPITATIONS,1
MY,PANCREATIC ABSCESS,1
MY,PANCREATITIS ACUTE,1
MY,PERIPHERAL VASCULAR DISORDER,1
MY,PLANTAR FASCIITIS,1
MY,PLEURAL EFFUSION,1
MY,POLYMYOSITIS,1
MY,POST PROCEDURAL STROKE,1
MY,PREMATURE BABY,1
MY,PRODUCT USE ISSUE,1
MY,RASH,1
MY,RASH ERYTHEMATOUS,1
MY,REFUSAL OF TREATMENT BY PATIENT,1
MY,RENAL CANCER METASTATIC,1
MY,RENAL CELL CARCINOMA,1
MY,RENAL FAILURE ACUTE,1
MY,RENAL HAEMATOMA,1
MY,RENAL IMPAIRMENT,1
MY,RHEUMATOID ARTHRITIS,1
MY,RHINORRHOEA,1
MY,SEPSIS,1
MY,SKIN DISCOLOURATION,1
MY,SOMNOLENCE,1
MY,STAPHYLOCOCCAL INFECTION,1
MY,SWOLLEN TONGUE,1
MY,THROAT IRRITATION,1
MY,THROMBOPHLEBITIS,1
MY,TINNITUS,1
MY,TREATMENT FAILURE,1
MY,TUBERCULOSIS,1
MY,UNRESPONSIVE TO STIMULI,1
MY,UPPER GASTROINTESTINAL HAEMORRHAGE,1
MY,URINARY TRACT INFECTION,1
MT,COUGH,3
MT,ANALGESIC DRUG LEVEL INCREASED,1
MT,BLOOD PRESSURE DECREASED,1
MT,DEATH,1
MT,DERMATITIS BULLOUS,1
MT,DIARRHOEA,1
MT,DRUG DOSE OMISSION,1
MT,EYE IRRITATION,1
MT,EYELID INJURY,1
MT,EYELID SKIN DRYNESS,1
MT,FLUID RETENTION,1
MT,HEPATITIS CHOLESTATIC,1
MT,HYPERSENSITIVITY,1
MT,INFLUENZA,1
MT,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
MT,NAUSEA,1
MT,OCULAR HYPERAEMIA,1
MT,PERIPHERAL SWELLING,1
MT,PRURITUS,1
MT,PULMONARY OEDEMA,1
MT,RASH ERYTHEMATOUS,1
MT,RASH GENERALISED,1
MT,RASH PRURITIC,1
MT,RHABDOMYOLYSIS,1
MT,SPINAL OSTEOARTHRITIS,1
MT,SWELLING FACE,1
MT,SYNCOPE,1
MT,VOMITING,1
MT,WEIGHT INCREASED,1
MU,THROMBOSIS IN DEVICE,2
MU,DEATH,1
MU,DIABETIC KETOACIDOSIS,1
MX,HYPERTENSION,8
MX,MYOCARDIAL INFARCTION,8
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,7
MX,CARDIAC FAILURE,6
MX,DIABETES MELLITUS,6
MX,DIZZINESS,6
MX,FALL,6
MX,PRODUCT USE IN UNAPPROVED INDICATION,6
MX,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,6
MX,CEREBROVASCULAR ACCIDENT,5
MX,DIARRHOEA,5
MX,DRUG PRESCRIBING ERROR,5
MX,FATIGUE,5
MX,HEADACHE,5
MX,PYREXIA,5
MX,ARRHYTHMIA,4
MX,BLOOD GLUCOSE INCREASED,4
MX,BLOOD PRESSURE INCREASED,4
MX,CARDIAC ARREST,4
MX,DEATH,4
MX,DEPRESSION,4
MX,DRUG INEFFECTIVE,4
MX,FEELING ABNORMAL,4
MX,MEMORY IMPAIRMENT,4
MX,ANAEMIA,3
MX,ASTHENIA,3
MX,CARDIAC DISORDER,3
MX,CATARACT,3
MX,CEREBRAL INFARCTION,3
MX,COUGH,3
MX,GAIT DISTURBANCE,3
MX,GASTRIC DISORDER,3
MX,GENERAL PHYSICAL HEALTH DETERIORATION,3
MX,HYPERGLYCAEMIA,3
MX,HYPERSOMNIA,3
MX,HYPOTHYROIDISM,3
MX,ILEUS PARALYTIC,3
MX,INFARCTION,3
MX,INFLAMMATION,3
MX,OESOPHAGITIS,3
MX,PAIN,3
MX,PAIN IN EXTREMITY,3
MX,PRODUCT USE ISSUE,3
MX,PROSTATIC DISORDER,3
MX,RENAL FAILURE,3
MX,STOMATITIS,3
MX,TOXICITY TO VARIOUS AGENTS,3
MX,VISUAL IMPAIRMENT,3
MX,VITH NERVE PARALYSIS,3
MX,WEIGHT DECREASED,3
MX,ABASIA,2
MX,ABDOMINAL PAIN,2
MX,ACUTE PULMONARY OEDEMA,2
MX,AGGRESSION,2
MX,ANGINA UNSTABLE,2
MX,ANXIETY,2
MX,APPLICATION SITE HAEMORRHAGE,2
MX,BACK PAIN,2
MX,BLOOD GLUCOSE DECREASED,2
MX,BLOOD PRESSURE DECREASED,2
MX,BRADYCARDIA,2
MX,BREAST CANCER,2
MX,CARDIOVASCULAR DISORDER,2
MX,CEREBRAL ATROPHY,2
MX,CEREBRAL HAEMORRHAGE,2
MX,COLITIS,2
MX,CONSTIPATION,2
MX,DRUG DOSE OMISSION,2
MX,DRUG INTOLERANCE,2
MX,GLAUCOMA,2
MX,HAEMORRHAGE,2
MX,HEAD INJURY,2
MX,HEARING IMPAIRED,2
MX,HEART RATE INCREASED,2
MX,HERPES ZOSTER,2
MX,HIATUS HERNIA,2
MX,HYPOKINESIA,2
MX,HYPOTENSION,2
MX,INFECTION,2
MX,LOSS OF CONSCIOUSNESS,2
MX,MALAISE,2
MX,NERVOUSNESS,2
MX,PRE-ECLAMPSIA,2
MX,SEPTIC SHOCK,2
MX,SKIN DISCOLOURATION,2
MX,SOMNOLENCE,2
MX,THROMBOSIS,2
MX,TREMOR,2
MX,URINARY TRACT INFECTION,2
MX,VERTIGO,2
MX,VOMITING,2
MX,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
MX,ABDOMINAL DISCOMFORT,1
MX,ABDOMINAL DISTENSION,1
MX,ABDOMINAL PAIN UPPER,1
MX,ABSCESS LIMB,1
MX,ACCIDENT,1
MX,ACNE,1
MX,ACUTE MYOCARDIAL INFARCTION,1
MX,AGEUSIA,1
MX,AKINESIA,1
MX,ANEURYSM,1
MX,ANTIPHOSPHOLIPID SYNDROME,1
MX,ANURIA,1
MX,AORTIC VALVE SCLEROSIS,1
MX,APPARENT DEATH,1
MX,APPLICATION SITE ERYTHEMA,1
MX,APPLICATION SITE IRRITATION,1
MX,ARTHRALGIA,1
MX,ARTHRITIS REACTIVE,1
MX,ASPHYXIA,1
MX,AZOTAEMIA,1
MX,BALANCE DISORDER,1
MX,BLINDNESS UNILATERAL,1
MX,BLOOD CHOLESTEROL ABNORMAL,1
MX,BLOOD POTASSIUM ABNORMAL,1
MX,BLOOD POTASSIUM DECREASED,1
MX,BLOOD SODIUM ABNORMAL,1
MX,BONE DISORDER,1
MX,BONE MARROW FAILURE,1
MX,BRAIN HYPOXIA,1
MX,BRAIN INJURY,1
MX,BURNING MOUTH SYNDROME,1
MX,BURNING SENSATION,1
MX,CARDIAC ANEURYSM,1
MX,CARDIAC DISCOMFORT,1
MX,CARDIOACTIVE DRUG LEVEL INCREASED,1
MX,CARDIOMEGALY,1
MX,CARDIOMYOPATHY,1
MX,CHEST PAIN,1
MX,CHILLS,1
MX,CHOLELITHIASIS,1
MX,CHRONIC MYELOID LEUKAEMIA,1
MX,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
MX,COGNITIVE DISORDER,1
MX,COMA,1
MX,CONCOMITANT DISEASE PROGRESSION,1
MX,CONDITION AGGRAVATED,1
MX,CONFUSIONAL STATE,1
MX,CONTRAINDICATED PRODUCT ADMINISTERED,1
MX,COORDINATION ABNORMAL,1
MX,CORONARY ARTERY OCCLUSION,1
MX,DEAFNESS,1
MX,DECUBITUS ULCER,1
MX,DEEP VEIN THROMBOSIS,1
MX,DEHYDRATION,1
MX,DELIRIUM,1
MX,DEMENTIA,1
MX,DEMENTIA ALZHEIMER^S TYPE,1
MX,DENTAL CARIES,1
MX,DEPRESSED LEVEL OF CONSCIOUSNESS,1
MX,DERMATITIS ALLERGIC,1
MX,DIPLOPIA,1
MX,DISCOMFORT,1
MX,DISORIENTATION,1
MX,DISSEMINATED INTRAVASCULAR COAGULATION,1
MX,DISSEMINATED TUBERCULOSIS,1
MX,DIVERTICULITIS,1
MX,DRUG ADMINISTRATION ERROR,1
MX,DRUG LEVEL DECREASED,1
MX,DRY SKIN,1
MX,DYSGRAPHIA,1
MX,DYSPHONIA,1
MX,DYSPNOEA,1
MX,DYSSTASIA,1
MX,DYSURIA,1
MX,EAR CONGESTION,1
MX,ELECTROCARDIOGRAM QT PROLONGED,1
MX,EMBOLISM,1
MX,ENTEROCOLITIS HAEMORRHAGIC,1
MX,EPISTAXIS,1
MX,ESCHERICHIA TEST POSITIVE,1
MX,EXPOSURE DURING PREGNANCY,1
MX,EYE DISORDER,1
MX,FAECES DISCOLOURED,1
MX,FEELING OF DESPAIR,1
MX,FLUID RETENTION,1
MX,FOETAL EXPOSURE DURING PREGNANCY,1
MX,FOOD INTOLERANCE,1
MX,FOREIGN BODY,1
MX,FREEZING PHENOMENON,1
MX,GAIT INABILITY,1
MX,GANGRENE,1
MX,GASTRIC HAEMORRHAGE,1
MX,GASTRITIS,1
MX,GASTROINTESTINAL HAEMORRHAGE,1
MX,GINGIVAL BLEEDING,1
MX,GLOSSITIS,1
MX,GLUCOSE TOLERANCE IMPAIRED,1
MX,GUILLAIN-BARRE SYNDROME,1
MX,HAEMATURIA,1
MX,HAEMOGLOBIN DECREASED,1
MX,HAEMOPTYSIS,1
MX,HAEMORRHOIDS,1
MX,HEPATIC CANCER,1
MX,HEPATIC FAILURE,1
MX,HEPATIC FIBROSIS,1
MX,HIGH RISK PREGNANCY,1
MX,HIP SURGERY,1
MX,HISTOLOGY ABNORMAL,1
MX,HOSPITALISATION,1
MX,HYPERAESTHESIA,1
MX,HYPERTHYROIDISM,1
MX,HYPOXIA,1
MX,IATROGENIC INJURY,1
MX,IMMUNODEFICIENCY,1
MX,IMPATIENCE,1
MX,INFLUENZA,1
MX,INGUINAL HERNIA,1
MX,INJURY,1
MX,INSOMNIA,1
MX,INTERNAL HAEMORRHAGE,1
MX,INTESTINAL OBSTRUCTION,1
MX,INTESTINAL ULCER,1
MX,IRREGULAR BREATHING,1
MX,JOINT INJURY,1
MX,LAZINESS,1
MX,LEUKOCYTOSIS,1
MX,LEUKOPENIA,1
MX,LID SULCUS DEEPENED,1
MX,LIVER FUNCTION TEST ABNORMAL,1
MX,LOW BIRTH WEIGHT BABY,1
MX,LOWER RESPIRATORY TRACT INFECTION,1
MX,LOWER RESPIRATORY TRACT INFECTION BACTERIAL,1
MX,LUNG INFECTION,1
MX,LYMPH NODE TUBERCULOSIS,1
MX,MATERNAL EXPOSURE DURING PREGNANCY,1
MX,MESENTERIC VEIN THROMBOSIS,1
MX,METASTASES TO PANCREAS,1
MX,MOBILITY DECREASED,1
MX,MOOD ALTERED,1
MX,MOVEMENT DISORDER,1
MX,MUCOSAL INFLAMMATION,1
MX,MULTI-ORGAN FAILURE,1
MX,MUSCLE INJURY,1
MX,MUSCLE RIGIDITY,1
MX,MUSCULAR WEAKNESS,1
MX,MYALGIA,1
MX,MYOCARDIAL ISCHAEMIA,1
MX,MYOPATHY,1
MX,NAIL DISORDER,1
MX,NEONATAL ASPHYXIA,1
MX,NEOPLASM PROGRESSION,1
MX,NEURALGIA,1
MX,NEUTROPENIA,1
MX,OCULAR VASCULITIS,1
MX,OEDEMA PERIPHERAL,1
MX,OESOPHAGEAL CANDIDIASIS,1
MX,OESOPHAGEAL VARICES HAEMORRHAGE,1
MX,OLIGURIA,1
MX,ORAL INFECTION,1
MX,OVARIAN CYST,1
MX,OVERDOSE,1
MX,PALPITATIONS,1
MX,PANCREATIC DISORDER,1
MX,PANCREATIC NEOPLASM,1
MX,PARKINSONIAN CRISIS,1
MX,PARKINSON^S DISEASE,1
MX,PEMPHIGUS,1
MX,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
MX,PERIPHERAL SWELLING,1
MX,PERIPHERAL VASCULAR DISORDER,1
MX,PERITONITIS,1
MX,PNEUMONIA,1
MX,POLYARTHRITIS,1
MX,POLYURIA,1
MX,PREMATURE BABY,1
MX,PREMATURE DELIVERY,1
MX,PRESCRIBED UNDERDOSE,1
MX,PRODUCT SUBSTITUTION ISSUE,1
MX,PROTEINURIA,1
MX,PSEUDOMEMBRANOUS COLITIS,1
MX,PSYCHOMOTOR HYPERACTIVITY,1
MX,PULMONARY EMBOLISM,1
MX,PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME,1
MX,RASH,1
MX,RASH MACULO-PAPULAR,1
MX,REGURGITATION,1
MX,RENAL CYST,1
MX,RENAL IMPAIRMENT,1
MX,RESPIRATORY DISORDER,1
MX,RETINAL DETACHMENT,1
MX,RETINAL INFARCTION,1
MX,RHABDOMYOLYSIS,1
MX,RHINORRHOEA,1
MX,SEDATION,1
MX,SEIZURE,1
MX,SEPSIS,1
MX,SILENT MYOCARDIAL INFARCTION,1
MX,SKIN EXFOLIATION,1
MX,SPEECH DISORDER,1
MX,SPINAL COLUMN INJURY,1
MX,SQUAMOUS CELL CARCINOMA,1
MX,STRESS,1
MX,SUBILEUS,1
MX,SUDDEN DEATH,1
MX,SWELLING,1
MX,SYNCOPE,1
MX,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
MX,TACHYCARDIA,1
MX,THERAPEUTIC PRODUCT INEFFECTIVE,1
MX,THERAPY CESSATION,1
MX,THROAT LESION,1
MX,THROMBOCYTOPENIA,1
MX,TONGUE BLISTERING,1
MX,TONGUE DISORDER,1
MX,TOOTHACHE,1
MX,TORSADE DE POINTES,1
MX,TRANSIENT ISCHAEMIC ATTACK,1
MX,TRANSPLANT REJECTION,1
MX,TUBERCULOSIS,1
MX,ULCER,1
MX,UNDERDOSE,1
MX,URINE ANALYSIS ABNORMAL,1
MX,VARICOSE VEIN,1
MX,VENTRICULAR EXTRASYSTOLES,1
MX,VENTRICULAR FIBRILLATION,1
MX,VISION BLURRED,1
MX,VITAMIN B12 DEFICIENCY,1
MX,XEROPHTHALMIA,1
MX,YELLOW SKIN,1
ME,HEPATOTOXICITY,2
ME,JAUNDICE,2
ME,LIVER INJURY,2
ME,PRURITUS GENERALISED,2
ME,RASH,2
ME,ACUTE HEPATIC FAILURE,1
ME,ALANINE AMINOTRANSFERASE INCREASED,1
ME,ASPARTATE AMINOTRANSFERASE INCREASED,1
ME,BILIRUBIN CONJUGATED INCREASED,1
ME,BLOOD ALKALINE PHOSPHATASE INCREASED,1
ME,BLOOD BILIRUBIN INCREASED,1
ME,CARDIAC ARREST,1
ME,CEREBRAL ISCHAEMIA,1
ME,CONTUSION,1
ME,DIZZINESS,1
ME,DIZZINESS POSTURAL,1
ME,DRUG-INDUCED LIVER INJURY,1
ME,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
ME,HAEMATOMA,1
ME,PNEUMONIA,1
ME,VERTIGO,1
MA,FOETAL EXPOSURE DURING PREGNANCY,2
MA,MATERNAL EXPOSURE DURING PREGNANCY,2
MA,STILLBIRTH,2
MA,ALTERED STATE OF CONSCIOUSNESS,1
MA,APHASIA,1
MA,C-REACTIVE PROTEIN INCREASED,1
MA,CYSTITIS,1
MA,DYSPNOEA,1
MA,HAEMOPTYSIS,1
MA,HAEMORRHAGIC INFARCTION,1
MA,HAEMORRHAGIC STROKE,1
MA,HEMIPLEGIA,1
MA,ISCHAEMIC STROKE,1
MA,LOW BIRTH WEIGHT BABY,1
MA,PREMATURE BABY,1
MA,PULMONARY ALVEOLAR HAEMORRHAGE,1
MA,PYELONEPHRITIS ACUTE,1
MA,PYREXIA,1
MA,WHITE BLOOD CELL COUNT INCREASED,1
NP,ACCIDENTAL OVERDOSE,1
NP,DIZZINESS,1
NP,HYPOTENSION,1
NP,MYASTHENIA GRAVIS,1
NP,PRESYNCOPE,1
NL,PNEUMONIA,11
NL,PYREXIA,9
NL,CARDIAC DISORDER,6
NL,DYSPNOEA,6
NL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,6
NL,RASH,6
NL,ANAEMIA,5
NL,ANGINA PECTORIS,5
NL,DIARRHOEA,5
NL,ANGIOPATHY,4
NL,ARTERIAL HAEMORRHAGE,4
NL,ATRIAL FIBRILLATION,4
NL,CHEST PAIN,4
NL,HAEMORRHAGE,4
NL,INFECTION,4
NL,PLASMA CELL MYELOMA,4
NL,ASTHENIA,3
NL,CARDIAC ARREST,3
NL,DEATH,3
NL,DEHYDRATION,3
NL,HAEMORRHAGIC STROKE,3
NL,HUMERUS FRACTURE,3
NL,HYPONATRAEMIA,3
NL,HYPOTENSION,3
NL,NEUTROPENIA,3
NL,OEDEMA,3
NL,RHABDOMYOLYSIS,3
NL,THROMBOSIS IN DEVICE,3
NL,VISION BLURRED,3
NL,ABDOMINAL PAIN,2
NL,ABDOMINAL PAIN UPPER,2
NL,ADMINISTRATION SITE REACTION,2
NL,ANGIOEDEMA,2
NL,AORTIC ANEURYSM RUPTURE,2
NL,ARRHYTHMIA,2
NL,ARTHRALGIA,2
NL,ATRIAL FLUTTER,2
NL,BLOOD CREATININE INCREASED,2
NL,BRADYCARDIA,2
NL,CARDIAC FAILURE,2
NL,CEREBROVASCULAR ACCIDENT,2
NL,CHEST DISCOMFORT,2
NL,CHOLECYSTITIS,2
NL,COLITIS,2
NL,CONDITION AGGRAVATED,2
NL,COUGH,2
NL,DIZZINESS,2
NL,ENDOCRINE DISORDER,2
NL,EPILEPSY,2
NL,EYE DISORDER,2
NL,FACIAL PAIN,2
NL,FALL,2
NL,FATIGUE,2
NL,FEBRILE INFECTION,2
NL,FEBRILE NEUTROPENIA,2
NL,GASTROINTESTINAL DISORDER,2
NL,GASTROINTESTINAL HAEMORRHAGE,2
NL,GENERAL PHYSICAL HEALTH DETERIORATION,2
NL,HAEMATEMESIS,2
NL,HAEMATOTOXICITY,2
NL,HAEMODYNAMIC INSTABILITY,2
NL,HYPERCHOLESTEROLAEMIA,2
NL,HYPERHIDROSIS,2
NL,HYPERKALAEMIA,2
NL,HYPERTENSION,2
NL,INSOMNIA,2
NL,INTRA-ABDOMINAL HAEMORRHAGE,2
NL,ISCHAEMIC STROKE,2
NL,JOINT SWELLING,2
NL,MALIGNANT NEOPLASM PROGRESSION,2
NL,MELAENA,2
NL,MENTAL DISORDER,2
NL,METABOLIC DISORDER,2
NL,MUCOSAL INFLAMMATION,2
NL,MULTI-ORGAN FAILURE,2
NL,MUSCLE RUPTURE,2
NL,MUSCLE SPASMS,2
NL,MUSCULAR WEAKNESS,2
NL,MUSCULOSKELETAL DISORDER,2
NL,MYALGIA,2
NL,MYOCARDIAL INFARCTION,2
NL,NAUSEA,2
NL,NEUROPATHY PERIPHERAL,2
NL,PANCREATITIS,2
NL,PLEURAL EFFUSION,2
NL,POLYNEUROPATHY,2
NL,PRURITUS,2
NL,PULMONARY EMBOLISM,2
NL,RENAL DISORDER,2
NL,RENAL FAILURE,2
NL,RENAL FAILURE ACUTE,2
NL,RENAL IMPAIRMENT,2
NL,RESPIRATORY DISORDER,2
NL,RESPIRATORY TRACT INFECTION,2
NL,RETINAL INFARCTION,2
NL,SEPSIS,2
NL,SHOCK,2
NL,SKIN DISORDER,2
NL,SWOLLEN TONGUE,2
NL,TENDON RUPTURE,2
NL,THROMBOCYTOPENIA,2
NL,THROMBOTIC THROMBOCYTOPENIC PURPURA,2
NL,TOOTH INJURY,2
NL,UPPER RESPIRATORY TRACT INFECTION,2
NL,WHIPPLE^S DISEASE,2
NL,ABDOMINAL DISTENSION,1
NL,ACUTE KIDNEY INJURY,1
NL,ACUTE MYOCARDIAL INFARCTION,1
NL,ADRENAL DISORDER,1
NL,ADVERSE EVENT,1
NL,ALOPECIA,1
NL,AMNESIA,1
NL,ANAPHYLACTIC SHOCK,1
NL,ANGINA UNSTABLE,1
NL,ANGIOPLASTY,1
NL,ANXIETY,1
NL,APHASIA,1
NL,APHTHOUS ULCER,1
NL,ASTHMA,1
NL,BASAL CELL CARCINOMA,1
NL,BENIGN BREAST NEOPLASM,1
NL,BILE DUCT STONE,1
NL,BLADDER IRRITATION,1
NL,BLISTER,1
NL,BLOOD PRESSURE DECREASED,1
NL,BLOOD UREA INCREASED,1
NL,BREAST CANCER METASTATIC,1
NL,BRONCHOPULMONARY ASPERGILLOSIS,1
NL,BRONCHOSPASM,1
NL,BULBAR PALSY,1
NL,C-REACTIVE PROTEIN ABNORMAL,1
NL,CARDIAC DEATH,1
NL,CARDIAC FAILURE CONGESTIVE,1
NL,CARDIOGENIC SHOCK,1
NL,CATHETER SITE HAEMATOMA,1
NL,CELLULITIS,1
NL,CEREBRAL HAEMORRHAGE,1
NL,CEREBRAL INFARCTION,1
NL,CHILLS,1
NL,CHOLELITHIASIS,1
NL,CHROMATURIA,1
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NL,CIRCULATORY COLLAPSE,1
NL,COGNITIVE DISORDER,1
NL,COLON CANCER,1
NL,CONSTIPATION,1
NL,CONTRAST ENCEPHALOPATHY,1
NL,CORONARY ARTERY RESTENOSIS,1
NL,CORONARY ARTERY THROMBOSIS,1
NL,CRITICAL ILLNESS POLYNEUROPATHY,1
NL,CYSTITIS,1
NL,DEEP VEIN THROMBOSIS,1
NL,DEPRESSED MOOD,1
NL,DEPRESSION,1
NL,DERMATITIS EXFOLIATIVE,1
NL,DIPLOPIA,1
NL,DISTURBANCE IN ATTENTION,1
NL,DRY EYE,1
NL,DRY MOUTH,1
NL,DUODENITIS,1
NL,DYSAESTHESIA,1
NL,DYSPNOEA EXERTIONAL,1
NL,ELECTROCARDIOGRAM QT PROLONGED,1
NL,EMBOLISM,1
NL,EMPHYSEMA,1
NL,ENTERITIS,1
NL,EPIDIDYMITIS,1
NL,EPISTAXIS,1
NL,ERYTHEMA,1
NL,ESCHERICHIA URINARY TRACT INFECTION,1
NL,EYELID MARGIN CRUSTING,1
NL,EYELID OEDEMA,1
NL,FLATULENCE,1
NL,FLUID RETENTION,1
NL,GASTRIC ULCER,1
NL,GASTROENTERITIS,1
NL,GASTROINTESTINAL ANGIODYSPLASIA HAEMORRHAGIC,1
NL,GASTROINTESTINAL INFECTION,1
NL,GASTROINTESTINAL INJURY,1
NL,HAEMATURIA,1
NL,HAEMOGLOBIN DECREASED,1
NL,HAEMOPTYSIS,1
NL,HAEMORRHAGE CORONARY ARTERY,1
NL,HEART RATE DECREASED,1
NL,HEPATIC FUNCTION ABNORMAL,1
NL,HEPATOTOXICITY,1
NL,HERPES ZOSTER,1
NL,HIP FRACTURE,1
NL,HORDEOLUM,1
NL,HYPERSENSITIVITY,1
NL,HYPOCALCAEMIA,1
NL,HYPOKALAEMIA,1
NL,IMMUNE THROMBOCYTOPENIC PURPURA,1
NL,INCORRECT DRUG ADMINISTRATION DURATION,1
NL,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
NL,INFARCTION,1
NL,INFREQUENT BOWEL MOVEMENTS,1
NL,INTERSTITIAL LUNG DISEASE,1
NL,INTESTINAL ISCHAEMIA,1
NL,KIDNEY TRANSPLANT REJECTION,1
NL,LACTIC ACIDOSIS,1
NL,LARGE INTESTINE POLYP,1
NL,LEFT VENTRICULAR HYPERTROPHY,1
NL,LIP SWELLING,1
NL,LIVER DISORDER,1
NL,LONG QT SYNDROME,1
NL,LOWER RESPIRATORY TRACT INFECTION FUNGAL,1
NL,LUNG INFILTRATION,1
NL,MALAISE,1
NL,MALIGNANT MELANOMA,1
NL,MICROCYTIC ANAEMIA,1
NL,MOBILITY DECREASED,1
NL,NASOPHARYNGITIS,1
NL,NEURALGIA,1
NL,NON-ALCOHOLIC STEATOHEPATITIS,1
NL,NON-CARDIAC CHEST PAIN,1
NL,OCULAR HYPERAEMIA,1
NL,OESOPHAGEAL CARCINOMA,1
NL,OESOPHAGEAL OBSTRUCTION,1
NL,OVERDOSE,1
NL,PAIN,1
NL,PAIN IN EXTREMITY,1
NL,PALLOR,1
NL,PANCREATITIS ACUTE,1
NL,PARKINSONISM,1
NL,PERIPHERAL SENSORY NEUROPATHY,1
NL,PERITONEAL DISORDER,1
NL,PERITONEAL HAEMATOMA,1
NL,PERITONEAL HAEMORRHAGE,1
NL,PERITONITIS,1
NL,PNEUMONIA ASPIRATION,1
NL,POST PROCEDURAL HAEMORRHAGE,1
NL,POSTOPERATIVE WOUND INFECTION,1
NL,PREMATURE SEPARATION OF PLACENTA,1
NL,PRESCRIBED OVERDOSE,1
NL,PROCEDURAL COMPLICATION,1
NL,PROCEDURAL PAIN,1
NL,PRODUCT SUBSTITUTION ISSUE,1
NL,PULMONARY ARTERIAL HYPERTENSION,1
NL,PULMONARY FIBROSIS,1
NL,RECTAL HAEMORRHAGE,1
NL,REGURGITATION,1
NL,RESPIRATORY FAILURE,1
NL,RHINITIS,1
NL,RIGHT VENTRICULAR HYPERTROPHY,1
NL,SEIZURE,1
NL,SIGMOIDOSCOPY ABNORMAL,1
NL,SKIN LESION,1
NL,SPLENIC INJURY,1
NL,SPLENIC RUPTURE,1
NL,SPONDYLOLISTHESIS,1
NL,STAPHYLOCOCCAL BACTERAEMIA,1
NL,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
NL,SUICIDAL IDEATION,1
NL,TEMPORAL ARTERITIS,1
NL,TENSION HEADACHE,1
NL,TOXICITY TO VARIOUS AGENTS,1
NL,TRANSIENT ISCHAEMIC ATTACK,1
NL,URINARY BLADDER HAEMORRHAGE,1
NL,URINARY TRACT INFECTION,1
NL,VAGINAL HAEMORRHAGE,1
NL,VASCULAR PSEUDOANEURYSM,1
NL,VASCULITIS,1
NL,VASODILATATION,1
NL,VENTRICULAR FIBRILLATION,1
NL,VERTIGO,1
NL,VITH NERVE PARESIS,1
NL,VOMITING,1
NL,WEIGHT DECREASED,1
NZ,DYSPNOEA,13
NZ,PNEUMONIA,12
NZ,ACUTE MYOCARDIAL INFARCTION,10
NZ,FALL,10
NZ,FATIGUE,9
NZ,ACUTE KIDNEY INJURY,8
NZ,HEADACHE,8
NZ,HYPONATRAEMIA,8
NZ,MYOCARDIAL INFARCTION,8
NZ,ASTHENIA,7
NZ,CHEST PAIN,7
NZ,DEATH,7
NZ,CEREBROVASCULAR ACCIDENT,6
NZ,COUGH,6
NZ,DIARRHOEA,6
NZ,MALAISE,6
NZ,PAIN,6
NZ,CARDIAC ARREST,5
NZ,DEHYDRATION,5
NZ,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
NZ,GAIT DISTURBANCE,5
NZ,HYPOMAGNESAEMIA,5
NZ,NAUSEA,5
NZ,PYREXIA,5
NZ,ARTHRALGIA,4
NZ,DEPRESSION,4
NZ,HAEMOGLOBIN DECREASED,4
NZ,HYPERTHYROIDISM,4
NZ,HYPOKALAEMIA,4
NZ,HYPOTENSION,4
NZ,LOWER RESPIRATORY TRACT INFECTION,4
NZ,MYALGIA,4
NZ,NEUTROPHIL COUNT INCREASED,4
NZ,PLASMA CELL MYELOMA,4
NZ,PNEUMONIA ASPIRATION,4
NZ,RHABDOMYOLYSIS,4
NZ,SEIZURE,4
NZ,URTICARIA,4
NZ,VASCULITIS CEREBRAL,4
NZ,VOMITING,4
NZ,WHITE BLOOD CELL COUNT INCREASED,4
NZ,ABDOMINAL PAIN,3
NZ,ACTIVITIES OF DAILY LIVING IMPAIRED,3
NZ,AGITATION,3
NZ,ANAEMIA,3
NZ,ARTHRITIS,3
NZ,ASTHMA,3
NZ,BACK PAIN,3
NZ,BALANCE DISORDER,3
NZ,BLOOD GLUCOSE INCREASED,3
NZ,BLOOD PRESSURE INCREASED,3
NZ,C-REACTIVE PROTEIN INCREASED,3
NZ,CARDIAC DISORDER,3
NZ,CARDIAC FAILURE,3
NZ,CARDIOTOXICITY,3
NZ,CHILLS,3
NZ,CONFUSIONAL STATE,3
NZ,DYSARTHRIA,3
NZ,DYSPHAGIA,3
NZ,FEELING ABNORMAL,3
NZ,GASTROINTESTINAL HAEMORRHAGE,3
NZ,HAEMATURIA,3
NZ,HYPOCALCAEMIA,3
NZ,INFECTION,3
NZ,JOINT SWELLING,3
NZ,LIVER FUNCTION TEST ABNORMAL,3
NZ,MEMORY IMPAIRMENT,3
NZ,OEDEMA PERIPHERAL,3
NZ,PARKINSON^S DISEASE,3
NZ,PRODUCT USE ISSUE,3
NZ,PRURITUS,3
NZ,RASH ERYTHEMATOUS,3
NZ,RESPIRATORY DISTRESS,3
NZ,SOMNOLENCE,3
NZ,SQUAMOUS CELL CARCINOMA OF SKIN,3
NZ,SYNCOPE,3
NZ,VERTIGO,3
NZ,ABDOMINAL PAIN UPPER,2
NZ,AGGRESSION,2
NZ,ANAPHYLACTIC REACTION,2
NZ,ANGINA UNSTABLE,2
NZ,ANXIETY,2
NZ,ATRIAL FIBRILLATION,2
NZ,BASAL CELL CARCINOMA,2
NZ,CARDIOGENIC SHOCK,2
NZ,CEREBRAL HAEMORRHAGE,2
NZ,CHEST DISCOMFORT,2
NZ,CHONDROCALCINOSIS PYROPHOSPHATE,2
NZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
NZ,CIRCULATORY COLLAPSE,2
NZ,CONDITION AGGRAVATED,2
NZ,CONVULSION,2
NZ,DECREASED APPETITE,2
NZ,DELIRIUM,2
NZ,DIABETIC FOOT INFECTION,2
NZ,DIZZINESS,2
NZ,EMOTIONAL DISTRESS,2
NZ,EOSINOPHILIA,2
NZ,GASTRIC ULCER HAEMORRHAGE,2
NZ,GLOMERULAR FILTRATION RATE DECREASED,2
NZ,HEART RATE INCREASED,2
NZ,HEPATIC FAILURE,2
NZ,IMPAIRED WORK ABILITY,2
NZ,INSOMNIA,2
NZ,INTENTIONAL OVERDOSE,2
NZ,ISCHAEMIC STROKE,2
NZ,JOINT EFFUSION,2
NZ,LACTIC ACIDOSIS,2
NZ,LOSS OF CONSCIOUSNESS,2
NZ,MALIGNANT MELANOMA,2
NZ,MELAENA,2
NZ,METASTASES TO LUNG,2
NZ,MUSCULAR WEAKNESS,2
NZ,MUSCULOSKELETAL PAIN,2
NZ,MYOCARDIAL ISCHAEMIA,2
NZ,NEUROPATHY PERIPHERAL,2
NZ,NEUTROPHIL COUNT DECREASED,2
NZ,OEDEMA,2
NZ,OSTEONECROSIS,2
NZ,PANCYTOPENIA,2
NZ,PARAESTHESIA,2
NZ,PERIORBITAL OEDEMA,2
NZ,POST PROCEDURAL HAEMORRHAGE,2
NZ,PULMONARY EMBOLISM,2
NZ,RECTAL HAEMORRHAGE,2
NZ,RENAL FAILURE,2
NZ,RESPIRATORY FAILURE,2
NZ,RHINORRHOEA,2
NZ,SHOCK,2
NZ,SLEEP DISORDER,2
NZ,STAPHYLOCOCCAL ABSCESS,2
NZ,STENT PLACEMENT,2
NZ,STRESS,2
NZ,SUBDURAL HAEMORRHAGE,2
NZ,SUICIDAL IDEATION,2
NZ,SWELLING,2
NZ,THROMBOCYTOPENIA,2
NZ,TORSADE DE POINTES,2
NZ,TRANSIENT ISCHAEMIC ATTACK,2
NZ,UPPER GASTROINTESTINAL HAEMORRHAGE,2
NZ,URINARY TRACT INFECTION,2
NZ,VASCULAR STENT THROMBOSIS,2
NZ,VIITH NERVE PARALYSIS,2
NZ,WHITE BLOOD CELL COUNT DECREASED,2
NZ,ABDOMINAL WALL HAEMATOMA,1
NZ,ABNORMAL LOSS OF WEIGHT,1
NZ,ACCELERATED HYPERTENSION,1
NZ,ACUTE PULMONARY OEDEMA,1
NZ,ADENOCARCINOMA OF COLON,1
NZ,ADVERSE REACTION,1
NZ,AFFECTIVE DISORDER,1
NZ,ALOPECIA,1
NZ,ALTERED STATE OF CONSCIOUSNESS,1
NZ,ANAPHYLACTIC SHOCK,1
NZ,ANGER,1
NZ,ANGIOPATHY,1
NZ,ARTERIOSCLEROSIS,1
NZ,ARTHRITIS INFECTIVE,1
NZ,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
NZ,BASAL GANGLIA HAEMORRHAGE,1
NZ,BLADDER CANCER,1
NZ,BLISTER,1
NZ,BLOOD ALKALINE PHOSPHATASE INCREASED,1
NZ,BLOOD BILIRUBIN INCREASED,1
NZ,BLOOD CREATININE ABNORMAL,1
NZ,BLOOD CREATININE INCREASED,1
NZ,BLOOD PARATHYROID HORMONE DECREASED,1
NZ,BLOOD PRESSURE DECREASED,1
NZ,BLOOD PRESSURE ORTHOSTATIC DECREASED,1
NZ,BLOOD SODIUM DECREASED,1
NZ,BODY TEMPERATURE DECREASED,1
NZ,BRONCHITIS,1
NZ,BRONCHOSPASM,1
NZ,CARDIAC ANEURYSM,1
NZ,CARDIAC DISCOMFORT,1
NZ,CARDIAC FAILURE CONGESTIVE,1
NZ,CARDIAC FAILURE HIGH OUTPUT,1
NZ,CARDIOMYOPATHY,1
NZ,CARPAL TUNNEL SYNDROME,1
NZ,CELLULITIS,1
NZ,CEREBELLAR HAEMORRHAGE,1
NZ,CEREBELLAR INFARCTION,1
NZ,CEREBRAL INFARCTION,1
NZ,CHOKING,1
NZ,CHOLANGITIS,1
NZ,CHOLECYSTITIS,1
NZ,CHOLESTASIS,1
NZ,CHONDROPATHY,1
NZ,COLD SWEAT,1
NZ,COLON ADENOMA,1
NZ,COMA SCALE ABNORMAL,1
NZ,CONCOMITANT DISEASE PROGRESSION,1
NZ,CONJUNCTIVITIS,1
NZ,CONTUSION,1
NZ,CORONARY ARTERY DISEASE,1
NZ,CORONARY ARTERY STENOSIS,1
NZ,CORONARY ARTERY THROMBOSIS,1
NZ,CRANIOCEREBRAL INJURY,1
NZ,CREPITATIONS,1
NZ,CRYING,1
NZ,CRYSTAL ARTHROPATHY,1
NZ,CYANOSIS,1
NZ,DEMENTIA,1
NZ,DEMYELINATION,1
NZ,DEPRESSED LEVEL OF CONSCIOUSNESS,1
NZ,DEVICE DEPOSIT ISSUE,1
NZ,DIABETES MELLITUS,1
NZ,DIABETES MELLITUS INADEQUATE CONTROL,1
NZ,DIABETIC FOOT,1
NZ,DISEASE PROGRESSION,1
NZ,DISEASE RECURRENCE,1
NZ,DIVERTICULITIS,1
NZ,DRUG ADMINISTRATION ERROR,1
NZ,DRUG ERUPTION,1
NZ,DRUG INEFFECTIVE,1
NZ,DRUG-INDUCED LIVER INJURY,1
NZ,DRY MOUTH,1
NZ,DRY SKIN,1
NZ,DUODENAL ULCER,1
NZ,DYSACUSIS,1
NZ,DYSGEUSIA,1
NZ,DYSKINESIA,1
NZ,DYSPEPSIA,1
NZ,DYSPNOEA EXERTIONAL,1
NZ,DYSURIA,1
NZ,ECZEMA,1
NZ,EJECTION FRACTION DECREASED,1
NZ,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
NZ,ELECTROCARDIOGRAM QT PROLONGED,1
NZ,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
NZ,ELECTROCARDIOGRAM T WAVE INVERSION,1
NZ,EMOTIONAL DISORDER,1
NZ,EPIDIDYMITIS,1
NZ,EPISTAXIS,1
NZ,ERYTHEMA,1
NZ,ESCHERICHIA SEPSIS,1
NZ,ESSENTIAL THROMBOCYTHAEMIA,1
NZ,EYELID PTOSIS,1
NZ,FAT TISSUE INCREASED,1
NZ,FEBRILE NEUTROPENIA,1
NZ,FEMORAL NECK FRACTURE,1
NZ,FIBROUS HISTIOCYTOMA,1
NZ,FLANK PAIN,1
NZ,FLUID OVERLOAD,1
NZ,FLUID RETENTION,1
NZ,FOAMING AT MOUTH,1
NZ,FOETAL EXPOSURE DURING PREGNANCY,1
NZ,FOLATE DEFICIENCY,1
NZ,FURUNCLE,1
NZ,GASTRIC ULCER,1
NZ,GASTROENTERITIS AEROMONAS,1
NZ,GASTROINTESTINAL ANGIODYSPLASIA,1
NZ,GASTROOESOPHAGEAL REFLUX DISEASE,1
NZ,GENE MUTATION IDENTIFICATION TEST POSITIVE,1
NZ,GENERALISED TONIC-CLONIC SEIZURE,1
NZ,GLIOSIS,1
NZ,GLOSSITIS,1
NZ,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
NZ,HAEMATOCHEZIA,1
NZ,HAEMOGLOBIN ABNORMAL,1
NZ,HAEMORRHAGE,1
NZ,HAEMORRHAGE INTRACRANIAL,1
NZ,HAEMORRHAGE URINARY TRACT,1
NZ,HAEMORRHAGIC STROKE,1
NZ,HEAD DISCOMFORT,1
NZ,HEART RATE IRREGULAR,1
NZ,HEMIANOPIA,1
NZ,HEMIPARESIS,1
NZ,HEPATIC CONGESTION,1
NZ,HEPATIC ENZYME INCREASED,1
NZ,HYPERBILIRUBINAEMIA,1
NZ,HYPERCALCAEMIA,1
NZ,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,1
NZ,HYPERGLYCAEMIA,1
NZ,HYPERTENSION,1
NZ,HYPOAESTHESIA,1
NZ,HYPOPHAGIA,1
NZ,HYPOTONIA,1
NZ,HYPOXIA,1
NZ,IMPAIRED HEALING,1
NZ,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
NZ,INCREASED APPETITE,1
NZ,INFUSION RELATED REACTION,1
NZ,INJECTION SITE REACTION,1
NZ,INTENTIONAL PRODUCT MISUSE,1
NZ,INTERMITTENT CLAUDICATION,1
NZ,INTERNAL HAEMORRHAGE,1
NZ,INTERSTITIAL LUNG DISEASE,1
NZ,INTESTINAL ISCHAEMIA,1
NZ,INTRACARDIAC THROMBUS,1
NZ,INVASIVE DUCTAL BREAST CARCINOMA,1
NZ,IRON DEFICIENCY,1
NZ,ISCHAEMIA,1
NZ,KERATITIS,1
NZ,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
NZ,LARGE INTESTINE POLYP,1
NZ,LETHARGY,1
NZ,LIMB DISCOMFORT,1
NZ,LIPOHYPERTROPHY,1
NZ,LISTERIOSIS,1
NZ,LIVING IN RESIDENTIAL INSTITUTION,1
NZ,LOCAL SWELLING,1
NZ,LOCALISED INFECTION,1
NZ,LUMBAR VERTEBRAL FRACTURE,1
NZ,LUNG ADENOCARCINOMA,1
NZ,LUPUS-LIKE SYNDROME,1
NZ,LYMPHADENOPATHY,1
NZ,LYMPHOCYTE COUNT DECREASED,1
NZ,MALIGNANT LYMPHOID NEOPLASM,1
NZ,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,1
NZ,MANIA,1
NZ,MEDICATION ERROR,1
NZ,MENINGIOMA,1
NZ,MENORRHAGIA,1
NZ,METASTASES TO ABDOMINAL CAVITY,1
NZ,METASTASES TO PERITONEUM,1
NZ,METASTATIC MALIGNANT MELANOMA,1
NZ,MICTURITION URGENCY,1
NZ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
NZ,MUSCLE HAEMORRHAGE,1
NZ,MUSCLE INJURY,1
NZ,MUSCLE RUPTURE,1
NZ,MYASTHENIA GRAVIS,1
NZ,MYCOBACTERIAL INFECTION,1
NZ,MYELODYSPLASTIC SYNDROME,1
NZ,MYELOFIBROSIS,1
NZ,MYOCARDIAL FIBROSIS,1
NZ,MYOCARDITIS,1
NZ,MYOSITIS,1
NZ,NASOPHARYNGITIS,1
NZ,NECK MASS,1
NZ,NECK PAIN,1
NZ,NERVOUS SYSTEM DISORDER,1
NZ,NEUTROPENIA,1
NZ,NEUTROPENIC SEPSIS,1
NZ,NIGHTMARE,1
NZ,OBSTRUCTIVE AIRWAYS DISORDER,1
NZ,OESOPHAGITIS,1
NZ,ORAL HERPES,1
NZ,ORTHOSTATIC HYPOTENSION,1
NZ,OSTEOARTHRITIS,1
NZ,OSTEOMYELITIS,1
NZ,OVARIAN FIBROMA,1
NZ,OVERDOSE,1
NZ,PAIN IN EXTREMITY,1
NZ,PALLOR,1
NZ,PALPITATIONS,1
NZ,PANCREATIC CARCINOMA,1
NZ,PANCREATITIS,1
NZ,PARAESTHESIA ORAL,1
NZ,PARAINFLUENZAE VIRUS INFECTION,1
NZ,PARANOIA,1
NZ,PATHOLOGICAL FRACTURE,1
NZ,PELVIC FRACTURE,1
NZ,PEPTIC ULCER HAEMORRHAGE,1
NZ,PERICARDITIS,1
NZ,PERIPHERAL COLDNESS,1
NZ,PERIPHERAL VASCULAR DISORDER,1
NZ,PHARYNGITIS,1
NZ,PHOTOPHOBIA,1
NZ,PLATELET TOXICITY,1
NZ,POISONING DELIBERATE,1
NZ,POLYARTHRITIS,1
NZ,POLYDIPSIA,1
NZ,POLYPECTOMY,1
NZ,POLYURIA,1
NZ,PRODUCT QUALITY ISSUE,1
NZ,PRODUCT SUBSTITUTION ISSUE,1
NZ,PRODUCT USE IN UNAPPROVED INDICATION,1
NZ,PROSTATE CANCER METASTATIC,1
NZ,PROSTATISM,1
NZ,PROSTATOMEGALY,1
NZ,PSYCHIATRIC SYMPTOM,1
NZ,PSYCHOTIC DISORDER,1
NZ,PULMONARY FIBROSIS,1
NZ,PULMONARY HAEMORRHAGE,1
NZ,PULMONARY OEDEMA,1
NZ,RASH,1
NZ,RASH GENERALISED,1
NZ,RASH MACULAR,1
NZ,RASH MACULO-PAPULAR,1
NZ,RASH PRURITIC,1
NZ,RED BLOOD CELL COUNT ABNORMAL,1
NZ,RENAL CANCER,1
NZ,RENAL FAILURE ACUTE,1
NZ,RESTLESSNESS,1
NZ,RETROPERITONEAL HAEMATOMA,1
NZ,RETROPERITONEAL HAEMORRHAGE,1
NZ,REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT,1
NZ,RHEUMATIC DISORDER,1
NZ,RIGHT VENTRICULAR FAILURE,1
NZ,ROTATOR CUFF SYNDROME,1
NZ,SALIVARY HYPERSECRETION,1
NZ,SEDATION,1
NZ,SELF-MEDICATION,1
NZ,SENSORY LOSS,1
NZ,SINUS BRADYCARDIA,1
NZ,SINUS TACHYCARDIA,1
NZ,SKIN BURNING SENSATION,1
NZ,SLEEP APNOEA SYNDROME,1
NZ,SOFT TISSUE INJURY,1
NZ,SPEECH DISORDER,1
NZ,SPLENECTOMY,1
NZ,SPONTANEOUS HAEMORRHAGE,1
NZ,SQUAMOUS CELL CARCINOMA,1
NZ,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,1
NZ,STRIDOR,1
NZ,SUDDEN DEATH,1
NZ,SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED,1
NZ,SUPRAVENTRICULAR TACHYCARDIA,1
NZ,SURGERY,1
NZ,SWELLING FACE,1
NZ,TACHYCARDIA,1
NZ,TACHYPNOEA,1
NZ,TEARFULNESS,1
NZ,TENSION,1
NZ,TERMINAL STATE,1
NZ,THINKING ABNORMAL,1
NZ,THYROID DISORDER,1
NZ,TOXICITY TO VARIOUS AGENTS,1
NZ,TRACHEAL CALCIFICATION,1
NZ,TRANSIENT GLOBAL AMNESIA,1
NZ,TREATMENT FAILURE,1
NZ,TROPONIN INCREASED,1
NZ,TUMOUR LYSIS SYNDROME,1
NZ,TYPE 2 DIABETES MELLITUS,1
NZ,UNRESPONSIVE TO STIMULI,1
NZ,URINARY RETENTION,1
NZ,URINARY TRACT OBSTRUCTION,1
NZ,URINE OUTPUT INCREASED,1
NZ,UROSEPSIS,1
NZ,VASCULAR STENT OCCLUSION,1
NZ,VASOGENIC CEREBRAL OEDEMA,1
NZ,VENTRICULAR FIBRILLATION,1
NZ,VENTRICULAR TACHYCARDIA,1
NZ,VIRAL INFECTION,1
NZ,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
NZ,VITAMIN B12 DEFICIENCY,1
NZ,VITREOUS DETACHMENT,1
NZ,WEIGHT BEARING DIFFICULTY,1
NZ,WEIGHT DECREASED,1
NZ,WEIGHT INCREASED,1
NZ,WHEEZING,1
NZ,WOUND HAEMORRHAGE,1
NI,ATRIAL FIBRILLATION,1
NI,SHOCK HAEMORRHAGIC,1
NG,CARDIAC ANEURYSM,2
NG,CARDIAC VENTRICULAR THROMBOSIS,2
NG,HYPOTENSION,2
NG,LEFT VENTRICULAR DYSFUNCTION,2
NG,ANGIOEDEMA,1
NG,DRUG INEFFECTIVE,1
NG,PRURITUS,1
NG,RASH PAPULAR,1
NG,TREATMENT FAILURE,1
NO,ANAEMIA,9
NO,STRONGYLOIDIASIS,8
NO,CEREBRAL HAEMORRHAGE,7
NO,DEATH,7
NO,BLOOD CREATININE INCREASED,6
NO,CYTOMEGALOVIRUS TEST POSITIVE,6
NO,INFECTION REACTIVATION,6
NO,C-REACTIVE PROTEIN INCREASED,5
NO,LEUKOCYTOSIS,5
NO,EOSINOPHIL COUNT INCREASED,4
NO,EPISTAXIS,4
NO,FATIGUE,4
NO,MELAENA,4
NO,MONOCYTE COUNT INCREASED,4
NO,RENAL FAILURE,4
NO,RENAL IMPAIRMENT,4
NO,SEPSIS,4
NO,SMALL INTESTINAL HAEMORRHAGE,4
NO,SOMNOLENCE,4
NO,VENTRICULAR TACHYCARDIA,4
NO,BODY TEMPERATURE DECREASED,3
NO,DRUG ADMINISTRATION ERROR,3
NO,DUODENAL ULCER HAEMORRHAGE,3
NO,DYSPNOEA,3
NO,HAEMORRHAGE,3
NO,HEADACHE,3
NO,IMPAIRED GASTRIC EMPTYING,3
NO,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
NO,PYREXIA,3
NO,THROMBOCYTOPENIA,3
NO,ASTHENIA,2
NO,BLINDNESS,2
NO,CONFUSIONAL STATE,2
NO,CONSTIPATION,2
NO,COUGH,2
NO,DISORIENTATION,2
NO,DIZZINESS,2
NO,GINGIVITIS,2
NO,HEAD TITUBATION,2
NO,INTERNATIONAL NORMALISED RATIO INCREASED,2
NO,MYALGIA,2
NO,NASOPHARYNGITIS,2
NO,ORAL HERPES,2
NO,ORGAN FAILURE,2
NO,PETECHIAE,2
NO,POST PROCEDURAL HAEMORRHAGE,2
NO,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
NO,ABDOMINAL PAIN,1
NO,ACUTE KIDNEY INJURY,1
NO,ANEURYSM,1
NO,ANGIOEDEMA,1
NO,ATRIOVENTRICULAR BLOCK,1
NO,BRAIN HERNIATION,1
NO,BRAIN STEM HAEMORRHAGE,1
NO,CEREBELLAR HAEMORRHAGE,1
NO,CRANIOTOMY,1
NO,CYTOMEGALOVIRUS INFECTION,1
NO,DELIRIUM,1
NO,DIARRHOEA,1
NO,DRUG WITHDRAWAL SYNDROME,1
NO,DRUG-INDUCED LIVER INJURY,1
NO,DUODENAL ULCER,1
NO,DYSPEPSIA,1
NO,EYE HAEMORRHAGE,1
NO,GENERALISED TONIC-CLONIC SEIZURE,1
NO,HAEMOGLOBIN DECREASED,1
NO,HYPERHIDROSIS,1
NO,HYPOTENSION,1
NO,HYPOXIA,1
NO,INCORRECT DOSE ADMINISTERED,1
NO,INTRAVENTRICULAR HAEMORRHAGE,1
NO,LEUKOPENIA,1
NO,LOW BIRTH WEIGHT BABY,1
NO,MICROCYTIC ANAEMIA,1
NO,MUCOSAL INFECTION,1
NO,NEUTROPENIA,1
NO,PANCREATIC CARCINOMA,1
NO,PLASMA CELL MYELOMA,1
NO,POLYNEUROPATHY,1
NO,POST PROCEDURAL HAEMATOMA,1
NO,PREMATURE BABY,1
NO,PULMONARY FIBROSIS,1
NO,PULMONARY HAEMORRHAGE,1
NO,SLEEP APNOEA SYNDROME,1
NO,SUBDURAL HAEMATOMA EVACUATION,1
NO,SUBDURAL HAEMORRHAGE,1
NO,UPPER RESPIRATORY TRACT INFECTION,1
OM,HAEMATURIA,2
OM,MELAENA,2
OM,ATRIAL FIBRILLATION,1
OM,DEATH,1
OM,DIZZINESS,1
OM,DRUG INEFFECTIVE,1
OM,DYSPNOEA,1
OM,HEADACHE,1
OM,HEPARIN-INDUCED THROMBOCYTOPENIA,1
OM,HYPOTENSION,1
OM,HYPOXIA,1
OM,JUGULAR VEIN THROMBOSIS,1
OM,LEFT VENTRICULAR DYSFUNCTION,1
OM,LOCAL SWELLING,1
OM,LOSS OF CONSCIOUSNESS,1
OM,MENORRHAGIA,1
OM,MUCOSAL HAEMORRHAGE,1
OM,NO THERAPEUTIC RESPONSE,1
OM,OXYGEN SATURATION ABNORMAL,1
OM,PERIPHERAL ISCHAEMIA,1
OM,PNEUMONIA ASPIRATION,1
OM,PULMONARY ARTERY THROMBOSIS,1
OM,PYREXIA,1
OM,RESPIRATORY FAILURE,1
OM,SEPSIS,1
OM,SHOCK,1
OM,SKIN DISCOLOURATION,1
OM,VENA CAVA THROMBOSIS,1
PK,ABSCESS,1
PK,ANGIOPLASTY,1
PK,BLOOD CREATININE INCREASED,1
PK,BLOOD GLUCOSE DECREASED,1
PK,BLOOD UREA INCREASED,1
PK,CARDIAC TAMPONADE,1
PK,CEREBRAL HAEMORRHAGE,1
PK,DEATH,1
PK,DEHYDRATION,1
PK,DIARRHOEA,1
PK,PERICARDIAL HAEMORRHAGE,1
PK,RENAL FAILURE CHRONIC,1
PK,VOMITING,1
PW,ANGINA UNSTABLE,1
PS,ABDOMINAL PAIN UPPER,1
PS,BLOOD PARATHYROID HORMONE INCREASED,1
PS,ELECTROLYTE IMBALANCE,1
PS,NAUSEA,1
PS,TREMOR,1
PS,VOMITING,1
PA,HAEMOGLOBIN DECREASED,4
PA,ARTHRALGIA,3
PA,DIARRHOEA,3
PA,SERUM FERRITIN INCREASED,3
PA,SICKLE CELL ANAEMIA WITH CRISIS,3
PA,ABDOMINAL PAIN UPPER,2
PA,CHEST PAIN,2
PA,MALAISE,2
PA,PAIN IN EXTREMITY,2
PA,ABASIA,1
PA,ABDOMINAL DISCOMFORT,1
PA,ABDOMINAL PAIN,1
PA,AGGRESSION,1
PA,ANAEMIA MEGALOBLASTIC,1
PA,APPARENT DEATH,1
PA,ARTHRITIS,1
PA,ASTHENIA,1
PA,BACK PAIN,1
PA,BLOOD FOLATE INCREASED,1
PA,BLOOD GROWTH HORMONE INCREASED,1
PA,BLOOD PRESSURE FLUCTUATION,1
PA,BONE LOSS,1
PA,BREAST CANCER,1
PA,BURNING SENSATION,1
PA,CAROTID ARTERY OCCLUSION,1
PA,CHOLELITHIASIS,1
PA,CONTUSION,1
PA,DECREASED APPETITE,1
PA,DEHYDRATION,1
PA,DIABETES MELLITUS,1
PA,DIZZINESS,1
PA,DYSPNOEA,1
PA,EXOPHTHALMOS,1
PA,FALL,1
PA,FEELING ABNORMAL,1
PA,FLATULENCE,1
PA,GENERAL PHYSICAL HEALTH DETERIORATION,1
PA,HAEMATOCHEZIA,1
PA,HEAD DISCOMFORT,1
PA,HEADACHE,1
PA,HEPATIC SIDEROSIS,1
PA,HORMONE LEVEL ABNORMAL,1
PA,HYPOACUSIS,1
PA,HYPOPHYSITIS,1
PA,HYPOTHALAMO-PITUITARY DISORDER,1
PA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PA,INCORRECT DOSE ADMINISTERED,1
PA,INCORRECT DRUG ADMINISTRATION DURATION,1
PA,ISCHAEMIC STROKE,1
PA,MEMORY IMPAIRMENT,1
PA,MOOD SWINGS,1
PA,MOYAMOYA DISEASE,1
PA,MUSCLE CONTRACTIONS INVOLUNTARY,1
PA,MUSCULOSKELETAL PAIN,1
PA,NAUSEA,1
PA,OSTEOARTHRITIS,1
PA,PAIN,1
PA,PRIAPISM,1
PA,RESPIRATORY DISTRESS,1
PA,SKIN DISORDER,1
PA,SPINAL PAIN,1
PA,STRESS,1
PA,WOUND,1
PY,CHRONIC MYELOID LEUKAEMIA,1
PY,MALIGNANT NEOPLASM PROGRESSION,1
PY,MATERNAL EXPOSURE DURING PREGNANCY,1
PY,PREGNANCY ON CONTRACEPTIVE,1
PY,SEPTIC SHOCK,1
PY,SYSTEMIC LUPUS ERYTHEMATOSUS,1
PE,DIZZINESS,2
PE,HEADACHE,2
PE,IRON DEFICIENCY ANAEMIA,2
PE,VOMITING,2
PE,ANGINA UNSTABLE,1
PE,ARRHYTHMIA,1
PE,ASTHMA,1
PE,BRAIN STEM STROKE,1
PE,CARCINOMA IN SITU,1
PE,CATARACT,1
PE,CEREBROVASCULAR ACCIDENT,1
PE,CYSTADENOCARCINOMA PANCREAS,1
PE,DEATH,1
PE,DEEP VEIN THROMBOSIS,1
PE,DIABETES MELLITUS,1
PE,DYSPNOEA,1
PE,EMBOLISM,1
PE,ENCEPHALOPATHY,1
PE,EPISTAXIS,1
PE,FALL,1
PE,FATIGUE,1
PE,GENERAL PHYSICAL HEALTH DETERIORATION,1
PE,GYNAECOMASTIA,1
PE,HEPATIC CIRRHOSIS,1
PE,HEREDITARY NON-POLYPOSIS COLORECTAL CANCER SYNDROME,1
PE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PE,INFECTED SKIN ULCER,1
PE,INFECTION,1
PE,LIMB INJURY,1
PE,LIVER DISORDER,1
PE,LOSS OF CONSCIOUSNESS,1
PE,LOWER GASTROINTESTINAL HAEMORRHAGE,1
PE,MALAISE,1
PE,MALIGNANT NEOPLASM PROGRESSION,1
PE,METASTASIS,1
PE,MYOSITIS,1
PE,NAUSEA,1
PE,NEUROPATHY PERIPHERAL,1
PE,OCULAR DISCOMFORT,1
PE,OESOPHAGEAL CANDIDIASIS,1
PE,PARANEOPLASTIC DERMATOSIS,1
PE,PARANEOPLASTIC NEUROLOGICAL SYNDROME,1
PE,PLEURAL EFFUSION,1
PE,POLYP,1
PE,PULMONARY MASS,1
PE,RECURRENT CANCER,1
PE,RENAL CYST,1
PE,RESPIRATORY FAILURE,1
PE,SEPSIS,1
PE,SEPTIC SHOCK,1
PE,STAPHYLOCOCCAL INFECTION,1
PE,SYNCOPE,1
PE,VASCULITIS,1
PH,CEREBROVASCULAR ACCIDENT,6
PH,ACUTE MYOCARDIAL INFARCTION,3
PH,ACUTE RESPIRATORY FAILURE,3
PH,ANAEMIA,2
PH,ARRHYTHMIA,2
PH,BLOOD PRESSURE INCREASED,2
PH,CARDIOGENIC SHOCK,2
PH,CHOLELITHIASIS,2
PH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
PH,GASTROINTESTINAL HAEMORRHAGE,2
PH,HYPERSENSITIVITY,2
PH,PNEUMONIA,2
PH,TRANSIENT ISCHAEMIC ATTACK,2
PH,ABDOMINAL PAIN,1
PH,ALANINE AMINOTRANSFERASE INCREASED,1
PH,ALPHA 1 FOETOPROTEIN INCREASED,1
PH,ANGIOPLASTY,1
PH,BLOOD CREATINE PHOSPHOKINASE MM INCREASED,1
PH,BRONCHITIS,1
PH,CARDIAC FAILURE CONGESTIVE,1
PH,CARDIAC VENTRICULAR THROMBOSIS,1
PH,CATARACT,1
PH,CEREBRAL HAEMORRHAGE,1
PH,CEREBRAL INFARCTION,1
PH,CHRONIC MYELOID LEUKAEMIA,1
PH,COR PULMONALE,1
PH,CORONARY ARTERY DISEASE,1
PH,CYTOPENIA,1
PH,DEEP VEIN THROMBOSIS,1
PH,DEHYDRATION,1
PH,DEMENTIA,1
PH,DERMATITIS EXFOLIATIVE,1
PH,DIARRHOEA,1
PH,DISEASE PROGRESSION,1
PH,DRUG INEFFECTIVE,1
PH,DRY MOUTH,1
PH,DYSPHAGIA,1
PH,DYSPNOEA,1
PH,ELECTROLYTE IMBALANCE,1
PH,EXFOLIATIVE RASH,1
PH,GASTRITIS,1
PH,GASTROENTERITIS,1
PH,HAEMATOCHEZIA,1
PH,HAEMORRHAGE URINARY TRACT,1
PH,HEADACHE,1
PH,HEPATIC CIRRHOSIS,1
PH,HEPATOCELLULAR CARCINOMA,1
PH,HYPOALBUMINAEMIA,1
PH,HYPOGLYCAEMIA,1
PH,INCORRECT DOSE ADMINISTERED,1
PH,INTESTINAL MASS,1
PH,ISCHAEMIC CARDIOMYOPATHY,1
PH,LUNG INFECTION,1
PH,MELAENA,1
PH,MOUTH SWELLING,1
PH,MULTIPLE FRACTURES,1
PH,MYOCARDIAL INFARCTION,1
PH,OESOPHAGEAL ULCER,1
PH,ORAL MUCOSAL ERYTHEMA,1
PH,OROPHARYNGEAL CANDIDIASIS,1
PH,PLEURAL EFFUSION,1
PH,PNEUMOTHORAX,1
PH,PULMONARY SEPSIS,1
PH,RASH,1
PH,RENAL FAILURE,1
PH,RENAL FAILURE ACUTE,1
PH,RENAL FAILURE CHRONIC,1
PH,RHINITIS,1
PH,SEPTIC SHOCK,1
PH,SYNCOPE,1
PH,THROMBOSIS IN DEVICE,1
PH,THROMBOTIC STROKE,1
PH,TRACHEOBRONCHITIS,1
PH,TUBERCULOSIS,1
PH,WHEEZING,1
PL,ANGIOEDEMA,12
PL,C-REACTIVE PROTEIN INCREASED,9
PL,INTERLEUKIN LEVEL INCREASED,9
PL,URTICARIA,8
PL,ATRIAL FIBRILLATION,7
PL,DYSPNOEA,7
PL,MYOCARDIAL INFARCTION,7
PL,DRUG INEFFECTIVE,6
PL,GASTRIC ULCER,6
PL,SUICIDE ATTEMPT,6
PL,CARDIAC ARREST,5
PL,PNEUMONIA,5
PL,ANAEMIA,4
PL,CARDIAC FAILURE,4
PL,CHEST PAIN,4
PL,COUGH,4
PL,ISCHAEMIC STROKE,4
PL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,4
PL,NAUSEA,4
PL,OVERDOSE,4
PL,SYNCOPE,4
PL,VENTRICULAR TACHYCARDIA,4
PL,VERTIGO,4
PL,VOMITING,4
PL,ABDOMINAL PAIN,3
PL,ABDOMINAL PAIN UPPER,3
PL,ACUTE MYOCARDIAL INFARCTION,3
PL,ASTHENIA,3
PL,CHRONIC KIDNEY DISEASE,3
PL,CONDITION AGGRAVATED,3
PL,CONFUSIONAL STATE,3
PL,CORONARY ARTERY DISEASE,3
PL,DEATH,3
PL,DECREASED APPETITE,3
PL,DRUG RESISTANCE,3
PL,ELECTROCARDIOGRAM QT PROLONGED,3
PL,FATIGUE,3
PL,GASTRIC HAEMORRHAGE,3
PL,GASTRITIS,3
PL,HAEMORRHAGIC TRANSFORMATION STROKE,3
PL,LACTIC ACIDOSIS,3
PL,OBSTRUCTION GASTRIC,3
PL,TORSADE DE POINTES,3
PL,VASCULAR PSEUDOANEURYSM,3
PL,WITHDRAWAL SYNDROME,3
PL,ACUTE RESPIRATORY FAILURE,2
PL,ANGINA PECTORIS,2
PL,ANGINA UNSTABLE,2
PL,ATRIAL THROMBOSIS,2
PL,BRADYCARDIA,2
PL,CHOLECYSTITIS,2
PL,CONTRAINDICATED DRUG ADMINISTERED,2
PL,DELIRIUM,2
PL,DIARRHOEA,2
PL,DISEASE PROGRESSION,2
PL,DYSPHAGIA,2
PL,EXERCISE TOLERANCE DECREASED,2
PL,FALL,2
PL,FEBRILE NEUTROPENIA,2
PL,GASTROINTESTINAL NECROSIS,2
PL,GASTROINTESTINAL OBSTRUCTION,2
PL,HAEMATOCHEZIA,2
PL,HAEMORRHAGIC STROKE,2
PL,HYPOKALAEMIA,2
PL,HYPOMAGNESAEMIA,2
PL,HYPOTENSION,2
PL,INTENTIONAL OVERDOSE,2
PL,INTENTIONAL PRODUCT MISUSE,2
PL,LOSS OF CONSCIOUSNESS,2
PL,MUSCLE SPASMS,2
PL,MYALGIA,2
PL,PAIN,2
PL,PERIPHERAL SWELLING,2
PL,PULMONARY OEDEMA,2
PL,RHABDOMYOLYSIS,2
PL,RHINITIS,2
PL,SINUS NODE DYSFUNCTION,2
PL,SMALL INTESTINAL HAEMORRHAGE,2
PL,SOMNOLENCE,2
PL,SPEECH DISORDER,2
PL,THROMBOSIS IN DEVICE,2
PL,TRANSAMINASES INCREASED,2
PL,TRANSIENT ISCHAEMIC ATTACK,2
PL,UPPER GASTROINTESTINAL HAEMORRHAGE,2
PL,VASCULAR STENT THROMBOSIS,2
PL,VENTRICULAR ARRHYTHMIA,2
PL,VENTRICULAR FIBRILLATION,2
PL,WEIGHT DECREASED,2
PL,ABDOMINAL DISCOMFORT,1
PL,ACANTHOSIS,1
PL,ACUTE KIDNEY INJURY,1
PL,ADAMS-STOKES SYNDROME,1
PL,AGRANULOCYTOSIS,1
PL,ALANINE AMINOTRANSFERASE INCREASED,1
PL,ANAL STENOSIS,1
PL,ANORECTAL VARICES,1
PL,ANURIA,1
PL,ARTERIOSCLEROSIS,1
PL,ASPARTATE AMINOTRANSFERASE INCREASED,1
PL,ASTHMA,1
PL,ATOPY,1
PL,ATRIOVENTRICULAR BLOCK COMPLETE,1
PL,BLADDER DILATATION,1
PL,BLOOD BILIRUBIN INCREASED,1
PL,BLOOD GLUCOSE INCREASED,1
PL,BRADYARRHYTHMIA,1
PL,BRONCHOSPASM,1
PL,BUNDLE BRANCH BLOCK LEFT,1
PL,CARDIAC DEATH,1
PL,CARDIOGENIC SHOCK,1
PL,CAROTID ARTERY OCCLUSION,1
PL,CATHETER SITE HAEMATOMA,1
PL,CENTRAL NERVOUS SYSTEM LESION,1
PL,CEREBRAL ATAXIA,1
PL,CEREBRAL HAEMORRHAGE,1
PL,CEREBRAL VENOUS THROMBOSIS,1
PL,CEREBROSPINAL FLUID LEAKAGE,1
PL,CEREBROVASCULAR ACCIDENT,1
PL,CHOLELITHIASIS,1
PL,CHRONIC GASTRITIS,1
PL,COGNITIVE DISORDER,1
PL,COLON CANCER METASTATIC,1
PL,COMA,1
PL,CONJUNCTIVAL HAEMORRHAGE,1
PL,CONTRAINDICATED PRODUCT ADMINISTERED,1
PL,CONTUSION,1
PL,CORONARY ARTERY STENOSIS,1
PL,CORONARY ARTERY THROMBOSIS,1
PL,CREPITATIONS,1
PL,DEEP VEIN THROMBOSIS,1
PL,DEHYDRATION,1
PL,DERMATITIS,1
PL,DIABETES MELLITUS,1
PL,DIPLOPIA,1
PL,DISORIENTATION,1
PL,DIVERTICULITIS,1
PL,DRUG ADMINISTRATION ERROR,1
PL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
PL,DRUG INTOLERANCE,1
PL,DUODENITIS,1
PL,DYSPEPSIA,1
PL,DYSPNOEA EXERTIONAL,1
PL,ECCHYMOSIS,1
PL,EJECTION FRACTION DECREASED,1
PL,EMBOLISM,1
PL,EMBOLISM VENOUS,1
PL,EPISTAXIS,1
PL,EROSIVE DUODENITIS,1
PL,ESCHERICHIA URINARY TRACT INFECTION,1
PL,EXPOSURE DURING PREGNANCY,1
PL,FACIAL ASYMMETRY,1
PL,FEELING ABNORMAL,1
PL,FIBRIN D DIMER INCREASED,1
PL,FOETAL EXPOSURE DURING PREGNANCY,1
PL,GAIT DISTURBANCE,1
PL,GALLBLADDER DISORDER,1
PL,GASTRIC DISORDER,1
PL,GASTRIC POLYPS,1
PL,GASTRIC ULCER HAEMORRHAGE,1
PL,GASTRITIS EROSIVE,1
PL,GASTRITIS HAEMORRHAGIC,1
PL,GASTROENTERITIS,1
PL,GASTROINTESTINAL MUCOSAL NECROSIS,1
PL,GENERAL PHYSICAL HEALTH DETERIORATION,1
PL,HAEMATEMESIS,1
PL,HAEMOGLOBIN DECREASED,1
PL,HAEMORRHAGE,1
PL,HAEMORRHAGE INTRACRANIAL,1
PL,HAEMORRHAGIC DIATHESIS,1
PL,HEADACHE,1
PL,HEART RATE IRREGULAR,1
PL,HELICOBACTER INFECTION,1
PL,HENOCH-SCHONLEIN PURPURA,1
PL,HEPATIC ENZYME INCREASED,1
PL,HEPATIC LESION,1
PL,HEPATIC STEATOSIS,1
PL,HEPATOMEGALY,1
PL,HYPERTENSION,1
PL,HYPOTHERMIA,1
PL,HYPOTONIA,1
PL,HYPOVOLAEMIA,1
PL,INTERMITTENT CLAUDICATION,1
PL,INTERVERTEBRAL DISC DISORDER,1
PL,ISCHAEMIA,1
PL,KUSSMAUL RESPIRATION,1
PL,LABILE HYPERTENSION,1
PL,LARGE INTESTINE POLYP,1
PL,LEFT VENTRICULAR DYSFUNCTION,1
PL,LIMB INJURY,1
PL,LIP OEDEMA,1
PL,LIVE BIRTH,1
PL,LIVER ABSCESS,1
PL,LIVER INJURY,1
PL,LOW BIRTH WEIGHT BABY,1
PL,LOW DENSITY LIPOPROTEIN INCREASED,1
PL,LOWER GASTROINTESTINAL HAEMORRHAGE,1
PL,MACROCYTOSIS,1
PL,MALAISE,1
PL,MALIGNANT NEOPLASM PROGRESSION,1
PL,MATERNAL EXPOSURE DURING PREGNANCY,1
PL,MEDICATION ERROR,1
PL,MELAENA,1
PL,MEMORY IMPAIRMENT,1
PL,MENORRHAGIA,1
PL,METABOLIC ACIDOSIS,1
PL,METASTASES TO CENTRAL NERVOUS SYSTEM,1
PL,MONOPARESIS,1
PL,MUCOSAL HAEMORRHAGE,1
PL,MUSCULAR WEAKNESS,1
PL,MYASTHENIA GRAVIS,1
PL,NECK PAIN,1
PL,NEPHROPATHY,1
PL,NERVE INJURY,1
PL,NEUROLOGICAL SYMPTOM,1
PL,NOCTURIA,1
PL,NON-CARDIAC CHEST PAIN,1
PL,OBESITY,1
PL,OEDEMA,1
PL,ORAL MUCOSA EROSION,1
PL,ORTHOPNOEA,1
PL,OSTEONECROSIS OF JAW,1
PL,PARAESTHESIA,1
PL,PERIPHERAL ISCHAEMIA,1
PL,PHYSICAL DISABILITY,1
PL,PLATELET AGGREGATION INCREASED,1
PL,PLATELET COUNT DECREASED,1
PL,PLEURAL EFFUSION,1
PL,PNEUMONITIS,1
PL,POISONING,1
PL,POST PROCEDURAL HAEMORRHAGE,1
PL,PREMATURE BABY,1
PL,PREMATURE DELIVERY,1
PL,PRESCRIBED OVERDOSE,1
PL,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,1
PL,PRINZMETAL ANGINA,1
PL,PRODUCT USE IN UNAPPROVED INDICATION,1
PL,PROTHROMBIN LEVEL DECREASED,1
PL,PRURITUS GENERALISED,1
PL,PYLORIC STENOSIS,1
PL,RASH,1
PL,RASH PAPULAR,1
PL,RENAL FAILURE,1
PL,SCINTILLATING SCOTOMA,1
PL,SINUS BRADYCARDIA,1
PL,SINUS TACHYCARDIA,1
PL,SOFT TISSUE INFLAMMATION,1
PL,SPINAL CORD COMPRESSION,1
PL,SPINAL CORD NEOPLASM,1
PL,SPINAL CORD OEDEMA,1
PL,SUDDEN CARDIAC DEATH,1
PL,SUPRAVENTRICULAR TACHYCARDIA,1
PL,SYSTOLIC DYSFUNCTION,1
PL,THERAPEUTIC RESPONSE SHORTENED,1
PL,THROMBOCYTOPENIA,1
PL,TINNITUS,1
PL,TONGUE HAEMATOMA,1
PL,TONGUE OEDEMA,1
PL,TONSILLITIS,1
PL,TORTICOLLIS,1
PL,TOXICITY TO VARIOUS AGENTS,1
PL,TOXOPLASMOSIS,1
PL,UPPER RESPIRATORY TRACT INFECTION,1
PL,URINARY INCONTINENCE,1
PL,URINARY TRACT INFECTION,1
PL,VENOUS INSUFFICIENCY,1
PL,VENOUS STENOSIS,1
PL,VESSEL PUNCTURE SITE THROMBOSIS,1
PL,WHITE BLOOD CELL COUNT DECREASED,1
PT,DRUG INEFFECTIVE,11
PT,VOMITING,5
PT,ACUTE KIDNEY INJURY,4
PT,DIARRHOEA,4
PT,SEPSIS,4
PT,ANAEMIA,3
PT,ANGIOEDEMA,3
PT,CEREBROVASCULAR ACCIDENT,3
PT,GENERALISED ERYTHEMA,3
PT,HYPERAMMONAEMIC ENCEPHALOPATHY,3
PT,LINEAR IGA DISEASE,3
PT,MYALGIA,3
PT,NECROSIS,3
PT,RASH GENERALISED,3
PT,ANGINA UNSTABLE,2
PT,ASPIRATION,2
PT,ATRIAL FIBRILLATION,2
PT,BLOOD CREATININE INCREASED,2
PT,CARDIO-RESPIRATORY ARREST,2
PT,CONDITION AGGRAVATED,2
PT,CONTRAINDICATED PRODUCT ADMINISTERED,2
PT,DERMATITIS BULLOUS,2
PT,DRUG HYPERSENSITIVITY,2
PT,DRY GANGRENE,2
PT,DYSPNOEA,2
PT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
PT,GENERALISED TONIC-CLONIC SEIZURE,2
PT,HEADACHE,2
PT,HEPATOTOXICITY,2
PT,HYPERKALAEMIA,2
PT,HYPERTENSION,2
PT,HYPOTENSION,2
PT,INFECTION,2
PT,LACTIC ACIDOSIS,2
PT,LIP OEDEMA,2
PT,MATERNAL EXPOSURE DURING PREGNANCY,2
PT,METABOLIC ACIDOSIS,2
PT,NAUSEA,2
PT,NEUROLOGICAL SYMPTOM,2
PT,PLEURAL EFFUSION,2
PT,PNEUMONIA,2
PT,PRODUCT QUALITY ISSUE,2
PT,PRODUCT USE ISSUE,2
PT,RASH PRURITIC,2
PT,RENAL IMPAIRMENT,2
PT,RETROPERITONEAL HAEMORRHAGE,2
PT,TACHYCARDIA,2
PT,THROMBOCYTOPENIA,2
PT,TYPE IV HYPERSENSITIVITY REACTION,2
PT,ABDOMINAL DISCOMFORT,1
PT,ABDOMINAL DISTENSION,1
PT,ABDOMINAL PAIN,1
PT,ABORTION INDUCED,1
PT,ACUTE MYOCARDIAL INFARCTION,1
PT,ACUTE PULMONARY OEDEMA,1
PT,AGE-RELATED MACULAR DEGENERATION,1
PT,ALLERGY TO METALS,1
PT,ANAPHYLACTIC REACTION,1
PT,ANAPHYLACTIC SHOCK,1
PT,ANTINUCLEAR ANTIBODY POSITIVE,1
PT,ARRHYTHMIA,1
PT,ARTHRALGIA,1
PT,ARTHRITIS,1
PT,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,1
PT,AUTOIMMUNE HEPATITIS,1
PT,BACK PAIN,1
PT,BLOOD ALKALINE PHOSPHATASE INCREASED,1
PT,BLOOD BLISTER,1
PT,BLOOD LACTIC ACID INCREASED,1
PT,BLOOD UREA INCREASED,1
PT,BLOOD URIC ACID INCREASED,1
PT,BRAIN DEATH,1
PT,BUNDLE BRANCH BLOCK RIGHT,1
PT,C-REACTIVE PROTEIN INCREASED,1
PT,CARDIAC FAILURE,1
PT,CARDIAC FAILURE ACUTE,1
PT,CARDIAC TAMPONADE,1
PT,CEREBRAL HAEMORRHAGE,1
PT,CEREBRAL VENOUS THROMBOSIS,1
PT,CHEST DISCOMFORT,1
PT,CHEST PAIN,1
PT,CHOLESTASIS,1
PT,COMA,1
PT,COMA HEPATIC,1
PT,COMA SCALE,1
PT,CONFUSIONAL STATE,1
PT,CONTUSION,1
PT,DEATH,1
PT,DECREASED APPETITE,1
PT,DEHYDRATION,1
PT,DEVICE EMBOLISATION,1
PT,DIABETIC KETOACIDOSIS,1
PT,DISEASE PROGRESSION,1
PT,DIZZINESS,1
PT,DNA ANTIBODY POSITIVE,1
PT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
PT,DRY EYE,1
PT,DYSENTERY,1
PT,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
PT,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
PT,ENDOCRINE DISORDER,1
PT,EOSINOPHILIA,1
PT,EPILEPSY,1
PT,ERYTHEMA OF EYELID,1
PT,ESCHERICHIA URINARY TRACT INFECTION,1
PT,EXPOSURE DURING PREGNANCY,1
PT,EYE PAIN,1
PT,EYELASH CHANGES,1
PT,FATIGUE,1
PT,FEBRILE NEUTROPENIA,1
PT,FOREIGN BODY SENSATION IN EYES,1
PT,FULL BLOOD COUNT DECREASED,1
PT,GASTROINTESTINAL HAEMORRHAGE,1
PT,GINGIVAL INFECTION,1
PT,GINGIVAL PAIN,1
PT,HAEMATOMA,1
PT,HAEMATOTOXICITY,1
PT,HAEMORRHAGE INTRACRANIAL,1
PT,HAEMORRHAGIC STROKE,1
PT,HEMIANOPIA,1
PT,HEMIPARESIS,1
PT,HIATUS HERNIA,1
PT,HYPERAMMONAEMIA,1
PT,HYPERGLYCAEMIA,1
PT,HYPERHIDROSIS,1
PT,HYPERLACTACIDAEMIA,1
PT,HYPERTHYROIDISM,1
PT,HYPOCHROMIC ANAEMIA,1
PT,HYPOGLYCAEMIA,1
PT,HYPOKALAEMIA,1
PT,HYPONATRAEMIA,1
PT,HYPOVOLAEMIC SHOCK,1
PT,HYPOXIA,1
PT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PT,INCREASED TENDENCY TO BRUISE,1
PT,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
PT,INTERSTITIAL LUNG DISEASE,1
PT,INTESTINAL ISCHAEMIA,1
PT,ISCHAEMIC STROKE,1
PT,JOINT SWELLING,1
PT,LEG AMPUTATION,1
PT,LEUKOCYTOSIS,1
PT,LIVE BIRTH,1
PT,LIVER DISORDER,1
PT,LOWER RESPIRATORY TRACT INFECTION,1
PT,LUPUS-LIKE SYNDROME,1
PT,MACULOPATHY,1
PT,MALAISE,1
PT,MASTICATION DISORDER,1
PT,MECHANICAL VENTILATION,1
PT,MESENTERIC ARTERY STENOSIS,1
PT,MICROCYTIC ANAEMIA,1
PT,MONOCYTE COUNT INCREASED,1
PT,MOTOR DYSFUNCTION,1
PT,MULTI-ORGAN FAILURE,1
PT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
PT,MUSCLE TWITCHING,1
PT,MYOCLONUS,1
PT,MYOPATHY TOXIC,1
PT,NEUTROPHIL COUNT INCREASED,1
PT,OCULAR TOXICITY,1
PT,OESOPHAGEAL CANDIDIASIS,1
PT,OESOPHAGEAL HAEMORRHAGE,1
PT,OLIGURIA,1
PT,PAIN,1
PT,PALLOR,1
PT,PANCYTOPENIA,1
PT,PARAESTHESIA,1
PT,PARKINSON^S DISEASE,1
PT,PEPTIC ULCER,1
PT,PERIPHERAL ARTHRITIS,1
PT,PERIPHERAL ISCHAEMIA,1
PT,PERITONITIS,1
PT,PHYSICAL ASSAULT,1
PT,PLATELET COUNT INCREASED,1
PT,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
PT,POLYCYTHAEMIA,1
PT,POSTICTAL PARALYSIS,1
PT,POSTURE ABNORMAL,1
PT,POTENTIATING DRUG INTERACTION,1
PT,PREMATURE BABY,1
PT,PREMATURE LABOUR,1
PT,PREMATURE RUPTURE OF MEMBRANES,1
PT,PRODUCT SUBSTITUTION ISSUE,1
PT,PRODUCTIVE COUGH,1
PT,PRURITUS,1
PT,PRURITUS GENERALISED,1
PT,PULMONARY FIBROSIS,1
PT,PULMONARY OEDEMA,1
PT,PULMONARY TOXICITY,1
PT,PYOGENIC GRANULOMA,1
PT,PYREXIA,1
PT,RASH,1
PT,RENAL FUNCTION TEST ABNORMAL,1
PT,RENAL INJURY,1
PT,RESPIRATORY FAILURE,1
PT,RESPIRATORY TRACT INFECTION,1
PT,ROAD TRAFFIC ACCIDENT,1
PT,SELF-MEDICATION,1
PT,SEPTIC SHOCK,1
PT,SHOCK,1
PT,SKIN INFECTION,1
PT,SKIN LESION,1
PT,SKIN NEOPLASM BLEEDING,1
PT,SKIN ULCER,1
PT,SKIN WOUND,1
PT,SPINAL FRACTURE,1
PT,SPLENIC RUPTURE,1
PT,STUPOR,1
PT,SUBDURAL HAEMATOMA,1
PT,SUBDURAL HAEMORRHAGE,1
PT,SYNOVITIS,1
PT,TACHYPNOEA,1
PT,THREATENED LABOUR,1
PT,THYROID DISORDER,1
PT,TOXICITY TO VARIOUS AGENTS,1
PT,TRANSFUSION,1
PT,TREATMENT FAILURE,1
PT,TREMOR,1
PT,TYPE 1 DIABETES MELLITUS,1
PT,URINARY RETENTION,1
PT,URINE FLOW DECREASED,1
PT,URINE OUTPUT DECREASED,1
PT,VISUAL IMPAIRMENT,1
PR,INJECTION SITE PAIN,32
PR,NASOPHARYNGITIS,23
PR,PAIN IN EXTREMITY,19
PR,HEADACHE,18
PR,ARTHRALGIA,16
PR,PAIN,15
PR,PSORIASIS,13
PR,DRUG INEFFECTIVE,11
PR,NAUSEA,11
PR,HYPERTENSION,10
PR,ASTHENIA,9
PR,ASTHMA,9
PR,DIARRHOEA,9
PR,DIZZINESS,9
PR,FALL,8
PR,BURNING SENSATION,7
PR,DECREASED APPETITE,7
PR,FATIGUE,7
PR,GAIT DISTURBANCE,7
PR,INFLAMMATION,7
PR,PERIPHERAL SWELLING,7
PR,PYREXIA,7
PR,VOMITING,7
PR,BACK PAIN,6
PR,CATARACT,6
PR,MALAISE,6
PR,ABDOMINAL DISCOMFORT,5
PR,ABDOMINAL PAIN,5
PR,ABDOMINAL PAIN UPPER,5
PR,BLOOD GLUCOSE INCREASED,5
PR,CHEST PAIN,5
PR,GASTRITIS,5
PR,HYPERSENSITIVITY,5
PR,INFLUENZA,5
PR,INJECTION SITE ERYTHEMA,5
PR,INJECTION SITE PRURITUS,5
PR,URINARY TRACT INFECTION,5
PR,VENOUS OCCLUSION,5
PR,BRONCHITIS,4
PR,CARDIAC DISORDER,4
PR,DRUG DOSE OMISSION,4
PR,DYSPNOEA,4
PR,HAEMATOCHEZIA,4
PR,HAEMATOMA,4
PR,INCORRECT DOSE ADMINISTERED,4
PR,INSOMNIA,4
PR,MYOCARDIAL INFARCTION,4
PR,NECK PAIN,4
PR,VISUAL IMPAIRMENT,4
PR,WEIGHT DECREASED,4
PR,ABSCESS,3
PR,ARTHRITIS,3
PR,CEREBROVASCULAR ACCIDENT,3
PR,CONFUSIONAL STATE,3
PR,COUGH,3
PR,DERMATITIS ALLERGIC,3
PR,DRY MOUTH,3
PR,FEELING ABNORMAL,3
PR,GASTROINTESTINAL INFLAMMATION,3
PR,HAEMOGLOBIN DECREASED,3
PR,HEAD INJURY,3
PR,HEPATIC ENZYME INCREASED,3
PR,INJECTION SITE HAEMATOMA,3
PR,INJECTION SITE RASH,3
PR,LUNG DISORDER,3
PR,MYALGIA,3
PR,MYOCARDIAL NECROSIS MARKER INCREASED,3
PR,PALPITATIONS,3
PR,PARAESTHESIA,3
PR,PNEUMONIA,3
PR,PRODUCTIVE COUGH,3
PR,PRURITUS GENERALISED,3
PR,PULMONARY OEDEMA,3
PR,RASH,3
PR,RASH MACULAR,3
PR,RHEUMATOID ARTHRITIS,3
PR,TACHYCARDIA,3
PR,UNEVALUABLE EVENT,3
PR,VISION BLURRED,3
PR,ANAEMIA,2
PR,ARRHYTHMIA,2
PR,ARTHROPATHY,2
PR,BACTERIAL INFECTION,2
PR,BLINDNESS,2
PR,BLOOD CHOLESTEROL INCREASED,2
PR,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
PR,CARDIOVASCULAR DISORDER,2
PR,CELLULITIS,2
PR,CEREBRAL INFARCTION,2
PR,CHIKUNGUNYA VIRUS INFECTION,2
PR,CHILLS,2
PR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
PR,CONSTIPATION,2
PR,DEPRESSION,2
PR,DIABETES MELLITUS,2
PR,DIABETES MELLITUS INADEQUATE CONTROL,2
PR,DRUG EFFECT DECREASED,2
PR,DYSURIA,2
PR,EAR DISCOMFORT,2
PR,EAR INFECTION,2
PR,ERYTHEMA,2
PR,FEMUR FRACTURE,2
PR,FLATULENCE,2
PR,FOOT FRACTURE,2
PR,GALLBLADDER DISORDER,2
PR,HIATUS HERNIA,2
PR,HYPERCHOLESTEROLAEMIA,2
PR,HYPERKERATOSIS,2
PR,HYPOAESTHESIA,2
PR,INFARCTION,2
PR,INJECTION SITE HAEMORRHAGE,2
PR,INJECTION SITE INDURATION,2
PR,INJECTION SITE REACTION,2
PR,INJECTION SITE URTICARIA,2
PR,INJECTION SITE WARMTH,2
PR,INTERNAL HAEMORRHAGE,2
PR,JOINT SWELLING,2
PR,LIMB INJURY,2
PR,LOCALISED INFECTION,2
PR,MENISCUS INJURY,2
PR,MUSCULOSKELETAL DISORDER,2
PR,MUSCULOSKELETAL PAIN,2
PR,NAIL DISORDER,2
PR,NERVOUSNESS,2
PR,OEDEMA PERIPHERAL,2
PR,OROPHARYNGEAL PAIN,2
PR,OSTEOPENIA,2
PR,POSTOPERATIVE WOUND INFECTION,2
PR,PRURITUS,2
PR,RECTAL HAEMORRHAGE,2
PR,RESPIRATORY ARREST,2
PR,RESPIRATORY TRACT CONGESTION,2
PR,SINUSITIS,2
PR,SLEEP APNOEA SYNDROME,2
PR,TINNITUS,2
PR,TOOTH FRACTURE,2
PR,VAGINAL HAEMORRHAGE,2
PR,WHITE BLOOD CELL COUNT INCREASED,2
PR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
PR,ABDOMINAL ABSCESS,1
PR,ABDOMINAL DISTENSION,1
PR,ABDOMINAL RIGIDITY,1
PR,ABSCESS BACTERIAL,1
PR,ABSCESS LIMB,1
PR,ACNE,1
PR,ACQUIRED CARDIAC SEPTAL DEFECT,1
PR,ADMINISTRATION SITE REACTION,1
PR,ADVERSE EVENT,1
PR,AGGRESSION,1
PR,AGITATION,1
PR,ALOPECIA,1
PR,AMNESIA,1
PR,AMYLASE INCREASED,1
PR,ANGIOEDEMA,1
PR,ANKLE FRACTURE,1
PR,ANXIETY,1
PR,APHASIA,1
PR,ARTERIAL OCCLUSIVE DISEASE,1
PR,ARTHROPOD BITE,1
PR,ASPHYXIA,1
PR,ATRIAL FIBRILLATION,1
PR,AUDITORY DISORDER,1
PR,BALANCE DISORDER,1
PR,BLOOD GLUCOSE ABNORMAL,1
PR,BLOOD GLUCOSE DECREASED,1
PR,BLOOD POTASSIUM DECREASED,1
PR,BLOOD PRESSURE DECREASED,1
PR,BLOOD PRESSURE INCREASED,1
PR,BONE OPERATION,1
PR,BONE PAIN,1
PR,BONE SWELLING,1
PR,BOREDOM,1
PR,BOWEL MOVEMENT IRREGULARITY,1
PR,BREAST DISORDER FEMALE,1
PR,BREAST ENLARGEMENT,1
PR,BRONCHITIS CHRONIC,1
PR,BRONCHOSPASM,1
PR,BURNS SECOND DEGREE,1
PR,CANDIDA INFECTION,1
PR,CARDIAC ANEURYSM,1
PR,CARDIAC FAILURE,1
PR,CARDIAC FAILURE CONGESTIVE,1
PR,CARDIAC MURMUR,1
PR,CARDIAC PACEMAKER REPLACEMENT,1
PR,CARDIO-RESPIRATORY ARREST,1
PR,CARDIOMEGALY,1
PR,CAROTID ARTERY OCCLUSION,1
PR,CERVICAL VERTEBRAL FRACTURE,1
PR,CHOLECYSTITIS,1
PR,CHOLELITHIASIS,1
PR,COLD SWEAT,1
PR,COLITIS,1
PR,COLORECTAL CANCER,1
PR,CONDITION AGGRAVATED,1
PR,CONTUSION,1
PR,CORONARY ARTERY OCCLUSION,1
PR,CORONARY VEIN STENOSIS,1
PR,CYST,1
PR,DEAFNESS UNILATERAL,1
PR,DEATH,1
PR,DEHYDRATION,1
PR,DENTAL CARE,1
PR,DEVICE ALLERGY,1
PR,DEVICE MALFUNCTION,1
PR,DIABETIC NEUROPATHY,1
PR,DISCOMFORT,1
PR,DIVERTICULITIS,1
PR,DRUG ADMINISTRATION ERROR,1
PR,DRUG PRESCRIBING ERROR,1
PR,DRY EYE,1
PR,DRY SKIN,1
PR,DRY THROAT,1
PR,DYSARTHRIA,1
PR,DYSGEUSIA,1
PR,DYSMENORRHOEA,1
PR,DYSPEPSIA,1
PR,DYSPHAGIA,1
PR,DYSPHONIA,1
PR,ECHOCARDIOGRAM ABNORMAL,1
PR,ENDOMETRIOSIS,1
PR,EPISTAXIS,1
PR,EXOSTOSIS,1
PR,EXPOSURE DURING PREGNANCY,1
PR,EYE DISORDER,1
PR,EYE HAEMORRHAGE,1
PR,EYE INFLAMMATION,1
PR,EYE SWELLING,1
PR,FACE OEDEMA,1
PR,FACIAL PAIN,1
PR,FACIAL PARESIS,1
PR,FEEDING DISORDER,1
PR,FEELING HOT,1
PR,FINGER DEFORMITY,1
PR,FLANK PAIN,1
PR,FOOD CRAVING,1
PR,FORMICATION,1
PR,FREQUENT BOWEL MOVEMENTS,1
PR,FUNGAL INFECTION,1
PR,GALLBLADDER PERFORATION,1
PR,GANGRENE,1
PR,GASTRITIS EROSIVE,1
PR,GASTROENTERITIS VIRAL,1
PR,GASTROINTESTINAL HAEMORRHAGE,1
PR,GASTROOESOPHAGEAL REFLUX DISEASE,1
PR,GENITAL DISCOMFORT,1
PR,GINGIVITIS,1
PR,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
PR,HAEMOPTYSIS,1
PR,HEAD DISCOMFORT,1
PR,HEART RATE DECREASED,1
PR,HEART RATE INCREASED,1
PR,HEPATIC MASS,1
PR,HEPATITIS,1
PR,HEPATOMEGALY,1
PR,HERNIA,1
PR,HOSPITALISATION,1
PR,HYPERTENSIVE CRISIS,1
PR,HYPOACUSIS,1
PR,HYPOPHAGIA,1
PR,HYPOXIA,1
PR,HYSTERECTOMY,1
PR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PR,INCOHERENT,1
PR,INCORRECT PRODUCT STORAGE,1
PR,INFECTION,1
PR,INJECTION SITE DISCOMFORT,1
PR,INJECTION SITE SWELLING,1
PR,INTENTIONAL PRODUCT MISUSE,1
PR,INTERVERTEBRAL DISC PROTRUSION,1
PR,INTESTINAL POLYP,1
PR,INTRACRANIAL ANEURYSM,1
PR,IRRITABILITY,1
PR,ISCHAEMIC STROKE,1
PR,JAW DISORDER,1
PR,JOINT RANGE OF MOTION DECREASED,1
PR,KNEE ARTHROPLASTY,1
PR,LIPASE INCREASED,1
PR,LIVE BIRTH,1
PR,LOSS OF CONSCIOUSNESS,1
PR,LOWER LIMB FRACTURE,1
PR,LUPUS-LIKE SYNDROME,1
PR,MALIGNANT NEOPLASM OF THORAX,1
PR,MALIGNANT NEOPLASM PROGRESSION,1
PR,MEDICATION ERROR,1
PR,MELAENA,1
PR,MELANOCYTIC NAEVUS,1
PR,MEMORY IMPAIRMENT,1
PR,MENORRHAGIA,1
PR,MENTAL DISORDER,1
PR,MIGRAINE,1
PR,MOOD ALTERED,1
PR,MUSCLE SPASMS,1
PR,MUSCULAR WEAKNESS,1
PR,MUSCULOSKELETAL DISCOMFORT,1
PR,MUSCULOSKELETAL STIFFNESS,1
PR,NASAL CONGESTION,1
PR,NEPHROLITHIASIS,1
PR,NERVE BLOCK,1
PR,NERVE COMPRESSION,1
PR,NEUROPATHY PERIPHERAL,1
PR,NODULE,1
PR,OEDEMA,1
PR,ORAL PAIN,1
PR,ORAL SURGERY,1
PR,OROPHARYNGEAL DISCOMFORT,1
PR,OSTEITIS,1
PR,OSTEOPOROSIS,1
PR,OXYGEN SATURATION ABNORMAL,1
PR,OXYGEN SATURATION DECREASED,1
PR,PAINFUL DEFAECATION,1
PR,PALLOR,1
PR,PANCREATITIS,1
PR,PARAESTHESIA ORAL,1
PR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
PR,PERIPHERAL ARTERY OCCLUSION,1
PR,PERIPROSTHETIC FRACTURE,1
PR,PHARYNGITIS,1
PR,PHLEBITIS,1
PR,PLATELET COUNT DECREASED,1
PR,POLYMYOSITIS,1
PR,POLYP,1
PR,POST PROCEDURAL CELLULITIS,1
PR,POST PROCEDURAL COMPLICATION,1
PR,POST PROCEDURAL INFECTION,1
PR,POST PROCEDURAL STROKE,1
PR,PREMATURE DELIVERY,1
PR,PRETERM PREMATURE RUPTURE OF MEMBRANES,1
PR,PRODUCT USE ISSUE,1
PR,PROSTATIC DISORDER,1
PR,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
PR,PSORIATIC ARTHROPATHY,1
PR,PULMONARY HYPERTENSION,1
PR,PURULENT DISCHARGE,1
PR,RASH PRURITIC,1
PR,RENAL IMPAIRMENT,1
PR,RESPIRATORY FAILURE,1
PR,RHINORRHOEA,1
PR,RHONCHI,1
PR,ROAD TRAFFIC ACCIDENT,1
PR,ROTATOR CUFF SYNDROME,1
PR,SEIZURE,1
PR,SENSORY DISTURBANCE,1
PR,SKIN DISCOLOURATION,1
PR,SKIN DISORDER,1
PR,SKIN EXFOLIATION,1
PR,SKIN FISSURES,1
PR,SKIN HYPERPLASIA,1
PR,SKIN SWELLING,1
PR,SKIN ULCER,1
PR,SLOW SPEECH,1
PR,SNEEZING,1
PR,SOMNOLENCE,1
PR,SPEECH DISORDER,1
PR,SPINAL FRACTURE,1
PR,SPINAL OSTEOARTHRITIS,1
PR,STOMA SITE DISCHARGE,1
PR,STOMA SITE ERYTHEMA,1
PR,SUICIDAL IDEATION,1
PR,SURGERY,1
PR,SWELLING FACE,1
PR,SYNCOPE,1
PR,THIRST,1
PR,THROMBOPHLEBITIS,1
PR,THROMBOSIS,1
PR,THYROID CANCER,1
PR,THYROID CANCER METASTATIC,1
PR,THYROID DISORDER,1
PR,TOOTH INFECTION,1
PR,TOOTHACHE,1
PR,TRACHEAL INFLAMMATION,1
PR,TRANSFUSION RELATED COMPLICATION,1
PR,TRANSIENT ISCHAEMIC ATTACK,1
PR,TYPE 2 DIABETES MELLITUS,1
PR,UPPER GASTROINTESTINAL HAEMORRHAGE,1
PR,UPPER LIMB FRACTURE,1
PR,URINARY INCONTINENCE,1
PR,URINARY TRACT INFECTION BACTERIAL,1
PR,URINE ABNORMALITY,1
PR,URTICARIA,1
PR,UTERINE CYST,1
PR,UTERINE DISORDER,1
PR,UTERINE ENLARGEMENT,1
PR,UTERINE HAEMATOMA,1
PR,UTERINE LEIOMYOMA,1
PR,VARICOSE VEIN,1
PR,VERTIGO,1
PR,VIRAL INFECTION,1
PR,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
PR,VITAMIN D DEFICIENCY,1
PR,VITREOUS FLOATERS,1
PR,VULVOVAGINAL MYCOTIC INFECTION,1
PR,WHITE BLOOD CELL COUNT DECREASED,1
PR,WOUND,1
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
QA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
QA,DRUG INEFFECTIVE,2
QA,SEROTONIN SYNDROME,2
QA,ASPHYXIA,1
QA,DIABETIC KETOACIDOSIS,1
QA,GASTROINTESTINAL HAEMORRHAGE,1
QA,MUSCLE SPASMS,1
QA,MYOCARDIAL INFARCTION,1
QA,THROMBOSIS IN DEVICE,1
QA,TOXIC EPIDERMAL NECROLYSIS,1
QA,TREMOR,1
QA,VENTRICULAR ARRHYTHMIA,1
RO,DRUG INEFFECTIVE,9
RO,DEATH,5
RO,ISCHAEMIC STROKE,5
RO,PYREXIA,4
RO,VASCULAR STENT THROMBOSIS,4
RO,ACUTE MYOCARDIAL INFARCTION,3
RO,ASTHENIA,3
RO,HYPOTENSION,3
RO,THROMBOSIS,3
RO,THROMBOSIS IN DEVICE,3
RO,TREATMENT NONCOMPLIANCE,3
RO,ABDOMINAL PAIN,2
RO,ANGINA PECTORIS,2
RO,ANXIETY,2
RO,ARTERIOSCLEROSIS,2
RO,CHEST PAIN,2
RO,CHOLECYSTITIS ACUTE,2
RO,CHOLESTASIS,2
RO,CONDITION AGGRAVATED,2
RO,CONSTIPATION,2
RO,CORONARY ARTERY DISEASE,2
RO,DIZZINESS,2
RO,DRUG INTOLERANCE,2
RO,DRUG RESISTANCE,2
RO,DYSGEUSIA,2
RO,FALL,2
RO,FOETAL EXPOSURE DURING PREGNANCY,2
RO,HAEMORRHOIDS,2
RO,INTENTIONAL DOSE OMISSION,2
RO,INTENTIONAL PRODUCT MISUSE,2
RO,MYOCARDIAL INFARCTION,2
RO,PANCREATITIS,2
RO,RECTAL HAEMORRHAGE,2
RO,RHEUMATOID ARTHRITIS,2
RO,TREMOR,2
RO,VENTRICULAR TACHYCARDIA,2
RO,ABDOMINAL DISTENSION,1
RO,ABDOMINAL PAIN UPPER,1
RO,ABDOMINAL WALL HAEMATOMA,1
RO,ADVERSE EVENT,1
RO,AMNESIA,1
RO,ANAPHYLACTIC REACTION,1
RO,ANEURYSM,1
RO,ANTERIOR CHAMBER CLEAVAGE SYNDROME,1
RO,APHASIA,1
RO,APPENDICECTOMY,1
RO,ASTHMA,1
RO,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
RO,BALANCE DISORDER,1
RO,BALLISMUS,1
RO,BLOOD CHOLESTEROL INCREASED,1
RO,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
RO,BLOOD GLUCOSE INCREASED,1
RO,BLOOD PRESSURE FLUCTUATION,1
RO,BLOOD PRESSURE INCREASED,1
RO,CARDIAC ANEURYSM,1
RO,CARDIAC FAILURE ACUTE,1
RO,CARDIAC VENTRICULAR THROMBOSIS,1
RO,CARDIOGENIC SHOCK,1
RO,CATARACT,1
RO,CHILLS,1
RO,CHRONIC KIDNEY DISEASE,1
RO,COARCTATION OF THE AORTA,1
RO,COMA,1
RO,CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY,1
RO,CORNEAL DISORDER,1
RO,CORNEAL LEUKOMA,1
RO,CORNEAL NEOVASCULARISATION,1
RO,CORNEAL OPACITY,1
RO,CORONARY ARTERY ANEURYSM,1
RO,CORONARY ARTERY THROMBOSIS,1
RO,CREATININE RENAL CLEARANCE DECREASED,1
RO,DEHYDRATION,1
RO,DELIRIUM,1
RO,DEMYELINATION,1
RO,DEPRESSION,1
RO,DEVELOPMENTAL GLAUCOMA,1
RO,DIABETES MELLITUS,1
RO,DIARRHOEA,1
RO,DISEASE RECURRENCE,1
RO,DIVERTICULITIS INTESTINAL HAEMORRHAGIC,1
RO,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
RO,DRUG EFFECT INCOMPLETE,1
RO,DYSPNOEA,1
RO,EPISTAXIS,1
RO,ERYTHEMA,1
RO,EXPOSURE DURING PREGNANCY,1
RO,EYE DISORDER,1
RO,FOETAL GROWTH RESTRICTION,1
RO,GASTROINTESTINAL HAEMORRHAGE,1
RO,GENERAL PHYSICAL HEALTH DETERIORATION,1
RO,GENERALISED ERYTHEMA,1
RO,HAEMORRHAGE,1
RO,HAEMORRHAGIC STROKE,1
RO,HEADACHE,1
RO,HEMIPLEGIA,1
RO,HIGH DENSITY LIPOPROTEIN DECREASED,1
RO,HYPERCALCAEMIA,1
RO,HYPERHIDROSIS,1
RO,HYPERTENSION,1
RO,HYPERTENSIVE ANGIOPATHY,1
RO,HYPOGLYCAEMIA,1
RO,IMMUNE THROMBOCYTOPENIC PURPURA,1
RO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
RO,INTERVERTEBRAL DISC PROTRUSION,1
RO,KLEBSIELLA INFECTION,1
RO,LIVEDO RETICULARIS,1
RO,LOCALISED INFECTION,1
RO,LOW DENSITY LIPOPROTEIN INCREASED,1
RO,METRORRHAGIA,1
RO,MICROPHTHALMOS,1
RO,MITRAL VALVE INCOMPETENCE,1
RO,MUSCULAR WEAKNESS,1
RO,MYALGIA,1
RO,MYOCARDIAL RUPTURE,1
RO,MYOPATHY,1
RO,NASAL INJURY,1
RO,NAUSEA,1
RO,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
RO,NEUTROPENIA,1
RO,ORAL CANDIDIASIS,1
RO,ORTHOSTATIC HYPOTENSION,1
RO,PALPITATIONS,1
RO,PERICARDITIS,1
RO,PERIPHERAL SWELLING,1
RO,PREMATURE BABY,1
RO,PRODUCT USE IN UNAPPROVED INDICATION,1
RO,PROSTATE CANCER,1
RO,PRURITUS GENERALISED,1
RO,QUADRIPLEGIA,1
RO,RENAL FAILURE,1
RO,REOCCLUSION,1
RO,RETROPERITONEAL HAEMATOMA,1
RO,RHABDOMYOLYSIS,1
RO,SEPSIS NEONATAL,1
RO,SINUS ARREST,1
RO,SKIN ULCER,1
RO,SUDDEN CARDIAC DEATH,1
RO,SWOLLEN TONGUE,1
RO,SYSTOLIC DYSFUNCTION,1
RO,TACHYPNOEA,1
RO,TENDONITIS,1
RO,THERAPEUTIC RESPONSE DECREASED,1
RO,THROMBOCYTOPENIA,1
RO,TREATMENT FAILURE,1
RO,VERTIGO,1
RO,VITREOUS DETACHMENT,1
RO,VOMITING,1
RO,WEIGHT DECREASED,1
RU,MYOCARDIAL INFARCTION,21
RU,THROMBOSIS IN DEVICE,14
RU,MYOCARDIAL RUPTURE,13
RU,CHEST PAIN,12
RU,VASCULAR STENT THROMBOSIS,12
RU,DYSPNOEA,10
RU,ACUTE MYOCARDIAL INFARCTION,9
RU,BLOOD PRESSURE INCREASED,9
RU,ANGINA PECTORIS,7
RU,ASTHENIA,7
RU,CONTUSION,7
RU,GASTRITIS EROSIVE,7
RU,ISCHAEMIC STROKE,7
RU,CARDIAC FAILURE,6
RU,CARDIOGENIC SHOCK,6
RU,DEATH,6
RU,EPISTAXIS,6
RU,PRODUCT USE ISSUE,6
RU,ATRIAL FIBRILLATION,5
RU,BLOOD PRESSURE DECREASED,5
RU,CEREBROVASCULAR ACCIDENT,5
RU,DIZZINESS,5
RU,GASTRIC ULCER,5
RU,GASTROINTESTINAL HAEMORRHAGE,5
RU,HAEMORRHAGE,5
RU,PRURITUS,5
RU,URTICARIA,5
RU,ALANINE AMINOTRANSFERASE INCREASED,4
RU,ASPARTATE AMINOTRANSFERASE INCREASED,4
RU,HAEMATOMA,4
RU,HYPERTENSION,4
RU,PERICARDIAL HAEMORRHAGE,4
RU,PULMONARY OEDEMA,4
RU,ANAEMIA,3
RU,ANGINA UNSTABLE,3
RU,ANGIOEDEMA,3
RU,ATRIAL FLUTTER,3
RU,CORONARY ARTERY OCCLUSION,3
RU,CORONARY ARTERY RESTENOSIS,3
RU,DRUG INEFFECTIVE,3
RU,FALL,3
RU,GINGIVAL BLEEDING,3
RU,HAEMORRHAGIC ANAEMIA,3
RU,SPEECH DISORDER,3
RU,THROMBOCYTOPENIA,3
RU,VASCULAR OCCLUSION,3
RU,ABDOMINAL ABSCESS,2
RU,ABDOMINAL PAIN UPPER,2
RU,ARRHYTHMIA,2
RU,ARTERIOSCLEROSIS CORONARY ARTERY,2
RU,ASTHMA,2
RU,ATRIAL THROMBOSIS,2
RU,BACK PAIN,2
RU,BLOOD GLUCOSE INCREASED,2
RU,BODY TEMPERATURE INCREASED,2
RU,CARDIAC VENTRICULAR THROMBOSIS,2
RU,CHOLECYSTITIS,2
RU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
RU,COAGULOPATHY,2
RU,CORONARY ARTERY DISEASE,2
RU,CORONARY ARTERY STENOSIS,2
RU,COUGH,2
RU,CYSTITIS HAEMORRHAGIC,2
RU,DERMATITIS ALLERGIC,2
RU,GASTROINTESTINAL DISORDER,2
RU,HAEMOGLOBIN DECREASED,2
RU,HEMIPARESIS,2
RU,HYPERSENSITIVITY,2
RU,INJURY,2
RU,MALAISE,2
RU,MELAENA,2
RU,MYOCARDIAL ISCHAEMIA,2
RU,NEPHROLITHIASIS,2
RU,OEDEMA,2
RU,PAIN,2
RU,PALPITATIONS,2
RU,PLATELET COUNT DECREASED,2
RU,PLATELET COUNT INCREASED,2
RU,PULMONARY EMBOLISM,2
RU,PULMONARY HYPERTENSION,2
RU,RASH,2
RU,RASH PAPULAR,2
RU,RECTAL HAEMORRHAGE,2
RU,RENAL COLIC,2
RU,SMALL INTESTINAL HAEMORRHAGE,2
RU,TACHYCARDIA,2
RU,THERAPY CESSATION,2
RU,TRANSIENT ISCHAEMIC ATTACK,2
RU,URINARY RETENTION,2
RU,VASCULAR STENT OCCLUSION,2
RU,VENTRICULAR FIBRILLATION,2
RU,WEIGHT INCREASED,2
RU,ABDOMINAL PAIN,1
RU,ACTIVITIES OF DAILY LIVING IMPAIRED,1
RU,ACUTE CORONARY SYNDROME,1
RU,ACUTE LEFT VENTRICULAR FAILURE,1
RU,ADAMS-STOKES SYNDROME,1
RU,ADENOCARCINOMA GASTRIC,1
RU,ADENOCARCINOMA OF COLON,1
RU,AGRANULOCYTOSIS,1
RU,ALLERGIC OEDEMA,1
RU,AORTIC THROMBOSIS,1
RU,ATRIOVENTRICULAR BLOCK,1
RU,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
RU,BLADDER CANCER,1
RU,BLOOD BILIRUBIN INCREASED,1
RU,BLOOD CHOLESTEROL DECREASED,1
RU,BLOOD CREATININE INCREASED,1
RU,BLOOD IRON DECREASED,1
RU,BRADYCARDIA,1
RU,BRAIN HERNIATION,1
RU,BRAIN OEDEMA,1
RU,BRONCHOSPASM,1
RU,BUNDLE BRANCH BLOCK LEFT,1
RU,BUNDLE BRANCH BLOCK RIGHT,1
RU,CARDIAC FAILURE ACUTE,1
RU,CARDIAC FAILURE CHRONIC,1
RU,CARDIAC FAILURE CONGESTIVE,1
RU,CARDIAC FIBRILLATION,1
RU,CARDITIS,1
RU,CAROTID ARTERY STENOSIS,1
RU,CATHETER SITE HAEMATOMA,1
RU,CEREBELLAR HAEMATOMA,1
RU,CEREBRAL ARTERIOSCLEROSIS,1
RU,CEREBRAL INFARCTION,1
RU,CEREBRAL ISCHAEMIA,1
RU,CHILLS,1
RU,CHOKING SENSATION,1
RU,CIRCULATORY COLLAPSE,1
RU,COLITIS ULCERATIVE,1
RU,COLON CANCER,1
RU,CONSTIPATION,1
RU,CONTRAINDICATED PRODUCT ADMINISTERED,1
RU,CONTRAST MEDIA REACTION,1
RU,COR PULMONALE CHRONIC,1
RU,CORONARY ARTERY BYPASS,1
RU,DEEP VEIN THROMBOSIS,1
RU,DEVICE OCCLUSION,1
RU,DIABETES MELLITUS,1
RU,DIABETIC KETOACIDOSIS,1
RU,DIARRHOEA,1
RU,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
RU,DRUG DOSE OMISSION,1
RU,DRUG HYPERSENSITIVITY,1
RU,DRUG-INDUCED LIVER INJURY,1
RU,DRY MOUTH,1
RU,DUODENAL ULCER,1
RU,DYSPEPSIA,1
RU,DYSPNOEA EXERTIONAL,1
RU,ECZEMA,1
RU,EMBOLIC STROKE,1
RU,ENDOCARDITIS,1
RU,EROSIVE DUODENITIS,1
RU,EXCORIATION,1
RU,FACE OEDEMA,1
RU,FATIGUE,1
RU,FEAR,1
RU,FLUSHING,1
RU,FOREARM FRACTURE,1
RU,GANGRENE,1
RU,GASTRIC CANCER,1
RU,GASTRIC HAEMORRHAGE,1
RU,GASTRIC ULCER PERFORATION,1
RU,GASTRODUODENITIS,1
RU,GASTROINTESTINAL EROSION,1
RU,GASTROINTESTINAL POLYP HAEMORRHAGE,1
RU,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,1
RU,GLOMERULAR FILTRATION RATE DECREASED,1
RU,HAEMATEMESIS,1
RU,HAEMATOCHEZIA,1
RU,HAEMATURIA,1
RU,HAEMOPTYSIS,1
RU,HAEMORRHAGIC STROKE,1
RU,HAEMORRHAGIC TRANSFORMATION STROKE,1
RU,HAEMORRHOIDAL HAEMORRHAGE,1
RU,HEADACHE,1
RU,HEART DISEASE CONGENITAL,1
RU,HEART RATE DECREASED,1
RU,HEART RATE IRREGULAR,1
RU,HIP FRACTURE,1
RU,HYPERHIDROSIS,1
RU,HYPERTENSIVE CRISIS,1
RU,HYPOCOAGULABLE STATE,1
RU,HYPOTENSION,1
RU,INTENTIONAL DRUG MISUSE,1
RU,INTENTIONAL OVERDOSE,1
RU,INTERNATIONAL NORMALISED RATIO INCREASED,1
RU,INTESTINAL HAEMORRHAGE,1
RU,IRON DEFICIENCY ANAEMIA,1
RU,JAUNDICE,1
RU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
RU,LARYNGEAL OEDEMA,1
RU,LEG AMPUTATION,1
RU,LETHARGY,1
RU,LOSS OF CONSCIOUSNESS,1
RU,MALLORY-WEISS SYNDROME,1
RU,MATERNAL EXPOSURE DURING PREGNANCY,1
RU,MEDICATION ERROR,1
RU,MEMORY IMPAIRMENT,1
RU,MESENTERIC ARTERY THROMBOSIS,1
RU,METASTASES TO LIVER,1
RU,MULTI-ORGAN FAILURE,1
RU,MUSCULAR WEAKNESS,1
RU,MYOCARDIAL FIBROSIS,1
RU,NASOPHARYNGITIS,1
RU,NEPHROPATHY TOXIC,1
RU,OSTEOARTHRITIS,1
RU,OVERDOSE,1
RU,PAIN IN EXTREMITY,1
RU,PANCREATITIS ACUTE,1
RU,PANCREATITIS CHRONIC,1
RU,PANCREATITIS RELAPSING,1
RU,PERIPHERAL ARTERY THROMBOSIS,1
RU,PERITONITIS,1
RU,PLACENTAL INSUFFICIENCY,1
RU,PLATELET COUNT ABNORMAL,1
RU,PNEUMONIA,1
RU,PNEUMONIA CYTOMEGALOVIRAL,1
RU,POLLAKIURIA,1
RU,POST PROCEDURAL HAEMORRHAGE,1
RU,PROCEDURAL HAEMORRHAGE,1
RU,PRODUCT QUALITY ISSUE,1
RU,PRODUCT USE IN UNAPPROVED INDICATION,1
RU,PRURITUS GENITAL,1
RU,PYLORIC SPHINCTER INSUFFICIENCY,1
RU,PYREXIA,1
RU,RENAL FAILURE,1
RU,RENAL FAILURE ACUTE,1
RU,RENAL PAIN,1
RU,RESPIRATORY ARREST,1
RU,RESPIRATORY DISORDER,1
RU,RESPIRATORY FAILURE,1
RU,RHYTHM IDIOVENTRICULAR,1
RU,SEPSIS,1
RU,SHOCK,1
RU,SHOCK HAEMORRHAGIC,1
RU,SINOATRIAL BLOCK,1
RU,SINUS NODE DYSFUNCTION,1
RU,SKIN DISCOLOURATION,1
RU,SKIN EXFOLIATION,1
RU,STEVENS-JOHNSON SYNDROME,1
RU,SUBARACHNOID HAEMORRHAGE,1
RU,SUSPECTED COUNTERFEIT PRODUCT,1
RU,SYNOVIAL CYST,1
RU,THIRST,1
RU,TINNITUS,1
RU,TOOTH EXTRACTION,1
RU,TOXIC EPIDERMAL NECROLYSIS,1
RU,TREMOR,1
RU,UTERINE LEIOMYOMA,1
RU,VASCULAR STENOSIS,1
RU,VENTRICULAR TACHYCARDIA,1
RU,VIRAL INFECTION,1
RU,VIRAL LOAD,1
RU,VOMITING,1
RU,WHITE BLOOD CELL COUNT ABNORMAL,1
RU,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
SA,NEUROLEPTIC MALIGNANT SYNDROME,4
SA,SEROTONIN SYNDROME,4
SA,ALANINE AMINOTRANSFERASE INCREASED,3
SA,DRUG INEFFECTIVE,3
SA,HAEMOGLOBIN DECREASED,3
SA,CHEST PAIN,2
SA,CONDITION AGGRAVATED,2
SA,CORONARY REVASCULARISATION,2
SA,DYSPNOEA,2
SA,GASTROINTESTINAL HAEMORRHAGE,2
SA,HEPATOTOXICITY,2
SA,HYPERGLYCAEMIA,2
SA,HYPOTENSION,2
SA,LACTIC ACIDOSIS,2
SA,MELAENA,2
SA,MILK-ALKALI SYNDROME,2
SA,ABDOMINAL PAIN UPPER,1
SA,ACUTE KIDNEY INJURY,1
SA,ANGINA PECTORIS,1
SA,ASTHENIA,1
SA,ATRIOVENTRICULAR BLOCK COMPLETE,1
SA,BLOOD PRESSURE INCREASED,1
SA,BODY TEMPERATURE INCREASED,1
SA,BRADYARRHYTHMIA,1
SA,CARDIAC DISORDER,1
SA,CEREBROVASCULAR ACCIDENT,1
SA,CHOLECYSTITIS,1
SA,CONFUSIONAL STATE,1
SA,COUGH,1
SA,DEATH,1
SA,DEHYDRATION,1
SA,DEPRESSED LEVEL OF CONSCIOUSNESS,1
SA,DIARRHOEA,1
SA,DISORIENTATION,1
SA,DIZZINESS,1
SA,DRUG LEVEL INCREASED,1
SA,DRUG-INDUCED LIVER INJURY,1
SA,EPISTAXIS,1
SA,ERYTHEMA,1
SA,EXPOSURE DURING PREGNANCY,1
SA,FOETAL DEATH,1
SA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SA,GANGRENE,1
SA,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
SA,HAEMOPTYSIS,1
SA,HEART RATE INCREASED,1
SA,HEPATIC ENZYME INCREASED,1
SA,HEPATIC STEATOSIS,1
SA,HYPERCALCAEMIA,1
SA,HYPERNATRAEMIA,1
SA,HYPOGLYCAEMIA,1
SA,HYPOKALAEMIA,1
SA,HYPOMAGNESAEMIA,1
SA,HYPOPHOSPHATAEMIA,1
SA,ILL-DEFINED DISORDER,1
SA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
SA,INTENTIONAL PRODUCT MISUSE,1
SA,LETHARGY,1
SA,LIVER INJURY,1
SA,LOSS OF CONSCIOUSNESS,1
SA,MENTAL STATUS CHANGES,1
SA,METABOLIC ALKALOSIS,1
SA,MICROALBUMINURIA,1
SA,MYOCARDIAL REPERFUSION INJURY,1
SA,NEPHROPATHY TOXIC,1
SA,NON-ALCOHOLIC STEATOHEPATITIS,1
SA,OEDEMA PERIPHERAL,1
SA,OLIGOHYDRAMNIOS,1
SA,PAIN,1
SA,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
SA,PERIPHERAL ISCHAEMIA,1
SA,PLEURAL EFFUSION,1
SA,PRESYNCOPE,1
SA,PRODUCT SUBSTITUTION ISSUE,1
SA,PRURITUS GENERALISED,1
SA,PULMONARY HAEMORRHAGE,1
SA,RETROPERITONEAL HAEMATOMA,1
SA,ROTATOR CUFF SYNDROME,1
SA,SKIN LESION,1
SA,SMALL INTESTINAL OBSTRUCTION,1
SA,SUBCUTANEOUS ABSCESS,1
SA,THERAPY CESSATION,1
SA,TOXICITY TO VARIOUS AGENTS,1
SA,VASCULAR STENT THROMBOSIS,1
SA,VENTRICULAR ASYSTOLE,1
SA,VOMITING,1
RS,HAEMATEMESIS,4
RS,POLYMYOSITIS,4
RS,URINARY RETENTION,4
RS,ABDOMINAL DISTENSION,3
RS,APHASIA,3
RS,CONSTIPATION,3
RS,GASTROINTESTINAL HAEMORRHAGE,3
RS,MUSCULAR WEAKNESS,3
RS,ACUTE MYOCARDIAL INFARCTION,2
RS,CEREBRAL HAEMORRHAGE,2
RS,DISORIENTATION,2
RS,EPISTAXIS,2
RS,GASTROINTESTINAL HYPOMOTILITY,2
RS,GENERAL PHYSICAL HEALTH DETERIORATION,2
RS,HAEMORRHAGE INTRACRANIAL,2
RS,HEMIPLEGIA,2
RS,INTRAVENTRICULAR HAEMORRHAGE,2
RS,MALAISE,2
RS,MELAENA,2
RS,MYOCARDIAL INFARCTION,2
RS,PULMONARY EMBOLISM,2
RS,ABDOMINAL PAIN,1
RS,ALANINE AMINOTRANSFERASE INCREASED,1
RS,ANAEMIA,1
RS,ANGIOEDEMA,1
RS,ARRHYTHMIA,1
RS,ASPARTATE AMINOTRANSFERASE INCREASED,1
RS,ASTHENIA,1
RS,BACK PAIN,1
RS,BLOOD 1_25-DIHYDROXYCHOLECALCIFEROL DECREASED,1
RS,BLOOD CHOLESTEROL INCREASED,1
RS,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
RS,BLOOD DISORDER,1
RS,BLOOD GLUCOSE INCREASED,1
RS,BLOOD LACTATE DEHYDROGENASE INCREASED,1
RS,BLOOD TRIGLYCERIDES INCREASED,1
RS,BLOOD URIC ACID INCREASED,1
RS,BRAIN OEDEMA,1
RS,CEREBELLAR HAEMORRHAGE,1
RS,COMA,1
RS,CONDITION AGGRAVATED,1
RS,DIARRHOEA,1
RS,DISEASE PROGRESSION,1
RS,DRUG INEFFECTIVE,1
RS,DUODENAL ULCER,1
RS,DYSPNOEA,1
RS,ERYTHEMA MULTIFORME,1
RS,FATIGUE,1
RS,FUNCTIONAL GASTROINTESTINAL DISORDER,1
RS,GASTROINTESTINAL OBSTRUCTION,1
RS,HEADACHE,1
RS,HEPATIC HAEMORRHAGE,1
RS,HYPOKINESIA,1
RS,ILEUS PARALYTIC,1
RS,IMMOBILE,1
RS,INCONTINENCE,1
RS,INFECTIOUS PLEURAL EFFUSION,1
RS,LUNG TRANSPLANT,1
RS,MICTURITION URGENCY,1
RS,MOBILITY DECREASED,1
RS,MYOPATHY,1
RS,OROPHARYNGEAL PAIN,1
RS,PARESIS,1
RS,POSTURE ABNORMAL,1
RS,PRURITUS,1
RS,PULMONARY ARTERIAL HYPERTENSION,1
RS,PYREXIA,1
RS,RASH,1
RS,RECTAL HAEMORRHAGE,1
RS,RENAL FAILURE ACUTE,1
RS,RENAL FAILURE CHRONIC,1
RS,RIGHT VENTRICULAR FAILURE,1
RS,THROMBOSIS IN DEVICE,1
RS,WEIGHT INCREASED,1
RS,WITHDRAWAL SYNDROME,1
SG,DIARRHOEA,7
SG,DYSPNOEA,6
SG,NAUSEA,5
SG,VOMITING,5
SG,ABDOMINAL DISTENSION,4
SG,ABDOMINAL PAIN,4
SG,CONFUSIONAL STATE,4
SG,DYSPHAGIA,4
SG,GASTROOESOPHAGEAL REFLUX DISEASE,4
SG,PERIORBITAL OEDEMA,4
SG,SEPSIS,4
SG,ANAEMIA,3
SG,FLATULENCE,3
SG,GASTRITIS,3
SG,HYPOKALAEMIA,3
SG,ISCHAEMIC STROKE,3
SG,SPINAL EPIDURAL HAEMATOMA,3
SG,ACUTE MYOCARDIAL INFARCTION,2
SG,ANGIOEDEMA,2
SG,CIRCULATORY COLLAPSE,2
SG,DECREASED APPETITE,2
SG,DUODENAL ULCER,2
SG,EXPOSURE DURING PREGNANCY,2
SG,FACE OEDEMA,2
SG,GASTROINTESTINAL DISORDER,2
SG,GASTROINTESTINAL HAEMORRHAGE,2
SG,HAEMATEMESIS,2
SG,HAEMOPTYSIS,2
SG,HAEMORRHOIDS,2
SG,HEADACHE,2
SG,HYPERSENSITIVITY VASCULITIS,2
SG,HYPERTENSION,2
SG,HYPOCHROMIC ANAEMIA,2
SG,HYPOTENSION,2
SG,LONG QT SYNDROME,2
SG,MENTAL DISORDER,2
SG,MOUTH ULCERATION,2
SG,MYOCARDIAL ISCHAEMIA,2
SG,PNEUMONIA,2
SG,SYNCOPE,2
SG,THROMBOCYTOPENIA,2
SG,UPPER RESPIRATORY TRACT INFECTION,2
SG,ACUTE PULMONARY OEDEMA,1
SG,ADENOCARCINOMA OF COLON,1
SG,ANGINA UNSTABLE,1
SG,ASTHMA,1
SG,BACK PAIN,1
SG,BLEEDING TIME PROLONGED,1
SG,CARDIAC FAILURE,1
SG,CEREBRAL ARTERIOSCLEROSIS,1
SG,CEREBRAL INFARCTION,1
SG,CEREBROVASCULAR DISORDER,1
SG,CHRONIC GASTRITIS,1
SG,COLON CANCER,1
SG,CONSTIPATION,1
SG,CONTUSION,1
SG,CORONARY ARTERY DISEASE,1
SG,DEEP VEIN THROMBOSIS,1
SG,DEPRESSION,1
SG,DERMATITIS EXFOLIATIVE,1
SG,DIABETES MELLITUS INADEQUATE CONTROL,1
SG,DISEASE PROGRESSION,1
SG,DRUG ADMINISTRATION ERROR,1
SG,DYSPEPSIA,1
SG,ELECTROCARDIOGRAM QT PROLONGED,1
SG,ELECTROLYTE IMBALANCE,1
SG,EYE SWELLING,1
SG,FALL,1
SG,FLUSHING,1
SG,FOETAL GROWTH RESTRICTION,1
SG,GASTRIC CANCER,1
SG,GASTROINTESTINAL SOUNDS ABNORMAL,1
SG,GASTROINTESTINAL TOXICITY,1
SG,GOUT,1
SG,HAEMODYNAMIC INSTABILITY,1
SG,HAEMOGLOBIN DECREASED,1
SG,HELLP SYNDROME,1
SG,HEMIPARESIS,1
SG,HYPOAESTHESIA,1
SG,INFECTION,1
SG,ISCHAEMIC HEPATITIS,1
SG,JOINT RANGE OF MOTION DECREASED,1
SG,LARGE INTESTINE POLYP,1
SG,MALLORY-WEISS SYNDROME,1
SG,METABOLIC ACIDOSIS,1
SG,MOOD SWINGS,1
SG,MUSCULAR WEAKNESS,1
SG,MUSCULOSKELETAL STIFFNESS,1
SG,MYOCARDIAL INFARCTION,1
SG,NERVE COMPRESSION,1
SG,NEUTROPENIC SEPSIS,1
SG,OCCULT BLOOD,1
SG,OCCULT BLOOD POSITIVE,1
SG,OROMANDIBULAR DYSTONIA,1
SG,PAIN,1
SG,PALPITATIONS,1
SG,PANCREATIC CARCINOMA,1
SG,PANCREATITIS ACUTE,1
SG,PANIC ATTACK,1
SG,PERITONITIS,1
SG,PLASMA CELL MYELOMA,1
SG,PREMATURE SEPARATION OF PLACENTA,1
SG,PRODUCT USE ISSUE,1
SG,PULMONARY HYPERTENSION,1
SG,RASH,1
SG,RECTOSIGMOID CANCER,1
SG,REGURGITATION,1
SG,RESPIRATORY ACIDOSIS,1
SG,RESPIRATORY FAILURE,1
SG,ROTATOR CUFF SYNDROME,1
SG,SINUS RHYTHM,1
SG,STILLBIRTH,1
SG,SUPRAVENTRICULAR TACHYCARDIA,1
SG,THROMBOSIS IN DEVICE,1
SG,THUNDERCLAP HEADACHE,1
SG,TORSADE DE POINTES,1
SG,UPPER GASTROINTESTINAL HAEMORRHAGE,1
SG,URINARY RETENTION,1
SG,URINARY TRACT INFECTION,1
SG,URTICARIA,1
SG,VASCULITIS,1
SG,VENTRICULAR FIBRILLATION,1
SG,VENTRICULAR TACHYCARDIA,1
SG,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
SG,WEIGHT DECREASED,1
SK,FOETAL EXPOSURE TIMING UNSPECIFIED,6
SK,LOW BIRTH WEIGHT BABY,6
SK,PREMATURE BABY,6
SK,PREMATURE DELIVERY,5
SK,CAESAREAN SECTION,4
SK,MATERNAL EXPOSURE DURING PREGNANCY,4
SK,EXPOSURE DURING PREGNANCY,3
SK,FOETAL GROWTH RESTRICTION,3
SK,ABNORMAL LOSS OF WEIGHT,2
SK,COLITIS MICROSCOPIC,2
SK,DEEP VEIN THROMBOSIS,2
SK,DIARRHOEA,2
SK,DRUG ADMINISTRATION ERROR,2
SK,GASTRITIS EROSIVE,2
SK,LIVER DISORDER,2
SK,MYOCARDIAL INFARCTION,2
SK,PRE-ECLAMPSIA,2
SK,THROMBOCYTOPENIA,2
SK,ABORTION SPONTANEOUS,1
SK,ANAEMIA,1
SK,ANGINA UNSTABLE,1
SK,ARRHYTHMIA,1
SK,CANDIDA TEST POSITIVE,1
SK,CARDIOGENIC SHOCK,1
SK,CIRCULATORY COLLAPSE,1
SK,DEHYDRATION,1
SK,DRUG INTOLERANCE,1
SK,GASTROINTESTINAL CANDIDIASIS,1
SK,HAEMATEMESIS,1
SK,HELLP SYNDROME,1
SK,HYPOTENSION,1
SK,LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR,1
SK,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
SK,MATERNAL EXPOSURE BEFORE PREGNANCY,1
SK,OLIGOHYDRAMNIOS,1
SK,PREMATURE BABY DEATH,1
SK,VASCULAR STENT THROMBOSIS,1
SI,DIZZINESS,8
SI,DYSPNOEA,8
SI,BLOOD PRESSURE DECREASED,5
SI,BRADYCARDIA,5
SI,FATIGUE,5
SI,OEDEMA PERIPHERAL,5
SI,CHEST PAIN,4
SI,CHOKING,4
SI,COUGH,4
SI,DEPRESSION,4
SI,GENERAL PHYSICAL HEALTH DETERIORATION,4
SI,SOMNOLENCE,4
SI,ACUTE MYOCARDIAL INFARCTION,3
SI,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
SI,GAIT DISTURBANCE,3
SI,HYPERTENSION,3
SI,MALAISE,3
SI,METASTATIC SQUAMOUS CELL CARCINOMA,3
SI,PRODUCT USE IN UNAPPROVED INDICATION,3
SI,RENAL FAILURE,3
SI,SQUAMOUS CELL CARCINOMA OF SKIN,3
SI,APPENDICITIS,2
SI,ARRHYTHMIA,2
SI,ATRIAL FIBRILLATION,2
SI,BACTERIAL INFECTION,2
SI,C-REACTIVE PROTEIN INCREASED,2
SI,CARDIAC FAILURE,2
SI,CARDIOMEGALY,2
SI,CONSTIPATION,2
SI,CYANOSIS,2
SI,EJECTION FRACTION DECREASED,2
SI,EPILEPSY,2
SI,FALL,2
SI,HALLUCINATION,2
SI,HEMIPLEGIA,2
SI,HIP FRACTURE,2
SI,HYPERKALAEMIA,2
SI,HYPOTENSION,2
SI,INFUSION RELATED REACTION,2
SI,ISCHAEMIC STROKE,2
SI,JOINT DISLOCATION,2
SI,LIVER DISORDER,2
SI,METABOLIC ACIDOSIS,2
SI,PNEUMONIA,2
SI,PRURITUS,2
SI,PULMONARY HAEMATOMA,2
SI,RESPIRATORY FAILURE,2
SI,RESPIRATORY TRACT INFECTION,2
SI,TACHYCARDIA,2
SI,TOXICITY TO VARIOUS AGENTS,2
SI,ABDOMINAL PAIN,1
SI,ABNORMAL FAECES,1
SI,ABSCESS SOFT TISSUE,1
SI,ACQUIRED IMMUNODEFICIENCY SYNDROME,1
SI,ACUTE KIDNEY INJURY,1
SI,ACUTE MYELOID LEUKAEMIA,1
SI,ACUTE RESPIRATORY FAILURE,1
SI,AGEUSIA,1
SI,AGRANULOCYTOSIS,1
SI,ALANINE AMINOTRANSFERASE INCREASED,1
SI,AMNESIA,1
SI,ANAEMIA MACROCYTIC,1
SI,ANGINA PECTORIS,1
SI,ANISOCYTOSIS,1
SI,ANURIA,1
SI,AORTIC ANEURYSM,1
SI,ARTHRALGIA,1
SI,ASPARTATE AMINOTRANSFERASE INCREASED,1
SI,BASAL CELL CARCINOMA,1
SI,BLINDNESS UNILATERAL,1
SI,BLOOD ALKALINE PHOSPHATASE INCREASED,1
SI,BLOOD CHOLESTEROL INCREASED,1
SI,BLOOD CREATININE INCREASED,1
SI,BLOOD PARATHYROID HORMONE INCREASED,1
SI,BLOOD TRIGLYCERIDES INCREASED,1
SI,BONE TUBERCULOSIS,1
SI,BRONCHITIS,1
SI,BUNDLE BRANCH BLOCK LEFT,1
SI,CAMPYLOBACTER GASTROENTERITIS,1
SI,CARDIAC ARREST,1
SI,CARDIOGENIC SHOCK,1
SI,CATHETER SITE INFECTION,1
SI,CEREBROVASCULAR ACCIDENT,1
SI,CERVICAL RADICULOPATHY,1
SI,CHEST DISCOMFORT,1
SI,CHEYNE-STOKES RESPIRATION,1
SI,CHILLS,1
SI,CHOLECYSTITIS ACUTE,1
SI,CHOLELITHIASIS,1
SI,CHRONIC GASTRITIS,1
SI,CHRONIC KIDNEY DISEASE,1
SI,COLITIS,1
SI,COLON CANCER,1
SI,COMA,1
SI,CROHN^S DISEASE,1
SI,CYTOKINE RELEASE SYNDROME,1
SI,DEATH,1
SI,DERMATITIS ALLERGIC,1
SI,DIABETIC ENTEROPATHY,1
SI,DIABETIC NEPHROPATHY,1
SI,DIARRHOEA,1
SI,DIPLOPIA,1
SI,DIVERTICULITIS,1
SI,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
SI,DRUG ADMINISTRATION ERROR,1
SI,DYSARTHRIA,1
SI,DYSPNOEA AT REST,1
SI,DYSPNOEA EXERTIONAL,1
SI,EMBOLIC STROKE,1
SI,ENTERITIS,1
SI,EYE MOVEMENT DISORDER,1
SI,EYELID OEDEMA,1
SI,FACE INJURY,1
SI,FOLATE DEFICIENCY,1
SI,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SI,GASTROINTESTINAL HAEMORRHAGE,1
SI,GASTROINTESTINAL MUCOSAL NECROSIS,1
SI,GASTROOESOPHAGEAL REFLUX DISEASE,1
SI,HAEMATEMESIS,1
SI,HAEMORRHAGIC TRANSFORMATION STROKE,1
SI,HEADACHE,1
SI,HEPATIC CONGESTION,1
SI,HEPATIC ENZYME INCREASED,1
SI,HEPATOTOXICITY,1
SI,HOSPITALISATION,1
SI,HUMERUS FRACTURE,1
SI,HYPOCALCAEMIA,1
SI,HYPOCHROMASIA,1
SI,HYPOKALAEMIA,1
SI,HYPOPNOEA,1
SI,HYPOTHYROIDISM,1
SI,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
SI,INFECTION,1
SI,INFLUENZA,1
SI,ISCHAEMIC CARDIOMYOPATHY,1
SI,JOINT INJURY,1
SI,LEFT VENTRICULAR DYSFUNCTION,1
SI,LIVER INJURY,1
SI,LOSS OF CONSCIOUSNESS,1
SI,LUNG INFECTION,1
SI,MACROCYTOSIS,1
SI,MEDICATION MONITORING ERROR,1
SI,METASTASES TO SPINE,1
SI,MOBILITY DECREASED,1
SI,MOTOR DYSFUNCTION,1
SI,MUSCULAR WEAKNESS,1
SI,MYELOPEROXIDASE DEFICIENCY,1
SI,MYOCARDIAL ISCHAEMIA,1
SI,MYOPATHY,1
SI,NEOPLASM,1
SI,NERVE COMPRESSION,1
SI,NERVOUS SYSTEM DISORDER,1
SI,OEDEMA,1
SI,PANCYTOPENIA,1
SI,PARESIS,1
SI,PERIPHERAL ISCHAEMIA,1
SI,PERITONEAL ABSCESS,1
SI,PLEURAL EFFUSION,1
SI,PRODUCT USE ISSUE,1
SI,PYREXIA,1
SI,RASH GENERALISED,1
SI,RED BLOOD CELL COUNT INCREASED,1
SI,RENAL FAILURE CHRONIC,1
SI,RESPIRATORY RATE INCREASED,1
SI,RHABDOMYOLYSIS,1
SI,RIB FRACTURE,1
SI,RIGHT VENTRICULAR FAILURE,1
SI,SECONDARY ADRENOCORTICAL INSUFFICIENCY,1
SI,SINUS BRADYCARDIA,1
SI,SPINAL OSTEOARTHRITIS,1
SI,SQUAMOUS CELL CARCINOMA,1
SI,STAPHYLOCOCCAL SEPSIS,1
SI,STRUCTURAL VALVE DETERIORATION,1
SI,SUBILEUS,1
SI,SUFFOCATION FEELING,1
SI,SUICIDE ATTEMPT,1
SI,SYNCOPE,1
SI,TENDON PAIN,1
SI,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
SI,TRAUMATIC ARTHROSIS,1
SI,TUBERCULOSIS GASTROINTESTINAL,1
SI,ULCER,1
SI,VASCULAR STENT THROMBOSIS,1
SI,VEIN DISORDER,1
SI,VENTRICULAR EXTRASYSTOLES,1
ZA,DIABETES MELLITUS INADEQUATE CONTROL,4
ZA,DYSPNOEA,4
ZA,HAEMATEMESIS,4
ZA,ARTERIOSPASM CORONARY,3
ZA,CARDIAC FAILURE,3
ZA,CHEST DISCOMFORT,3
ZA,DIZZINESS,3
ZA,HEART RATE IRREGULAR,3
ZA,HYPOGLYCAEMIA,3
ZA,HYPOTENSION,3
ZA,LUNG DISORDER,3
ZA,PALLOR,3
ZA,PLATELET AGGREGATION,3
ZA,PNEUMONIA,3
ZA,VENTRICULAR TACHYCARDIA,3
ZA,ACUTE MYOCARDIAL INFARCTION,2
ZA,ANAEMIA,2
ZA,BLOOD GASES ABNORMAL,2
ZA,CENTRAL OBESITY,2
ZA,CONFUSIONAL STATE,2
ZA,CONTUSION,2
ZA,DEATH,2
ZA,DECUBITUS ULCER,2
ZA,DEHYDRATION,2
ZA,DIABETES MELLITUS,2
ZA,DRUG TOLERANCE DECREASED,2
ZA,ESSENTIAL HYPERTENSION,2
ZA,FALL,2
ZA,FEMUR FRACTURE,2
ZA,GASTROINTESTINAL HAEMORRHAGE,2
ZA,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
ZA,HYPERKALAEMIA,2
ZA,HYPERLIPIDAEMIA,2
ZA,HYPERTENSION,2
ZA,ISCHAEMIC STROKE,2
ZA,LOWER RESPIRATORY TRACT INFECTION,2
ZA,MYOCARDIAL INFARCTION,2
ZA,PERIPHERAL EMBOLISM,2
ZA,RENAL FAILURE,2
ZA,RENAL IMPAIRMENT,2
ZA,RENAL TUBULAR NECROSIS,2
ZA,VISUAL ACUITY REDUCED,2
ZA,ACUTE ABDOMEN,1
ZA,ACUTE CORONARY SYNDROME,1
ZA,ACUTE KIDNEY INJURY,1
ZA,ALTERED STATE OF CONSCIOUSNESS,1
ZA,ANGIOEDEMA,1
ZA,AORTIC STENOSIS,1
ZA,ARTERIOGRAM CORONARY,1
ZA,ATRIAL FIBRILLATION,1
ZA,ATRIOVENTRICULAR BLOCK COMPLETE,1
ZA,ATYPICAL PNEUMONIA,1
ZA,BACK PAIN,1
ZA,BLOOD CHOLESTEROL INCREASED,1
ZA,BLOOD FIBRINOGEN INCREASED,1
ZA,BRADYCARDIA,1
ZA,BRAIN NATRIURETIC PEPTIDE INCREASED,1
ZA,BRAIN STEM HAEMORRHAGE,1
ZA,BRONCHITIS,1
ZA,C-REACTIVE PROTEIN INCREASED,1
ZA,CARDIAC MURMUR,1
ZA,COLON CANCER,1
ZA,DECREASED APPETITE,1
ZA,DEVICE MISUSE,1
ZA,DIABETIC KETOACIDOSIS,1
ZA,DRUG INEFFECTIVE,1
ZA,DRUG-INDUCED LIVER INJURY,1
ZA,EMBOLISM,1
ZA,EXERCISE TOLERANCE DECREASED,1
ZA,FATIGUE,1
ZA,FEELING ABNORMAL,1
ZA,FIBRIN D DIMER INCREASED,1
ZA,GAIT DISTURBANCE,1
ZA,GASTROOESOPHAGEAL REFLUX DISEASE,1
ZA,GLUCOSE TOLERANCE IMPAIRED,1
ZA,GRANULOMATOSIS WITH POLYANGIITIS,1
ZA,HAEMATOCHEZIA,1
ZA,HEART RATE DECREASED,1
ZA,HIV INFECTION,1
ZA,HYPONATRAEMIA,1
ZA,HYPOVOLAEMIC SHOCK,1
ZA,INSOMNIA,1
ZA,ISCHAEMIC HEPATITIS,1
ZA,KIDNEY INFECTION,1
ZA,KOUNIS SYNDROME,1
ZA,LEUKOCYTOSIS,1
ZA,LOW DENSITY LIPOPROTEIN INCREASED,1
ZA,MELAENA,1
ZA,MUSCULAR WEAKNESS,1
ZA,MYOCARDIAL FIBROSIS,1
ZA,MYOCARDIAL ISCHAEMIA,1
ZA,MYOCARDIAL NECROSIS MARKER INCREASED,1
ZA,NAUSEA,1
ZA,NEOPLASM PROGRESSION,1
ZA,OESOPHAGITIS,1
ZA,ORTHOSTATIC HYPOTENSION,1
ZA,PAIN IN EXTREMITY,1
ZA,PANCREATITIS,1
ZA,PILOERECTION,1
ZA,PLEURAL EFFUSION,1
ZA,PLEURITIC PAIN,1
ZA,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
ZA,PNEUMOTHORAX,1
ZA,PO2 DECREASED,1
ZA,POSTPARTUM HAEMORRHAGE,1
ZA,PROCALCITONIN INCREASED,1
ZA,PULMONARY HAEMORRHAGE,1
ZA,PULMONARY THROMBOSIS,1
ZA,PULMONARY TUBERCULOSIS,1
ZA,PYREXIA,1
ZA,SEPTIC SHOCK,1
ZA,SKIN LESION,1
ZA,SNORING,1
ZA,SUBARACHNOID HAEMORRHAGE,1
ZA,SUBDURAL HAEMORRHAGE,1
ZA,TROPONIN T INCREASED,1
ZA,UPPER GASTROINTESTINAL HAEMORRHAGE,1
ZA,URINARY INCONTINENCE,1
ZA,URINARY TRACT INFECTION,1
ZA,URTICARIA,1
ES,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,18
ES,ACUTE KIDNEY INJURY,17
ES,ASTHMA,13
ES,EYE DISORDER,13
ES,NASAL DISORDER,13
ES,PYREXIA,12
ES,ANAEMIA,11
ES,ANAPHYLACTIC REACTION,11
ES,ANGIOEDEMA,11
ES,PNEUMONIA,11
ES,DYSPNOEA,10
ES,RHABDOMYOLYSIS,10
ES,ACUTE MYOCARDIAL INFARCTION,8
ES,ASTHENIA,8
ES,URTICARIA,8
ES,LACTIC ACIDOSIS,7
ES,PANCYTOPENIA,7
ES,CARDIAC FAILURE,6
ES,CEREBRAL HAEMORRHAGE,6
ES,DRUG INEFFECTIVE,6
ES,HAEMORRHAGE,6
ES,HAEMORRHAGE INTRACRANIAL,6
ES,HEPATOTOXICITY,6
ES,TOXICITY TO VARIOUS AGENTS,6
ES,ABDOMINAL PAIN,5
ES,ATRIAL FIBRILLATION,5
ES,ATRIOVENTRICULAR BLOCK COMPLETE,5
ES,DEATH,5
ES,DERMATITIS BULLOUS,5
ES,FEBRILE NEUTROPENIA,5
ES,HYPERTENSION,5
ES,HYPOTENSION,5
ES,OEDEMA PERIPHERAL,5
ES,VASCULAR STENT THROMBOSIS,5
ES,CHEST PAIN,4
ES,DIZZINESS,4
ES,ELECTROCARDIOGRAM QT PROLONGED,4
ES,EXPOSURE DURING PREGNANCY,4
ES,FATIGUE,4
ES,FOETAL EXPOSURE DURING PREGNANCY,4
ES,HAEMATURIA,4
ES,HEPATIC ENCEPHALOPATHY,4
ES,HEPATITIS,4
ES,HYPOGLYCAEMIA,4
ES,METABOLIC ACIDOSIS,4
ES,MUCOSAL INFLAMMATION,4
ES,NAUSEA,4
ES,PLATELET COUNT DECREASED,4
ES,PRODUCT USE IN UNAPPROVED INDICATION,4
ES,RENAL FAILURE,4
ES,RESPIRATORY FAILURE,4
ES,RESPIRATORY TRACT INFECTION,4
ES,THROMBOCYTOPENIA,4
ES,VOMITING,4
ES,ACUTE HEPATIC FAILURE,3
ES,ANGINA UNSTABLE,3
ES,BACK PAIN,3
ES,BRAIN ABSCESS,3
ES,CEREBROVASCULAR ACCIDENT,3
ES,CHEST DISCOMFORT,3
ES,DIARRHOEA,3
ES,DRUG ADMINISTRATION ERROR,3
ES,HYPERGLYCAEMIA,3
ES,HYPONATRAEMIA,3
ES,INTERSTITIAL LUNG DISEASE,3
ES,IRON DEFICIENCY ANAEMIA,3
ES,ISCHAEMIC STROKE,3
ES,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
ES,LISTERIOSIS,3
ES,MALAISE,3
ES,MATERNAL EXPOSURE DURING PREGNANCY,3
ES,MULTI-ORGAN FAILURE,3
ES,MYOCARDIAL INFARCTION,3
ES,PAIN IN EXTREMITY,3
ES,PREMATURE BABY,3
ES,PREMATURE DELIVERY,3
ES,PULMONARY ALVEOLAR HAEMORRHAGE,3
ES,PULMONARY HAEMORRHAGE,3
ES,RENAL FAILURE ACUTE,3
ES,SOMNOLENCE,3
ES,THROMBOSIS IN DEVICE,3
ES,TRANSIENT ISCHAEMIC ATTACK,3
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,3
ES,VENTRICULAR FIBRILLATION,3
ES,ACTIVITIES OF DAILY LIVING IMPAIRED,2
ES,ACUTE CORONARY SYNDROME,2
ES,ACUTE RESPIRATORY FAILURE,2
ES,APHASIA,2
ES,CARDIAC ARREST,2
ES,COUGH,2
ES,CYTOMEGALOVIRUS INFECTION,2
ES,DEHYDRATION,2
ES,DIABETES MELLITUS INADEQUATE CONTROL,2
ES,DISORIENTATION,2
ES,DRUG HYPERSENSITIVITY,2
ES,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
ES,EPISTAXIS,2
ES,FOETAL GROWTH RESTRICTION,2
ES,GASTRIC ULCER HAEMORRHAGE,2
ES,GASTROINTESTINAL HAEMORRHAGE,2
ES,GENERAL PHYSICAL HEALTH DETERIORATION,2
ES,HEADACHE,2
ES,HYPERKALAEMIA,2
ES,HYPERSENSITIVITY VASCULITIS,2
ES,HYPOTHYROIDISM,2
ES,INSOMNIA,2
ES,INTESTINAL HAEMORRHAGE,2
ES,JAUNDICE,2
ES,LOSS OF CONSCIOUSNESS,2
ES,MELAENA,2
ES,MUSCLE SPASMS,2
ES,MYOCLONUS,2
ES,NASOPHARYNGITIS,2
ES,NEUTROPENIA,2
ES,OEDEMA,2
ES,OVERDOSE,2
ES,PERIPHERAL ISCHAEMIA,2
ES,PORPHYRIA ACUTE,2
ES,PROTEINURIA,2
ES,PSYCHOMOTOR HYPERACTIVITY,2
ES,RASH,2
ES,RENAL IMPAIRMENT,2
ES,RESPIRATORY DISTRESS,2
ES,RIGHT VENTRICULAR FAILURE,2
ES,SEPTIC SHOCK,2
ES,SHOCK,2
ES,SKIN ULCER,2
ES,SYNCOPE,2
ES,TORSADE DE POINTES,2
ES,TRANSAMINASES INCREASED,2
ES,TREATMENT NONCOMPLIANCE,2
ES,URINARY TRACT DISCOMFORT,2
ES,WEIGHT DECREASED,2
ES,ABASIA,1
ES,ABNORMAL BEHAVIOUR,1
ES,ABSCESS OF SALIVARY GLAND,1
ES,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
ES,ACUTE LYMPHOCYTIC LEUKAEMIA,1
ES,ACUTE PRERENAL FAILURE,1
ES,ACUTE PSYCHOSIS,1
ES,ACUTE PULMONARY OEDEMA,1
ES,ADENOCARCINOMA GASTRIC,1
ES,ADVERSE EVENT,1
ES,AFFECT LABILITY,1
ES,AGITATION,1
ES,AGRANULOCYTOSIS,1
ES,ALANINE AMINOTRANSFERASE INCREASED,1
ES,AMPUTATION,1
ES,AMYLOID RELATED IMAGING ABNORMALITIES,1
ES,ANAPHYLACTIC SHOCK,1
ES,ANGIOPATHY,1
ES,ANURIA,1
ES,APLASTIC ANAEMIA,1
ES,ARTHRALGIA,1
ES,ASPARTATE AMINOTRANSFERASE INCREASED,1
ES,ASPHYXIA,1
ES,ASTERIXIS,1
ES,ATRIAL THROMBOSIS,1
ES,ATRIOVENTRICULAR BLOCK,1
ES,ATYPICAL FIBROXANTHOMA,1
ES,BALANCE DISORDER,1
ES,BEZOAR,1
ES,BILIARY COLIC,1
ES,BLINDNESS TRANSIENT,1
ES,BLINDNESS UNILATERAL,1
ES,BLISTER,1
ES,BLOOD ALKALINE PHOSPHATASE INCREASED,1
ES,BLOOD CREATININE INCREASED,1
ES,BLOOD PRESSURE DECREASED,1
ES,BLOOD URIC ACID INCREASED,1
ES,BODY TEMPERATURE INCREASED,1
ES,BRADYCARDIA,1
ES,BRONCHITIS,1
ES,BRONCHOSPASM,1
ES,CAESAREAN SECTION,1
ES,CARDIAC FAILURE CONGESTIVE,1
ES,CARDIAC FUNCTION TEST ABNORMAL,1
ES,CARDIAC PACEMAKER INSERTION,1
ES,CARDIO-RESPIRATORY ARREST,1
ES,CARDIOGENIC SHOCK,1
ES,CAROTID ARTERY OCCLUSION,1
ES,CATHETER SITE HAEMORRHAGE,1
ES,CELLULITIS,1
ES,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,1
ES,CEREBELLAR INFARCTION,1
ES,CEREBRAL AMYLOID ANGIOPATHY,1
ES,CEREBRAL DISORDER,1
ES,CEREBRAL ISCHAEMIA,1
ES,CHOLANGITIS,1
ES,CHOLECYSTITIS,1
ES,CHOLELITHIASIS,1
ES,CHOLURIA,1
ES,CHROMATURIA,1
ES,COLITIS,1
ES,COLITIS ISCHAEMIC,1
ES,COMPLICATIONS OF TRANSPLANTED HEART,1
ES,CONCOMITANT DISEASE AGGRAVATED,1
ES,CONCOMITANT DISEASE PROGRESSION,1
ES,CONDITION AGGRAVATED,1
ES,CONFUSIONAL STATE,1
ES,CONSTIPATION,1
ES,CONTINUOUS HAEMODIAFILTRATION,1
ES,CONTRAINDICATED PRODUCT ADMINISTERED,1
ES,CORONARY ARTERY DISEASE,1
ES,CUSHINGOID,1
ES,DECREASED APPETITE,1
ES,DEEP VEIN THROMBOSIS,1
ES,DENTAL NECROSIS,1
ES,DEPRESSION,1
ES,DERMATITIS EXFOLIATIVE GENERALISED,1
ES,DEVICE RELATED INFECTION,1
ES,DIABETES MELLITUS,1
ES,DIABETIC KETOACIDOSIS,1
ES,DIPLOPIA,1
ES,DISCOMFORT,1
ES,DISEASE PROGRESSION,1
ES,DISEASE RECURRENCE,1
ES,DIVERTICULUM,1
ES,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
ES,DRUG LEVEL INCREASED,1
ES,DRUG RESISTANCE,1
ES,DYSARTHRIA,1
ES,DYSPEPSIA,1
ES,DYSPNOEA EXERTIONAL,1
ES,DYSTHYMIC DISORDER,1
ES,ELECTROCARDIOGRAM QRS COMPLEX SHORTENED,1
ES,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
ES,EMBOLISM,1
ES,EPILEPSY,1
ES,ERYTHEMA,1
ES,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
ES,FOOD INTERACTION,1
ES,GAIT DISTURBANCE,1
ES,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
ES,GASTRIC HAEMORRHAGE,1
ES,GASTRIC PERFORATION,1
ES,GASTRIC POLYPS,1
ES,GASTRITIS,1
ES,GASTRODUODENAL HAEMORRHAGE,1
ES,GASTROENTERITIS,1
ES,GASTROINTESTINAL ANGIODYSPLASIA HAEMORRHAGIC,1
ES,GASTROINTESTINAL DISORDER,1
ES,GASTROINTESTINAL TOXICITY,1
ES,GASTROINTESTINAL TRACT ADENOMA,1
ES,GASTROINTESTINAL ULCER,1
ES,GENERALISED OEDEMA,1
ES,GENITAL CANDIDIASIS,1
ES,HAEMATEMESIS,1
ES,HAEMATOCHEZIA,1
ES,HAEMATOCRIT DECREASED,1
ES,HAEMATOMA,1
ES,HAEMATOTOXICITY,1
ES,HAEMODYNAMIC INSTABILITY,1
ES,HAEMOGLOBIN DECREASED,1
ES,HAEMOPHILUS INFECTION,1
ES,HAEMORRHAGIC ANAEMIA,1
ES,HAEMORRHAGIC EROSIVE GASTRITIS,1
ES,HAEMORRHAGIC INFARCTION,1
ES,HAEMORRHAGIC STROKE,1
ES,HAEMORRHOIDAL HAEMORRHAGE,1
ES,HAEMORRHOIDS,1
ES,HELLP SYNDROME,1
ES,HEMIPLEGIA,1
ES,HEPATIC ENZYME INCREASED,1
ES,HEPATIC FAILURE,1
ES,HEPATITIS CHOLESTATIC,1
ES,HERBAL INTERACTION,1
ES,HYPERHIDROSIS,1
ES,HYPERNATRAEMIA,1
ES,HYPERSENSITIVITY,1
ES,HYPERTHYROIDISM,1
ES,HYPOCALCAEMIA,1
ES,HYPOCOAGULABLE STATE,1
ES,HYPOKALAEMIA,1
ES,HYPOMAGNESAEMIA,1
ES,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
ES,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
ES,INCORRECT DRUG ADMINISTRATION RATE,1
ES,INDUCED LABOUR,1
ES,INFARCTION,1
ES,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
ES,INFLAMMATION,1
ES,INFLUENZA,1
ES,INTENTIONAL PRODUCT MISUSE,1
ES,INTESTINAL POLYP,1
ES,INTRACARDIAC THROMBUS,1
ES,IRIDOCYCLITIS,1
ES,KERATITIS,1
ES,KOEBNER PHENOMENON,1
ES,KOUNIS SYNDROME,1
ES,LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR,1
ES,LARGE INTESTINE POLYP,1
ES,LARYNGOSPASM,1
ES,LEFT VENTRICULAR HYPERTROPHY,1
ES,LEG AMPUTATION,1
ES,LEUKOPENIA,1
ES,LIVE BIRTH,1
ES,LOWER GASTROINTESTINAL HAEMORRHAGE,1
ES,LUDWIG ANGINA,1
ES,LUNG ADENOCARCINOMA,1
ES,LUNG INFILTRATION,1
ES,MATERNAL DRUGS AFFECTING FOETUS,1
ES,MEGACOLON,1
ES,MEMORY IMPAIRMENT,1
ES,METABOLIC ALKALOSIS,1
ES,MIGRAINE,1
ES,MITRAL VALVE INCOMPETENCE,1
ES,MOTOR DYSFUNCTION,1
ES,MUSCULAR WEAKNESS,1
ES,MUSCULOSKELETAL CHEST PAIN,1
ES,MYOCARDIAL ISCHAEMIA,1
ES,MYOCARDIAL RUPTURE,1
ES,MYOCARDITIS,1
ES,MYOPATHY,1
ES,NASAL CONGESTION,1
ES,NECROTISING FASCIITIS,1
ES,NEOPLASM,1
ES,NEPHROGENIC DIABETES INSIPIDUS,1
ES,NEPHROPATHY,1
ES,NEPHROPATHY TOXIC,1
ES,NEPHROTIC SYNDROME,1
ES,NERVOUS SYSTEM DISORDER,1
ES,NERVOUSNESS,1
ES,NEUROLEPTIC MALIGNANT SYNDROME,1
ES,NEUROLOGICAL SYMPTOM,1
ES,NEUTROPHIL COUNT DECREASED,1
ES,NODAL RHYTHM,1
ES,NORMAL NEWBORN,1
ES,NYSTAGMUS,1
ES,OPTIC DISC HAEMORRHAGE,1
ES,ORAL CANDIDIASIS,1
ES,OROPHARYNGEAL PAIN,1
ES,ORTHOPNOEA,1
ES,PAIN,1
ES,PANCREATITIS ACUTE,1
ES,PAPILLOPHLEBITIS,1
ES,PARAESTHESIA,1
ES,PARKINSON^S DISEASE,1
ES,PERFORMANCE STATUS DECREASED,1
ES,PERIODONTITIS,1
ES,PERITONITIS,1
ES,PNEUMONIA STAPHYLOCOCCAL,1
ES,PNEUMONIA STREPTOCOCCAL,1
ES,POISONING,1
ES,PORPHYRINS URINE INCREASED,1
ES,POST PROCEDURAL HAEMORRHAGE,1
ES,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
ES,POSTOPERATIVE WOUND COMPLICATION,1
ES,PRESYNCOPE,1
ES,PRIMARY HYPERALDOSTERONISM,1
ES,PROCTITIS,1
ES,PRURIGO,1
ES,PRURITUS,1
ES,PSEUDOPORPHYRIA,1
ES,PULMONARY ARTERIAL HYPERTENSION,1
ES,PULMONARY EMBOLISM,1
ES,PULSE ABSENT,1
ES,RASH PUSTULAR,1
ES,RECTAL HAEMORRHAGE,1
ES,RENAL FAILURE CHRONIC,1
ES,RENAL FUNCTION TEST ABNORMAL,1
ES,RENAL TUBULAR NECROSIS,1
ES,RENAL VESSEL DISORDER,1
ES,RESPIRATORY DISORDER,1
ES,RETINAL HAEMORRHAGE,1
ES,SHOCK HAEMORRHAGIC,1
ES,SINUS RHYTHM,1
ES,SKIN EXFOLIATION,1
ES,SPINAL CORD COMPRESSION,1
ES,SPINAL EPIDURAL HAEMATOMA,1
ES,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,1
ES,STAPHYLOCOCCAL BACTERAEMIA,1
ES,STEM CELL TRANSPLANT,1
ES,SUBENDOCARDIAL ISCHAEMIA,1
ES,SUBMANDIBULAR MASS,1
ES,SUFFOCATION FEELING,1
ES,SUPERINFECTION,1
ES,SWELLING,1
ES,TENDON RUPTURE,1
ES,THROMBOPHLEBITIS,1
ES,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
ES,TOOTHACHE,1
ES,TOXIC EPIDERMAL NECROLYSIS,1
ES,TOXOPLASMOSIS,1
ES,TRANSFUSION,1
ES,TREMOR,1
ES,TREPOPNOEA,1
ES,TUBULOINTERSTITIAL NEPHRITIS,1
ES,TUMOUR LYSIS SYNDROME,1
ES,TYPE I HYPERSENSITIVITY,1
ES,UPPER RESPIRATORY TRACT INFECTION,1
ES,URINARY TRACT INFECTION,1
ES,URINARY TRACT INFECTION ENTEROCOCCAL,1
ES,VASOPLEGIA SYNDROME,1
ES,VENTRICULAR ASYSTOLE,1
ES,VENTRICULAR FLUTTER,1
ES,VENTRICULAR TACHYCARDIA,1
ES,VERTIGO,1
ES,VIRAL DIARRHOEA,1
ES,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
ES,XERODERMA,1
LK,MYOPATHY,7
LK,ACUTE KIDNEY INJURY,1
LK,ACUTE MYOCARDIAL INFARCTION,1
LK,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
LK,CARDIAC ARREST,1
LK,CARDIO-RESPIRATORY ARREST,1
LK,CONTRAST MEDIA REACTION,1
LK,ECHOCARDIOGRAM ABNORMAL,1
LK,EJECTION FRACTION DECREASED,1
LK,HYPOKALAEMIA,1
LK,HYPONATRAEMIA,1
LK,HYPOREFLEXIA,1
LK,HYPOTENSION,1
LK,INFECTION,1
LK,LEFT VENTRICULAR FAILURE,1
LK,MEMORY IMPAIRMENT,1
LK,OEDEMA PERIPHERAL,1
LK,PALLOR,1
LK,RESPIRATORY FAILURE,1
LK,UPPER GASTROINTESTINAL HAEMORRHAGE,1
SR,PNEUMONIA,1
SE,NAUSEA,5
SE,ANGIOEDEMA,4
SE,ARRHYTHMIA,4
SE,PNEUMONIA,4
SE,DYSPNOEA,3
SE,GASTRITIS,3
SE,SYNCOPE,3
SE,VOMITING,3
SE,ABDOMINAL PAIN,2
SE,ACUTE KIDNEY INJURY,2
SE,ASCITES,2
SE,BLOOD BILIRUBIN INCREASED,2
SE,CONFUSIONAL STATE,2
SE,CONSTIPATION,2
SE,DEHYDRATION,2
SE,HAEMATURIA,2
SE,HEADACHE,2
SE,HEPATITIS TOXIC,2
SE,INFLUENZA,2
SE,INGUINAL HERNIA,2
SE,LIVER FUNCTION TEST ABNORMAL,2
SE,PORTAL VEIN THROMBOSIS,2
SE,PULMONARY EMBOLISM,2
SE,RENAL TUBULAR NECROSIS,2
SE,SWELLING FACE,2
SE,URINARY TRACT INFECTION,2
SE,ACCIDENTAL OVERDOSE,1
SE,ANAEMIA,1
SE,ARTHROPATHY,1
SE,BILIARY POLYP,1
SE,BLINDNESS,1
SE,BLOOD CREATININE INCREASED,1
SE,BLOOD POTASSIUM INCREASED,1
SE,BLOOD PRESSURE INCREASED,1
SE,BLOOD TEST ABNORMAL,1
SE,BLOOD URINE PRESENT,1
SE,BRADYCARDIA,1
SE,BREAST CANCER,1
SE,CARDIAC DISORDER,1
SE,CEREBRAL HAEMORRHAGE,1
SE,CHEST PAIN,1
SE,COLITIS MICROSCOPIC,1
SE,COUGH,1
SE,DEATH,1
SE,DEPRESSION,1
SE,DIZZINESS,1
SE,DRUG ADMINISTRATION ERROR,1
SE,DYSPHAGIA,1
SE,FALL,1
SE,FATIGUE,1
SE,FEBRILE NEUTROPENIA,1
SE,FEMORAL ARTERY OCCLUSION,1
SE,GASTROENTERITIS CRYPTOSPORIDIAL,1
SE,GASTROINTESTINAL DISORDER,1
SE,GASTROINTESTINAL MUCOSAL DISORDER,1
SE,HAEMATOMA,1
SE,HAEMORRHAGE,1
SE,HAEMORRHAGIC STROKE,1
SE,HALLUCINATION,1
SE,HEPATIC CIRRHOSIS,1
SE,HIP FRACTURE,1
SE,HYPERKALAEMIA,1
SE,HYPOKALAEMIA,1
SE,INFARCTION,1
SE,INFECTION SUSCEPTIBILITY INCREASED,1
SE,INJURY,1
SE,IRON DEFICIENCY ANAEMIA,1
SE,ISCHAEMIA,1
SE,JAUNDICE,1
SE,LIVER DISORDER,1
SE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
SE,MYALGIA,1
SE,NEPHRITIS,1
SE,NEPHROSCLEROSIS,1
SE,NEUTROPENIA,1
SE,OESOPHAGEAL STENOSIS,1
SE,PANCREATITIS,1
SE,PERIPHERAL SWELLING,1
SE,PLASMA CELL MYELOMA,1
SE,PORTAL HYPERTENSION,1
SE,PRODUCT USE ISSUE,1
SE,RENAL IMPAIRMENT,1
SE,RIGHT VENTRICULAR FAILURE,1
SE,SINUS NODE DYSFUNCTION,1
SE,STAPHYLOCOCCAL SEPSIS,1
SE,SUBARACHNOID HAEMORRHAGE,1
SE,SUDDEN CARDIAC DEATH,1
SE,THROMBOSIS IN DEVICE,1
SE,VASCULAR OPERATION,1
SE,VASCULAR PSEUDOANEURYSM,1
SE,WOUND,1
SE,YELLOW SKIN,1
CH,DYSPNOEA,18
CH,NAUSEA,17
CH,ANAEMIA,15
CH,TOXICITY TO VARIOUS AGENTS,14
CH,VOMITING,14
CH,CONFUSIONAL STATE,13
CH,FALL,13
CH,GASTROINTESTINAL HAEMORRHAGE,13
CH,RENAL FAILURE,13
CH,ACUTE KIDNEY INJURY,12
CH,ASTHENIA,10
CH,HAEMOGLOBIN DECREASED,10
CH,MELAENA,10
CH,DIARRHOEA,9
CH,DRUG PRESCRIBING ERROR,9
CH,HEPATIC ENZYME INCREASED,9
CH,HYPONATRAEMIA,9
CH,THROMBOCYTOPENIA,9
CH,ACUTE MYOCARDIAL INFARCTION,8
CH,C-REACTIVE PROTEIN INCREASED,8
CH,CONDITION AGGRAVATED,8
CH,DEHYDRATION,8
CH,DELIRIUM,8
CH,METABOLIC ACIDOSIS,8
CH,OVERDOSE,8
CH,RENAL FAILURE ACUTE,8
CH,SYNCOPE,8
CH,TREMOR,8
CH,AGITATION,7
CH,AGRANULOCYTOSIS,7
CH,ANGINA PECTORIS,7
CH,CARDIAC FAILURE,7
CH,DRUG-INDUCED LIVER INJURY,7
CH,HAEMORRHAGIC ANAEMIA,7
CH,HYPERTENSION,7
CH,MYALGIA,7
CH,PNEUMONIA,7
CH,CEREBRAL HAEMORRHAGE,6
CH,FOETAL EXPOSURE DURING PREGNANCY,6
CH,HAEMATURIA,6
CH,HAEMOLYSIS,6
CH,HAEMORRHAGE,6
CH,HEADACHE,6
CH,HYPOKALAEMIA,6
CH,HYPOTENSION,6
CH,JAUNDICE,6
CH,MYOCARDIAL INFARCTION,6
CH,PANCYTOPENIA,6
CH,PYREXIA,6
CH,UPPER GASTROINTESTINAL HAEMORRHAGE,6
CH,ABDOMINAL PAIN,5
CH,BLOOD BILIRUBIN INCREASED,5
CH,CHOLESTASIS,5
CH,COUGH,5
CH,DEATH,5
CH,DECREASED APPETITE,5
CH,DIZZINESS,5
CH,ELECTROCARDIOGRAM QT PROLONGED,5
CH,FEBRILE NEUTROPENIA,5
CH,GASTRIC ULCER,5
CH,GENERAL PHYSICAL HEALTH DETERIORATION,5
CH,HAEMORRHAGIC STROKE,5
CH,HYPERKALAEMIA,5
CH,LEUKOPENIA,5
CH,PARAESTHESIA,5
CH,RASH,5
CH,SHOCK,5
CH,THROMBOSIS,5
CH,WEIGHT DECREASED,5
CH,ANGIOEDEMA,4
CH,ATRIAL FIBRILLATION,4
CH,BLOOD ALKALINE PHOSPHATASE INCREASED,4
CH,BLOOD PRESSURE DECREASED,4
CH,BRONCHOPNEUMONIA,4
CH,CEREBROVASCULAR ACCIDENT,4
CH,CHEST PAIN,4
CH,CORONARY ARTERY RESTENOSIS,4
CH,DEPRESSION,4
CH,DRUG INEFFECTIVE,4
CH,DYSPHAGIA,4
CH,EJECTION FRACTION DECREASED,4
CH,EOSINOPHILIA,4
CH,EPILEPSY,4
CH,FATIGUE,4
CH,HAEMATEMESIS,4
CH,HAEMOPTYSIS,4
CH,HYPOCALCAEMIA,4
CH,HYPOGLYCAEMIA,4
CH,INTENTIONAL OVERDOSE,4
CH,INTERNATIONAL NORMALISED RATIO INCREASED,4
CH,LEUKOCYTOSIS,4
CH,LINEAR IGA DISEASE,4
CH,MYELODYSPLASTIC SYNDROME,4
CH,NEUTROPENIA,4
CH,NORMOCHROMIC NORMOCYTIC ANAEMIA,4
CH,POTENTIATING DRUG INTERACTION,4
CH,PRURITUS,4
CH,SOMNOLENCE,4
CH,SUBDURAL HAEMATOMA,4
CH,SUDDEN CARDIAC DEATH,4
CH,SUICIDE ATTEMPT,4
CH,TACHYCARDIA,4
CH,URINARY RETENTION,4
CH,ALANINE AMINOTRANSFERASE INCREASED,3
CH,APPLICATION SITE HAEMORRHAGE,3
CH,ARTHRALGIA,3
CH,ASPARTATE AMINOTRANSFERASE INCREASED,3
CH,BLISTER,3
CH,CARDIAC FAILURE CONGESTIVE,3
CH,CONSTIPATION,3
CH,DRUG ADMINISTRATION ERROR,3
CH,DYSKINESIA,3
CH,EPISTAXIS,3
CH,ERYTHEMA,3
CH,EXPOSURE DURING PREGNANCY,3
CH,EXTRAPYRAMIDAL DISORDER,3
CH,GASTRITIS,3
CH,GENITAL EROSION,3
CH,HAEMARTHROSIS,3
CH,HAEMATOCHEZIA,3
CH,HAEMATOMA,3
CH,HALLUCINATION_ AUDITORY,3
CH,HEAD INJURY,3
CH,HEPARIN-INDUCED THROMBOCYTOPENIA,3
CH,HEPATOCELLULAR INJURY,3
CH,HYPERGLYCAEMIA,3
CH,HYPERHIDROSIS,3
CH,HYPOTHYROIDISM,3
CH,HYPOTONIA,3
CH,INFLAMMATION,3
CH,INFLUENZA LIKE ILLNESS,3
CH,JAUNDICE CHOLESTATIC,3
CH,LOSS OF CONSCIOUSNESS,3
CH,MALAISE,3
CH,MATERNAL EXPOSURE DURING PREGNANCY,3
CH,METASTASES TO CENTRAL NERVOUS SYSTEM,3
CH,METASTASES TO LIVER,3
CH,MUCOSAL INFLAMMATION,3
CH,MUSCLE SPASMS,3
CH,NEUROPATHY PERIPHERAL,3
CH,PANCREATITIS,3
CH,PNEUMONIA ASPIRATION,3
CH,POLYNEUROPATHY,3
CH,PRESYNCOPE,3
CH,PULMONARY EMBOLISM,3
CH,PULMONARY OEDEMA,3
CH,RASH ERYTHEMATOUS,3
CH,RESPIRATORY DISTRESS,3
CH,RESPIRATORY FAILURE,3
CH,SEPSIS,3
CH,SKIN LESION,3
CH,SKIN ULCER,3
CH,STOMATITIS,3
CH,TRANSAMINASES INCREASED,3
CH,TRANSIENT ISCHAEMIC ATTACK,3
CH,TYPE I HYPERSENSITIVITY,3
CH,TYPE IV HYPERSENSITIVITY REACTION,3
CH,URINARY TRACT INFECTION,3
CH,ABASIA,2
CH,ABDOMINAL DISCOMFORT,2
CH,ABDOMINAL PAIN UPPER,2
CH,ABORTION INDUCED,2
CH,ACCIDENTAL EXPOSURE TO PRODUCT,2
CH,ALVEOLITIS ALLERGIC,2
CH,ANAPHYLACTIC SHOCK,2
CH,ANGINA UNSTABLE,2
CH,APRAXIA,2
CH,ARTERIAL INJURY,2
CH,ASCITES,2
CH,ASTHMA,2
CH,ATRIOVENTRICULAR BLOCK COMPLETE,2
CH,AUTOIMMUNE HEPATITIS,2
CH,BALANCE DISORDER,2
CH,BEZOAR,2
CH,BLADDER TAMPONADE,2
CH,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
CH,BLOOD CREATININE INCREASED,2
CH,BONE PAIN,2
CH,BRADYCARDIA,2
CH,BRAIN OEDEMA,2
CH,CARDIAC DISORDER,2
CH,CARDIAC TAMPONADE,2
CH,CARDIOGENIC SHOCK,2
CH,CARDIOVASCULAR DISORDER,2
CH,CHILLS,2
CH,CHRONIC KIDNEY DISEASE,2
CH,COGNITIVE DISORDER,2
CH,COLITIS,2
CH,COMA,2
CH,COMPLETED SUICIDE,2
CH,CORONARY ARTERY DISEASE,2
CH,CORONARY ARTERY STENOSIS,2
CH,CREATININE RENAL CLEARANCE DECREASED,2
CH,DEPRESSED MOOD,2
CH,DERMATITIS,2
CH,DEVICE OCCLUSION,2
CH,DIARRHOEA HAEMORRHAGIC,2
CH,DISEASE PROGRESSION,2
CH,DRUG RESISTANCE,2
CH,DUODENAL ULCER,2
CH,DYSPNOEA EXERTIONAL,2
CH,ENTERITIS,2
CH,ERYSIPELAS,2
CH,FOETAL GROWTH RESTRICTION,2
CH,GAIT DISTURBANCE,2
CH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
CH,GASTROENTERITIS,2
CH,GENERALISED TONIC-CLONIC SEIZURE,2
CH,GOUT,2
CH,HAEMODYNAMIC INSTABILITY,2
CH,HEPATIC STEATOSIS,2
CH,HEPATITIS CHOLESTATIC,2
CH,HERPES SIMPLEX,2
CH,HYPOKINESIA,2
CH,HYPOMAGNESAEMIA,2
CH,HYPOPARATHYROIDISM SECONDARY,2
CH,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,2
CH,IMMUNE THROMBOCYTOPENIC PURPURA,2
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
CH,INCORRECT DOSE ADMINISTERED,2
CH,INGUINAL HERNIA,2
CH,JOINT EFFUSION,2
CH,LACTIC ACIDOSIS,2
CH,LOWER GASTROINTESTINAL HAEMORRHAGE,2
CH,MALIGNANT NEOPLASM PROGRESSION,2
CH,MALNUTRITION,2
CH,MEDICATION ERROR,2
CH,METABOLIC ENCEPHALOPATHY,2
CH,METASTASES TO BONE,2
CH,METASTASES TO LUNG,2
CH,MOUTH ULCERATION,2
CH,MUSCLE ATROPHY,2
CH,MUSCLE RIGIDITY,2
CH,MUSCULOSKELETAL STIFFNESS,2
CH,MYDRIASIS,2
CH,MYOCARDIAL ISCHAEMIA,2
CH,OEDEMA,2
CH,ORTHOSTATIC HYPOTENSION,2
CH,OSTEONECROSIS,2
CH,PAIN,2
CH,PAIN IN EXTREMITY,2
CH,PANCREATITIS ACUTE,2
CH,PARKINSON^S DISEASE,2
CH,PEMPHIGOID,2
CH,PETECHIAE,2
CH,PNEUMOCOCCAL SEPSIS,2
CH,PRODUCT USE IN UNAPPROVED INDICATION,2
CH,PROSTATE CANCER,2
CH,PSYCHOMOTOR RETARDATION,2
CH,PSYCHOTIC SYMPTOM,2
CH,PURPURA,2
CH,RENAL IMPAIRMENT,2
CH,RESPIRATORY ALKALOSIS,2
CH,SEIZURE,2
CH,SEPTIC SHOCK,2
CH,SEROTONIN SYNDROME,2
CH,SHOCK HAEMORRHAGIC,2
CH,SINUS BRADYCARDIA,2
CH,SKIN EXFOLIATION,2
CH,SLOW SPEECH,2
CH,SPONTANEOUS HAEMATOMA,2
CH,SUBARACHNOID HAEMORRHAGE,2
CH,TONGUE OEDEMA,2
CH,TOXIC ENCEPHALOPATHY,2
CH,TOXIC EPIDERMAL NECROLYSIS,2
CH,TRAUMATIC HAEMATOMA,2
CH,VENTRICULAR TACHYCARDIA,2
CH,VERTIGO,2
CH,WEIGHT INCREASED,2
CH,WHITE BLOOD CELL COUNT INCREASED,2
CH,ABNORMAL BEHAVIOUR,1
CH,ABORTION SPONTANEOUS,1
CH,ABSCESS,1
CH,ACCIDENTAL OVERDOSE,1
CH,ACTINIC KERATOSIS,1
CH,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
CH,ACUTE CORONARY SYNDROME,1
CH,ACUTE HEPATIC FAILURE,1
CH,ACUTE MYELOID LEUKAEMIA,1
CH,ACUTE PRERENAL FAILURE,1
CH,ACUTE PULMONARY OEDEMA,1
CH,ACUTE RESPIRATORY FAILURE,1
CH,ADVERSE DRUG REACTION,1
CH,AFFECT LABILITY,1
CH,AGEUSIA,1
CH,AGGRESSION,1
CH,AGITATION POSTOPERATIVE,1
CH,AKINESIA,1
CH,ALBUMINURIA,1
CH,ALCOHOL ABUSE,1
CH,ALOPECIA,1
CH,ALTERED STATE OF CONSCIOUSNESS,1
CH,ANAEMIA POSTOPERATIVE,1
CH,ANAESTHETIC COMPLICATION NEUROLOGICAL,1
CH,ANEURYSM,1
CH,ANION GAP DECREASED,1
CH,ANTICOAGULATION DRUG LEVEL INCREASED,1
CH,ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC,1
CH,ANTIDEPRESSANT DRUG LEVEL INCREASED,1
CH,ANTIPHOSPHOLIPID ANTIBODIES POSITIVE,1
CH,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
CH,ANURIA,1
CH,ANXIETY,1
CH,AORTIC STENOSIS,1
CH,AORTIC VALVE SCLEROSIS,1
CH,APHASIA,1
CH,APHTHOUS ULCER,1
CH,APNOEA,1
CH,ARRHYTHMIA,1
CH,ARTERIOSCLEROSIS,1
CH,ASTHMATIC CRISIS,1
CH,ATRIOVENTRICULAR BLOCK,1
CH,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
CH,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
CH,ATYPICAL PNEUMONIA,1
CH,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
CH,BALANOPOSTHITIS,1
CH,BASAL CELL CARCINOMA,1
CH,BICYTOPENIA,1
CH,BLADDER CANCER,1
CH,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,1
CH,BLOOD CHLORIDE INCREASED,1
CH,BLOOD CREATINE PHOSPHOKINASE,1
CH,BLOOD LACTIC ACID INCREASED,1
CH,BLOOD PH DECREASED,1
CH,BLOOD PHOSPHORUS DECREASED,1
CH,BLOOD PRESSURE INCREASED,1
CH,BLOOD SODIUM INCREASED,1
CH,BONE CONTUSION,1
CH,BONE MARROW FAILURE,1
CH,BONE MARROW INFILTRATION,1
CH,BRADYPNOEA,1
CH,BRAIN STEM INFARCTION,1
CH,BRONCHOSCOPY ABNORMAL,1
CH,BURSITIS,1
CH,CACHEXIA,1
CH,CAESAREAN SECTION,1
CH,CANDIDA INFECTION,1
CH,CARDIAC ANEURYSM,1
CH,CARDIAC ARREST,1
CH,CARDIAC VALVE REPLACEMENT COMPLICATION,1
CH,CARDIAC VENTRICULAR THROMBOSIS,1
CH,CARDIOMYOPATHY,1
CH,CARDIOVASCULAR INSUFFICIENCY,1
CH,CELLULITIS,1
CH,CELLULITIS PHARYNGEAL,1
CH,CENTRAL NERVOUS SYSTEM LESION,1
CH,CEREBELLAR HAEMORRHAGE,1
CH,CEREBRAL HAEMATOMA,1
CH,CEREBROVASCULAR DISORDER,1
CH,CERVICAL CORD COMPRESSION,1
CH,CHEST DISCOMFORT,1
CH,CHOLECYSTITIS,1
CH,CHOLELITHIASIS,1
CH,CHOLESTATIC LIVER INJURY,1
CH,CHONDROSARCOMA METASTATIC,1
CH,CHOREOATHETOSIS,1
CH,CIRCULATORY COLLAPSE,1
CH,CLOSTRIDIUM COLITIS,1
CH,CLOSTRIDIUM DIFFICILE COLITIS,1
CH,COLITIS ISCHAEMIC,1
CH,COLITIS ULCERATIVE,1
CH,COMPLEMENT FACTOR C3 DECREASED,1
CH,CONCUSSION,1
CH,CONGENITAL FOOT MALFORMATION,1
CH,CONGENITAL HAND MALFORMATION,1
CH,CONGENITAL INGUINAL HERNIA,1
CH,CONGESTIVE CARDIOMYOPATHY,1
CH,CONTRAINDICATED DRUG ADMINISTERED,1
CH,CONTRAINDICATED PRODUCT ADMINISTERED,1
CH,CONTUSION,1
CH,CONVULSION,1
CH,CORONARY ARTERY DISSECTION,1
CH,CORONARY ARTERY THROMBOSIS,1
CH,CRANIOCEREBRAL INJURY,1
CH,CSF GLUCOSE INCREASED,1
CH,CUTANEOUS VASCULITIS,1
CH,CYTOMEGALOVIRUS GASTROENTERITIS,1
CH,CYTOMEGALOVIRUS VIRAEMIA,1
CH,DELUSION,1
CH,DEMENTIA,1
CH,DEVICE ISSUE,1
CH,DEVICE RELATED INFECTION,1
CH,DIABETIC KETOACIDOSIS,1
CH,DILATATION ATRIAL,1
CH,DISINHIBITION,1
CH,DISORIENTATION,1
CH,DISSEMINATED INTRAVASCULAR COAGULATION,1
CH,DISTURBANCE IN ATTENTION,1
CH,DRUG ABUSE,1
CH,DRUG CLEARANCE DECREASED,1
CH,DRUG HYPERSENSITIVITY,1
CH,DRUG INTOLERANCE,1
CH,DRUG LEVEL INCREASED,1
CH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
CH,DRY SKIN,1
CH,DUODENAL ULCER HAEMORRHAGE,1
CH,DYSARTHRIA,1
CH,DYSLIPIDAEMIA,1
CH,DYSPNOEA AT REST,1
CH,EATING DISORDER,1
CH,ECZEMA,1
CH,ECZEMA EYELIDS,1
CH,EJECTION FRACTION ABNORMAL,1
CH,ELECTROCARDIOGRAM ABNORMAL,1
CH,ELECTROLYTE IMBALANCE,1
CH,EMBOLISM,1
CH,ENCEPHALITIS,1
CH,EOSINOPHILIC PNEUMONIA,1
CH,EROSIVE OESOPHAGITIS,1
CH,ERYTHEMA MULTIFORME,1
CH,ERYTHROMELALGIA,1
CH,ESCHERICHIA BACTERAEMIA,1
CH,EXTRADURAL HAEMATOMA,1
CH,EYE INFECTION INTRAOCULAR,1
CH,FAT EMBOLISM,1
CH,FEBRILE INFECTION,1
CH,FEELING HOT,1
CH,FEMORAL ARTERY OCCLUSION,1
CH,FEMORAL NECK FRACTURE,1
CH,FEMUR FRACTURE,1
CH,FLANK PAIN,1
CH,FOAMING AT MOUTH,1
CH,FOLLICULITIS,1
CH,FREEZING PHENOMENON,1
CH,GALLBLADDER DISORDER,1
CH,GASTRIC HAEMORRHAGE,1
CH,GASTROINTESTINAL DISORDER,1
CH,GASTROINTESTINAL NECROSIS,1
CH,GASTROOESOPHAGEAL REFLUX DISEASE,1
CH,GENERALISED OEDEMA,1
CH,GINGIVAL BLEEDING,1
CH,GLAUCOMA,1
CH,GLOMERULAR FILTRATION RATE DECREASED,1
CH,GLOMERULONEPHRITIS MEMBRANOUS,1
CH,GRIEF REACTION,1
CH,GROIN PAIN,1
CH,HAEMATOCRIT DECREASED,1
CH,HAEMATOLOGY TEST ABNORMAL,1
CH,HAEMATOMA INFECTION,1
CH,HAEMORRHAGIC CYST,1
CH,HAEMORRHAGIC EROSIVE GASTRITIS,1
CH,HALLUCINATION,1
CH,HENOCH-SCHONLEIN PURPURA,1
CH,HEPATIC CANCER,1
CH,HEPATIC CIRRHOSIS,1
CH,HEPATIC INFILTRATION EOSINOPHILIC,1
CH,HEPATIC LESION,1
CH,HEPATITIS C,1
CH,HEPATITIS FULMINANT,1
CH,HEPATOCELLULAR CARCINOMA,1
CH,HEPATOMEGALY,1
CH,HIRSUTISM,1
CH,HYPERINTENSITY IN BRAIN DEEP NUCLEI,1
CH,HYPERPHOSPHATAEMIA,1
CH,HYPERSENSITIVITY,1
CH,HYPERTENSIVE CRISIS,1
CH,HYPERTHERMIA,1
CH,HYPOCHROMIC ANAEMIA,1
CH,HYPOPYON,1
CH,HYPORESPONSIVE TO STIMULI,1
CH,HYPOVOLAEMIA,1
CH,HYPOVOLAEMIC SHOCK,1
CH,IDIOPATHIC PULMONARY FIBROSIS,1
CH,ILEUS,1
CH,IMMOBILE,1
CH,IMMUNOSUPPRESSION,1
CH,IMPAIRED HEALING,1
CH,INFLUENZA,1
CH,INJECTION SITE ABSCESS,1
CH,INJECTION SITE PUSTULE,1
CH,INJECTION SITE RASH,1
CH,INJECTION SITE VESICLES,1
CH,INJURY,1
CH,INTENTIONAL PRODUCT MISUSE,1
CH,INTESTINAL INFARCTION,1
CH,INTESTINAL OBSTRUCTION,1
CH,INTRACRANIAL PRESSURE INCREASED,1
CH,INTRAOCULAR PRESSURE INCREASED,1
CH,IRON DEFICIENCY,1
CH,ISCHAEMIA,1
CH,ISCHAEMIC STROKE,1
CH,JOINT SWELLING,1
CH,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
CH,LABORATORY TEST ABNORMAL,1
CH,LABORATORY TEST INTERFERENCE,1
CH,LACERATION,1
CH,LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED,1
CH,LEISHMANIASIS,1
CH,LICHENOID KERATOSIS,1
CH,LIGAMENT INJURY,1
CH,LIP EROSION,1
CH,LIP HAEMORRHAGE,1
CH,LIPASE INCREASED,1
CH,LIVER DISORDER,1
CH,LIVER FUNCTION TEST INCREASED,1
CH,LIVER INJURY,1
CH,LOCALISED INFECTION,1
CH,LOCALISED OEDEMA,1
CH,LOW DENSITY LIPOPROTEIN INCREASED,1
CH,LUNG ADENOCARCINOMA,1
CH,LUNG ADENOCARCINOMA STAGE IV,1
CH,LUNG CANCER METASTATIC,1
CH,LUNG CONSOLIDATION,1
CH,LUNG INFECTION,1
CH,LUNG INFILTRATION,1
CH,LUNG SQUAMOUS CELL CARCINOMA METASTATIC,1
CH,LYMPHADENOPATHY,1
CH,LYMPHANGIOSIS CARCINOMATOSA,1
CH,LYMPHOCYTE COUNT DECREASED,1
CH,MANIA,1
CH,MEDICATION OVERUSE HEADACHE,1
CH,MENINGEAL DISORDER,1
CH,MENINGITIS ASEPTIC,1
CH,MENTAL DISORDER,1
CH,METASTASES TO ADRENALS,1
CH,METASTASES TO KIDNEY,1
CH,METASTASES TO PLEURA,1
CH,METHAEMOGLOBINAEMIA,1
CH,MICROANGIOPATHY,1
CH,MITRAL VALVE INCOMPETENCE,1
CH,MOUTH HAEMORRHAGE,1
CH,MUCOCUTANEOUS ULCERATION,1
CH,MUCOSAL HAEMORRHAGE,1
CH,MUCOSAL TOXICITY,1
CH,MULTI-ORGAN FAILURE,1
CH,MUSCLE CONTRACTIONS INVOLUNTARY,1
CH,MYOPATHY,1
CH,NECROSIS,1
CH,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
CH,NEPHROPATHY TOXIC,1
CH,NERVE COMPRESSION,1
CH,NEURALGIC AMYOTROPHY,1
CH,NEUROLOGICAL SYMPTOM,1
CH,NEUTROPHILIC DERMATOSIS,1
CH,NO THERAPEUTIC RESPONSE,1
CH,ODYNOPHAGIA,1
CH,OEDEMA PERIPHERAL,1
CH,ON AND OFF PHENOMENON,1
CH,OROPHARYNGEAL PAIN,1
CH,PANIC ATTACK,1
CH,PAPILLOEDEMA,1
CH,PARKINSONIAN CRISIS,1
CH,PATHOLOGICAL FRACTURE,1
CH,PCO2 INCREASED,1
CH,PEMPHIGUS,1
CH,PERICARDIAL EFFUSION,1
CH,PERICARDIAL HAEMORRHAGE,1
CH,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CH,PERIPHERAL ARTERY THROMBOSIS,1
CH,PERIPHERAL ISCHAEMIA,1
CH,PERIPHERAL VASCULAR DISORDER,1
CH,PERITONSILLAR ABSCESS,1
CH,PERSECUTORY DELUSION,1
CH,PHARYNGITIS BACTERIAL,1
CH,PLACENTAL INSUFFICIENCY,1
CH,PLASMACYTOMA,1
CH,PLATELET FUNCTION TEST ABNORMAL,1
CH,PLEURAL EFFUSION,1
CH,PNEUMATOSIS INTESTINALIS,1
CH,PNEUMONIA BACTERIAL,1
CH,PNEUMONIA ESCHERICHIA,1
CH,PNEUMONIA INFLUENZAL,1
CH,PNEUMONIA LEGIONELLA,1
CH,PNEUMONIA PNEUMOCOCCAL,1
CH,PNEUMONITIS,1
CH,PNEUMONITIS CHEMICAL,1
CH,POISONING,1
CH,POST PROCEDURAL HAEMORRHAGE,1
CH,POST TRANSPLANT DISTAL LIMB SYNDROME,1
CH,PRE-EXISTING CONDITION IMPROVED,1
CH,PREGNANCY ON CONTRACEPTIVE,1
CH,PREMATURE BABY,1
CH,PREMATURE DELIVERY,1
CH,PRINZMETAL ANGINA,1
CH,PRODUCT USE ISSUE,1
CH,PRURIGO,1
CH,PSORIASIS,1
CH,PSYCHOMOTOR HYPERACTIVITY,1
CH,PULMONARY ARTERIAL HYPERTENSION,1
CH,PULMONARY CONGESTION,1
CH,PULMONARY HYPERTENSION,1
CH,PULMONARY SEPSIS,1
CH,PULMONARY VASCULAR DISORDER,1
CH,PYOGENIC GRANULOMA,1
CH,QUADRIPLEGIA,1
CH,RASH GENERALISED,1
CH,RASH MACULAR,1
CH,RASH PRURITIC,1
CH,RASH PUSTULAR,1
CH,REACTIVE PERFORATING COLLAGENOSIS,1
CH,RED BLOOD CELL COUNT DECREASED,1
CH,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
CH,RENAL TUBULAR DISORDER,1
CH,RENAL TUBULAR NECROSIS,1
CH,RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE,1
CH,RESTLESSNESS,1
CH,RETROPERITONEAL HAEMATOMA,1
CH,RETROPERITONEAL HAEMORRHAGE,1
CH,RHABDOMYOLYSIS,1
CH,RHINITIS,1
CH,RICHTER^S SYNDROME,1
CH,ROAD TRAFFIC ACCIDENT,1
CH,SCAB,1
CH,SECOND PRIMARY MALIGNANCY,1
CH,SEDATION,1
CH,SKIN INFECTION,1
CH,SKIN NECROSIS,1
CH,SKIN TEST POSITIVE,1
CH,SKIN TOXICITY,1
CH,SOFT TISSUE INFECTION,1
CH,SOPOR,1
CH,SPINAL FRACTURE,1
CH,SQUAMOUS CELL CARCINOMA,1
CH,SQUAMOUS CELL CARCINOMA OF LUNG,1
CH,SQUAMOUS CELL CARCINOMA OF SKIN,1
CH,STAPHYLOCOCCAL BACTERAEMIA,1
CH,STAPHYLOCOCCAL INFECTION,1
CH,STAPHYLOCOCCAL SEPSIS,1
CH,STATUS EPILEPTICUS,1
CH,STOMA SITE DISCHARGE,1
CH,STOMA SITE HYPERGRANULATION,1
CH,STREPTOCOCCAL INFECTION,1
CH,STRESS,1
CH,STRIDOR,1
CH,SUBARACHNOID HAEMATOMA,1
CH,SUBCORNEAL PUSTULAR DERMATOSIS,1
CH,SUDDEN DEATH,1
CH,SUICIDAL IDEATION,1
CH,SUPRAVENTRICULAR TACHYCARDIA,1
CH,SYNDACTYLY,1
CH,T-CELL LYMPHOMA,1
CH,TACHYPNOEA,1
CH,TENDON INJURY,1
CH,TENDON RUPTURE,1
CH,TENDONITIS,1
CH,TENSION,1
CH,TESTICULAR PAIN,1
CH,TETANY,1
CH,THERAPEUTIC RESPONSE INCREASED,1
CH,THERAPEUTIC RESPONSE UNEXPECTED,1
CH,THERAPY NON-RESPONDER,1
CH,THERMAL BURN,1
CH,THINKING ABNORMAL,1
CH,THROMBOPHLEBITIS SEPTIC,1
CH,THROMBOSIS IN DEVICE,1
CH,TINNITUS,1
CH,TOTAL LUNG CAPACITY DECREASED,1
CH,TRACHEOBRONCHITIS,1
CH,TRANSPLANT REJECTION,1
CH,TREATMENT FAILURE,1
CH,TREATMENT NONCOMPLIANCE,1
CH,TUBULOINTERSTITIAL NEPHRITIS,1
CH,TUMOUR EMBOLISM,1
CH,UNDERDOSE,1
CH,UNRESPONSIVE TO STIMULI,1
CH,VASCULITIC RASH,1
CH,VASCULITIS,1
CH,VENOUS THROMBOSIS,1
CH,VENTRICULAR FIBRILLATION,1
CH,VENTRICULAR HYPOKINESIA,1
CH,VERTEBRAL ARTERY OCCLUSION,1
CH,VIRAL MUTATION IDENTIFIED,1
CH,VISUAL IMPAIRMENT,1
CH,VITREOUS DISORDER,1
CH,VITREOUS FLOATERS,1
CH,VITRITIS,1
CH,WALKING DISTANCE TEST ABNORMAL,1
CH,WITHDRAWAL SYNDROME,1
CH,WOUND,1
SY,THROMBOSIS IN DEVICE,1
TW,CORONARY ARTERY DILATATION,15
TW,DYSPNOEA,13
TW,PYREXIA,13
TW,CEREBRAL INFARCTION,11
TW,CARDIAC FAILURE CONGESTIVE,9
TW,PNEUMONIA,8
TW,RENAL FAILURE ACUTE,8
TW,ACUTE KIDNEY INJURY,7
TW,CORONARY ARTERY DISEASE,7
TW,DIZZINESS,7
TW,SEPSIS,7
TW,ACUTE MYOCARDIAL INFARCTION,6
TW,EOSINOPHILIA,6
TW,CELLULITIS,5
TW,CHEST DISCOMFORT,5
TW,DEATH,5
TW,DRUG LEVEL INCREASED,5
TW,HYPOTENSION,5
TW,ISCHAEMIC STROKE,5
TW,ANAEMIA,4
TW,ATRIAL FIBRILLATION,4
TW,CHEST PAIN,4
TW,COUGH,4
TW,DECREASED APPETITE,4
TW,FALL,4
TW,GASTROINTESTINAL HAEMORRHAGE,4
TW,HAEMORRHAGIC TRANSFORMATION STROKE,4
TW,LEUKOPENIA,4
TW,MELAENA,4
TW,MUSCULAR WEAKNESS,4
TW,PERICARDIAL EFFUSION,4
TW,RHABDOMYOLYSIS,4
TW,URINARY TRACT INFECTION,4
TW,WHITE BLOOD CELL COUNT DECREASED,4
TW,ABDOMINAL PAIN,3
TW,ACUTE PULMONARY OEDEMA,3
TW,ARTERIOSCLEROSIS CORONARY ARTERY,3
TW,ASCITES,3
TW,BRUCELLOSIS,3
TW,CARDIAC ARREST,3
TW,CARDIAC FAILURE,3
TW,CARDIOGENIC SHOCK,3
TW,CARDIOMEGALY,3
TW,CEREBRAL HAEMORRHAGE,3
TW,CONDITION AGGRAVATED,3
TW,CONTUSION,3
TW,DRUG HYPERSENSITIVITY,3
TW,DYSPHAGIA,3
TW,DYSPNOEA EXERTIONAL,3
TW,FUNGAL INFECTION,3
TW,GENERAL PHYSICAL HEALTH DETERIORATION,3
TW,HAEMOGLOBIN DECREASED,3
TW,HYPERHIDROSIS,3
TW,LIVER DISORDER,3
TW,LOSS OF CONSCIOUSNESS,3
TW,MALAISE,3
TW,NEUTROPENIA,3
TW,PAIN,3
TW,PAIN IN EXTREMITY,3
TW,PALPITATIONS,3
TW,PANCREATITIS ACUTE,3
TW,PANCYTOPENIA,3
TW,PLEURAL EFFUSION,3
TW,SPLENOMEGALY,3
TW,THROMBOCYTOPENIA,3
TW,VASCULAR CALCIFICATION,3
TW,ABDOMINAL DISCOMFORT,2
TW,ABDOMINAL PAIN UPPER,2
TW,ACUTE RESPIRATORY DISTRESS SYNDROME,2
TW,ALANINE AMINOTRANSFERASE INCREASED,2
TW,ALTERED STATE OF CONSCIOUSNESS,2
TW,ANGINA PECTORIS,2
TW,ANGINA UNSTABLE,2
TW,ANGIOEDEMA,2
TW,ARTERIAL RESTENOSIS,2
TW,ASPARTATE AMINOTRANSFERASE INCREASED,2
TW,ASTHENIA,2
TW,BLOOD ALBUMIN DECREASED,2
TW,BLOOD CREATININE INCREASED,2
TW,BRADYCARDIA,2
TW,BRAIN OEDEMA,2
TW,C-REACTIVE PROTEIN INCREASED,2
TW,CANDIDA INFECTION,2
TW,CHROMATURIA,2
TW,CHRONIC KIDNEY DISEASE,2
TW,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
TW,CORONARY ARTERY STENOSIS,2
TW,CYTOMEGALOVIRUS INFECTION,2
TW,DEPRESSED LEVEL OF CONSCIOUSNESS,2
TW,DIARRHOEA,2
TW,DRUG RESISTANCE,2
TW,DUODENAL ULCER HAEMORRHAGE,2
TW,DYSARTHRIA,2
TW,DYSURIA,2
TW,FATIGUE,2
TW,FEMORAL NECK FRACTURE,2
TW,FOLLICULITIS,2
TW,FUNGAEMIA,2
TW,HAEMATOMA,2
TW,HAEMORRHAGIC ANAEMIA,2
TW,HYPERCHOLESTEROLAEMIA,2
TW,HYPERGLYCAEMIA,2
TW,HYPERLIPIDAEMIA,2
TW,HYPERTENSION,2
TW,HYPOGLYCAEMIA,2
TW,HYPOVOLAEMIC SHOCK,2
TW,INFECTION,2
TW,INSOMNIA,2
TW,INTERNAL HAEMORRHAGE,2
TW,LIVER FUNCTION TEST ABNORMAL,2
TW,LUNG INFILTRATION,2
TW,LYMPHADENOPATHY,2
TW,MYOCARDIAL INFARCTION,2
TW,NAUSEA,2
TW,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
TW,PRURITUS,2
TW,PULMONARY HAEMORRHAGE,2
TW,QUADRIPARESIS,2
TW,RASH,2
TW,RENAL CYST,2
TW,RENAL FAILURE CHRONIC,2
TW,RHINORRHOEA,2
TW,SEPTIC SHOCK,2
TW,STAPHYLOCOCCAL BACTERAEMIA,2
TW,SUBARACHNOID HAEMORRHAGE,2
TW,SUBDURAL HAEMATOMA,2
TW,TACHYCARDIA,2
TW,TOXICITY TO VARIOUS AGENTS,2
TW,UROSEPSIS,2
TW,VASCULAR STENT THROMBOSIS,2
TW,ABDOMINAL DISTENSION,1
TW,ABDOMINAL WALL MASS,1
TW,ACUTE RESPIRATORY FAILURE,1
TW,AMYLASE INCREASED,1
TW,AMYOTROPHIC LATERAL SCLEROSIS,1
TW,ANAL FISTULA,1
TW,ANGIOPLASTY,1
TW,ANKYLOSING SPONDYLITIS,1
TW,AORTIC ANEURYSM,1
TW,AORTIC CALCIFICATION,1
TW,AORTIC DISORDER,1
TW,AORTIC DISSECTION,1
TW,AORTIC THROMBOSIS,1
TW,AORTIC VALVE INCOMPETENCE,1
TW,AORTIC VALVE STENOSIS,1
TW,AORTITIS,1
TW,APHTHOUS STOMATITIS,1
TW,ARRHYTHMIA,1
TW,ARTERIAL OCCLUSIVE DISEASE,1
TW,ARTHRITIS,1
TW,ASTHMA,1
TW,BACILLUS TEST POSITIVE,1
TW,BACTERIAL TEST POSITIVE,1
TW,BILE DUCT STONE,1
TW,BLISTER,1
TW,BLOOD ALKALINE PHOSPHATASE INCREASED,1
TW,BLOOD BILIRUBIN INCREASED,1
TW,BLOOD CALCIUM DECREASED,1
TW,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
TW,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
TW,BLOOD LACTIC ACID INCREASED,1
TW,BLOOD UREA INCREASED,1
TW,BOWEN^S DISEASE,1
TW,BRONCHOSPASM,1
TW,CALCULUS BLADDER,1
TW,CARDIAC AMYLOIDOSIS,1
TW,CARDIAC FAILURE ACUTE,1
TW,CARDIAC TAMPONADE,1
TW,CARDIORENAL SYNDROME,1
TW,CARDIOVASCULAR DISORDER,1
TW,CATHETERISATION CARDIAC,1
TW,CEREBRAL THROMBOSIS,1
TW,CEREBROVASCULAR ACCIDENT,1
TW,CHEMICAL PERITONITIS,1
TW,CHILLS,1
TW,CHOLECYSTITIS,1
TW,CHOLELITHIASIS,1
TW,COLD SWEAT,1
TW,COMA HEPATIC,1
TW,COMPARTMENT SYNDROME,1
TW,CONJUNCTIVAL DISCOLOURATION,1
TW,CONJUNCTIVAL HAEMORRHAGE,1
TW,CONJUNCTIVAL PALLOR,1
TW,CYP2C19 POLYMORPHISM,1
TW,DEAFNESS BILATERAL,1
TW,DEGENERATIVE AORTIC VALVE DISEASE,1
TW,DERMATITIS,1
TW,DEVICE DISLOCATION,1
TW,DIABETES MELLITUS INADEQUATE CONTROL,1
TW,DIASTOLIC DYSFUNCTION,1
TW,DISEASE PROGRESSION,1
TW,DISSEMINATED TUBERCULOSIS,1
TW,DIVERTICULAR PERFORATION,1
TW,DIZZINESS POSTURAL,1
TW,DRUG CLEARANCE DECREASED,1
TW,DRUG INEFFECTIVE,1
TW,DRUG WITHDRAWAL SYNDROME,1
TW,DRY GANGRENE,1
TW,DRY MOUTH,1
TW,DYSPEPSIA,1
TW,EMBOLIC STROKE,1
TW,END STAGE RENAL DISEASE,1
TW,ENDOCARDITIS,1
TW,EPIDERMAL NECROSIS,1
TW,EXOSTOSIS,1
TW,FAECES DISCOLOURED,1
TW,FEBRILE NEUTROPENIA,1
TW,FINGER AMPUTATION,1
TW,FLUID OVERLOAD,1
TW,FOOT FRACTURE,1
TW,FULL BLOOD COUNT ABNORMAL,1
TW,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
TW,GASTRIC MUCOSAL LESION,1
TW,GASTRIC ULCER,1
TW,GASTRIC ULCER HAEMORRHAGE,1
TW,GASTROOESOPHAGEAL REFLUX DISEASE,1
TW,GENERALISED OEDEMA,1
TW,GINGIVAL BLEEDING,1
TW,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
TW,HAEMATOCRIT DECREASED,1
TW,HAEMATURIA,1
TW,HAEMODYNAMIC INSTABILITY,1
TW,HAEMORRHAGE INTRACRANIAL,1
TW,HAEMORRHOIDS,1
TW,HEADACHE,1
TW,HEART INJURY,1
TW,HEART RATE IRREGULAR,1
TW,HELICOBACTER INFECTION,1
TW,HEMIPARESIS,1
TW,HEPATIC CIRRHOSIS,1
TW,HEPATIC HAEMORRHAGE,1
TW,HEPATIC NEOPLASM,1
TW,HEPATIC STEATOSIS,1
TW,HEPATITIS,1
TW,HEPATITIS FULMINANT,1
TW,HEPATOCELLULAR CARCINOMA,1
TW,HERPES VIRUS INFECTION,1
TW,HERPES ZOSTER,1
TW,HYDROCEPHALUS,1
TW,HYPEREOSINOPHILIC SYNDROME,1
TW,HYPERSENSITIVITY,1
TW,HYPERTENSIVE HEART DISEASE,1
TW,HYPOAESTHESIA,1
TW,HYPOALBUMINAEMIA,1
TW,HYPOKALAEMIA,1
TW,HYPOVOLAEMIA,1
TW,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
TW,IMPLANT SITE EXTRAVASATION,1
TW,INFECTIOUS COLITIS,1
TW,INFLAMMATION,1
TW,INFLUENZA,1
TW,INFUSION SITE PHLEBITIS,1
TW,INTRACARDIAC THROMBUS,1
TW,INTRACRANIAL PRESSURE INCREASED,1
TW,JAUNDICE,1
TW,LEFT VENTRICULAR DYSFUNCTION,1
TW,LEG AMPUTATION,1
TW,LIMB DISCOMFORT,1
TW,LIPASE INCREASED,1
TW,LIVER INJURY,1
TW,LUNG CONSOLIDATION,1
TW,LUNG INFECTION,1
TW,LUNG NEOPLASM MALIGNANT,1
TW,LYMPHOCYTE PERCENTAGE DECREASED,1
TW,MEDICATION ERROR,1
TW,METABOLIC ACIDOSIS,1
TW,MITRAL VALVE INCOMPETENCE,1
TW,MOUTH ULCERATION,1
TW,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
TW,MUSCLE HAEMORRHAGE,1
TW,MYOCARDIAL ISCHAEMIA,1
TW,NEOPLASM RECURRENCE,1
TW,NEUTROPHIL COUNT DECREASED,1
TW,NODAL ARRHYTHMIA,1
TW,OLIGURIA,1
TW,ORAL CANDIDIASIS,1
TW,ORTHOPNOEA,1
TW,OSTEOARTHRITIS,1
TW,PEMPHIGOID,1
TW,PENETRATING ATHEROSCLEROTIC ULCER,1
TW,PEPTIC ULCER,1
TW,PERICARDITIS,1
TW,PERIODONTITIS,1
TW,PERIPHERAL ARTERY OCCLUSION,1
TW,PERITONEAL HAEMORRHAGE,1
TW,PERITONITIS,1
TW,PERITONITIS BACTERIAL,1
TW,PHARYNGITIS,1
TW,PLATELET COUNT DECREASED,1
TW,PLATELET COUNT INCREASED,1
TW,PNEUMONIA ASPIRATION,1
TW,PNEUMONIA BACTERIAL,1
TW,PORTAL VEIN THROMBOSIS,1
TW,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
TW,PRESYNCOPE,1
TW,PRODUCT SIZE ISSUE,1
TW,PRODUCT USE IN UNAPPROVED INDICATION,1
TW,PRODUCT USE ISSUE,1
TW,PROTEIN TOTAL DECREASED,1
TW,PSEUDOMONAS INFECTION,1
TW,PULMONARY CONGESTION,1
TW,PULMONARY HYPERTENSION,1
TW,PULMONARY OEDEMA,1
TW,RALES,1
TW,RANULA,1
TW,RECTOSIGMOID CANCER,1
TW,RED CELL DISTRIBUTION WIDTH INCREASED,1
TW,RENAL IMPAIRMENT,1
TW,RESPIRATORY DISTRESS,1
TW,RETROPERITONEAL HAEMORRHAGE,1
TW,RHINITIS,1
TW,ROAD TRAFFIC ACCIDENT,1
TW,SALMONELLA TEST POSITIVE,1
TW,SICK SINUS SYNDROME,1
TW,SINUSITIS,1
TW,SKIN ULCER,1
TW,SOMNOLENCE,1
TW,SPINAL FRACTURE,1
TW,SPINAL OSTEOARTHRITIS,1
TW,STEVENS-JOHNSON SYNDROME,1
TW,STOMATITIS,1
TW,SUBCLAVIAN STEAL SYNDROME,1
TW,SUDDEN CARDIAC DEATH,1
TW,SUDDEN DEATH,1
TW,SUPERINFECTION,1
TW,SWELLING,1
TW,THROMBOLYSIS,1
TW,THROMBOTIC STROKE,1
TW,TRANSIENT ISCHAEMIC ATTACK,1
TW,TREATMENT NONCOMPLIANCE,1
TW,TRICUSPID VALVE INCOMPETENCE,1
TW,TROPONIN I INCREASED,1
TW,TUMOUR HAEMORRHAGE,1
TW,UPPER GASTROINTESTINAL HAEMORRHAGE,1
TW,UPPER RESPIRATORY TRACT INFECTION,1
TW,URINARY RETENTION,1
TW,URINE OUTPUT DECREASED,1
TW,VASCULAR GRAFT COMPLICATION,1
TW,VASCULAR GRAFT OCCLUSION,1
TW,VASCULAR PSEUDOANEURYSM,1
TW,VASCULAR STENT RESTENOSIS,1
TW,VENTRICULAR FIBRILLATION,1
TW,VENTRICULAR TACHYCARDIA,1
TW,VERTIGO,1
TW,VISION BLURRED,1
TW,VOMITING,1
TW,WEIGHT INCREASED,1
TW,WHEEZING,1
TW,WHITE BLOOD CELL COUNT INCREASED,1
TW,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
TH,ACUTE KIDNEY INJURY,3
TH,HYPOGLYCAEMIA,3
TH,ACUTE MYOCARDIAL INFARCTION,2
TH,ANGINA UNSTABLE,2
TH,ATRIAL FIBRILLATION,2
TH,CARDIAC FAILURE CONGESTIVE,2
TH,CHOLELITHIASIS,2
TH,DIZZINESS,2
TH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
TH,HEPATIC FUNCTION ABNORMAL,2
TH,INTERNATIONAL NORMALISED RATIO INCREASED,2
TH,PNEUMONIA,2
TH,SEPTIC SHOCK,2
TH,STEVENS-JOHNSON SYNDROME,2
TH,URINARY TRACT INFECTION,2
TH,VENTRICULAR TACHYCARDIA,2
TH,ACUTE PULMONARY OEDEMA,1
TH,AGITATION,1
TH,ANAEMIA,1
TH,ANGIOEDEMA,1
TH,ARTHRALGIA,1
TH,ATAXIA,1
TH,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
TH,BACK PAIN,1
TH,BLOOD CREATININE INCREASED,1
TH,BLOOD PRESSURE FLUCTUATION,1
TH,CARDIAC ARREST,1
TH,CEREBRAL HAEMORRHAGE,1
TH,CHEST DISCOMFORT,1
TH,CHOLECYSTITIS ACUTE,1
TH,CHRONIC GASTRITIS,1
TH,CONDITION AGGRAVATED,1
TH,CONGESTIVE CARDIOMYOPATHY,1
TH,CONSTIPATION,1
TH,DEATH,1
TH,DELIRIUM,1
TH,DIARRHOEA,1
TH,DRUG INEFFECTIVE,1
TH,DUODENAL ULCER HAEMORRHAGE,1
TH,DYSPNOEA,1
TH,ENTEROCOLITIS,1
TH,FEBRILE NEUTROPENIA,1
TH,FEMORAL NECK FRACTURE,1
TH,FOOD INTERACTION,1
TH,GANGRENE,1
TH,GASTRIC POLYPS,1
TH,GASTROINTESTINAL HAEMORRHAGE,1
TH,HAEMATOCHEZIA,1
TH,HAEMATURIA,1
TH,HAEMOLYSIS,1
TH,HAEMORRHAGE INTRACRANIAL,1
TH,HEPATIC FAILURE,1
TH,HEPATITIS,1
TH,HERPES ZOSTER,1
TH,HIP FRACTURE,1
TH,HYPERAESTHESIA,1
TH,HYPERGLYCAEMIA,1
TH,HYPERKALAEMIA,1
TH,HYPOKALAEMIA,1
TH,HYPONATRAEMIA,1
TH,ILEAL ULCER,1
TH,INCONTINENCE,1
TH,INTRAVENTRICULAR HAEMORRHAGE,1
TH,IRON DEFICIENCY ANAEMIA,1
TH,ISCHAEMIA,1
TH,ISCHAEMIC CARDIOMYOPATHY,1
TH,JOINT RANGE OF MOTION DECREASED,1
TH,LACUNAR INFARCTION,1
TH,LARGE INTESTINAL HAEMORRHAGE,1
TH,LARGE INTESTINAL ULCER,1
TH,MONONEUROPATHY MULTIPLEX,1
TH,MOUTH ULCERATION,1
TH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
TH,OCULAR ICTERUS,1
TH,OEDEMA PERIPHERAL,1
TH,OESOPHAGITIS HAEMORRHAGIC,1
TH,PAIN IN EXTREMITY,1
TH,PANCREATITIS ACUTE,1
TH,PERIPHERAL SENSORY NEUROPATHY,1
TH,PLASMA CELL MYELOMA,1
TH,POLYARTERITIS NODOSA,1
TH,PRESYNCOPE,1
TH,PRODUCT USE ISSUE,1
TH,PYREXIA,1
TH,RASH ERYTHEMATOUS,1
TH,RASH MACULO-PAPULAR,1
TH,RESPIRATORY FAILURE,1
TH,SEPSIS,1
TH,SERUM SICKNESS,1
TH,SOMNOLENCE,1
TH,SYNCOPE,1
TH,THERAPEUTIC RESPONSE INCREASED,1
TH,TOXIC EPIDERMAL NECROLYSIS,1
TH,TREMOR,1
TH,URETERIC STENOSIS,1
TH,VASCULITIS,1
TT,ANGINA PECTORIS,1
TT,ARRHYTHMIA,1
TT,BLOOD GLUCOSE DECREASED,1
TT,BLOOD GLUCOSE INCREASED,1
TT,BLOOD PRESSURE INCREASED,1
TT,CARDIAC FAILURE,1
TT,CARDIAC FAILURE CONGESTIVE,1
TT,CATARACT,1
TT,CHEST DISCOMFORT,1
TT,CONGESTIVE CARDIOMYOPATHY,1
TT,DRUG DOSE OMISSION,1
TT,DYSPNOEA,1
TT,HILAR LYMPHADENOPATHY,1
TT,LYMPHADENOPATHY MEDIASTINAL,1
TT,MYOCARDIAL INFARCTION,1
TT,NAUSEA,1
TT,RENAL IMPAIRMENT,1
TT,STRESS CARDIOMYOPATHY,1
TT,SUPRAVENTRICULAR TACHYCARDIA,1
TT,WEIGHT DECREASED,1
TN,CARDIAC ARREST,8
TN,CHEST PAIN,5
TN,CARDIAC FAILURE,4
TN,MYOCARDIAL INFARCTION,4
TN,DYSPNOEA,3
TN,ACUTE PULMONARY OEDEMA,2
TN,BACK PAIN,2
TN,DECREASED APPETITE,2
TN,ISCHAEMIC STROKE,2
TN,LUNG NEOPLASM MALIGNANT,2
TN,RENAL FAILURE CHRONIC,2
TN,SEPTIC SHOCK,2
TN,ANAEMIA,1
TN,ASTHENIA,1
TN,CARDIO-RESPIRATORY ARREST,1
TN,CARDIOGENIC SHOCK,1
TN,CEREBROVASCULAR ACCIDENT,1
TN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
TN,COLON CANCER,1
TN,COMA,1
TN,CONDITION AGGRAVATED,1
TN,CORONARY ARTERY BYPASS,1
TN,DEPRESSION,1
TN,DEVICE OCCLUSION,1
TN,DIALYSIS RELATED COMPLICATION,1
TN,DIARRHOEA,1
TN,DRUG ERUPTION,1
TN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
TN,ERYSIPELAS,1
TN,FATIGUE,1
TN,GASTRIC HAEMORRHAGE,1
TN,GENERAL PHYSICAL HEALTH DETERIORATION,1
TN,HEPATOCELLULAR INJURY,1
TN,HYPERGLYCAEMIA,1
TN,HYPOKALAEMIA,1
TN,HYPOTENSION,1
TN,LEFT VENTRICULAR FAILURE,1
TN,LIVER INJURY,1
TN,MALNUTRITION,1
TN,MUSCULOSKELETAL PAIN,1
TN,PAIN,1
TN,PAIN IN EXTREMITY,1
TN,PALLOR,1
TN,PANCREATIC CARCINOMA,1
TN,PERIPHERAL ISCHAEMIA,1
TN,PROSTATE CANCER,1
TN,PRURITUS,1
TN,PYREXIA,1
TN,RASH ERYTHEMATOUS,1
TN,RASH MACULO-PAPULAR,1
TN,RENAL FAILURE,1
TN,RESPIRATORY DISORDER,1
TN,RESPIRATORY FAILURE,1
TN,RHEUMATIC DISORDER,1
TN,SHOCK,1
TN,SUDDEN DEATH,1
TN,SUFFOCATION FEELING,1
TN,SWELLING,1
TN,THROMBOSIS IN DEVICE,1
TN,TOXIC EPIDERMAL NECROLYSIS,1
TN,TREMOR,1
TN,WEIGHT DECREASED,1
TR,NAUSEA,15
TR,DYSPNOEA,12
TR,LOSS OF CONSCIOUSNESS,11
TR,DRUG INEFFECTIVE,10
TR,SINUS BRADYCARDIA,10
TR,DEATH,9
TR,RHABDOMYOLYSIS,9
TR,ASTHENIA,8
TR,EXPOSURE DURING PREGNANCY,8
TR,FOETAL EXPOSURE DURING PREGNANCY,8
TR,VOMITING,8
TR,ACUTE KIDNEY INJURY,7
TR,HYPOTENSION,7
TR,INTENTIONAL OVERDOSE,7
TR,CARDIAC ARREST,6
TR,CARDIAC FAILURE,6
TR,CEREBROVASCULAR ACCIDENT,6
TR,COUGH,6
TR,LACTIC ACIDOSIS,6
TR,PREMATURE BABY,6
TR,ANGIOEDEMA,5
TR,BRADYCARDIA,5
TR,CONFUSIONAL STATE,5
TR,DIZZINESS,5
TR,FALL,5
TR,HAEMOGLOBIN DECREASED,5
TR,HALLUCINATION_ VISUAL,5
TR,ISCHAEMIA,5
TR,SOMNOLENCE,5
TR,SUICIDE ATTEMPT,5
TR,TACHYPNOEA,5
TR,THROMBOCYTOPENIA,5
TR,TOXICITY TO VARIOUS AGENTS,5
TR,ABDOMINAL DISTENSION,4
TR,ABDOMINAL PAIN,4
TR,ARRHYTHMIA,4
TR,ATRIAL FIBRILLATION,4
TR,CARDIAC DISORDER,4
TR,CHEST PAIN,4
TR,DIPLOPIA,4
TR,EPSTEIN-BARR VIRUS INFECTION,4
TR,FATIGUE,4
TR,GASTRIC HAEMORRHAGE,4
TR,HAEMORRHAGE,4
TR,HISTIOCYTOSIS HAEMATOPHAGIC,4
TR,HYPOTHYROIDISM,4
TR,METABOLIC ACIDOSIS,4
TR,NASAL CONGESTION,4
TR,PAIN,4
TR,PRODUCT USE ISSUE,4
TR,PULMONARY ALVEOLAR HAEMORRHAGE,4
TR,RHINORRHOEA,4
TR,THROMBOSIS IN DEVICE,4
TR,VISION BLURRED,4
TR,ABORTION SPONTANEOUS,3
TR,BLINDNESS,3
TR,BLOOD GLUCOSE INCREASED,3
TR,BLOOD URIC ACID INCREASED,3
TR,C-REACTIVE PROTEIN INCREASED,3
TR,CONTUSION,3
TR,DIARRHOEA,3
TR,DRUG ADMINISTRATION ERROR,3
TR,DYSARTHRIA,3
TR,EMBOLISM,3
TR,EPISTAXIS,3
TR,GAIT DISTURBANCE,3
TR,HAEMATURIA,3
TR,HYPERGLYCAEMIA,3
TR,HYPERTENSION,3
TR,INTRA-ABDOMINAL HAEMORRHAGE,3
TR,JAUNDICE NEONATAL,3
TR,MALAISE,3
TR,MALIGNANT NEOPLASM PROGRESSION,3
TR,MUSCLE SPASMS,3
TR,PALPITATIONS,3
TR,PANCREATITIS ACUTE,3
TR,PLATELET COUNT DECREASED,3
TR,PYREXIA,3
TR,THROMBOSIS,3
TR,URTICARIA,3
TR,VERTIGO,3
TR,ACUTE MOTOR-SENSORY AXONAL NEUROPATHY,2
TR,ACUTE RESPIRATORY DISTRESS SYNDROME,2
TR,ADENOCARCINOMA GASTRIC,2
TR,ALOPECIA,2
TR,ANAEMIA,2
TR,ANEURYSM,2
TR,BACK PAIN,2
TR,BLOOD CREATININE INCREASED,2
TR,BLOOD PRESSURE DECREASED,2
TR,BLOOD UREA INCREASED,2
TR,CARDIAC VALVE REPLACEMENT COMPLICATION,2
TR,CARDIO-RESPIRATORY ARREST,2
TR,CEREBRAL HAEMORRHAGE,2
TR,COMA,2
TR,COMA SCALE ABNORMAL,2
TR,COMPLETED SUICIDE,2
TR,DEEP VEIN THROMBOSIS,2
TR,DELIRIUM,2
TR,DEPRESSED LEVEL OF CONSCIOUSNESS,2
TR,DIABETES MELLITUS,2
TR,DISEASE PROGRESSION,2
TR,DISORIENTATION,2
TR,DRUG HYPERSENSITIVITY,2
TR,ECCHYMOSIS,2
TR,EYE HAEMORRHAGE,2
TR,FEBRILE NEUTROPENIA,2
TR,FLUSHING,2
TR,FORCED EXPIRATORY VOLUME DECREASED,2
TR,GASTROINTESTINAL HAEMORRHAGE,2
TR,GUILLAIN-BARRE SYNDROME,2
TR,HAEMORRHAGE INTRACRANIAL,2
TR,HAEMORRHAGE SUBCUTANEOUS,2
TR,HAEMOTHORAX,2
TR,HALLUCINATION,2
TR,HEADACHE,2
TR,HEART RATE INCREASED,2
TR,HEPATIC ENZYME INCREASED,2
TR,HYPERHIDROSIS,2
TR,HYPOAESTHESIA ORAL,2
TR,INTENTIONAL PRODUCT MISUSE,2
TR,INVASIVE DUCTAL BREAST CARCINOMA,2
TR,ISCHAEMIC STROKE,2
TR,LEUKOPENIA,2
TR,LONG QT SYNDROME,2
TR,LUNG INFILTRATION,2
TR,MEDICATION ERROR,2
TR,MELAENA,2
TR,MEMORY IMPAIRMENT,2
TR,MUSCLE CONTRACTIONS INVOLUNTARY,2
TR,MYALGIA,2
TR,MYOCARDIAL INFARCTION,2
TR,NEONATAL INFECTION,2
TR,NEONATAL RESPIRATORY DISTRESS SYNDROME,2
TR,NEPHROLITHIASIS,2
TR,NERVOUSNESS,2
TR,NEUTROPENIA,2
TR,OEDEMA PERIPHERAL,2
TR,OVARIAN HAEMORRHAGE,2
TR,OVARIAN RUPTURE,2
TR,OVERDOSE,2
TR,PRODUCT QUALITY ISSUE,2
TR,PRODUCTIVE COUGH,2
TR,PULMONARY EMBOLISM,2
TR,PULMONARY OEDEMA,2
TR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
TR,RENAL DISORDER,2
TR,RENAL IMPAIRMENT,2
TR,RETINAL DETACHMENT,2
TR,STILLBIRTH,2
TR,SWOLLEN TONGUE,2
TR,SYNCOPE,2
TR,TACHYCARDIA,2
TR,TREATMENT NONCOMPLIANCE,2
TR,UNEVALUABLE EVENT,2
TR,UPPER GASTROINTESTINAL HAEMORRHAGE,2
TR,URINARY TRACT INFECTION,2
TR,URINE OUTPUT DECREASED,2
TR,VENTRICULAR TACHYCARDIA,2
TR,VISUAL IMPAIRMENT,2
TR,WHEEZING,2
TR,ABDOMINAL PAIN UPPER,1
TR,ABDOMINAL WALL HAEMATOMA,1
TR,ABORTION THREATENED,1
TR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
TR,ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED,1
TR,ACUTE CORONARY SYNDROME,1
TR,ACUTE PRERENAL FAILURE,1
TR,ADENOCARCINOMA PANCREAS,1
TR,ADENOSINE DEAMINASE INCREASED,1
TR,AGGRESSION,1
TR,AGITATION,1
TR,ALANINE AMINOTRANSFERASE ABNORMAL,1
TR,ALANINE AMINOTRANSFERASE INCREASED,1
TR,ALCOHOL INTERACTION,1
TR,ALCOHOL USE,1
TR,ALTERED STATE OF CONSCIOUSNESS,1
TR,ANXIETY,1
TR,AORTIC VALVE REPLACEMENT,1
TR,AORTO-OESOPHAGEAL FISTULA,1
TR,APHASIA,1
TR,ARTERIAL OCCLUSIVE DISEASE,1
TR,ARTERIOSCLEROSIS CORONARY ARTERY,1
TR,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
TR,ASPARTATE AMINOTRANSFERASE INCREASED,1
TR,ASTHMA,1
TR,ATAXIA,1
TR,ATELECTASIS,1
TR,ATRIAL FLUTTER,1
TR,ATRIAL THROMBOSIS,1
TR,ATRIOVENTRICULAR BLOCK,1
TR,BALANCE DISORDER,1
TR,BILIRUBIN CONJUGATED INCREASED,1
TR,BLOOD BILIRUBIN INCREASED,1
TR,BLOOD CHLORIDE DECREASED,1
TR,BLOOD GLUCOSE DECREASED,1
TR,BLOOD IRON DECREASED,1
TR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
TR,BLOOD LACTIC ACID INCREASED,1
TR,BLOOD OSMOLARITY DECREASED,1
TR,BLOOD PHOSPHORUS INCREASED,1
TR,BLOOD POTASSIUM INCREASED,1
TR,BLOOD PRESSURE DIASTOLIC DECREASED,1
TR,BLOOD PRESSURE INCREASED,1
TR,BLOOD SODIUM DECREASED,1
TR,BLOOD TRIGLYCERIDES INCREASED,1
TR,BRADYKINESIA,1
TR,BRONCHITIS,1
TR,BURNING SENSATION,1
TR,CARBOHYDRATE ANTIGEN 125 INCREASED,1
TR,CARDIAC ANEURYSM,1
TR,CARDIAC PACEMAKER INSERTION,1
TR,CARDIOVASCULAR DISORDER,1
TR,CARDIOVASCULAR INSUFFICIENCY,1
TR,CAROTID ARTERY STENOSIS,1
TR,CATARACT,1
TR,CEREBRAL ARTERY OCCLUSION,1
TR,CEREBRAL MICROHAEMORRHAGE,1
TR,CEREBRAL THROMBOSIS,1
TR,CHEMICAL INJURY,1
TR,CHEST DISCOMFORT,1
TR,CHEST WALL HAEMATOMA,1
TR,CHOLESTASIS OF PREGNANCY,1
TR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
TR,COLON OPERATION,1
TR,COMPRESSION FRACTURE,1
TR,CONDITION AGGRAVATED,1
TR,CORONARY ARTERIAL STENT INSERTION,1
TR,CORONARY ARTERY ANEURYSM,1
TR,CORONARY ARTERY DISEASE,1
TR,CORONARY ARTERY OCCLUSION,1
TR,CORONARY ARTERY STENOSIS,1
TR,CORONARY ARTERY THROMBOSIS,1
TR,DEAFNESS,1
TR,DECREASED APPETITE,1
TR,DECUBITUS ULCER,1
TR,DEHYDRATION,1
TR,DEMENTIA WITH LEWY BODIES,1
TR,DERMATITIS ACNEIFORM,1
TR,DEVICE OCCLUSION,1
TR,DISABILITY,1
TR,DISCOMFORT,1
TR,DISSEMINATED INTRAVASCULAR COAGULATION,1
TR,DISTRACTIBILITY,1
TR,DRUG LEVEL INCREASED,1
TR,DRUG-INDUCED LIVER INJURY,1
TR,DRY SKIN,1
TR,DYSKINESIA,1
TR,DYSSTASIA,1
TR,DYSURIA,1
TR,EJECTION FRACTION DECREASED,1
TR,ELECTROCARDIOGRAM ABNORMAL,1
TR,ENCEPHALOPATHY,1
TR,EOSINOPHIL COUNT INCREASED,1
TR,ERYTHEMA,1
TR,ERYTHEMA MULTIFORME,1
TR,EXCHANGE BLOOD TRANSFUSION,1
TR,EYE MOVEMENT DISORDER,1
TR,FAECES DISCOLOURED,1
TR,FEELING COLD,1
TR,FEMORAL NECK FRACTURE,1
TR,FEMORAL NERVE PALSY,1
TR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
TR,GASTRIC POLYPS,1
TR,GASTRIC ULCER,1
TR,GASTRITIS EROSIVE,1
TR,GENERAL PHYSICAL HEALTH DETERIORATION,1
TR,GINGIVAL BLEEDING,1
TR,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
TR,HAEMATOCRIT DECREASED,1
TR,HAEMATOCRIT INCREASED,1
TR,HAEMATOMA,1
TR,HAEMOLYTIC ANAEMIA,1
TR,HAEMOPTYSIS,1
TR,HAEMORRHAGIC TRANSFORMATION STROKE,1
TR,HAND FRACTURE,1
TR,HEART RATE IRREGULAR,1
TR,HEART VALVE INCOMPETENCE,1
TR,HEMIPARESIS,1
TR,HEPATIC FAILURE,1
TR,HEPATIC STEATOSIS,1
TR,HIGH DENSITY LIPOPROTEIN DECREASED,1
TR,HIP SURGERY,1
TR,HUMERUS FRACTURE,1
TR,HYDRONEPHROSIS,1
TR,HYPERBILIRUBINAEMIA,1
TR,HYPERCALCAEMIA,1
TR,HYPERURICAEMIA,1
TR,HYPOAESTHESIA,1
TR,HYPOCALCAEMIA,1
TR,HYPOKALAEMIA,1
TR,HYPONATRAEMIA,1
TR,HYPOPARATHYROIDISM,1
TR,HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION,1
TR,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
TR,IMMATURE RESPIRATORY SYSTEM,1
TR,INAPPROPRIATE AFFECT,1
TR,INCREASED APPETITE,1
TR,INFECTION,1
TR,INJECTION SITE BRUISING,1
TR,INJECTION SITE ERYTHEMA,1
TR,INJECTION SITE NECROSIS,1
TR,INJECTION SITE NODULE,1
TR,INJECTION SITE RASH,1
TR,INSOMNIA,1
TR,INTERNATIONAL NORMALISED RATIO DECREASED,1
TR,INTRACRANIAL ANEURYSM,1
TR,IRIDOCYCLITIS,1
TR,IRON BINDING CAPACITY TOTAL INCREASED,1
TR,IRON BINDING CAPACITY UNSATURATED INCREASED,1
TR,JOINT SWELLING,1
TR,KOUNIS SYNDROME,1
TR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
TR,LACUNAR INFARCTION,1
TR,LANGUAGE DISORDER,1
TR,LEFT ATRIAL DILATATION,1
TR,LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED,1
TR,LIBIDO DECREASED,1
TR,LIVE BIRTH,1
TR,LOCAL SWELLING,1
TR,LOW BIRTH WEIGHT BABY,1
TR,LOWER LIMB FRACTURE,1
TR,LUNG ADENOCARCINOMA,1
TR,LYMPHOCYTE COUNT DECREASED,1
TR,MACULAR OEDEMA,1
TR,MALIGNANT ASCITES,1
TR,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
TR,MEAN CELL VOLUME DECREASED,1
TR,MECONIUM ASPIRATION SYNDROME,1
TR,MENTAL STATUS CHANGES,1
TR,METASTASES TO KIDNEY,1
TR,METASTASES TO LIVER,1
TR,METASTASES TO OVARY,1
TR,METASTASES TO PERITONEUM,1
TR,MITRAL VALVE INCOMPETENCE,1
TR,MONOCYTE COUNT DECREASED,1
TR,MOYAMOYA DISEASE,1
TR,MUCOSAL HAEMORRHAGE,1
TR,MULTIPLE FRACTURES,1
TR,MYOCARDIAL DEPRESSION,1
TR,NECK PAIN,1
TR,NEPHROPATHY,1
TR,NEUROLOGICAL DECOMPENSATION,1
TR,NEUTROPHIL COUNT DECREASED,1
TR,OBESITY,1
TR,OEDEMA,1
TR,OPTIC DISC HAEMORRHAGE,1
TR,ORTHOPNOEA,1
TR,OSTEOPOROSIS,1
TR,OVARIAN HYPERSTIMULATION SYNDROME,1
TR,OXYGEN SATURATION DECREASED,1
TR,PAIN OF SKIN,1
TR,PALPABLE PURPURA,1
TR,PANCREATIC FISTULA,1
TR,PANCREATITIS,1
TR,PANOPHTHALMITIS,1
TR,PARAESTHESIA,1
TR,PARAPARESIS,1
TR,PEMPHIGOID,1
TR,PERIPHERAL SWELLING,1
TR,PERIPHERAL VASCULAR DISORDER,1
TR,PLEURAL EFFUSION,1
TR,PNEUMONIA,1
TR,PO2 ABNORMAL,1
TR,POLYCYTHAEMIA,1
TR,POLYDIPSIA,1
TR,POLYURIA,1
TR,PORTAL HYPERTENSIVE GASTROPATHY,1
TR,PREMATURE RUPTURE OF MEMBRANES,1
TR,PROCTECTOMY,1
TR,PRODUCT COUNTERFEIT,1
TR,PROSTATIC DISORDER,1
TR,PROTEIN TOTAL DECREASED,1
TR,PROTHROMBIN TIME ABNORMAL,1
TR,PRURITUS,1
TR,PSORIASIS,1
TR,PULMONARY ARTERIAL PRESSURE ABNORMAL,1
TR,PULMONARY HAEMORRHAGE,1
TR,PULMONARY TOXICITY,1
TR,PULMONARY TUBERCULOSIS,1
TR,RALES,1
TR,RECTAL HAEMORRHAGE,1
TR,RED CELL DISTRIBUTION WIDTH INCREASED,1
TR,REFLUX GASTRITIS,1
TR,RENAL CYST,1
TR,RESPIRATION ABNORMAL,1
TR,RESPIRATORY ALKALOSIS,1
TR,RESPIRATORY ARREST,1
TR,RESPIRATORY DISORDER NEONATAL,1
TR,RESPIRATORY FAILURE,1
TR,RETROPERITONEAL HAEMATOMA,1
TR,RIGHT-TO-LEFT CARDIAC SHUNT,1
TR,SELF-MEDICATION,1
TR,SEPSIS,1
TR,SEPTIC SHOCK,1
TR,SERUM FERRITIN DECREASED,1
TR,SIGNET-RING CELL CARCINOMA,1
TR,SINUS ARREST,1
TR,SKIN ATROPHY,1
TR,SKIN DISCOLOURATION,1
TR,SKIN EXFOLIATION,1
TR,SKIN HAEMORRHAGE,1
TR,SKIN LESION,1
TR,SKIN MASS,1
TR,SKIN STRIAE,1
TR,SLEEP APNOEA SYNDROME,1
TR,SMALL INTESTINAL HAEMORRHAGE,1
TR,SNEEZING,1
TR,SPEECH DISORDER,1
TR,SPINAL COMPRESSION FRACTURE,1
TR,SPINAL EPIDURAL HAEMATOMA,1
TR,STATUS EPILEPTICUS,1
TR,STEVENS-JOHNSON SYNDROME,1
TR,STOMACH MASS,1
TR,SUBARACHNOID HAEMORRHAGE,1
TR,SUBRETINAL FLUID,1
TR,SUDDEN CARDIAC DEATH,1
TR,SUDDEN DEATH,1
TR,SUDDEN HEARING LOSS,1
TR,SUICIDAL IDEATION,1
TR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
TR,TENSION,1
TR,THERAPEUTIC PRODUCT CROSS-REACTIVITY,1
TR,THYROTOXIC CRISIS,1
TR,TINNITUS,1
TR,TONGUE HAEMATOMA,1
TR,TORSADE DE POINTES,1
TR,TRACHEAL OBSTRUCTION,1
TR,TRANSFERRIN SATURATION DECREASED,1
TR,TREMOR,1
TR,TRICUSPID VALVE INCOMPETENCE,1
TR,TUBERCULOSIS,1
TR,TYPE I HYPERSENSITIVITY,1
TR,UNDERDOSE,1
TR,UPPER AIRWAY OBSTRUCTION,1
TR,URINARY BLADDER HAEMORRHAGE,1
TR,URINARY TRACT OBSTRUCTION,1
TR,URINE OSMOLARITY DECREASED,1
TR,VAGINAL HAEMORRHAGE,1
TR,VARICES OESOPHAGEAL,1
TR,VARICOSE VEIN,1
TR,VASCULAR RUPTURE,1
TR,VASCULAR STENT THROMBOSIS,1
TR,VENTRICULAR HYPERTROPHY,1
TR,VITAMIN B12 DECREASED,1
TR,WEIGHT DECREASED,1
TR,WHITE BLOOD CELL COUNT DECREASED,1
TR,WRIST FRACTURE,1
TM,ABDOMINAL PAIN UPPER,1
TM,ALANINE AMINOTRANSFERASE INCREASED,1
TM,AMYLASE INCREASED,1
TM,ASPARTATE AMINOTRANSFERASE INCREASED,1
TM,BLOOD BILIRUBIN INCREASED,1
TM,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
TM,VOMITING,1
UG,DIABETES MELLITUS,1
UA,VASCULAR STENT THROMBOSIS,4
UA,ACUTE MYOCARDIAL INFARCTION,3
UA,ASTHENIA,2
UA,DYSPNOEA,2
UA,GASTROINTESTINAL HAEMORRHAGE,2
UA,HAEMORRHAGIC STROKE,2
UA,MYOCARDIAL INFARCTION,2
UA,PRURITUS,2
UA,THROMBOSIS IN DEVICE,2
UA,ACUTE CORONARY SYNDROME,1
UA,ANAEMIA,1
UA,ANGINA PECTORIS,1
UA,ANGINA UNSTABLE,1
UA,ARTHROPOD BITE,1
UA,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
UA,BLOOD PRESSURE INCREASED,1
UA,BRADYCARDIA,1
UA,CALCULUS URINARY,1
UA,CARDIAC TAMPONADE,1
UA,CARDIOGENIC SHOCK,1
UA,CIRCULATORY COLLAPSE,1
UA,COMA,1
UA,CORONARY ARTERY DISSECTION,1
UA,CORONARY ARTERY STENOSIS,1
UA,CORONARY ARTERY THROMBOSIS,1
UA,CRANIOCEREBRAL INJURY,1
UA,DECREASED APPETITE,1
UA,DRUG INEFFECTIVE,1
UA,ERYTHEMA,1
UA,GASTRIC CANCER STAGE IV,1
UA,GASTRIC ULCER,1
UA,HAEMOPTYSIS,1
UA,HAEMORRHAGIC ANAEMIA,1
UA,HEPATITIS TOXIC,1
UA,HYPERSENSITIVITY,1
UA,MUSCULAR WEAKNESS,1
UA,MYOCARDIAL RUPTURE,1
UA,NAUSEA,1
UA,POST PROCEDURAL MYOCARDIAL INFARCTION,1
UA,PURPURA,1
UA,RASH,1
UA,REACTIVE PSYCHOSIS,1
UA,SWELLING,1
UA,TACHYCARDIA,1
UA,THERAPY CESSATION,1
UA,TRANSAMINASES INCREASED,1
UA,TYPE IV HYPERSENSITIVITY REACTION,1
UA,VOMITING,1
AE,VOMITING,5
AE,NAUSEA,4
AE,DEHYDRATION,3
AE,DIARRHOEA,3
AE,DYSPNOEA,3
AE,PNEUMONIA,3
AE,ACUTE KIDNEY INJURY,2
AE,CHEST PAIN,2
AE,DEATH,2
AE,DRY SKIN,2
AE,HEADACHE,2
AE,HEART RATE IRREGULAR,2
AE,HYPOTENSION,2
AE,LACTIC ACIDOSIS,2
AE,ABDOMINAL PAIN UPPER,1
AE,ACUTE MYOCARDIAL INFARCTION,1
AE,ANXIETY,1
AE,ARTERIOSCLEROSIS CORONARY ARTERY,1
AE,ASCITES,1
AE,ATRIAL FIBRILLATION,1
AE,BACK PAIN,1
AE,BRAIN COMPRESSION,1
AE,BRAIN MIDLINE SHIFT,1
AE,BRAIN OEDEMA,1
AE,CARDIAC ARREST,1
AE,CARDIAC FAILURE,1
AE,CHOLANGITIS,1
AE,CONFUSIONAL STATE,1
AE,COUGH,1
AE,DECREASED APPETITE,1
AE,DIZZINESS,1
AE,DYSARTHRIA,1
AE,DYSLIPIDAEMIA,1
AE,EPISTAXIS,1
AE,ESSENTIAL HYPERTENSION,1
AE,FATIGUE,1
AE,GASTROINTESTINAL HAEMORRHAGE,1
AE,HAEMORRHAGE INTRACRANIAL,1
AE,HEMIPARESIS,1
AE,HEPATIC FAILURE,1
AE,HYPERHIDROSIS,1
AE,HYPOAESTHESIA,1
AE,HYPOAESTHESIA ORAL,1
AE,LOSS OF CONSCIOUSNESS,1
AE,MULTIPLE SCLEROSIS,1
AE,MYALGIA,1
AE,ORAL LICHEN PLANUS,1
AE,OSTEOPOROTIC FRACTURE,1
AE,PAIN IN EXTREMITY,1
AE,PALPITATIONS,1
AE,PLEURAL EFFUSION,1
AE,PNEUMOTHORAX,1
AE,PULMONARY HYPERTENSION,1
AE,PYREXIA,1
AE,RENAL FAILURE ACUTE,1
AE,SEPSIS,1
AE,SHOCK,1
AE,SKIN EXFOLIATION,1
AE,SKIN ULCER,1
AE,TRANSIENT ISCHAEMIC ATTACK,1
AE,TYPE 2 DIABETES MELLITUS,1
AE,URINARY TRACT INFECTION,1
AE,VISION BLURRED,1
GB,DYSPNOEA,616
GB,MALAISE,553
GB,CONFUSIONAL STATE,441
GB,DIZZINESS,407
GB,DIARRHOEA,401
GB,ACUTE KIDNEY INJURY,396
GB,MYALGIA,390
GB,FATIGUE,386
GB,VOMITING,332
GB,NAUSEA,331
GB,HYPOTENSION,316
GB,HYPONATRAEMIA,310
GB,HEADACHE,296
GB,FALL,265
GB,CHEST PAIN,264
GB,PAIN IN EXTREMITY,260
GB,BRADYCARDIA,228
GB,COUGH,223
GB,RENAL FAILURE ACUTE,218
GB,ARTHRALGIA,213
GB,ABDOMINAL PAIN,204
GB,RASH,203
GB,SYNCOPE,202
GB,ATRIAL FIBRILLATION,193
GB,LOWER RESPIRATORY TRACT INFECTION,191
GB,PNEUMONIA,188
GB,ASTHENIA,180
GB,TREMOR,174
GB,CIRCULATORY COLLAPSE,173
GB,GASTROINTESTINAL HAEMORRHAGE,168
GB,PAIN,166
GB,LIVER FUNCTION TEST ABNORMAL,165
GB,RENAL IMPAIRMENT,155
GB,CONDITION AGGRAVATED,154
GB,PRURITUS,154
GB,LETHARGY,151
GB,PALPITATIONS,149
GB,SOMNOLENCE,149
GB,MUSCULAR WEAKNESS,147
GB,MUSCLE SPASMS,145
GB,CONSTIPATION,142
GB,PARAESTHESIA,142
GB,HYPERKALAEMIA,136
GB,INSOMNIA,136
GB,PYREXIA,135
GB,SEPSIS,135
GB,ANXIETY,134
GB,ANAEMIA,133
GB,DECREASED APPETITE,133
GB,SWOLLEN TONGUE,133
GB,LIP SWELLING,132
GB,RHABDOMYOLYSIS,131
GB,SWELLING FACE,131
GB,WEIGHT DECREASED,131
GB,DEPRESSION,127
GB,MYOCARDIAL INFARCTION,127
GB,FEELING ABNORMAL,123
GB,AGITATION,122
GB,ABDOMINAL PAIN UPPER,121
GB,ANGIOEDEMA,119
GB,BALANCE DISORDER,119
GB,BACK PAIN,117
GB,CONTUSION,117
GB,DEHYDRATION,113
GB,LOSS OF CONSCIOUSNESS,113
GB,DEATH,112
GB,WHEEZING,112
GB,DYSPHAGIA,110
GB,GAIT DISTURBANCE,110
GB,VISION BLURRED,110
GB,OEDEMA PERIPHERAL,109
GB,PERIPHERAL SWELLING,109
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,109
GB,JOINT SWELLING,107
GB,ELECTROCARDIOGRAM QT PROLONGED,106
GB,MELAENA,106
GB,HYPERHIDROSIS,105
GB,TACHYCARDIA,105
GB,HYPOAESTHESIA,103
GB,HAEMATEMESIS,102
GB,HAEMOGLOBIN DECREASED,102
GB,HALLUCINATION,101
GB,URINARY TRACT INFECTION,100
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,98
GB,VISUAL IMPAIRMENT,97
GB,CARDIAC ARREST,95
GB,ABDOMINAL DISTENSION,94
GB,MOBILITY DECREASED,94
GB,UNRESPONSIVE TO STIMULI,94
GB,ACUTE MYOCARDIAL INFARCTION,93
GB,DRUG INEFFECTIVE,93
GB,CEREBROVASCULAR ACCIDENT,92
GB,RECTAL HAEMORRHAGE,91
GB,ALANINE AMINOTRANSFERASE INCREASED,87
GB,EPISTAXIS,87
GB,FAECES DISCOLOURED,87
GB,JAUNDICE,87
GB,HYPERSENSITIVITY,85
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,82
GB,HAEMATURIA,76
GB,TOXICITY TO VARIOUS AGENTS,74
GB,VERTIGO,74
GB,AMNESIA,73
GB,CARDIAC FAILURE,72
GB,HYPERTENSION,72
GB,ANGINA PECTORIS,71
GB,HAEMORRHAGE,71
GB,OVERDOSE,71
GB,HYPOGLYCAEMIA,69
GB,DYSARTHRIA,68
GB,ALOPECIA,67
GB,ORTHOSTATIC HYPOTENSION,67
GB,PHARYNGEAL OEDEMA,67
GB,TUBULOINTERSTITIAL NEPHRITIS,67
GB,AGGRESSION,66
GB,CHEST DISCOMFORT,66
GB,MUSCULOSKELETAL PAIN,66
GB,SKIN EXFOLIATION,66
GB,TRANSIENT ISCHAEMIC ATTACK,66
GB,ANAPHYLACTIC REACTION,64
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,63
GB,ERYTHEMA,63
GB,RASH ERYTHEMATOUS,62
GB,SUICIDAL IDEATION,62
GB,HYPOKALAEMIA,61
GB,NIGHTMARE,61
GB,HYPOMAGNESAEMIA,60
GB,PALLOR,60
GB,THROMBOCYTOPENIA,60
GB,WHITE BLOOD CELL COUNT INCREASED,60
GB,CELLULITIS,59
GB,SEIZURE,59
GB,DEPRESSED MOOD,58
GB,DISTURBANCE IN ATTENTION,58
GB,DYSPEPSIA,58
GB,INTENTIONAL OVERDOSE,58
GB,BLOOD CREATININE INCREASED,57
GB,DISORIENTATION,57
GB,NEUTROPENIA,57
GB,ABDOMINAL DISCOMFORT,56
GB,SKIN DISCOLOURATION,56
GB,DRY MOUTH,55
GB,TINNITUS,54
GB,MEMORY IMPAIRMENT,53
GB,PULMONARY EMBOLISM,53
GB,URTICARIA,53
GB,CONVULSION,52
GB,PANCYTOPENIA,52
GB,PULMONARY OEDEMA,51
GB,DIABETIC KETOACIDOSIS,50
GB,DRY SKIN,50
GB,UROSEPSIS,50
GB,CHILLS,48
GB,PLEURAL EFFUSION,48
GB,PRODUCTIVE COUGH,48
GB,DRUG PRESCRIBING ERROR,47
GB,HYPERGLYCAEMIA,47
GB,HYPOCALCAEMIA,47
GB,INFECTION,47
GB,RASH PRURITIC,47
GB,SLEEP DISORDER,47
GB,GLOMERULAR FILTRATION RATE DECREASED,46
GB,HAEMOPTYSIS,46
GB,INTERNATIONAL NORMALISED RATIO INCREASED,46
GB,NEUTROPENIC SEPSIS,46
GB,OXYGEN SATURATION DECREASED,46
GB,PRESYNCOPE,46
GB,RESPIRATORY FAILURE,46
GB,GASTRITIS,45
GB,HEART RATE INCREASED,44
GB,MOUTH ULCERATION,44
GB,RENAL FAILURE,44
GB,BLOOD GLUCOSE INCREASED,43
GB,BLOOD PRESSURE INCREASED,43
GB,DYSKINESIA,43
GB,FLUID OVERLOAD,43
GB,LACTIC ACIDOSIS,43
GB,PLATELET COUNT DECREASED,43
GB,APHASIA,42
GB,MYOCARDIAL ISCHAEMIA,42
GB,PRURITUS GENERALISED,42
GB,ATRIOVENTRICULAR BLOCK FIRST DEGREE,41
GB,BLISTER,41
GB,DIPLOPIA,41
GB,GENERAL PHYSICAL HEALTH DETERIORATION,41
GB,HEPATITIS,41
GB,MUSCLE ATROPHY,41
GB,MUSCULOSKELETAL STIFFNESS,41
GB,ACUTE CORONARY SYNDROME,40
GB,DYSGEUSIA,40
GB,ERECTILE DYSFUNCTION,40
GB,HEPATIC FUNCTION ABNORMAL,40
GB,ABNORMAL LOSS OF WEIGHT,39
GB,COGNITIVE DISORDER,39
GB,EXTRAPYRAMIDAL DISORDER,39
GB,RESTLESSNESS,39
GB,SPEECH DISORDER,39
GB,ABNORMAL DREAMS,38
GB,CARDIAC DISORDER,38
GB,DEAFNESS,38
GB,PSORIASIS,38
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,37
GB,C-REACTIVE PROTEIN INCREASED,37
GB,PERITONITIS,37
GB,RASH MACULAR,37
GB,SUICIDE ATTEMPT,37
GB,CLOSTRIDIUM DIFFICILE INFECTION,36
GB,DIABETES MELLITUS,36
GB,FOETAL EXPOSURE DURING PREGNANCY,36
GB,INFLUENZA LIKE ILLNESS,36
GB,SINUS BRADYCARDIA,36
GB,WHITE BLOOD CELL COUNT DECREASED,36
GB,EYE SWELLING,35
GB,HEART RATE DECREASED,35
GB,MEDICATION ERROR,35
GB,MYOSITIS,35
GB,NECK PAIN,35
GB,VISUAL ACUITY REDUCED,35
GB,WEIGHT INCREASED,35
GB,ASTHMA,34
GB,DRUG DISPENSING ERROR,34
GB,ECZEMA,34
GB,FEELING HOT,34
GB,METABOLIC ACIDOSIS,34
GB,OBSTRUCTIVE AIRWAYS DISORDER,34
GB,QUALITY OF LIFE DECREASED,34
GB,ABNORMAL WEIGHT GAIN,33
GB,BLOOD CHOLESTEROL INCREASED,33
GB,CARDIAC FAILURE CONGESTIVE,33
GB,CATARACT,33
GB,MYOPATHY,33
GB,SWELLING,33
GB,URINARY INCONTINENCE,33
GB,DYSURIA,32
GB,GASTROOESOPHAGEAL REFLUX DISEASE,32
GB,OEDEMA,32
GB,PRODUCT SUBSTITUTION ISSUE,32
GB,BLOOD BILIRUBIN INCREASED,31
GB,CEREBRAL HAEMORRHAGE,31
GB,GYNAECOMASTIA,31
GB,LIMB DISCOMFORT,31
GB,RASH GENERALISED,31
GB,ARRHYTHMIA,30
GB,DELIRIUM,30
GB,OESOPHAGITIS,30
GB,RENAL DISORDER,30
GB,TREATMENT FAILURE,30
GB,EXPOSURE DURING PREGNANCY,29
GB,FEMUR FRACTURE,29
GB,LOCAL SWELLING,29
GB,NEUROPATHY PERIPHERAL,29
GB,TENDONITIS,29
GB,BURNING SENSATION,28
GB,CHOLELITHIASIS,28
GB,COORDINATION ABNORMAL,28
GB,DEEP VEIN THROMBOSIS,28
GB,DRUG HYPERSENSITIVITY,28
GB,EYELID PTOSIS,28
GB,FLUSHING,28
GB,HYPOXIA,28
GB,MENTAL DISORDER,28
GB,PARAESTHESIA ORAL,28
GB,STEVENS-JOHNSON SYNDROME,28
GB,THROAT TIGHTNESS,28
GB,VENTRICULAR TACHYCARDIA,28
GB,BLOOD MAGNESIUM DECREASED,27
GB,BRONCHOSPASM,27
GB,COMA SCALE ABNORMAL,27
GB,EYE PAIN,27
GB,HIATUS HERNIA,27
GB,NEUTROPHIL COUNT DECREASED,27
GB,OROPHARYNGEAL PAIN,27
GB,PULMONARY FIBROSIS,27
GB,AGEUSIA,26
GB,CHROMATURIA,26
GB,DRUG LEVEL INCREASED,26
GB,HAEMATOMA,26
GB,MOOD ALTERED,26
GB,MULTI-ORGAN FAILURE,26
GB,MUSCLE TWITCHING,26
GB,PNEUMONITIS,26
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,25
GB,ATRIOVENTRICULAR BLOCK,25
GB,BLOOD POTASSIUM DECREASED,25
GB,BONE PAIN,25
GB,CHRONIC KIDNEY DISEASE,25
GB,INCORRECT DOSE ADMINISTERED,25
GB,INCORRECT DRUG ADMINISTRATION DURATION,25
GB,PNEUMONIA ASPIRATION,25
GB,POLLAKIURIA,25
GB,RASH MACULO-PAPULAR,25
GB,WITHDRAWAL SYNDROME,25
GB,ACCIDENTAL OVERDOSE,24
GB,ANGER,24
GB,BLOOD PRESSURE DECREASED,24
GB,BLOOD UREA INCREASED,24
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,24
GB,LEFT VENTRICULAR DYSFUNCTION,24
GB,COLD SWEAT,23
GB,DISCOMFORT,23
GB,DRUG DOSE OMISSION,23
GB,GROIN PAIN,23
GB,HEMIPARESIS,23
GB,HYPOPHAGIA,23
GB,MOUTH SWELLING,23
GB,NEUTROPHIL COUNT INCREASED,23
GB,NOCTURIA,23
GB,OCULAR HYPERAEMIA,23
GB,RHINORRHOEA,23
GB,TEMPORAL ARTERITIS,23
GB,TYPE 2 DIABETES MELLITUS,23
GB,BASAL CELL CARCINOMA,22
GB,DIZZINESS POSTURAL,22
GB,FLATULENCE,22
GB,HOT FLUSH,22
GB,INTERSTITIAL LUNG DISEASE,22
GB,ORAL PAIN,22
GB,SALIVARY HYPERSECRETION,22
GB,SKIN ULCER,22
GB,URINE OUTPUT DECREASED,22
GB,BLOOD PRESSURE ABNORMAL,21
GB,COMPLETED SUICIDE,21
GB,DRUG INTOLERANCE,21
GB,DYSTONIA,21
GB,FACIAL PARALYSIS,21
GB,FEBRILE NEUTROPENIA,21
GB,FLUID RETENTION,21
GB,ISCHAEMIC STROKE,21
GB,PARALYSIS,21
GB,TENDERNESS,21
GB,TOOTHACHE,21
GB,TROPONIN INCREASED,21
GB,VIITH NERVE PARALYSIS,21
GB,DERMATITIS EXFOLIATIVE,20
GB,DYSPNOEA EXERTIONAL,20
GB,HAEMORRHAGE INTRACRANIAL,20
GB,HALLUCINATION_ VISUAL,20
GB,MYDRIASIS,20
GB,NIGHT SWEATS,20
GB,PANCREATITIS ACUTE,20
GB,PRODUCT USE IN UNAPPROVED INDICATION,20
GB,TREATMENT NONCOMPLIANCE,20
GB,URINARY RETENTION,20
GB,ACUTE HEPATIC FAILURE,19
GB,BLADDER CANCER,19
GB,BLOOD SODIUM DECREASED,19
GB,CONTRAINDICATED DRUG ADMINISTERED,19
GB,ERYTHEMA MULTIFORME,19
GB,FAECAL INCONTINENCE,19
GB,HERPES ZOSTER,19
GB,LIVER INJURY,19
GB,MATERNAL EXPOSURE DURING PREGNANCY,19
GB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,19
GB,OLIGURIA,19
GB,PRODUCT USE ISSUE,19
GB,ARTHRITIS,18
GB,BLOOD CALCIUM DECREASED,18
GB,CEREBRAL INFARCTION,18
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,18
GB,DRUG-INDUCED LIVER INJURY,18
GB,EOSINOPHILIA,18
GB,EYE MOVEMENT DISORDER,18
GB,FAECES PALE,18
GB,GASTROINTESTINAL DISORDER,18
GB,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,18
GB,LEFT VENTRICULAR HYPERTROPHY,18
GB,LUNG NEOPLASM MALIGNANT,18
GB,NYSTAGMUS,18
GB,PSYCHIATRIC SYMPTOM,18
GB,STOMATITIS,18
GB,STRESS FRACTURE,18
GB,BLOOD URINE PRESENT,17
GB,DRUG ADMINISTRATION ERROR,17
GB,DUODENAL ULCER PERFORATION,17
GB,EATING DISORDER,17
GB,GASTRIC ULCER HAEMORRHAGE,17
GB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,17
GB,INTESTINAL PERFORATION,17
GB,LARYNGEAL OEDEMA,17
GB,LOSS OF LIBIDO,17
GB,OSTEONECROSIS OF JAW,17
GB,PSYCHOTIC DISORDER,17
GB,PURPURA,17
GB,SKIN IRRITATION,17
GB,SKIN WARM,17
GB,SUBARACHNOID HAEMORRHAGE,17
GB,SUBDURAL HAEMATOMA,17
GB,ABNORMAL BEHAVIOUR,16
GB,AORTIC STENOSIS,16
GB,ARTERIOSCLEROSIS CORONARY ARTERY,16
GB,BLINDNESS,16
GB,BLOOD LACTIC ACID INCREASED,16
GB,BRUXISM,16
GB,COLITIS,16
GB,DUODENAL ULCER,16
GB,FEELING COLD,16
GB,GASTROENTERITIS,16
GB,GENERALISED TONIC-CLONIC SEIZURE,16
GB,HEART RATE IRREGULAR,16
GB,HYPERCALCAEMIA,16
GB,LIVER DISORDER,16
GB,MOOD SWINGS,16
GB,PANCREATITIS,16
GB,PETECHIAE,16
GB,RENAL FAILURE CHRONIC,16
GB,SENSORY DISTURBANCE,16
GB,SEXUAL DYSFUNCTION,16
GB,SKIN LESION,16
GB,TARDIVE DYSKINESIA,16
GB,THROAT IRRITATION,16
GB,TRANSAMINASES INCREASED,16
GB,UVEITIS,16
GB,VASCULITIS,16
GB,ABASIA,15
GB,ACIDOSIS,15
GB,ATRIAL FLUTTER,15
GB,ATRIOVENTRICULAR BLOCK COMPLETE,15
GB,DRUG WITHDRAWAL SYNDROME,15
GB,DYSSTASIA,15
GB,EJACULATION FAILURE,15
GB,EMOTIONAL DISTRESS,15
GB,EPILEPSY,15
GB,FEELING OF BODY TEMPERATURE CHANGE,15
GB,HYPOACUSIS,15
GB,LEUKOPENIA,15
GB,LYMPHOCYTE COUNT DECREASED,15
GB,MENTAL IMPAIRMENT,15
GB,OESOPHAGEAL ULCER,15
GB,PANIC ATTACK,15
GB,PHOTOPHOBIA,15
GB,PLEURITIC PAIN,15
GB,RASH PUSTULAR,15
GB,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,15
GB,ASPARTATE AMINOTRANSFERASE INCREASED,14
GB,B-CELL LYMPHOMA,14
GB,BLOOD POTASSIUM INCREASED,14
GB,BUNDLE BRANCH BLOCK LEFT,14
GB,CONJUNCTIVAL HAEMORRHAGE,14
GB,DELUSION,14
GB,DERMATITIS ALLERGIC,14
GB,DIABETES MELLITUS INADEQUATE CONTROL,14
GB,DISEASE PROGRESSION,14
GB,EXCORIATION,14
GB,EYE PRURITUS,14
GB,GASTRIC ULCER,14
GB,GOUT,14
GB,HEAD DISCOMFORT,14
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,14
GB,INTRAOCULAR PRESSURE INCREASED,14
GB,MIGRAINE WITH AURA,14
GB,MUCOUS MEMBRANE DISORDER,14
GB,NON-CARDIAC CHEST PAIN,14
GB,OESOPHAGEAL PERFORATION,14
GB,PANCREATIC CARCINOMA,14
GB,PELVIC PAIN,14
GB,POTENTIATING DRUG INTERACTION,14
GB,PROSTATE CANCER,14
GB,RESTLESS LEGS SYNDROME,14
GB,SNEEZING,14
GB,TENDON RUPTURE,14
GB,THIRST,14
GB,ADDISON^S DISEASE,13
GB,ADVERSE EVENT,13
GB,AGRANULOCYTOSIS,13
GB,CANDIDA INFECTION,13
GB,CARDIOVASCULAR DISORDER,13
GB,CHOLECYSTITIS ACUTE,13
GB,DEMENTIA,13
GB,DIVERTICULITIS,13
GB,DUODENITIS,13
GB,DYSPHONIA,13
GB,EYELID OEDEMA,13
GB,GASTRIC HAEMORRHAGE,13
GB,IMMUNE THROMBOCYTOPENIC PURPURA,13
GB,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,13
GB,IMPAIRED HEALING,13
GB,LUNG INFECTION,13
GB,MICROCYTIC ANAEMIA,13
GB,MUSCLE RIGIDITY,13
GB,MUSCLE TIGHTNESS,13
GB,ORAL DISCOMFORT,13
GB,PAIN IN JAW,13
GB,PAIN OF SKIN,13
GB,PARKINSON^S DISEASE,13
GB,PHOTOSENSITIVITY REACTION,13
GB,PLANTAR FASCIITIS,13
GB,POLYURIA,13
GB,PROCEDURAL PAIN,13
GB,PULMONARY CONGESTION,13
GB,PULMONARY HAEMORRHAGE,13
GB,RECTOCELE,13
GB,SEDATION,13
GB,SINUS ARREST,13
GB,STRESS,13
GB,TONGUE BITING,13
GB,UPPER RESPIRATORY TRACT INFECTION,13
GB,VENTRICULAR FIBRILLATION,13
GB,ABDOMINAL PAIN LOWER,12
GB,ABDOMINAL WALL HAEMATOMA,12
GB,ABSCESS,12
GB,ANGIOPATHY,12
GB,BLOOD GLUCOSE ABNORMAL,12
GB,BRONCHOPNEUMONIA,12
GB,COMPARTMENT SYNDROME,12
GB,CONJUNCTIVITIS,12
GB,CORONARY ARTERY DISEASE,12
GB,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,12
GB,ELECTROCARDIOGRAM ABNORMAL,12
GB,ELECTROLYTE IMBALANCE,12
GB,FACIAL PARESIS,12
GB,GASTROINTESTINAL ULCER,12
GB,GINGIVITIS,12
GB,HYPOAESTHESIA ORAL,12
GB,HYPOTHYROIDISM,12
GB,IDIOPATHIC PULMONARY FIBROSIS,12
GB,INCONTINENCE,12
GB,INFECTED SKIN ULCER,12
GB,INHIBITORY DRUG INTERACTION,12
GB,IRON DEFICIENCY ANAEMIA,12
GB,IRRITABILITY,12
GB,JOINT STIFFNESS,12
GB,LARGE INTESTINE POLYP,12
GB,LOOSE TOOTH,12
GB,MOVEMENT DISORDER,12
GB,MUSCLE RUPTURE,12
GB,MUSCULOSKELETAL CHEST PAIN,12
GB,OESOPHAGEAL CARCINOMA,12
GB,PERICARDITIS,12
GB,PERIPHERAL ISCHAEMIA,12
GB,PLATELET COUNT INCREASED,12
GB,PSYCHOMOTOR HYPERACTIVITY,12
GB,RALES,12
GB,SEPTIC SHOCK,12
GB,SKIN DISORDER,12
GB,SKIN FISSURES,12
GB,SQUAMOUS CELL CARCINOMA,12
GB,TORSADE DE POINTES,12
GB,VIRAL INFECTION,12
GB,ABDOMINAL SEPSIS,11
GB,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,11
GB,ATYPICAL FEMUR FRACTURE,11
GB,BODY TEMPERATURE INCREASED,11
GB,CARDIOPULMONARY FAILURE,11
GB,CARPAL TUNNEL SYNDROME,11
GB,COAGULOPATHY,11
GB,CROHN^S DISEASE,11
GB,CYSTITIS,11
GB,ELECTROCARDIOGRAM T WAVE INVERSION,11
GB,EOSINOPHIL COUNT INCREASED,11
GB,FOREIGN BODY,11
GB,GLYCOSYLATED HAEMOGLOBIN INCREASED,11
GB,GUILLAIN-BARRE SYNDROME,11
GB,HAEMARTHROSIS,11
GB,HAEMATOCHEZIA,11
GB,HEMIPLEGIA,11
GB,HEPATOTOXICITY,11
GB,HIGH DENSITY LIPOPROTEIN DECREASED,11
GB,HYPERTONIA,11
GB,INFLAMMATORY MARKER INCREASED,11
GB,INTESTINAL ISCHAEMIA,11
GB,LACRIMATION INCREASED,11
GB,LIP BLISTER,11
GB,LOCALISED INFECTION,11
GB,MASS,11
GB,ONYCHOMADESIS,11
GB,ORAL MUCOSAL BLISTERING,11
GB,OSTEOARTHRITIS,11
GB,POLYDIPSIA,11
GB,RASH PAPULAR,11
GB,RHEUMATOID ARTHRITIS,11
GB,SCIATICA,11
GB,SMALL FOR DATES BABY,11
GB,SMALL INTESTINAL OBSTRUCTION,11
GB,SUPRAVENTRICULAR TACHYCARDIA,11
GB,THROMBOSIS,11
GB,WEIGHT LOSS POOR,11
GB,ACUTE INTERSTITIAL PNEUMONITIS,10
GB,ADVERSE DRUG REACTION,10
GB,ANORGASMIA,10
GB,ATAXIA,10
GB,BLOOD PHOSPHORUS DECREASED,10
GB,BODY TEMPERATURE ABNORMAL,10
GB,CHOLANGITIS,10
GB,CHRONIC LYMPHOCYTIC LEUKAEMIA,10
GB,COAGULATION TIME PROLONGED,10
GB,CYANOSIS,10
GB,DERMATITIS,10
GB,DIARRHOEA HAEMORRHAGIC,10
GB,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,10
GB,DYSPNOEA AT REST,10
GB,EAR INFECTION,10
GB,HEAD INJURY,10
GB,HEPATIC ENZYME INCREASED,10
GB,HEPATIC FAILURE,10
GB,HEPATIC STEATOSIS,10
GB,HEPATOMEGALY,10
GB,HYPERCHOLESTEROLAEMIA,10
GB,INTENTIONAL PRODUCT MISUSE,10
GB,LIVER FUNCTION TEST INCREASED,10
GB,LOW DENSITY LIPOPROTEIN INCREASED,10
GB,LUPUS-LIKE SYNDROME,10
GB,MOUTH HAEMORRHAGE,10
GB,NASAL CONGESTION,10
GB,NASOPHARYNGITIS,10
GB,NODULE,10
GB,OCULAR DISCOMFORT,10
GB,PANCREATITIS NECROTISING,10
GB,PARANOIA,10
GB,PARKINSONISM,10
GB,PERIPHERAL COLDNESS,10
GB,POLYARTHRITIS,10
GB,POST PROCEDURAL HAEMORRHAGE,10
GB,PROCTALGIA,10
GB,PROTEINURIA,10
GB,RADIAL NERVE PALSY,10
GB,RENAL PAIN,10
GB,SINUS NODE DYSFUNCTION,10
GB,SINUS TACHYCARDIA,10
GB,TOTAL LUNG CAPACITY DECREASED,10
GB,VITH NERVE PARALYSIS,10
GB,ABORTION SPONTANEOUS,9
GB,ACANTHOSIS,9
GB,ADVERSE REACTION,9
GB,ALVEOLITIS,9
GB,ANAPHYLACTIC SHOCK,9
GB,ANGLE CLOSURE GLAUCOMA,9
GB,ASCITES,9
GB,ASPIRATION,9
GB,ATYPICAL FRACTURE,9
GB,AZOTAEMIA,9
GB,BONE MARROW FAILURE,9
GB,BRAIN NATRIURETIC PEPTIDE INCREASED,9
GB,CAMPYLOBACTER INFECTION,9
GB,CARDIOMEGALY,9
GB,DRUG ERUPTION,9
GB,DRY EYE,9
GB,DRY THROAT,9
GB,ELECTROCARDIOGRAM T WAVE ABNORMAL,9
GB,EXTRAVASATION BLOOD,9
GB,FACIAL NERVE DISORDER,9
GB,GLOSSODYNIA,9
GB,GRAND MAL CONVULSION,9
GB,HAEMORRHAGIC STROKE,9
GB,HAIR COLOUR CHANGES,9
GB,HYPOVENTILATION,9
GB,INGUINAL HERNIA,9
GB,INTENTION TREMOR,9
GB,LACERATION,9
GB,LID LAG,9
GB,MANIA,9
GB,MICTURITION URGENCY,9
GB,MIGRAINE,9
GB,MONOCLONAL B-CELL LYMPHOCYTOSIS,9
GB,MUSCLE INJURY,9
GB,NECROSIS,9
GB,NEPHROPATHY,9
GB,NERVOUSNESS,9
GB,NEUTROPHILIC DERMATOSIS,9
GB,OCULAR MYASTHENIA,9
GB,PIGMENTATION DISORDER,9
GB,PREMATURE BABY,9
GB,PROCEDURAL HAEMORRHAGE,9
GB,PRODUCT QUALITY ISSUE,9
GB,RENAL CYST,9
GB,RETROPERITONEAL HAEMATOMA,9
GB,SCHIZOPHRENIA,9
GB,SENSITIVITY OF TEETH,9
GB,SENSORY LOSS,9
GB,SEROTONIN SYNDROME,9
GB,SKIN OEDEMA,9
GB,SPLENIC RUPTURE,9
GB,THERAPEUTIC RESPONSE UNEXPECTED,9
GB,THROMBOSIS IN DEVICE,9
GB,THROMBOTIC THROMBOCYTOPENIC PURPURA,9
GB,TINEA PEDIS,9
GB,TONGUE DISCOLOURATION,9
GB,TOXIC EPIDERMAL NECROLYSIS,9
GB,VENTRICULAR DYSFUNCTION,9
GB,ACQUIRED HAEMOPHILIA,8
GB,ACUTE MYELOID LEUKAEMIA,8
GB,ADAMTS13 ACTIVITY DECREASED,8
GB,ANTERIOR CHAMBER INFLAMMATION,8
GB,ANURIA,8
GB,ATRIAL TACHYCARDIA,8
GB,BLINDNESS TRANSIENT,8
GB,BLOOD BILIRUBIN ABNORMAL,8
GB,CARDIAC MURMUR,8
GB,CEREBELLAR ATAXIA,8
GB,CHOKING,8
GB,CHOLESTASIS,8
GB,CIRCUMORAL OEDEMA,8
GB,CLAUDICATION OF JAW MUSCLES,8
GB,COMA,8
GB,CORNEAL DEPOSITS,8
GB,DEREALISATION,8
GB,DUODENAL ULCER HAEMORRHAGE,8
GB,ESCHERICHIA SEPSIS,8
GB,EXERCISE TOLERANCE DECREASED,8
GB,FACIAL PAIN,8
GB,GASTRIC DISORDER,8
GB,GASTROINTESTINAL INFECTION,8
GB,HAEMORRHAGE SUBCUTANEOUS,8
GB,HAND-EYE COORDINATION IMPAIRED,8
GB,HEPATIC CIRRHOSIS,8
GB,HYPERSOMNIA,8
GB,HYPOMANIA,8
GB,HYPOVOLAEMIC SHOCK,8
GB,INCREASED UPPER AIRWAY SECRETION,8
GB,ISCHAEMIC CARDIOMYOPATHY,8
GB,LACUNAR INFARCTION,8
GB,LIP PAIN,8
GB,LIVEDO RETICULARIS,8
GB,MUCOSAL INFLAMMATION,8
GB,NAIL DISCOLOURATION,8
GB,OESOPHAGITIS HAEMORRHAGIC,8
GB,PNEUMOPERITONEUM,8
GB,PNEUMOTHORAX,8
GB,POLYMYALGIA RHEUMATICA,8
GB,PRESCRIBED OVERDOSE,8
GB,PRINZMETAL ANGINA,8
GB,RED BLOOD CELL COUNT DECREASED,8
GB,RESPIRATORY TRACT INFECTION,8
GB,RETROPERITONEAL HAEMORRHAGE,8
GB,SKIN HYPERTROPHY,8
GB,SKIN REACTION,8
GB,SOCIAL PROBLEM,8
GB,SPINAL CORD COMPRESSION,8
GB,SPINAL OSTEOARTHRITIS,8
GB,STAPHYLOCOCCAL INFECTION,8
GB,STATUS ASTHMATICUS,8
GB,SUBDURAL HAEMORRHAGE,8
GB,SYSTEMIC LUPUS ERYTHEMATOSUS,8
GB,THINKING ABNORMAL,8
GB,TUNNEL VISION,8
GB,ULCER,8
GB,VASCULAR COMPRESSION,8
GB,VENTRICULAR SEPTAL DEFECT,8
GB,WEIGHT BEARING DIFFICULTY,8
GB,ACUTE LEFT VENTRICULAR FAILURE,7
GB,ACUTE RESPIRATORY DISTRESS SYNDROME,7
GB,ALPHA 1 FOETOPROTEIN INCREASED,7
GB,ARTERITIS,7
GB,ATRIOVENTRICULAR BLOCK SECOND DEGREE,7
GB,BLADDER ADENOCARCINOMA STAGE UNSPECIFIED,7
GB,BLOOD CHOLESTEROL ABNORMAL,7
GB,BLOOD PRESSURE SYSTOLIC INCREASED,7
GB,BRADYPHRENIA,7
GB,BREAST PAIN,7
GB,BREATHING-RELATED SLEEP DISORDER,7
GB,CARDIO-RESPIRATORY ARREST,7
GB,CARDIOGENIC SHOCK,7
GB,CONTRAINDICATED PRODUCT ADMINISTERED,7
GB,CORONARY ARTERY OCCLUSION,7
GB,CRYING,7
GB,DECUBITUS ULCER,7
GB,DIET REFUSAL,7
GB,DIFFUSE ALVEOLAR DAMAGE,7
GB,EAR PAIN,7
GB,EMPHYSEMA,7
GB,EMPYEMA,7
GB,EROSIVE DUODENITIS,7
GB,ESSENTIAL TREMOR,7
GB,FEMORAL NECK FRACTURE,7
GB,FOETAL DEATH,7
GB,FOETAL GROWTH RESTRICTION,7
GB,HAEMOLYSIS,7
GB,HEPATIC CANCER METASTATIC,7
GB,HEPATITIS ACUTE,7
GB,HYPERSENSITIVITY VASCULITIS,7
GB,INFLAMMATION,7
GB,INFUSION RELATED REACTION,7
GB,INTENTIONAL PRODUCT USE ISSUE,7
GB,INTERMITTENT CLAUDICATION,7
GB,INTESTINAL DIAPHRAGM DISEASE,7
GB,ISCHAEMIA,7
GB,JAUNDICE CHOLESTATIC,7
GB,JOINT EFFUSION,7
GB,JOINT WARMTH,7
GB,LEFT VENTRICULAR FAILURE,7
GB,LICHENOID KERATOSIS,7
GB,MALIGNANT NEOPLASM PROGRESSION,7
GB,MUSCLE CONTRACTURE,7
GB,MUSCULOSKELETAL DISCOMFORT,7
GB,NEPHROPATHY TOXIC,7
GB,OSTEOMYELITIS,7
GB,PERIPHERAL VASCULAR DISORDER,7
GB,PHOTOPSIA,7
GB,PNEUMOBILIA,7
GB,POOR QUALITY SLEEP,7
GB,PRESCRIBED UNDERDOSE,7
GB,PRODUCT PACKAGING CONFUSION,7
GB,PROSTATE CANCER METASTATIC,7
GB,PULMONARY HYPERTENSION,7
GB,REACTION TO DRUG EXCIPIENTS,7
GB,RHINITIS ALLERGIC,7
GB,SEIZURE LIKE PHENOMENA,7
GB,STARING,7
GB,STRABISMUS,7
GB,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,7
GB,SYNOVIAL DISORDER,7
GB,TEARFULNESS,7
GB,TOOTH DISORDER,7
GB,TRANSPOSITION OF THE GREAT VESSELS,7
GB,TRIGGER FINGER,7
GB,UPPER-AIRWAY COUGH SYNDROME,7
GB,VASCULITIC RASH,7
GB,VERBAL ABUSE,7
GB,ABDOMINAL SYMPTOM,6
GB,ACOUSTIC NEUROMA,6
GB,ALVEOLITIS ALLERGIC,6
GB,ANAPHYLACTOID REACTION,6
GB,APATHY,6
GB,APHAGIA,6
GB,ARTHROPATHY,6
GB,BEDRIDDEN,6
GB,BILIARY SEPSIS,6
GB,BLADDER CANCER STAGE 0_ WITH CANCER IN SITU,6
GB,BLEEDING TIME PROLONGED,6
GB,BLOOD ALBUMIN DECREASED,6
GB,BLOOD GLUCOSE DECREASED,6
GB,BRAIN INJURY,6
GB,BRONCHITIS,6
GB,CHILLBLAINS,6
GB,CHOLECYSTITIS,6
GB,CLONIC CONVULSION,6
GB,CLOSTRIDIUM DIFFICILE COLITIS,6
GB,CONCOMITANT DISEASE PROGRESSION,6
GB,CONGENITAL BLADDER ANOMALY,6
GB,CONGENITAL HYDRONEPHROSIS,6
GB,DIABETIC RETINOPATHY,6
GB,DIVERTICULUM,6
GB,DRUG DISPENSED TO WRONG PATIENT,6
GB,ENCEPHALITIS,6
GB,ESCHERICHIA URINARY TRACT INFECTION,6
GB,EXFOLIATIVE RASH,6
GB,EXTRADURAL HAEMATOMA,6
GB,EYE COLOUR CHANGE,6
GB,EYE HAEMORRHAGE,6
GB,FEEDING DISORDER,6
GB,FOETAL CHROMOSOME ABNORMALITY,6
GB,FOETAL PLACENTAL THROMBOSIS,6
GB,FOOD INTERACTION,6
GB,GASTRIC MUCOSAL LESION,6
GB,GASTRIC ULCER PERFORATION,6
GB,GASTROENTERITIS VIRAL,6
GB,GASTROINTESTINAL PAIN,6
GB,HAEMORRHAGIC TRANSFORMATION STROKE,6
GB,HALLUCINATIONS_ MIXED,6
GB,HEARING IMPAIRED,6
GB,HIP FRACTURE,6
GB,HUNGER,6
GB,HYDRONEPHROSIS,6
GB,HYPERMETROPIA,6
GB,HYPERTHYROIDISM,6
GB,HYPERVENTILATION,6
GB,HYPOPHOSPHATAEMIA,6
GB,INAPPROPRIATE AFFECT,6
GB,INFLUENZA,6
GB,JOINT LOCK,6
GB,LARGE INTESTINAL ULCER,6
GB,LIVER ABSCESS,6
GB,LOGORRHOEA,6
GB,LOWER GASTROINTESTINAL HAEMORRHAGE,6
GB,MADAROSIS,6
GB,METASTASES TO LIVER,6
GB,MUCOUS STOOLS,6
GB,NEUROLOGICAL SYMPTOM,6
GB,ORAL CANDIDIASIS,6
GB,PARAKERATOSIS,6
GB,PARTIAL SEIZURES,6
GB,PENIS DISORDER,6
GB,PERIORBITAL OEDEMA,6
GB,PLACENTAL INFARCTION,6
GB,PLACENTAL INSUFFICIENCY,6
GB,PREMATURE LABOUR,6
GB,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,6
GB,PULMONARY FUNCTION TEST DECREASED,6
GB,PYELOCALIECTASIS,6
GB,RESPIRATORY DEPRESSION,6
GB,RESPIRATORY DISTRESS,6
GB,RESPIRATORY TRACT OEDEMA,6
GB,SENSATION OF HEAVINESS,6
GB,SINGLE UMBILICAL ARTERY,6
GB,SPLENOMEGALY,6
GB,STAPHYLOCOCCAL BACTERAEMIA,6
GB,STAPHYLOCOCCAL SEPSIS,6
GB,SUDDEN DEATH,6
GB,THROAT LESION,6
GB,TONGUE DISCOMFORT,6
GB,TONGUE OEDEMA,6
GB,TONGUE ULCERATION,6
GB,TONIC CLONIC MOVEMENTS,6
GB,TROPONIN T INCREASED,6
GB,VITILIGO,6
GB,WRONG TECHNIQUE IN DRUG USAGE PROCESS,6
GB,ABDOMINAL TENDERNESS,5
GB,ACQUIRED EPIDERMOLYSIS BULLOSA,5
GB,AMENORRHOEA,5
GB,ANAL ULCER,5
GB,ANISOCYTOSIS,5
GB,AORTIC ANEURYSM,5
GB,BLISTER RUPTURE,5
GB,BLOOD CREATININE ABNORMAL,5
GB,BLOOD PRESSURE FLUCTUATION,5
GB,BRAIN NEOPLASM,5
GB,BREAST CANCER,5
GB,BUNDLE BRANCH BLOCK RIGHT,5
GB,CARDIOMYOPATHY,5
GB,CHEMICAL BURN OF RESPIRATORY TRACT,5
GB,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,5
GB,CLUSTER HEADACHE,5
GB,COLITIS MICROSCOPIC,5
GB,CONTRAINDICATION TO MEDICAL TREATMENT,5
GB,CYTOGENETIC ABNORMALITY,5
GB,DECREASED INTEREST,5
GB,DEMENTIA ALZHEIMER^S TYPE,5
GB,DERMATITIS BULLOUS,5
GB,DEVICE RELATED INFECTION,5
GB,DISSOCIATION,5
GB,DROOLING,5
GB,DYSLIPIDAEMIA,5
GB,EAR DISCOMFORT,5
GB,ECCHYMOSIS,5
GB,ENERGY INCREASED,5
GB,EPIGLOTTIS ULCER,5
GB,EPIGLOTTITIS,5
GB,ESCHERICHIA BACTERAEMIA,5
GB,ESSENTIAL HYPERTENSION,5
GB,EXTENSOR PLANTAR RESPONSE,5
GB,FEELING DRUNK,5
GB,FUNGAL INFECTION,5
GB,FURUNCLE,5
GB,GASTROINTESTINAL WALL THICKENING,5
GB,GENITAL BLISTER,5
GB,GINGIVAL SWELLING,5
GB,HAEMOTHORAX,5
GB,HAIR GROWTH ABNORMAL,5
GB,HAND-ARM VIBRATION SYNDROME,5
GB,HEPATIC FIBROSIS,5
GB,HEPATITIS E,5
GB,HERPES SIMPLEX,5
GB,HOSPITALISATION,5
GB,HYPERCHLORHYDRIA,5
GB,HYPOGAMMAGLOBULINAEMIA,5
GB,IMMOBILE,5
GB,IMMUNE SYSTEM DISORDER,5
GB,INCORRECT ROUTE OF DRUG ADMINISTRATION,5
GB,INJURY,5
GB,INTESTINAL OBSTRUCTION,5
GB,INTRA-ABDOMINAL HAEMORRHAGE,5
GB,LARYNGEAL ULCERATION,5
GB,LIGAMENT INJURY,5
GB,LUNG ADENOCARCINOMA,5
GB,LUNG CONSOLIDATION,5
GB,LYMPHOCYTIC INFILTRATION,5
GB,LYMPHOCYTOSIS,5
GB,MENISCUS INJURY,5
GB,METABOLIC ALKALOSIS,5
GB,MITRAL VALVE INCOMPETENCE,5
GB,MOTOR NEURONE DISEASE,5
GB,MYASTHENIA GRAVIS,5
GB,NAEVUS FLAMMEUS,5
GB,NASAL DRYNESS,5
GB,NEEDLE ISSUE,5
GB,NEOPLASM MALIGNANT,5
GB,NERVOUS SYSTEM DISORDER,5
GB,OESOPHAGEAL CANDIDIASIS,5
GB,PAINFUL ERECTION,5
GB,PLASMA CELL MYELOMA,5
GB,PLEURISY,5
GB,PNEUMOCYSTIS JIROVECII PNEUMONIA,5
GB,POIKILOCYTOSIS,5
GB,POST PROCEDURAL HAEMATOMA,5
GB,PREMATURE DELIVERY,5
GB,RESPIRATORY ARREST,5
GB,RIGHT VENTRICULAR FAILURE,5
GB,SCLERAL DISCOLOURATION,5
GB,SCROTAL DISORDER,5
GB,SCROTAL SWELLING,5
GB,SHOCK,5
GB,SICK SINUS SYNDROME,5
GB,SKIN EROSION,5
GB,SKIN MASS,5
GB,SKIN NECROSIS,5
GB,SKIN TIGHTNESS,5
GB,SPINAL COLUMN STENOSIS,5
GB,STREPTOCOCCAL INFECTION,5
GB,SUPERFICIAL VEIN PROMINENCE,5
GB,SUSPICIOUSNESS,5
GB,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,5
GB,SYSTOLIC DYSFUNCTION,5
GB,TELANGIECTASIA,5
GB,TENDON PAIN,5
GB,TENOSYNOVITIS,5
GB,TESTICULAR HYPERTROPHY,5
GB,TROPONIN I INCREASED,5
GB,ULTRASOUND ANTENATAL SCREEN,5
GB,URINARY BLADDER HAEMORRHAGE,5
US,FATIGUE,6744
US,GASTROINTESTINAL HAEMORRHAGE,6619
US,DRUG INEFFECTIVE,5503
US,DYSPNOEA,5377
US,DIARRHOEA,5321
US,MYOCARDIAL INFARCTION,5013
US,NAUSEA,4971
US,DIZZINESS,4139
US,HEADACHE,3700
US,FALL,3694
US,ASTHENIA,3615
US,PAIN,3456
US,CARDIAC FAILURE CONGESTIVE,3296
US,PNEUMONIA,3204
US,CEREBROVASCULAR ACCIDENT,2989
US,WEIGHT DECREASED,2784
US,MALAISE,2747
US,DRUG DOSE OMISSION,2722
US,DEATH,2712
US,PAIN IN EXTREMITY,2678
US,ARTHRALGIA,2653
US,RASH,2558
US,VOMITING,2495
US,ANAEMIA,2410
US,CHEST PAIN,2290
US,COUGH,2282
US,BACK PAIN,2186
US,INSOMNIA,2166
US,CONSTIPATION,2146
US,PRURITUS,2105
US,DECREASED APPETITE,2015
US,HYPERTENSION,1975
US,GAIT DISTURBANCE,1886
US,MUSCLE SPASMS,1852
US,CORONARY ARTERY DISEASE,1795
US,FEELING ABNORMAL,1778
US,DRUG HYPERSENSITIVITY,1665
US,EPISTAXIS,1655
US,PERIPHERAL SWELLING,1619
US,URINARY TRACT INFECTION,1615
US,PYREXIA,1601
US,ATRIAL FIBRILLATION,1568
US,ANXIETY,1564
US,CONTUSION,1545
US,HYPOTENSION,1535
US,WEIGHT INCREASED,1535
US,DEPRESSION,1497
US,ABDOMINAL PAIN UPPER,1474
US,ABDOMINAL DISCOMFORT,1369
US,ACUTE MYOCARDIAL INFARCTION,1351
US,HAEMORRHAGE,1346
US,NASOPHARYNGITIS,1335
US,DEHYDRATION,1314
US,MYALGIA,1312
US,BLOOD GLUCOSE INCREASED,1305
US,ABDOMINAL PAIN,1254
US,PRODUCT QUALITY ISSUE,1245
US,ACUTE KIDNEY INJURY,1241
US,HYPOAESTHESIA,1226
US,OEDEMA PERIPHERAL,1207
US,PARAESTHESIA,1185
US,PRODUCT USE ISSUE,1174
US,BLOOD PRESSURE INCREASED,1168
US,FLUSHING,1161
US,INJECTION SITE PAIN,1146
US,RECTAL HAEMORRHAGE,1144
US,TREMOR,1142
US,MEMORY IMPAIRMENT,1128
US,MUSCULAR WEAKNESS,1127
US,CONDITION AGGRAVATED,1120
US,SOMNOLENCE,1118
US,CONFUSIONAL STATE,1073
US,NEUROPATHY PERIPHERAL,1068
US,HAEMOGLOBIN DECREASED,1065
US,ALOPECIA,1038
US,UPPER GASTROINTESTINAL HAEMORRHAGE,1038
US,VISION BLURRED,1031
US,INCORRECT DOSE ADMINISTERED,989
US,GASTROOESOPHAGEAL REFLUX DISEASE,978
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,976
US,BALANCE DISORDER,974
US,THROMBOSIS,962
US,DYSPEPSIA,954
US,INTENTIONAL PRODUCT MISUSE,949
US,SINUSITIS,938
US,WHITE BLOOD CELL COUNT DECREASED,920
US,CEREBRAL HAEMORRHAGE,918
US,BRONCHITIS,907
US,ERYTHEMA,903
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,893
US,HAEMATURIA,861
US,CARDIAC DISORDER,853
US,PLATELET COUNT DECREASED,846
US,ARTHRITIS,834
US,HYPERHIDROSIS,829
US,SYNCOPE,818
US,DEEP VEIN THROMBOSIS,816
US,INFLUENZA,813
US,RENAL FAILURE,809
US,CHEST DISCOMFORT,800
US,HYPERSENSITIVITY,800
US,DYSGEUSIA,797
US,CHILLS,796
US,SEPSIS,790
US,LOSS OF CONSCIOUSNESS,780
US,JOINT SWELLING,776
US,PULMONARY EMBOLISM,750
US,DRY MOUTH,745
US,CATARACT,737
US,MUSCULOSKELETAL PAIN,735
US,VISUAL IMPAIRMENT,723
US,PLASMA CELL MYELOMA,715
US,HAEMORRHAGIC ANAEMIA,706
US,TRANSIENT ISCHAEMIC ATTACK,703
US,OROPHARYNGEAL PAIN,698
US,ABDOMINAL DISTENSION,690
US,HEART RATE INCREASED,689
US,PALPITATIONS,688
US,URTICARIA,685
US,DYSPHAGIA,678
US,PSORIASIS,667
US,INJECTION SITE BRUISING,631
US,HOT FLUSH,628
US,DYSPHONIA,627
US,RESPIRATORY FAILURE,623
US,DIABETES MELLITUS,612
US,DISEASE PROGRESSION,611
US,THROMBOCYTOPENIA,611
US,LOWER GASTROINTESTINAL HAEMORRHAGE,604
US,INFECTION,603
US,AMNESIA,600
US,RHINORRHOEA,588
US,FLUID RETENTION,584
US,BURNING SENSATION,570
US,INTERNAL HAEMORRHAGE,566
US,FLATULENCE,565
US,NEUTROPENIA,562
US,OSTEOARTHRITIS,561
US,HAEMATOCHEZIA,555
US,SWELLING,548
US,DRY SKIN,547
US,CORONARY ARTERIAL STENT INSERTION,543
US,CARDIAC ARREST,538
US,BLOOD CHOLESTEROL INCREASED,536
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,534
US,PLEURAL EFFUSION,532
US,CELLULITIS,525
US,INJECTION SITE HAEMORRHAGE,525
US,NASAL CONGESTION,525
US,SEIZURE,524
US,COAGULOPATHY,520
US,NECK PAIN,520
US,MUSCULOSKELETAL STIFFNESS,516
US,INFLUENZA LIKE ILLNESS,515
US,RENAL FAILURE ACUTE,514
US,BLOOD PRESSURE DECREASED,510
US,HAEMOPTYSIS,509
US,THERAPY CESSATION,505
US,TYPE 2 DIABETES MELLITUS,503
US,STOMATITIS,500
US,OEDEMA,492
US,ULCER HAEMORRHAGE,490
US,UNEVALUABLE EVENT,489
US,DRUG EFFECT DECREASED,486
US,ANGINA PECTORIS,485
US,UPPER RESPIRATORY TRACT INFECTION,484
US,ARTHROPATHY,482
US,ASTHMA,481
US,DRUG INTOLERANCE,481
US,CORONARY ARTERY OCCLUSION,477
US,BLOOD CREATININE INCREASED,468
US,ADVERSE EVENT,466
US,CORONARY ARTERY BYPASS,462
US,OSTEOPOROSIS,457
US,THERAPEUTIC RESPONSE UNEXPECTED,457
US,HERPES ZOSTER,456
US,POLLAKIURIA,455
US,OVERDOSE,453
US,NERVOUSNESS,451
US,ADVERSE DRUG REACTION,450
US,FEELING HOT,444
US,INJURY,444
US,HALLUCINATION,443
US,BONE PAIN,442
US,INJECTION SITE ERYTHEMA,439
US,HAEMATOMA,437
US,RHEUMATOID ARTHRITIS,431
US,UNDERDOSE,429
US,DRUG EFFECT INCOMPLETE,420
US,SKIN DISCOLOURATION,419
US,RASH PRURITIC,417
US,FULL BLOOD COUNT DECREASED,414
US,STRESS,413
US,DYSPNOEA EXERTIONAL,412
US,HAEMORRHAGE INTRACRANIAL,411
US,MALIGNANT NEOPLASM PROGRESSION,411
US,PRODUCTIVE COUGH,403
US,MULTIPLE INJURIES,402
US,PULMONARY OEDEMA,397
US,CARDIAC FAILURE,395
US,GASTROINTESTINAL DISORDER,395
US,SLEEP DISORDER,393
US,SWELLING FACE,392
US,BODY HEIGHT DECREASED,391
US,MIGRAINE,389
US,NEPHROLITHIASIS,387
US,LETHARGY,384
US,BLOOD GLUCOSE DECREASED,383
US,MOBILITY DECREASED,383
US,HIP FRACTURE,375
US,MULTIPLE SCLEROSIS RELAPSE,374
US,BLOOD POTASSIUM DECREASED,373
US,BLISTER,372
US,WHEEZING,372
US,RENAL IMPAIRMENT,371
US,SKIN EXFOLIATION,366
US,DRUG ADMINISTRATION ERROR,356
US,PRODUCT USE IN UNAPPROVED INDICATION,354
US,VERTIGO,354
US,RENAL DISORDER,346
US,DYSURIA,344
US,VISUAL ACUITY REDUCED,344
US,TACHYCARDIA,343
US,HEPATIC ENZYME INCREASED,341
US,GASTRIC DISORDER,339
US,CYSTITIS,334
US,INTENTIONAL PRODUCT USE ISSUE,334
US,SLEEP APNOEA SYNDROME,332
US,INCORRECT DRUG ADMINISTRATION DURATION,329
US,LOCAL SWELLING,329
US,ABASIA,328
US,ANGINA UNSTABLE,328
US,PANCREATITIS,326
US,SUBDURAL HAEMATOMA,326
US,BLOOD URINE PRESENT,323
US,DIVERTICULITIS,320
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,320
US,RED BLOOD CELL COUNT DECREASED,319
US,HOSPITALISATION,318
US,BRADYCARDIA,317
US,HEAD INJURY,317
US,SPEECH DISORDER,315
US,ORAL PAIN,313
US,ARRHYTHMIA,312
US,HYPOACUSIS,311
US,TOXICITY TO VARIOUS AGENTS,310
US,THROAT IRRITATION,308
US,HAEMORRHAGIC STROKE,307
US,PANCYTOPENIA,305
US,RIB FRACTURE,303
US,OXYGEN SATURATION DECREASED,302
US,MENTAL STATUS CHANGES,300
US,HEART RATE DECREASED,298
US,GASTRITIS,297
US,DEVICE MALFUNCTION,295
US,GOUT,294
US,HYPOXIA,294
US,PAIN IN JAW,293
US,LIMB DISCOMFORT,291
US,LABORATORY TEST ABNORMAL,290
US,ACUTE RESPIRATORY FAILURE,286
US,AGITATION,286
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,285
US,FAECES DISCOLOURED,285
US,NIGHT SWEATS,283
US,URINARY INCONTINENCE,283
US,ROAD TRAFFIC ACCIDENT,282
US,EYE PAIN,281
US,IMPAIRED HEALING,281
US,WHITE BLOOD CELL COUNT INCREASED,281
US,ACTIVITIES OF DAILY LIVING IMPAIRED,279
US,HYPOKALAEMIA,279
US,INTERNATIONAL NORMALISED RATIO INCREASED,279
US,STAPHYLOCOCCAL INFECTION,278
US,INTERVERTEBRAL DISC PROTRUSION,277
US,HYPOTHYROIDISM,270
US,TINNITUS,270
US,HEART RATE IRREGULAR,269
US,LIMB INJURY,269
US,CHOLELITHIASIS,268
US,TOOTH DISORDER,268
US,HYPONATRAEMIA,266
US,IRRITABILITY,265
US,HYPERLIPIDAEMIA,264
US,DRY EYE,258
US,CHRONIC KIDNEY DISEASE,257
US,PERICARDIAL EFFUSION,257
US,COGNITIVE DISORDER,256
US,INJECTION SITE PRURITUS,256
US,AGEUSIA,255
US,TREATMENT NONCOMPLIANCE,255
US,PULMONARY HYPERTENSION,254
US,ISCHAEMIC STROKE,252
US,MELAENA,252
US,RASH GENERALISED,252
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,251
US,URINARY RETENTION,251
US,ALANINE AMINOTRANSFERASE INCREASED,249
US,DISTURBANCE IN ATTENTION,249
US,BONE DISORDER,245
US,LACERATION,244
US,LUNG DISORDER,244
US,MYOCARDIAL ISCHAEMIA,242
US,JOINT INJURY,241
US,EMOTIONAL DISTRESS,240
US,GENERAL PHYSICAL HEALTH DETERIORATION,240
US,CLOSTRIDIUM DIFFICILE INFECTION,238
US,HIATUS HERNIA,238
US,RASH ERYTHEMATOUS,238
US,ASPARTATE AMINOTRANSFERASE INCREASED,237
US,LOCALISED INFECTION,237
US,PRURITUS GENERALISED,237
US,INCREASED TENDENCY TO BRUISE,236
US,DYSSTASIA,235
US,DISCOMFORT,234
US,PULMONARY MASS,234
US,HAEMATEMESIS,231
US,GASTRIC ULCER,230
US,LACRIMATION INCREASED,230
US,FEMUR FRACTURE,229
US,DISORIENTATION,228
US,HYPERSOMNIA,228
US,CARDIO-RESPIRATORY ARREST,227
US,IRON DEFICIENCY ANAEMIA,227
US,DEPRESSED MOOD,226
US,HYPOGLYCAEMIA,224
US,SKIN ULCER,223
US,CARDIOMYOPATHY,222
US,DYSARTHRIA,222
US,HYPERGLYCAEMIA,222
US,SINUS DISORDER,222
US,STENT PLACEMENT,222
US,SUICIDAL IDEATION,222
US,VAGINAL HAEMORRHAGE,221
US,DEMENTIA,220
US,SEPTIC SHOCK,220
US,INJECTION SITE SWELLING,219
US,BLINDNESS,217
US,HAEMORRHOIDS,217
US,CONVULSION,216
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,216
US,UPPER LIMB FRACTURE,216
US,CHROMATURIA,215
US,FEELING COLD,214
US,FUNGAL INFECTION,214
US,MUSCULOSKELETAL DISCOMFORT,214
US,FOOT FRACTURE,213
US,LUNG NEOPLASM MALIGNANT,213
US,COLITIS,209
US,OCULAR HYPERAEMIA,209
US,DEVICE ISSUE,208
US,SWOLLEN TONGUE,208
US,EYE DISORDER,207
US,GASTRIC ULCER HAEMORRHAGE,207
US,HYPERKALAEMIA,207
US,RASH MACULAR,206
US,PRESYNCOPE,204
US,HAEMATOCRIT DECREASED,203
US,SURGERY,203
US,BACK DISORDER,202
US,DYSKINESIA,201
US,LEUKOCYTOSIS,201
US,OSTEOMYELITIS,201
US,ACNE,200
US,BLOOD COUNT ABNORMAL,200
US,EYE IRRITATION,199
US,INJECTION SITE MASS,199
US,ARTERIOSCLEROSIS,198
US,APHASIA,197
US,JOINT STIFFNESS,197
US,FLUID OVERLOAD,196
US,INTESTINAL OBSTRUCTION,196
US,NEURALGIA,196
US,BREAST CANCER,194
US,CROHN^S DISEASE,194
US,EYE SWELLING,194
US,MEDICATION ERROR,194
US,FIBROMYALGIA,193
US,HAEMORRHAGIC ARTERIOVENOUS MALFORMATION,192
US,LIP SWELLING,192
US,THERAPEUTIC RESPONSE DECREASED,192
US,DRUG PRESCRIBING ERROR,191
US,SKIN DISORDER,191
US,ABNORMAL DREAMS,190
US,GLAUCOMA,189
US,RETCHING,189
US,ROTATOR CUFF SYNDROME,189
US,VIRAL INFECTION,189
US,ARTERIOSCLEROSIS CORONARY ARTERY,188
US,HYPOPHAGIA,188
US,OSTEOPENIA,188
US,DEAFNESS,187
US,SPINAL FRACTURE,187
US,LIVER FUNCTION TEST ABNORMAL,186
US,POST PROCEDURAL HAEMORRHAGE,186
US,MOVEMENT DISORDER,185
US,ACUTE CORONARY SYNDROME,184
US,INTENTIONAL DRUG MISUSE,184
US,LYMPHADENOPATHY,184
US,CARPAL TUNNEL SYNDROME,183
US,DIVERTICULUM INTESTINAL HAEMORRHAGIC,183
US,MULTIPLE SCLEROSIS,183
US,VITAMIN D DEFICIENCY,182
US,GINGIVAL BLEEDING,181
US,MUSCULOSKELETAL CHEST PAIN,181
US,ANGIOEDEMA,180
US,EXPIRED PRODUCT ADMINISTERED,180
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,180
US,INTERVERTEBRAL DISC DEGENERATION,180
US,SPINAL OSTEOARTHRITIS,180
US,BLOOD PRESSURE ABNORMAL,179
US,PRODUCT SUBSTITUTION ISSUE,179
US,GASTROENTERITIS VIRAL,178
US,WOUND,178
US,FEBRILE NEUTROPENIA,177
US,GASTRIC HAEMORRHAGE,177
US,INJECTION SITE REACTION,177
US,SKIN BURNING SENSATION,177
US,RESTLESS LEGS SYNDROME,176
US,VENTRICULAR TACHYCARDIA,176
US,ERUCTATION,175
US,LUNG INFECTION,175
US,ARTERIAL OCCLUSIVE DISEASE,173
US,NEOPLASM MALIGNANT,173
US,BASAL CELL CARCINOMA,171
US,CHOKING,171
US,HEMIPARESIS,169
US,NEUTROPHIL COUNT DECREASED,169
US,NIGHTMARE,169
US,PANIC ATTACK,169
US,SUBARACHNOID HAEMORRHAGE,169
US,NOCTURIA,168
US,SHOCK HAEMORRHAGIC,168
US,DIPLOPIA,167
US,PRODUCT ADHESION ISSUE,167
US,APPLICATION SITE ERYTHEMA,166
US,DIVERTICULUM,166
US,EYE HAEMORRHAGE,166
US,GLOSSODYNIA,165
US,PROSTATE CANCER,165
US,RHABDOMYOLYSIS,165
US,BLOOD TESTOSTERONE DECREASED,164
US,ECCHYMOSIS,164
US,GALLBLADDER DISORDER,164
US,SPINAL COLUMN STENOSIS,164
US,BLOOD TRIGLYCERIDES INCREASED,163
US,SEASONAL ALLERGY,163
US,BLOOD PRESSURE FLUCTUATION,162
US,TOOTHACHE,162
US,EATING DISORDER,160
US,EAR INFECTION,158
US,IRRITABLE BOWEL SYNDROME,158
US,ATRIAL FLUTTER,157
US,CEREBRAL INFARCTION,157
US,FEELING JITTERY,157
US,PRESCRIBED UNDERDOSE,157
US,ANKLE FRACTURE,156
US,SKIN LESION,156
US,NO ADVERSE EVENT,155
US,POOR QUALITY SLEEP,155
US,PRE-EXISTING CONDITION IMPROVED,155
US,ATELECTASIS,154
US,DRUG WITHDRAWAL SYNDROME,153
US,HERNIA,153
US,VITAMIN D DECREASED,153
US,CRYING,152
US,HAEMORRHOIDAL HAEMORRHAGE,152
US,SCIATICA,152
US,ANAPHYLACTIC REACTION,151
US,RESPIRATORY TRACT CONGESTION,151
US,UNRESPONSIVE TO STIMULI,151
US,CANDIDA INFECTION,150
US,SKIN CANCER,150
US,THYROID DISORDER,150
US,BLOOD POTASSIUM INCREASED,148
US,INFLAMMATION,148
US,LOWER LIMB FRACTURE,147
US,MENTAL DISORDER,147
US,SNEEZING,147
US,DIABETIC KETOACIDOSIS,146
US,ORTHOSTATIC HYPOTENSION,146
US,VASCULAR GRAFT,146
US,ABNORMAL BEHAVIOUR,145
US,BLOOD SODIUM DECREASED,143
US,RESPIRATORY DISORDER,143
US,ULCER,143
US,RESPIRATORY DISTRESS,142
US,MENTAL IMPAIRMENT,141
US,APPLICATION SITE PRURITUS,140
US,CARDIOMEGALY,140
US,DRUG DISPENSING ERROR,140
US,SINUS CONGESTION,140
US,MACULAR DEGENERATION,139
US,PANCREATITIS ACUTE,139
US,LIVER DISORDER,138
US,PLATELET COUNT INCREASED,138
US,INJECTION SITE NODULE,137
US,LEUKOPENIA,137
US,OSTEONECROSIS OF JAW,137
US,CARDIOVASCULAR DISORDER,136
US,KNEE ARTHROPLASTY,136
US,MITRAL VALVE INCOMPETENCE,136
US,PNEUMONIA ASPIRATION,136
US,THROMBOTIC THROMBOCYTOPENIC PURPURA,136
US,ANGER,135
US,RESPIRATORY TRACT INFECTION,135
US,AGGRESSION,134
US,EXOSTOSIS,134
US,BLOOD GLUCOSE ABNORMAL,133
US,ENCEPHALOPATHY,133
US,EXTRA DOSE ADMINISTERED,133
US,NERVOUS SYSTEM DISORDER,133
US,TOOTH INFECTION,133
US,BLOOD MAGNESIUM DECREASED,132
US,EYE PRURITUS,132
US,MULTIPLE FRACTURES,132
US,PHARYNGEAL OEDEMA,132
US,BLOOD UREA INCREASED,131
US,BURSITIS,131
US,EAR PAIN,131
US,MUSCLE TWITCHING,131
US,FREQUENT BOWEL MOVEMENTS,130
US,DELIRIUM,129
US,MASS,129
US,INFUSION RELATED REACTION,128
US,THINKING ABNORMAL,127
US,THROAT TIGHTNESS,127
US,TRANSFUSION,127
US,INCONTINENCE,126
US,KIDNEY INFECTION,126
US,PALLOR,126
US,PULMONARY ARTERIAL HYPERTENSION,126
US,RESTLESSNESS,126
US,CLOSTRIDIUM DIFFICILE COLITIS,125
US,EMPHYSEMA,125
US,FEEDING DISORDER,124
US,MUSCULOSKELETAL DISORDER,124
US,PULMONARY THROMBOSIS,124
US,ABNORMAL LOSS OF WEIGHT,123
US,SKIN IRRITATION,123
US,BLOOD BILIRUBIN INCREASED,122
US,HYPERCALCAEMIA,122
US,PSORIATIC ARTHROPATHY,122
US,AORTIC ANEURYSM,121
US,HYPOKINESIA,121
US,PULMONARY CONGESTION,121
US,COMA,120
US,EJECTION FRACTION DECREASED,120
US,ERECTILE DYSFUNCTION,120
US,INCREASED APPETITE,119
US,ISCHAEMIC CARDIOMYOPATHY,119
US,MOOD SWINGS,119
US,MOUTH HAEMORRHAGE,119
US,NEOPLASM PROGRESSION,119
US,THROMBOSIS IN DEVICE,119
US,DIABETIC NEUROPATHY,118
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,118
US,ILL-DEFINED DISORDER,118
US,LARGE INTESTINE POLYP,118
US,RENAL FAILURE CHRONIC,118
US,SPINAL COMPRESSION FRACTURE,118
US,BLOOD CALCIUM INCREASED,117
US,MUSCLE TIGHTNESS,117
US,WEIGHT FLUCTUATION,117
US,TOOTH FRACTURE,116
US,ABDOMINAL PAIN LOWER,115
US,FEAR,115
US,INCORRECT PRODUCT STORAGE,115
US,SUPRAVENTRICULAR TACHYCARDIA,115
US,APPLICATION SITE PAIN,114
US,BLOOD IRON DECREASED,114
US,HAIR COLOUR CHANGES,114
US,HEARING IMPAIRED,114
US,MOOD ALTERED,114
US,WRIST FRACTURE,114
US,ASCITES,113
US,BACK INJURY,113
US,COLD SWEAT,113
US,HAIR TEXTURE ABNORMAL,113
US,COLITIS ULCERATIVE,112
US,PARKINSON^S DISEASE,112
US,PERIPHERAL COLDNESS,112
US,SQUAMOUS CELL CARCINOMA OF SKIN,112
US,CARDIOGENIC SHOCK,111
US,PERIPHERAL VASCULAR DISORDER,111
US,DENTAL CARIES,110
US,OESOPHAGITIS,110
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,110
US,PNEUMONITIS,110
US,PRESCRIBED OVERDOSE,110
US,SMALL INTESTINAL OBSTRUCTION,110
US,VENTRICULAR EXTRASYSTOLES,110
US,WITHDRAWAL SYNDROME,110
US,DEVICE RELATED INFECTION,109
US,HEPATIC STEATOSIS,109
US,METABOLIC ACIDOSIS,109
US,PRODUCT PHYSICAL ISSUE,109
US,BLOOD ALKALINE PHOSPHATASE INCREASED,108
US,RASH PAPULAR,108
US,SENSORY DISTURBANCE,108
US,TENDERNESS,108
US,MULTIPLE ALLERGIES,107
US,ORAL DISCOMFORT,107
US,PANCREATIC CARCINOMA,107
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,106
US,HEAD DISCOMFORT,106
US,MIDDLE INSOMNIA,106
US,BLADDER DISORDER,105
US,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,105
US,LARYNGITIS,105
US,LIGAMENT SPRAIN,105
US,MENISCUS INJURY,105
US,NERVE COMPRESSION,105
US,NERVE INJURY,105
US,OBESITY,105
US,SKIN HAEMORRHAGE,105
US,MALIGNANT MELANOMA,104
US,SPLENOMEGALY,104
US,METASTASES TO BONE,103
US,METASTASES TO LIVER,103
US,MUSCLE STRAIN,103
US,PETECHIAE,103
US,SCAB,103
US,VITREOUS FLOATERS,103
US,EMOTIONAL DISORDER,102
US,MICTURITION URGENCY,102
US,PAIN OF SKIN,102
US,PULMONARY HAEMORRHAGE,102
US,TENDONITIS,102
US,EYE INFECTION,101
US,LUNG INFILTRATION,101
US,NODULE,101
US,PNEUMOTHORAX,101
US,TOOTH ABSCESS,101
US,WALKING AID USER,101
US,CAROTID ARTERY OCCLUSION,100
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,99
US,CYST,99
US,HYPERCHOLESTEROLAEMIA,99
US,AORTIC STENOSIS,98
US,DRY THROAT,98
US,SYSTEMIC LUPUS ERYTHEMATOSUS,98
US,CARDIAC MURMUR,97
US,CAROTID ARTERY STENOSIS,97
US,COLON CANCER,97
US,INTENTIONAL OVERDOSE,97
US,INJECTION SITE RASH,96
US,PROCEDURAL PAIN,96
US,PULMONARY FIBROSIS,95
US,GINGIVAL PAIN,94
US,IMPAIRED DRIVING ABILITY,94
US,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,94
US,SCAR,94
US,TROPONIN INCREASED,94
US,UPPER-AIRWAY COUGH SYNDROME,94
US,ESSENTIAL HYPERTENSION,93
US,HEPATIC CIRRHOSIS,93
US,SUICIDE ATTEMPT,93
US,ANHEDONIA,92
US,BLADDER CANCER,92
US,DIZZINESS POSTURAL,92
US,JOINT DISLOCATION,92
US,LIVER FUNCTION TEST INCREASED,92
US,POST PROCEDURAL COMPLICATION,92
US,SKIN FISSURES,92
US,DIABETES MELLITUS INADEQUATE CONTROL,91
US,HEPATIC FAILURE,91
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,91
US,PANCREATIC CARCINOMA METASTATIC,91
US,THIRST,91
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,91
US,APHONIA,90
US,HYPOAESTHESIA ORAL,90
US,IMPAIRED WORK ABILITY,90
US,INTERSTITIAL LUNG DISEASE,90
US,PARAESTHESIA ORAL,90
US,TRICUSPID VALVE INCOMPETENCE,90
US,BLOOD GLUCOSE FLUCTUATION,89
US,CORONARY ARTERY STENOSIS,89
US,CYTOPENIA,89
US,TREATMENT FAILURE,89
US,UROSEPSIS,89
US,BLOOD CHOLESTEROL ABNORMAL,88
US,CONCUSSION,88
US,ORAL CANDIDIASIS,88
US,PHOTOSENSITIVITY REACTION,88
US,RENAL CYST,88
US,DERMATITIS,87
US,ELECTROCARDIOGRAM QT PROLONGED,87
US,JOINT RANGE OF MOTION DECREASED,87
US,LOW DENSITY LIPOPROTEIN INCREASED,87
US,ONYCHOCLASIS,87
US,PERICARDIAL HAEMORRHAGE,87
US,SQUAMOUS CELL CARCINOMA,87
US,BLINDNESS UNILATERAL,86
US,CARDIAC OPERATION,86
US,ACCIDENTAL OVERDOSE,85
US,BEDRIDDEN,85
US,BONE DENSITY DECREASED,85
US,FLANK PAIN,85
US,MULTI-ORGAN FAILURE,85
US,MYELODYSPLASTIC SYNDROME,85
US,PRODUCT TASTE ABNORMAL,85
US,WOUND INFECTION,85
US,CATHETERISATION CARDIAC,84
US,DUODENAL ULCER HAEMORRHAGE,84
US,HAND FRACTURE,84
US,NO THERAPEUTIC RESPONSE,84
US,SCOLIOSIS,84
US,SECRETION DISCHARGE,84
US,THROMBOPHLEBITIS SUPERFICIAL,84
US,TOOTH LOSS,84
US,EAR DISCOMFORT,83
US,EXPOSURE DURING PREGNANCY,83
US,NON-CARDIAC CHEST PAIN,83
US,RETROPERITONEAL HAEMORRHAGE,83
US,TENDON RUPTURE,83
US,HUNGER,82
US,HYPERKERATOSIS,82
US,SINUS BRADYCARDIA,82
US,APPLICATION SITE RASH,81
US,BOWEL MOVEMENT IRREGULARITY,81
US,DECUBITUS ULCER,81
US,ELECTROLYTE IMBALANCE,81
US,GASTROENTERITIS,81
US,GROIN PAIN,81
US,HYPOCALCAEMIA,81
US,HYPOMAGNESAEMIA,81
US,RENAL HAEMORRHAGE,81
US,WOUND HAEMORRHAGE,81
US,BACTERAEMIA,80
US,CONTRAINDICATED PRODUCT ADMINISTERED,80
US,DELUSION,80
US,DUODENAL ULCER,80
US,FOOT DEFORMITY,80
US,GASTROINTESTINAL PAIN,80
US,MEDICATION RESIDUE PRESENT,80
US,MUSCLE DISORDER,80
US,POLYP,80
US,ACCIDENTAL EXPOSURE TO PRODUCT,79
US,MUSCLE ATROPHY,79
US,NAIL DISORDER,79
US,BLOOD TEST ABNORMAL,78
US,CATARACT OPERATION,78
US,COLITIS ISCHAEMIC,78
US,ECZEMA,78
US,FRACTURE,78
US,GAIT INABILITY,78
US,MALNUTRITION,78
US,VENTRICULAR FIBRILLATION,78
US,BACTERIAL INFECTION,77
US,CARDIAC VALVE DISEASE,77
US,CENTRAL NERVOUS SYSTEM LESION,77
US,DEPRESSED LEVEL OF CONSCIOUSNESS,77
US,FAILURE TO THRIVE,77
US,SCRATCH,77
US,SINUS TACHYCARDIA,77
US,BLOOD CALCIUM DECREASED,76
US,COORDINATION ABNORMAL,76
US,HICCUPS,76
US,HIP ARTHROPLASTY,76
US,LYMPHOCYTE COUNT DECREASED,76
US,LYMPHOEDEMA,76
US,URINE OUTPUT DECREASED,76
US,ATRIOVENTRICULAR BLOCK,75
US,END STAGE RENAL DISEASE,75
US,GLOMERULAR FILTRATION RATE DECREASED,75
US,HYPOVOLAEMIC SHOCK,75
US,INITIAL INSOMNIA,75
US,INJECTION SITE EXTRAVASATION,75
US,LOWER RESPIRATORY TRACT INFECTION,75
US,PARALYSIS,75
US,BARRETT^S OESOPHAGUS,74
US,CHOLECYSTITIS,74
US,DEVICE OCCLUSION,74
US,EXTRASYSTOLES,74
US,IMMUNE SYSTEM DISORDER,74
US,LYMPHOMA,74
US,MENORRHAGIA,74
US,MOUTH ULCERATION,74
US,MUSCLE SPASTICITY,74
US,SLUGGISHNESS,74
US,BREAST PAIN,73
US,CHOLECYSTECTOMY,73
US,HAEMORRHAGIC DIATHESIS,73
US,RENAL INJURY,73
US,BLOOD BLISTER,72
US,ELECTROCARDIOGRAM ABNORMAL,72
US,SPINAL DISORDER,72
US,TEMPERATURE INTOLERANCE,72
US,WOUND COMPLICATION,72
US,DECREASED INTEREST,71
US,GASTRITIS HAEMORRHAGIC,71
US,GLUCOSE TOLERANCE IMPAIRED,71
US,MUCOSAL INFLAMMATION,71
US,ORAL HERPES,71
US,PARANOIA,71
US,PELVIC PAIN,71
US,PROSTATOMEGALY,71
US,SKIN ABRASION,71
US,CARDIAC FLUTTER,70
US,CARDIAC PACEMAKER INSERTION,70
US,COMPRESSION FRACTURE,70
US,DEVICE USE ERROR,70
US,DISEASE RECURRENCE,70
US,INTRAOCULAR PRESSURE INCREASED,70
US,ORAL DISORDER,70
US,PELVIC FRACTURE,70
US,RIGHT VENTRICULAR FAILURE,70
US,ANEURYSM,69
US,BLOOD PRESSURE SYSTOLIC INCREASED,69
US,BODY TEMPERATURE INCREASED,69
US,JAUNDICE,69
US,RENAL CANCER,69
US,SMALL INTESTINAL HAEMORRHAGE,69
US,ABSCESS,68
US,DEMENTIA ALZHEIMER^S TYPE,68
US,EMBOLIC STROKE,68
US,INJECTION SITE URTICARIA,68
US,OSTEONECROSIS,68
US,POOR QUALITY DRUG ADMINISTERED,68
US,PROTEINURIA,68
US,TRANSAMINASES INCREASED,68
US,HYPOVOLAEMIA,67
US,INJECTION SITE DISCOLOURATION,67
US,JOINT EFFUSION,67
US,MOTOR DYSFUNCTION,67
US,PSYCHOMOTOR HYPERACTIVITY,67
US,SENSORY LOSS,67
US,ASPIRATION,66
US,DISABILITY,66
US,HAEMARTHROSIS,66
US,HAIR DISORDER,66
US,INTRAVENTRICULAR HAEMORRHAGE,66
US,LACTIC ACIDOSIS,66
US,LUMBAR SPINAL STENOSIS,66
US,NASAL DISCOMFORT,66
US,NASAL DRYNESS,66
US,PHOTOPHOBIA,66
US,PSYCHOLOGICAL TRAUMA,66
US,RETINAL HAEMORRHAGE,66
US,SPINAL PAIN,66
US,URINE ODOUR ABNORMAL,66
US,ANGIOPATHY,65
US,ARTHROPOD BITE,65
US,EYE DISCHARGE,65
US,GENERALISED OEDEMA,65
US,HAEMORRHAGIC TRANSFORMATION STROKE,65
US,IMPAIRED GASTRIC EMPTYING,65
US,ISCHAEMIA,65
US,LEFT VENTRICULAR HYPERTROPHY,65
US,MADAROSIS,65
US,SUBDURAL HAEMORRHAGE,65
US,THERAPY NON-RESPONDER,65
US,TUBULOINTERSTITIAL NEPHRITIS,65
US,FACIAL BONES FRACTURE,64
US,FURUNCLE,64
US,HUMERUS FRACTURE,64
US,LEFT VENTRICULAR DYSFUNCTION,64
US,NICOTINE DEPENDENCE,64
US,ATAXIA,63
US,BRAIN INJURY,63
US,DERMATITIS CONTACT,63
US,DEVICE DISLOCATION,63
US,HEMIPLEGIA,63
US,LIBIDO DECREASED,63
US,PHOTOPSIA,63
US,VISUAL FIELD DEFECT,63
US,BIPOLAR DISORDER,62
US,BONE LOSS,62
US,DRUG EFFECT DELAYED,62
US,HAIR GROWTH ABNORMAL,62
US,INTERVERTEBRAL DISC DISORDER,62
US,ORAL MUCOSAL BLISTERING,62
US,BENIGN PROSTATIC HYPERPLASIA,61
US,BONE MARROW FAILURE,61
US,DEFORMITY,61
US,EYELID OEDEMA,61
US,PERONEAL NERVE PALSY,61
US,SKIN ATROPHY,61
US,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,61
US,TOOTH EXTRACTION,61
US,ACUTE RESPIRATORY DISTRESS SYNDROME,60
US,BONE LESION,60
US,CARDIAC FAILURE ACUTE,60
US,GENERALISED TONIC-CLONIC SEIZURE,60
US,HAEMOTHORAX,60
US,IMMUNODEFICIENCY,60
US,PRODUCT PACKAGING ISSUE,60
US,RASH MACULO-PAPULAR,60
US,RENAL PAIN,60
US,FACIAL PAIN,59
US,LIVER INJURY,59
US,PAROSMIA,59
US,PHARYNGITIS,59
US,PLASMACYTOMA,59
US,SKIN MASS,59
US,TRIGGER FINGER,59
US,CARDIAC TAMPONADE,58
US,EYELID PTOSIS,58
US,FACIAL PARALYSIS,58
US,GASTROINTESTINAL INFECTION,58
US,HALLUCINATION_ VISUAL,58
US,INCREASED UPPER AIRWAY SECRETION,58
US,INTENTIONAL UNDERDOSE,58
US,NEOPLASM,58
US,PATHOLOGICAL FRACTURE,58
US,PEPTIC ULCER,58
US,SHOCK,58
US,SPINAL OPERATION,58
US,SPUTUM DISCOLOURED,58
US,BLOOD PRESSURE INADEQUATELY CONTROLLED,57
US,FAECAL INCONTINENCE,57
US,INJECTION SITE WARMTH,57
US,RESPIRATORY ARREST,57
US,RETINAL DETACHMENT,57
US,RHINITIS ALLERGIC,57
US,SKIN INFECTION,57
US,TONGUE DISORDER,57
US,CALCIUM DEFICIENCY,56
US,HEART VALVE INCOMPETENCE,56
US,HYPERAESTHESIA,56
US,MUSCLE HAEMORRHAGE,56
US,RETROPERITONEAL HAEMATOMA,56
US,APHAGIA,55
US,APPETITE DISORDER,55
US,BUNDLE BRANCH BLOCK RIGHT,55
US,DECREASED ACTIVITY,55
US,DIVERTICULUM INTESTINAL,55
US,INTRACRANIAL ANEURYSM,55
US,LARGE INTESTINAL HAEMORRHAGE,55
US,POST PROCEDURAL HAEMATOMA,55
US,POSTOPERATIVE WOUND INFECTION,55
US,PULMONARY ALVEOLAR HAEMORRHAGE,55
US,SINUS HEADACHE,55
US,ABDOMINAL TENDERNESS,54
US,ABDOMINAL WALL HAEMATOMA,54
US,ABNORMAL FAECES,54
US,AORTIC VALVE INCOMPETENCE,54
US,ATRIOVENTRICULAR BLOCK COMPLETE,54
US,DYSGRAPHIA,54
US,FEELING DRUNK,54
US,HYPERTHYROIDISM,54
US,METASTASES TO LUNG,54
US,PLASMA CELL MYELOMA RECURRENT,54
US,PSYCHOTIC DISORDER,54
US,SEDATION,54
US,CLAVICLE FRACTURE,53
US,CONJUNCTIVITIS,53
US,DEVICE FAILURE,53
US,INCOHERENT,53
US,INJURY ASSOCIATED WITH DEVICE,53
US,IRON DEFICIENCY,53
US,OESOPHAGEAL DISORDER,53
US,APPARENT DEATH,52
US,COMPLETED SUICIDE,52
US,DYSLIPIDAEMIA,52
US,GASTROINTESTINAL ANGIODYSPLASIA HAEMORRHAGIC,52
US,MALABSORPTION,52
US,ONYCHOMYCOSIS,52
US,PERITONITIS,52
US,PHYSICAL DISABILITY,52
US,PLEURISY,52
US,POST PROCEDURAL INFECTION,52
US,ABDOMINAL HERNIA,51
US,HAEMORRHAGE URINARY TRACT,51
US,HEPATITIS,51
US,LACTOSE INTOLERANCE,51
US,MULTIPLE ORGAN DYSFUNCTION SYNDROME,51
US,PHARYNGITIS STREPTOCOCCAL,51
US,POLYURIA,51
US,RENAL CELL CARCINOMA,51
US,ACCIDENT,50
US,ACUTE MYELOID LEUKAEMIA,50
US,APATHY,50
US,BLOOD THYROID STIMULATING HORMONE INCREASED,50
US,DIALYSIS,50
US,FOREIGN BODY,50
US,HYSTERECTOMY,50
US,INTESTINAL ISCHAEMIA,50
US,SUDDEN CARDIAC DEATH,50
US,SUNBURN,50
US,WRONG DRUG ADMINISTERED,50
US,DIASTOLIC DYSFUNCTION,49
US,DRUG DEPENDENCE,49
US,ILEUS,49
US,MATERNAL EXPOSURE DURING PREGNANCY,49
US,SYNOVIAL CYST,49
US,WHITE BLOOD CELL COUNT ABNORMAL,49
US,WOUND SECRETION,49
US,BLOOD DISORDER,48
US,DERMATITIS ALLERGIC,48
US,EXERCISE TOLERANCE DECREASED,48
US,FAECES SOFT,48
US,FORMICATION,48
US,HAEMOGLOBIN ABNORMAL,48
US,HEPATOMEGALY,48
US,HYDRONEPHROSIS,48
UY,DEEP VEIN THROMBOSIS,1
UY,ISCHAEMIC STROKE,1
VE,ASTHENIA,7
VE,MALAISE,7
VE,SPEECH DISORDER,5
VE,FATIGUE,4
VE,GAIT DISTURBANCE,4
VE,DEATH,3
VE,GENERAL PHYSICAL HEALTH DETERIORATION,3
VE,HYPERTENSION,3
VE,PARKINSON^S DISEASE,3
VE,PNEUMONIA,3
VE,PYREXIA,3
VE,VOMITING,3
VE,ABASIA,2
VE,ABDOMINAL DISTENSION,2
VE,ABDOMINAL PAIN UPPER,2
VE,ASTHMA,2
VE,BRADYCARDIA,2
VE,CHEST PAIN,2
VE,CHOKING,2
VE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
VE,CRYING,2
VE,DISEASE PROGRESSION,2
VE,DRUG INEFFECTIVE,2
VE,DYSPNOEA,2
VE,EATING DISORDER,2
VE,FEELING ABNORMAL,2
VE,HAEMORRHAGIC STROKE,2
VE,HEADACHE,2
VE,LUNG DISORDER,2
VE,MENTAL DISORDER,2
VE,MOVEMENT DISORDER,2
VE,MUSCLE SPASMS,2
VE,MUSCULOSKELETAL STIFFNESS,2
VE,MYOCARDIAL INFARCTION,2
VE,NAUSEA,2
VE,NEOPLASM,2
VE,PAIN,2
VE,PRODUCT USE ISSUE,2
VE,RESPIRATORY DISORDER,2
VE,SEIZURE,2
VE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
VE,ABDOMINAL PAIN,1
VE,ABORTION SPONTANEOUS,1
VE,ACQUIRED MACROGLOSSIA,1
VE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
VE,ACUTE PULMONARY OEDEMA,1
VE,AGGRESSION,1
VE,ANGINA PECTORIS,1
VE,APPARENT DEATH,1
VE,ARTERIAL DISORDER,1
VE,ARTERIAL OCCLUSIVE DISEASE,1
VE,ASPHYXIA,1
VE,BIFASCICULAR BLOCK,1
VE,BLOOD POTASSIUM DECREASED,1
VE,BLOOD PRESSURE ABNORMAL,1
VE,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
VE,BRAIN HYPOXIA,1
VE,BREAST CANCER,1
VE,BREAST CANCER METASTATIC,1
VE,BREAST HAEMORRHAGE,1
VE,BREAST INJURY,1
VE,BRONCHIAL SECRETION RETENTION,1
VE,CARDIAC DISORDER,1
VE,CARDIAC FAILURE,1
VE,CARDIAC FAILURE CONGESTIVE,1
VE,CARDIAC MURMUR,1
VE,CARDIO-RESPIRATORY ARREST,1
VE,CARDIOGENIC SHOCK,1
VE,CARDIOVASCULAR DISORDER,1
VE,CATHETERISATION CARDIAC,1
VE,CEREBRAL ARTERIOSCLEROSIS,1
VE,CEREBRAL INFARCTION,1
VE,CEREBRAL ISCHAEMIA,1
VE,CEREBROVASCULAR ACCIDENT,1
VE,CHEST DISCOMFORT,1
VE,CHIKUNGUNYA VIRUS INFECTION,1
VE,CHILLS,1
VE,CONJUNCTIVAL DEPOSIT,1
VE,CORONARY ARTERY OCCLUSION,1
VE,COUGH,1
VE,DECREASED ACTIVITY,1
VE,DECREASED APPETITE,1
VE,DEPRESSED MOOD,1
VE,DIARRHOEA,1
VE,DISEASE RECURRENCE,1
VE,DIZZINESS,1
VE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
VE,DRY SKIN,1
VE,DYSPNOEA AT REST,1
VE,DYSPNOEA EXERTIONAL,1
VE,DYSPNOEA PAROXYSMAL NOCTURNAL,1
VE,DYSSTASIA,1
VE,DYSURIA,1
VE,EAR DISCOMFORT,1
VE,EMPHYSEMA,1
VE,ERYTHEMA,1
VE,EXERCISE TOLERANCE DECREASED,1
VE,EXPIRED PRODUCT ADMINISTERED,1
VE,EXPOSURE DURING PREGNANCY,1
VE,EYE INFECTION,1
VE,EYE MOVEMENT DISORDER,1
VE,FALL,1
VE,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
VE,FOETAL EXPOSURE DURING PREGNANCY,1
VE,GASTROINTESTINAL HAEMORRHAGE,1
VE,GENERALISED OEDEMA,1
VE,GENERALISED TONIC-CLONIC SEIZURE,1
VE,GLAUCOMA,1
VE,GRAFT LOSS,1
VE,HAEMOGLOBIN DECREASED,1
VE,HALLUCINATION,1
VE,HEART RATE DECREASED,1
VE,HEMIPLEGIA,1
VE,HIP FRACTURE,1
VE,HYPERGLYCAEMIA,1
VE,HYPERLIPIDAEMIA,1
VE,HYPERSENSITIVITY,1
VE,HYPERTENSIVE CRISIS,1
VE,HYPERTENSIVE HEART DISEASE,1
VE,HYPOAESTHESIA,1
VE,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
VE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
VE,INCORRECT DOSAGE ADMINISTERED,1
VE,INCORRECT DOSE ADMINISTERED,1
VE,INFECTION,1
VE,INFLAMMATION,1
VE,INFLUENZA,1
VE,INSOMNIA,1
VE,INTRACRANIAL ANEURYSM,1
VE,IRRITABLE BOWEL SYNDROME,1
VE,ISCHAEMIC STROKE,1
VE,LIMB DISCOMFORT,1
VE,LOW BIRTH WEIGHT BABY,1
VE,MALIGNANT MELANOMA,1
VE,MALIGNANT NEOPLASM PROGRESSION,1
VE,MATERNAL EXPOSURE DURING PREGNANCY,1
VE,MEMORY IMPAIRMENT,1
VE,MENISCAL DEGENERATION,1
VE,METASTASES TO LUNG,1
VE,MITRAL VALVE STENOSIS,1
VE,MOBILITY DECREASED,1
VE,MUCOSAL INFLAMMATION,1
VE,MUSCLE FATIGUE,1
VE,MUSCULAR WEAKNESS,1
VE,MYOCARDIAL ISCHAEMIA,1
VE,NEPHROTIC SYNDROME,1
VE,NERVOUSNESS,1
VE,ORAL DISCOMFORT,1
VE,PALLOR,1
VE,PARAESTHESIA,1
VE,PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA,1
VE,PERFORATED ULCER,1
VE,PLEURAL EFFUSION,1
VE,POLYMYALGIA RHEUMATICA,1
VE,PREMATURE BABY,1
VE,PREMATURE DELIVERY,1
VE,PRODUCT SUPPLY ISSUE,1
VE,PRODUCTIVE COUGH,1
VE,PROSTATE CANCER,1
VE,PROTEIN-LOSING GASTROENTEROPATHY,1
VE,PRURITUS,1
VE,PULMONARY CALCIFICATION,1
VE,PULMONARY HAEMORRHAGE,1
VE,PULMONARY OEDEMA,1
VE,RASH,1
VE,RASH GENERALISED,1
VE,RASH PAPULAR,1
VE,RESPIRATORY ARREST,1
VE,RESPIRATORY TRACT ULCERATION,1
VE,RETINAL DETACHMENT,1
VE,SCREAMING,1
VE,SKIN DISCOLOURATION,1
VE,SLEEP DISORDER,1
VE,SLOW SPEECH,1
VE,SPINAL DISORDER,1
VE,STAPHYLOCOCCAL INFECTION,1
VE,SYNCOPE,1
VE,THROMBOSIS,1
VE,TOOTHACHE,1
VE,TOTAL LUNG CAPACITY DECREASED,1
VE,TREMOR,1
VE,TYPE 2 DIABETES MELLITUS,1
VE,ULCER,1
VE,UNRESPONSIVE TO STIMULI,1
VE,URINARY TRACT INFECTION,1
VE,URINE OUTPUT INCREASED,1
VE,VIRAL INFECTION,1
VE,WEIGHT DECREASED,1
VE,WHEEZING,1
VN,FATIGUE,2
VN,VASCULAR STENT THROMBOSIS,2
VN,ABSCESS LIMB,1
VN,ACNE,1
VN,ACUTE CORONARY SYNDROME,1
VN,ANAEMIA,1
VN,ANGINA UNSTABLE,1
VN,APHASIA,1
VN,BLOOD PRESSURE INCREASED,1
VN,CARDIAC FAILURE,1
VN,CEREBRAL HAEMORRHAGE,1
VN,CIRCULATORY COLLAPSE,1
VN,COAGULOPATHY,1
VN,CORONARY ARTERY STENOSIS,1
VN,DEATH,1
VN,DECREASED APPETITE,1
VN,DIPLEGIA,1
VN,DIZZINESS,1
VN,DRUG DOSE OMISSION,1
VN,DYSPNOEA,1
VN,FISTULA OF SMALL INTESTINE,1
VN,GASTROINTESTINAL HAEMORRHAGE,1
VN,HAEMORRHAGE,1
VN,HAEMORRHAGE INTRACRANIAL,1
VN,HEADACHE,1
VN,HYPERTENSION,1
VN,INFECTION,1
VN,INTRAVENTRICULAR HAEMORRHAGE,1
VN,NAUSEA,1
VN,NORMOCHROMIC ANAEMIA,1
VN,PANCREATITIS,1
VN,PARONYCHIA,1
VN,PHARYNGEAL HAEMORRHAGE,1
VN,POSTOPERATIVE WOUND INFECTION,1
VN,PRURITUS,1
VN,QUADRIPLEGIA,1
VN,SKIN FISSURES,1
VN,TACHYCARDIA,1
VN,VESTIBULAR DISORDER,1
VI,COUGH,1
VI,DRUG EFFECT DECREASED,1
VI,HAEMATEMESIS,1
YE,HALLUCINATION_ VISUAL,1
